<SEC-DOCUMENT>0001217234-24-000042.txt : 20240429
<SEC-HEADER>0001217234-24-000042.hdr.sgml : 20240429
<ACCEPTANCE-DATETIME>20240429161902
ACCESSION NUMBER:		0001217234-24-000042
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		36
CONFORMED PERIOD OF REPORT:	20240613
FILED AS OF DATE:		20240429
DATE AS OF CHANGE:		20240429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CareDx, Inc.
		CENTRAL INDEX KEY:			0001217234
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				943316839
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36536
		FILM NUMBER:		24891125

	BUSINESS ADDRESS:	
		STREET 1:		8000 MARINA BLVD
		STREET 2:		4TH FLOOR
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		415-287-2300

	MAIL ADDRESS:	
		STREET 1:		8000 MARINA BLVD
		STREET 2:		4TH FLOOR
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XDx, Inc.
		DATE OF NAME CHANGE:	20071010

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXPRESSION DIAGNOSTICS INC
		DATE OF NAME CHANGE:	20030203
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>cdna-20240429.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:e535fb6e-fa63-4a06-988b-b27d43a4689d,g:0fcc6b31-711c-45cb-b6dc-ed4481561477,d:60d05261c6404879b68233510f10856b-->
<html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:cdna="http://caredxinc.com/20240429" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cdna-20240429</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-2">0001217234</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-3">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-4">DEF 14A</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cdna-20240429.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrMaagMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cdna:TotalEquityCompensationActuallyPaidAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cdna:TotalEquityCompensationActuallyPaidAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cdna:TotalEquityCompensationActuallyPaidAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i60d05261c6404879b68233510f10856b_1"></div><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:24pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%">SCHEDULE&#160;14A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Proxy Statement&#160;Pursuant to Section&#160;14(a) of the</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Securities Exchange Act of&#160;1934</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by the Registrant  Filed by a Party other than the Registrant </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.242%"><tr><td style="width:1.0%"/><td style="width:3.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.238%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary Proxy Statement</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Confidential, for Use of the Commission Only (as permitted by Rule&#160;14a-6(e)(2))</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Proxy Statement</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Additional Materials</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting Material under &#167;240.14a-12</span></td></tr></table></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-1">CareDx, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Name of Registrant as Specified In Its Charter)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of Filing Fee (Check all boxes that apply):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.242%"><tr><td style="width:1.0%"/><td style="width:3.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.238%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No fee required.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee paid previously with preliminary materials.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee computed on table in exhibit required by Item&#160;25(b) per Exchange Act Rules&#160;14a-6(i)(1) and&#160;0-11.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i60d05261c6404879b68233510f10856b_4"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAREDX, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8000 Marina Boulevard, 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Floor</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Brisbane, CA&#160;94005</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To Be Held at&#160;10:00 a.m. Pacific Time on Thursday, June 13, 2024</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Stockholder:</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are cordially invited to attend the&#160;2024 annual meeting of stockholders (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Meeting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of CareDx, Inc., a Delaware corporation (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CareD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x,&#8221; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">we</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">us</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, or the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  The Annual Meeting will be held on Thursday, June 13, 2024 at&#160;10:00 a.m. Pacific Time, virtually via live webcast at http://www.virtualshareholdermeeting.com/CDNA2024, for the following purposes, as more fully described in the accompanying proxy statement:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To elect three Class I directors to serve until the&#160;2027 annual meeting of stockholders or until their successors are duly elected and qualified;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To ratify the appointment of Deloitte &amp; Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To approve, on an advisory basis, the compensation of our named executive officers;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To approve our 2024 Equity Incentive Plan; and</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To conduct any other business properly brought before the Annual Meeting and any adjournments or postponements thereof.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has fixed the close of business on April 18, 2024 as the record date for the Annual Meeting.  Only stockholders of record on April 18, 2024 are entitled to notice of and to vote at the Annual Meeting.  Further information regarding voting rights and the matters to be voted upon are more fully described in the accompanying proxy statement.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or about April 29, 2024 we expect to mail our stockholders a Notice of Internet Availability of Proxy Materials (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) containing instructions on how to access our proxy statement and our annual report.  The Notice provides instructions on how to vote via the Internet or by telephone and includes instructions on how to receive a paper copy of our proxy materials by mail.  The accompanying proxy statement and our annual report can be accessed directly at http://investors.caredxinc.com/financial-information/annual-reports.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">YOUR VOTE IS IMPORTANT.  Whether or not you plan to attend the Annual Meeting, we urge you to submit your vote via the Internet, telephone or mail as soon as possible so that your shares can be voted at the Annual Meeting in accordance with your instructions.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thank you for your continued support of CareDx.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By order of the Board of Directors,</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ Michael D. Goldberg</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chairperson of the Board of Directors</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brisbane, California</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 29, 2024</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i60d05261c6404879b68233510f10856b_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">TABLE OF CONTENTS</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:94.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_13">QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_13">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_16">PROPOSAL NO. 1 ELECTION OF DIRECTORS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_16">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_19">Nominees</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_19">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_22">Vote Required; Board Recommendation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_22">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_25">BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_25">10</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_28">Directors with Terms Expiring at the Annual Meeting-Nominees for Director</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_28">11</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_31">Continuing Directors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_31">14</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_34">Considerations in Evaluating Director Nominees</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_34">21</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_37">Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_37">21</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_40">Board Leadership Structure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_40">21</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_43">Office of Chief Executive Officer</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_43">22</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_46">Board Diversity of Skills and Expertise</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_46">22</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_49">Legal Proceedings with Directors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_49">23</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_52">Agreements with Directors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_52">23</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_55">Board and Committee Meetings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_55">23</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_58">Compensation Committee Interlocks and Insider Participation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_58">26</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_61">Stockholder Feedback and Engagement</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_61">28</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_64">Board Diversity Matrix</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_64">29</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_67">Stockholder Recommendations for Nominations to the Board of Directors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_67">29</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_70">Communications with the Board of Directors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_70">30</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_73">Corporate Governance Guidelines and Code of Business Conduct and Ethics</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_73">30</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_76">Clawback Policy</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_76">30</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_79">Non-Employee Director Stock Ownership Policy</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_79">30</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_82">Executive Officer Stock Ownership Policy</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_82">31</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_88">Board of Directors&#8217; Role in Risk Oversight</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_88">31</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_91">Director Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_91">32</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_94">PROPOSAL NO. 2 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_94">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_97">Fees Paid to the Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_97">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_100">Auditor Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_100">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_103">Audit and Finance Committee Policy on Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_103">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_106">Vote Required; Board Recommendation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_115">38</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_109">AUDIT AND FINANCE COMMITTEE REPORT</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_109">37</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_112">PROPOSAL NO. 3 ADVISORY VOTE ON EXECUTIVE COMPENSATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_112">38</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_115">Vote Required; Board Recommendation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_115">38</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_118">PROPOSAL NO. 4 APPROVAL OF 2024 EQUITY INCENTIVE PLAN</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_118">39</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_121">Shares Reserved Under the 2024 Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_121">39</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_124">Important Considerations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_124">39</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_127">Key Features and Governance Practices</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_127">40</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:94.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_130">Information on Equity Compensation Plans as of March 31, 2024</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_130">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_133">Dilution</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_133">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_136">Historical Burn Rate</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_136">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_139">Summary of the 2024 Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_139">42</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_142">Form S-8 Registration Statement</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_142">48</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_145">New Plan Benefits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_145">48</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_148">Federal Income Tax Consequences</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_148">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_115">Vote Required; Board Recommendation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_151">51</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_154">EXECUTIVE OFFICERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_154">52</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_157">Legal Proceedings with Executive Officers</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_157">52</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_160">EXECUTIVE COMPENSATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_160">53</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_163">Compensation Discussion and Analysis</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_163">53</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_166">I. Executive Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_166">53</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_169">II. Compensation Philosophy</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_169">55</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_172">III. Compensation Determination Process</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_172">56</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_175">IV. Pay Components</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_175">58</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_178">Compensation Committee Report</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_178">64</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_181">Summary Compensation Table</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_181">64</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_184">Grants of Plan-Based Awards</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_184">65</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_187">Outstanding Equity Awards at Fiscal Year-End</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_187">66</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_190">Option Exercises and Stock Vested</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_190">71</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_193">Pension Benefits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_193">71</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_199">Pay Ratio Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_199">73</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_202">Pay Versus Performance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_202">74</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt 0 19pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_205">Equity Compensation Plan Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_205">79</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_208">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_208">80</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_211">RELATED PARTY TRANSACTIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_211">83</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_214">Indemnification Agreements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_214">83</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_217">Rule 10b5-1 Sales Plans</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_217">83</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_220">Policies and Procedures for Related Party Transactions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_220">83</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_223">OTHER MATTERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_223">84</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_226">Delinquent Section 16(a) Reports</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_226">84</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_229">Available Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_229">84</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_232">Note About Forward-Looking Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_232">84</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_235">Householding</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_235">84</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_238">Company Website</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_238">85</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_241">APPENDIX A &#8211; 2024 Equity Incentive Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_241">A</a>-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i60d05261c6404879b68233510f10856b_241">1</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i60d05261c6404879b68233510f10856b_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAREDX, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROXY STATEMENT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR&#160;2024 ANNUAL MEETING OF STOCKHOLDERS</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To Be Held at&#160;10:00 a.m. Pacific Time on Thursday, June 13, 2024</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sent you this proxy statement and the enclosed proxy card because the Board of Directors (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board of Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of CareDx, Inc. (sometimes referred to as &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">we</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CareDx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is soliciting your proxy to vote at the Company&#8217;s&#160;2024 annual meeting of stockholders (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Meeting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and any postponements, adjournments or continuations thereof.  The Annual Meeting will be held on Thursday, June 13, 2024 at&#160;10:00 a.m. Pacific Time, virtually via live webcast at http://www.virtualshareholdermeeting.com/CDNA2024.  You are invited to attend the Annual Meeting and we request that you vote on the proposals described in this proxy statement.  However, you do not need to attend the Annual Meeting to vote your shares.  Instead, you may complete, sign and return the enclosed proxy card or submit your proxy through the Internet or by telephone according to the instructions contained in the enclosed proxy card.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notice of Internet Availability of Proxy Materials (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) containing instructions on how to access this proxy statement and our annual report is first being mailed on or about April 29, 2024 to all stockholders entitled to receive notice of and to vote at the Annual Meeting.</span></div><div id="i60d05261c6404879b68233510f10856b_13"></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information provided in the &#8220;question and answer&#8221; format below addresses certain frequently asked questions but is not intended to be a summary of all matters contained in this proxy statement.  Please read the entire proxy statement carefully before voting your shares.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What matters am I voting on?</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You will be voting on:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the election of three Class I directors to hold office until the&#160;2027 annual meeting of stockholders or until their successors are duly elected and qualified;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a proposal to ratify the appointment of Deloitte &amp; Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a proposal to approve, on an advisory basis, the compensation of our named executive officers;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a proposal to approve our 2024 Equity Incentive Plan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2024 Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;); and</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any other business properly brought before the Annual Meeting or any adjournments or postponements thereof.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How does our Board of Directors recommend that I vote?</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors recommends that you vote:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR the election of each of the three directors nominated by our Board of Directors and named in this proxy statement as Class&#160;I directors to serve for a three-year term;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR the ratification of the appointment of Deloitte &amp; Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR the approval of the compensation paid to our named executive officers as disclosed in this proxy statement; and</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR the approval of our 2024 Plan.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Will there be any other items of business on the agenda?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any other items of business or other matters are properly brought before the Annual Meeting, your proxy gives discretionary authority to the persons named on the proxy card concerning those items of business or other matters.  The </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">persons named on the proxy card intend to vote the proxy in accordance with their best judgment.  Our Board of Directors does not intend to bring any other matters to be voted on at the Annual Meeting, and we are not currently aware of any matters that may be properly presented by others for consideration at the Annual Meeting.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Who is entitled to vote at the Annual Meeting?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of our common stock at the close of business on April 18, 2024, the record date for the Annual Meeting (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Record Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), are entitled to notice of and to vote at the Annual Meeting.  Each stockholder is entitled to one vote for each share of our common stock held as of the Record Date.  Stockholders are not permitted to cumulate votes with respect to the election of directors.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the Record Date, there were&#160;52,008,077 shares of common stock outstanding and entitled to vote.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What is the difference between holding shares as a stockholder of record and as a beneficial owner?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder of Record: Shares Registered in Your Name</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If, at the close of business on the Record Date, your shares were registered directly in your name with Computershare Trust Company, N.A., our transfer agent, then you are the stockholder of record for such shares.  As the stockholder of record, you may vote either electronically at the Annual Meeting or by proxy.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Beneficial Owners: Shares Registered in the Name of a Broker, Bank or Other Nominee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If, at the close of business on the Record Date, your shares were held, not in your name, but rather in a stock brokerage account or by a bank or other nominee on your behalf, then you are considered the beneficial owner of shares held in &#8220;street name.&#8221; As the beneficial owner, you have the right to direct your broker, bank or other nominee how to vote your shares by following the voting instructions your broker, bank or other nominee provides.  If you do not provide your broker, bank or other nominee with instructions on how to vote your shares, your broker, bank or other nominee may, in its discretion, vote your shares with respect to routine matters but may not vote your shares with respect to any non-routine matters.  Please see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">What if I do not specify how my shares are to be voted?</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for additional information.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Do I have to do anything in advance if I plan to attend the Annual Meeting?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Annual Meeting will be a virtual audio meeting of stockholders, which will be conducted via live audio webcast.  You are entitled to participate in the Annual Meeting only if you were a holder of our common stock as of the close of business on the Record Date or if you hold a valid proxy for the Annual Meeting.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To participate in the Annual Meeting, you will need the control number included on your proxy card or the Notice.  The live audio webcast will begin promptly at&#160;10:00 a.m. Pacific Time.  We encourage you to access the meeting prior to the start time.  Online check-in will begin at&#160;9:45 a.m. Pacific Time and you should allow ample time for the check-in procedures.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How can I get help if I have trouble checking in or listening to the meeting online?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you encounter any difficulties accessing the virtual meeting during the check-in or meeting time, please call the technical support number that will be posted on the log-in page at http://www.virtualshareholdermeeting.com/CDNA2024.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How do I vote and what are the voting deadlines?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder of Record: Shares Registered in Your Name</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If you are a stockholder of record, you can vote in one of the following ways:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">You may vote via the Internet or by telephone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To vote via the Internet or by telephone, follow the instructions provided in the Notice.  If you vote via the Internet or by telephone, you do not need to return a proxy card by mail.  Internet and telephone voting are available&#160;24 hours a day.  Votes submitted through the Internet or by telephone must be received by&#160;11:59 p.m. Eastern Time on June 12, 2024 at&#160;1-800-690-6903, or the Internet at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.proxyvote.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">You may vote by mail</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If you have received printed proxy materials by mail and would like to vote by mail, you need to complete, date and sign the proxy card that accompanies this proxy statement and promptly mail it to the tabulation agent in the enclosed postage-paid envelope so that it is received no later than June 12, 2024.  You do not </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">need to put a stamp on the enclosed envelope if you mail it from within the United States.  The persons named in the proxy card will vote the shares you own in accordance with your instructions on the proxy card you mail.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">You may vote electronically at the Annual Meeting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If you plan to attend the Annual Meeting, please log into http://www.virtualshareholdermeeting.com/CDNA2024 as a &#8220;Stockholder&#8221; using the control number available on your proxy card or the Notice, and vote during the Annual Meeting following the instructions at http://www.virtualshareholdermeeting.com/CDNA2024.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Note</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: If you vote via the Internet, return a proxy card by mail or vote electronically at the Annual Meeting, but do not give any instructions on a particular matter to be voted on at the Annual Meeting, Michael D. Goldberg, Alex Johnson and Abhishek Jain, the persons who have been designated as proxy holders by our Board of Directors, will vote the shares you own in accordance with the recommendations of our Board of Directors.  Our Board of Directors recommends that you vote FOR the election of each of the three directors nominated by our Board of Directors and named in this proxy statement as Class&#160;I directors to serve for a three-year term (Proposal No. 1), FOR the ratification of the appointment of Deloitte &amp; Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024 (Proposal No. 2), FOR the approval of the compensation paid to our named executive officers as disclosed in this proxy statement&#160;(Proposal No. 3), and FOR the approval of our 2024 Equity Incentive Plan (Proposal No. 4).</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Beneficial Owners: Shares Registered in the Name of a Broker, Bank or Other Nominee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If you are the beneficial owner of shares held of record by a broker, bank or other nominee, you will receive voting instructions from your broker, bank or other nominee.  You must follow the voting instructions provided by your broker, bank or other nominee in order to instruct your broker, bank or other nominee how to vote your shares.  The availability of Internet and telephone voting options will depend on the voting process of your broker, bank or other nominee.  As discussed above, if you are a beneficial owner, you may not vote your shares electronically at the Annual Meeting unless you obtain a legal proxy from your broker, bank or other nominee.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Can I change my vote or revoke my proxy?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder of Record: Shares Registered in Your Name</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If you are a stockholder of record, you may revoke your proxy or change your proxy instructions at any time before your proxy is voted at the Annual Meeting by:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">entering a new vote by Internet or telephone;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">signing and returning a new proxy card with a later date;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delivering a written notice of revocation to our Corporate Secretary prior to the Annual Meeting; or</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attending the Annual Meeting and voting electronically.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Beneficial Owners: Shares Registered in the Name of a Broker, Bank or Other Nominee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If you are the beneficial owner of your shares, you must contact the broker, bank or other nominee holding your shares and follow their instructions to change your vote or revoke your proxy.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What is the effect of giving a proxy?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proxies are solicited by and on behalf of our Board of Directors.  Michael D. Goldberg, Alex Johnson and Abhishek Jain have been designated as proxy holders by our Board of Directors.  When a proxy is properly dated, executed and returned, the shares represented by the proxy will be voted at the Annual Meeting in accordance with the instructions of the stockholder.  If no specific instructions are given, however, the shares will be voted in accordance with the recommendations of our Board of Directors.  If any matters not described in this proxy statement are properly presented at the Annual Meeting, the proxy holders will use their own judgment to determine how to vote your shares.  If the Annual Meeting is postponed or adjourned, the proxy holders can vote your shares on the new meeting date, unless you have properly revoked your proxy, as described above.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What if I do not specify how my shares are to be voted?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder of Record: Shares Registered in Your Name</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If you are a stockholder of record and you submit a proxy but you do not provide voting instructions, your shares will be voted:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR the election of each of the three directors nominated by our Board of Directors and named in this proxy statement as Class&#160;I directors to serve for a three-year term (Proposal No. 1);</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR the ratification of the appointment of Deloitte &amp; Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024 (Proposal No. 2);</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR the approval of the compensation paid to our named executive officers as disclosed in this proxy statement&#160;(Proposal No. 3); </span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR the approval of our 2024 Equity Incentive Plan (Proposal No. 4); and</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the discretion of the named proxy holders regarding any other matters properly presented for a vote at the Annual Meeting.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Beneficial Owners: Shares Registered in the Name of a Broker, Bank or Other Nominee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If you are a beneficial owner and you do not provide your broker, bank or other nominee that holds your shares with voting instructions, then your broker, bank or other nominee will determine if it has discretion to vote on each matter.  Brokers do not have discretion to vote on non-routine matters.  Proposal No. 1 (election of directors), Proposal No. 3 (approval of the compensation of our named executive officers), and Proposal No. 4 (approval of our 2024 Equity Incentive Plan) are non-routine matters, while Proposal No. 2 (ratification of appointment of independent registered public accounting firm) is a routine matter.  As a result, if you do not provide voting instructions to your broker, bank or other nominee, then your broker, bank or other nominee may not vote your shares with respect to Proposal No. 1, Proposal No. 3, or Proposal No. 4, which would result in a &#8220;broker non-vote,&#8221; but may, in its discretion, vote your shares with respect to Proposal No. 2.  For additional information regarding broker non-votes, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">What are the effects of abstentions and broker non-votes?</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What is a quorum?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A quorum is the minimum number of shares required to be present at the Annual Meeting for the meeting to be properly held under our amended and restated bylaws (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Bylaws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and Delaware law.  A majority of the shares of common stock outstanding and entitled to vote, at the Annual Meeting or by proxy, constitutes a quorum for the transaction of business at the Annual Meeting.  As noted above, as of the Record Date, there were a total of&#160;52,008,077 shares of common stock outstanding, which means that 26,004,040 shares of common stock must be represented virtually or by proxy at the Annual Meeting to have a quorum.  If there is no quorum, either the chairperson of the meeting or a majority of the shares present at the Annual Meeting may adjourn the meeting to a later date.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What are the effects of abstentions and broker non-votes?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An abstention represents a stockholder&#8217;s affirmative choice to decline to vote on a proposal.  If a stockholder indicates on its proxy card that such stockholder wishes to abstain from voting such stockholder&#8217;s shares, or if a broker, bank or other nominee holding its customers&#8217; shares of record causes abstentions to be recorded for shares, these shares will be considered present and entitled to vote at the Annual Meeting.  As a result, abstentions will be counted for purposes of determining the presence or absence of a quorum and will also count as votes against a proposal in cases where approval of the proposal requires the affirmative vote of a majority of the shares present and entitled to vote at the Annual Meeting (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., Proposal No. 2, Proposal No. 3, and Proposal No. 4).  However, because the outcome of Proposal No. 1 will be determined by a plurality vote (see the next question below for an explanation of what a plurality vote means), abstentions will have no impact on the outcome of such proposal as long as a quorum exists.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A broker non-vote occurs when a broker, bank or other nominee holding shares for a beneficial owner does not vote on a particular proposal because the broker, bank or other nominee does not have discretionary voting power with respect to such proposal and has not received voting instructions from the beneficial owner of the shares.  Broker non-votes are not considered votes cast or entitled to vote on a proposal and therefore will be counted for purposes of calculating whether a quorum is present at the Annual Meeting, but will not have any effect on the results of Proposals Nos. 1 through&#160;4.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How many votes are needed for approval of each proposal and how are votes counted?</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal No. 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The election of Class&#160;I directors requires a plurality vote of the shares of our common stock present virtually or by proxy at the Annual Meeting and entitled to vote thereon to be approved.  This means that the three nominees who receive the most FOR votes will be elected.  You may (i)&#160;vote FOR all nominees, (ii)&#160;WITHHOLD your vote as to all nominees, or (iii)&#160;vote FOR all nominees except for those specific nominees from whom you WITHHOLD your vote.  Any shares not voted FOR a particular nominee (whether as a result of voting withheld or a broker non-vote) will not be counted in such nominee&#8217;s favor and will have no effect on the outcome of the election.  If you WITHHOLD your vote as to all nominees, you will be deemed to have abstained from voting on Proposal No. 1, and such abstention will have no effect on the outcome of the proposal.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal No. 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The ratification of the appointment of Deloitte &amp; Touche LLP requires an affirmative vote of a majority of the shares of our common stock present virtually or by proxy at the Annual Meeting and entitled to vote thereon to be approved.  You may vote FOR, AGAINST or ABSTAIN.  If you ABSTAIN from voting on Proposal No. 2, the abstention will have the same effect as a vote AGAINST the proposal.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal No. 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The approval, on an advisory basis, of the compensation of our named executive officers requires an affirmative vote of a majority of the shares of our common stock present virtually or by proxy at the Annual Meeting and entitled to vote thereon to be approved.  You may vote FOR, AGAINST or ABSTAIN.  If you ABSTAIN from voting on Proposal No. 3, the abstention will have the same effect as a vote AGAINST the proposal.  As an advisory vote, this proposal is not binding.  However, our Board of Directors and Compensation and Human Capital Committee will consider the outcome of the vote when making future compensation decisions for our named executive officers.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal No. 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The approval of our 2024 Equity Incentive Plan requires an affirmative vote of a majority of the shares of our common stock present virtually or by proxy at the Annual Meeting and entitled to vote thereon to be approved.  You may vote FOR, AGAINST or ABSTAIN.  If you ABSTAIN from voting on Proposal No. 4, the abstention will have the same effect as a vote AGAINST the proposal.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How are proxies solicited for the Annual Meeting and who is paying for such solicitation?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors is soliciting proxies for use at the Annual Meeting by means of the proxy materials.  We will bear the entire cost of proxy solicitation, including the preparation, assembly, printing, mailing and distribution of the proxy materials.  Copies of solicitation materials will also be made available upon request to brokers, banks and other nominees to forward to the beneficial owners of the shares held of record by such brokers, banks or other nominees.  The original solicitation of proxies may be supplemented by solicitation by telephone, electronic communication, or other means by our directors, officers, employees or agents.  No additional compensation will be paid to these individuals for any such services, although we may reimburse such individuals for their reasonable out-of-pocket expenses in connection with such solicitation.  We have retained D.F. King &amp; Co., Inc. to help us solicit proxies.  We will pay D.F. King &amp; Co., Inc. $10,000 plus reasonable expenses for its services.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you choose to access the proxy materials and/or vote over the Internet, you are responsible for Internet access charges you may incur.  If you choose to vote by telephone, you are responsible for telephone charges you may incur.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Why did I receive the Notice instead of a full set of proxy materials?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the rules of the Securities and Exchange Commission (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SEC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), we have elected to furnish our proxy materials, including this proxy statement and our annual report, primarily via the Internet.  Stockholders may request to receive proxy materials in printed form by mail or electronically by e-mail by following the instructions contained in the Notice.  We encourage stockholders to take advantage of the availability of our proxy materials on the Internet to help reduce the environmental impact of our annual meetings of stockholders.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What does it mean if I received more than one Notice?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you receive more than one Notice, your shares may be registered in more than one name or in different accounts.  Please follow the voting instructions on each Notice to ensure that all of your shares are voted.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Who will count the votes?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The votes will be counted, tabulated and certified by Broadridge Financial Solutions, Inc.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Is my vote confidential?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proxies, ballots and voting tabulations are handled on a confidential basis to protect your voting privacy.  This information will not be disclosed either within CareDx or to third parties, except as necessary to meet applicable legal requirements, to allow for the tabulation of votes and certification of the vote, or to facilitate a successful proxy solicitation.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Do CareDx&#8217;s executive officers and directors have an interest in any of the matters to be acted upon at the Annual Meeting?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Bickerstaff, Ms. Cournoyer and Dr. Valantine each have an interest in Proposal No. 1 (election of directors), as each nominee is currently a member of our Board of Directors.  Members of our Board of Directors and our executive officers do not have any interest in Proposal No. 2 (ratification of appointment of independent registered public accounting firm).  Our executive officers have an interest in Proposal No. 3 (approval of the compensation of our named executive officers), as compensation for our current and former executive officers is subject to this vote.  Members of our Board of Directors and our executive officers have an interest in Proposal No. 4 (approval of our 2024 Equity Incentive Plan), as each would be eligible to receive equity awards under the plan. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Will members of the Board of Directors attend the Annual Meeting?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We encourage, but do not require, the members of our Board of Directors to attend the Annual Meeting.  Those who do attend will be available to answer appropriate questions from stockholders.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I share an address with another stockholder, and we received only one paper copy of the proxy materials.  How may I obtain an additional copy of the proxy materials?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are sending only one annual report and proxy materials to multiple stockholders who share the same address unless we received contrary instructions from one or more of the stockholders.  This practice, known as &#8220;householding,&#8221; reduces our printing and mailing costs.  Stockholders who participate in householding will continue to be able to access and receive separate proxy cards.  Upon written or oral request, we will promptly deliver a separate copy of the proxy materials and annual report to any stockholder at a shared address to which we delivered a single copy of any of these documents.  To receive a separate copy, or, if you are receiving multiple copies, to request that we only send a single copy of next year&#8217;s proxy materials and annual report, you may contact us as follows:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CareDx, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention: Corporate Secretary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8000 Marina Boulevard, 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Floor</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brisbane, CA&#160;94005</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(415) 287-2300</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders who hold shares in street name may contact their broker, bank or other nominee to request information about householding.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How can I find out the results of the voting at the Annual Meeting?</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preliminary voting results will be announced at the Annual Meeting.  In addition, final voting results will be published in a Current Report on Form&#160;8-K (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form&#160;8-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) that we expect to file within four business days after the Annual Meeting.  If final voting results are not available to us by such date, we intend to file a Form&#160;8-K to publish preliminary results and, within four business days after the final results are known to us, file an amendment to the Form&#160;8-K to publish the final results.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What is the deadline to propose actions for consideration at next year&#8217;s annual meeting of stockholders or to nominate individuals to serve as directors?</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder Proposals</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders may present proper proposals for inclusion in our proxy statement and for consideration at the next annual meeting of stockholders by submitting their proposals in writing to our Corporate Secretary in a timely manner.  For a stockholder proposal to be considered for inclusion in our proxy statement for our&#160;2025 annual meeting of stockholders, our Corporate Secretary must receive the written proposal at our principal executive offices not later than December 30, 2024.  In addition, stockholder proposals must comply with the requirements of Rule&#160;14a-8 under the Securities Exchange Act of&#160;1934, as amended (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), regarding the inclusion of stockholder proposals in company-sponsored proxy materials.  Stockholder proposals should be addressed to:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CareDx, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention: Corporate Secretary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8000 Marina Boulevard, 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Floor</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brisbane, CA&#160;94005</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bylaws also establish an advance notice procedure for stockholders who wish to present a proposal before an annual meeting of stockholders but do not intend for the proposal to be included in our proxy statement.  Our Bylaws provide that the only business that may be conducted at an annual meeting is business that is brought (i)&#160;pursuant to our proxy materials with respect to the annual meeting specified in the notice of meeting (or any supplement thereto), (ii)&#160;by or at the direction of our Board of Directors, or (iii)&#160;properly before the annual meeting by a stockholder of record entitled to vote at the annual meeting who has delivered timely written notice to our Corporate Secretary, which notice must contain the information specified in our Bylaws.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be timely for our&#160;2025 annual meeting of stockholders, our Corporate Secretary must receive the written notice at our principal executive offices:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">not earlier than February 13, 2025; and</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">not later than March 15, 2025.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we hold our&#160;2025 annual meeting of stockholders more than&#160;30&#160;days before or after the first anniversary of the date of the Annual Meeting, then notice of a stockholder proposal that is not intended to be included in our proxy statement must be received no earlier than the close of business on the&#160;120th day before such annual meeting and no later than the close of business on the later of the following two dates:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the&#160;90th day prior to such annual meeting; or</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the&#160;10th day following the day on which public announcement of the date of such annual meeting is first made.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a stockholder who has notified us of such stockholder&#8217;s intention to present a proposal at an annual meeting does not appear to present such stockholder&#8217;s proposal at such annual meeting, we are not required to present the proposal for a vote at such annual meeting.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, pursuant to Rule&#160;14a-19 of the Exchange Act (&#8220;Rule&#160;14a-19&#8221;), the SEC&#8217;s universal proxy rule, notices of a solicitation of proxies in support of director nominees other than our own nominees must be postmarked or electronically submitted no later than April 14, 2025, and each nomination must comply with the SEC regulations under Rule&#160;14a-19, which requires, among other things, that such notice include a statement that such person intends to solicit the holders of shares representing at least&#160;67% of the voting power of shares entitled to vote on the election of directors.  If, however, the date of the&#160;2025 annual meeting of stockholders is more than&#160;30&#160;days before or after June 13, 2025, then the Rule&#160;14a-19 deadline shall be the later of&#160;60 calendar days prior to the date of the&#160;2025 Annual Meeting of Stockholders or the&#160;10th calendar day following the day on which we first make a public announcement of the date of our&#160;2025 annual meeting of stockholders.  A nomination that does not comply with the requirements set forth in the Certificate of Incorporation and Bylaws will not be considered for presentation at the annual meeting.  We intend to file our proxy statement and white proxy card with the SEC in connection with our solicitation of proxies for our&#160;2025 annual meeting of stockholders.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nomination of Director Candidates</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may propose director candidates for consideration by our Governance and Nominating Committee.  Any such recommendations should include the nominee&#8217;s name and qualifications for membership on our Board of Directors and should be directed to our Corporate Secretary at the address set forth above.  For additional information regarding stockholder recommendations for director candidates, see &#8220;Board of Directors and Corporate Governance - Stockholder Recommendations for Nominations to the Board of Directors.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our Bylaws permit stockholders to nominate directors for election at an annual meeting of stockholders.  To nominate a director, the stockholder must provide the information required by our Bylaws.  The stockholder must also give timely notice to our Corporate Secretary in accordance with our Bylaws, which, in general, require that the notice be received by our Corporate Secretary within the time period described above under &#8220;Stockholder Proposals&#8221; for stockholder proposals that are not intended to be included in a proxy statement.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Availability of Bylaws</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of our Bylaws may be obtained by accessing our public filings on the SEC&#8217;s website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  You may also contact our Corporate Secretary at our principal executive office for a copy of the relevant Bylaw provisions regarding the requirements for making stockholder proposals and nominating director candidates.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 1</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELECTION OF DIRECTORS</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors is currently composed of eleven members.  In accordance with our amended and restated certificate of incorporation (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certificate of Incorporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), our Board of Directors is currently divided into three classes with staggered three-year terms.  At the Annual Meeting, three Class I directors will be elected for a three-year term to succeed the same class whose term is then expiring. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each director&#8217;s term continues until the election and qualification of such director&#8217;s successor, or such director&#8217;s earlier death, resignation, or removal.  Any increase or decrease in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third of our directors.  The current classification of our Board of Directors may have the effect of delaying or preventing changes in control of our company. However, our Certificate of Incorporation provides for the gradual elimination of the classification of our Board of Directors over a three year period starting in 2025 and provides for the annual election of all directors beginning at our 2027 annual meeting of stockholders.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of our current directors, Grace E. Col&#243;n, Ph.D., is not standing for re-election and will be stepping down from the Board when her current term expires at the Annual Meeting. We would like to thank Dr. Col&#243;n for her guidance and valuable contributions during her years of dedicated service on the Board of Directors.</span></div><div id="i60d05261c6404879b68233510f10856b_19"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nominees</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Governance and Nominating Committee has recommended, and our Board of Directors has approved, George W. Bickerstaff, III, Christine M. Cournoyer and Hannah Valantine, M.D. as nominees for election as Class&#160;I directors at the Annual Meeting.  If elected, Mr. Bickerstaff, Ms. Cournoyer and Dr. Valantine will each serve as Class&#160;I directors until the&#160;2027 annual meeting of stockholders or until their successors are duly elected and qualified.  Each of the nominees is currently a director of our company.  For information concerning the nominees, please see the section titled &#8220;Board of Directors and Corporate Governance.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you are a stockholder of record and you sign your proxy card or vote over the Internet or by telephone but do not give instructions with respect to the voting of directors, your shares will be voted FOR the re-election of Mr. Bickerstaff, Ms. Cournoyer and Dr. Valantine.  We expect that Mr. Bickerstaff, Ms. Cournoyer and Dr. Valantine will each accept such nomination; however, in the event that a director nominee is unable or declines to serve as a director at the time of the Annual Meeting, the proxies will be voted for any nominee who shall be designated by our Board of Directors to fill such vacancy.  If you are a beneficial owner of shares of our common stock and you do not give voting instructions to your broker, bank or other nominee, then your broker, bank or other nominee will leave your shares unvoted on this matter.</span></div><div id="i60d05261c6404879b68233510f10856b_22"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required; Board Recommendation</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The election of Class&#160;I directors requires a plurality vote of the shares of our common stock present virtually or by proxy at the Annual Meeting and entitled to vote thereon to be approved.  Abstentions and broker non-votes will have no effect on this proposal.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUR BOARD OF DIRECTORS RECOMMENDS A VOTE &#8220;FOR&#8221; THE ELECTION OF EACH OF THE THREE DIRECTORS NOMINATED BY OUR BOARD OF DIRECTORS AND NAMED IN THIS PROXY STATEMENT&#160;AS CLASS&#160;I DIRECTORS TO SERVE FOR A THREE-YEAR TERM.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business affairs are managed under the direction of our Board of Directors, which is currently composed of eleven members.  Our Board of Directors is divided into three classes with staggered three-year terms.  At the Annual Meeting, a class of directors will be elected for a three-year term to succeed the same class whose term is then expiring. As noted above, our Certificate of Incorporation provides for the gradual elimination of the classification of our Board of Directors over a three year period starting in 2025 and provides for the annual election of all directors beginning at our 2027 annual meeting of stockholders.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the name, age as of April 29, 2024 and certain other information of each of our directors:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Position</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Director<br/>Since</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current<br/>Term<br/>Expires</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expiration<br/>of Term<br/>For Which<br/>Nominated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Directors with Terms Expiring at the Annual Meeting</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Director Nominees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">George W. Bickerstaff, III</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Christine M. Cournoyer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)(3)(6)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hannah A. Valantine, M.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Non-Continuing Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Grace E. Col&#243;n, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2) (5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Continuing Directors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fred E. Cohen, M.D., D. Phil</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">William A. Hagstrom</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R. Bryan Riggsbee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michael D. Goldberg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(3)4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairperson of the Board of Directors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John W. Hanna</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Peter Maag, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Arthur A. Torres</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Member of our Compensation and Human Capital Committee.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Member of our Science and Technology Committee.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Member of our Audit and Finance Committee.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Member of our Governance and Nominating Committee.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Dr. Col&#243;n is not standing for re-election. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">On April 24, 2024, in connection with Dr. Col&#243;n stepping down from the Board of Directors and to equally apportion the director classes as close as practicable, Ms. Cournoyer resigned as a Class II director and was appointed by the Board of Directors as a Class I director, in each case effective immediately prior to the Annual Meeting, to serve with a term to expire at the Annual Meeting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors with Terms Expiring at the Annual Meeting</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Director Nominees</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.810%"/><td style="width:0.1%"/></tr><tr style="height:116pt"><td colspan="3" rowspan="16" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><img src="cdna-20240429_g1.jpg" alt="1.jpg" style="height:144px;margin-bottom:5pt;vertical-align:text-bottom;width:144px"/></div><div><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">George W.</span></div><div style="margin-bottom:12pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Bickerstaff, III</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Independent Director</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Age: </span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">68</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Independent Director since&#160;</span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2014</span></div><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Committees:</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Audit &amp; Finance </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Governance &amp; Nominating</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional Experience</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Partner &amp; MD, M.M. Dillon &amp; Co. (2005 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Scientific Advisor, American Oriental Bioengineering (Nasdaq: AOBI) (2008 - 2012)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">CFO, Novartis Pharma AG (2000 - 2005)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">EVP &amp; CFO, Workspace (1999 - 2000)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">EVP &amp; CFO, Uniscribe Professional Services (1998 - 1999)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">EVP &amp; CFO, Intellisource Group (1998)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Vice President (Finance), Cognizant (1997)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">CFO, IMS Health (1990 - 1997)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Senior Vice President (Finance), Dun &amp; Bradstreet (NYSE: DNB) (1985 - 1989)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Auditor &amp; Engineer, General Electric (1978 - 1984)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:107pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key Skills &amp; Qualifications</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Business and Operations Leadership Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Through various executive positions, including as CFO of Novartis Pharma, Mr. Bickerstaff has developed a deep understanding of business and operations in the healthcare sector.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Investment, Finance or Accounting Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Mr. Bickerstaff&#8217;s experience in investment banking at MM Dillon as well as more than a decade of experience in senior finance roles equip him with the necessary knowledge to advise on financial matters.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Public Company Board or Governance Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Mr. Bickerstaff has served on the boards of multiple public healthcare companies, including most recently at Innoviva, Sio Gene Therapies and Inovio Pharmaceuticals.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:166pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Boards</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, InCarda Therapeutics (2020 - 2023)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Innoviva (Nasdaq: INVA) (2017 - 2023)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, RoosterBio (2017 - 2020)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chairman, Optical Academy (2017 - 2019)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Independent Chairman, Cardax (2016 - 2021)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Aegis Health Analytics (2014 - 2016)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Livwel Therapeutics (2008 - 2011)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Sio Gene Therapies (Nasdaq: SIOX) (2018 - 2020)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Inovio Pharmaceuticals (Nasdaq: INO) (2017 - 2018)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Ariad Pharmaceuticals (Nasdaq: ARIA) (2016 - 2017)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Viventia Bio Inc. (2015 - 2017)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Cyclica Inc. (2010 - 2014)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, BMP Sunstone (Nasdaq: BJGP) (2008 - 2009)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Vion Pharmaceuticals (Nasdaq: VION) (2005 - 2008)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Amazys Holding (2005 - 2006) </span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current Organizations</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Founding Member, The Global Leaders</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chairperson, International Vaccine Institute</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:59pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Previous Organizations</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Vice Chairman, International Centre for Missing &amp; Exploited Children</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chairman, Global Oncology</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Center for Disease Dynamics, Economics &amp; Policy Inc.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Gavi, the Vaccine Alliance </span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:39pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Education</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">B.S., Rutgers University</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">B.A., Rutgers University</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.810%"/><td style="width:0.1%"/></tr><tr style="height:68pt"><td colspan="3" rowspan="16" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><img src="cdna-20240429_g2.jpg" alt="2.jpg" style="height:144px;margin-bottom:5pt;vertical-align:text-bottom;width:144px"/></div><div><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hannah A.</span></div><div style="margin-bottom:12pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Valantine, M.D.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Independent Director</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Age: </span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">72</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Independent Director since&#160;</span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></div><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Committees:</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Governance &amp; Nominating</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Science &amp; Technology</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional Experience</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Professor of Medicine, Stanford School of Medicine (2000 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chief Officer (Scientific Workforce Diversity), National Institutes of Health (2014 - 2020)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Senior Associate Dean for Diversity and Leadership, Stanford School of Medicine (2005 - 2014)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Assistant Professor of Medicine, Stanford School of Medicine (1987 - 2000)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Registrar, Hammersmith Hospitals NHS Trust</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:155pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key Skills &amp; Qualifications</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Relevant Industry Knowledge</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Dr. Valantine has more than thirty-five years of expertise in transplant medicine.  She is an international leader in the development and application of genomic-based diagnostics for acute rejection, having led the first ever randomized controlled trial of gene-expression profiling published in the New England Journal of Medicine, setting the stage for FDA approval.  She further advanced the field by publishing the first application of donor-derived cell-free DNA as a sensitive and specific biomarker for heart transplant rejection, an approach that has become widely adopted across all other solid organ transplants.  Her pioneering work across several platforms has enabled the advancement of a multi-modality approach to molecular diagnostics services.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">ESG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Dr. Valantine&#8217;s experience in ESG matters spans more than two decades.  She is nationally recognized for her transformative approaches to enhancing both gender and racial diversity among faculty.  As the inaugural Senior Associate Dean for Diversity and Leadership at Stanford University School of Medicine, and then as the inaugural NIH Chief Officer for scientific workforce diversity, she has built and disseminated successful national programs to ensure both workforce diversity and health equity across the NIH research ecosystem.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:39pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Boards</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, BridgeBio Pharma (Nasdaq: BBIO) (2021 - Present)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Pacific Biosciences (Nasdaq: PACB) (2021 - Present)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:48pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current Organizations</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Founder &amp; Principal, HAV</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Member, National Academy of Medicine</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Member, Stanford Cardiovascular Institute </span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:30pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Previous Organizations</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">President (Western State Affiliation), American Heart Association </span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:48pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Education</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">M.D., London University</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Fellowship, Stanford University</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">M.B.B.S., London University</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.810%"/><td style="width:0.1%"/></tr><tr style="height:78pt"><td colspan="3" rowspan="13" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><img src="cdna-20240429_g3.jpg" alt="3.jpg" style="height:144px;margin-bottom:5pt;vertical-align:text-bottom;width:144px"/></div><div style="margin-bottom:12pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Christine M. Cournoyer</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Independent Director</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Age: </span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">72</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Independent Director since&#160;</span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></div><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Committees:</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Audit &amp; Finance</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Compensation &amp; Human Capital (Chairperson)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Science &amp; Technology Committee</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional Experience</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chairman &amp; CEO, N-of-One (2012 - 2019)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Vice President (Clinical Analytics), Optum (part of UnitedHealth Group) (2010 - 2011)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">President &amp; COO, Picis (acquired by UnitedHealth Group) (2006 - 2010)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Managing Director (Solutions), Harte-Hanks (2005 - 2006)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">CIO &amp; Division Vice President, IBM (NYSE: IBM) (1995 - 2002)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">SVP, CIO, Lotus Development (1994 - 1995)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:116pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key Skills &amp; Qualifications</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Relevant Industry Knowledge</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Ms. Cournoyer has extensive experience as an executive in the life sciences industry and healthcare technology, including at N-of-One, Optum and Picis.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">M&amp;A or Corporate Development Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Ms. Cournoyer has led or contributed to two transformative M&amp;A transactions - while CEO at N-of-One, Ms. Cournoyer led the strategic sales process and successful sale to QIAGEN, and while at Picis, she contributed to Picis&#8217; sale to UnitedHealth Group in an executive capacity.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Investment, Finance or Accounting Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Ms. Cournoyer managed P&amp;L, raised capital and managed cash operations for different organizations including N-of-One, Picis and IBM, among others.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Risk Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: As a former CIO, Ms. Cournoyer has a deep understanding of IT controls and cyber security.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:78pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Boards</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chairman, Spok Holdings (Nasdaq: SPOK) (2022 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Emerson Hospital (2012 - 2018)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, BJ&#8217;s Wholesale Club (NYSE: BJ) (2008 - 2011)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Greenland Technologies (Nasdaq: GTEC) (2003 - 2006)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Lightbridge (Nasdaq: LTBR) (2002 - 2003)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Stride Rite (Nasdaq: LRN) (2001 - 2007) </span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:48pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current Organizations</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Editorial Board Member, Clinical OMICs</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Board of Advisors, Manning School of Business</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Member, Madam Chair</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:39pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Education</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">M.A., Northeastern University</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">B.S., University of Massachusetts Lowell </span></div></td></tr></table></div><div style="margin-bottom:24pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Continuing Directors</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.810%"/><td style="width:0.1%"/></tr><tr style="height:68pt"><td colspan="3" rowspan="16" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><img src="cdna-20240429_g4.jpg" alt="5.jpg" style="height:144px;margin-bottom:5pt;vertical-align:text-bottom;width:144px"/></div><div style="margin-bottom:12pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Fred E. Cohen, M.D., D. Phil</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Independent Director</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Age: </span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">67</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Independent Director since&#160;</span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2014</span></div><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Committees:</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Compensation &amp; Human Capital</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Science &amp; Technology Committee</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional Experience</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Founder &amp; Chairman, Monograph Capital Partners (2021 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Founder &amp; Senior Managing Director, Vida Ventures (2017 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Senior Advisor &amp; Partner, TPG (2001 - Present)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Professor (Cellular and Molecular Pharmacology), University of California, San Francisco (UCSF) (1988 - 2016)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:107pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key Skills &amp; Qualifications</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Relevant Industry Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Dr. Cohen&#8217;s thought leadership in biotechnology as an elected member of the National Academy of Medicine of the National Academy of Sciences and fellow of the American College of Physicians, among other organizations, and experience as Professor of Cellular and Molecular Pharmacology at UCSF, is an asset to the Board in assessing the firm&#8217;s strategy.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Investment, Finance or Accounting Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: As founder and Senior Managing Director of Vida Ventures and as a Partner and more recently a Senior Advisor at TPG, Dr. Cohen is well-versed in investment and financial matters specific to biotechnology companies.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Public Company Board or Governance Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Dr. Cohen has served on multiple public boards and committees including most recently at Progyny, Intellia Therapeutics and Urogen Pharma.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:144pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Boards</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Kyverna Therapeutics (2020 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Progyny (Nasdaq: PGNY) (2019 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Intellia Therapeutics (Nasdaq: NTLA) (2019 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Urogen Pharma (Nasdaq: URGN) (2017 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Novotech (2017 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Tandem Diabetes (Nasdaq: TNDM) (2013 - 2019)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Biocryst (Nasdaq: BCRX) (2013 - 2019)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Five Prime Therapeutics (Nasdaq: FPRX) (2013 - 2018)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Veracyte (Nasdaq: VCYT) (2013 - 2019)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Roka Biosciences (Nasdaq: ROKA) (2014 - 2017)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Quintiles (NYSE: Q) (merged with IQVIA Holdings) (2013 - 2015)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Genomic Health (Nasdaq: GHDX) (acquired by Exact Sciences) (2005 - 2019)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Matrix Laboratories (2004 - 2009) </span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:48pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current Organizations</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Member, American Academy of Arts and Sciences</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Fellow, National Academy of Medicine</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Fellow, American Medical Informatics Association </span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:68pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Previous Organizations</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Trustee, Autistica</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Fellow, American College of Physicians</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Member, Association of American Physicians</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Fellow, Western Association of Physicians</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Member, American Society for Clinical Investigation</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:77pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Education</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Ph.D., Oxford University</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">M.D., Stanford University</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">B.S., Yale University</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.810%"/><td style="width:0.1%"/></tr><tr style="height:116pt"><td colspan="3" rowspan="16" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><img src="cdna-20240429_g5.jpg" alt="6.jpg" style="height:144px;margin-bottom:5pt;vertical-align:text-bottom;width:144px"/></div><div><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">William A.</span></div><div style="margin-bottom:12pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hagstrom</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Independent Director</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Age: </span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">66</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Independent Director since&#160;</span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2015</span></div><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Committees:</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Audit &amp; Finance</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Compensation &amp; Human Capital</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional Experience</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Co-Founder and Chairman (2023 &#8211; Present) and CEO (2016 - 2023), Octave Biosciences </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">CEO, Crescendo Bioscience (acquired by Myriad Genetics, Nasdaq: MYGN) (2007 - 2014)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">President, Alpha BioPartners</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Co-Founder, Biolytx Pharmaceuticals</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Co-Founder, Altheus Therapeutics</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Interim CEO, Selexys Pharmaceuticals (2003 - 2004)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Interim CEO, Inoveon (2001 - 2003)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chairman, President &amp; CEO, Urocor (Nasdaq: UCOR) (1989 - 1999)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Division Vice President (Scientific Products Division), Baxter Travenol (1985 - 1989)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:116pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key Skills &amp; Qualifications</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Investment, Finance or Accounting Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Mr. Hagstrom has deep knowledge of finance, capital formation and financial modeling through his track record as a founder and executive, including as the former President of Crescendo Bioscience, which was acquired by Myriad Genetics.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Business and Operations Leadership Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Mr. Hagstrom has extensive experience developing pipelines, infrastructure and commercial strategy at several companies in specialty and molecular diagnostics, as demonstrated by his tenure at Crescendo Bioscience and as the co-founder and CEO of Octave Biosciences.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Regulatory and Legal Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: In addition to his experience as a founder, Mr. Hagstrom held multiple management and executive positions at large multinational healthcare companies where he managed the legal and regulatory risks specific to medical products companies.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:107pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Boards</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, CoFactor Genomics (2018 &#8211; Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Genalyte (2016 - 2019)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Navican Genomics (2016 - 2017)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Executive Director, Crescendo Bioscience (2007 - 2014)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Inoveon (2000 - 2003)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Prometheus Labs (1998 - 2003)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chairman, Urocor (Nasdaq: UCOR) (1989 - 1999)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Zymetx (Nasdaq: ZMTX) (1994 - 1998)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chairman, President &amp; CEO, Urocor (Nasdaq: UCOR) (1989 - 1999)</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:30pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current Organizations</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Advisor, Biolytx Pharmaceuticals</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:39pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Previous Organizations</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Advisor, Convergent Genomics</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Advisor, Guardant Health </span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:30pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Education</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">B.S., Bob Jones University</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.810%"/><td style="width:0.1%"/></tr><tr style="height:107pt"><td colspan="3" rowspan="13" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-6.85pt"><img src="cdna-20240429_g6.jpg" alt="7.jpg" style="height:144px;margin-bottom:5pt;vertical-align:text-bottom;width:144px"/></div><div style="margin-bottom:12pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Peter K. Maag, Ph.D.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Director</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Age: </span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">57</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Director since&#160;</span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2012</span></div><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Committees:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Science &amp; Technology Committee</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional Experience</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">CEO, Kyverna Therapeutics (Nasdaq: KYTX) (2022 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Executive Chairman, CareDx (Nasdaq: CDNA) (2020 - 2021)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">CEO &amp; President, CareDx (Nasdaq: CDNA) (2012 - 2020)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Division President, Novartis Diagnostics AG (NYSE: NVS) (2009 - 2012)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">CEO &amp; Country President, Novartis AG, Germany (NYSE: NVS) (2006 - 2008)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">CEO &amp; Country President, Novartis AG, Korea (2003 - 2005)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Head of Division (Franchise Infectious Diseases), Novartis AG (2002 - 2003)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Head of Strategy (Pharma Division), Novartis AG (2001 - 2002)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Associate Principal, McKinsey &amp; Company (1994 - 2001) </span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:116pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key Skills &amp; Qualifications</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Business and Operations Leadership Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Dr. Maag&#8217;s&#160;20+ years of executive management experience in the pharmaceutical and diagnostic industry including as former CEO of CareDx and as President of Diagnostics qualify him to advise the Board on matters specific to CareDx&#8217;s business and strategy.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Risk Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Dr. Maag has deep expertise in risk management as he has served as a director of multiple healthcare companies, including Novartis, MiroMatrix Medical, and as the former Chairman and CEO of CareDx.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">M&amp;A or Corporate Development Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Dr. Maag served in positions at Novartis Pharma and Novartis Diagnostics including as Head of Strategy where he was instrumental in the global growth of the organization.  During his tenure at CareDx, he has led multiple acquisitions and financial transactions.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:107pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Boards</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Kyverna Therapeutics (2022 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, MiroMatrix Medical (2021 - 2023), MiroMatrix was acquired by United Therapeutics (Nasdaq: UTHR) in December 2023</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Phoenix Pharmahandel (2012 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, MolecularMD (2012 - 2020)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Chiron France (2009 - 2012)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Novartis AG, Germany (2006 - 2008)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Zuellig Pharma (2003 - 2005)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Novartis, Korea (2003 - 2005)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:39pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current Organizations</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Personalized Medicine Coalition</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, BluLake Ventures LLC</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Education</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Ph.D., University of Berlin</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">MSc, University of Heidelberg, University of London</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.810%"/><td style="width:0.1%"/></tr><tr style="height:59pt"><td colspan="3" rowspan="13" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><img src="cdna-20240429_g7.jpg" alt="8.jpg" style="height:153px;margin-bottom:5pt;vertical-align:text-bottom;width:153px"/></div><div style="margin-bottom:12pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Michael Goldberg</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Chairperson of the Board of Directors</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Age: </span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">66</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Independent Director since&#160;</span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2011</span></div><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Committees:</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Audit &amp; Finance</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Governance &amp; Nominating</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Compensation &amp; Human Capital</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional Experience</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Partner, Mohr Davidow Ventures (2005 - 2011)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Founder &amp; CEO, Axion (1987 - 1995) (acquired by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Bristol-Myers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Squibb, NYSE: BMS)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Partner, Sevin Rosen Management Company (1985 - 1987)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director (Corporate Development), Cetus Corporation (1981 - 1985)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:126pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key Skills &amp; Qualifications</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Relevant Industry Knowledge</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Mr. Goldberg has a track record of leadership in healthcare, as the former CEO of Axion and a founding and a former Board member of the California Institute for Regenerative Medicine. Mr. Goldberg is also a former director of Cetus Corporation, which developed the foundational PCR technology for precision medicine.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Public Company Board or Governance Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: As a director at multiple public companies, Mr. Goldberg has extensive experience working with management teams and Board members on business matters and governance policies.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Business and Operations Leadership Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Mr. Goldberg&#8217;s experience as founder and CEO of Axion, as well as Executive Chair at DNAnexus and Senior Executive and Venture Capital Investor with numerous companies in the Life Sciences industry, helps the Board develop and oversee our operations and business strategy.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:87pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Boards</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Executive Chairman &amp; Director, DNAnexus (2013 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chairman; Director, YorLabs (2018 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chairman, iRhythm Technologies (Nasdaq: IRTC) (2007 - 2010)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chairman, Crescendo Biosciences (2007 - 2010) (acquired by Myriad Genetics, Nasdaq: MYGN)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, eHealth (Nasdaq: EHTH) (1999 - 2021)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, Genomic Health (acquired by Exact Sciences, Nasdaq: EXAS) (2001 - 2007)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:96pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Previous Organizations</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Founding Board Member, California Institute for Regenerative Medicine</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Board Member, Western Association of Venture Capitalists</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Advisory Board Member, Harvard Center for Genetics and Genomics</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Advisory Board Member, Berkeley Center for Law and Technology</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Advisory Board Member, UCSF Center for Translational and Policy Research on Personalized Medicine</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Advisory Board Member, Stanford Distinguished Careers Institute</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Trustee, National Childhood Cancer Foundation</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Education</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">M.B.A., Stanford Graduate School of Business</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">B.A., Brandeis University</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.810%"/><td style="width:0.1%"/></tr><tr style="height:96pt"><td colspan="3" rowspan="13" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><img src="cdna-20240429_g8.jpg" alt="9.jpg" style="height:144px;margin-bottom:5pt;vertical-align:text-bottom;width:144px"/></div><div style="margin-bottom:12pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Arthur A. Torres</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Independent Director</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Age: </span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">77</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Independent Director since&#160;</span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></div><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Committees:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Governance &amp; Nominating (Chairperson)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional Experience</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Director, San Francisco Municipal Transportation Agency (2017 - 2020)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">President &amp; Member, San Francisco Public Utilities Commission (2010 - 2014)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chairman, California Democratic Party (1996 - 2009)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Senator, California State Senate (1982 - 1994)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chair, California Senate Insurance Committee</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chair, California Senate Toxics Committee</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Assembly Member, California State Assembly (1974 - 1982)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chair, California Assembly Health Committee</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:96pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key Skills &amp; Qualifications</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Regulatory and Legal Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Mr. Torres&#8217; extensive career in politics and government and background in law qualifies him to advise on regulatory and legal matters.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Relevant Industry Knowledge</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: As Chair of the California Assembly Health Committee and California Senate Insurance Committee and as a Board member of Covered California, Mr. Torres has the experience necessary to set strategy for our organization.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">ESG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: During his tenure in the California state legislature, Mr. Torres worked to provide a voice for his constituents as co-author of the California Clean Water Act and consultant on immigration reform, among other initiatives.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:30pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current Organization</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Vice Chair, One Legacy Foundation</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:96pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Previous Organizations</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Vice Chair Emeritus, California Institute for Regenerative Medicine</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Vice Chair, One Legacy Foundation</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Alumni Regent &amp; President Emeritus, University of California Alumni Association</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Alumni Regent Designate Emeritus, University of California</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Board Member Emeritus, Covered California</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">JFK Teaching Fellow, Harvard University</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Visiting Professor, University of San Francisco School of Nursing</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">German Marshall Fund Fellow</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Education</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">J.D., University of California Davis School of Law</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">B.A. (Government), University of California Santa Cruz</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.810%"/><td style="width:0.1%"/></tr><tr style="height:59pt"><td colspan="3" rowspan="13" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><img src="cdna-20240429_g9.jpg" alt="10.jpg" style="height:144px;margin-bottom:5pt;vertical-align:text-bottom;width:144px"/></div><div style="margin-bottom:12pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">R. Bryan Riggsbee</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Independent Director</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Age: </span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">53</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Independent Director since&#160;</span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></div><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Committees:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Audit &amp; Finance (Chairperson)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional Experience</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">CFO, Myriad Genetics (Nasdaq: MYGN) (2014 &#8211; 2024)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Interim President and CEO, Myriad Genetics (Nasdaq: MYGN) (2020)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Senior Vice President, Corporate Finance, Laboratory Corporation of America (LabCorp) (NYSE: LH) (2004-2014)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:78pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key Skills &amp; Qualifications</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Financial Planning and Analysis</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Strategic Planning</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Risk Management</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Compliance and Regulatory Standards</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Treasury</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Certified Public Accountant licensed in the state of North Carolina</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:30pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current Organization</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">N/A</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:59pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Previous Organizations</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Myriad Genetics</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Laboratory Corporation of America (LabCorp)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">General Electric</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">KPMG</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:54pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Education</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">M.B.A., Northwestern University</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">B.A. (Political Science), University of North Carolina at Chapel Hill</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">B.A. (Accounting), North Carolina State University</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.810%"/><td style="width:0.1%"/></tr><tr style="height:65pt"><td colspan="3" rowspan="13" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><img src="cdna-20240429_g10.jpg" alt="11.jpg" style="height:144px;margin-bottom:5pt;vertical-align:text-bottom;width:144px"/></div><div style="margin-bottom:12pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">John W. Hanna</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Director, President and Chief Executive Officer of CareDx</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Age: </span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">44</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Director since&#160;</span><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></div><div style="margin-bottom:6pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional Experience</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">President and Chief Executive Officer, CareDx, Inc. (2024 - Present)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.5pt">Vice President, Corporate Development (Pacific Biosciences of California, Inc.  (2023 &#8211; 2024)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">CEO, Apton Biosystem, Inc. (2021 &#8211; 2023)</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Chief Commercial Officer, Veracyte, Inc. (2011 &#8211; 2021)</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:116pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key Skills &amp; Qualifications</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Relevant Industry Knowledge</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Mr. Hanna has over two decades of experience in the molecular diagnostics and life sciences tools industries.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;padding-left:15.2pt">Business and Operations Leadership Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">: Mr. Hanna previously served as CEO of Apton Biosystems, Inc. where he led the development of a high throughput next-generation (NGS) platform for liquid biopsy and other clinical applications.  The company was acquired by Pacific Biosciences of California, Inc. in August 2023, where he served as Vice President of Corporate Development.  Mr. Hanna previously spent ten years at Veracyte, Inc., an oncology diagnostics company in the fields of thyroid, lung, breast, and prostate cancer, where he held numerous roles including Chief Commercial Office and Vice President of Marketing.  Prior to Veracyte, Mr. Hanna held leadership roles at Humana and IBM.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:30pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current Organization</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">CareDx, Inc.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:48pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Previous Organizations</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Pacific Biosciences of California, Inc.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Apton Biosystem, Inc.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Veracyte, Inc.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #bfbfbf;padding:0 1pt"/></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#c6190c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Education</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">M.B.A., University of Miami</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">B.S. (Political Science), Hampden Sydney College</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Considerations in Evaluating Director Nominees</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Governance and Nominating Committee uses a variety of methods for identifying and evaluating director nominees.  In its evaluation of director candidates, our Governance and Nominating Committee will consider the composition of our Board of Directors, including, without limitation, issues of character, integrity, judgment, diversity, age, independence, skills, education, expertise, business acumen, business experience, length of service, understanding of our business and other commitments.  Members of our Board of Directors are expected to prepare for, attend, and participate in all Board of Directors and applicable committee meetings.  Our Governance and Nominating Committee requires the following minimum qualifications to be satisfied by any nominee for a position on our Board of Directors: (i)&#160;the highest personal and professional ethics and integrity, (ii)&#160;proven achievement and competence in the nominee&#8217;s field and the ability to exercise sound business judgment, (iii)&#160;skills that are complementary to those of the existing Board of Directors, (iv)&#160;the ability to assist and support management and make significant contributions to our success, and (v)&#160;an understanding of the fiduciary responsibilities that are required of a member of our Board of Directors and the commitment of time and energy necessary to diligently carry out those responsibilities.  Other than the foregoing, there are no stated minimum criteria for director nominees, although our Governance and Nominating Committee may also consider such other factors as it may deem, from time to time, are in our and our stockholders&#8217; best interests.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although our Board of Directors does not maintain a specific policy with respect to board diversity, our Board of Directors believes that our Board of Directors should be a diverse body, and our Governance and Nominating Committee considers a broad range of backgrounds and experiences.  In determining nominations of directors, our Governance and Nominating Committee may take into account the benefits of diverse viewpoints.  Our Governance and Nominating Committee also considers these and other factors as it oversees the annual Board of Directors and committee evaluations.  After completing its review and evaluation of director candidates, our Governance and Nominating Committee recommends to our full Board of Directors the director nominees for selection.</span></div><div id="i60d05261c6404879b68233510f10856b_37"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Independence</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is listed on the Nasdaq Global Market.  Under the rules of The Nasdaq Stock Market LLC (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nasdaq Rules</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), independent directors must comprise a majority of a listed company&#8217;s Board of Directors.  In addition, the Nasdaq Rules require that, subject to specified exceptions, each member of a listed company&#8217;s audit, compensation, and nominating and corporate governance committees be independent.  Under the Nasdaq Rules, a director will only qualify as an &#8220;independent director&#8221; if, in the opinion of the listed company&#8217;s Board of Directors, the director does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit and Finance Committee members must also satisfy the independence criteria set forth in Rule&#160;10A-3 under the Exchange Act and the Nasdaq Rules.  In addition, Compensation and Human Capital Committee members must satisfy the independence criteria set forth in Rule&#160;10C-1 under the Exchange Act and the Nasdaq Rules.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has undertaken a review of the independence of each director and considered whether such director has a material relationship with us that could compromise the director&#8217;s ability to exercise independent judgment in carrying out the director&#8217;s responsibilities.  As a result of this review, our Board of Directors has determined that Mr. Goldberg, Mr. Bickerstaff, Dr. Cohen, Dr. Col&#243;n, Ms. Cournoyer, Mr. Hagstrom, Mr. Riggsbee, Senator Torres and Dr. Valantine are &#8220;independent directors&#8221; as defined under the applicable rules and regulations of the SEC and the Nasdaq Rules.  Accordingly, all of the members, including the chairperson, of each of the Audit and Finance Committee, the Compensation and Human Capital Committee and the Governance and Nominating Committee are independent directors.</span></div><div id="i60d05261c6404879b68233510f10856b_40"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Leadership Structure</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has an independent Chairperson, Mr. Goldberg, and we believe that having independent leadership is an important component of our governance structure.  Our independent Chairperson has authority, among other things, to preside over Board of Directors meetings, including meetings of the independent directors, and to call special meetings of our Board of Directors.  Accordingly, the independent Chairperson has substantial ability to shape the work of our Board of Directors.  We currently believe that having an independent Chairperson creates an environment that is more conducive to objective evaluation and oversight of management&#8217;s performance, increasing management accountability and improving the ability of our Board of Directors to monitor whether management&#8217;s actions are in the best interests of our company and our stockholders.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we believe that separation of the roles of Chairperson and Chief Executive Officer enhances the accountability of our Chief Executive Officer to our Board of Directors and encourages balanced decision making.  While our Chief Executive Officer is responsible for our day-to-day leadership and operations, our independent Chairperson provides guidance to our Board of Directors and set the agenda for the meetings of the Board of Directors.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, no single leadership model is right for all companies and at all times.  Our Board of Directors recognizes that, depending on the circumstances, other leadership models, such as combining the role of Chairperson with the role of Chief Executive Officer, might be appropriate.  Accordingly, our Board of Directors periodically reviews its leadership structure and will continue to evaluate and implement the leadership structure that it concludes most effectively supports our Board of Directors in fulfilling its responsibilities.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">President and Chief Executive Officer</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 15, 2024, we appointed John W. Hanna as CareDx&#8217;s President and Chief Executive Officer, and as a Class III director of the Company. Because Mr. Hanna joined the Company as President and Chief Executive Officer in April 2024, he is not a &#8220;Named Executive Officer&#8221; in respect of the fiscal year ended December 31, 2023 for the purposes of this proxy statement. </span></div><div id="i60d05261c6404879b68233510f10856b_43"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Office of Chief Executive Officer</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective November 1, 2023, and continuing until the appointment of Mr. Hanna as our President and Chief Executive Officer on April 15, 2024, CareDx established an Office of the Chief Executive Officer, comprised of Michael D. Goldberg, Chairperson of the Board, Abhishek Jain, the Company&#8217;s Chief Financial Officer, and Alexander L. Johnson, the Company&#8217;s President of Patient &amp; Testing Services, to assume the duties of Chief Executive Officer. Mr. Johnson also assumed the duties of the Company&#8217;s principal executive officer as of such date. Our Board of Directors determined that Mr. Goldberg&#8217;s interim position as a member of the Office of the Chief Executive Officer does not impair Mr. Goldberg&#8217;s independence. Concurrently with Mr. Hanna&#8217;s appointment, the Office of the Chief Executive Officer was dissolved and its former members Michael D. Goldberg, Abhishek Jain and Alexander L. Johnson will continue to serve as the Chairperson of the Board, the Company&#8217;s Chief Financial Officer and the Company&#8217;s President of Patient &amp; Testing Services, respectively.</span></div><div id="i60d05261c6404879b68233510f10856b_46"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Diversity of Skills and Expertise</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is an overview of the collective experiences, qualifications and attributes of our Board of Directors.  Please see the sections titled &#8220;Directors with Terms Expiring at the Annual Meeting-Nominees for Director&#8221; and &#8220;Continuing Directors&#8221; for individual details regarding the experience and expertise of each of our directors.</span></div><div style="margin-bottom:42pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.997%"/><td style="width:0.1%"/></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #244c81;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #244c81;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #244c81;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #244c81;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #244c81;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #244c81;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #244c81;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #244c81;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #244c81;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #244c81;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #244c81;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #244c81;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #244c81;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#c10101;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Director Skills /<br/>Qualifications</span></td><td colspan="3" style="background-color:#c10101;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Goldberg</span></td><td colspan="3" style="background-color:#c10101;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Bickerstaff</span></td><td colspan="3" style="background-color:#c10101;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cohen</span></td><td colspan="3" style="background-color:#c10101;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Col&#243;n</span></td><td colspan="3" style="background-color:#c10101;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cournoyer</span></td><td colspan="3" style="background-color:#c10101;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hagstrom</span></td><td colspan="3" style="background-color:#c10101;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hanna</span></td><td colspan="3" style="background-color:#c10101;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maag</span></td><td colspan="6" style="background-color:#c10101;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#f8f8f8;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Riggsbee</span></td><td colspan="3" style="background-color:#c10101;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Torres</span></td><td colspan="3" style="background-color:#c10101;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Valantine</span></td><td colspan="3" style="background-color:#c10101;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Board<br/>Composition</span></td></tr><tr><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Relevant Industry Knowledge</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8226;</span></td><td colspan="6" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11 of 11</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business and Operations Leadership Experience</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9 of 11</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Investment, Finance or Accounting Experience</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.25pt;padding-right:0.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9 of 11</span></td></tr><tr><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Public Company Board or Governance Experience</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:0 1pt"/><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="6" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:0 1pt"/><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9 of 11</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Risk Management</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9 of 11</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">M&amp;A or Corporate Development Experience</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9 of 11</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Regulatory and Legal Experience</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10 of 11</span></td></tr><tr><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">ESG</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:0 1pt"/><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:0 1pt"/><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="6" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9 of 11</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Female</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3 of 11</span></td></tr><tr><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Race / Ethnicity</span></td><td colspan="3" style="background-color:#f1f1f1;padding:0 1pt"/><td colspan="3" style="background-color:#f1f1f1;padding:0 1pt"/><td colspan="3" style="background-color:#f1f1f1;padding:0 1pt"/><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:0 1pt"/><td colspan="3" style="background-color:#f1f1f1;padding:0 1pt"/><td colspan="3" style="background-color:#f1f1f1;padding:0 1pt"/><td colspan="3" style="background-color:#f1f1f1;padding:0 1pt"/><td colspan="3" style="background-color:#f1f1f1;padding:0 1pt"/><td colspan="6" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="background-color:#f1f1f1;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3 of 11</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LGBTQ+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1 of 11</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Independent</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9 of 11</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><img src="cdna-20240429_g11.jpg" alt="386" style="height:201px;margin-bottom:5pt;vertical-align:text-bottom;width:211px"/><img src="cdna-20240429_g12.jpg" alt="387" style="height:201px;margin-bottom:5pt;vertical-align:text-bottom;width:211px"/><img src="cdna-20240429_g13.jpg" alt="388" style="height:201px;margin-bottom:5pt;vertical-align:text-bottom;width:211px"/></div><div style="text-align:center"><img src="cdna-20240429_g14.jpg" alt="390" style="height:201px;margin-bottom:5pt;vertical-align:text-bottom;width:211px"/><img src="cdna-20240429_g15.jpg" alt="391" style="height:201px;margin-bottom:5pt;vertical-align:text-bottom;width:211px"/><img src="cdna-20240429_g16.jpg" alt="392" style="height:201px;margin-bottom:5pt;vertical-align:text-bottom;width:211px"/></div><div id="i60d05261c6404879b68233510f10856b_49"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal Proceedings with Directors</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no legal proceedings related to any of the directors or director nominees that require disclosure pursuant to Items&#160;103 or&#160;401(f) of Regulation&#160;S-K.</span></div><div id="i60d05261c6404879b68233510f10856b_52"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Agreements with Directors</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the directors or nominees for director was selected pursuant to any arrangement or understanding, other than compensation arrangements in the ordinary course of business.</span></div><div id="i60d05261c6404879b68233510f10856b_55"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board and Committee Meetings</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year&#160;2023, our Board of Directors held eight meetings (including regularly scheduled and special meetings), and took action by written consent one time.  Each director attended at least&#160;75% of the aggregate of (i)&#160;the total number of meetings of our Board of Directors held during the period for which he or she served as a director, and (ii)&#160;the total number of meetings held by all committees of our Board of Directors on which he or she served during the periods that he or she served.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is the policy of our Board of Directors to regularly have separate meeting times for independent directors without management.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we do not have a formal policy regarding attendance by members of our Board of Directors at annual meetings of stockholders, we encourage, but do not require, our directors to attend. Mr. Goldberg and Reginald Seeto, our former President and Chief Executive Officer and director, attended our&#160;2023 annual meeting of stockholders.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has four standing committees: the Audit and Finance Committee, the Compensation and Human Capital Committee, the Governance and Nominating Committee and the Science and Technology Committee.  The composition and responsibilities of each of the committees and the subcommittee of our Board of Directors as of April 29, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024 are described below.  Members will serve on these committees (or the subcommittee) until their resignation or until otherwise determined by our Board of Directors.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Audit and<br/>Finance<br/>Committee</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Governance<br/>and Nominating<br/>Committee</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Compensation<br/>and Human<br/>Capital<br/>Committee</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Science and<br/>Technology<br/>Committee</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">George W. Bickerstaff, III</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fred E. Cohen, M.D., D. Phil</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grace E. Col&#243;n, Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine M. Cournoyer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael D. Goldberg</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William A. Hagstrom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter Maag, Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.1pt;padding-right:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R. Bryan Riggsbee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arthur A. Torres</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hannah A. Valantine, M.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X: Committee Member</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*: Committee Chairperson</span></div><div style="margin-bottom:12pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Prior to Mr. Riggsbee joining our Board of Directors in March 2024, Mr. Bickerstaff served as the Chairperson of the Audit and Finance Committee and served in such role during all of 2023.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit and Finance Committee</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a separately-designated standing audit and finance committee established in accordance with Section&#160;3(a)(58)(A) of the Exchange Act.  Our Audit and Finance Committee is currently comprised of George W. Bickerstaff, III, Christine M. Cournoyer, Michael D. Goldberg, William A. Hagstrom and R. Bryan Riggsbee, each of whom is a non-employee member of our Board of Directors. Mr. Riggsbee has served as the chairperson of our Audit and Finance Committee since his appointment to our Board of Directors in March 2024.  Prior to that, and during all of 2023, Mr. Bickerstaff served as the chairperson of our Audit and Finance Committee. Our Board of Directors has determined that each of the members of our Audit and Finance Committee satisfies the requirements for independence and financial literacy under the rules and regulations of the SEC, including Rule&#160;10A-3 under the Exchange Act and the Nasdaq Rules.  Our Board of Directors has determined that each of Messrs.  Bickerstaff, Goldberg, Hagstrom and Riggsbee and Ms. Cournoyer qualifies as an &#8220;audit committee financial expert&#8221; as defined by the applicable SEC rules and satisfies the financial sophistication requirements of the Nasdaq Rules.  This designation does not impose on Messrs.  Bickerstaff, Goldberg. Hagstrom or Riggsbee or Ms. Cournoyer any duties, obligations or liabilities that are greater than those generally imposed on members of our Audit and Finance Committee and our Board of Directors.  Our Audit and Finance Committee is responsible for, among other things:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appointing, compensating and overseeing the work of our independent registered public accounting firm;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing the qualifications, performance and independence of our independent registered public accounting firm;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-approving any audit and permissible non-audit services to be performed by our independent registered public accounting firm;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overseeing our internal accounting and financial controls, including procedures for the treatment of complaints on accounting controls, internal accounting controls or auditing matters and procedures for the submission of confidential, anonymous employee comments about questionable accounting or auditing matters;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">providing to our Board of Directors such information and materials as it may deem necessary to make our Board of Directors aware of significant financial matters that require the attention of our Board of Directors;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overseeing our financial and treasury policies and strategies, including our cash position, capital structure and strategies, and insurance coverage;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing the terms and conditions of material financing plans and making recommendations to our Board of Directors on such plans;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing our Board of Directors&#8217; delegated authority to our officers and related spending and transaction authority guidelines, matrices or policies;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing with our management and independent registered public accounting firm the organization and performance of our internal audit function;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and discussing with our management and the independent registered public accounting firm the results of our annual audit, our quarterly financial statements and financial statements included in our publicly filed reports;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and approving related party transactions;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">preparing and providing the Audit Committee report that the SEC requires in our annual proxy statements;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing our guidelines and policies with respect to risk assessment and risk management, including risks relating to our accounting matters, financial reporting, legal and regulatory compliance and general business risks and the steps taken by management to monitor and control these exposures;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">assisting with the resolution of any actual or potential conflicts of interest with respect to members of our Board of Directors; and</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and evaluating, at least annually, the performance of the Audit and Finance Committee and its members.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Audit and Finance Committee operates under a written charter that satisfies the applicable rules and regulations of the SEC and the Nasdaq Rules.  A copy of the charter of our Audit and Finance Committee is available on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.caredx.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Corporate Governance section of our Investors webpage.  During fiscal year&#160;2023, our Audit and Finance Committee held 11 standalone meetings and did not take any action by written consent.  Our Audit and Finance Committee also held five joint meetings with our Compensation and Human Capital Committee and our Governance and Nominating Committee during fiscal 2023.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation and Human Capital Committee</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation and Human Capital Committee is comprised of Christine M. Cournoyer, Fred E. Cohen, M.D., D. Phil, Grace E. Col&#243;n, Ph.D., Michael D. Goldberg and William A. Hagstrom, each of whom is a non-employee member of our Board of Directors.  Ms. Cournoyer serves as the current chairperson of our Compensation and Human Capital Committee.  Our Board of Directors has determined that each member of our Compensation and Human Capital Committee meets the requirements for independence under the rules and regulations of the SEC, including Rule&#160;10C-1 under the Exchange Act, and the Nasdaq Rules and is a &#8220;non-employee director&#8221; within the meaning of Rule&#160;16b-3 under the Exchange Act.  Our Compensation and Human Capital Committee is responsible for, among other things:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and approving all salaries, incentive awards and bonuses, equity awards, severance arrangements, change in control agreements and any other compensation and benefit plans for our Chief Executive Officer and all other executive officers;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">administering our equity compensation plans and the issuance of stock options and other stock-related awards not granted pursuant to a plan;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing, at least annually, our stock plans, performance goals, incentive awards and the overall composition and coverage of its compensation plans;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">preparing and providing the annual report on executive compensation that the SEC requires in our annual proxy statements;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing the results of any stockholder advisory vote on executive compensation and considering whether to recommend adjustments to the our executive compensation policies and practices as a result of such vote;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and recommending to our Board of Directors for approval the frequency with which we will conduct the stockholder advisory vote on named executive officer compensation, taking into account the results of the most recent stockholder advisory vote;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">evaluating risks arising from our compensation plans, policies and programs for our employees;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developing and implementing policies with respect to the recovery of any excess compensation paid to our executive officers based on erroneous data;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">evaluating and making recommendations to our Board of Directors about director compensation;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overseeing our overall compensation philosophy, compensation plans and benefits programs;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overseeing and reviewing our human capital management practices, including talent management and diversity, equity and inclusion considerations in the context of our compensation plans, programs and pay equity practices; and</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and evaluating, at least annually, the performance of the Compensation and Human Capital Committee and its members.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation and Human Capital Committee operates under a written charter that satisfies the applicable rules and regulations of the SEC and the Nasdaq Rules.  A copy of the charter of our Compensation and Human Capital Committee is available on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.caredx.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Corporate Governance section of our Investors webpage.  During fiscal year&#160;2023, our Compensation and Human Capital Committee held five standalone meetings and took action by written consent five times. As disclosed above, our Compensation and Human Capital Committee also held five joint meetings with our Audit and Finance Committee and our Governance and Nominating Committee during fiscal 2023.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation and Human Capital Committee adopted an Equity Award Grant Policy, pursuant to which our Compensation and Human Capital Committee delegated our Chief Executive Officer the power and authority, separately but concurrently with the power and authority of our Compensation and Human Capital Committee, to grant stock options, restricted stock awards and stock-settled stock appreciation rights under our&#160;2014 Equity Incentive Plan (as amended, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2014 Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to our employees (other than executives and directors), consultants or advisors of our company that are natural persons.  During fiscal year&#160;2023, Dr. Seeto, our former president and chief executive officer, and our office of the chief executive officer, which was formed on November 1, 2023, exercised his and its authority by written consent pursuant to this policy on an approximately monthly basis.</span></div><div id="i60d05261c6404879b68233510f10856b_58"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee Interlocks and Insider Participation</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No member of our Compensation and Human Capital Committee in&#160;2023 was at any time during&#160;2023 or at any other time an officer or employee of ours, and none had or have any relationships with us that are required to be disclosed under Item&#160;404 of Regulation&#160;S-K.  None of our executive officers has served as a member of the board of directors, or as a member of the compensation or similar committee, of any entity that has one or more executive officers who served on our Board of Directors or Compensation and Human Capital Committee during&#160;2023.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governance and Nominating Committee</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Governance and Nominating Committee is comprised of Michael D. Goldberg, Arthur A. Torres, George W. Bickerstaff, III and Hannah A. Valantine, M.D., each of whom is a non-employee member of our Board of Directors.  Senator Torres is the chairperson of our Governance and Nominating Committee.  Our Board of Directors has determined that each member of our Governance and Nominating Committee meets the requirements for independence under the Nasdaq Rules.  Our Governance and Nominating Committee is responsible for, among other things:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and making recommendations regarding the composition and size of our Board of Directors and determine the relevant criteria (including any minimum qualifications) for membership on our Board of Directors;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overseeing our Board of Directors&#8217; evaluation process, including conducting periodic evaluations of the performance of our Board of Directors as a whole and each committee of our Board of Directors, and evaluating the performance of members of our Board of Directors eligible for re-election;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and recommending candidates for election to our Board of Directors (including candidates proposed by our stockholders) at the annual meeting of stockholders in compliance with our policies and procedures for consideration of Board of Directors candidates;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing disclosures about our nomination process in our annual proxy statement;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and making recommendations about our corporate governance guidelines and overseeing compliance with laws and regulations by our Board of Directors and its committees;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overseeing and providing input to management on our risks, policies, strategies and programs related to matters of sustainability, corporate social responsibility, corporate culture, corporate governance, Environmental, Social and Governance (&#8220;ESG&#8221;)&#160;matters, as well as diversity, equity and inclusion (&#8220;DEI&#8221;)&#160;matters;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overseeing our compliance program, including policies and practices designed to ensure our compliance with applicable legal, regulatory and ethical requirements, except with respect to matters of financial compliance, which are the responsibility of the Audit and Finance Committee;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overseeing our response to regulatory actions and investigations (except for financial, accounting and internal control matters, which are responsibilities of the Audit and Finance Committee) and investigating any matter within the scope of its responsibilities that it determines appropriate;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">determining the manner in which stockholders may send communications to our Board of Directors, as well as the process by which stockholder communications will be relayed to our Board of Directors and what our Board of Directors&#8217; response, if any, should be;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing governance-related stockholder proposals and recommending our Board of Directors&#8217; responses;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and approving conflicts of interest of our directors and corporate officers, other than related party transactions reviewed by the Audit and Finance Committee; and</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and evaluating, at least annually, the performance of the Governance and Nominating Committee and its members.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Governance and Nominating Committee operates under a written charter that satisfies the Nasdaq Rules.  A copy of the charter of our Governance and Nominating Committee is available on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.caredx.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Corporate Governance section of our Investors webpage.  During fiscal year&#160;2023, our Governance and Nominating Committee held two standalone meetings and did not take any action by written consent. As disclosed above, our Governance and Nominating Committee also held five joint meetings with our Audit and Finance Committee and our Compensation and Human Capital Committee during fiscal 2023.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Science and Technology Committee</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Science and Technology Committee is comprised of Fred E. Cohen, M.D., D. Phil, Grace E. Col&#243;n, Ph.D., Christine M. Cournoyer, Peter Maag, Ph.D. and Hannah A. Valantine, M.D., each of whom is a non-employee member of our Board of Directors.  Dr. Col&#243;n is the chairperson of our Science and Technology Committee.  Our Science and Technology Committee is responsible for, among other things:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">meeting with our science and technology leaders to review our internal research and technology development activities and providing input as it deems appropriate;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing technologies that we consider for licensing or acquisition and providing input as it deems appropriate;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing our development of our technical goals and research and development strategies and providing input as it deems appropriate;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">periodically reporting to our Board of Directors regarding the Science and Technology Committee&#8217;s review and assessment of our internal technology development, technology assessment, technology review and technical goals and research and development strategies and any other matters as it deems appropriate; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and evaluating, at least annually, the performance of the Science and Technology Committee and its members.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Science and Technology Committee operates under a written charter.  During fiscal year&#160;2023, our Science and Technology Committee held four meetings and did not take any actions by written consent.</span></div><div id="i60d05261c6404879b68233510f10856b_61"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholder Feedback and Engagement</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that engaging with our stockholders is fundamental to our commitment to good governance and is essential in aligning our corporate governance practices with evolving best practices.  Throughout&#160;2023, we connected with our institutional and individual investors and other stakeholders to share and receive feedback on updates to our corporate governance practices and gain valuable insights into current and emerging global governance trends.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the past&#160;12&#160;months, we engaged with over&#160;50 institutional investors, representing the holders of over&#160;40% of our outstanding shares of common stock.  The key issues we discussed with our investors included Medicare reimbursement, management changes, board composition, sustainability reporting and disclosures, our long-term business strategy and other related matters.  We conducted these meetings throughout the year and organized a systematic outreach campaign to engage with our stockholders and receive feedback prior to preparing our proxy materials for the Annual Meeting.  Although stockholder engagement is primarily undertaken by our management, members of our Board of Directors also participate when appropriate.  We utilize the insights gained from these stockholder meetings as key inputs in improving and evolving our long-term corporate governance and sustainability practices.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strive to adopt a collaborative approach in these stockholder meetings, which contributed to our improved understanding of the variety of perspectives and motivations of our investors.  While not exhaustive, some examples of key feedback from our stockholders in the past&#160;12&#160;months included (i)&#160;suggestions for improved disclosure regarding the mix of skills of our Board of Directors; (ii)&#160;suggestions for improved board diversity disclosure; (iii)&#160;appreciation for our improved stockholder engagement efforts; and (iv)&#160;dialogue regarding the continued evaluation of our corporate governance practices.  In response to our dialogue with our stockholders on corporate governance matters in and after 2023 and in line with our commitment to good governance, we have enhanced the Board of Directors&#8217; oversight of financial and treasury policies and strategies by amending our Audit and Finance Committee charter to explicitly state that the Audit and Finance Committee has oversight over such matters.  In addition, in response to our stockholders&#8217; continued interests in ESG and DEI matters, we have strengthened the Board of Directors&#8217; oversight of our ESG and DEI program by amending our Governance and Nominating Committee charter to explicitly include responsibilities for oversight of ESG and DEI related matters.  We have also amended our Compensation and Human Capital Committee charter to expand oversight of critical human capital matters.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also recognize that many investors believe that the election of directors is the primary means for stockholders to influence corporate governance policies and hold management accountable for implementing those policies.  As part of our regular review and consideration of our corporate governance practices, and taking into account conversations with our stockholders, in 2023 our Board of Directors determined that it was in the best interests of the Company and our stockholders to gradually declassify the Board of Directors. Accordingly the Board presented the gradual declassification of our Board of Directors for approval by our stockholders at our 2023 Annual Meeting of Stockholders and our stockholders approved the proposal at the meeting. In addition, in response to the feedback we received from our stockholders in 2023, we shared the feedback with our Board of Directors and enhanced the relevant disclosures in our proxy materials.  Please see the sections titled &#8220;Board Diversity of Skills and Expertise,&#8221; &#8220;Board Diversity Matrix&#8221; and &#8220;Board and Committee Meetings&#8221; for additional information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_64"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Diversity Matrix</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides an enhanced disclosure regarding the diversity of the members and nominees of our Board of Directors.  Each of the categories listed in the below table has the meaning as it is used in Nasdaq Rule&#160;5605(f).</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Board Diversity Matrix (As of April 29, 2024)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Board Size:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Number of Directors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Male</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Female</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Binary</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gender Undisclosed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part I: Gender Identity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of directors based on gender identity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II: Demographic Background</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">African American or Black</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaskan Native or Native American</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asian</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hispanic or Latinx</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Native Hawaiian or Pacific Islander</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">White</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Two or More Races or Ethnicities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LGBTQ+</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Did not Disclose Demographic Background</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div id="i60d05261c6404879b68233510f10856b_67"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholder Recommendations for Nominations to the Board of Directors</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Governance and Nominating Committee will consider candidates for director recommended by stockholders holding at least one percent of our fully diluted capitalization continuously for at least&#160;12&#160;months prior to the date of the submission of the recommendation.  Our Governance and Nominating Committee will evaluate such recommendations in accordance with its charter, our Bylaws, our policies and procedures for director candidates, as well as the regular director nominee criteria described above.  This process is designed to ensure that our Board of Directors includes members with diversity of experience, skills and experience, including appropriate financial and other expertise relevant to our business.  Stockholders wishing to recommend a candidate for nomination should contact our Corporate Secretary in writing.  Such recommendations must include the candidate&#8217;s name, home and business contact information, detailed biographical data, relevant qualifications, a signed letter from the candidate confirming willingness to serve on our Board of Directors, information regarding any relationships between the candidate and CareDx and evidence of the recommending stockholder&#8217;s ownership of our common stock.  Such recommendations must also include a statement from the recommending stockholder in support of the candidate, particularly within the context of the criteria for Board of Directors&#8217; membership.  Our Governance and Nominating Committee has discretion to decide which individuals to recommend for nomination as directors.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A stockholder can nominate a candidate directly for election to our Board of Directors by complying with the procedures in Section&#160;2.4(ii) of our Bylaws and the rules and regulations of the SEC.  Any eligible stockholder who wishes to submit a nomination should review the requirements in our Bylaws on nominations by stockholders.  Any nomination should be sent in writing to our Corporate Secretary at CareDx, Inc., 8000 Marina Boulevard, 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Floor, Brisbane, California&#160;94005.  To be timely for our&#160;2025 annual meeting of stockholders, our Corporate Secretary must receive the nomination no earlier than February 13, 2025 and no later than March 15, 2025.  The notice must state the information required by Section&#160;2.4(ii) of our Bylaws and otherwise must comply with applicable federal and state law.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, pursuant to Rule&#160;14a-19, the SEC&#8217;s universal proxy rule, notices of a solicitation of proxies in support of director nominees other than our own nominees must be postmarked or electronically submitted no later than April 14, 2025, and each nomination must comply with the SEC regulations under Rule&#160;14a-19, which requires, among other things, that such notice include a statement that such person intends to solicit the holders of shares representing at least&#160;67% of the voting power of shares entitled to vote on the election of directors.  If, however, the date of the&#160;2025 annual meeting of stockholders is more than&#160;30&#160;days before or after June 13, 2025, then the Rule&#160;14a-19 deadline shall be the later of&#160;60 calendar days prior to the date of the&#160;2025 annual meeting of stockholders or the&#160;10th calendar day following the day on </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which we first make a public announcement of the date of our&#160;2025 annual meeting of stockholders.  A nomination that does not comply with the requirements set forth in the Certificate of Incorporation and Bylaws will not be considered for presentation at the annual meeting.  We intend to file a proxy statement and white proxy card with the SEC in connection with our solicitation of proxies for our&#160;2025 annual meeting of stockholders.</span></div><div id="i60d05261c6404879b68233510f10856b_70"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Communications with the Board of Directors</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders wishing to communicate with our Board of Directors or with an individual member of our Board of Directors may do so by writing to our Board of Directors or to the particular member of our Board of Directors, and mailing the correspondence to our Chief Financial Officer at CareDx, Inc., 8000 Marina Boulevard, 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Floor, Brisbane, California&#160;94005.  Our Chief Financial Officer will review all incoming stockholder communications (excluding mass mailings, product complaints or inquiries, job inquiries, business solicitations and patently offensive or otherwise inappropriate material), and if deemed appropriate, the stockholder communications will be forwarded to the appropriate member or members of our Board of Directors, or if none is specified, to the Chairperson of the Board of Directors.  This procedure does not apply to stockholder proposals submitted pursuant to Rule&#160;14a-8 under the Exchange Act.</span></div><div id="i60d05261c6404879b68233510f10856b_73"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Governance Guidelines and Code of Business Conduct and Ethics</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has adopted Corporate Governance Guidelines.  These guidelines address items such as the qualifications and responsibilities of our directors and director candidates and corporate governance policies and standards applicable to us in general.  In addition, our Board of Directors has adopted a Code of Business Conduct and Ethics that applies to all of our employees, officers and directors, including our Chief Executive Officer, Chief Financial Officer, and other executive and senior financial officers.  The full text of our Corporate Governance Guidelines and our Code of Business Conduct and Ethics is posted on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.caredx.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Corporate Governance section of our Investors webpage.  We intend to post any amendments to our Code of Business Conduct and Ethics, and any waivers of our Code of Business Conduct and Ethics for directors and executive officers, on the same website.</span></div><div id="i60d05261c6404879b68233510f10856b_76"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clawback Policy</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective October 1, 2023, our Board of Directors adopted a restated compensation recovery (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">clawback</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) policy pursuant to the listing standards approved by The Nasdaq Stock Market LLC implementing Rule&#160;10D-1 under the Exchange Act. The clawback policy is administered by our Compensation and Human Capital Committee and applies to current and former executive officers of the Company as defined in Rule 10D-1 (each an &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Affected Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). U</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nder the&#160;clawback policy, if the Company is required to prepare an accounting restatement to correct the Company&#8217;s material noncompliance with any financial reporting requirement under securities laws, including restatements that correct an error in previously issued financial statements that is material to the previously issued financial statements or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (collectively, a &#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restatement</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Company is obligated to recover erroneously awarded incentive-based compensation received from the Company by Affected Officers. Incentive-based compensation includes any compensation that is granted, earned or vested based in whole or in part on the attainment of a financial reporting measure.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Erroneously awarded incentive-based compensation is the amount of incentive-based compensation received that exceeds the amount of incentive-based compensation that otherwise would have been received had it been determined based on an applicable Restatement.</span></div><div id="i60d05261c6404879b68233510f10856b_79"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Employee Director Stock Ownership Policy</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation and Human Capital Committee has adopted a stock ownership policy that is applicable to each of our non-employee directors.  Our Compensation and Human Capital Committee believes this policy is an important tool in aligning the interests of our non-employee directors with the long-term interests of our stockholders.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This policy requires that our non-employee directors hold shares of our common stock with a value equal to at least&#160;300% of such director&#8217;s annual cash retainer for service on our Board of Directors (excluding service on any committee of our Board of Directors).  For purposes of calculating ownership under this policy, the following sources are included: shares held in the director&#8217;s name; shares held in trust for the benefit of the director or his or her family; shares held by the director jointly with, or separately by, certain family members of the director; shares held by the director through a profit sharing or savings plan; the &#8220;in the money&#8221; portion of vested, but unexercised, stock options or stock-settled stock appreciation rights; shares issued or vested pursuant to the achievement of the performance conditions of a performance-based equity award even if such shares are subject to additional time-based vesting requirements (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vested Performance </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;); vested restricted stock unit awards; deferred share units; shares held by the director under any deferral plan; and restricted stock or phantom stock held by the director.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following shares do not count towards the requirements: (i)&#160;shares that directors have the right to acquire through the exercise of stock options or stock appreciation rights that are not &#8220;in the money&#8221;, (ii)&#160;shares underlying stock options or stock appreciation rights that have not yet vested or (iii)&#160;shares that may be issued pursuant to unvested performance-based restricted stock units (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PRSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or other performance-based equity awards (other than Vested Performance Awards).</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of these requirements, a director&#8217;s annual cash retainer shall be deemed to be the director&#8217;s annual cash retainer earned by such director for the calendar year immediately preceding the applicable date of calculation.  To give our non-employee directors time to comply with our stock ownership policy, the policy provides that our non-employee directors have until the later of our&#160;2024 annual meeting of stockholders or the first annual meeting of stockholders held after the date that is six years following their appointment as a director to comply with the stock ownership provisions in the policy.</span></div><div id="i60d05261c6404879b68233510f10856b_82"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Officer Stock Ownership Policy</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation and Human Capital Committee adopted a stock ownership policy that is applicable to each of our executive officers.  Our Compensation and Human Capital Committee believes this policy is an important tool in aligning the interests of our executive officers with the long-term interests of our stockholders.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This policy requires that our executive officers hold shares of our common stock with a value equal to a multiple of his or her base salary, as follows: 3X in the case of our Chief Executive Officer and&#160;1X in the case of each of our other executive officers.  For purposes of calculating ownership under this policy, the following sources are included: shares held in the executive officer&#8217;s name; shares held in trust for the benefit of the executive officer or his or her family; shares held by the executive officer jointly with, or separately by, certain family members of the executive officer; shares held by the executive officer through a profit sharing or savings plan; the &#8220;in the money&#8221; portion of vested, but unexercised, stock options or stock-settled stock appreciation rights; Vested Performance Awards; vested restricted stock unit awards; deferred share units; shares held by the executive officer under any deferral plan; and restricted stock or phantom stock held by the executive officer.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following shares do not count towards the requirements: (i)&#160;shares that the executive officers have the right to acquire through the exercise of stock options or stock appreciation rights that are not &#8220;in the money&#8221;, (ii)&#160;shares underlying stock options or stock appreciation rights that have not yet vested or (iii)&#160;shares that may be issued pursuant to unvested PRSUs or other performance-based equity awards (other than Vested Performance Awards).</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of these requirements, an executive officer&#8217;s base salary during any calendar year is deemed to be his or her base salary as of the close of business on December&#160;31st of the immediately preceding year.  To give our executive officers time to comply with our stock ownership policy, the policy provides that our executive officers have until the later of our&#160;2024 annual meeting of stockholders or the first annual meeting of stockholders held after the date that is six years following the date such individual first becomes an executive officer to comply with the stock ownership provisions in the policy.</span></div><div id="i60d05261c6404879b68233510f10856b_88"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board of Directors&#8217; Role in Risk Oversight</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk is inherent with every business, and we face a number of risks, including strategic, financial, business and operational, legal and compliance, and reputational risks.  We have designed and implemented processes to manage risk in our operations.  Management is responsible for the day-to-day management of risks we face, while our Board of Directors, as a whole and assisted by its committees, has responsibility for the oversight of risk management.  In its risk oversight role, our Board of Directors has the responsibility to satisfy itself that the risk management processes designed and implemented by management are appropriate and functioning as designed.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors believes that open communication between management and our Board of Directors is essential for effective risk management and oversight.  Our Board of Directors meets with our Chief Executive Officer and other members of the senior management team at quarterly meetings of our Board of Directors, where, among other topics, they discuss strategy and risks facing us, as well as at such other times as they deem appropriate.  Moreover, our management regularly briefs our Board of Directors with respect to environmental and social risk, information and cybersecurity risk, enterprise risk and other governance matters.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our Board of Directors is ultimately responsible for risk oversight, our board committees assist our Board of Directors in fulfilling its oversight responsibilities in certain areas of risk.  Our Audit and Finance Committee assists our Board of Directors in fulfilling its oversight responsibilities with respect to risk management in the areas of internal control over financial reporting and disclosure controls and procedures, legal and regulatory compliance, and discusses with management and the independent auditor guidelines and policies with respect to risk assessment and risk management.  Our Audit and Finance Committee also reviews our major financial risk exposures, including liquidity risks, and the steps management has taken to monitor and control these exposures.  In addition, our Audit and Finance Committee monitors certain key risks on a regular basis throughout the fiscal year, such as risk associated with internal control over financial reporting and liquidity risk, as well as cybersecurity risks as further described below.  Our Governance and Nominating Committee assists our Board of Directors in fulfilling its oversight responsibilities with respect to the management of risk associated with board organization, membership and structure and corporate governance.  Our Compensation and Human Capital Committee assesses risks created by the incentives inherent in our compensation and human capital policies.  Finally, our full Board of Directors reviews strategic and operational risk in the context of reports from the management team, receives reports on all significant committee activities at each regular meeting, and evaluates the risks inherent in significant transactions.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to cybersecurity risks, our Board of Directors and Audit and Finance Committee each receive regular presentations and reports on developments in the cybersecurity space, including risk management practices, recent developments, evolving standards, vulnerability assessments, third-party and independent reviews, the threat environment, technological trends, and information security issues encountered by our peers and third parties. Our Board of Directors and Audit and Finance Committee also receive prompt and timely information regarding any cybersecurity risk that meets pre-established reporting thresholds. Annually, our Board of Directors and Audit and Finance Committee discuss our approach to overseeing cybersecurity threats with our Chief Information Security Officer/Chief Information Officer and other senior management members.  We also conduct periodic assessments and testing of our policies, standards, processes, and practices in a manner designed to address cybersecurity threats and events. The results of such assessments, audits, and reviews are evaluated by management and reported to our Audit and Finance Committee, and we adjust our cybersecurity policies, standards, processes, and practices as necessary based on the information provided by these assessments, audits, and reviews. For further information regarding our oversight of cybersecurity risks, please see the &#8220;Cybersecurity&#8221; section of our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023 that was filed with the SEC on February 28, 2024.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Workforce Diversity</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have zero-tolerance policy for discrimination.  In&#160;2021, we established a Diversity, Equity, and Inclusion committee to engage, retain and develop talent from diverse backgrounds by facilitating diversity, equity and inclusion advocacy through event sponsorship, learning and client engagement.  We have increased the diversity of our Board of Directors and leadership teams and will continue to focus on maintaining a diverse organization.  Our employees come from numerous countries and various backgrounds and we strive to provide a diverse and inclusive environment.  Our senior leadership team includes leaders with diverse skills, experience, racial backgrounds and genders.</span></div><div id="i60d05261c6404879b68233510f10856b_91"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Compensation</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Policy</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors who are employees do not receive any additional compensation for their service on our Board of Directors.  We reimburse our non-employee directors for their reasonable out-of-pocket costs and travel expenses in connection with their attendance at Board of Directors and committee meetings in accordance with our travel policy.  In&#160;2023, our non-employee directors received cash compensation, restricted stock unit awards and options to purchase shares of our common stock pursuant to our outside director compensation policy in effect during&#160;2023 as set forth below.  Pursuant to our outside director compensation policy, during fiscal&#160;2023 through March 31, 2023, our non-employee directors received an annual retainer of $40,000 for their service on our Board of Directors, members of our Audit and Finance Committee, Compensation and Human Capital Committee, Governance and Nominating Committee and Science and Technology Committee, other than the chairperson of each such committee, received an additional annual retainer of $10,000, $6,000, $5,000 and $5,000, respectively, the chairperson of our Audit and Finance Committee, Compensation and Human Capital Committee, Governance and Nominating Committee and Science and Technology Committee each received an additional annual retainer of $20,000, $12,000, $10,000 and $10,000, respectively, and the independent Chairperson of our Board of Directors received an additional annual retainer of $80,000, in all cases pro-rated for the three-month period. Effective April&#160;1, 2023, our Compensation and Human Capital Committee approved an amendment and restatement of our outside </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">director compensation policy, pursuant to which the annual cash retainer for the outside directors was increased to $45,000, the annual cash retainer for the chairperson of the Compensation and Human Capital Committee was increased to $15,000 and the annual cash retainer for the other members of the Compensation and Human Capital Committee was increased to $7,500, in all cases pro-rated for the nine-month period between April 1, 2023 and December 31, 2023. Effective December 21, 2023, our Compensation and Human Capital Committee approved an amendment and restatement of our outside director compensation policy, pursuant to which our independent Board Chairperson receives an additional annual cash retainer of $45,000 in his capacity as Board Chairperson (totaling $125,000 on an annualized basis), beginning with the quarter ended December 31, 2023.  All annual retainers were paid quarterly and pro-rated for partial service in any year.  Our non-employee directors are entitled to elect the ratio of shares of our common stock to cash issuable or payable to the non-employee director for the payment of the annual retainers.  </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our outside director compensation policy, any director first appointed to our Board going forward is automatically granted, on a nondiscretionary basis, an option to purchase shares of our common stock having a grant date fair value of $100,000, rounded down to the nearest whole share, at an exercise price equal to the fair market value of our common stock on the grant date, and an award of restricted stock units (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) having a grant date fair value of $100,000, rounded down to the nearest whole share.  Each of these options vests and become exercisable in equal monthly installments beginning with the first monthly anniversary after the grant date over the following three years, and each of these RSUs vests at a rate of one-third on each one-year anniversary of the grant date.  The vesting of the options and the RSUs described above will accelerate in full upon a &#8220;change in control,&#8221; as defined in our&#160;2014 Plan. In addition, for 2023, on the first business day after each annual meeting of our stockholders, each non-employee director who continues to serve on our Board of Directors was automatically granted, on a nondiscretionary basis, an option to purchase shares of our common stock having a grant date fair value of $150,000, rounded down to the nearest whole share, at an exercise price equal to the fair market value of our common stock on the grant date, and an award of RSUs having a grant date fair value of $150,000, rounded down to the nearest whole share.  Each of these options vests and becomes exercisable in equal monthly installments beginning with the first monthly anniversary after the grant date over the following one year, and each of these RSUs vests in one installment on the one year anniversary of the grant date.  The vesting of the options and the RSUs described above will accelerate in full upon a &#8220;change in control,&#8221; as defined in our&#160;2014 Plan. In addition, pursuant to our outside director compensation policy, in January 2024, Mr. Goldberg, our independent Board Chairperson, received an additional award of restricted stock units having a grant date fair value of $200,000, rounded down to the nearest whole share, which will vest in full on the one-year anniversary of the grant date and will accelerate in full upon a &#8220;change in control,&#8221; as defined in our&#160;2014 Plan.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any provisions in our outside director compensation policy, pursuant to the terms of our 2014 Plan, (a) no outside director may be granted, in any fiscal year, cash-settled equity awards with a grant date fair value (determined in accordance with U.S. generally accepted accounting principles) of greater than $300,000, increased to $500,000 in the fiscal year of such director&#8217;s initial service as an outside director, and (b) subject to the provisions of Section 14 of the 2014 Plan, no outside director may be granted, in any fiscal year, equity awards covering more than 250,000 shares of common stock, increased to 500,000 shares of common stock in the fiscal year of such director&#8217;s initial service as an outside director. See &#8220;Proposal No. 4 (Approval of 2024 Equity Incentive Plan)&#8221; for a discussion of new outside director compensation limits that would become effective if our 2024 Equity Incentive Plan is approved by our stockholders at the Annual Meeting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Compensation Table</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the compensation accrued or paid by us to our non-employee directors during the year ended December&#160;31, 2023 for service on our Board of Directors and its committees.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.678%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fees Earned or<br/>Paid in Cash<br/>($)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt;padding-right:3.1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Awards</span></div><div style="padding-left:1.55pt;padding-right:1.55pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt;padding-right:3.1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Option Awards</span></div><div style="padding-left:1.55pt;padding-right:1.55pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total ($)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael D. Goldberg</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 4.1pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156,032</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,998</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,995</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">George W. Bickerstaff, III</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,750</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,998</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,995</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,743</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fred E. Cohen, M.D., D. Phil</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,998</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,995</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355,868</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grace E. Col&#243;n, Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,875</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,998</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,995</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,868</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine M. Cournoyer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.1pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84,453</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,998</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,995</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384,446</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter Maag, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.1pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54,935</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,998</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,995</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,928</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William A. Hagstrom</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,875</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,998</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,995</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,868</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arthur A. Torres</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,750</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,998</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,995</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,743</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hannah A. Valantine, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,750</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,998</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,995</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,743</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts represent the aggregate fair value of the stock awards computed as of the grant date of each stock award in accordance with Financial Accounting Standards Board (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">FASB</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;) Accounting Standards Codification (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">ASC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;)&#160;Topic&#160;718.  Our assumptions with respect to the calculation of these values are set forth in Note&#160;13 of the consolidated financial statements included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023 that was filed with the SEC on February 28, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As of December&#160;31, 2023, each of our then-current non-employee directors held the following number of RSUs: Mr. Goldberg: 21,457; Mr. Bickerstaff: 18,844; Dr. Cohen: 18,844; Dr. Col&#243;n: 18,844; Ms. Cournoyer: 18,844; Mr. Hagstrom: 18,844; Dr. Maag: 227,036; Senator Torres: 19,596 and Dr. Valantine: 19,387.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts represent the aggregate fair value of the option awards computed as of the grant date of each option award in accordance with FASB ASC Topic&#160;718.  Our assumptions with respect to the calculation of these values are set forth in Note&#160;13 of the consolidated financial statements included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023 that was filed with the SEC on February 28, 2024.  There can be no assurance that option awards will be exercised (in which case no value will be realized by the individual) or that the value on exercise will approximate the fair value as computed in accordance with FASB ASC Topic&#160;718.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As of December&#160;31, 2023, each of our then-current non-employee directors held options to purchase the following number of shares of common stock: Mr. Goldberg: 114,151; Mr. Bickerstaff: 75,419; Dr. Cohen: 47,683; Dr. Col&#243;n: 50,100; Ms. Cournoyer: 53,832; Mr. Hagstrom: 68,886; Dr. Maag:  237,692; Senator Torres: 38,997 and Dr. Valantine:  38,372.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Mr. Goldberg elected to receive part of his annual cash retainer fees in the form of unrestricted shares of our common stock pursuant to our outside director compensation policy.  Mr. Goldberg was paid $48,645 in cash retainer fees and the remaining $107,387 of the reported amount represents the aggregate fair value of the stock awards granted to Mr. Goldberg in lieu of annual cash retainers computed as of the grant date of each stock award in accordance with FASB ASC Topic&#160;718.  Our assumptions with respect to the calculation of these values are set forth in Note&#160;13 of the consolidated financial statements included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023 that was filed with the SEC on February 28, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Ms. Cournoyer elected to receive part of her annual cash retainer fees in the form of unrestricted shares of our common stock pursuant to our outside director compensation policy.  Ms. Cournoyer was paid $41,752 in cash retainer fees and the remaining $42,701 of the reported amount represents the aggregate fair value of the stock awards granted to Ms. Cournoyer in lieu of annual cash retainers computed as of the grant date of each stock award in accordance with FASB ASC Topic&#160;718.  Our assumptions with respect to the calculation of these values are set forth in Note&#160;13 of the consolidated financial statements included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023 that was filed with the SEC on February 28, 2024.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Dr. Maag elected to receive all of his annual cash retainer fees in the form of unrestricted shares of our common stock pursuant to our outside director compensation policy. The reported amount represents the aggregate fair value of the stock awards granted to Dr. Maag in lieu of annual cash retainers computed as of the grant date of each stock award in accordance with FASB ASC Topic&#160;718.  Our assumptions with respect to the calculation of these values are set forth in Note&#160;13 of the consolidated financial statements included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023 that was filed with the SEC on February 28, 2024.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferral Election Program</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December&#160;2018, our Compensation and Human Capital Committee approved an RSU and performance unit deferral election program, which is still in effect, pursuant to which our non-employee directors, executive officers and certain other employees may elect, on an annual basis, to defer the settlement of all RSU and performance unit awards granted to such individuals until the first to occur of (i)&#160;a &#8220;change in control,&#8221; as defined in our&#160;2014 Plan, (ii)&#160;the individual&#8217;s death, or (iii)&#160;a specified number of years following the individual&#8217;s separation of service with us, in which case the shares will settle in a number of substantially equal annual installments selected by the individual, on every June&#160;30 starting in the calendar year immediately following the year in which the individual incurs a separation of service.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-employee directors who elect to defer the settlement of RSU and performance units must make these deferral elections by the end of the calendar year preceding the date of the grant of the stock award (or on such earlier date as specified by us).  As of December&#160;31, 2023, none of our non-employee directors held any deferred stock awards, except for Mr. Goldberg, who elected to defer the settlement of RSUs with an aggregate value of $31,356 as of December 31, 2023, and Dr. Maag, who elected to defer the settlement of RSUs with an aggregate value of $2,914,464 as of December 31, 2023.  Not only does the RSU and performance unit deferral election program allow our eligible participants to defer the federal income taxes otherwise payable upon the delivery of RSUs, but our Compensation and Human Capital Committee also believes that with respect to non-employee directors and executives who avail themselves of the deferral features, such person will necessarily hold our common stock for a longer period of time.  Accordingly, any deferred RSUs will continue to align such portion of our non-employee directors&#8217; and named executive officers&#8217; compensation with the interests of our stockholders for a longer period of time than would be provided by typical vesting periods.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 2</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RATIFICATION OF APPOINTMENT OF</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Audit and Finance Committee has appointed Deloitte &amp; Touche LLP (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deloitte</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) as our independent registered public accounting firm to audit our consolidated financial statements for our fiscal year ending December 31, 2024.  Deloitte also served as our independent registered public accounting firm for our fiscal year ended December&#160;31, 2023.  Deloitte was appointed as our independent registered public accounting firm on April&#160;10, 2018.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Annual Meeting, stockholders are being asked to ratify the appointment of Deloitte as our independent registered public accounting firm for our fiscal year ending December 31, 2024.  Stockholder ratification of the appointment of Deloitte is not required by our Bylaws or other applicable legal requirements.  However, our Board of Directors is submitting the appointment of Deloitte to our stockholders for ratification as a matter of good corporate governance.  In the event that this appointment is not ratified by the affirmative vote of a majority of the shares present virtually or by proxy at the Annual Meeting and entitled to vote, such appointment will be reconsidered by our Audit and Finance Committee.  Even if the appointment is ratified, our Audit and Finance Committee, in its sole discretion, may appoint another independent registered public accounting firm at any time during our fiscal year ending December 31, 2024 if our Audit and Finance Committee believes that such a change would be in the best interests of CareDx and its stockholders.  A representative of Deloitte is expected to be present at the Annual Meeting.  Such representative will have an opportunity to make a statement if he or she wishes to do so and is expected to be available to respond to appropriate questions from stockholders.</span></div><div id="i60d05261c6404879b68233510f10856b_97"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fees Paid to the Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth fees in connection with services rendered by Deloitte, our independent registered public accounting firm, for our fiscal years ended December 31, 2023 and 2022.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:70.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 4.12pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,262,072</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 4.12pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,894,833</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,375</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Other Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,895</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 4.12pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265,862</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 4.12pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,962,103</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Audit Fees include fees and out-of-pocket expenses, whether or not yet invoiced, for professional services associated with the annual audit of our financial statements, the reviews of our interim financial statements, statutory audits, issuance of consents and comfort letters in connection with public offerings and registration statement filings with the SEC.  Audit fees include audit services provided in connection with the accounting for acquisitions in 2023.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Tax Fees include fees for corporate tax advisory.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">All Other Fees include any fees billed that are not audit, audit-related or tax fees.  All other fees include fees for a subscription service to a technical accounting research tool.</span></div><div id="i60d05261c6404879b68233510f10856b_100"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Auditor Independence</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In&#160;2023, there were no other professional services provided by Deloitte that would have required our Audit and Finance Committee to consider their compatibility with maintaining the independence of Deloitte.</span></div><div id="i60d05261c6404879b68233510f10856b_103"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit and Finance Committee Policy on Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Audit and Finance Committee has established a policy governing our use of the services of our independent registered public accounting firm.  Under the policy, our Audit and Finance Committee is required to pre-approve all audit and permissible non-audit services performed by our independent registered public accounting firm to ensure that the provision of such services does not impair such accounting firm&#8217;s independence.  The policy generally pre-approves specified services in the defined categories of audit services, audit-related services, tax services and other services up to specified amounts.  The pre-approval of services may be delegated to one or more of the Audit and Finance Committee&#8217;s members, but the decision must be reported to the full Audit and Finance Committee at its next scheduled meeting.  In the years ended December&#160;31, 2023 and&#160;2022, services and related fees identified above under the captions &#8220;Audit Fees,&#8221; &#8220;Tax </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fees,&#8221; and &#8220;All Other Fees&#8221; that were billed by Deloitte were approved by the Audit and Finance Committee in accordance with SEC requirements.</span></div><div id="i60d05261c6404879b68233510f10856b_106"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required; Board Recommendation</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ratification of the appointment of Deloitte requires the affirmative vote of a majority of the shares of our common stock present virtually or by proxy at the Annual Meeting and entitled to vote thereon.  Abstentions will have the effect of a vote AGAINST the proposal.  Broker non-votes will have no effect on this proposal.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUR BOARD OF DIRECTORS RECOMMENDS A VOTE &#8220;FOR&#8221; THE RATIFICATION OF THE APPOINTMENT OF DELOITTE &amp; TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2024.</span></div><div id="i60d05261c6404879b68233510f10856b_109"></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AUDIT AND FINANCE COMMITTEE REPORT</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The information contained in the following Audit and Finance Committee Report shall not be deemed to be soliciting material or to be filed with the Securities and Exchange Commission, nor shall such information be incorporated by reference into any future filing under the Securities Act of&#160;1933, as amended, or the Securities Exchange Act of&#160;1934, as amended, except to the extent that CareDx, Inc. (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8221;) specifically incorporates it by reference in such filing.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit and Finance Committee has reviewed and discussed the Company&#8217;s audited consolidated financial statements with management and Deloitte &amp; Touche LLP (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deloitte</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Company&#8217;s independent registered public accounting firm.  The Audit and Finance Committee has discussed with Deloitte the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board and the Securities and Exchange Commission (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SEC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit and Finance Committee has received and reviewed the written disclosures and the letter from Deloitte required by the applicable requirements of the Public Company Accounting Oversight Board regarding Deloitte&#8217;s communications with the Audit and Finance Committee concerning independence, and has discussed with Deloitte its independence.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the review and discussions referred to above, the Audit and Finance Committee recommended to the Board of Directors that the Company&#8217;s audited consolidated financial statements be included in the Company&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2023 for filing with the SEC.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Respectfully submitted by the members of the Audit and Finance Committee of the Board of Directors:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">George W. Bickerstaff, III</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Christine M. Cournoyer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michael D. Goldberg</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">William A. Hagstrom</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 3</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADVISORY VOTE ON EXECUTIVE COMPENSATION</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the proxy rules under the Exchange Act and as required by Section&#160;951 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, we are presenting to our stockholders with a non-binding, advisory vote to approve the compensation of our named executive officers as described in this proxy statement.  This proposal is commonly referred to as a &#8220;Say-on-Pay&#8221; proposal.  In accordance with the results of the advisory vote held at our&#160;2020 annual meeting of stockholders on the frequency of future say-on-pay votes, we are conducting say-on-pay votes every year.  After the Annual Meeting, our next say-on-pay vote will be held at our&#160;2025 annual meeting of stockholders.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation of our named executive officers is designed to attract, motivate and retain talented and experienced executives, who are critical to our success.  Our executive compensation contains elements of cash and equity-based compensation.  Our Board of Directors and our Compensation and Human Capital Committee believe that our executive compensation directly and substantially link rewards to measurable corporate performance and are designed to align the interests of our named executive officers with those of our stockholders and to reward our named executive officers for the achievement of our near-term and longer-term financial and strategic goals.  The process for determining compensation packages requires that our Board of Directors and our Compensation and Human Capital Committee use judgment and experience to determine the optimal components and amounts of compensation for each named executive officer.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Say-on-Pay vote gives you as a stockholder the opportunity to express your views regarding the compensation of our named executive officers by voting to approve or not approve such compensation as described in this proxy statement.  This vote is advisory and will not be binding upon our Board of Directors or our Compensation and Human Capital Committee.  However, our Board of Directors and our Compensation and Human Capital Committee value the opinion of our stockholders and will take into account the outcome of the vote when considering future executive compensation arrangements.  The vote on this resolution is not intended to address any specific element of compensation, but rather relates to the overall compensation of our named executive officers, as described in this proxy statement in accordance with the compensation disclosure rules of the SEC.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We encourage our stockholders to read the &#8220;Executive Compensation&#8221; section in this proxy statement, including the compensation tables and the related narrative disclosure, which describes the structure and amounts of the compensation of our named executive officers in fiscal year&#160;2023.</span></div><div id="i60d05261c6404879b68233510f10856b_115"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required; Board Recommendation</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The advisory approval of this Proposal No. 3 requires the affirmative vote of a majority of the shares of our common stock present virtually or by proxy at the Annual Meeting and entitled to vote thereon.  Abstentions will have the effect of a vote AGAINST the proposal.  Broker non-votes will have no effect on this proposal.  Although this vote is advisory in nature and does not impose any action on our Board of Directors or our Compensation and Human Capital Committee, we strongly encourage all stockholders to vote on this matter.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUR BOARD OF DIRECTORS RECOMMENDS A VOTE &#8220;FOR&#8221; THE APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THIS PROXY STATEMENT.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 4</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APPROVAL OF 2024 EQUITY INCENTIVE PLAN</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to incentivize our employees and other service providers, our Board of Directors adopted the 2024 Plan, subject to stockholder approval at the Annual Meeting. If the 2024 Plan is approved by our stockholders, it will become effective on the date of our Annual Meeting (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). No further grants may be made under the 2014 Plan. However, the terms and conditions of the 2014 Plan will continue to govern any outstanding awards thereunder.</span></div><div id="i60d05261c6404879b68233510f10856b_121"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares Reserved Under the 2024 Plan</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initially, the maximum number of shares of our common stock that may be issued under the 2024 Plan will not exceed 3.5 million shares of our common stock. The maximum number of shares of our common stock that may be issued on the exercise of incentive stock options (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ISOs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the 2024 Plan is 3.5 million shares. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Compensation and Human Capital Committee&#8217;s recommendation to our Board of Directors to approve the 2024 Plan, including the total number of shares proposed to be reserved for issuance under the 2024 Plan, the Compensation and Human Capital Committee considered the March 2024 expiration date of the 2014 Plan and advice from Alpine Rewards, its independent compensation consultant. The Compensation and Human Capital Committee also carefully analyzed our historical burn rate, anticipated future equity award needs to help drive our long-term strategic plan and the dilutive impact of the 2024 Plan&#8217;s share reserve.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the 2024 Plan is not approved, we will not be able to grant stock options, restricted shares, restricted stock units (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), performance equity awards or other forms of equity incentives and we would be forced to consider cash replacement alternatives to provide a market-competitive total compensation package necessary to attract, retain and motivate the employee talent critical to our future successes. These cash replacement alternatives could, among other things, reduce the cash available for investment in growth and development and misalign the interests of our employees and other service providers from the long-term interests of our stockholders. Accordingly, if the 2024 Plan is not approved, we would likely be required to again seek approval from our stockholders of a new equity incentive plan at a special meeting of stockholders prior to our 2025 annual meeting of stockholders, which would increase costs and would be a distraction from our management team&#8217;s execution of our business goals.</span></div><div id="i60d05261c6404879b68233510f10856b_124"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Important Considerations</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the following are important considerations for stockholders in determining whether to approve the 2024 Plan:</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Equity Awards are Essential to Talent Acquisition and Retention:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity awards, similar to those typically offered by our competitors are, and we believe will continue to be, an integral component of our overall compensation program, enabling us to attract qualified and skilled employees and directors, retain our existing employees, including our experienced management team and provide incentives for our employees to exert maximum efforts for our success, ultimately contributing to the creation of stockholder value. If the 2024 Plan is not approved by our stockholders at the Annual Meeting, we will not have the ability to grant equity awards to all our employees and directors in and after 2024.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Broad-based Eligibility for Equity Awards:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our equity incentive program is broad-based, with all eligible employees in good standing eligible to receive equity awards annually as part of our annual performance review based upon level, performance and contribution. Furthermore, since we have historically granted awards to employees annually that generally vest over a three or four-year period, employees generally must remain with us for a substantial period of time in order to realize the potential benefits of their equity awards.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Aligns Employee and Director Interests with Stockholder Interests:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Providing our employees and non-employee directors with compensation in the form of equity directly aligns the interests of those employees and non-employee directors with the interests of our stockholders. If the 2024 Plan is approved by stockholders, we will be able to continue granting equity incentives that foster this alignment between our employees and non-employee directors and our stockholders.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">We are Committed to Executing on our Strategic Priorities: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of equity awards assists us and will continue to assist us in ensuring that our executives and employees are focused on long-term value creation for our stockholders and in enabling us to attract and retain the talent needed to execute on our strategic priorities while </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">managing our cash flow. We believe that the approval of the 2024 Plan as described in this proposal is instrumental to our ongoing success and our ability to provide increased value to our stockholders.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">We are Managing our Annual Burn Rate:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we thoughtfully manage our equity award use, balancing attraction, retention and incentivization of our employees against dilution and burn rate considerations.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">A Material Portion of Our Equity Program is Performance-Based:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation and Human Capital Committee believes that performance-based restricted stock units (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PRSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) align the objectives of management with those of our stockholders with respect to long-term performance and our success. For 2022 and 2023, the equity grants to our executive officers reflected a 35%/50%/15% value split among options, RSUs and PRSUs.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Duration that Shares Available for Issuance under the 2024 Plan are Expected to Last</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Based on the requested number of shares to be reserved under the 2024 Plan and on our three-year average burn rate, we expect that the share reserve will cover awards for approximately one year. However, a change in hiring activity, business conditions, company strategy, the equity markets or our stock price performance could alter this projection.</span></div><div id="i60d05261c6404879b68233510f10856b_127"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Features and Governance Practices</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incorporated a number of provisions in the 2024 Plan that are designed to protect stockholders and that we believe reflect strong governance practices, including the following:</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">No Evergreen:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Plan does not include an automatic share reload or &#8220;evergreen&#8221; provision. Additional stockholder approval will be required to increase the maximum number of shares reserved under the 2024 Plan.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">No Repricing:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Plan prohibits the repricing of stock options and stock appreciation rights (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SARs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) without stockholder approval, the exchange or substitution of one award for another award that has the effect of reducing the exercise or purchase price and the cancellation or exchange of underwater awards for cash, another award or other property, except in the event of a capitalization adjustment (described below). </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">No Dividends on Unvested Awards:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends or dividend equivalents credited or payable in connection with an award under the 2024 Plan that is not yet vested will be subject to the same restrictions and risk of forfeiture as the underlying award.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">No Liberal Share Recycling:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Plan prohibits liberal share recycling. Shares tendered by a participant or withheld by the Company in payment of the purchase price of a stock option or to satisfy any tax withholding obligation with respect to any option or SAR do not become available for issuance as future awards under the 2024 Plan.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Limit on Non-Employee Director Compensation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Plan contains an annual limit on cash and equity-based compensation that may be paid or granted, whether under the 2024 Plan or otherwise, to our non-employee directors of $750,000 (or $1,500,000 in the calendar year that the non-employee director first joins our Board of Directors).</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Minimum Vesting:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The 2024 Plan imposes a one-year minimum vesting requirement on awards granted thereunder, subject to certain exceptions set forth in the 2024 Plan.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Clawback Provision:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards under the 2024 Plan are subject to our current clawback policy and to any future clawback policies that we may adopt. See &#8220;&#8212;Clawback/Recovery&#8221; discussed below.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">No Automatic Single Trigger Acceleration:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a corporate transaction (described below), the 2024 Plan does not provide for automatic single trigger acceleration.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Term and Exercise Price Limits on Options and SARs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options and SARs granted under the 2024 Plan are subject to a maximum term of 10 years and, with the exception of certain awards assumed in a corporate transaction, may not be granted at a discount to the fair market value of our common stock on the grant date.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">No Change in Control/280G Tax Gross-Ups:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We do not provide our employees with tax gross-ups on change in control benefits.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">No Liberal Change in Control Definition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The definition of Change in Control in the 2024 Plan does not include events where an actual change in control of the Company may not occur (e.g., commencement or announcement of a tender offer or shareholder approval of a merger).</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Limited Transferability: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards are not transferable except by will or by the laws of descent and distribution, or under a domestic relations order, subject to limited approvals that may be approved by the plan administrator; provided, unless approved by stockholders, no award can be transferred for value and no stock option or SAR can be transferred to a third-party financial institution.</span></div><div id="i60d05261c6404879b68233510f10856b_130"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information on Equity Compensation Plans as of March 31, 2024</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, a total of 51,782,612 shares of our common stock were outstanding and the fair market value of our common stock was $10.59 per share based on the closing sale price of our common stock on the Nasdaq Global Market. The following table sets forth information regarding equity awards outstanding under our equity plans as of March 31, 2024 other than the CareDx, Inc. 2014 Employee Stock Purchase Plan (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2014 ESPP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). As of March 31, 2024, 644,047 shares of our common stock remained available for future issuance pursuant to the 2014 ESPP. </span></div><div style="padding-left:3.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.818%"><tr><td style="width:1.0%"/><td style="width:82.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.551%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total shares underlying outstanding stock options</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,974,042</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average exercise price of outstanding stock options</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25.08</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining life of outstanding stock options (in years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total shares underlying outstanding restricted stock units (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,832,059</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total shares underlying outstanding PRSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,843</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total number of shares remaining available for future awards under our equity plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509,836</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Comprised of the 2014 Plan, the CareDx, Inc. 2016 Inducement Equity Incentive Plan and the CareDx, Inc. 2019 Inducement Equity Incentive Plan (collectively, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Excludes the 2024 Plan and the 2014 ESPP. The number of shares remaining available for future grant under the 2014 Plan reflects PRSUs at the target payout</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">even though a lesser or greater number of shares may be or have been issued. Actual shares delivered will be based on the performance results outlined in the specific plan governing the PRSUs.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Assumes performance at the target performance level even though a lesser or greater number of shares may be or have been issued. Actual shares delivered will be based on the performance results outlined in the specific plan governing the PRSUs.</span></div><div id="i60d05261c6404879b68233510f10856b_133"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dilution</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dilution is commonly measured by &#8220;overhang,&#8221; which we calculate as the total number of equity awards outstanding </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;letter-spacing:-0.01em;line-height:120%">(with PRSUs included at &#8220;target&#8221; levels) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plus the total number of shares available for grant under our equity plans (other than the 2014 ESPP), divided by the sum of the total common stock outstanding, the number of equity awards outstanding </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;letter-spacing:-0.01em;line-height:120%">(with PRSUs included at &#8220;target&#8221; levels) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the total number of shares available for grant under our equity plans (other than the 2014 ESPP). </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, our calculated overhang was 17%. If the 2024 Plan is approved, our overhang (as calculated above) will be approximately 21% (after taking into consideration the expiration of our 2014 Plan and excluding our 2014 ESPP).</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the 2,974,042 stock options currently outstanding, many relate to underwater stock options. As shown above, we had approximately 2,974,042 stock options outstanding, with a weighted average exercise price of $25.08. This included 1,982,374 options currently exercisable, with a weighted average exercise price of $25.23, and 991,668 options not yet vested, with a weighted average exercise price of $24.78. This compares to a closing stock price on March 28, 2024, of $10.59. The 2,542,485 stock options currently underwater account for 4% of our overhang if the 2024 Plan is approved.</span></div><div id="i60d05261c6404879b68233510f10856b_136"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Historical Burn Rate</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate equity burn rate by dividing (x) the number of stock options, RSUs and restricted shares granted to participants during a fiscal year, plus (y) the number of PRSUs granted to participants during a fiscal year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;letter-spacing:-0.01em;line-height:120%">(with PRSUs included at &#8220;target&#8221; levels)</span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, by the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sum of the total common stock outstanding plus the number of equity awards outstanding </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;letter-spacing:-0.01em;line-height:120%">(with PRSUs included at &#8220;target&#8221; levels)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during such year. </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of the table above, the number of shares issuable </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under an award that provides for issuance of a variable number of shares based on the extent to which performance targets are </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">satisfied</span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is deemed to be the target number of shares that may be issued on attainment of target performance targets, even though a lesser or greater number of shares may be or may have been issued based on actual performance. Note that our calculation of equity burn rate differs, or may differ, from calculations of burn rate conducted by proxy advisory or other groups.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our equity plan share usage over 2021, 2022 and 2023 represented a three-year average burn rate of 6%, as described in the table below.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.115%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Time-based<br/>Stock Options<br/>Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance-<br/>based Stock<br/>Options Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs<br/>Granted<br/>and PRSUs<br/>Granted at<br/>Target</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.95pt;padding-right:0.95pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Burn</span></div><div style="padding-left:0.47pt;padding-right:0.47pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 1.97pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,241,076</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,514</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159,947</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.97pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,321,625</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864,465</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397,369</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.97pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,764,705</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680,788</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,028,424</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9%</span></td></tr></table></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Burn rate defined as: time-based stock options granted, performance-based stock options grants, RSUs granted and PRSUs granted at target as a percentage of weighted average common shares outstanding.</span></div><div id="i60d05261c6404879b68233510f10856b_139"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of the 2024 Plan</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary describes the material terms of the 2024 Plan. This summary of the 2024 Plan is not a complete </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">description</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of all provisions of the 2024 Plan and is qualified in its entirety by reference to the 2024 Plan, which is attached hereto as Appendix A. Stockholders are encouraged to read the 2024 Plan in its entirety.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purpose. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the 2024 Plan is to provide incentives for our employees, directors and consultants to exert maximum efforts for the </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">success</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company and our affiliates and to promote the creation of long-term value for the stockholders of the Company by closely aligning the interests of such individuals with those of such stockholders.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Authorized Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Initially, the maximum number of shares of our common stock that may be issued under the 2024 Plan will not exceed 3.5 million shares of our common stock.  The maximum number of shares of our common stock that may be issued on the exercise of ISOs under the 2024 Plan is 3.5 million shares.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any awards granted under the 2024 Plan are forfeited, expire, terminate, otherwise lapse or are surrendered pursuant to an exchange program or otherwise settled for cash, in whole or in part, without the delivery of shares, the shares covered by such forfeited, expired, terminated or lapsed award or award surrendered or settled in cash will be added back to and again become available for issuance under the 2024 Plan. Any shares withheld in respect of taxes, any shares tendered or withheld to pay the exercise price of options and any shares underlying an award of stock appreciation rights will not be added back to or again become available for issuance under the 2024 Plan. For the avoidance of doubt, awards granted under the 2024 Plan that by their terms settle in cash will not reduce the 2024 Plan&#8217;s share reserve.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan Administration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our Board of Directors, or a duly authorized committee of our Board of Directors (referred to collectively as the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">plan administrator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), will administer the 2024 Plan. The plan administrator may, in accordance with the terms of the 2024 Plan, delegate to one or more of our officers the authority to determine (i) award recipients, (ii) how and when each award will be granted, (iii) the types of awards to be granted, (iv) grant dates, (v) the number of shares subject to each award, (vi) the fair market value of our common stock, and (vii) the provisions of each award, including the period of exercisability and the vesting schedule applicable to an award.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2024 Plan, (i) the plan administrator will not, without stockholder approval, (A) reduce the exercise or strike price of an option or stock appreciation right (other than in connection with a capitalization adjustment), (B) at any time when the exercise or strike price of an option or stock appreciation right is above the fair market value of a share of our common stock, cancel and re-grant or exchange such option or stock appreciation right for a new award with a lower (or no) purchase price or for cash and (C) institute and determine the terms and conditions of an &#8220;exchange program&#8221; under which outstanding awards are surrendered or cancelled in exchange for awards of the same type (which may have higher or lower exercise prices and different terms), awards of a different type, and/or cash, participants would have the opportunity to transfer any outstanding awards to a financial institution or other person or entity selected by the plan administrator, and/</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or the exercise price of an outstanding award is increased or reduced, and (ii) a participant&#8217;s rights under any award will not be amended to materially adversely affect such participant&#8217;s rights thereunder without the participant&#8217;s written consent.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will also designate a plan administrator to administer the day-to-day operations of the 2024 Plan.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Awards Under the 2024 Plan</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Plan provides for the grant of incentive stock options, or ISOs, within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), to our employees and our parent and subsidiary corporations&#8217; employees, and for the grant of nonstatutory stock options (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">NSOs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), stock appreciation rights, restricted stock awards, restricted stock unit awards and other forms of awards to our employees, directors and consultants and any of our affiliates&#8217; employees and consultants.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ISOs and NSOs will be granted under stock option agreements adopted by the plan administrator. The plan administrator will determine the exercise price for stock options, within the terms and conditions of the 2024 Plan, except the exercise price of a stock option (other than an option assumed or substituted in connection with a corporate transaction) generally will not be less than 100% (or 110% in the case of ISOs granted to a person who owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any of our parent or subsidiary corporations, or a ten percent stockholder) of the fair market value of our common stock on the date of grant. Options granted under the 2024 Plan will vest at the rate specified in the stock option agreement as will be determined by the plan administrator. The terms and conditions of separate options need not be identical.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No option will be exercisable after the expiration of ten years (or five years in the case of ISOs granted to a ten percent stockholder) or a shorter period specified in the applicable award agreement. Unless otherwise determined by the plan administrator or the terms of an option holder&#8217;s stock option agreement, or other written agreement between us and the recipient, provide otherwise, if an option holder&#8217;s service relationship with us or any of our affiliates ceases for any reason other than disability, death, or cause, the option holder may generally exercise any vested options for a period of three months following the cessation of service. This period may be extended in the event that exercise of the option is prohibited by applicable securities laws. If an option holder&#8217;s service relationship with us or any of our affiliates ceases due to death, or an option holder dies within a certain period following cessation of service, the option holder or a beneficiary may generally exercise any vested options for a period of 12 months following the date of death. If an option holder&#8217;s service relationship with us or any of our affiliates ceases due to disability, the option holder may generally exercise any vested options for a period of 12 months following the cessation of service. In the event of a termination for cause, options generally terminate upon the termination date. If a participant is suspended pending investigation of whether his or her service relationship with us or any of our affiliates shall be terminated for cause, the participant&#8217;s rights to exercise an option will be suspended during the investigation period. An option holder may not exercise an option at any time that the issuance of shares upon such exercise would violate applicable law. Unless determined by the Board or provided otherwise in the option holder&#8217;s stock option agreement or other written agreement between an option holder and us, if an option holder&#8217;s service relationship with us or any of our affiliates ceases for any reason other than for cause and, at any time during the last thirty days of the applicable post-termination exercise period: (i) the exercise of the option holder&#8217;s option would be prohibited solely because the issuance of shares upon such exercise would violate applicable law, (ii) the immediate sale of any shares issued upon such exercise would violate our trading policy or (iii) the plan administrator has suspended exercisability of such option holder&#8217;s option pending investigation of whether his or her service relationship with us or any of our affiliates shall be terminated for cause, then the applicable post-termination exercise period will be extended to the last day of the calendar month that begins after the date the award would otherwise expire, with an additional extension of the exercise period to the last day of the next calendar month to apply if any of the foregoing restrictions apply at any time during such extended exercise period. There is no limitation as to the maximum permitted number of extensions. However, in no event may an option be exercised beyond the expiration of its term.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acceptable consideration for the purchase of common stock issued upon the exercise of a stock option will be determined by the plan administrator and may include (i) cash, check, bank draft or money order payable to us; (ii) a broker-assisted cashless exercise; (iii) subject to certain conditions, the tender of shares of our common stock previously owned by the option holder; (iv) a net exercise of the option if it is an NSO; or (v) other legal consideration approved by the plan administrator.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the plan administrator provides otherwise, options or stock appreciation rights generally will not be transferable except by will or the laws of descent and distribution. Subject to approval of the plan administrator or a duly authorized officer, an option may be transferred pursuant to a domestic relations order.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Limitations on ISOs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The aggregate fair market value, determined at the time of grant, of our common stock with respect to ISOs that are exercisable for the first time by any participant during any calendar year under all of our stock plans or plans of our affiliates may not exceed $100,000. Options or portions thereof that exceed such limit will generally be treated as NSOs. No ISO may be granted to any person who, at the time of the grant, is a ten percent stockholder unless (i) the option exercise price is at least 110% of the fair market value of the stock subject to the option on the date of grant; and (ii) the term of the ISO does not exceed five years from the date of grant.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Unit Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the terms of the 2024 Plan, each restricted stock unit award will have such terms and conditions as determined by the plan administrator. A restricted stock unit award represents a participant&#8217;s right to be issued on a future date the number of shares of our common stock that is equal to the number of restricted stock units subject to the award. A participant will not have voting or any other rights as a stockholder of ours with respect to any restricted stock unit award (unless and until shares are actually issued in settlement of a vested restricted stock unit award). A restricted stock unit award will generally be granted in consideration for a participant&#8217;s services to us or an affiliate, such that the participant will not be required to make any payment to us (other than such services) with respect to the grant or vesting of the restricted stock unit award, or the issuance of any shares pursuant to the restricted stock unit award. If, at the time of grant, the plan administrator determines that a participant must pay consideration upon the issuance of shares pursuant to a restricted stock unit award, such consideration may be paid in any form of legal consideration that may be acceptable to the plan administrator and permissible under applicable law. A restricted stock unit award may be settled by cash, delivery of stock (or any combination of our common stock and cash), or in any other form of consideration determined by the plan administrator and set forth in the restricted stock unit award agreement. At the time of grant, the plan administrator may impose such restrictions or conditions on the award of restricted stock units that delay delivery to a date following the vesting of the award in a manner intended to comply with Section 409A of the Code, as applicable. Additionally, dividends or dividend equivalents may be paid or credited in respect of shares covered by a restricted stock unit award, subject to the same restrictions on transferability and forfeitability as the underlying award with respect to which such dividends or dividend equivalents are granted and subject to such other terms and conditions as determined by the plan administrator and specified in the applicable restricted stock unit award agreement. Except as determined by the plan administrator or otherwise provided in the applicable award agreement, or other written agreement between us and the recipient, restricted stock unit awards that have not vested will be forfeited once the participant&#8217;s continuous service ends for any reason.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Restricted stock awards will be granted under restricted stock award agreements adopted by the plan administrator. A restricted stock award may be awarded in consideration for cash, check, bank draft or money order, past or future services to us or any of our affiliates, or any other form of legal consideration that may be acceptable to the plan administrator and permissible under applicable law. The plan administrator will determine the terms and conditions of restricted stock awards, including vesting and forfeiture terms. Dividends or dividend equivalents may be paid or credited with respect to shares subject to a restricted stock award, subject to the same restrictions on transferability and forfeitability as the underlying award with respect to which such dividends or dividend equivalents are granted and subject to such other terms and conditions as determined by the plan administrator and specified in the applicable restricted stock award agreement. If a participant&#8217;s service relationship with us ends for any reason, we may receive any or all of the shares of our common stock held by the participant that have not vested as of the date the participant terminates service with us through a forfeiture condition or a repurchase right.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Appreciation Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Stock appreciation rights will be granted under stock appreciation right agreements adopted by the plan administrator and denominated in shares of common stock equivalents. The terms of separation stock appreciation rights need not be identical. The plan administrator will determine the purchase price or strike price for a stock appreciation right, which generally will not be less than 100% of the fair market value of our common stock on the date of grant. A stock appreciation right granted under the 2024 Plan will vest at the rate specified in the stock appreciation right agreement as will be determined by the plan administrator. Stock appreciation rights may be settled in cash or shares of our common stock (or any combination of our common stock and cash) or in any other form of payment, as determined by the plan administrator and specified in the stock appreciation right agreement.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The plan administrator will determine the term of stock appreciation rights granted under the 2024 Plan, up to a maximum of 10 years. If a participant&#8217;s service relationship with us or any of our affiliates ceases for any reason other than cause, disability, or death, the participant may generally exercise any vested stock appreciation right for a period of three months following the cessation of service. This period may be further extended in the event that exercise of the stock appreciation right following such a termination of service is prohibited by applicable securities laws. If a participant&#8217;s service relationship with us or any of our affiliates ceases due to disability or death, or a participant dies within a certain period following cessation of service, the participant or a beneficiary may generally exercise any vested stock appreciation rights </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a period of 18 months following the date of death. If a participant&#8217;s service relationship with us or any of our affiliates ceases due to disability, the participant may generally exercise any vested stock appreciation rights for a period of 12 months following the cessation of service. In the event of a termination for cause, stock appreciation rights generally terminate upon the termination date. If a participant is suspended pending investigation of whether his or her service relationship with us or any of our affiliates shall be terminated for cause, the participant&#8217;s rights to exercise a stock appreciation right will be suspended during the investigation period. A holder of a stock appreciation right may not exercise a stock appreciation right at any time that the issuance of shares upon such exercise would violate applicable law. Unless determined by the plan administrator or provided otherwise in the stock appreciation right agreement or other written agreement between the participant and us, if a participant&#8217;s service relationship with us or any of our affiliates ceases for any reason other than for cause and, at any time during the last thirty days of the applicable post-termination exercise period: (i) the exercise of the participant&#8217;s stock appreciation right would be prohibited solely because the issuance of shares upon such exercise would violate applicable law, (ii) the immediate sale of any shares issued upon such exercise would violate our trading policy or (iii) the plan administrator has suspended exercisability of such option holder&#8217;s option pending investigation of whether his or her service relationship with us or any of our affiliates shall be terminated for cause, then the applicable post-termination exercise period will be extended to the last day of the calendar month that begins after the date the award would otherwise expire, with an additional extension of the exercise period to the last day of the next calendar month to apply if any of the foregoing restrictions apply at any time during such extended exercise period. There is no limitation as to the maximum permitted number of extensions. However, in no event may a stock appreciation right be exercised beyond the expiration of its term.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Stock Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The plan administrator will be permitted to grant other awards, based in whole or in part by reference to, or otherwise based on, our common stock, either alone or in addition to other awards. The plan administrator will have the sole and complete discretion to determine the persons to whom and the time or times at which other stock awards will be granted, the number of shares under the other stock award (or cash equivalent), the form of payment (for example, shares of stock, cash or other property) and all other terms and conditions of such awards.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Awards; Performance Criteria</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards made pursuant to the 2024 Plan may be made subject to the attainment of performance goals relating to one or more business criteria. For purposes of the 2024 Plan, such business criteria may include (but is not limited to) any one or more of the following performance criteria, either individually, alternatively, or in any combination: earnings (including earnings per share and net earnings); earnings before interest, taxes and depreciation; earnings before interest, taxes, depreciation and amortization; total stockholder return; return on equity or average stockholder&#8217;s equity; return on assets, investment, or capital employed; stock price; margin (including gross margin); income (before or after taxes); operating income; operating income after taxes; pre-tax profit; operating cash flow; sales or revenue targets; increases in revenue or product revenue; expenses and cost reduction goals; improvement in or attainment of working capital levels; economic value added (or an equivalent metric); market share; cash flow; cash flow per share; share price performance; debt reduction; customer satisfaction; stockholders&#8217; equity; capital expenditures; debt levels; operating profit or net operating profit; workforce diversity; growth of net income or operating income; billings; pre-clinical development related compound goals; financing; regulatory milestones, including approval of a compound; stockholder liquidity; corporate governance and compliance; product commercialization; intellectual property; personnel matters; progress of internal research or clinical programs; progress of partnered programs; partner satisfaction; budget management; clinical achievements; completing phases of a clinical study (including the treatment phase); announcing or presenting preliminary or final data from clinical studies; in each case, whether on particular timelines or generally; timely completion of clinical trials; submission of INDs and NDAs and other regulatory achievements; partner or collaborator achievements; internal controls, including those related to the Sarbanes-Oxley Act of 2002; research progress, including the development of programs; investor relations, analysts and communication; manufacturing achievements (including obtaining particular yields from manufacturing runs and other measurable objectives related to process development activities); strategic partnerships or transactions (including in-licensing and out-licensing of intellectual property; establishing relationships with commercial entities with respect to the marketing, distribution and sale of our products (including with group purchasing organizations, distributors and other vendors)); supply chain achievements (including establishing relationships with manufacturers or suppliers of active pharmaceutical ingredients and other component materials and manufacturers of our products); co-development, co-marketing, profit sharing, joint venture or other similar arrangements; individual performance goals; corporate development and planning goals; and other measures of performance selected by our Board of Directors or our Compensation and Human Capital Committee. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining performance outcomes related to such measures or criteria, the plan administrator may provide for the exclusion of the impact of an event or occurrence which the plan administrator determines should appropriately be </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">excluded, including: (a) restructuring and/or other nonrecurring charges, (b) exchange rate effects, (c) the effects of changes to generally accepted accounting principles, (d) the effects of any statutory adjustments to corporate tax rates, (e) the effects of items that are &#8220;unusual&#8221; in nature or occur &#8220;infrequently&#8221; as determined under generally accepted accounting principles, (f) the dilutive effects of acquisitions or joint ventures, (g) exclusions to assume that any business divested by us achieved performance objectives at targeted levels during the balance of a performance period following such divestiture, (h) the effect of any change in the outstanding shares of our common stock by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends, (i) the effects of stock based compensation and the award of bonuses under the Company&#8217;s bonus plans, (j) costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles and (k) the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting principles.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Employee Director Compensation Limit</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate value of all compensation granted or paid following the effective date of the 2024 Plan to any individual for service as a non-employee director with respect to any fiscal year, including awards granted under the 2024 Plan (valued based on the grant date fair value for financial reporting purposes) and cash fees paid by us to such non-employee director, will not exceed $750,000 in total value, except such amount will increase to $1,500,000 for the year in which a non-employee director is first appointed or elected to our Board. For the avoidance of doubt, any awards granted and cash fees paid to a non-employee director for his or her service as a non-employee director in respect of any fiscal year will count against the annual compensation limits for the fiscal year to which such awards and fees related, regardless of any deferral of such Awards or fees.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes to Capital Structure</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event there is a specified type of change in our capital structure, such as a stock split, reverse stock split, or recapitalization, the plan administrator will appropriately and proportionately adjust (i) the class and maximum number of shares subject to the 2024 Plan; (ii) the class and maximum number of shares that may be issued on the exercise of ISOs; and (iii) the class and number of shares and exercise price, strike price, or purchase price, if applicable, of all outstanding awards granted under the 2024 Plan.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event of a corporate transaction (as defined below), all outstanding awards as of the date of such corporate transaction will be treated in the manner described in the definitive agreement evidencing such corporate transaction (or, in the event that such corporate transaction is not effected pursuant to a definitive agreement to which the Company is a party, in the manner determined by our Board of Directors).  For the avoidance of doubt, the definitive agreement (or the Board of Directors&#8217; determination) does not need to treat all awards outstanding under the 2024 Plan (or portions thereof) in an identical matter. Unless otherwise provided in a participant&#8217;s award agreement or other written agreement with us or one of our affiliates or unless otherwise expressly provided by the plan administrator at the time of grant (and without limiting the prior sentence), any awards outstanding under the 2024 Plan may be assumed, continued or substituted for, in whole or in part, by any surviving or acquiring corporation (or its parent company), and any reacquisition or repurchase rights held by us with respect to our common stock issued pursuant to awards may be assigned to the successor (or its parent company). If the surviving or acquiring corporation (or its parent company) does not assume, continue or substitute for such awards, then (i) with respect to any such awards that are held by participants whose continuous service has not terminated prior to the effective time of the corporate transaction, or current participants, the vesting (and exercisability, if applicable) of such awards will be accelerated in full (or, in the case of awards with performance-based vesting with multiple vesting levels depending on the level of performance, unless provided otherwise in the applicable award agreement, vesting will accelerate at 100% of the target level or such greater level as determined by the Board) to a date prior to the effective time of the corporate transaction (contingent upon the effectiveness of the corporate transaction), and such awards will terminate if not exercised (if applicable) at or prior to the effective time of the corporate transaction, and any reacquisition or repurchase rights held by us with respect to such awards will lapse (contingent upon the effectiveness of the corporate transaction); and (ii) any such awards that are held by persons other than current participants will terminate if not exercised (if applicable) prior to the occurrence of the corporate transaction, except that any reacquisition or repurchase rights held by us with respect to such awards will not terminate and may continue to be exercised notwithstanding the corporate transaction.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event an award will terminate if not exercised prior to the effective time of a corporate transaction, the plan administrator may provide, in its sole discretion, that the holder of such award may not exercise such award but instead will </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receive a payment, in such form as may be determined by the plan administrator, equal in value to the excess (if any) of (i) the value of the property the participant would have received upon the exercise of the award, over (ii) any per share exercise price payable by such holder, if applicable. As a condition to the receipt of an award, a participant will be deemed to have agreed that the award will be subject to the terms of any agreement under the 2024 Plan governing a corporate transaction involving us.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2024 Plan, a &#8220;corporate transaction&#8221; generally will be the consummation, in a single transaction or in a series of related transactions, of (i) a sale or other disposition of all or substantially all, as determined by the plan administrator, of our consolidated assets; (ii) a sale or other disposition of at least 50% of our outstanding securities; (iii) a merger, consolidation or similar transaction following which we are not the surviving corporation; or (iv) a merger, consolidation or similar transaction following which we are the surviving corporation but the shares of our common stock outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of the transaction.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards to be granted under the 2024 Plan may be subject to acceleration of vesting and exercisability upon or after a change in control (as defined below) as may be provided in the applicable stock award agreement or in any other written agreement between us or any affiliate and the participant, but in the absence of such provision, no such acceleration will automatically occur.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2024 Plan, a &#8220;change in control&#8221; generally will be: (i) the acquisition by any person or company of more than 50% of the combined voting power of our then outstanding stock; (ii) a merger, consolidation or similar transaction in which our stockholders immediately before the transaction do not own, directly or indirectly, more than 50% of the combined voting power of the surviving entity (or the parent of the surviving entity) in substantially the same proportions as their ownership immediately prior to such transaction; (iii) stockholder approval of a complete dissolution or liquidation; (iv) a sale, lease, exclusive license or other disposition of all or substantially all of our assets other than to an entity more than 50% of the combined voting power of which is owned by our stockholders in substantially the same proportions as their ownership of our outstanding voting securities immediately prior to such transaction; or (v) when a majority of our Board of Directors becomes comprised of individuals who were not serving on our Board of Directors on the date of the underwriting agreement related to this offering, or the incumbent board, or whose nomination, appointment, or election was not approved by a majority of the incumbent board still in office.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Minimum Vesting Conditions</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the proviso below, awards granted under the 2024 Plan will vest no earlier than the first anniversary of the date on which the award is granted; provided, that the following will not be subject to the foregoing minimum vesting requirement: (i) awards to non-employee directors that vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders, which is at least 50 weeks after the immediately preceding year&#8217;s annual meeting; (ii) additional awards the plan administrator may grant, up to a maximum of five percent (5%) of the available share reserve authorized for issuance under the 2024 Plan (subject to the 2024 Plan&#8217;s adjustment provisions); and (iii)&#160;any decision by our Board to provide for accelerated vesting of any award in connection with the termination of a participant&#8217;s continuous service in exchange of a release of claims. The foregoing restriction does not apply to the plan administrator&#8217;s discretion to provide for accelerated exercisability or vesting of any award in the event of change in control in which the surviving corporation or acquiring corporation (or its parent company) does not assume or continue such award or substitute a similar award.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prohibition on Repricing</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than pursuant to certain equitable adjustments as described in the 2024 Plan, the plan administrator will not, without the approval of the Company&#8217;s stockholders, lower the option price per share of an option (or base price of a SAR) after it is granted, cancel an option or SAR when the exercise price per share exceeds the fair market value of one share in exchange for cash or another award (other than in connection with a change in control), or take any other action with respect to an option or SAR that would be treated as a repricing under the rules and regulations of the principal U.S. national securities exchange on which the shares are listed.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferral</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its discretion and subject to such terms and conditions as it may impose, the plan administrator may permit a participant to elect to defer receipt of shares of common stock issuable pursuant to any equity award granted under the 2024 Plan to a time later than the time the shares otherwise would be issued to the participant; provided that such deferral election </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complies with rules adopted by the plan administrator, which comply with, or are exempt from, the requirements of Section 409A of the Code. In such event, the plan administrator may, in its discretion, provide for the payment by the Company of an additional amount representing interest at a reasonable rate or the actual rate of return on one or more predetermined specific investments, as determined by the plan administrator.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Employees and Consultants</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards may be granted to participants who are foreign nationals or employed or providing services outside the United States, or both, on such terms and conditions different from those applicable to awards to employees or consultants providing services in the United States as may, in the judgment of the plan administrator, be necessary or desirable in order to recognize differences in local law or tax policy.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transferability</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as determined by the Board or expressly provided in the 2024 Plan or the form of award agreement, awards granted under the 2024 Plan may not be transferred or assigned by a participant. After the vested shares subject to an award have been issued, or in the case of a restricted stock award and similar awards, after the issued shares have vested, the holder of such shares is free to assign, hypothecate, donate, encumber or otherwise dispose of any interest in such shares provided that any such actions are in compliance with the terms of our trading policy and applicable law.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clawback/Recovery</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All awards granted under the 2024 Plan will be subject to recoupment in accordance with our current clawback policy and as otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law, and any clawback policy that we otherwise adopt, to the extent applicable and permissible under applicable law. See &#8220;Board of Directors and Corporate Governance&#8212;Clawback Policy&#8221;. In addition, the plan administrator may impose such other clawback, recovery or recoupment provisions in an award agreement as the plan administrator determines necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of our common stock or other cash or property upon the occurrence of cause.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amendment or Termination</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The plan administrator may accelerate the time at which an award granted under the 2024 Plan may first be exercised or the time during which an award grant under the 2024 Plan or any part thereof will vest, notwithstanding the provisions in the award agreement stating the time at which it may first be exercised or the time during which it will vest. The plan administrator will have the authority to amend, suspend or terminate the 2024 Plan at any time, provided that such action does not materially impair the existing rights of any participant without such participant&#8217;s written consent. Certain material amendments will also require the approval of our stockholders. No ISOs may be granted after the tenth anniversary of the Effective Date. No awards may be granted under the 2024 Plan while it is suspended or after it is terminated.</span></div><div id="i60d05261c6404879b68233510f10856b_142"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form S-8 Registration Statement</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to file a registration statement on Form S-8 to register all of the shares of our common stock reserved for issuance under the 2024 Plan.</span></div><div id="i60d05261c6404879b68233510f10856b_145"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Plan Benefits</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described above, the selection of participants who will receive awards under the 2024 Plan and the size and types of awards will be determined by the plan administrator in its discretion. None of the shares authorized by the 2024 Plan have been awarded to any of the directors or employees, and no commitment has been made to award any such shares. The plan administrator has authority to authorize future awards under the 2024 Plan from time to time. The value of any future equity awards will ultimately depend on the nature and size of the awards, the future price of our common stock and the exercise decisions made by the participants, among other factors, and will be subject to such vesting conditions under the 2024 Plan as the plan administrator determines from time to time. Therefore, the amount of any future awards under the 2024 Plan is not yet determinable and it is not possible to predict the benefits or amounts that will be received by, or allocated to, particular individuals or groups of employees. Currently, our non-employee directors are entitled to receive cash and equity compensation for their service as directors as described above under &#8220;Board of Directors and Corporate Governance&#8212;Director Compensation&#8221;. For further details on the awards granted during the fiscal year ended December </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31, 2023 under the 2014 Plan, please refer to the executive and director compensation tables beginning on page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i60d05261c6404879b68233510f10856b_160">62</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i60d05261c6404879b68233510f10856b_91">34</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, of this proxy statement.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div id="i60d05261c6404879b68233510f10856b_148"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal Income Tax Consequences</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the U.S. federal income tax treatment applicable to us and the participants who receive awards under the 2024 Plan based on the federal income tax laws in effect on the date of this proxy statement. This summary is not intended to be exhaustive and does not address all matters relevant to a particular participant based on their specific circumstances. The summary expressly does not discuss the income tax laws of any state, municipality or non-U.S. taxing jurisdiction, or the gift, estate, excise or other tax laws other than U.S. federal income tax law. Because individual circumstances may vary, we recommend that all participants to consult their own tax advisor concerning the tax implications of awards granted under the 2024 Plan.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Option Grants</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options granted under the 2024 Plan may be either be ISOs, which satisfy the requirements of Section 422 of the Code, or NSOs, which are not intended to meet such requirements. The U.S. federal income tax treatment for the two types of options differs as follows:</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incentive Stock Options</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No taxable income is recognized by the participant at the time of the grant of an ISO, and no taxable income is recognized for ordinary income tax purposes at the time the ISO is exercised, although taxable income may arise at that time for alternative minimum tax purposes. Unless there is a disqualifying disposition, as described below, the participant will recognize long-term capital gain in an amount equal to the excess of (i) the amount realized upon the sale or other disposition of the purchased shares over (ii) the exercise price paid for the shares.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A disqualifying disposition occurs if the disposition is less than two years after the date of grant or less than one year after the exercise date. If there is a disqualifying disposition of the shares, then the excess of (i) the fair market value of those shares on the exercise date or (if less) the amount realized upon such sale or disposition over (ii) the exercise price paid for the shares will be taxable as ordinary income to the participant. Any additional gain or loss recognized upon the disposition will be a capital gain or loss.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the participant makes a disqualifying disposition of the purchased shares, then we will be entitled to an income tax deduction, for the taxable year in which such disposition occurs, equal to the amount of ordinary income recognized by the participant as a result of the disposition. We will not be entitled to any income tax deduction if the participant makes a qualifying disposition of the shares.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Statutory Stock Options</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No taxable income is recognized by a participant upon the grant of an NSO. The participant in general will recognize ordinary income, in the year in which the NSO is exercised, equal to the excess of the fair market value of the purchased shares on the exercise date over the exercise price paid for the shares. We will be entitled to an income tax deduction equal to the amount of ordinary income recognized by the participant with respect to the exercised non-statutory stock option.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SARs</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No taxable income is recognized upon receipt of an SAR. The holder will recognize ordinary income in the year in which the SAR is exercised, in an amount equal to the excess of (i) the fair market value of the underlying shares of common stock on the exercise date over (ii) the base price in effect for the exercised right. We will be entitled to an income tax deduction equal to the amount of ordinary income recognized by the holder in connection with the exercise of the SAR.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Awards</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participants will recognize ordinary income at the time unrestricted stock awards are granted in an amount equal to the excess of (i) the fair market value of the shares on the grant date over (ii) the cash consideration (if any) paid for the shares.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No taxable income is recognized at the time restricted stock awards are issued, but the participant will have to report as ordinary income, as and when those shares subsequently vest, an amount equal to the excess of (i) the fair market value of the shares on the vesting date over (ii) the cash consideration (if any) paid for the shares. The participant may, however, elect under Section 83(b) of the Code to include as ordinary income in the year the unvested shares are issued an amount equal to the excess of (a) the fair market value of those shares on the issue date over (b) the cash consideration (if any) paid for such shares. If the Section 83(b) election is made, the participant will not recognize any additional income as and when the shares subsequently vest.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be entitled to an income tax deduction equal to the amount of ordinary income recognized by the participant at the time such ordinary income is recognized by the participant.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Awards</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, no taxable income is recognized upon receipt of stock units (including RSUs), performance awards or cash awards. The holder will recognize ordinary income in the year in which the shares subject to the award are actually issued or in the year in which the award is settled in cash. The amount of that income will be equal to the fair market value of the shares on the date of issuance or the amount of the cash paid in settlement of the award.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be entitled to an income tax deduction equal to the amount of ordinary income recognized by the holder at the time the shares are issued or the cash amount is paid.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Withholding</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the delivery of any shares of our common stock or cash pursuant to a 2024 Plan award (or exercise thereof), the Company will have the power and the right to deduct or withhold, or require a participant to remit to the Company, an amount sufficient to satisfy federal, state, and local taxes or other amounts (including the participant&#8217;s FICA obligation) required to be withheld with respect to such award (or exercise thereof). The plan administrator, in its sole discretion and pursuant to such procedures as it may specify from time to time, may permit a participant to satisfy such tax withholding obligation, in whole or in part by (a) electing to have the Company withhold otherwise deliverable shares of our common stock, or (b) delivering to the Company already-owned shares of our common stock having a fair market value equal to the minimum amount required to be withheld. If the plan administrator permits shares of our common stock to be withheld from the award to satisfy applicable withholding obligations, the fair market value of the shares of our common stock withheld, as determined as of the date of withholding, will not exceed the amount determined by the applicable minimum statutory withholding rates unless the plan administrator determines an additional amount can be withheld and will not result in adverse accounting consequences, and the plan administrator authorizes such additional withholding.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Section 409A of the Code</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain types of awards under the 2024 Plan may constitute, or provide for, a deferral of compensation subject to Section 409A of the Code. Unless certain requirements set forth in Section 409A of the Code are complied with, holders of such awards may be taxed earlier than would otherwise be the case (e.g., at the time of vesting instead of the time of payment) and may be subject to an additional 20% penalty tax (and, potentially, certain interest, penalties and additional state taxes). To the extent applicable, the 2024 Plan and awards granted under the 2024 Plan are intended to be structured and interpreted in a manner intended to either comply with or be exempt from Section 409A of the Code and the Department of Treasury regulations and other interpretive guidance that may be issued under Section 409A of the Code. To the extent determined necessary or appropriate by the plan administrator, the 2024 Plan and applicable award agreements may be amended to further comply with Section 409A of the Code or to exempt the applicable awards from Section 409A of the Code.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deductibility of Executive Compensation</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 162(m) of the Code limits the deductibility for federal income tax purposes of certain annual compensation paid to any &#8220;covered employee&#8221; in excess of $1 million. For purposes of Section 162(m), the term &#8220;covered employee&#8221; includes any individual who serves or has served as our chief executive officer, chief financial officer or one of the other three most highly compensated executive officers for 2017 or any subsequent calendar year. It is expected that compensation deductions for any covered employee with respect to awards under the 2024 Plan will be subject to the $1 million annual deduction limitation.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_151"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required; Board Recommendation</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approval of the 2024 Plan requires the affirmative vote of a majority of the shares of our common stock present virtually or by proxy at the Annual Meeting and entitled to vote thereon. Abstentions will have the effect of a vote AGAINST the proposal.&#160; Broker non-votes will have no effect on this proposal.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUR BOARD OF DIRECTORS RECOMMENDS A VOTE &#8220;FOR&#8221; THE APPROVAL OF THE 2024 EQUITY INCENTIVE PLAN.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_154"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OFFICERS</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table identifies certain information about our executive officers as of April 29, 2024.  There are no family relationships among any of our directors or executive officers.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:65.720%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Position(s)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John W. Hanna</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alex Johnson</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President of Patient and Testing Services</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abhishek Jain</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeff Novack</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Counsel and Secretary</span></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">John W. Hanna</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was appointed as our President and Chief Executive Officer, effective April 15, 2024. Prior to his appointment, Mr. Hanna served as the Chief Executive Officer of Apton Biosystems, Inc., from April 2021 to August 2023. Apton Biosystems, Inc. was acquired by Pacific Biosciences of California, Inc. in August 2023, where Mr. Hanna served as Vice President of Corporate Development from August 2023 to March 2024. Mr. Hanna previously served for ten years with Veracyte, Inc. from September 2011 to March 2021, where his most recent position was as its Chief Commercial Officer since March 2017. Prior to Veracyte, Mr. Hanna held leadership roles at Humana and IBM. Mr. Hanna received a B.S. in Political Science from Hampden Sydney College in 2001 and an M.B.A. from the University of Miami in 2008.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alex Johnson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our President of Patient and Testing Services since September&#160;2022 and as a member of the Office of the Chief Executive Officer from November 1, 2023 to April 15, 2024.  Mr. Johnson served as our Chief Business Officer and Head of Testing Services from July&#160;2021 to September&#160;2022.  Prior to that, he served as Senior Vice President, Products at Cell Therapy &amp; Business Development of our company since May&#160;2020 and previously served as Vice President at Laboratory Solutions Business from August&#160;2018 to May&#160;2020 and Vice President at Finance from April&#160;2018 to July&#160;2018.  Prior to joining us, Mr. Johnson was Chief Operating Officer of BioGraph&#160;55, a venture-backed immuno-oncology drug development company that uses advanced imaging analytics and machine learning to capture clinically relevant content from the tumor microenvironment, from September&#160;2015 to August&#160;2018.  From August&#160;2014 to January&#160;2015, Mr. Johnson served as President of Diadexus, Inc. From&#160;2009 to&#160;2014, Mr. Johnson was with Novartis, with roles at Novartis Diagnostics, a global provider of blood screening solutions, and Novartis AG based in Basel, Switzerland where he led acquisitions in oncology and diagnostics.  Prior to Novartis, Mr. Johnson worked at UBS Investment Bank in the Global Healthcare group.  Mr. Johnson studied economics at Union College (NY)&#160;and received his M.B.A. in Finance from Columbia Business School.  A petition of bankruptcy was filed by Diadexus, Inc. in June&#160;2016.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abhishek Jain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Financial Officer since September&#160;2022 and as a member of the Office of the Chief Executive Officer from November 1, 2023 to April 15, 2024. Mr. Jain served as our Interim Chief Financial Officer from May&#160;2022 to September&#160;2022.  Prior to that, since joining us in August&#160;2021, Mr. Jain had served as our Vice President, Corporate Controller, where he was responsible for global accounting functions and SEC filings.  During that time, he worked closely with our Audit and Finance Committee of our Board of Directors, financial planning and analysis team and business partners.  Prior to joining us, Mr. Jain spent approximately&#160;20 years at Agilent Technologies, Inc., in a number of progressing finance positions and customer-facing roles, including his last role, where he helped drive above-market growth for orders of an approximately $5&#160;billion business.  Mr. Jain has extensive knowledge in driving channel strategy, expanding margins, scaling operations and leading global teams.  Mr. Jain is a member of the Institute of Chartered Accountants of India.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jeff Novack </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">joined CareDx in 2021 and has served as our General Counsel since December 2023 and as our Secretary since April 2024. Before joining CareDx, Mr. Novack served as an Assistant Attorney General in the Investor Protection Bureau of the New York Attorney General&#8217;s Office. Prior to that, Jeff practiced at two international law firms and clerked for The Honorable Ren&#233;e Marie Bumb, Chief Judge of the United States District Court for the District of New Jersey. Mr. Novack is a graduate of New York University School of Law and Washington University in St. Louis &#8211; Olin Business School. Mr. Novack is admitted to practice law in New York and New Jersey.</span></div><div id="i60d05261c6404879b68233510f10856b_157"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings with Executive Officers</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no legal proceedings related to any of the executive officers that require disclosure pursuant to Items&#160;103 or&#160;401(f) of Regulation&#160;S-K.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_160"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION</span></div><div id="i60d05261c6404879b68233510f10856b_163"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Discussion and Analysis</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Compensation Discussion and Analysis (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CD&amp;A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), we provide an overview of our executive compensation philosophy and objectives, as well as a description of the material components of our executive compensation program.  This CD&amp;A is intended to be read in conjunction with the tables that immediately follow this section, which provide further historical compensation information.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year&#160;2023, the following executive officers constituted our Named Executive Officers (collectively, our &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">NEOs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;): </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Position(s)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.1pt;padding-right:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alex Johnson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President of Patient and Testing Services, Former Chief Business Officer, Acting Principal Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Abhishek Jain</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt;padding-right:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reginald Seeto, MBBS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Former President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt;padding-right:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Abraham Ronai</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Former Chief Administrative &amp; Legal Officer and Secretary</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Mr. Johnson assumed the role of Principal Executive Officer on November 1, 2023.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Dr. Seeto&#8217;s employment with us as our President and Chief Executive Officer terminated effective November 1, 2023. </span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Mr. Ronai&#8217;s employment with us as our Chief Administrative&#160;&amp; Legal Officer and Secretary terminated effective September 30, 2023.</span></div><div id="i60d05261c6404879b68233510f10856b_166"></div><div style="margin-bottom:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:2.61pt">Executive Summary</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Business Highlights</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the course of&#160;2023, we furthered our growth in the healthcare solutions market by leveraging our innovative testing services, products and digital tools.  To date, we have devoted substantially all of our efforts to product development, increasing revenue and continuing innovation.  2023 was an important year for CareDx as we achieved the following:</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Financials and Performance</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Reported full year revenue of $280.3 million, exceeding the high end of updated guidance for 2023.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Reported full year Testing Services revenue of $209.7 million and delivered approximately 165,700 patient results in 2023.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Grew Testing Services patient results for the second quarter in a row to approximately 39,900, an increase of 4% as compared to the third quarter of 2023.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Reported full year revenue of $37.1 million for Patient and Digital Solutions and $33.5 million for Product, representing year-over-year growth of 29% and 15%, respectively.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Ended 2023 with cash and cash equivalents, and marketable securities of approximately $235.4 million, with no debt.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Achieved the fifth consecutive quarter of collections at over 100% of Testing Services revenue driven by revenue cycle management initiatives. Collected $17 million in cash over its revenue in 2023.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Repurchased 2.9 million shares of common stock for $27.5 million under share buyback program in 2023.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Received Medicare coverage for HeartCare and AlloSure Lung.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In achieving the above, we have continued to execute on our business objectives, improving our products and technologies, and strengthening our financial position.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, our long-term total stockholder return has outperformed our competitors over the long-term:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TOTAL SHAREHOLDER RETURN</span></div><div style="margin-bottom:27pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1, 3 AND&#160;5-YEAR PERIODS</span></div><div style="margin-bottom:36pt;text-align:center"><img src="cdna-20240429_g17.jpg" alt="1775" style="height:364px;margin-bottom:5pt;vertical-align:text-bottom;width:652px"/></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Key&#160;2023 Compensation Decisions</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aligned with our accomplishments in&#160;2023 and strong business and company performance as outlined above, we took certain actions related to our compensation program.  Specifically, we sought to add more &#8220;at-risk&#8221; pay for our executives by adding long-term performance based incentives (including PRSUs), while balancing retention needs and building share ownership among our executives.  Our performance-based incentives aim to strengthen the pay-for-performance relationship and drive fulfillment of key strategic goals.  We continue to manage award design, with a goal of maintaining broad-based equity participation, delivering value that is aligned with our compensation philosophy and proactively managing our share usage as well as dilution during a period of rapid growth.  Moreover, cash incentive bonuses were paid out below target based on a&#160;70% achievement of company goals during&#160;2023 (see &#8220;Section&#160;IV.  Pay Components-Annual Incentives&#8221; below for further discussion).</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Fiscal&#160;2022 Stockholder Advisory Vote</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At our&#160;2023 Annual Meeting of Stockholders, our stockholders approved our Say-on-Pay proposal with approximately&#160;95.5% of the votes in favor of the fiscal&#160;2022 compensation of our named executive officers.  We believe that the&#160;2023 vote approving our Say-on-Pay proposal once again conveyed our stockholders&#8217; consistent strong support and endorsement of our existing executive compensation program and affirmed that our overall executive compensation program is aligned with the interests of our stockholders.  Our Compensation and Human Capital Committee will continue to consider feedback from our stockholders when making future compensation decisions, and will continue to benchmark, against peers, our governance practices and executive compensation program.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since we first conducted the Say-on-Pay vote, we have implemented a systematic stockholder outreach program to seek ongoing feedback on our governance and compensation policies.  We are committed to regular and transparent communication and engagement with our current and future stockholders and reach out to our largest stockholders at least annually.  During&#160;2023, our management contacted stockholders representing over&#160;50 of our institutional stockholdings and engaged with stockholders representing over&#160;40% of our institutional stockholdings to discuss, among other things, our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">executive compensation program.  In response to the feedback received from our stockholders over the last two years, we have made the following changes to our governance practices and compensation program:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adopted director and executive officer stock ownership guidelines;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Amended our equity incentive plans to provide that equity awards granted thereunder are generally subject to minimum vesting of at least one year and to prohibit cash buyouts of options and option repricings without the consent of our stockholders;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adopted a restated compensation recovery (&#8220;clawback&#8221;) policy;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our cash bonus program for our executive officers for&#160;2023 and&#160;2024 includes both financial and non-financial metrics that were pre-set at the beginning of the applicable year; and</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The PRSUs granted to our executive officers in&#160;2023 are based on a two-year performance period with one year of additional vesting (if performance criteria are achieved, 50% will vest at the end of the two-year performance period and the remaining&#160;50% will vest the following year).</span></div><div id="i60d05261c6404879b68233510f10856b_169"></div><div style="margin-bottom:12pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:3.22pt">Compensation Philosophy</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate within a complex business environment in a competitive industry, which requires a very strong management team.  Our business model requires our management team to be adept at developing competitive technologies to support multiple customers, including hospitals, all within multiple geographies.  Many of our competitors have substantially greater capital resources and larger sales forces than we do.  In addition, the diagnostics industry is characterized by rapid product development and technological advances, which require our management team to be adept at managing these key areas of the business.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, the Compensation and Human Capital Committee believes that it is critical to attract, develop and retain a highly-qualified management team with the experience, knowledge, expertise and vision capable of not only operating, but also excelling, in this complex and competitive business environment, including competing against larger competitors and developing and commercializing new products, new and improved technologies and new applications for our existing technologies.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive compensation program is intended to help us achieve and foster a goal-oriented, highly-motivated management team with a clear understanding of our business objectives and shared corporate values.  To this end, the Compensation and Human Capital Committee believes that our executive compensation program should provide compensation that:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attracts and retains the best executive talent;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appropriately aligns our business objectives and stockholder interests;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintains a reasonable balance across types and purposes of compensation;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">motivates our executive officers to achieve our annual and long-term strategic goals and rewards performance based on the attainment of such goals;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appropriately considers risk and reward in the context of our business environment and long-range business plans;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recognizes individual value and contributions to our success; and</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">considers, but does not exclusively rely upon, competitive market data.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to achieve these objectives in a way that is consistent with the long-term interests of our company and those of our stakeholders, including our stockholders and employees.  We structure the annual compensation of our executive officers, including our NEOs, using three principal elements: base salary, annual cash incentives and long-term compensation opportunities in the form of equity awards.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation and Human Capital Committee believes that our compensation program should align executive interests with the drivers of growth and stockholder returns, and support achievement of our primary business goals.  The expertise, leadership and contributions of our executives are critical to our ability to create sustained long-term stockholder value.  Consequently, our Compensation and Human Capital Committee believes the substantial majority of NEO compensation should be at-risk, variable pay to facilitate the successful execution of our business strategy.</span></div><div id="i60d05261c6404879b68233510f10856b_172"></div><div style="margin-bottom:12pt;padding-left:16.2pt;text-indent:-16.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:2.03pt">Compensation Determination Process</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Role of Compensation and Human Capital Committee</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation and Human Capital Committee discharges the responsibilities of our Board of Directors relating to the compensation of our executive officers.  The Compensation and Human Capital Committee consists of directors who are &#8220;independent&#8221; directors as required by the Nasdaq Rules and Exchange Act Rule&#160;10C-1, and &#8220;non-employee directors&#8221; for purposes of Exchange Act Rule&#160;16b-3.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation and Human Capital Committee has responsibility for (i)&#160;overseeing our compensation and benefits policies generally, including DEI considerations in the context of our compensation plans, programs and pay equity practices and (ii)&#160;overseeing, evaluating and approving the compensation plans, policies and programs applicable to our Chief Executive Officer, as well as our other executive officers, including our other NEOs.  In carrying out its responsibilities, the Compensation and Human Capital Committee evaluates our compensation policies and practices with a focus on the degree to which these policies and practices reflect our executive compensation philosophy, develops recommendations, makes decisions that it believes advances our philosophy and reviews the performance of our executive officers when making decisions with respect to their compensation.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation and Human Capital Committee conducts reviews of our compensation policies and programs on at least an annual basis to ensure that they enhance stockholder value, align pay and performance, and attract and retain top executive talent.  This includes a review of internal pay equity among the executive team.  With the assistance of our independent compensation consultant, the Compensation and Human Capital Committee seeks to maintain appropriate base salary, annual bonus and equity compensation plans for our executives.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Role of Chief Executive Officer &amp; Management</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2023, the former CEO made recommendations with respect to salary, 2023 bonus targets and equity awards granted in Q1 2023 to executive officers, other than himself. The Office of the Chief Executive Officer was formed in November 2023 and provided input to the compensation process with respect to performance against objectives for the 2023 calendar year.  Mr. Jain, on behalf of the Office of the Chief Executive Officer, and in consultation with our Senior Vice President, Head of Human Resources, made recommendations to our Compensation and Human Capital Committee regarding short-and long-term compensation for all executive officers (other than himself) based on our results, an individual executive officer&#8217;s contribution toward these results and performance toward individual goal achievement.  Our Compensation and Human Capital Committee then reviews the recommendations and other data and makes decisions as to total compensation for each executive officer other than the Chief Executive Officer and each employee member of the Office of the Chief Executive Officer, as well as each individual compensation component.  Our Compensation and Human Capital Committee makes recommendations to our Board of Directors regarding, or determines, compensation for our Chief Executive Officer and each employee member of the Office of the Chief Executive Officer.  The Compensation and Human Capital Committee or the independent members of our Board of Directors make the final decisions regarding executive compensation for our Chief Executive Officer and each employee member of the Office of the Chief Executive Officer.  The Compensation and Human Capital Committee does not delegate any of its functions to others in deciding executive compensation.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Independent Compensation Consultant</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation and Human Capital Committee is authorized to retain the services of one or more executive compensation advisors, as it sees fit, in connection with the establishment of our compensation programs and related policies.  The Compensation and Human Capital Committee previously retained Aon&#8217;s Human Capital Solutions practice (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Aon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), a division of Aon plc, as its independent outside compensation consultant from 2014 through part of 2023 to assist with setting executive and outside director compensation. Beginning in September 2023, the Compensation and Human Capital Committee retained Alpine Rewards (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Alpine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) as its independent outside compensation consultant to assist with setting executive compensation and the Company&#8217;s broader employee equity strategy. The Compensation and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Human Capital Committee has sole authority to retain or replace such independent compensation consultants.  The Compensation and Human Capital Committee annually evaluates the compensation consultant&#8217;s independence and performance under the Nasdaq Rules.  The Compensation and Human Capital Committee believes that working with an independent compensation consultant furthers our objectives to recruit and retain qualified executives, align executive interests with those of stockholders and ensure that executive compensation packages will appropriately motivate and reward ongoing achievement of business goals.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In&#160;2023, Aon and Alpine provided the following services to the Compensation and Human Capital Committee:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reviewed and recommended adjustments to our peer group;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conducted an extensive executive compensation assessment; and</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provided key insights on executive and outside director compensation based on relevant market data.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither Aon nor Alpine provided any services to us other than the consulting services to the Compensation and Human Capital Committee.  The Compensation and Human Capital Committee conducted a review of its relationship with each of Aon and Alpine in&#160;2023 and determined that Aon&#8217;s and Alpine&#8217;s work for the Compensation and Human Capital Committee did not raise any conflicts of interest.  The Compensation and Human Capital Committee determined that Aon&#8217;s and Alpine&#8217;s work has conformed to the independence factors and guidance provided by the SEC and The Nasdaq Stock Market LLC.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of a Peer Group</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the assistance and recommendations of Aon, the Compensation and Human Capital Committee has developed a peer group of companies as a reference group to provide a broad perspective on competitive pay levels and practices with respect to compensation paid in 2023.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December&#160;2022, the Compensation and Human Capital Committee approved a peer group for use in making&#160;2023 compensation decisions.  When selecting appropriate peers, the general criteria used were:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Industry</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; medical device and commercial bio pharmaceutical companies</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Between $150&#160;million and $800&#160;million</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Market Capitalization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; between $250 million and $2.3 billion</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For compensation decisions for fiscal year&#160;2023, the following public companies were selected as our peer group:</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2023 Peer Group</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:29.704%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.704%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adaptive Biotechnologies<br/>Corporation</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guardant Health, Inc.</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Castle Biosciences,<br/>Inc.</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Meridian Bioscience,<br/>Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exact Sciences Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nanostring Technologies, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Invitae Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NeoGenomics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Myriad Genetics, Inc.</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pacific Biosciences of California, Inc.</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natera, Inc.</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quanterix Corporation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OraSure Technologies, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Veracyte, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cerus Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TransMedics Group*</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Twist Bioscience Corporation</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;padding-left:5.76pt;text-align:justify;text-indent:-5.77pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:0.77pt">New for&#160;2023. Berkeley Lights, Inc. and Personalis, Inc. were removed for 2023 from the 2022 peer group of companies.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation and Human Capital Committee does not engage in formal benchmarking against other companies&#8217; compensation programs or practices to establish our compensation levels or make specific compensation decisions with respect to our executive officers, including our NEOs.  Instead, in making its determinations, the Compensation and Human Capital Committee reviews information summarizing the compensation paid at a representative group of peer companies, to the extent that the executive positions at these companies are considered comparable to our positions and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">informative of the competitive environment, as well as more broad-based compensation surveys to gain a general understanding of market compensation levels.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assessment of Risk</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation and Human Capital Committee also evaluates and considers the potential risks in our business when designing and administering our executive compensation program, and discusses these risks with our management to determine whether our compensation philosophy and practices encourage excessive risk-taking.  We believe our balanced approach to performance measurement and pay delivery works to avoid misaligned incentives for individuals to undertake excessive or inappropriate risk, and our Compensation and Human Capital Committee has determined that the risks arising from our compensation policies and practices are not reasonably likely to have a material adverse effect on our company.</span></div><div id="i60d05261c6404879b68233510f10856b_175"></div><div style="margin-bottom:12pt;padding-left:16.2pt;text-indent:-16.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:2.59pt">Pay Components</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive compensation program consists of three primary elements: base salaries, annual cash incentives, and long-term equity awards:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.326%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Element</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance<br/>Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Objective</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Measured / Rewarded</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Salary</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attracts, retains, and rewards top talent and reflects an NEO&#8217;s responsibilities, performance, and relevant market data</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provides NEOs with fixed compensation that acts as a vehicle to motivate and retain executives</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rewards executives for key performance and contributions</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Short-Term<br/>Incentives</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards achievement of our annual goals subject to meeting individual performance expectations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rewards NEOs for their individual performance and our performance over the fiscal year&#160;2023</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cash bonuses, which are based on our financial and strategic goals, and the three metrics used for&#160;2023 cash bonuses were:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues - 40% weighting</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA - 40% weighting</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pipeline and Approvals - 20% weighting</span></div></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Term<br/>Incentives</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-Term (four years)</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aligns the interests of management and stockholders and serves as an important retention vehicle; Supports the achievement of strong stock price growth</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NEOs receive a mix of:</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Options and RSUs vest over four years to encourage employee retention</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Stock options to reward long-term stock price growth Performance-based RSUs (&#8220;PRSUs&#8221;), which have a two-year performance period with one year of additional vesting thereafter, and are based on our financial and strategic goals. The two metrics used for PRSUs granted in&#160;2023 with a two-year performance period (combined for&#160;2023 and&#160;2024) were:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues - 50% weighting</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA - 50% weighting</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to a strong performance orientation in our compensation program and effective corporate governance practices for a company at our development stage and industry.  As such we routinely review our policies and program design.  Some of our best practices in governance that we observe include:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.294%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">What We Do</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pay-for-performance based on both financial and non-financial metrics, and our PRSUs have a two-year performance period with one year of additional vesting thereafter</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Maintain an Insider Trading Policy</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Align compensation with stockholder interests</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Maintain &#8220;Double Trigger&#8221; benefits in the case of a Change in Control</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Annual compensation review</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recommending annual stockholder advisory vote on named executive officer compensation</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Provide only very limited perquisites to executives</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Director and executive officer stock ownership guidelines</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Balanced pay mix of fixed and variable pay </span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Multi-year vesting requirements for stock options and certain restricted stock unit awards </span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Robust anti-hedging and pledging policies</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Retain an independent compensation consultant</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Only independent directors serve on our board committees</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Maintain compensation recovery (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">clawback</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) policy</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Provide that equity awards granted under our equity incentive plans are subject to minimum vesting of at least one year</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">What We Don&#8217;t Do</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Provide excessive severance payments</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Use excise tax gross-ups</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Utilize guaranteed bonuses</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Provide single trigger change-in-control severance payments</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Provide excessive perquisites</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Provide supplemental executive retirement plans</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Provide special welfare benefits to our executive officers</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Permit the payment of dividends on RSUs or PRSUs prior to vesting</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Permit cash buyouts of options without stockholder consent</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Permit option repricings without stockholder consent</span></div></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Base Salary</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Base salary is the only fixed component of our executive officers&#8217; total cash compensation and provides competitive pay to attract and retain our executives.  Generally, we use base salary to provide each executive officer with a specified level of cash compensation during the year with the expectation that he or she will perform his or her responsibilities to the best of his or her ability and in our best interests.  Annual salary decisions are made in recognition of competitive data as well as the skills and experience that each individual brings to CareDx and the performance contributions each makes.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Base salary changes in&#160;2023 varied by executive due either to merit increases and/or market adjustments.  The increases in&#160;2023 were based on a review of market data from Aon for similar roles and positions within our compensation peer group and an assessment of the following factors:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Peer group data and external market information;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Individual performance;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The level of responsibility assumed and the nature and complexity of each NEO&#8217;s role;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The leadership demonstrated to create and promote a day-to-day working environment; and</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The desire to attract, engage and retain NEOs capable of achieving our strategic objectives and the marketability and criticality of retention of NEOs. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:56.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Named Executive Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alex Johnson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$415,000&#160;</span></td><td style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$388,125&#160;</span></td><td style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abhishek Jain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reginald Seeto, MBBS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620,000&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558,900&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abraham Ronai</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14pt">See footnotes for a description of the changes to base salary that were effected throughout&#160;2023.  Actual amounts of salary paid to our NEOs are described in the &#8220;Summary Compensation Table&#8221; below.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective March 1, 2023, Mr. Johnson&#8217;s annual base salary was increased from $388,125 to $415,000.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective March 1, 2023, Mr. Jain&#8217;s annual base salary was increased from $375,000 to $415,000.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective March 1, 2023, Dr. Seeto&#8217;s annual base salary was increased from $558,900 to $620,000. Dr. Seeto&#8217;s employment with us terminated effective November 1, 2023.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective March 1, 2023, Mr. Ronai&#8217;s annual base salary was increased from $388,125 to $415,000. Mr. Ronai&#8217;s employment with us terminated effective September 30, 2023.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Annual Incentives</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash bonus program is designed to provide a financial incentive to reward key executives for the achievement of annual corporate performance objectives. Under the cash bonus program, each NEO has an award opportunity expressed as a percentage of his or her base salary. Payments under the cash bonus program and vesting of the PRSUs are ultimately based on the achievement of pre-established Company metrics. Actual performance against these metrics determines the Company factor for purposes of calculating payments under the cash bonus program (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Factor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and determines the level of vesting of the PRSUs. Threshold levels of performance must be met for bonuses to be earned and vesting to occur.  For purposes of our cash bonus program, in&#160;2023, the Company Factor could range from zero to&#160;200%.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For&#160;2023, the cash bonus program used three metrics for funding: Revenues, Pipeline and Approvals (number of products or services added to our pipeline and number of approvals obtained) and Adjusted EBITDA.  We define Adjusted EBITDA as non-GAAP net income/(loss) before net interest expense, income tax expense, depreciation and amortization, other expense, and net loss attributable to noncontrolling interest.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each of these three metrics, in the first quarter of&#160;2023, the Compensation and Human Capital Committee established performance thresholds at the following levels: less than&#160;25% achievement; 25% achievement; 50% achievement; 100% achievement; 150% achievement; and&#160;200% or greater achievement.  The Compensation and Human Capital Committee set the Company Factor, for purposes of the bonuses earned for&#160;2023, at&#160;70% based on our&#160;2023 achievements.  In setting the Company Factor at&#160;70%, the majority of the cash bonus assessment was based on our Total Sales for&#160;2023 relative to a Total Sales target, while minority weights were given to the number of Pipeline Additions in&#160;2023 and our&#160;2023 Adjusted EBITDA relative to an Adjusted EBITDA target.  A discretionary nominal weight was also awarded to account for sustained efforts in a challenging market and success in the areas of increased testing volumes and maintaining a strong balance sheet.  The Compensation and Human Capital Committee determined that, although the targets were not fully achieved, the actions taken by management in&#160;2023 after first quarter&#160;2023 targets were missed were taken in order to better position the Company for profitability in&#160;2024.  Once the Company Factor was determined based on Company performance against the metrics above, a modifier was applied based on individual performance.  Our Compensation and Human Capital Committee had discretion to grant individual cash bonus awards at, below, or above target based on individual performance and the funding available in the bonus pool.  Final awards under the program were subject to adjustment, positively or negatively, for individual performance against key Company objectives.  Therefore, through our cash bonus program, NEOs may earn a significantly higher payout if target performance is exceeded.  NEOs also bear the risk of a lower payout if target performance is not achieved, and the risk of no payout for below-threshold results.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except with respect to Dr. Seeto and Mr. Ronai, to arrive at each NEO&#8217;s earned bonus for&#160;2023, the Compensation and Human Capital Committee multiplied the NEO&#8217;s base salary, by the NEO&#8217;s annual target bonus percentage, by the Company Factor (70%), by the NEO&#8217;s individual performance factor, as determined by the Compensation and Human Capital Committee.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual incentive cash bonuses paid to our NEOs for&#160;2023 were: </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Named Executive Officer*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Salary<br/>for Purposes<br/>of Bonus</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 Annual</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bonus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(% of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">base)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factor</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Individual</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Multiplier</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 Earned<br/>Bonus</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alex Johnson</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$415,000&#160;</span></td><td style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$174,300&#160;</span></td><td style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abhishek Jain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$415,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$174,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reginald Seeto</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$620,000&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$620,000&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abraham Ronai</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$420,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$252,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pursuant to our separation agreement with Dr. Seeto, dated November 1, 2023, we agreed to pay Dr. Seeto his full annual bonus for 2023 at target ($620,000), payable in accordance with our standard bonus schedule in February 2024. This amount is included in the &#8220;All Other Compensation&#8221; column of the &#8220;Summary Compensation Table&#8221; below.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pursuant to our separation agreement with Mr. Ronai, dated September 30, 2023, we agreed to pay Mr. Ronai his full annual bonus for 2023 at target ($252,000), payable in accordance with our standard bonus schedule in February 2024. This amount is included in the &#8220;All Other Compensation&#8221; column of the &#8220;Summary Compensation Table&#8221; below.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported by us, in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March and May 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Palmetto MolDX issued new billing articles related to the Local Coverage Determination entitled Molecular Testing for Solid Organ Allograft Rejection. The billing article issued in May 2023 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revised Billing Article</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and together with the billing article issued in March 2023 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Billing Articles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), impacted Medicare coverage for AlloSure Kidney, AlloSure Heart, AlloMap Heart and AlloSure Lung, and required certain companies, including us, to implement new processes to address the requirements related to Medicare claim submissions. Noridian adopted the Revised Billing Article on August 17, 2023, with a retroactive effective date of March 31, 2023. Addressing the Billing Articles required substantial work from our executive officers and legal teams during 2023 and required us to materially re-prioritization our 2023 corporate objectives during the year. In addition, in 2023, our former Chief Executive Officer and President and our former Chief Legal Officer each resigned from the company, which required other members of our executive team to substantially increase their roles and responsibilities with us during the fourth quarter of 2023.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation and Human Capital Committee determined that Mr. Jain&#8217;s individual performance multiplier was&#160;1.0 based on performance managing the Billing Article matters and executive officer transitions discussed above, as well as his service on the Office of the Chief Executive for the fourth quarter of 2023. In considering the individual performance of Mr. Johnson, the Compensation and Human Capital Committee considered his performance managing the Billing Article matters and executive officer transitions discussed above, as well as his service on the Office of the Chief Executive for the fourth quarter of 2023 and determined his individual performance multiplier to be&#160;1.0.  </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Incentives</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our focus on long-term value creation results in our executive compensation program having a heavy weighting toward equity compensation, which includes stock options, RSUs and PRSUs. We rely heavily on equity compensation that vests over a multi-year period to ensure that a significant portion of a named executive officer&#8217;s compensation opportunity is related to factors that directly or indirectly influence stockholder value. Our Compensation and Human Capital Committee believes this serves as a reward for appreciation in our stock price and long-term value creation, and enables us to achieve our retention objectives. Further, equity participation establishes a sense of ownership and aligns executives&#8217; interests with those of our stockholders.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In&#160;2023, we provided a significant portion of our executives&#8217; target long-term incentives via a mix of stock options, RSUs and PRSUs. Approximately&#160;20% of the value of our equity awards granted in&#160;2023 was in the form of long-term stock options (four-year vesting period), 60% of the value was in the form of long-term RSUs (four-year vesting period) and&#160;20% of the value was in the form of PRSUs with a two-year performance period and time vesting over three years.  The Compensation and Human Capital Committee believes this structure is appropriate for us given our current competitive recruiting landscape, our current company size and our current growth trajectory.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Annual Equity Grants</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our regular, annual cycle grants for&#160;2023, which were granted on February 1, 2023, is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PRSUs</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Named Executive Officer</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(#)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(#)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(#)</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Alex Johnson</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,800</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591,948</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,100</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,332,600</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,100</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">481,973</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Abhishek Jain</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,800</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591,948</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,100</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,332,600</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,100</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">481,973</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reginald Seeto, MBBS</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,250</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,102,355</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302,000</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,729,320</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,000</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,704,940</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Abraham Ronai</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,800</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591,948</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,100</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,332,600</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,100</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">481,973</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The PRSUs were granted on February 1, 2023. Amounts set forth in this column generally represent the aggregate grant date fair value of the PRSU awards granted to each listed NEO, computed in accordance with FASB ASC Topic&#160;718.  These amounts do not represent the actual amounts paid to or realized by the NEOs.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The RSUs were granted on February 1, 2023. Amounts set forth in this column generally represent the aggregate grant date fair value of the RSU awards granted to each listed NEO, computed in accordance with FASB ASC Topic&#160;718.  These amounts do not represent the actual amounts paid to or realized by the NEOs.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The stock options were granted on February 1, 2023. Amounts set forth in this column reflect the grant date fair value of the option awards, computed in accordance with FASB ASC Topic&#160;718.  All of these amounts reflect certain assumptions with respect to the option awards and do not necessarily correspond to the actual value that will be recognized by our NEOs.  The actual value, if any, that may be realized from an option award is contingent upon the satisfaction of the conditions to vesting of that award, and upon the excess of the stock price over the exercise price, if any, on the date the option award is exercised.  See Note&#160;13 of the consolidated financial statements included in our Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2023 that was filed with the SEC on February 28, 2024 for a discussion of the assumptions made in determining the grant date fair value of the stock options.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PRSUs</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In early 2023, our Compensation and Human Capital Committee granted PRSUs to our executive officers.  The PRSUs are designed to further reward key executives for the achievement of corporate performance objectives.  The PRSUs use two metrics for funding and vesting purposes, which were weighted equally: Total Sales and Adjusted EBITDA (defined as described above).  In determining the metrics to be used for the PRSUs, the Compensation and Human Capital Committee chose Total Sales and Adjusted EBITDA because it determined that these were the two most important financial measures for our company to focus on for the 2023-2024 performance period.  For each of these two metrics, for purposes of the PRSUs, the Compensation and Human Capital Committee established performance thresholds at the following levels: greater than&#160;50% achievement; 80% or greater achievement; and 100% or greater achievement.  The PRSUs are long-term incentives and have a two-year performance period with one year of additional vesting (if performance criteria are achieved, 50% will vest at the end of the two-year performance period and the remaining&#160;50% will vest the following year).</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RSUs - Vesting</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing RSU grants vest over four years in equal annual installments on the anniversary of the date of grant, beginning on the first anniversary of the date of grant, subject to the executive&#8217;s continuing service on each vesting date.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options - Vesting</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One quarter of the foregoing option grants vest on the first anniversary of the date of grant.  The balance of the option grants vest monthly over the following three-year period, subject to the executive&#8217;s continuing service on each vesting date.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Special Retention Awards</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Company entered into retention bonus agreements with Mr. Johnson and Mr. Jain.  In granting these retention awards, the primary goal of our Compensation and Human Capital Committee was to ensure stability during a time of transition following the departures of Dr. Seeto and Mr. Ronai and the search for a new Chief Executive Officer.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separation Agreements and Consulting Agreements</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation and Human Capital Committee determined that, in connection with the departures of Dr. Seeto and Mr. Ronai, both of which occurred after extensive discussions with members of our Board of Directors, and given the need for a smooth transition, it was in our best interests to enter into separation agreements with Dr. Seeto and Mr. Ronai that </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provided each with severance and consulting agreements that provided the Company with their consulting services during an extended transition period.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Welfare and Health Benefits</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our NEOs participate in our employee benefit plans on the same terms as all of our other eligible employees.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a tax-qualified Code Section&#160;401(k) defined contribution plan in which all of our employees, including our executive officers, who satisfy certain eligibility requirements, including requirements relating to age and length of service, are entitled to participate.  Employees may contribute their own funds on a pre-tax basis.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The plan permits us to make matching contributions and we have historically provided employer contributions that match eligible employee contributions (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employer Matching Contributions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), generally limited to&#160;3% of the compensation (up to a maximum matching contribution of $5,000&#160;per year) that can be taken into account for this purpose under federal law.  On January&#160;1, 2018, we began to make contributions to the employee plan.  Employer matching contributions vest according to a four-year graded plan at a rate of&#160;25% per year with employees being fully vested in Employer Matching Contributions after completing four years of service. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we provide health care, dental, vision and life insurance, an employee assistance plan and both short-term and long-term disability and accidental death and dismemberment benefits to all full-time employees.  These benefits are subject to applicable laws and at benefit levels that we believe are generally consistent with the benefits of companies with which we compete for talent.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Limited Perquisites</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In&#160;2023, the Company provided certain limited perquisites to our NEOs, which included electronic allowances and gym allowances.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedging and Pledging Prohibitions</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our insider trading policy prohibits our directors, officers (including our executive officers), employees and agents, as well as their immediate family members, from engaging in short sales of our securities and from engaging in transactions in publicly-traded options and other derivative securities with respect to our securities.  This prohibition extends to any hedging or similar transactions designed to decrease the risks associated with holding our securities.  Our insider trading policy also prohibits certain individuals, including our directors and executive officers, from pledging our securities as collateral for loans.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting and Tax Considerations</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for equity-based compensation paid to employees under FASB ASC Topic&#160;718, which requires the Company to estimate and record an expense over the service period of an option award.  Thus, the Company may record an expense in one year for awards granted in earlier years.  Accounting rules also require the recording of cash compensation as an expense at the time the obligation is accrued.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;162(m) of the Internal Revenue Code of&#160;1986, as amended, generally disallows public companies a tax deduction for federal income tax purposes of compensation in excess of $1&#160;million paid to their chief executive officer, the chief financial officer and three other most highly-compensated executive officers in any taxable year.  In making compensation decisions, the Compensation and Human Capital Committee considered the potential effects of Section&#160;162(m) on the compensation paid our executive officers who are subject to the deduction limit (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">covered executives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  The exemption from Section&#160;162(m)&#8217;s deduction limit for performance-based compensation was generally repealed for taxable years beginning after December&#160;31, 2017, such that compensation paid to our covered executives in excess of $1&#160;million will generally not be deductible unless it qualifies for transition relief applicable to certain arrangements in place as of November&#160;2, 2017.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To maintain flexibility in compensating the NEOs in a manner designed to promote varying corporate goals, the Compensation and Human Capital Committee has not adopted a policy that all compensation payable to the covered executives must be deductible for federal income tax purposes.  Accordingly, while the Compensation and Human Capital Committee considers the deductibility of awards as one factor in determining executive compensation, the Compensation </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Human Capital Committee also looks at other factors in making its decisions and retains the flexibility to award compensation that it determines to be consistent with the goals of our executive compensation program even if the awards are not deductible by us for tax purposes.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to considering the tax consequences, the Compensation and Human Capital Committee considers the accounting consequences of its decisions, including the impact of expenses being recognized in connection with equity-based awards, in determining the size and form of different equity-based awards.</span></div><div id="i60d05261c6404879b68233510f10856b_178"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee Report</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation and Human Capital Committee has reviewed and discussed the Compensation Discussion and Analysis required by Item&#160;402(b) of Regulation&#160;S-K of the SEC&#8217;s rules and regulations with management and, based on such review and discussions, the Compensation and Human Capital Committee recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this proxy statement.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation and Human Capital Committee:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Christine M. Cournoyer (Chairperson)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fred E. Cohen, M.D., D. Phil</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Grace E. Col&#243;n, Ph.D.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michael D. Goldberg</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">William A. Hagstrom</span></div><div id="i60d05261c6404879b68233510f10856b_181"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary Compensation Table</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding the compensation awarded to, or earned by, our NEOs during&#160;2021, 2022 and&#160;2023.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.268%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Summary Compensation Table</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name and<br/>Principal<br/>Position</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Salary ($)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Bonus <br/>($)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Awards</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Awards</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incentive Plan</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">All Other<br/>Compensation<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total ($)</span></td></tr><tr style="height:17pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Alex Johnson</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">President of President and Testing Services</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">408,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,924,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">481,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">174,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,097,438&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">384,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,519,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,657,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">161,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,724,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">332,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,088,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,162,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">382,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,967,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:17pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Abhishek Jain</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Chief Financial Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">405,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,924,614&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">481,973&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">174,300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,820&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,094,707&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318,917&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">904,723&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,013,007&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,260&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,343,307&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:17pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reginald Seeto, MBBS </span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Former Chief Executive Officer and President</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">556,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,831,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,704,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,458,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,551,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">554,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,746,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,085,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">399,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,786,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">540,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,866,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,710,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">972,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,090,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:17pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Abraham Ronai</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Former Chief Administrative &amp; Legal Officer and Secretary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">330,992&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,394,214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">481,973&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">933,801&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,140,980&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">384,844&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,190,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,936,460&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">181,643&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,693,641&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The amounts in this column represent the fair value of the award computed as of the grant date of each stock award in accordance with FASB ASC Topic&#160;718. Our assumptions with respect to the calculation of these values are set forth in Note&#160;13 of the consolidated financial statements included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023 that was filed with the SEC on February 28, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The amounts in this column represent the aggregate fair value of the award computed as of the grant date of each option award in accordance with FASB ASC Topic&#160;718. Our assumptions with respect to the calculation of these values are set forth in Note&#160;13 of the consolidated financial statements included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023 that was filed with the SEC on February 28, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents amounts paid as a discretionary bonus to our executive officers, including our NEOs, for their performance in&#160;2023 as compared against the performance goals set in our Equity Plans.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In accordance with SEC guidance, compensation information for Abhishek Jain for fiscal year 2021 has not been included in this table because Mr. Jain was not a named executive officer for fiscal year 2021. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Dr. Seeto&#8217;s employment with us terminated effective November 1, 2023, at which time he began serving as our consultant.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">All other compensation for Dr. Seeto for the year ended December&#160;31, 2023 includes (i) $1,343,324 in severance payments (inclusive of $620,000 representing Dr. Seeto&#8217;s 2023 annual target bonus) pursuant to the Seeto Separation Agreement (as defined below), (ii) $56,278 representing the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">cost of reimbursement for health insurance coverage under COBRA pursuant to the Seeto Separation Agreement, and (iii)&#160;$50,000 in consulting fees paid during 2023 pursuant to the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Seeto Consulting Agreement (as defined below). </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In accordance with SEC guidance, compensation information for Abraham Ronai for fiscal year 2021 has not been included in this table because Mr. Ronai was not a named executive officer for fiscal year 2021. Mr. Ronai&#8217;s employment with us terminated effective September 30, 2023, at which time he began serving as our consultant.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">All other compensation for Mr. Ronai for the year ended December&#160;31, 2023 includes (i) $742,000 in severance payments (inclusive of $252,000 representing Mr. Ronai&#8217;s 2023 annual target bonus) pursuant to the Ronai Separation Agreement (as defined below), (ii) $54,114 representing the cost of reimbursement for health insurance coverage under COBRA pursuant to the Ronai Separation Agreement, (iii) $115,000 in consulting fees paid during 2023 pursuant to the Ronai Consulting Agreement (as defined below), and (iv) housing allowance and reimbursement of certain electronics cost provided to Mr. Ronai. </span></div><div id="i60d05261c6404879b68233510f10856b_184"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grants of Plan-Based Awards</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents, for each of the NEOs, information concerning each grant of an equity award made during the fiscal year ended December&#160;31, 2023.  This information supplements the information about these awards set forth in the Summary Compensation Table and the Outstanding Equity Awards at Fiscal Year-End Table.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.995%"/><td style="width:0.1%"/></tr><tr style="height:27pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Future Payouts <br/>Under Equity Incentive Plan<br/>Awards</span></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.12pt;padding-right:0.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All Other Stock</span></div><div style="padding-left:0.12pt;padding-right:0.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards: Number</span></div><div style="padding-left:0.12pt;padding-right:0.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of shares of stock</span></div><div style="padding-left:0.12pt;padding-right:0.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">or units (#)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.12pt;padding-right:0.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All Other Option</span></div><div style="padding-left:0.12pt;padding-right:0.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards: Number of</span></div><div style="padding-left:0.12pt;padding-right:0.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities Underlying</span></div><div style="padding-left:0.12pt;padding-right:0.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options (#)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise<br/>Price Per<br/>Share ($)</span></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.12pt;padding-right:0.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Grant Date Fair</span></div><div style="padding-left:0.12pt;padding-right:0.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value of Stock and </span></div><div style="padding-left:0.12pt;padding-right:0.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option Awards </span></div><div style="padding-left:0.12pt;padding-right:0.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:20pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Threshold<br/>(#)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Target<br/>(#)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum<br/>(#)</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Alex<br/>Johnson</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.25pt;padding-right:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85,100</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,332,666</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.25pt;padding-right:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,780</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,800</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,800</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$591,948</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.25pt;padding-right:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,100</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$15.66</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$481,973</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Abhishek Jain</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.25pt;padding-right:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85,100</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,332,666</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.25pt;padding-right:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,780</span></td><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,800</span></td><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,800</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$591,948</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.25pt;padding-right:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,100</span></td><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$15.66</span></td><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$481,973</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Reginald Seeto,<br/>MBBS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.25pt;padding-right:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">302,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$4,729,320</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.25pt;padding-right:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,425</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134,250</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134,250</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$2,102,355</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.25pt;padding-right:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">156,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$15.66</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,704,940</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Abraham<br/>Ronai</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.25pt;padding-right:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)(6)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85,100</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,332,666</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.25pt;padding-right:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)(6)</span></div></td><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,780</span></td><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,800</span></td><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,800</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$591,948</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.25pt;padding-right:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)(6)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,100</span></td><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$15.66</span></td><td colspan="3" style="padding:2px 1.27pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$481,973</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reflect the aggregate grant date fair value of the RSUs and stock option awards, determined in accordance with FASB ASC Topic&#160;718.  This amount does not reflect the actual economic value realized by the named executive officer.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Vesting of the RSU is subject to the executive&#8217;s continued service on the applicable vesting date with the following schedule: 25% of the total number of shares vesting on the one-year anniversary of the grant date, with&#160;25% vesting on each successive grant date anniversary.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents a grant of a PRSU, which have a two-year performance period with one year of additional vesting. Upon the achievement of certain milestones relating to Revenues and Adjusted EBITDA, 50% will vest at the end of the two-year performance period and the remaining 50% will vest the following year. Grant date fair value reflects the target (and maximum) number of shares subject to the PRSU award, assuming all performance goals and other requirements are met.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Vesting of the option is subject to the executive&#8217;s continued service on the applicable vesting date with the following schedule: 25% of the total number of shares vesting on the one-year anniversary of the grant date, with&#160;1/48th vesting monthly thereafter.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In addition, all unvested equity awards then held by Dr.&#160;Seeto will automatically accelerate in full: (a)&#160;in the event of Dr.&#160;Seeto&#8217;s death or disability (as set forth in the Seeto Consulting Agreement), (b) if the Seeto Consulting Agreement term is not renewed, (c)&#160;if Dr.&#160;Seeto terminates the Seeto Consulting Agreement for &#8220;good reason&#8221;, or (d)&#160;if the Company terminates the Seeto Consulting Agreement without &#8220;good cause&#8221; (all as defined in the Seeto Consulting Agreement).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In addition, all unvested equity awards then held by Mr.&#160;Ronai will automatically accelerate in full: (a)&#160;in the event of Mr.&#160;Ronai&#8217;s death or disability (as set forth in the Ronai Consulting Agreement), (b) if the Consulting Agreement term is not renewed, (c)&#160;if Mr.&#160;Ronai terminates the Ronai Consulting Agreement for &#8220;good reason&#8221;, or (d)&#160;if the Company terminates the Ronai Consulting Agreement without &#8220;good cause&#8221; (all as defined in the Ronai Consulting Agreement).</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Certain option and stock awards held by Dr. Seeto and Mr. Ronai were modified at the time of their respective departures during 2023.  However, the modifications did not result in an incremental increase to the fair value of the respective awards.  As a result, such modifications are not reflected in this Grant of Plan-Based Awards table and no amounts are included in the Summary Compensation Table on account of such modifications. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_187"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding Equity Awards at Fiscal Year-End</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents certain information concerning equity awards held by our NEOs as of December&#160;31, 2023. </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.059%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Options<br/>(#)&#160;Exercisable</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Options<br/>(#)&#160;Unexercisable</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option<br/>Exercise<br/>Price ($)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option<br/>Expiration<br/>Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Shares<br/>or Units<br/>of Stock<br/>That<br/>Have<br/>Not<br/>Vested<br/>(#)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market<br/>Value of<br/>Shares or<br/>Units of<br/>Stock<br/>That<br/>Have Not<br/>Vested<br/>($)*</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>Incentive<br/>Plan<br/>Awards:<br/>Number of<br/>Unearned<br/>Shares,<br/>Units or<br/>Other<br/>Rights<br/>That Have<br/>Not Vested<br/>(#)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>Incentive<br/>Plan<br/>Awards:<br/>Market or<br/>Payout<br/>Value of<br/>Unearned<br/>Shares,<br/>Units or<br/>Other<br/>Rights<br/>That Have<br/>Not Vested<br/>($) </span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Alex<br/>Johnson</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/18/2018</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,917</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/18/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/29/2018</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,437</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/29/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/4/2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,667</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/4/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/3/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,334</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/3/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/6/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,135</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">365</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/6/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/3/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,667</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,333</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/3/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,055</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,278</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/2/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,704</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,196</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/2/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/9/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,247</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,411</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/9/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,100</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2033</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/3/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(11)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,000</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/6/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(12)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/3/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(13)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,000</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/19/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(14)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,666</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79,992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/2/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(15)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,925</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">179,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/2/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(16)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,950</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/9/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(17)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,512</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">438,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(18)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85,100</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,021,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(19) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,800</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">453,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Abhishek<br/>Jain</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/18/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(20)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,063</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,487</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/18/2032</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/6/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(21)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">417</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">583</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/6/2032</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/26/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(22)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,958</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,042</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.07&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/26/2032</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/7/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(23)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,396</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,604</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/7/2032</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,100</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2033</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/10/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(24)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,750</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4/18/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(25)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,912</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,944&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/6/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(26)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,500</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5/26/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(27)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,250</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/7/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(28)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,612</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199,344&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(18)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85,100</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,021,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(19) </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,800</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">453,600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Reginald Seeto, MBBS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(29)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/26/2018</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(30)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,048</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/26/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/4/2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(31)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,500</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/4/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/3/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(32)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,583</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">833</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/3/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/6/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(33)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,083</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,917</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/6/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/2/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(34)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,646</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,354</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/2/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/3/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,896</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,604</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/3/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/2/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,202</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,148</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/2/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/9/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,113</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106,855</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/9/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(10) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">156,000</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2033</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/3/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(35)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7/6/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(36)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,000</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11/2/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(37)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,525</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.059%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Options<br/>(#)&#160;Exercisable</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Options<br/>(#)&#160;Unexercisable</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option<br/>Exercise<br/>Price ($)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option<br/>Expiration<br/>Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Shares<br/>or Units<br/>of Stock<br/>That<br/>Have<br/>Not<br/>Vested<br/>(#)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market<br/>Value of<br/>Shares or<br/>Units of<br/>Stock<br/>That<br/>Have Not<br/>Vested<br/>($)*</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>Incentive<br/>Plan<br/>Awards:<br/>Number of<br/>Unearned<br/>Shares,<br/>Units or<br/>Other<br/>Rights<br/>That Have<br/>Not Vested<br/>(#)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity<br/>Incentive<br/>Plan<br/>Awards:<br/>Market or<br/>Payout<br/>Value of<br/>Unearned<br/>Shares,<br/>Units or<br/>Other<br/>Rights<br/>That Have<br/>Not Vested<br/>($) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/3/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(38)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,750</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/2/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(15)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,012</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">660,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/2/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(16)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,550</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">438,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/9/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(17)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62,608</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">751,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(18)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">302,000</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,624,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(19) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134,250</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,611,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Abraham</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Ronai </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(39)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/7/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(40)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,125</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,875</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/7/2031</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/2/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,996</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,904</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/2/2032</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/9/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,676</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,460</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/9/2032</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/7/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(23)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,250</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,750</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/7/2032</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(10) </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,100</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2033</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/7/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(41)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/2/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(15)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,925</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">179,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/2/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(16)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,950</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8/9/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(17)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,887</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250,644&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9/7/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(27)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,000</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">108,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(18)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85,100</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,021,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(19) </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,800</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">453,600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10/1/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(42)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">360,000</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,320,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:4.5pt;text-align:justify;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:0.5pt">Amounts in this column are calculated by multiplying the number of shares shown as unvested in the prior column by $12.00, the closing price of our common stock on December 29, 2023, as reported on the Nasdaq Global Market.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">One quarter of the total shares subject to an option for&#160;10,000 shares of common stock vested on April&#160;16, 2019, and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">One quarter of the total shares subject to an option for&#160;15,000 shares of common stock vested on April&#160;16, 2019, and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">One quarter of the total shares subject to an option for&#160;16,000 shares of common stock vested on January&#160;25, 2020, and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">One quarter of the total shares subject to an option for&#160;16,000 shares of common stock vested on January&#160;29, 2021, and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">One quarter of the total shares subject to an option for&#160;25,000 shares of common stock  vested on July&#160;6, 2021, and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">One quarter of the total shares vested on February&#160;3, 2022 and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">One quarter of the total shares vested on July&#160;19, 2022 and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">One quarter of the total shares vested on February&#160;2, 2023 and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">One quarter of the total shares vested on June&#160;16, 2023 and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">One quarter of the total shares vested on February 1, 2024 and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">2,000 of the shares subject to this RSU award vested on each of January&#160;29, 2021, January&#160;29, 2022, January&#160;29, 2023 and January&#160;29, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">1,250 of the shares subject to this RSU award vested on each of July&#160;6, 2021, July&#160;6, 2022 and July 6, 2023.  An additional&#160;1,250 of the shares subject to this RSU award will vest on July&#160;6 2024, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(13)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">2,000 of the shares subject to this RSU award vested on each of February&#160;3, 2022, February&#160;3, 2023 and February&#160;3, 2024.  An additional&#160;2,000 of the shares subject to this RSU award will vest on February&#160;3, 2025, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(14)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">3,333 of the shares subject to this RSU award vested on July&#160;19, 2022 and July 19, 2023.  An additional&#160;3,333 of the shares subject to this RSU award will vest on each of July&#160;19, 2024 and July&#160;19, 2025, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">25% of the shares subject to this RSU award vested on each of February&#160;2, 2023 and February&#160;3, 2024.  An additional&#160;25% of the shares subject to this RSU award will vest on each of February&#160;3, 2025 and February&#160;3, 2026, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(16)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">The shares subject to this PRSU will have a two-year performance period with one year of additional vesting.  Upon the achievement of certain milestones relating to Total Sales and Adjusted EBITDA, 50% of the shares subject to this PRSU vested on February&#160;1, 2024, and the remaining&#160;50% will vest upon the end of the additional one-year vesting period subject to the executive&#8217;s continued service.  The amounts reported in this table represent the target number of shares subject to the PRSU because the Company&#8217;s performance results were not available as of December 31, 2023.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(17)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">33.33% of the shares subject to this RSU award vested on June&#160;16, 2023. An additional&#160;33.33% of the shares subject to this RSU award will vest on each of June&#160;16, 2024 and June&#160;16, 2025, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(18)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">25% of the shares subject to this RSU award vested on February 1, 2024.  An additional 25% of the shares subject to this RSU award will vest on each of February 1, 2025, February 1, 2026 and February 1, 2027, subject to executive&#8217;s continued employment on each applicable vesting date. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(19)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">The shares subject to this PRSU will have a two-year performance period with one year of additional vesting.  Upon the achievement of certain milestones relating to Total Sales and Adjusted EBITDA, 50% of the shares subject to this PRSU will vest upon the determination of performance achievement following the completion of the two-year performance period (on or around February&#160;1, 2025), and the remaining&#160;50% will vest upon the end of the additional one-year vesting period subject to the executive&#8217;s continued service.  The amounts reported in this table represent the target number of shares subject to the PRSU.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(20)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">One quarter of the total shares vested on April&#160;18, 2023 and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(21)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">One quarter of the total shares vested on May&#160;6, 2023 and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(22)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">One quarter of the total shares vested on May&#160;26, 2023 and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(23)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">One quarter of the total shares vested on September&#160;7, 2023 and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(24)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">1,375 of the shares subject to this RSU award vested on each of September&#160;10, 2022 and September&#160;10, 2023.  An additional&#160;1,375 of the shares subject to this RSU award will vest on each of September&#160;10, 2024 and September&#160;10, 2025, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(25)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">25% of the shares subject to this RSU award vested on each of April&#160;18, 2023 and April&#160;18, 2024. An additional&#160;25% of the shares subject to this RSU award will vest on each of April&#160;18, 2025 and April&#160;18, 2026, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(26)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">25% of the shares subject to this RSU award vested on May&#160;6, 2023. An additional&#160;25% of the shares subject to this RSU award will vest on each of May&#160;6, 2024, May&#160;6, 2025 and May&#160;6, 2026, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(27)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">25% of the shares subject to this RSU award vested on May&#160;26, 2023. An additional&#160;25% of the shares subject to this RSU award will vest on each of May&#160;26, 2024, May&#160;26, 2025 and May&#160;26, 2026, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(28)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">25% of the shares subject to this RSU award will vest on each of September&#160;7, 2023, September&#160;7, 2024, September&#160;7, 2025 and September&#160;7, 2026, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(29)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Dr. Seeto&#8217;s employment with us terminated effective November 1, 2023, at which time he began serving as our consultant. With respect to Dr. Seeto, the references to his continued employment in the footnotes to this Outstanding Equity Awards at Fiscal Year-End table refer to his continued service pursuant to the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Seeto Consulting Agreement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">In addition, all unvested equity awards held by Dr.&#160;Seeto will automatically accelerate in full: (a)&#160;in the event of Dr.&#160;Seeto&#8217;s death or disability (as set forth in the Seeto Consulting Agreement), (b) if the Seeto Consulting Agreement term is not renewed, (c)&#160;if Dr.&#160;Seeto terminates the Seeto Consulting Agreement for &#8220;good reason&#8221;, or (d)&#160;if the Company terminates the Seeto Consulting Agreement without &#8220;good cause&#8221; (all as defined in the Seeto Consulting Agreement).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(30)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">One quarter of the total shares vested on November&#160;26, 2019, and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(31)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">One quarter of the total shares vested on January&#160;25, 2020 and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(32)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">One quarter of the total shares vested on January&#160;29, 2021 and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(33)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">One quarter of the total shares vested on July&#160;6, 2021 and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(34)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">One quarter of the total shares will vest on November&#160;1, 2021, and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(35)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">5,000 of the shares subject to this RSU award vested on each of January&#160;29, 2021, January&#160;29, 2022, January&#160;29, 2023 and January&#160;29, 2024.  </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(36)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">10,000 of the shares subject to this RSU award vested on each of July&#160;6, 2021, July&#160;6, 2022 and July&#160;6, 2023.  An additional&#160;10,000 of the shares subject to this RSU award will vest on July&#160;6, 2024, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(37)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">1,525 of the shares subject to this RSU award vested on each of November&#160;1, 2021 and November&#160;1, 2022.  An additional&#160;1,525 of the shares subject to this RSU award will vest on each of November&#160;1, 2023 and November&#160;1, 2024, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(38)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">7,375 of the shares subject to this RSU award vested on each of February&#160;3, 2022, February&#160;3, 2023 and February&#160;3, 2024.  An additional&#160;7,375 of the shares subject to this RSU award will vest on February&#160;3, 2025, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(39)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Mr. Ronai&#8217;s employment with us terminated effective September 30, 2023, at which time he began serving as our consultant. With respect to Mr. Ronai, the references to his continued employment in the footnotes to this Outstanding Equity Awards at Fiscal Year-End table refer to his continued service pursuant to the Ronai</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Consulting Agreement. In addition, all unvested equity awards held by Mr.&#160;Ronai will automatically accelerate in full: (a)&#160;in the event of Mr.&#160;Ronai&#8217;s death or disability (as set forth in the Ronai Consulting Agreement), (b) if the Consulting Agreement term is not renewed, (c)&#160;if Mr.&#160;Ronai terminates the Ronai Consulting Agreement for &#8220;good reason&#8221;, or (d)&#160;if the Company terminates the Ronai Consulting Agreement without &#8220;good cause&#8221; (all as defined in the Ronai Consulting Agreement).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">One quarter of the total shares subject to an option for&#160;15,000 shares of common stock vested on October&#160;6, 2022, and&#160;1/48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of the shares subject to the option vested and will vest each month thereafter, subject to executive&#8217;s continued employment on each applicable vesting date. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(41)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">2,500 of the shares subject to this RSU award vested on each of October&#160;6, 2022 and October&#160;6, 2023.  An additional&#160;2,500 of the shares subject to this RSU award will vest on each of October&#160;6, 2024 and October&#160;6, 2025, subject to executive&#8217;s continued employment on each applicable vesting date.</span></div><div style="margin-bottom:24pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(42)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">50% of the shares subject to this RSU award will vest upon the termination of the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Ronai Consulting Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, except for a termination by Mr. Ronai other than for &#8220;good reason&#8221; or a termination by the Company for &#8220;good cause&#8221; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(all as defined in the Ronai Consulting Agreement), and the remaining 50% will vest on the earlier of (i) October 1, 2024 and (ii) the termination </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Ronai Consulting Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, except for a termination by Mr. Ronai other than for &#8220;good reason&#8221; or a termination by the Company for &#8220;good cause.&#8221;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Narrative Disclosure to Summary Compensation Table and Grant of Plan-Based Awards Table</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employment, Separation and Consulting Agreement and Offer Letter Summaries</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into employment agreements or offer letters with each of the named executive officers.  These agreements provide for at-will employment and generally include the named executive officer&#8217;s initial base salary, and an indication of eligibility for an annual cash incentive award opportunity.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alex Johnson</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with Mr. Johnson&#8217;s promotion to our Chief Business Officer, we entered into a promotion letter with Mr. Johnson, dated July&#160;12, 2021.  The letter provides for &#8220;at-will&#8221; employment and sets forth certain agreed upon terms and conditions of employment.  Effective September&#160;7, 2022, Mr. Johnson transitioned from his role as Chief Business Officer and Head of Testing Services to the role of President of Patient and Testing Services.  During fiscal year&#160;2023, Mr. Johnson&#8217;s annual base salary was initially $388,125 which was increased to $415,000 effective April&#160;1, 2023.  In&#160;2023, he was eligible for a target annual performance bonus of up to&#160;60% of his base salary.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2023, in light of the departures of Dr. Seeto and Mr. Ronai, the Company entered into a retention bonus agreement with Mr. Johnson, which provides a retention bonus in an aggregate amount of $400,000.  Pursuant to the terms of the retention bonus agreement, 25% of the total retention bonus was paid in December 2023, subject to repayment if Mr. Johnson does not remain an employee of the Company through December 1, 2024, and the remaining 75% will be paid on the first payroll date in December 2024, subject to Mr. Johnson&#8217;s continued employment through such payroll date.  However, if Mr. Johnson&#8217;s employment is terminated by the Company without &#8220;cause&#8221; or by him for &#8220;good reason&#8221; (each as defined in the Company&#8217;s form of Change of Control and Severance Agreement) on or after January 1, 2024 and prior to December 1, 2024, the retention bonus will be paid in full and the repayment obligation on the first 25% of the retention bonus will be waived in full.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abhishek Jain</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with Mr. Jain&#8217;s promotion to our Interim Chief Financial Officer, we entered into a promotion letter with Mr. Jain, dated May&#160;21, 2022.  In accordance with the promotion letter, Mr. Jain&#8217;s annual base salary was increased to $305,000, effective as of May&#160;26, 2022, and he was eligible for a target annual performance bonus of up to&#160;35% of his base salary.  In connection with Mr. Jain&#8217;s appointment as our Chief Financial Officer, the Compensation and Human Capital Committee approved an increase in Mr. Jain&#8217;s annual base salary from $305,000 to $375,000, and an increase in his target annual performance bonus from&#160;35% to&#160;60% of his annual base salary, effective as of September&#160;7, 2022. During fiscal year 2023, Mr. Jain&#8217;s annual base salary was initially $375,000, which was increased to $415,000, effective April 1, 2023. In 2023, he was eligible for a target annual performance bonus of up to 60% of his base salary.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2023, in light of the departures of Dr. Seeto and Mr. Ronai, the Company entered into a retention bonus agreement with Mr. Jain, which provides a retention bonus in an aggregate amount of $400,000.  Pursuant to the terms of the retention bonus agreement, 25% of the total retention bonus was paid in December 2023, subject to repayment if Mr. Jain does not remain an employee of the Company through December 1, 2024, and the remaining 75% will be paid on the first payroll date in December 2024, subject to Mr. Jain&#8217;s continued employment through such payroll date.  However, if Mr. Jain&#8217;s employment is terminated by the Company without &#8220;cause&#8221; or by him for &#8220;good reason&#8221; (each as defined in the Company&#8217;s form of Change of Control and Severance Agreement) on or after January 1, 2024 and prior to December 1, 2024, the retention bonus will be paid in full and the repayment obligation on the first 25% of the retention bonus will be waived in full. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reginald Seeto, MBBS (former President and Chief Executive Officer)</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into an offer letter with Dr. Seeto, dated November&#160;16, 2018, under which Dr. Seeto initially served as our President and Chief Business Officer.  The agreement provided for &#8220;at-will&#8221; employment and set forth certain agreed upon terms and conditions of employment.  On November&#160;1, 2020, Dr. Seeto was appointed as the Company&#8217;s Chief Executive Officer.  During fiscal year&#160;2023, Dr. Seeto&#8217;s annual base salary was $558,900 which was increased to $620,000 effective April&#160;1, 2023.  In&#160;2023, Dr. Seeto was eligible for a target annual performance bonus of up to&#160;100% of his base salary. Dr. Seeto&#8217;s employment with us terminated effective November 1, 2023.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with Dr. Seeto&#8217;s resignation after discussions with the Board of Directors and a mutual decision about his ongoing role, on November 1, 2023, we entered into a separation agreement with Dr. Seeto (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Seeto Separation Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Pursuant to the Seeto Separation Agreement, Dr. Seeto released any claims against us, we released claims against Dr. Seeto arising out of his employment with, or separation from, us, and we agreed to (i) pay Dr. Seeto an amount equal to $51,666 per month for 14 months from the date of his separation, payable in accordance with our normal payroll practices, and $620,000, his full annual bonus for 2023 at target, payable in accordance with our standard bonus schedule in February 2024, and (ii) reimburse him for health insurance coverage under COBRA until the earlier of 18 months from his employment separation date or when he becomes eligible for group health insurance coverage through a new employer.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with Dr. Seeto&#8217;s resignation after discussions with the Board of Directors and a mutual decision about his ongoing role, we also entered into a consulting agreement with Dr. Seeto (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Seeto Consulting Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for services as a Senior Advisor to the Chairperson, which was effective November 2, 2023 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Seeto Commencement Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Pursuant to the Seeto Consulting Agreement, commencing November 2, 2023, Dr. Seeto will provide up to 40 hours of consulting services to us in any given month for an initial period of twelve months (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Seeto Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), which may be renewed for additional agreed upon periods upon written agreement of us and Dr. Seeto at least 90 days prior to the end of the Seeto Term (a &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Seeto Renewal Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). As consideration for the services to be provided by Dr. Seeto to us pursuant to the Seeto Consulting Agreement, we will pay Dr. Seeto $25,000 per month of services provided during the Seeto Term and any Seeto Renewal Term (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Seeto Fee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Additionally, Dr. Seeto&#8217;s outstanding unvested restricted stock unit awards continue vesting according to the original vesting schedules during the Seeto Term. If we terminate the Seeto Consulting Agreement prior to the expiration of the Seeto Term for any reason other than &#8220;Good Cause&#8221; (as defined in the Seeto Consulting Agreement), or Dr. Seeto terminates the Seeto Consulting Agreement prior to the expiration of the Seeto Term for &#8220;Good Reason&#8221; (as defined in the Seeto Consulting Agreement), we will be required to pay Dr. Seeto the then-unpaid Seeto Fee for the remaining portion of the Seeto Term. Pursuant to the Seeto Consulting Agreement, on January 12, 2024, we granted Dr. Seeto 340,000 restricted stock units (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Seeto RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), of which 50% shall vest upon termination of the Seeto Consulting Agreement, other than a termination by Dr. Seeto (unless for &#8220;Good Reason&#8221; (as defined in the Seeto Consulting Agreement)) or a termination by us for Good Cause, and the remaining 50% shall vest on the earlier of the one year anniversary of the Seeto Commencement Date and the termination of the Seeto Consulting Agreement other than a termination (y) by Dr. Seeto (unless for Good Reason) or (z) by us for Good Cause. In addition, all unvested equity awards then held by Dr. Seeto will automatically accelerate in full: (a) in the event of Dr. Seeto&#8217;s death or disability (as set forth in the Seeto Consulting Agreement), (b) if the Seeto Consulting Agreement term is not renewed, (c) if Dr. Seeto terminates the Seeto Consulting Agreement for Good Reason, or (d) if we terminate the Seeto Consulting Agreement without Good Cause.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraham Ronai (former Chief Administrative &amp; Legal Officer and Secretary)</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into an offer letter with Mr. Ronai, dated September&#160;2, 2021, under which Mr. Ronai initially served as our General Counsel.  The agreement provided for &#8220;at-will&#8221; employment and set forth certain agreed upon terms and conditions of employment.  During fiscal year&#160;2023, Mr. Ronai&#8217;s annual base salary was initially $388,125 which was increased to $415,000 effective April&#160;1, 2023.  In connection with Mr. Ronai&#8217;s promotion to our Chief Administrative &amp; Legal Officer and Secretary, Mr. Ronai&#8217;s target annual performance bonus was increased from&#160;50% to&#160;60% of his base salary, effective September&#160;7, 2022. Mr. Ronai&#8217;s employment with us terminated effective September 30, 2023.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with Mr. Ronai&#8217;s resignation after discussions with the Board of Directors and a mutual decision about his ongoing role,  on September 20, 2023, we entered into a Separation Agreement with Mr. Ronai (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ronai Separation Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Pursuant to the Ronai Separation Agreement, Mr. Ronai released any claims against us, we released claims against Mr. Ronai arising out of his employment with, or separation from, us, and we will (i) pay Mr. Ronai an amount equal to $35,000 per month for 14 months from the date of his separation, payable in accordance with our normal payroll practices, and $252,000, his full annual bonus for 2023 at target, payable in accordance with our standard bonus schedule in February 2024, and (ii) reimburse him for health insurance coverage under COBRA until the earlier of 18 months from his employment separation date or when he becomes eligible for group health insurance coverage through a new employer.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with Mr. Ronai&#8217;s resignation after discussions with the Board of Directors and a mutual decision about his ongoing role, we also entered into a legal Consulting Agreement with Mr. Ronai (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ronai Consulting Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for services as a Senior Legal Advisor to the Chairperson, which will be effective October 1, 2023. Pursuant to the Ronai Consulting Agreement, commencing October 1, 2023, Mr. Ronai will provide up to 40 hours (subsequently increased to 45) of consulting services to us in any given month for an initial period of twelve months (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ronai Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), which may be renewed for additional agreed upon periods upon written agreement of us and Mr. Ronai at least 90 days prior to the end of the Ronai Term. As consideration for the services to be provided by Mr. Ronai to us pursuant to the Ronai Consulting </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement, we will pay Mr. Ronai an aggregate of $115,000 for the first three months of the Ronai Term and $25,000 per month of services provided during the remainder of the Ronai Term (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ronai Fee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Additionally, Mr. Ronai&#8217;s outstanding unvested restricted stock unit awards shall continue vesting according to the original vesting schedules during the Ronai Term. If we terminate the Ronai Consulting Agreement prior to the expiration of the Ronai Term for any reason other than &#8220;Good Cause&#8221; (as defined in the Ronai Consulting Agreement), we shall pay Mr. Ronai a lump sum equal to the then-unpaid Ronai Fee for the remaining portion of the Ronai Term. Pursuant to the Ronai Consulting Agreement, we granted Mr. Ronai 360,000 restricted stock units, of which 50% shall vest upon termination of the Ronai Consulting Agreement, other than a termination by Mr. Ronai (unless for &#8220;Good Reason&#8221; (as defined in the Ronai Consulting Agreement)) or a termination by us for Good Cause, and the remaining 50% shall vest on the earlier of October 1, 2024 and the termination of the Ronai Consulting Agreement other than a termination (y) by Mr. Ronai (unless for Good Reason) or (z) by us for Good Cause. In addition, all unvested equity awards then held by Mr. Ronai will automatically accelerate in full: (a) in the event of Mr. Ronai&#8217;s death or disability (as set forth in the Ronai Consulting Agreement), (b) if the Ronai Consulting Agreement term is not renewed, (c) if Mr. Ronai terminates the Ronai Consulting Agreement for Good Reason, or (d) if we terminate the Ronai Consulting Agreement without Good Cause.</span></div><div id="i60d05261c6404879b68233510f10856b_190"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Option Exercises and Stock Vested</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents, for each of the NEOs, the number of shares of our common stock acquired upon the vesting and settlement of RSUs during&#160;2023 and the aggregate value realized upon the vesting and settlement of RSUs. None of our NEOs exercised any stock options during 2023.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.484%"><tr><td style="width:1.0%"/><td style="width:35.965%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.699%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.567%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.699%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name*</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of Shares<br/>Acquired on Vesting (#)</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value Realized on<br/>Vesting</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alex Johnson</span></td><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000000;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,890</span></td><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000000;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432,397&#160;</span></td><td style="background-color:#cff0fc;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abhishek Jain</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,551</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reginald Seeto, MBBS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,791</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873,602&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abraham Ronai</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 4.12pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,919</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Dr. Seeto&#8217;s employment with us terminated effective November 1, 2023, at which time he began serving as our consultant.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Mr. Ronai&#8217;s employment with us terminated effective September 30, 2023, at which time he began serving as our consultant.</span></div><div id="i60d05261c6404879b68233510f10856b_193"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pension Benefits</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No pension benefits were paid to any of our NEOs during fiscal&#160;2023.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential Payments and Benefits upon Termination or Change of Control for Officers</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alex Johnson</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Mr. Johnson&#8217;s Change of Control and Severance Agreement, effective July&#160;12, 2021, if within two months prior to, or twelve months following a change of control, we or our successor terminate Mr. Johnson&#8217;s employment without cause, Mr. Johnson will be entitled to (a)&#160;twelve months&#8217; severance based on Mr. Johnson&#8217;s annual base salary, (b)&#160;acceleration of vesting equal to&#160;100% of any unvested equity awards, (c)&#160;a lump sum payment equal to Mr. Johnson&#8217;s annual bonus (equal to the greater of target bonus or the actual bonus received for performance during the calendar year prior to the year in which the termination occurred) and (d)&#160;six months of continued benefits, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">that</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> such reimbursement will cease on the date that Mr. Johnson becomes covered under a similar plan of a new employer.  Pursuant to the agreement, if we or a successor terminates Mr. Johnson&#8217;s employment without cause and such termination occurs outside of a change of control event, Mr. Johnson will be entitled to (a)&#160;six months&#8217; severance based on Mr. Johnson&#8217;s annual base salary, and (b)&#160;six months of continued benefits, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">that</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> such reimbursement will cease on the date that Mr. Johnson becomes covered under a similar plan of a new employer.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abhishek Jain</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Mr. Jain&#8217;s Change of Control and Severance Agreement, effective September&#160;7, 2022, if within two months prior to, or twelve months following a change of control, we or our successor terminate Mr. Jain&#8217;s employment without cause, Mr. Jain will be entitled to (a)&#160;six months&#8217; severance based on Mr. Jain&#8217;s annual base salary, (b)&#160;acceleration of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vesting equal to&#160;100% of any unvested equity awards, (c)&#160;a lump sum payment equal to Mr. Jain&#8217;s annual bonus (equal to the greater of target bonus or the actual bonus received for performance during the calendar year prior to the year in which the termination occurred) and (d)&#160;six months of continued benefits, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">that</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> such reimbursement will cease on the date that Mr. Jain becomes covered under a similar plan of a new employer.  Pursuant to the agreement, if we or a successor terminates Mr. Jain&#8217;s employment without cause and such termination occurs outside of a change of control event, Mr. Jain will be entitled to (a)&#160;six months&#8217; severance based on Mr. Jain&#8217;s annual base salary, and (b)&#160;six months of continued benefits, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">that</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> such reimbursement will cease on the date that Mr. Jain becomes covered under a similar plan of a new employer.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of the current or former Change of Control and Severance Agreements with Messrs. Johnson and Jain, &#8220;cause&#8221; means generally:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">executive&#8217;s material failure to perform the executive&#8217;s stated duties after a written notice of failure and a cure period of ten days;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">executive&#8217;s material violation of our policies or any written agreement or covenant with us;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">executive&#8217;s conviction of, or entry of a plea of guilty or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nolo contendere</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to, a felony;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a willful act by executive that constitutes gross misconduct and which is injurious to us;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">executive&#8217;s commission of any act of fraud, embezzlement, dishonesty or any other willful misconduct that has caused or is reasonably expected to result in material injury to us;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the unauthorized use or disclosure by executive of any of our proprietary information or trade secrets or any other party to whom he or she owes an obligation of nondisclosure as a result of the executive&#8217;s relationship with us; or</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">executive&#8217;s willful failure to cooperate with an investigation by a governmental authority.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reginald Seeto, MBBS (former President and Chief Executive Officer) </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, Dr. Seeto&#8217;s employment with the Company terminated on November 1, 2023.  In connection with such termination and pursuant to the Seeto Separation Agreement, the Company agreed to pay Dr. Seeto (i) an amount equal to $51,666 per month for 14 months from the date of his separation, payable in accordance with our normal payroll practices (equal to $723,324 in the aggregate), (ii) a lump sum payment of $620,000, his full annual bonus for 2023 at target, payable in accordance with our standard bonus schedule in February 2024, and (iii) reimbursement of health insurance coverage under COBRA until the earlier of 18 months from his employment separation date or when he becomes eligible for group health insurance coverage through a new employer (equivalent to $56,278 in the aggregate).  Dr.&#160;Seeto&#8217;s unvested equity awards were not accelerated in connection with his termination of employment but will continue to vest according to the original vesting schedule during his consulting services, and all unvested equity awards then held by Dr. Seeto will automatically accelerate in full: (a) in the event of Dr. Seeto&#8217;s death or disability (as set forth in the Seeto Consulting Agreement), (b) if the Seeto Consulting Agreement term is not renewed, (c) if Dr. Seeto terminates the Seeto Consulting Agreement for Good Reason, or (d) if we terminate the Seeto Consulting Agreement without Good Cause.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraham Ronai (former Chief Administrative &amp; Legal Officer and Secretary)</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, Mr. Ronai&#8217;s employment with the Company terminated on September 20, 2023.  In connection with such termination and pursuant to the Ronai Separation Agreement, the Company agreed to pay Mr. Ronai (i) an amount equal to $35,000 per month for 14 months from the date of his separation, payable in accordance with our normal payroll practices (equal to $490,000 in the aggregate), (ii) a lump sum payment of $252,000, his full annual bonus for 2023 at target, payable in accordance with our standard bonus schedule in February 2024, and (iii)&#160;reimbursement of health insurance coverage under COBRA until the earlier of 18 months from his employment separation date or when he becomes eligible for group health insurance coverage through a new employer (equivalent to $54,114 in the aggregate).  Mr. Ronai&#8217;s unvested equity awards were not accelerated in connection with his termination of employment but will continue to vest according to the original vesting schedule during his consulting services, and all unvested equity awards then held by Mr. Ronai will automatically accelerate in full: (a) in the event of Mr. Ronai&#8217;s death or disability (as set forth in the Ronai Consulting Agreement), (b) if the Ronai Consulting Agreement term is not renewed, (c) if Mr. Ronai terminates the Ronai Consulting Agreement for Good Reason, or (d)&#160;if we terminate the Ronai Consulting Agreement without Good Cause.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table estimates the amounts payable to our named executive officers that were serving as such as of the end of December&#160;31, 2023 in the event that a change of control, termination of employment or both occurred on December&#160;31, 2023.  The closing price of our common stock on December&#160;29, 2023, as reported on the Nasdaq Global Market, was $12.00&#160;per share.  The following table excludes certain benefits, such as accrued vacation, that are available to all employees generally.  The actual amount of payments and benefits that would be provided can only be determined at the time of a change of control and/or the named executive officer&#8217;s qualifying separation from the Company: </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Termination by the Company<br/>Without Cause Outside of<br/>Change of Control Window</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Termination by the Company Without Cause<br/>During Change of Control Window</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Payments</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Continuation<br/>of Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Payments</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Continuation<br/>of Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Value of<br/>Equity<br/>Accelerated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alex Johnson</span></td><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$207,500</span></td><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13,209</span></td><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$369,010</span></td><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13,209</span></td><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,378,436</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abhishek Jain</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$207,500</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$311,760</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,883,088</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes Reginald Seeto as his employment terminated with the effective November 1, 2023 and we do not have any agreement with him providing for benefits in the event of a change of control pursuant to the Seeto Consulting Agreement. </span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes Abraham Ronai as his employment terminated with the effective September 30, 2023 and we do not have any agreement with him providing for benefits in the event of a change of control pursuant to the Ronai Consulting Agreement.</span></div><div id="i60d05261c6404879b68233510f10856b_199"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pay Ratio Disclosure</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients and caregivers. We offer testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey, and we are a leading provider of genomics-based information for transplant patients.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Item 402(u) of Regulation S-K, we are providing the following information about the relationship of the median of the annual total compensation of all our employees (other than our Chief Executive Officer) and the annual total compensation of Reginald Seeto, MBBS, our Chief Executive Officer and President (our &#8220;CEO&#8221;) on October 15, 2023. Neither the Compensation and Human Capital Committee nor our management used our CEO pay ratio measure in making compensation decisions. As explained by the SEC when it adopted Item 402(u), the rule was designed to allow stockholders to better understand and assess our compensation practices and pay ratio disclosures rather than to facilitate a comparison of this information from one company to another. However, the pay ratio rules provide companies with flexibility to select the methodology and assumptions used to identify the median employee, calculate the median employee's compensation and estimate the pay ratio. As a result, our methodology may differ from those used by other companies, which likely will make it difficult to compare pay ratios with other companies, including those within our industry.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CEO Pay Ratio for 2023</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The median of the 2023 annual total compensation of all our employees, excluding our CEO, was&#160;$139,100;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The 2023 annual total compensation of our CEO for purposes of this pay ratio disclosure was $9,833,514</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The ratio of the annual total compensation of our CEO to the median of the annual total compensation of all our employees was&#160;71</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to 1. This ratio is a reasonable estimate calculated in a manner consistent with SEC rules.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Methodology</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The methodology, including key assumptions and estimates, used to identify the employee (excluding our CEO) with compensation at the median of the annual total compensation of all our employees was based on the following:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In determining our employee population, we considered the individuals, excluding our CEO, who were employed by us and our consolidated subsidiaries as of October 15, 2023, whether employed on a full-time, part-time, seasonal or temporary basis. As of October 15, 2023, we had 676 employees. As permitted by the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;exception contained in Item 402(u)(4)(ii) of Regulation S-K, we have excluded our 14 employees in Belgium, Germany, Hungary, Italy </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Spain, leaving us with a population of 662 employees. We did not include any contractors or other non-employee workers in our employee population.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">To identify our median employee, we chose to use total cash and equity compensation as our consistently-applied compensation measure, which we calculated as of October 15, 2023. After applying our methodology, our median employee was a Sr Dev Ops Developer, based in the U.S.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">For employees paid other than in U.S. dollars, we converted their compensation to U.S. dollars using the applicable exchange rates in effect on October 15, 2023. For permanent employees hired during 2023, we annualized their total cash as if they had been employed for the entire measurement period. We did not make any cost-of-living adjustments.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Calculation</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Using the aforementioned methodology, the individual identified as the calculated median employee from our 2023 employee population had actual earnings consisting of&#160;base pay, bonus, equity granted and 401(k) match, for 2023 annual total compensation in the amount of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$139,100. The 2023 annual total compensation for Dr. Seeto differs from the Summary Compensation Table due to his termination.  Dr. Seeto&#8217;s compensation for purposes of the pay ratio disclosure has been adjusted as follows: base salary annualized; target bonus payout included; and severance payout, health insurance reimbursement and consulting fees removed for a total of $9,833,514.</span></div><div id="i60d05261c6404879b68233510f10856b_202"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pay Versus Performance</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive &#8220;compensation actually paid&#8221; (the &#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CAP</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to our principal executive officers (&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PEOs</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and our other NEOs (the &#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-PEO NEOs</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and certain financial performance of the Company. The CAP does not reflect the actual amount of compensation earned, realized or received by the PEOs or Non-PEO NEOs during the applicable fiscal year. The following table shows the total compensation for our NEOs for the past four fiscal&#160;years as set forth in the &#8220;Summary Compensation Table&#8221;, the CAP to our PEOs, and on an average basis, our Non-PEO NEOs (in each case, as determined under SEC rules), our Total Shareholder Return (&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">TSR</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the TSR for companies in the Nasdaq Biotech Index, our net income, and our Company-Selected Measure, Revenue.</span></div><ix:nonNumeric contextRef="c-1" name="ecd:PvpTableTextBlock" id="f-5" escape="true"><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Value of Initial<br/>Fixed<br/>$100<br/>Investment Based<br/>On:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Fiscal<br/>Year (a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Table</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%;text-decoration:underline">SCT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8221;)&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Mr.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Johnson</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(PEO&#160;1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">CAP to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Mr. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Johnson</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(PEO&#160;1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%;text-decoration:underline">SCT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#160;for Dr.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Seeto (PEO&#160;2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">CAP to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Dr. Seeto</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(PEO&#160;2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">SCT for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Dr. Maag</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(PEO&#160;3) (f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">CAP to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Dr. Maag</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(PEO&#160;3)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">SCT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">for Non-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">PEO NEOs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">CAP</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">to Non-PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">NEOs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">TSR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Peer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Group</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">TSR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(k)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(l)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Revenue</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(m)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-6">3,097,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-7">1,923,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-8">10,551,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-9">6,665,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-10">4,617,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-11">4,412,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-12">55.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-13">118.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-14">190,284</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ecd:CoSelectedMeasureAmt" format="ixt:num-dot-decimal" scale="3" id="f-15">280,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-16">12,786,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-17">648,097</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-18">3,784,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-19">118,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-20">52.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-21">113.65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-22">76,613</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ecd:CoSelectedMeasureAmt" format="ixt:num-dot-decimal" scale="3" id="f-23">321,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-24">7,090,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-25">50,411</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-26">2,605,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-27">140,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-28">210.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-29">126.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-30">30,662</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="ecd:CoSelectedMeasureAmt" format="ixt:num-dot-decimal" scale="3" id="f-31">296,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-32">5,618,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-33">17,196,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-34">6,400,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-35">32,731,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-36">1,979,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-37">7,956,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-38">335.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-39">126.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-40">18,714</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="ecd:CoSelectedMeasureAmt" format="ixt:num-dot-decimal" scale="3" id="f-41">192,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><ix:nonNumeric contextRef="c-1" name="ecd:NamedExecutiveOfficersFnTextBlock" id="f-42" continuedAt="f-42-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dollar amounts reported in columns (b), (d), and (f) are the amounts of total compensation reported for <ix:nonNumeric contextRef="c-11" name="ecd:PeoName" id="f-43">Mr. Johnson</ix:nonNumeric> (our Principal Executive Officer since November 1, 2023), <ix:nonNumeric contextRef="c-12" name="ecd:PeoName" id="f-44"><ix:nonNumeric contextRef="c-13" name="ecd:PeoName" id="f-45"><ix:nonNumeric contextRef="c-5" name="ecd:PeoName" id="f-46"><ix:nonNumeric contextRef="c-7" name="ecd:PeoName" id="f-47">Dr. Seeto</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> (Chief Executive Officer and Principal Executive Officer from November 1, 2020 to November 1, 2023) and <ix:nonNumeric contextRef="c-14" name="ecd:PeoName" id="f-48">Dr. Maag</ix:nonNumeric> (Chief Executive Officer until November 1, 2020) for each corresponding year in the &#8220;Total&#8221; column of the Summary Compensation Table. Refer to the &#8220;Summary Compensation Table&#8221; on page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i60d05261c6404879b68233510f10856b_181">64</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> for additional information. </span></ix:nonNumeric></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><ix:nonNumeric contextRef="c-1" name="ecd:AdjToPeoCompFnTextBlock" id="f-50" continuedAt="f-50-1" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="f-49" continuedAt="f-49-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dollar amounts reported in columns (c), (e), (g), and (i) represent the amount of the CAP, as computed in accordance with SEC rules. The CAP does not necessarily represent cash and/or equity value transferred to the applicable NEO without restriction, but rather is a value calculated under applicable SEC rules. These amounts reflect the total amount of compensation for our NEOs reported in the Summary Compensation Table with certain adjustments as described in the table below for the most recent fiscal year. We do not have a defined benefit plan so no adjustment for pension benefits is included. The valuation assumptions and processes used to recalculate fair values did not materially differ from those disclosed at the time of grant.</span></ix:nonNumeric></ix:nonNumeric></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-50-1"><ix:continuation id="f-49-1"><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fiscal<br/>Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Executives</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">SCT<br/>(a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Grant Date<br/>Value of New<br/>Awards<br/>(b)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year End<br/>Value of<br/>New Awards<br/>(i)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in<br/>Value of<br/>Outstanding<br/>Awards<br/>Granted in<br/>Prior Fiscal <br/>Year<br/>(ii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in<br/>Value of<br/>Vested<br/>Awards<br/>Granted in<br/>Prior<br/>Fiscal<br/>Years<br/>(iii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value<br/>of Vested<br/>Awards<br/>Granted<br/>and<br/>Vested in<br/>Current<br/>Fiscal<br/>Year<br/>(iv)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>Value at<br/>Start of<br/>Fiscal<br/>Year of<br/>Awards<br/>that<br/>Failed to<br/>Meet<br/>Vesting<br/>Conditions<br/>(v)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Value of<br/>Dividends<br/>Paid on<br/>Equity<br/>Awards<br/>not<br/>Reflected<br/>in Fair<br/>Value (vi)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Equity<br/>CAP<br/>(c)=(i)+(ii)+<br/>(iii)+(iv)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">CAP<br/>(d)=(a)-<br/>(b)+(c)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PEO&#160;1</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-51">3,097,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-52">2,406,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-53">1,347,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-54">55,129</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-55">59,986</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-56">-</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-57">-</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-58">-</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-59">1,232,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-60">1,923,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PEO 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-61">10,551,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-62">8,536,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-63">4,779,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-64">136,652</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-65">7,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-66">-</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-67">-</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-68">-</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-69">4,650,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-70">6,665,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-PEO<br/>NEO Avg</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-71">4,617,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-72">3,641,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-73">3,507,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-74">12,157</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-75">59,302</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-76">-</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-77">-</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-78">-</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-79">3,436,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-80">4,412,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><ix:nonNumeric contextRef="c-1" name="ecd:Additional402vDisclosureTextBlock" id="f-81" continuedAt="f-81-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.63pt">The dollar amounts reported in the Summary Compensation Table for the applicable year.</span></ix:nonNumeric></div><ix:continuation id="f-81-1" continuedAt="f-81-2"><div style="padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.18pt">The grant date fair value of equity awards represents the total of the amounts reported in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns of the Summary Compensation Table for the applicable year.</span></div></ix:continuation><div style="padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(c)</span><ix:nonNumeric contextRef="c-1" name="ecd:EquityValuationAssumptionDifferenceFnTextBlock" id="f-82" continuedAt="f-82-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.63pt">The recalculated value of equity awards for each applicable year includes the addition (or subtraction, as applicable) of the following:</span></ix:nonNumeric></div><ix:continuation id="f-82-1"><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.46pt">the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the applicable year;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.02pt">for awards that vest in the applicable year, the change in the fair value as of the vesting date from the beginning of the applicable year; </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.46pt">for awards that failed to meet vesting conditions in the applicable year, the fair value from the end of prior fiscal year. </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">for awards that failed to meet vesting conditions in the applicable year, the fair value from the end of prior fiscal year;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.46pt">value of dividend not otherwise captured in the calculation of each Fair Value used to calculate CAP</span></div></ix:continuation><div style="padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(d)</span><ix:continuation id="f-81-2" continuedAt="f-81-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.18pt">The CAP does not necessarily represent cash and/or equity value transferred to the applicable NEO without restriction, but rather is a value calculated under applicable SEC rules.</span></ix:continuation></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><ix:continuation id="f-42-1" continuedAt="f-42-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dollar amounts reported in column (h) are the average amounts of total compensation reported for the Non-PEO NEOs for each corresponding year in the &#8220;Total&#8221; column of the Summary Compensation Table. Refer to our &#8220;Summary Compensation Table&#8221; on page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i60d05261c6404879b68233510f10856b_181">64</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> for additional information. For each of fiscal years in the table, the Non-PEO NEOs were</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">:</span></ix:continuation></div><ix:continuation id="f-42-2"><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.144%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#aeaaaa;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#aeaaaa;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#aeaaaa;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#aeaaaa;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abhishek Jain</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abhishek Jain</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ankur Dhingra</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Bell</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abraham Ronai</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alex Johnson</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alex Johnson</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sasha King</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abraham Ronai</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sasha King</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marcel Konrad</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ankur Dhingra</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter Maag, Ph. D.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sasha King</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marcel Konrad</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div></ix:continuation><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><ix:nonNumeric contextRef="c-1" name="ecd:PeerGroupIssuersFnTextBlock" id="f-83" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">TSR is determined based on the value of an initial fixed investment of&#8201;$100. The TSR peer group consists of the Nasdaq Biotech Index companies. TSR is calculated by dividing (i) the difference between the stock price at the end of each measurement period shown and the beginning of the measurement period by (ii) the stock price at the beginning of the measurement period.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><ix:continuation id="f-81-3" continuedAt="f-81-4"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">We determined <ix:nonNumeric contextRef="c-1" name="ecd:CoSelectedMeasureName" id="f-84">Revenue</ix:nonNumeric> to be the most important financial performance measure used to link Company performance to the CAP to our PEOs and Non-PEO NEOs in 2023, consistent with the Total Sales targets used for our short-term incentives (annual bonuses) and long-term incentives (PRSUs). See page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i60d05261c6404879b68233510f10856b_163">53</a></span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="f-81-4"> of our CD&amp;A for additional information.</ix:continuation> </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Relationship Between the CAP and Performance Measures</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the table above shows the alignment between the CAP to the NEOs and the Company&#8217;s performance, consistent with our compensation philosophy as described in our CD&amp;A beginning on page </span><span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i60d05261c6404879b68233510f10856b_163">53</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The charts below show the relationship between the CAP to our PEOs and Non-PEO NEOs and (i)&#160;our TSR and the Peer Group TSR; (ii)&#160;our net income and (iii)&#160;our Company-Selected Measure, Revenue, during the four most recently completed fiscal years. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chart 1</span></div><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="f-86" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:TotalShareholderRtnVsPeerGroupTextBlock" id="f-85" escape="true"><div style="margin-bottom:12pt;text-align:justify"><img src="cdna-20240429_g18.jpg" alt="5272" style="height:432px;margin-bottom:5pt;vertical-align:text-bottom;width:662px"/></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:130%">Chart 2</span></div><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="f-87" escape="true"><div style="margin-bottom:12pt;text-align:justify"><img src="cdna-20240429_g19.jpg" alt="5282" style="height:432px;margin-bottom:5pt;vertical-align:text-bottom;width:662px"/></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chart 3</span></div><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock" id="f-88" escape="true"><div style="margin-bottom:12pt;text-align:justify"><img src="cdna-20240429_g20.jpg" alt="5292" style="height:432px;margin-bottom:5pt;vertical-align:text-bottom;width:662px"/></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="ecd:TabularListTableTextBlock" id="f-89" escape="true"><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.507%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 Most Important Performance Measures</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Compensation and Human Capital Committee uses a mix of performance measures throughout our annual and long-term incentive programs to align executive pay with Company performance. As required by SEC rules, the performance measures identified as the most important for all of our NEOs&#8217; 2023 compensation decisions are&#160;listed in the table to the right. The measures in this table are not ranked.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#aeaaaa;border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Most Important Performance Measures</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-41" name="ecd:MeasureName" id="f-90">Revenue</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#aeaaaa;border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-42" name="ecd:MeasureName" id="f-91">Adjusted EBITDA</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-43" name="ecd:MeasureName" id="f-92">Pipeline</ix:nonNumeric></span></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr></table></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_205"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information as of December&#160;31, 2023 with respect to shares of our common stock that may be issued under our existing equity compensation plans.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.864%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan Category</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(a) Number of Securities<br/>to be Issued Upon<br/>Exercise of Outstanding<br/>Options and Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(b) Weighted Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">and Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(c) Number of Securities<br/>Remaining Available for<br/>Future Issuance Under<br/>Equity Compensation<br/>Plans (Excluding<br/>Securities Reflected in<br/>Column (a))</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity compensation plans approved by stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,042,672</span></td><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.23&#160;</span></td><td style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670,455</span></td><td colspan="3" style="background-color:#cff0fc;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity compensation plans not approved by stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,311</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,656</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total:</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,061,983</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.21&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869,111</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The weighted average exercise price is calculated based solely on outstanding stock options and does not reflect the shares that will be issued upon the vesting of outstanding awards of RSUs, which have no exercise price.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes the following plans: CareDx, Inc. 1998 Equity Incentive Plan, CareDx, Inc. 2008 Equity Incentive Plan, ImmuMetrix&#160;2013 Equity Incentive Plan, the&#160;2014 Plan and the 2014 ESPP.  Our&#160;2014 Plan provides that on the first day of each fiscal year beginning in&#160;2015, the number of shares available for issuance thereunder is automatically increased by a number equal to the least of (i)&#160;four percent (4.0%)&#160;of the outstanding shares of common stock as of the last day of the immediately preceding fiscal year, or (ii)&#160;such other amount as may be determined by our Board of Directors.  Our 2014 ESPP provides that on the first day of each fiscal year beginning in&#160;2015, the number of shares available for issuance thereunder is automatically increased by a number equal to the least of (i) 133,900 shares of common stock, (ii)&#160;one and one-half percent (1.5%)&#160;of the outstanding shares of common stock on the last day of the immediately preceding fiscal year, or (iii)&#160;such other amount as may be determined by our Board of Directors.  On January&#160;1, 2024, the number of shares available for issuance under our&#160;2014 Plan and our 2014 ESPP increased by&#160;2,060,135 shares and&#160;133,900 shares, respectively, pursuant to these provisions.  These increases are not reflected in the table above.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of shares available for issuance under the CareDx, Inc. 2016 Inducement Equity Incentive Plan and the CareDx, Inc. 2019 Inducement Equity Incentive Plan.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_208"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain information with respect to the beneficial ownership of our common stock as of March 31, 2024 for:</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each of our current directors and nominees for director;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each of our named executive officers;</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">all of our current directors and executive officers as a group; and</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each person or group who beneficially owned more than&#160;5% of our common stock.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have determined beneficial ownership in accordance with the rules of the SEC and the information is not necessarily indicative of beneficial ownership for any other purpose.  Unless otherwise indicated below, to our knowledge, the persons and entities named in the table have sole voting and sole investment power with respect to all shares that they beneficially owned, subject to community property laws where applicable.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have based our calculation of the percentage of beneficial ownership on&#160;51,782,612 shares of our common stock outstanding as of March 31, 2024.  We have deemed shares of our common stock subject to warrants or stock options that are currently exercisable or exercisable within&#160;60&#160;days of March 31, 2024, or issuable pursuant to RSUs that are subject to vesting conditions expected to occur within&#160;60&#160;days of March 31, 2024, to be outstanding and to be beneficially owned by the person holding the warrants, stock option or RSUs for the purpose of computing the percentage ownership of that person.  We did not deem these shares outstanding, however, for the purpose of computing the percentage ownership of any other person.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated, the address of each beneficial owner listed in the table below is c/o CareDx, Inc., 8000 Marina Boulevard, 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Floor, Brisbane, California&#160;94005.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Beneficial Owner</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares <br/>Beneficially Owned</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage of Shares <br/>Beneficially Owned</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">5% Stockholders:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ARK Investment Management LLC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,194,722</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State Street Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,796,267</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Vanguard Group</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,119,682</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BlackRock, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,543,666</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sumitomo Mitsui Trust Holdings Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,874,899</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neil Gagnon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,373,476</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bellevue Group AG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,954,792</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Directors and Named Executive Officers:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abhishek Jain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,107</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alex Johnson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,155</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter Maag, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253,313</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">George W. Bickerstaff, III</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(11)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,321</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grace E. Col&#243;n, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(12)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,536</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine M. Cournoyer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(13)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,735</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fred E. Cohen, M.D., D. Phil</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(14)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,192</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael D. Goldberg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(15)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,750</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William A. Hagstrom</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(16)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John W. Hanna</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R. Bryan Riggsbee</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hannah A. Valantine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(17)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,357</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arthur A. Torres</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(18)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,284</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reginald Seeto, MBBS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(19)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543,799</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abraham Ronai</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(20)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,343</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All current directors and executive officers as a group (14&#160;persons)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(21)</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,624,226</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.34pt">Represents beneficial ownership of less than one percent (1%)&#160;of the outstanding shares of our common stock.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">ARK Investment Management LLC (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">ARK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;)&#160;filed a Schedule&#160;13G/A on January 29, 2024, reporting that it had sole voting and dispositive power with respect to&#160;7,194,722 shares and beneficial ownership of an aggregate of&#160;7,194,722  shares in its capacity as an investment adviser in accordance with Rule&#160;13d-1(b)(1)(ii)(E) under the Exchange Act.  ARK&#8217;s address is&#160;200 Central Avenue, St. Petersburg, FL&#160;33701.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">State Street Corporation (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">State Street</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;) filed a Schedule&#160;13G/A on January 10, 2024, reporting that it had shared voting power with respect to&#160;2,731,403 shares, shared dispositive power with respect to&#160;2,796,267 shares and beneficial ownership of an aggregate of&#160;2,796,267 shares in its capacity as a parent holding company or control person in accordance with Rule&#160;13d-1(b)(1)(ii)(G) under the Exchange Act.  The address of State Street is State Street Financial Center, 1 Congress Street, Suite 1, Boston, MA&#160;02114.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Vanguard Group (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Vanguard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;) filed a Schedule&#160;13G/A on February 13, 2024 reporting that it had shared voting power with respect to&#160;23,749 shares, sole dispositive power with respect to 4,075,831 shares, shared dispositive power with respect to 43,851 shares and beneficial ownership of an aggregate of 4,119,682 shares in its capacity as an investment adviser in accordance with Rule&#160;13d-1(b)(1)(ii)(E) under the Exchange Act.  Vanguard&#8217;s address is&#160;100 Vanguard Blvd., Malvern, PA&#160;19355.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">BlackRock, Inc. (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">BlackRock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;) filed a Schedule&#160;13G/A on January 24, 2024, reporting that it had sole voting power with respect to&#160;5,303,883 shares, sole dispositive power with respect to&#160;5,543,666 shares and beneficial ownership of an aggregate of&#160;5,543,666 shares in its capacity as a parent holding company or control person in accordance with Rule&#160;13d-1(b)(1)(ii)(G) under the Exchange Act.  BlackRock&#8217;s address is&#160;50 Hudson Yards, New York, New York&#160;10001.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Sumitomo Mitsui Trust Holdings, Inc. (&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Sumitomo</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;) filed a Schedule 13G on February 5, 2024, reporting that it had shared voting power and shared dispositive power with respect to 2,874,899 shares in its capacity as a parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G) under the Exchange Act and as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J) under the Exchange Act. Sumitomo&#8217;s Schedule 13G also reported that Nikko Asset Management Co., Ltd. (&#8220;NAM&#8221;) shared voting power and shared dispositive power with respect to 2,874,899 shares in its capacity as an investment advisor in accordance with Rule 13d-1(b)(1)(ii)(E) under the Exchange Act, as a parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G) under the Exchange Act and as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J) under the Exchange Act. The securities reported in the Schedule 13G filed by each of Sumitomo and NAM, as parent holding companies, are owned, or may be deemed to be beneficially owned, by their subsidiary Nikko Asset Management Americas, Inc. (&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Nikko</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;), which is classified as an investment advisor in accordance with Rule 13d-1(b)(1)(ii)(E) under the Exchange Act. Sumitomo&#8217;s address is 1-4-1 Marunouchi, Chyoda-ku, Tokyo 100-8233, Japan. NAM&#8217;s address is Midtown Tower, 9-7-1 Akasaka, Minato-ku, Tokyo 107-6242, Japan. Nikko filed a Schedule 13G with the SEC on February 12, 2023, reporting that it had shared voting power with respect to 2,033,682 shares, shared dispositive power with respect to 2,874,899 shares and beneficial ownership of an aggregate of 2,874,899 shares in its capacity as an investment advisor in accordance with Rule 13d-1(b)(1)(ii)(E) under the Exchange Act. Nikko&#8217;s address is 605 Third Avenue, 38th Floor, New York, NY 10158</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Neil Gagnon and related entities filed a Schedule&#160;13G/A on February 13, 2024, reporting that Mr. Gagnon had sole voting and dispositive power over&#160;169,879 shares, shared voting power over&#160;2,885,562 shares, shared dispositive power over&#160;3,203,597 shares and beneficial ownership of an aggregate of 3,373,476 shares.  The Schedule&#160;13G/A further reported that Mr. Gagnon is the managing member and principal owner of Gagnon Securities LLC (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Gagnon Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;), which is registered with the SEC as an investment adviser and a registered broker-dealer, in its role as investment manager to several customer accounts, foundations, partnerships and trusts (collectively referred to as the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;), to which it furnishes investment advice.  The Schedule&#160;13G/A further reported that Mr. Gagnon and Gagnon Securities may be deemed to share voting power with respect to 2,208,268 shares of common stock held in the Accounts and dispositive power with respect to&#160;2,518,484 shares of common stock held in the Accounts.  Gagnon Securities and Mr. Gagnon disclaim beneficial ownership of all securities held in the Accounts.  The Schedule&#160;13G/A further reported that Mr. Gagnon is the Chief Executive Officer of Gagnon Advisors, LLC (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Gagnon Advisors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;), which is registered with the SEC as an investment adviser.  The Schedule&#160;13G/A further reported that Mr. Gagnon and Gagnon Advisors, in its role as investment manager to Gagnon Investment Associates, LLC (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">GIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;), which is a private investment fund, may be deemed to share voting and dispositive power with respect to&#160;554,851 shares of common stock held by GIA.  Gagnon Advisors and Mr. Gagnon disclaim beneficial ownership of all securities held by GIA.  The address of Mr. Gagnon and related entities is&#160;1370 Avenue of the Americas, 26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Floor, New York, New York&#160;10019.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Bellevue Group AG (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Bellevue Group</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;) on behalf of its wholly-owned subsidiary, Bellevue Asset Management (UK)&#160;Ltd. (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Bellevue Asset Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;), filed a Schedule&#160;13G/A on February 13, 2024, reporting that it had shared voting and dispositive power with respect to&#160;3,954,792 shares and beneficial ownership of an aggregate of&#160;3,954,792 shares in its capacity as a parent holding company or control person in accordance with Rule&#160;13d-1(b)(1)(ii)(G) under the Exchange Act.  Bellevue Group&#8217;s address is Seestrasse&#160;16, Kuesnacht, Switzerland, CH-8700.  Bellevue Asset Management&#8217;s address is&#160;32 London Bridge Street, 24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Floor, London, England SE1 9SG.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents&#160;21,243 shares of common stock held by Mr. Jain, 47,434 shares subject to options that are immediately exercisable or exercisable within&#160;60&#160;days of March 31, 2024, and&#160;19,430 shares issuable pursuant to RSUs that are subject to vesting conditions expected to occur within&#160;60&#160;days of March 31, 2024. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents&#160;49,690 shares of common stock held by Mr. Johnson and&#160;159,922 shares subject to options that are immediately exercisable or exercisable within&#160;60&#160;days of March 31, 2024, and 14,543 shares issuable pursuant to RSUs that are subject to vesting conditions expected to occur within 60 days of March 31 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Represents&#160;285,622 shares of common stock held by Dr. Maag and&#160;967,691 shares subject to options that are immediately exercisable or exercisable within&#160;60&#160;days of March&#160;31, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Represents&#160;80,877 shares of common stock held by Mr. Bickerstaff and&#160;107,444 shares subject to options that are immediately exercisable or exercisable within&#160;60&#160;days of March 31, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Represents&#160;4,864 shares subject to options held by Dr. Col&#243;n and 47,672 shares subject to options that are immediately exercisable or exercisable within&#160;60&#160;days of March 31, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(13)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Represents&#160;24,331 shares of common stock held by Ms. Cournoyer and&#160;51,404 shares subject to options that are immediately exercisable or exercisable within&#160;60&#160;days of March 31, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(14)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Represents&#160;113,748 shares of common stock held by Dr. Cohen and&#160;107,444 shares subject to options that are immediately exercisable or exercisable within&#160;60&#160;days of March 31, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Represents&#160;84,007 shares of common stock held by Mr. Goldberg and&#160;202,743 shares subject to options that are immediately exercisable or exercisable within&#160;60&#160;days of March 31, 2024.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(16)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Represents&#160;24,565 shares of common stock held by Mr. Hagstrom and&#160;106,458 shares subject to options that are immediately exercisable or exercisable within&#160;60&#160;days of March 31, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(17)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Represents&#160;7,504 shares of common stock held by Dr. Valantine and&#160;35,853 shares subject to options that are immediately exercisable or exercisable within&#160;60&#160;days of March 31, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(18)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Represents&#160;6,966 shares of common stock held by Senator Torres and&#160;36,318 shares subject to options that are immediately exercisable or exercisable within&#160;60&#160;days of March 31, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(19)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Dr. Seeto&#8217;s employment with us terminated effective November 1, 2023, at which time he became a consultant to us. Represents&#160;134,482 shares of common stock held by Dr. Seeto and&#160;409,317 shares subject to options that are immediately exercisable or exercisable within&#160;60&#160;days of March 31, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(20)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Mr. Ronai&#8217;s employment with us terminated effective September 30, 2023, at which time he became a consultant to us. Represents&#160;47,324 shares of common stock held by Mr. Ronai and&#160;73,019 shares subject to options that are immediately exercisable or exercisable within&#160;60&#160;days of March 31, 2024.</span></div><div style="margin-bottom:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(21)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Comprised of shares included under &#8220;Directors and Named Executive Officers&#8221;, (a) excluding Dr. Seeto who ceased serving as an executive officer on November 1, 2023, (b) excluding Mr. Ronai who ceased serving as on executive officer on September 1, 2023, and (c) including Jeff Novack, who was appointed as an executive officer effective April 24, 2024 and held 5,018 shares of common stock, 2,213 shares subject to options that are immediately exercisable or exercisable within&#160;60&#160;days of March 31, 2024, and&#160;9,222 shares issuable pursuant to RSUs that are subject to vesting conditions expected to occur within&#160;60&#160;days of March 31, 2024.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_211"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RELATED PARTY TRANSACTIONS</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January&#160;1, 2023, there have not been any transactions or series of transactions, and there is currently no proposed transaction, to which we were or are to be a participant in which the amount involved in the transaction or series of transactions exceeds $120,000, and in which any of our directors, executive officers or persons who we know held more than five percent of any class of our capital stock, including their immediate family members, had or will have a direct or indirect material interest, other than compensation arrangements that are described under &#8220;Executive Compensation&#8221; above and the indemnification agreements described below.</span></div><div id="i60d05261c6404879b68233510f10856b_214"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnification Agreements</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also entered into indemnification agreements with our directors and certain of our executive officers.  The indemnification agreements and the Certificate of Incorporation and Bylaws require us to indemnify our directors and officers to the fullest extent permitted by Delaware law.</span></div><div id="i60d05261c6404879b68233510f10856b_217"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rule</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10b5-1 Sales Plans</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our directors and executive officers may adopt written plans, known as Rule&#160;10b5-1 plans, in which they will contract with a broker to buy or sell shares of our common stock on a periodic basis.  Under a Rule&#160;10b5-1 plan, a broker executes trades pursuant to parameters established by the director or executive officer when entering into the plan, without further direction from them.  The director or executive officer may amend a Rule&#160;10b5-1 plan in some circumstances and may terminate a plan at any time, subject to the terms of the plan.  Our directors and executive officers also may buy or sell additional shares outside of a Rule&#160;10b5-1 plan when they are not in possession of material nonpublic information, subject to compliance with the terms of our insider trading policy.</span></div><div id="i60d05261c6404879b68233510f10856b_220"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Policies and Procedures for Related Party Transactions</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Audit and Finance Committee adopted a formal written policy that our Audit and Finance Committee is responsible for reviewing &#8220;related party transactions.&#8221; A &#8220;related party transaction&#8221; is a transaction, arrangement, or relationship in which we (including any of our subsidiaries) and any &#8220;related party&#8221; were, are, or will be participants involving an amount that exceeds $120,000.  For purposes of this policy, a related party is defined as a director, nominee for director, executive officer, or greater than&#160;5% beneficial owner of our common stock and their immediate family members, any entity in which such person is employed or is a general partner or principal and any entity where such person has a&#160;5% or greater beneficial ownership interest.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under this policy, all related party transactions may be consummated or continued only if approved or ratified by our Audit and Finance Committee.  In determining whether to approve or ratify any such proposal, our Audit and Finance Committee will take into account, among other factors it deems appropriate, (a)&#160;whether the transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances, and (b)&#160;the extent of the related party&#8217;s interest in the transaction.  The policy grants standing pre-approval of certain transactions, including (1)&#160;certain compensation arrangements of executive officers, (2)&#160;certain director compensation arrangements, (3)&#160;transactions with another company at which a related party&#8217;s only relationship is as a non-executive employee, director or beneficial owner of less than&#160;5% of that company&#8217;s shares, (4)&#160;transactions where a related party&#8217;s interest arises solely from the ownership of our common stock and all holders of our common stock received the same benefit on a pro rata basis, and (5)&#160;transactions available to all U.S.&#160;employees generally.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_223"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER MATTERS</span></div><div id="i60d05261c6404879b68233510f10856b_226"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Delinquent Section</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16(a) Reports</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;16(a) of the Exchange Act requires that our executive officers and directors, and persons who own more than&#160;10% of our common stock, file reports of ownership and changes of ownership with the SEC.  Such directors, executive officers and&#160;10% stockholders are required by SEC regulation to furnish us with copies of all Section&#160;16(a) forms they file.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SEC regulations require us to identify in this proxy statement anyone who failed to file a timely required report during the most recent fiscal year.  Based solely upon our review of forms we received, or written representations from reporting persons stating that they were not required to file these forms, we believe that during our fiscal year ended December&#160;31, 2023, all Section&#160;16(a) filing requirements were satisfied on a timely basis, except for a Form 4 for Abraham Ronai reporting the acquisition of restricted stock units on September 20, 2023, which transaction was inadvertently reported late on a Form 4 that was filed on September 26, 2023.</span></div><div id="i60d05261c6404879b68233510f10856b_229"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial statements for our fiscal year ended December&#160;31, 2023 are included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023.  This proxy statement and our annual report are posted on the Investors section of our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">investors.caredxinc.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and are available from the SEC at its website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  You may also obtain a copy of our annual report without charge by sending a written request to CareDx, Inc., Attention: Investor Relations, 8000 Marina Boulevard, 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Floor, Brisbane, California&#160;94005.</span></div><div id="i60d05261c6404879b68233510f10856b_232"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note About Forward-Looking Statements</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This proxy statement contains forward-looking statements that involve a number of risks and uncertainties.  Words such as &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; and similar expressions are intended to identify forward-looking statements.  We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs.  These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023.  Moreover, we operate in a very competitive and rapidly changing environment.  New risks emerge from time to time.  It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make.  In light of these risks, uncertainties and assumptions, the future events and trends discussed in this proxy statement may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.  We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements, except as required by law.  Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.</span></div><div id="i60d05261c6404879b68233510f10856b_235"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Householding</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC has adopted rules that permit companies and intermediaries to satisfy the delivery requirements for Notice of Internet Availability of Proxy Materials (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or other proxy materials with respect to two or more stockholders sharing the same address by delivering a single notice or other annual meeting materials addressed to those stockholders.  This process, which is commonly referred to as householding, potentially provides extra convenience for stockholders and cost savings for companies.  Stockholders who participate in householding will continue to be able to access and receive separate proxy cards.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Notice will be delivered in one single envelope to multiple stockholders sharing an address unless contrary instructions have been received from one or more of the affected stockholders.  If, at any time, you no longer wish to participate in householding and would prefer to receive a separate Notice or other proxy materials, please notify your broker or call the Company&#8217;s Secretary at (415) 287-2300 or submit a request in writing to our Corporate Secretary, 8000 Marina Boulevard, 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Floor, Brisbane, California&#160;94005.  Stockholders who currently receive multiple copies of the Notice or other proxy materials at their address and would like to request householding of their communications should contact their broker.  In addition, we will promptly deliver, upon written or oral request to the address or telephone number above, a separate copy </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Notice or other proxy materials to a stockholder at a shared address to which a single copy of the documents was delivered.</span></div><div id="i60d05261c6404879b68233510f10856b_238"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Website</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.caredx.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Information contained on, or that can be accessed through, our website is not intended to be incorporated by reference into this proxy statement, and references to our website address in this proxy statement are inactive textual references only.</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors does not know of any other matters to be presented at the Annual Meeting.  If any additional matters are properly presented at the Annual Meeting, the persons named on the enclosed proxy card will have discretion to vote the shares of common stock they represent in accordance with their own judgment on such matters.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is important that your shares of common stock be represented at the Annual Meeting, regardless of the number of shares that you hold.  You are, therefore, urged to vote over the Internet or by telephone as instructed on the proxy card or execute and return, at your earliest convenience, the proxy card.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brisbane, California</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 29, 2024</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><img src="cdna-20240429_g21.jpg" alt="Proxy card page 1.jpg" style="height:849px;margin-bottom:5pt;vertical-align:text-bottom;width:660px"/></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><img src="cdna-20240429_g22.jpg" alt="Proxy card page 2.jpg" style="height:851px;margin-bottom:5pt;vertical-align:text-bottom;width:660px"/></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="i60d05261c6404879b68233510f10856b_241"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APPENDIX&#160;A</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024 Equity Incentive Plan</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">G</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ENERAL.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Plan Purpose</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company, by means of the Plan, seeks to secure and retain the services of Employees, Directors and Consultants, to provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and to promote the creation of long-term value for the stockholders of the Company by closely aligning the interests of such individuals with those of such stockholders.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Available Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Plan provides for the grant of the following Awards: (i)&#160;Incentive Stock Options; (ii)&#160;Nonstatutory Stock Options; (iii)&#160;SARs; (iv)&#160;Restricted Stock Awards; (v)&#160;RSU Awards; and (vi)&#160;Other Awards.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">Effective Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Plan will come into existence on the Effective Date.</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">HARES </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">UBJECT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">TO THE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">LAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Share Reserve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to adjustment in accordance with Section&#160;2(c) and any adjustments as necessary to implement any Capitalization Adjustments, the aggregate number of shares of Common Stock that may be issued pursuant to Awards will not exceed&#160;3,500,000 shares.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Aggregate Incentive Stock Option Limit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding anything to the contrary in Section&#160;2(a) and subject to any adjustments as necessary to implement any Capitalization Adjustments, the aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options is&#160;3,500,000 shares.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">Share Reserve Operation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt">Limit Applies to Common Stock Issued Pursuant to Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  For clarity, the Share Reserve is a limit on the number of shares of Common Stock that may be issued pursuant to Awards and does not limit the granting of Awards, except that the Company will keep available at all times the number of shares of Common Stock reasonably required to satisfy its obligations to issue shares pursuant to such Awards.  Shares may be issued in connection with a merger or acquisition as permitted by, as applicable, Nasdaq Listing Rule&#160;5635(c), NYSE Listed Company Manual Section&#160;303A.08, NYSE American Company Guide Section&#160;711 or other applicable rule, and such issuance will not reduce the number of shares available for issuance under the Plan.  For the avoidance of doubt, Awards that by their terms settle in cash shall not reduce the Share Reserve.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.8pt">Reversion of Previously Issued Shares of Common Stock to Share Reserve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If any Award is forfeited, expires, terminates, otherwise lapses or is surrendered pursuant to an Exchange Program or otherwise settled for cash, in whole or in part, without the delivery of Shares, then the Shares covered by such forfeited, expired, terminated or lapsed Award or Award surrendered or settled in cash shall be added back to the Share Reserve and again become available for issuance under the Plan.  For the avoidance of doubt, the following will not be added back to the Share Reserve or again available for issuance under the Plan: (A)&#160;any Shares withheld in respect of taxes, (B)&#160;any Shares tendered or withheld to pay the exercise price of Options, and (C)&#160;any Shares underlying an Award of stock-settled SARs.  </span></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">E</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">LIGIBILITY AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> L</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">IMITATIONS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Eligible Award Recipients</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the terms of the Plan, Employees, Directors and Consultants are eligible to receive Awards.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Specific Award Limitations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt">Limitations on Incentive Stock Option Recipients</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Incentive Stock Options may be granted only to Employees of the Company or a &#8220;parent corporation&#8221; or &#8220;subsidiary corporation&#8221; thereof (as such terms are defined in Sections&#160;424(e) and (f)&#160;of the Code).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.8pt">Incentive Stock Option $100,000 Limitation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent that the aggregate Fair Market Value (determined at the time of grant) of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Participant during any calendar year (under all plans of the Company and any Affiliates) exceeds $100,000 (or such other limit established in the Code) or otherwise does not comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order in which they were granted) or otherwise do not comply with such rules will be treated as Nonstatutory Stock Options, notwithstanding any contrary provision of the applicable Award Agreement(s).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.03pt">Limitations on Incentive Stock Options Granted to Ten Percent Stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Ten Percent Stockholder may not be granted an Incentive Stock Option unless (i)&#160;the exercise price of such Option is at least&#160;110% of the Fair Market Value on the date of grant of such Option and (ii)&#160;the Option is not exercisable after the expiration of five years from the date of grant of such Option.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.57pt">Limitations on Nonstatutory Stock Options and SARs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Nonstatutory Stock Options and SARs may not be granted to Employees, Directors and Consultants who are providing Continuous Service unless the stock underlying such Awards is treated as &#8220;service recipient stock&#8221; under Section&#160;409A or unless such Awards otherwise comply with the distribution requirements of Section&#160;409A or is not subject to Section 409A.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">Aggregate Incentive Stock Option Limit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options is the number of shares specified in Section&#160;2(b).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Non-Employee Director Compensation Limit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The aggregate value of all compensation granted or paid, as applicable, in each case following the Effective Date, to any individual for service as a Non-Employee Director with respect to any fiscal year, including Awards granted and cash fees paid by the Company to such Non-Employee Director for his or her service as a Non-Employee Director, will not exceed (i) $750,000 in total value or (ii)&#160;in the event such Non-Employee Director is first appointed or elected to the Board during such fiscal year, $1,500,000 in total value, in each case calculating the value of any equity awards based on the grant date fair value of such equity awards for financial reporting purposes. For the avoidance of doubt, any Awards granted and cash fees paid to a Non-Employee Director for his or her service as a Non-Employee Director in respect of any fiscal year shall count against the compensation limits set forth in this Section&#160;3(d) for the fiscal year to which such Awards and fees relate, regardless of any deferral of such Awards or fees.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">Minimum Vesting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding the Board&#8217;s discretion to determine the vesting schedule applicable to an Award, all Awards, and all portions of Awards, shall be subject to a vesting schedule that provides that the Award shall not vest with respect to any of the covered shares of Common Stock prior to the one year anniversary of the date of grant of the Award (or the date of commencement of employment or service, in the case of a grant made in connection with a Participant&#8217;s commencement of employment or service); provided, however, that (i) Awards with respect to 5% of the aggregate number of shares subject to the Share Reserve may be granted under the Plan to any one or more Participants (other than Officers) without respect to such minimum vesting provisions, (ii) vesting of any Award may accelerate pursuant to Section 6(c)(ii), (iii) Awards that vest on the earlier of the one-year anniversary of the date on which the Award was granted and the next annual meeting of stockholders (so long as such next annual meeting of stockholders is at least 50 weeks after the immediately preceding year&#8217;s annual meeting of stockholders) may be granted to Non-Employee Directors without respect to such minimum vesting provisions, and (iv) nothing herein shall prohibit the Board from accelerating the vesting of any Award in connection with the termination of a Participant&#8217;s Continuous Service in exchange for a release of claims.</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PTIONS AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">TOCK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PPRECIATION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">IGHTS.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Option and SAR will have such terms and conditions as determined by the Board.  Each Option will be designated in writing as an Incentive Stock Option or Nonstatutory Stock Option at the time of grant; provided, however, that if an Option is not so designated or if an Option designated as an Incentive Stock Option fails to qualify as an Incentive Stock Option, then such Option will be a Nonstatutory Stock Option, and the shares purchased upon exercise of each type of Option will be separately accounted for.  Each SAR will be denominated in shares of Common Stock equivalents.  The terms and conditions of separate Options and SARs need not be identical; provided, however, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that each Award Agreement will conform&#160;(through incorporation of provisions hereof by reference in the Award Agreement or otherwise) to the substance of each of the following provisions:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to Section&#160;3(b) regarding Ten Percent Stockholders, no Option or SAR will be exercisable after the expiration of ten years from the date of grant of such Award or such shorter period specified in the Award Agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Exercise or Strike Price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to Section&#160;3(b) regarding Ten Percent Stockholders, the exercise or strike price of each Option or SAR will not be less than&#160;100% of the Fair Market Value on the date of grant of such Award.  Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than&#160;100% of the Fair Market Value on the date of grant of such Award if such Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right pursuant to a corporate transaction and in a manner consistent with the provisions of Sections&#160;409A and, if applicable, 424(a) of the Code.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">Exercise Procedure and Payment of Exercise Price for Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In order to exercise an Option, the Participant must provide notice of exercise to the Plan Administrator in accordance with the procedures specified in the Award Agreement or otherwise provided by the Company.  The Board has the authority to grant Options that do not permit all of the following methods of payment (or otherwise restrict the ability to use certain methods) and to grant Options that require the consent of the Company to utilize a particular method of payment.  The exercise price of an Option may be paid, to the extent permitted by Applicable Law and as determined by the Board, by one or more of the following methods of payment to the extent set forth in the Award Agreement:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">by cash or check, bank draft or money order payable to the Company;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">pursuant to a &#8220;cashless exercise&#8221; program developed under Regulation&#160;T as promulgated by the U.S.&#160;Federal Reserve Board that, prior to the issuance of the Common Stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the exercise price to the Company from the sales proceeds;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">by delivery to the Company (either by actual delivery or attestation) of shares of Common Stock that are already owned by the Participant free and clear of any liens, claims, encumbrances or security interests, with a Fair Market Value on the date of exercise that does not exceed the exercise price, provided that (1)&#160;at the time of exercise the Common Stock is publicly traded, (2)&#160;any remaining balance of the exercise price not satisfied by such delivery is paid by the Participant in cash or other permitted form of payment, (3)&#160;such delivery would not violate any Applicable Law or agreement restricting the redemption of the Common Stock, (4)&#160;any certificated shares are endorsed or accompanied by an executed assignment separate from certificate and (5)&#160;such shares have been held by the Participant for any minimum period necessary to avoid adverse accounting treatment as a result of such delivery;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">if the Option is a Nonstatutory Stock Option, by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value on the date of exercise that does not exceed the exercise price, provided that (1)&#160;such shares used to pay the exercise price will not be exercisable thereafter and (2)&#160;any remaining balance of the exercise price not satisfied by such net exercise is paid by the Participant in cash or other permitted form of payment; or</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">in any other form of consideration that may be acceptable to the Board and permissible under Applicable Law.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Exercise Procedure and Payment of Appreciation Distribution for SARs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In order to exercise any SAR, the Participant must provide notice of exercise to the Plan Administrator in accordance with the Award Agreement.  The appreciation distribution payable to a Participant upon the exercise of a SAR will not be greater than an amount equal to the excess of (i)&#160;the aggregate Fair Market Value on the date of exercise of a number of shares of Common Stock equal to the number of Common Stock equivalents that are vested and being exercised under such SAR, over (ii)&#160;the strike price of such SAR.  Such appreciation distribution may be paid to the Participant in the form of Common Stock or cash (or any combination of Common Stock and cash) or in any other form of payment, as determined by the Board and specified in the Award Agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">Transferability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Options and SARs may not be transferred to third-party financial institutions for value.  The Board may impose such additional limitations on the transferability of an Option or SAR as it determines.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the absence of any such determination by the Board, the following restrictions on the transferability of Options and SARs will apply, provided that, except as explicitly provided herein, neither an Option nor a SAR may be transferred for consideration, and provided, further, that if an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt">Restrictions on Transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option or SAR will not be transferable, except by will or by the laws of descent and distribution, and will be exercisable during the lifetime of the Participant only by the Participant; provided, however, that the Board may permit transfer of an Option or SAR in a manner that is not prohibited by applicable tax and securities laws upon the Participant&#8217;s request, including to a trust if the Participant is considered to be the sole beneficial owner of such trust (as determined under Section&#160;671 of the Code and applicable U.S.&#160;state law) while such Option or SAR is held in such trust, provided that the Participant and the trustee enter into a transfer and other agreements required by the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.8pt">Domestic Relations Orders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding the foregoing, subject to the execution of transfer documentation in a format acceptable to the Company and subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred pursuant to a domestic relations order.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">f.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.17pt">Vesting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Board may impose such restrictions on or conditions to the vesting and/or exercisability of an Option or SAR as determined by the Board and vesting conditions may include achievement of one or more Performance Goals.  Except as otherwise determined by the Board or provided in the applicable Award Agreement or other written agreement between a Participant and the Company, vesting of Options and SARs will cease upon termination of the Participant&#8217;s Continuous Service.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Termination of Continuous Service for Cause</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as otherwise determined by the Board or explicitly provided in the Award Agreement or other written agreement between a Participant and the Company, if a Participant&#8217;s Continuous Service is terminated for Cause, the Participant&#8217;s Options and SARs will terminate and be forfeited immediately upon such termination of Continuous Service, and the Participant will be prohibited from exercising any portion (including any vested portion) of such Awards on and after the date of such termination of Continuous Service and the Participant will have no further right, title or interest in such forfeited Award, the shares of Common Stock subject to the forfeited Award, or any consideration in respect of the forfeited Award.  If a Participant is suspended pending investigation of whether his or her Continuous Service shall be terminated for Cause, the Participant&#8217;s rights to exercise an Option or SAR shall be suspended during the investigation period.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">h.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Post-Termination Exercise Period Following Termination of Continuous Service for Reasons Other than Cause</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to Section&#160;4(i), if a Participant&#8217;s Continuous Service terminates for any reason other than for Cause, the Participant may exercise his or her Option or SAR to the extent vested, but only within the following period of time or, if applicable, such other period of time determined by the Board or provided in the Award Agreement or other written agreement between a Participant and the Company; provided, however, that in no event may such Award be exercised after the expiration of its maximum term (as set forth in Section&#160;4(a)):</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">3 months following the date of such termination if such termination is a termination without Cause (other than any termination due to the Participant&#8217;s Disability or death); or</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">12 months following the date of such termination if such termination is due to the Participant&#8217;s Disability or the Participant&#8217;s death (or if the Participant&#8217;s death occurs following the date of such termination but during the period such Award is otherwise exercisable (as provided in (i)&#160;above)).</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the date of such termination, to the extent the Participant does not exercise such Award within the applicable Post-Termination Exercise Period (or, if earlier, prior to the expiration of the maximum term of such Award), such unexercised portion of the Award will terminate, and the Participant will have no further right, title or interest in terminated Award, the shares of Common Stock subject to the terminated Award, or any consideration in respect of the terminated Award.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.73pt">Restrictions on Exercise; Extension of Exercisability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant may not exercise an Option or SAR at any time that the issuance of shares of Common Stock upon such exercise would violate Applicable Law.  Except as otherwise determined by the Board or provided in the Award Agreement or other written agreement between a Participant and the Company, if a Participant&#8217;s Continuous Service terminates for any reason other than for Cause and, at any time during the last thirty days of the applicable Post-Termination Exercise Period: (i)&#160;the exercise of the Participant&#8217;s </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Option or SAR would be prohibited solely because the issuance of shares of Common Stock upon such exercise would violate Applicable Law, (ii)&#160;the immediate sale of any shares of Common Stock issued upon such exercise would violate the Company&#8217;s Trading Policy or (iii) the Board has suspended exercisability under Section 7(b), then the applicable Post-Termination Exercise Period will be extended to the last day of the calendar month that commences following the date the Award would otherwise expire, with an additional extension of the exercise period to the last day of the next calendar month to apply if any of the foregoing restrictions apply at any time during such extended exercise period, generally without limitation as to the maximum permitted number of extensions; provided, however, that in no event may such Award be exercised after the expiration of its maximum term (as set forth in Section&#160;4(a)).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">j.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.17pt">Non-Exempt Employees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  No Option or SAR, whether or not vested, granted to an Employee who is a non-exempt employee for purposes of the Fair Labor Standards Act of&#160;1938, as amended, will be first exercisable for any shares of Common Stock until at least six months following the date of grant of such Award.  Notwithstanding the foregoing, in accordance with the provisions of the Worker Economic Opportunity Act, any vested portion of such Award may be exercised earlier than six months following the date of grant of such Award in the event of (i)&#160;such Participant&#8217;s death or Disability, (ii)&#160;a corporate transaction in which such Award is not assumed, continued or substituted, (iii)&#160;a Change in Control, or (iv)&#160;such Participant&#8217;s retirement (as such term may be defined in the Award Agreement or another applicable agreement between the Employee and the Company or one of its Affiliates or, in the absence of any such definition, in accordance with the Company&#8217;s then current employment policies and guidelines).  This Section&#160;4(j) is intended to operate so that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">k.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Whole Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Options and SARs may be exercised only with respect to whole shares of Common Stock or their equivalents.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">l.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.73pt">Rights as a Stockholder.&#160; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends and dividend </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">equivalents</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> may not be paid or&#160;credited to Options or SARs, and a Participant shall have no rights to dividends, dividend equivalents or distributions or any other rights of a stockholder with respect to the Shares subject to an Option or SAR until the Participant has given written notice of the exercise thereof, has paid in full for such Shares and has satisfied the requirements of Section 4(c) or 4(d), as applicable.</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">WARDS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">THER</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">HAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PTIONS AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">TOCK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PPRECIATION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">IGHTS.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Restricted Stock Awards and RSU Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Restricted Stock Award and RSU Award will have such terms and conditions as determined by the Board; provided, however, that each Restricted Stock Award Agreement and RSU Award Agreement will conform&#160;(through incorporation of the provisions hereof by reference in the Award Agreement or otherwise) to the substance of each of the following provisions:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt">Form of Award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">RSAs: To the extent consistent with the Company&#8217;s Bylaws, at the Board&#8217;s election, shares of Common Stock subject to a Restricted Stock Award may be (i)&#160;held in book entry form subject to the Company&#8217;s instructions until such shares become vested or any other restrictions lapse, or (ii)&#160;evidenced by a certificate, which certificate will be held in such form and manner as determined by the Board.  Unless otherwise determined by the Board, a Participant will have voting and other rights as a stockholder of the Company with respect to any shares subject to a Restricted Stock Award.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">RSUs: A RSU Award represents a Participant&#8217;s right to be issued on a future date the number of shares of Common Stock that is equal to the number of restricted stock units subject to the RSU Award.  As a holder of a RSU Award, a Participant is an unsecured creditor of the Company with respect to the Company&#8217;s unfunded obligation, if any, to issue shares of Common Stock in settlement of such Award and nothing contained in the Plan or any Award Agreement, and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between a Participant and the Company or an Affiliate or any other person.  A Participant will not have voting or any other rights as a stockholder of the Company with respect to any RSU Award (unless and until shares are actually issued in settlement of a vested RSU Award).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.8pt">Consideration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">RSA: A Restricted Stock Award may be granted in consideration for (A)&#160;cash or check, bank draft or money order payable to the Company, (B)&#160;past services to the Company or an Affiliate, or (C)&#160;any other form of consideration as the Board may determine and permissible under Applicable Law.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">RSU: Unless otherwise determined by the Board at the time of grant, a RSU Award will be granted in consideration for the Participant&#8217;s services to the Company or an Affiliate, such that the Participant will not be required to make any payment to the Company (other than such services) with respect to the grant or vesting of the RSU Award, or the issuance of any shares of Common Stock pursuant to the RSU Award.  If, at the time of grant, the Board determines that any consideration must be paid by the Participant (in a form other than the Participant&#8217;s services to the Company or an Affiliate) upon the issuance of any shares of Common Stock in settlement of the RSU Award, such consideration may be paid in any form of consideration as the Board may determine and permissible under Applicable Law.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.03pt">Vesting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Board may impose such restrictions on or conditions to the vesting of a Restricted Stock Award or RSU Award as determined by the Board, which may include achievement of one or more Performance Goals.  Except as otherwise determined by the Board or provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, vesting of Restricted Stock Awards and RSU Awards will cease upon termination of the Participant&#8217;s Continuous Service.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.57pt">Termination of Continuous Service</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as otherwise determined by the Board or provided in the Award Agreement or other written agreement between a Participant and the Company, if a Participant&#8217;s Continuous Service terminates for any reason, (i)&#160;the Company may receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant under his or her Restricted Stock Award that have not vested as of the date of such termination as set forth in the Restricted Stock Award Agreement and (ii)&#160;any portion of his or her RSU Award that has not vested will be forfeited upon such termination and the Participant will have no further right, title or interest in the RSU Award, the shares of Common Stock issuable pursuant to the RSU Award, or any consideration in respect of the RSU Award; provided, however, that if the Company has a contingent contractual obligation to provide for accelerated vesting of a Participant&#8217;s Restricted Stock Award or RSU Award after termination of the Participant&#8217;s Continuous Service, the unvested portion of such Award subject to potential acceleration shall remain outstanding until the maximum contractual time for determining whether such contingency will occur, and terminate at such time if the contingency has not then occurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Dividends and Dividend Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Dividends or dividend equivalents may be paid or credited, as applicable, with respect to any shares of Common Stock subject to a Restricted Stock Award or RSU Award, subject to the same restrictions on transferability and forfeitability as the underlying Award with respect to which such dividends or dividend equivalents are granted and subject to such other terms and conditions as determined by the Board and specified in the Award Agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.57pt">Settlement of RSU Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A RSU Award may be settled by the issuance of shares of Common Stock or cash (or any combination thereof) or in any other form of payment, as determined by the Board and specified in the RSU Award Agreement.  At the time of grant, the Board may determine to impose such restrictions or conditions that delay such delivery to a date following the vesting of the RSU Award in a manner intended to comply with Section 409A, as applicable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Other Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Other Awards may be granted either alone or in addition to Awards provided for under Section&#160;4 and the preceding provisions of this Section&#160;5.  Subject to the provisions of the Plan, the Board will have sole and complete discretion to determine the persons to whom and the time or times at which such Other Awards will be granted, the number of shares of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Awards and all other terms and conditions of such Other Awards (including the form of settlement, which may be in the form of Common Stock, cash or other form of payment).</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">DJUSTMENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> U</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">HANGES IN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OMMON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">TOCK;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">THER</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ORPORATE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> E</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">VENTS.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Capitalization Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event of a Capitalization Adjustment, the Board shall appropriately and proportionately adjust: (i)&#160;the class(es) and maximum number of shares of Common Stock subject to the Plan, (ii)&#160;the class(es) and maximum number of shares that may be issued pursuant to the exercise of Incentive Stock </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options pursuant to Section&#160;2(b), and (iii)&#160;the class(es) and number of securities and exercise price, strike price or purchase price of Common Stock subject to outstanding Awards.  The Board shall make such adjustments, and its determination shall be final, binding and conclusive.  Notwithstanding the foregoing, no fractional shares or rights for fractional shares of Common Stock shall be created in order to implement any Capitalization Adjustment.  The Board shall determine an appropriate equivalent benefit, if any, for any fractional shares or rights to fractional shares that might be created by the adjustments referred to in the preceding provisions of this Section.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Dissolution or Liquidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as otherwise determined by the Board or provided in the Award Agreement, in the event of a dissolution or liquidation of the Company, all outstanding Awards (other than Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition or the Company&#8217;s right of repurchase) will terminate immediately prior to the completion of such dissolution or liquidation, and the shares of Common Stock subject to the Company&#8217;s repurchase rights or subject to a forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Award is providing Continuous Service, provided, however, that the Board may determine to cause some or all Awards to become fully vested, exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Awards have not previously expired or terminated) before the dissolution or liquidation is completed but contingent on its completion.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">Change in Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All Awards outstanding on the effective date of a Change in Control shall be treated in the manner described in the definitive agreement evidencing the Change in Control (or, in the event that the Change in Control is not effected pursuant to a definitive agreement to which the Company is party, in the manner determined by the Board, with such determination having final and binding effect on all parties), which agreement or determination need not treat all Awards (or portions thereof) in an identical manner.  Unless an Award Agreement provides otherwise, without limiting the prior sentence, the treatment specified in the transaction agreement or by the Board may include (without limitation) one or more of the following with respect to each outstanding Award:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt">Awards May Be Assumed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event of a Change in Control, any surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) may assume or continue any or all Awards outstanding under the Plan or may substitute similar awards for Awards outstanding under the Plan (including but not limited to, awards to acquire the same consideration paid to the stockholders of the Company pursuant to the Change in Control), and any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to Awards may be assigned by the Company to the successor of the Company (or the successor&#8217;s parent company, if any), in connection with such Change in Control.  A surviving corporation or acquiring corporation (or its parent) may choose to assume or continue only a portion of an Award or substitute a similar award for only a portion of an Award, or may choose to assume or continue the Awards held by some, but not all Participants.  The terms of any assumption, continuation or substitution will be set by the Board.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.8pt">Awards Held by Current Participants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event of a Change in Control in which the surviving corporation or acquiring corporation (or its parent company) does not assume or continue such outstanding Awards or substitute similar awards for such outstanding Awards, then with respect to Awards that have not been assumed, continued or substituted and that are held by Participants whose Continuous Service has not terminated prior to the effective time of the Change in Control (referred to as the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current Participants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the vesting of such Awards (and, with respect to Options and Stock Appreciation Rights, the time when such Awards may be exercised) will be accelerated in full to a date prior to the effective time of such Change in Control (contingent upon the effectiveness of the Change in Control) as the Board determines (or, if the Board does not determine such a date, to the date that is five days prior to the effective time of the Change in Control), and such Awards will terminate if not exercised (if applicable) at or prior to the effective time of the Change in Control, and any reacquisition or repurchase rights held by the Company with respect to such Awards will lapse (contingent upon the effectiveness of the Change in Control).  With respect to the vesting of Awards with performance-based vesting that will accelerate upon the occurrence of a Change in Control pursuant to this subsection&#160;(ii) and that have multiple vesting levels depending on the level of performance, unless otherwise provided in the Award Agreement, the vesting of such Awards will accelerate at 100% of the target level upon the occurrence of the Change in Control (or such greater level as determined by the Board).  With respect to the vesting of Awards that will accelerate upon the occurrence of a Change in Control pursuant to this subsection&#160;(ii) and are settled in the form of a cash payment, such cash payment will be made no later than&#160;30&#160;days following the occurrence of the Change in Control or such later date as required to comply with Section 409A.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.03pt">Awards Held by Persons other than Current Participants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event of a Change in Control in which the surviving corporation or acquiring corporation (or its parent company) does not assume or continue such outstanding Awards or substitute similar awards for such outstanding Awards, then with respect to Awards that have </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not been assumed, continued or substituted and that are held by persons other than Current Participants, such Awards will terminate if not exercised (if applicable) prior to the occurrence of the Change in Control; provided, however, that any reacquisition or repurchase rights held by the Company with respect to such Awards will not terminate and may continue to be exercised notwithstanding the Change in Control.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.57pt">Payment for Awards in Lieu of Exercise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding the foregoing, in the event an Award will terminate if not exercised prior to the effective time of a Change in Control, the Board may provide, in its sole discretion, that the holder of such Award may not exercise such Award but will receive a payment, in such form as may be determined by the Board, equal in value, at the effective time, to the excess, if any, of (1)&#160;the value of the property the Participant would have received upon the exercise of the Award (including, at the discretion of the Board, any unvested portion of such Award), over (2)&#160;any exercise price payable by such holder in connection with such exercise; for clarity, an Award may be cancelled without payment of any consideration if the value of such property is equal to or less than the exercise price.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Appointment of Stockholder Representative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  As a condition to the receipt of an Award under this Plan, a Participant will be deemed to have agreed that the Award will be subject to the terms of any agreement governing a Change in Control involving the Company, including, without limitation, a provision for the appointment of a stockholder representative that is authorized to act on the Participant&#8217;s behalf with respect to any escrow, indemnities and any contingent consideration.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">No Restriction on Right to Undertake Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The grant of any Award under the Plan and the issuance of shares pursuant to any Award does not affect or restrict in any way the right or power of the Company or the stockholders of the Company to make or authorize any adjustment, recapitalization, reorganization or other change in the Company&#8217;s capital structure or its business, any merger or consolidation of the Company, any issue of stock or of options, rights or options to purchase stock or of bonds, debentures, preferred or prior preference stocks whose rights are superior to or affect the Common Stock or the rights thereof or which are convertible into or exchangeable for Common Stock, or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets or business, or any other corporate act or proceeding, whether of a similar character or otherwise.</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30pt">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">DMINISTRATION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Administration by Board</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Board will administer the Plan unless and until the Board delegates administration of the Plan to a Committee or Committees, as provided in subsection&#160;(c) below.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Powers of Board</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">To determine from time to time: (1)&#160;which of the persons eligible under the Plan will be granted Awards; (2)&#160;when and how each Award will be granted; (3)&#160;what type or combination of types of Award will be granted; (4)&#160;the provisions of each Award granted (which need not be identical), including the time or times when a person will be permitted to receive an issuance of Common Stock or other payment pursuant to an Award (and whether and to what degree any applicable Performance Goals have been attained); (5)&#160;the number of shares of Common Stock or cash equivalent with respect to which an Award will be granted to each such person; (6)&#160;the Fair Market Value applicable to an Award; and (7)&#160;the terms of any Award with performance-based vesting that is not valued in whole or in part by reference to, or otherwise based on, the Common Stock, including the amount of cash payment or other property that may be earned and the timing of payment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for its administration.  The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or in any Award Agreement, in a manner and to the extent it deems necessary or expedient to make the Plan or Award fully effective.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">To settle all controversies regarding the Plan and Awards granted under it.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">To accelerate the time at which an Award may first be exercised or the time during which an Award or any part thereof will vest, notwithstanding the provisions in the Award Agreement stating the time at which it may first be exercised or the time during which it will vest.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">To prohibit the exercise of any Option, SAR or other exercisable Award during a period of up to&#160;30&#160;days prior to the consummation of any pending stock dividend, stock split, combination or exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Company assets to stockholders, or any other change affecting the shares of Common Stock or the share price of the Common Stock including any Change in Control, for reasons of administrative convenience or in connection with any other event pursuant to which the Board determines prohibition of exercise is necessary or reasonable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">To suspend or terminate the Plan at any time.  Suspension or termination of the Plan will not Materially Impair rights and obligations under any Award granted while the Plan is in effect except with the written consent of the affected Participant.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(vii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.8pt">To amend the Plan in any respect the Board deems necessary or advisable; provided, however, that stockholder approval will be required for any amendment to the extent required by Applicable Law.  Except as provided above, rights under any Award granted before amendment of the Plan will not be Materially Impaired by any amendment of the Plan unless (1)&#160;the Company requests the consent of the affected Participant, and (2)&#160;such Participant consents in writing.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(viii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.03pt">To submit any amendment to the Plan for stockholder approval.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ix)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">To institute and determine the terms and conditions of an Exchange Program; provided that the Board shall not implement an Exchange Program without stockholder approval.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(x)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; provided however, that, (1) the Board shall not, without stockholder approval, reduce the exercise or strike price of an Option or SAR (other than in connection with a Capitalization Adjustment) and, at any time when the exercise or strike price of an Option or SAR is above the Fair Market Value of a share of Common Stock, the Board shall not, without stockholder approval, cancel and re-grant or exchange such Option or SAR for a new Award with a lower (or no) purchase price or for cash, and (2) a Participant&#8217;s rights under any Award will not be Materially Impaired by any such amendment unless (A)&#160;the Company requests the consent of the affected Participant, and (B)&#160;such Participant consents in writing.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(xi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Plan or Awards.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(xii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.8pt">To adopt such procedures and sub-plans as are necessary or appropriate to permit and facilitate participation in the Plan by, or take advantage of specific tax treatment for Awards granted to, Employees, Directors or Consultants who are non-U.S.&#160;nationals or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Award Agreement to ensure or facilitate compliance with the laws of the relevant non-U.S.&#160;jurisdiction).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">Delegation to Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt">General</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Board may delegate some or all of the administration of the Plan to a Committee or Committees.  If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to another Committee or a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board.  Each Committee may retain the authority to concurrently administer the Plan with the Committee or subcommittee to which it has delegated its authority hereunder and may, at any time, revest in such Committee some or all of the powers previously delegated.  The Board will retain the authority to concurrently administer the Plan with any Committee and may, at any time, revest in the Board some or all of the powers previously delegated.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.8pt">Rule&#160;16b-3 Compliance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent an Award is intended to qualify for the exemption from Section&#160;16(b) of the Exchange Act that is available under Rule&#160;16b-3 of the Exchange Act, the Award will </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be granted by the Board or a Committee that consists solely of two or more Non-Employee Directors, as determined under Rule&#160;16b-3(b)(3) of the Exchange Act, and, thereafter, any action establishing or modifying the terms of the Award will be approved by the Board or a Committee meeting such requirements to the extent necessary for such exemption to remain available.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Effect of Board&#8217;s Decision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All determinations, interpretations and constructions made by the Board or any Committee in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">Delegation to an Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Board or any Committee may delegate to one or more Officers the authority to do one or both of the following (i)&#160;designate Employees who are not Officers to be recipients of Options and SARs (and, to the extent permitted by Applicable Law, other types of Awards) and, to the extent permitted by Applicable Law, the terms thereof, and (ii)&#160;determine the number of shares of Common Stock to be subject to such Awards granted to such Employees; provided, however, that the resolutions or charter adopted by the Board or any Committee evidencing such delegation will specify the total number of shares of Common Stock that may be subject to the Awards granted by such Officer and that such Officer may not grant an Award to himself or herself.  Any such Awards will be granted on the applicable form of Award Agreement most recently approved for use by the Board or the Committee, unless otherwise provided in the resolutions approving the delegation of authority.  Notwithstanding anything to the contrary herein, neither the Board nor any Committee may delegate to an Officer who is acting solely in the capacity of an Officer (and not also as a Director) the authority to determine the Fair Market Value.</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AX </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">W</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ITHHOLDING</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Withholding Authorization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  As a condition to acceptance of any Award under the Plan, a Participant authorizes withholding from payroll and any other amounts payable to such Participant, and otherwise agrees to make adequate provision for (including), any sums required to satisfy any U.S.&#160;and/or non-U.S.&#160;federal, state, or local tax or social insurance contribution withholding obligations of the Company or an Affiliate, if any, which arise in connection with the exercise, vesting or settlement of such Award, as applicable.  Accordingly, a Participant may not be able to exercise an Award even though the Award is vested, and the Company shall have no obligation to issue shares of Common Stock subject to an Award, unless and until such obligations are satisfied.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Satisfaction of Withholding Obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent permitted by the terms of an Award Agreement, the Company may, in its sole discretion, satisfy any U.S.&#160;and/or non-U.S.&#160;federal, state or local tax or social insurance withholding obligation relating to an Award by any of the following means or by a combination of such means: (i)&#160;causing the Participant to tender a cash payment; (ii)&#160;withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Award; (iii)&#160;withholding cash from an Award settled in cash; (iv)&#160;withholding payment from any amounts otherwise payable to the Participant; (v)&#160;by allowing a Participant to effectuate a &#8220;cashless exercise&#8221; pursuant to a program developed under Regulation&#160;T as promulgated by the U.S.&#160;Federal Reserve Board or (vi)&#160;by such other method as may be set forth in the Award Agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">No Obligation to Notify or Minimize Taxes; No Liability to Claims</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as required by Applicable Law, the Company has no duty or obligation to any Participant to advise such holder as to the time or manner of exercising such Award.  Furthermore, the Company has no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of an Award or a possible period in which the Award may not be exercised.  The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award and will not be liable to any holder of an Award for any adverse tax consequences to such holder in connection with an Award.  As a condition to accepting an Award under the Plan, each Participant (i)&#160;agrees not to make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates related to tax liabilities arising from such Award or other Company compensation and (ii)&#160;acknowledges that such Participant was advised to consult with his or her own personal tax, financial and other legal advisors regarding the tax consequences of the Award and has either done so or knowingly and voluntarily declined to do so.  Additionally, each Participant acknowledges any Option or SAR granted under the Plan is exempt from Section&#160;409A only if the exercise or strike price is at least equal to the &#8220;fair market value&#8221; of the Common Stock on the date of grant as determined by the Internal Revenue Service and there is no other impermissible deferral of compensation associated with the Award.  Additionally, as a condition to accepting an Option or SAR granted under the Plan, each Participant agrees not to make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates in the event that the U.S.&#160;Internal Revenue Service asserts that such exercise price or strike price is less than the &#8220;fair market value&#8221; of the Common Stock on the date of grant as subsequently determined by the U.S.&#160;Internal Revenue Service.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Withholding Indemnification</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  As a condition to accepting an Award under the Plan, in the event that the amount of the Company&#8217;s and/or its Affiliate&#8217;s withholding obligation in connection with such Award was greater than the amount actually withheld by the Company and/or its Affiliates, each Participant agrees to indemnify and hold the Company and/or its Affiliates harmless from any failure by the Company and/or its Affiliates to withhold the proper amount.</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ISCELLANEOUS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Source of Shares; Fractional Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market or otherwise.  No fractional shares of Common Stock will be issued or delivered pursuant to this Plan or any Award.  The Board may determine whether cash, other Awards or other securities or property will be issued or paid in lieu of such fractional shares or whether such fractional shares or any rights thereto will be forfeited or otherwise eliminated.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Use of Proceeds from Sales of Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Proceeds from the sale of shares of Common Stock pursuant to Awards will constitute general funds of the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">Corporate Action Constituting Grant of Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Corporate action constituting a grant by the Company of an Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant.  In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action approving the grant contain terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Stockholder Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares of Common Stock subject to such Award unless and until (i)&#160;such Participant has satisfied all requirements for exercise of the Award pursuant to its terms, if applicable, and (ii)&#160;the issuance of the Common Stock subject to such Award is reflected in the records of the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">No Employment or Other Service Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or affect the right of the Company or an Affiliate to terminate at will and without regard to any future vesting opportunity that a Participant may have with respect to any Award (i)&#160;the employment of an Employee with or without notice and with or without cause, (ii)&#160;the service of a Consultant pursuant to the terms of such Consultant&#8217;s agreement with the Company or an Affiliate or (iii)&#160;the service of a Director pursuant to the Bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the U.S.&#160;state or non-U.S.&#160;jurisdiction in which the Company or the Affiliate is incorporated, as the case may be.  Further, nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with any Award will constitute any promise or commitment by the Company or an Affiliate regarding the fact or nature of future positions, future work assignments, future compensation or any other term or condition of employment or service or confer any right or benefit under the Award or the Plan unless such right or benefit has specifically accrued under the terms of the Award Agreement and/or Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">f.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.17pt">Change in Time Commitment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event a Participant&#8217;s regular level of time commitment in the performance of his or her services for the Company and any Affiliates is reduced (for example, and without limitation, if the Participant is an Employee of the Company and the Employee has a change in status from a full-time Employee to a part-time Employee or takes an extended leave of absence) after the date of grant of any Award to the Participant, the Board may determine, to the extent permitted by Applicable Law and without the affected Participant&#8217;s consent, to (i)&#160;make a corresponding reduction in the number of shares or cash amount subject to any portion of such Award that is scheduled to vest or become payable after the date of such change in time commitment, and (ii)&#160;in lieu of or in combination with such a reduction, extend the vesting or payment schedule applicable to such Award.  In the event of any such reduction, the Participant will have no right with respect to any portion of the Award that is so reduced or extended.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Execution of Additional Documents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  As a condition to accepting an Award under the Plan, the Participant agrees to execute any additional documents or instruments necessary or desirable, as determined in the Plan </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Administrator&#8217;s sole discretion, to carry out the purposes or intent of the Award, or facilitate compliance with securities and/or other regulatory requirements, in each case at the Plan Administrator&#8217;s request.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">h.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Electronic Delivery and Participation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any reference herein or in an Award Agreement to a &#8220;written&#8221; agreement or document will include any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#8217;s intranet (or other shared electronic medium controlled by the Company to which the Participant has access).  By accepting any Award the Participant consents to receive documents by electronic delivery and to participate in the Plan through any on-line electronic system established and maintained by the Plan Administrator or another third party selected by the Plan Administrator.  The form of delivery of any Common Stock (e.g., a stock certificate or electronic entry evidencing such shares) shall be determined by the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.73pt">Clawback/Recovery</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other Applicable Law and any clawback policy that the Company otherwise adopts, to the extent applicable and permissible under Applicable Law.  In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of Cause.  No recovery of compensation under such a clawback policy will be an event giving rise to a Participant&#8217;s right to voluntarily terminate employment upon a &#8220;resignation for good reason,&#8221; or for a &#8220;constructive termination&#8221; or any similar term under any plan of or agreement with the Company or any of its Affiliates.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">j.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.17pt">Securities Law Compliance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant will not be issued any shares in respect of an Award unless either (i)&#160;the shares are registered under the Securities Act; or (ii)&#160;the Company has determined that such issuance would be exempt from the registration requirements of the Securities Act.  Each Award also must comply with other Applicable Law governing the Award, and a Participant will not receive such shares if the Company determines that such receipt would not be in material compliance with Applicable Law.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">k.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Transfer or Assignment of Awards; Issued Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as otherwise determined by the Board or expressly provided in the Plan or the form of Award Agreement, Awards granted under the Plan may not be transferred or assigned by the Participant.  After the vested shares subject to an Award have been issued, or in the case of Restricted Stock Awards and similar awards, after the issued shares have vested, the holder of such shares is free to assign, hypothecate, donate, encumber or otherwise dispose of any interest in such shares provided that any such actions are in compliance with the provisions herein, the terms of the Trading Policy and Applicable Law.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">l.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.73pt">Effect on Other Employee Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The value of any Award granted under the Plan, as determined upon grant, vesting or settlement, shall not be included as compensation, earnings, salaries, or other similar terms used when calculating any Participant&#8217;s benefits under any employee benefit plan sponsored by the Company or any Affiliate, except as such plan otherwise expressly provides.  The Company expressly reserves its rights to amend, modify, or terminate any of the Company&#8217;s or any Affiliate&#8217;s employee benefit plans.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">m.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.17pt">Deferrals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent permitted by Applicable Law, the Board, in its sole discretion, may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may establish programs and procedures for deferral elections to be made by Participants.  Deferrals will be made in accordance with the requirements of Section&#160;409A.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">n.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Section&#160;409A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless otherwise expressly provided for in an Award Agreement, the Plan and Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section&#160;409A, and, to the extent not so exempt, in compliance with the requirements of Section&#160;409A.  If the Board determines that any Award granted hereunder is not exempt from and is therefore subject to Section&#160;409A, the Award Agreement evidencing such Award will incorporate the terms and conditions necessary to avoid the consequences specified in Section&#160;409A(a)(1) of the Code, and to the extent an Award Agreement is silent on terms necessary for compliance, such terms are hereby incorporated by reference into the Award Agreement.  Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded, and if a Participant holding an Award that constitutes &#8220;deferred compensation&#8221; under Section&#160;409A is a &#8220;specified employee&#8221; for purposes of Section&#160;409A, no distribution or payment of any amount that is due </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">because of a &#8220;separation from service&#8221; (as defined in Section&#160;409A without regard to alternative definitions thereunder) will be issued or paid before the date that is six months and one day following the date of such Participant&#8217;s &#8220;separation from service&#8221; or, if earlier, the date of the Participant&#8217;s death, unless such distribution or payment can be made in a manner that complies with Section&#160;409A, and any amounts so deferred will be paid in a lump sum on the day after such six month period elapses, with the balance paid thereafter on the original schedule.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">o.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Choice of Law</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Plan and any controversy arising out of or relating to this Plan shall be governed by, and construed in accordance with, the internal laws of the State of Delaware, without regard to conflict of law principles that would result in any application of any law other than the law of the State of Delaware.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">p.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Data Privacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  As a condition of receipt of any Award, each Participant explicitly and unambiguously acknowledges that the Company and its Affiliates will process certain personal information about the Participant in accordance with the provisions of the Company&#8217;s privacy notice, a copy of which can be obtained by the Participant by contacting his or her local human resources representative.  Such personal information may include, but is not limited to, the Participant&#8217;s name, home address, email address and telephone number, date of birth, social security or insurance number, passport number or other identification number, salary, nationality, job title, any shares or directorships held in the Company, and details of all Awards or any other entitlement to shares of Common Stock awarded, canceled, exercised, vested, unvested or outstanding in Participant&#8217;s favor (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), for the exclusive purpose of implementing, administering and managing the Plan.  In certain jurisdictions, the Participant&#8217;s consent is required in order for the parties to process Participant&#8217;s personal information for the purpose of implementing, administering and managing Participant&#8217;s participation in the Plan pursuant to and in accordance with his or her Award Agreement.  Where such consent is required and without limiting any other specific consent provided by the Participant, including in any consent provided in a separate document, the Participant explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant&#8217;s personal data as described herein and any other applicable Award grant materials by and among, as applicable, the Company or any of its Affiliates for the exclusive purpose of implementing, administering and managing the Participant&#8217;s participation in the Plan.  The Participant understands that Data will be transferred to a stock plan service provider as may be selected by the Company from time-to-time (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Designated Broker</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), which is assisting the Company with the implementation, administration and management of the Plan.  The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient&#8217;s country of operation may have different data privacy laws and protections than the Participant&#8217;s country.  The Participant understands that if he or she resides outside the United States, he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative.  The Participant authorizes (where such authorization is required) the Company, the Designated Broker and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing his or her participation in the Plan.  The Participant understands that Data will be held only as long as is necessary to implement, administer and manage his or her participation in the Plan.  The Participant understands that if he or she resides outside the United States, he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or, where applicable, refuse or withdraw the consents herein, in any case without cost, by contacting in writing his or her local human resources representative.  Further, the Participant understands that where his or her consent is required by applicable law, he or she is providing the consents on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke his or her consent, his or her status as an Employee, Consultant or Director and career with the Company and its Affiliates will not be adversely affected; the only adverse consequence of refusing or withdrawing the Participant&#8217;s consent is that the Company would not be able to grant Awards to the Participant or administer or maintain such Awards.  Therefore, the Participant understands that refusing or withdrawing his or her consent may affect the Participant&#8217;s ability to participate in the Plan.  For more information on the consequences of the Participant&#8217;s refusal to consent or withdrawal of consent, the Participant understands that he or she may contact his or her local human resources representative.</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OMPLIANCE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> W</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ITH </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">L</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">AW</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will seek to obtain from each regulatory commission or agency, as may be deemed necessary, having jurisdiction over the Plan such authority as may be required to grant Awards and to issue and sell shares of Common Stock upon exercise or vesting of the Awards; provided, however, that this undertaking will not require the Company to register under the Securities Act the Plan, any Award or any Common Stock issued or issuable pursuant to any such Award.  If, after reasonable efforts and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary or advisable for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for failure to issue and sell </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common Stock upon exercise or vesting of such Awards unless and until such authority is obtained.  A Participant is not eligible for the grant of an Award or the subsequent issuance of Common Stock pursuant to the Award if such grant or issuance would be in violation of any Applicable Law.</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">EVERABILITY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If all or any part of the Plan or any Award Agreement is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity shall not invalidate any portion of the Plan or such Award Agreement not declared to be unlawful or invalid.  Any Section of the Plan or any Award Agreement (or part of such a Section) so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid.</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ERMINATION OF THE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">LAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board may suspend or terminate the Plan at any time.  No Incentive Stock Options may be granted after the tenth anniversary of the Effective Date.  No Awards may be granted under the Plan while the Plan is suspended or after it is terminated.</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt">D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">EFINITIONS.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in the Plan, the following definitions apply to the capitalized terms indicated below:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt"> &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Affiliate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule&#160;405 promulgated under the Securities Act.  The Board may determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Applicable Law</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Code and any applicable U.S.&#160;or non-U.S.&#160;securities, federal, state, material local or municipal or other law, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, listing rule, regulation, judicial decision, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body (including under the authority of any applicable self-regulating organization such as The Nasdaq Stock Market LLC, the New York Stock Exchange or the Financial Industry Regulatory Authority, Inc.).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any right to receive Common Stock, cash or other property granted under the Plan (including an Incentive Stock Option, a Nonstatutory Stock Option, a Restricted Stock Award, a RSU Award, a SAR or any Other Award).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Award Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a written agreement between the Company and a Participant evidencing the terms and conditions of an Award.  The Award Agreement generally consists of the Grant Notice and the agreement containing the written summary of the general terms and conditions applicable to the Award and which is provided to a Participant along with the Grant Notice.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the board of directors of the Company (or its designee).  Any decision or determination made by the Board shall be a decision or determination that is made in the sole discretion of the Board (or its designee), and such decision or determination shall be final and binding on all Participants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:26.01pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalization Adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any change that is made in, or other events that occur with respect to, the Common Stock subject to the Plan or subject to any Award after the Effective Date without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification Topic&#160;718 (or any successor thereto).  Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cause</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning ascribed to such term in any written agreement between the Participant and the Company defining such term and, in the absence of such agreement, such term means, with respect to a Participant, the occurrence of any of the following events: (i)&#160;the Participant&#8217;s theft, dishonesty, willful misconduct, breach </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of fiduciary duty for personal profit, or intentional falsification of any Company or Affiliate documents or records; (ii)&#160;the Participant&#8217;s material failure to abide by the Company&#8217;s Code of Conduct or other policies (including, without limitation, policies relating to confidentiality and reasonable workplace conduct and policies of any Affiliate, as applicable); (iii)&#160;the Participant&#8217;s unauthorized use, misappropriation, destruction or diversion of any tangible or intangible asset or corporate opportunity of the Company or any of its Affiliates (including, without limitation, the Participant&#8217;s improper use or disclosure of Company or Affiliate confidential or proprietary information); (iv)&#160;any intentional act by the Participant which has a material detrimental effect on the Company&#8217;s or its Affiliate&#8217;s reputation or business; (v)&#160;the Participant&#8217;s repeated failure or inability to perform any reasonable assigned duties after written notice from the Company (or its Affiliate, as applicable) of, and a reasonable opportunity to cure, such failure or inability; (vi)&#160;any material breach by the Participant of any employment or service agreement between the Participant and the Company (or its Affiliate, as applicable), which breach is not cured pursuant to the terms of such agreement; or (vii)&#160;the Participant&#8217;s conviction (including any plea of guilty or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nolo contendere</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) of any criminal act involving fraud, dishonesty, misappropriation or moral turpitude, or which impairs the Participant&#8217;s ability to perform his or her duties with the Company (or its Affiliate, as applicable).  The determination that a termination of the Participant&#8217;s Continuous Service is either for Cause or without Cause will be made by the Board with respect to Participants who are executive officers of the Company or members of the Board and by the Company&#8217;s Chief Executive Officer or his or her designee with respect to all other Participants.  Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Awards held by such Participant will have no effect upon any determination of the rights or obligations of the Company or such Participant for any other purpose.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;  means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events; provided, however, to the extent necessary to avoid adverse personal income tax consequences to the Participant in connection with an Award, also constitutes a Section&#160;409A Change in Control:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than&#160;50% of the combined voting power of the Company&#8217;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction.  Notwithstanding the foregoing, a Change in Control shall not be deemed to occur (A)&#160;on account of the acquisition of securities of the Company directly from the Company, (B)&#160;on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person that acquires the Company&#8217;s securities in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, or (C)&#160;solely because the level of Ownership held by any Exchange Act Person (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subject Person</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change in Control shall be deemed to occur;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own, directly or indirectly, either (A)&#160;outstanding voting securities representing more than&#160;50% of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B)&#160;more than&#160;50% of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">the stockholders of the Company approve or the Board approves a plan of complete dissolution or liquidation of the Company, or a complete dissolution or liquidation of the Company shall otherwise occur, except for a liquidation into a parent corporation;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, at least&#160;50% of the combined voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition; or</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">during any period of 12 consecutive months, individuals who, on the date the Plan is adopted by the Board, are members of the Board (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incumbent Board</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) cease for any reason to constitute at least a majority of the members of the Board; provided, however, that if the appointment or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member shall, for purposes of this Plan, be considered as a member of the Incumbent Board and that no individual initially elected or nominated as a member of the Board as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of any person other than the Board (a &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proxy Contest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), including by reason of any agreement intended to avoid or settle any Proxy Contest, shall be considered to be a member of the Incumbent Board.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing or any other provision of this Plan, (A)&#160;the term Change in Control shall not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company, and (B)&#160;the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant shall supersede the foregoing definition with respect to Awards subject to such agreement; provided, however, that if no definition of Change in Control or any analogous term is set forth in such an individual written agreement, the foregoing definition shall apply.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the U.S.&#160;Internal Revenue Code of&#160;1986, as amended, including any applicable regulations and guidance thereunder.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Compensation Committee and any other committee of one or more Directors to whom authority has been delegated by the Board or Compensation Committee in accordance with the Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(k)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the common stock, par value $0.001 per share, of the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(l)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means CareDx, Inc., a Delaware corporation, and any successor corporation thereto.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(m)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.01pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Compensation Committee of the Board.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(n)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consultant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person, including an advisor, who is (i)&#160;engaged by the Company or an Affiliate to render consulting or advisory services and is compensated for such services, or (ii)&#160;serving as a member of the board of directors of an Affiliate and is compensated for such services.  However, service solely as a Director, or payment of a fee for such service, will not cause a Director to be considered a &#8220;Consultant&#8221; for purposes of the Plan.  Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only if a Registration Statement on Form&#160;S-8 under the Securities Act is available to register either the offer or the sale of the Company&#8217;s securities to such person.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(o)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Continuous Service</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means that the Participant&#8217;s service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated.  A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Director or Consultant or a change in the Entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#8217;s service with the Company or an Affiliate, will not terminate a Participant&#8217;s Continuous Service; provided, however, that if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, such Participant&#8217;s Continuous Service will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate.  For example, a change in status from an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of Continuous Service.  To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#8217;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i)&#160;any leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii)&#160;transfers between the Company, an Affiliate, or their successors.  Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in an Award only to such extent as may be provided in the Company&#8217;s leave of absence policy, in the written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law.  In addition, to the extent required for exemption from or compliance with Section&#160;409A, the determination of whether there has been a termination of Continuous Service will be made, and such term will be construed, in a manner that is consistent with the definition of &#8220;separation from service&#8221; as defined under U.S.&#160;Treasury Regulation&#160;Section&#160;1.409A-1(h) (without regard to any alternative definition thereunder).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(p)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">determine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">determined</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means as determined by the Board or the Committee (or its designee) in its sole discretion.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(q)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Director</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a member of the Board.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(r)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to a Participant, such Participant is unable to engage in any substantial gainful activity after accounting for reasonable accommodations (if applicable and required by Applicable Law) by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than&#160;12&#160;months, as provided in Section&#160;22(e)(3) of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(s)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.45pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effective Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;&#160;means the date on which the Company&#8217;s stockholders approve the adoption of the Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(t)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person employed by the Company or an Affiliate.  However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#8220;Employee&#8221; for purposes of the Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(u)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company or the Affiliate that employs the Participant.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a corporation, partnership, limited liability company or other entity.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(w)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exchange Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the U.S.&#160;Securities Exchange Act of&#160;1934, as amended, and the rules and regulations promulgated thereunder.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(x)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exchange Act Person</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any natural person, Entity or &#8220;group&#8221; (within the meaning of Section&#160;13(d) or&#160;14(d) of the Exchange Act), except that &#8220;Exchange Act Person&#8221; will not include (i)&#160;the Company or any Subsidiary of the Company, (ii)&#160;any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii)&#160;an underwriter temporarily holding securities pursuant to a registered public offering of such securities, (iv)&#160;an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company; or (v)&#160;any natural person, Entity or &#8220;group&#8221; (within the meaning of Section&#160;13(d) or&#160;14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more than&#160;50% of the combined voting power of the Company&#8217;s then outstanding securities.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(y)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exchange Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a program subject to stockholder approval as set forth in Section 7(b)(ix) under which (i)&#160;outstanding Awards are surrendered or cancelled in exchange for awards of the same type (which may have higher or lower exercise prices and different terms), awards of a different type, and/or cash, (ii)&#160;Participants would have the opportunity to transfer any outstanding Awards to a financial institution or other person or entity selected by the Board or the Committee, and/or (iii) the exercise price of an outstanding Award is increased or reduced. The Board or the Committee will determine the terms and conditions of any Exchange Program in its sole discretion.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(z)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Market Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, as of any date, unless otherwise determined by the Board, the value of the Common Stock (as determined on a per share or aggregate basis, as applicable) determined as follows:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">if the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value will be the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported in a source the Board deems reliable;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">if there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists; or</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">in the absence of such markets for the Common Stock, or if otherwise determined by the Board, the Fair Market Value will be determined by the Board in good faith and in a manner that complies with Sections&#160;409A and&#160;422 of the Code.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(aa)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governmental Body</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any: (a)&#160;nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature; (b)&#160;U.S.&#160;or non-U.S.&#160;federal, state, local, municipal, or other government; (c)&#160;governmental or regulatory body, or quasi-governmental body of any nature (including any governmental division, department, administrative agency or bureau, commission, authority, instrumentality, official, ministry, fund, foundation, center, organization, unit, body or Entity and any court or other tribunal, and for the avoidance of doubt, any tax authority) or other body exercising similar powers or authority; or (d)&#160;self-regulatory organization (including The Nasdaq Stock Market LLC, the New York Stock Exchange, and the Financial Industry Regulatory Authority, Inc.).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(bb)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.22pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Grant Notice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the notice provided to a Participant that he or she has been granted an Award under the Plan and which includes the name of the Participant, the type of Award, the date of grant of the Award, number of shares of Common Stock subject to the Award or potential cash payment right, (if any), the vesting schedule for the Award (if any) and other key terms applicable to the Award.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(cc)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:20.48pt">&#8239;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incentive Stock Option</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an option granted pursuant to Section&#160;4 of the Plan that is intended to be, and qualifies as, an &#8220;incentive stock option&#8221; within the meaning of Section&#160;422 of the Code.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dd)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.22pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Materially Impair</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any amendment to the terms of the Award that materially adversely affects the Participant&#8217;s rights under the Award.  A Participant&#8217;s rights under an Award will not be deemed to have been Materially Impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially impair the Participant&#8217;s rights.  For example, the following types of amendments to the terms of an Award do not Materially Impair the Participant&#8217;s rights under the Award: (i)&#160;imposition of reasonable restrictions on the minimum number of shares subject to an Option that may be exercised; (ii)&#160;to maintain the qualified status of the Award as an Incentive Stock Option under Section&#160;422 of the Code; (iii)&#160;to change the terms of an Incentive Stock Option in a manner that disqualifies, impairs or otherwise affects the qualified status of the Award as an Incentive Stock Option under Section&#160;422 of the Code; (iv)&#160;to clarify the manner of exemption from, or to bring the Award into compliance with or qualify it for an exemption from, Section&#160;409A; or (v)&#160;to comply with other Applicable Laws.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ee)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.48pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Employee Director</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Director who either (i)&#160;is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item&#160;404(a) of Regulation&#160;S-K promulgated pursuant to the Securities Act (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulation&#160;S-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)), does not possess an interest in any other transaction for which disclosure would be required under Item&#160;404(a) of Regulation&#160;S-K, and is not engaged in a business relationship for which disclosure would be required pursuant to Item&#160;404(b) of Regulation&#160;S-K; or (ii)&#160;is otherwise considered a &#8220;non-employee director&#8221; for purposes of Rule&#160;16b-3.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ff)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonstatutory Stock Option</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any option granted pursuant to Section&#160;4 of the Plan that does not qualify as an Incentive Stock Option.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(gg)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a person who is an officer of the Company within the meaning of Section&#160;16 of the Exchange Act.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(hh)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.22pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an award valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof (e.g., options or stock rights with an exercise price or strike price less than&#160;100% of the Fair Market Value at the time of grant) that is not an Incentive Stock Option, Nonstatutory Stock Option, SAR, Restricted Stock Award or RSU Award.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(jj)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Award Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a written agreement between the Company and a holder of an Other Award evidencing the terms and conditions of an Other Award grant.  Each Other Award Agreement will be subject to the terms and conditions of the Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(kk)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.22pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Own,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Owned,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Owner,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ownership</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means that a person or Entity will be deemed to &#8220;Own,&#8221; to have &#8220;Owned,&#8221; to be the &#8220;Owner&#8221; of or to have acquired &#8220;Ownership&#8221; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ll)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Employee, Director or Consultant to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Award.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(mm)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.68pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the one or more criteria that the Board will select for purposes of establishing the Performance Goals for a Performance Period.  The Performance Criteria that will be used to establish such Performance Goals may include (but is not limited to) any one of, or combination of, the following as determined by the Board: earnings (including earnings per share and net earnings); earnings before interest, taxes and depreciation; earnings before interest, taxes, depreciation and amortization; total stockholder return; return on equity or average stockholder&#8217;s equity; return on assets, investment, or capital employed; stock price; margin (including gross margin); income (before or after taxes); operating income; operating income after taxes; pre-tax profit; operating cash flow; sales or revenue targets; increases in revenue or product revenue; expenses and cost reduction goals; improvement in or attainment of working capital levels; economic value added (or an equivalent metric); market share; cash flow; cash flow per share; share price performance; debt reduction; customer satisfaction; stockholders&#8217; equity; capital expenditures; debt levels; operating profit or net operating profit; workforce diversity; growth of net income or operating income; billings; pre-clinical development related compound goals; financing; regulatory milestones, including approval of a compound; stockholder liquidity; corporate governance and compliance; product commercialization; intellectual property; personnel matters; progress of internal research or clinical programs; progress of partnered programs; partner satisfaction; budget management; clinical achievements; completing phases of a clinical study (including the treatment phase); announcing or presenting preliminary or final data from clinical studies; in each case, whether on particular timelines or generally; timely completion of clinical trials; submission of INDs and NDAs and other regulatory achievements; partner or collaborator achievements; internal controls, including those related to the Sarbanes-Oxley Act of&#160;2002; research progress, including the development of programs; investor relations, analysts and communication; manufacturing achievements (including obtaining particular yields from manufacturing runs and other measurable objectives related to process development activities); strategic partnerships or transactions (including in-licensing and out-licensing of intellectual property; establishing relationships with commercial entities with respect to the marketing, distribution and sale of the Company&#8217;s products (including with group purchasing organizations, distributors and other vendors)); supply chain achievements (including establishing relationships with manufacturers or suppliers of active pharmaceutical ingredients and other component materials and manufacturers of the Company&#8217;s products); co-development, co-marketing, profit sharing, joint venture or other similar arrangements; individual performance goals; corporate development and planning goals; and other measures of performance selected by the Board.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(nn)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.22pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Goals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, for a Performance Period, the one or more goals established by the Board for the Performance Period based upon the Performance Criteria.  Performance Goals may be based on a Company-wide basis, with respect to one or more business units, divisions, Affiliates, or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices.  Unless specified otherwise by the Board (i)&#160;in the Award Agreement at the time the Award is granted or (ii)&#160;in such other document setting forth the Performance Goals at the time the Performance Goals are established, the Board will appropriately make adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows: (1)&#160;to exclude restructuring and/or other nonrecurring charges; (2)&#160;to exclude exchange rate effects; (3)&#160;to exclude the effects of changes to generally accepted accounting principles; (4)&#160;to exclude the effects of any statutory adjustments to corporate tax rates; (5)&#160;to exclude the effects of items that are &#8220;unusual&#8221; in nature or occur &#8220;infrequently&#8221; as determined under generally accepted accounting principles; (6)&#160;to exclude the dilutive effects of acquisitions or joint ventures; (7)&#160;to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such divestiture; (8)&#160;to exclude the effect of any change in the outstanding shares of Common Stock of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends; (9)&#160;to exclude the effects of stock based compensation and the award of bonuses under the Company&#8217;s bonus plans; (10)&#160;to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; and (11)&#160;to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting principles.  In addition, the Board retains the discretion to reduce or eliminate the compensation or economic benefit due upon attainment of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for such Performance Period.  Partial achievement of the specified criteria may result in the payment or vesting corresponding to the degree of achievement as specified in the Award Agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(oo)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period of time selected by the Board over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vesting or exercise of an Award.  Performance Periods may be of varying and overlapping duration, at the sole discretion of the Board.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(pp)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.22pt"> &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means this CareDx, Inc. 2024 Equity Incentive Plan, as amended from time to time.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(qq)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.22pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan Administrator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the person, persons, and/or third-party administrator designated by the Company to administer the day-to-day operations of the Plan and the Company&#8217;s other equity incentive programs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(rr)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.48pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Post-Termination Exercise Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period following termination of a Participant&#8217;s Continuous Service within which an Option or SAR is exercisable, as specified in Section&#160;4(h).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.56pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award of shares of Common Stock granted pursuant to the terms and conditions of Section&#160;5(a).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(tt)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Award Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant.  The Restricted Stock Award Agreement includes the Grant Notice for the Restricted Stock Award and the agreement containing the written summary of the general terms and conditions applicable to the Restricted Stock Award and which is provided to a Participant along with the Grant Notice.  Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(uu)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.22pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSU Award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSU</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award of restricted stock units representing the right to receive an issuance of shares of Common Stock which is granted pursuant to the terms and conditions of Section&#160;5(a).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(vv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSU Award Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a written agreement between the Company and a holder of a RSU Award evidencing the terms and conditions of a RSU Award.  The RSU Award Agreement includes the Grant Notice for the RSU Award and the agreement containing the written summary of the general terms and conditions applicable to the RSU Award and which is provided to a Participant along with the Grant Notice.  Each RSU Award Agreement will be subject to the terms and conditions of the Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ww)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.9pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rule&#160;16b-3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Rule&#160;16b-3 promulgated under the Exchange Act or any successor to Rule&#160;16b-3, as in effect from time to time.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(xx)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rule&#160;405</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Rule&#160;405 promulgated under the Securities Act.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(yy)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Section&#160;409A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Section&#160;409A of the Code and the regulations and other guidance thereunder.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(zz)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.48pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Section&#160;409A Change in Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a change in the ownership or effective control of the Company, or in the ownership of a substantial portion of the Company&#8217;s assets, as provided in Section&#160;409A(a)(2)(A)(v) of the Code and Treasury Regulations&#160;Section&#160;1.409A-3(i)(5) (without regard to any alternative definition thereunder).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(aaa)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.34pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the U.S.&#160;Securities Act of&#160;1933, as amended.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(bbb)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.66pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a share of Common Stock, as adjusted in accordance with Section&#160;6 of the Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ccc)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.05pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Reserve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the number of shares available for issuance under the Plan as set forth in Section&#160;2(a).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ddd)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.66pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Appreciation Right</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SAR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a right to receive the appreciation on Common Stock that is granted pursuant to the terms and conditions of Section&#160;4.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(eee)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.05pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to the Company, (i)&#160;any corporation of which more than&#160;50% of the outstanding Common Stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii)&#160;any partnership, limited liability company or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than&#160;50%.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(fff)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.35pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ten Percent Stockholder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a person who Owns (or is deemed to Own pursuant to Section&#160;424(d) of the Code) stock possessing more than&#160;10% of the total combined voting power of all classes of stock of the Company or any Affiliate.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ggg)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.34pt">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trading Policy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s policy permitting certain individuals to sell Company shares only during certain &#8220;window&#8221; periods and/or otherwise restricts the ability of certain individuals to transfer or encumber Company shares, as in effect from time to time.</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adopted by the Board of Directors (contingent on approval by the Stockholders) on April 24, 2024</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Approved by the Stockholders on [&#9679;], 2024</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-21</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>cdna-20240429.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:e535fb6e-fa63-4a06-988b-b27d43a4689d,g:0fcc6b31-711c-45cb-b6dc-ed4481561477-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cdna="http://caredxinc.com/20240429" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://caredxinc.com/20240429">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cdna-20240429_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cdna-20240429_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cdna-20240429_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cdna_DrSeetoMember" abstract="true" name="DrSeetoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="cdna_Mr.JohnsonMember" abstract="true" name="Mr.JohnsonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cdna_DrMaagMember" abstract="true" name="DrMaagMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="cdna_TotalEquityCompensationActuallyPaidAdjustmentMember" abstract="true" name="TotalEquityCompensationActuallyPaidAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>cdna-20240429_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:e535fb6e-fa63-4a06-988b-b27d43a4689d,g:0fcc6b31-711c-45cb-b6dc-ed4481561477-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_cdna_TotalEquityCompensationActuallyPaidAdjustmentMember_90af03b8-4f92-45b6-b11a-1c2e388b1004" xlink:href="cdna-20240429.xsd#cdna_TotalEquityCompensationActuallyPaidAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_cdna_TotalEquityCompensationActuallyPaidAdjustmentMember_90af03b8-4f92-45b6-b11a-1c2e388b1004" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_cdna_Mr.JohnsonMember_de01c197-2488-4722-8fcf-a8afa5222fd1" xlink:href="cdna-20240429.xsd#cdna_Mr.JohnsonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_cdna_Mr.JohnsonMember_de01c197-2488-4722-8fcf-a8afa5222fd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cdna_DrSeetoMember_935f8686-de04-4703-ae17-4f69924f78bb" xlink:href="cdna-20240429.xsd#cdna_DrSeetoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_cdna_DrSeetoMember_935f8686-de04-4703-ae17-4f69924f78bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cdna_DrMaagMember_71a43392-962f-4bb5-abab-2ba1c762fd78" xlink:href="cdna-20240429.xsd#cdna_DrMaagMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_cdna_DrMaagMember_71a43392-962f-4bb5-abab-2ba1c762fd78" xlink:type="arc" order="4"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cdna-20240429_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:e535fb6e-fa63-4a06-988b-b27d43a4689d,g:0fcc6b31-711c-45cb-b6dc-ed4481561477-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_cdna_DrSeetoMember_label_en-US" xlink:label="lab_cdna_DrSeetoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dr. Seeto [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cdna_DrSeetoMember" xlink:href="cdna-20240429.xsd#cdna_DrSeetoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cdna_DrSeetoMember" xlink:to="lab_cdna_DrSeetoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cdna_TotalEquityCompensationActuallyPaidAdjustmentMember_label_en-US" xlink:label="lab_cdna_TotalEquityCompensationActuallyPaidAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Equity Compensation Actually Paid Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cdna_TotalEquityCompensationActuallyPaidAdjustmentMember" xlink:href="cdna-20240429.xsd#cdna_TotalEquityCompensationActuallyPaidAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cdna_TotalEquityCompensationActuallyPaidAdjustmentMember" xlink:to="lab_cdna_TotalEquityCompensationActuallyPaidAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cdna_DrMaagMember_label_en-US" xlink:label="lab_cdna_DrMaagMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dr. Maag [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cdna_DrMaagMember" xlink:href="cdna-20240429.xsd#cdna_DrMaagMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cdna_DrMaagMember" xlink:to="lab_cdna_DrMaagMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cdna_Mr.JohnsonMember_label_en-US" xlink:label="lab_cdna_Mr.JohnsonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mr. Johnson [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cdna_Mr.JohnsonMember" xlink:href="cdna-20240429.xsd#cdna_Mr.JohnsonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cdna_Mr.JohnsonMember" xlink:to="lab_cdna_Mr.JohnsonMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cdna-20240429_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:e535fb6e-fa63-4a06-988b-b27d43a4689d,g:0fcc6b31-711c-45cb-b6dc-ed4481561477-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_cdna_TotalEquityCompensationActuallyPaidAdjustmentMember" xlink:href="cdna-20240429.xsd#cdna_TotalEquityCompensationActuallyPaidAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_cdna_TotalEquityCompensationActuallyPaidAdjustmentMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_cdna_Mr.JohnsonMember" xlink:href="cdna-20240429.xsd#cdna_Mr.JohnsonMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_cdna_Mr.JohnsonMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_cdna_DrSeetoMember" xlink:href="cdna-20240429.xsd#cdna_DrSeetoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_cdna_DrSeetoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_cdna_DrMaagMember" xlink:href="cdna-20240429.xsd#cdna_DrMaagMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_cdna_DrMaagMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>cdna-20240429_g1.jpg
<TEXT>
begin 644 cdna-20240429_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !P ' # 2(  A$! Q$!_\0
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7%E.V:P*<Y'L$=?2LK?ZAT-5@9ED__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>cdna-20240429_g10.jpg
<TEXT>
begin 644 cdna-20240429_g10.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !R ' # 2(  A$! Q$!_\0
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MUE]E86VZA0RE25#8@C!!K-57'V:?;08TD[&X1ZYN!;M$IX(T]<I"SRQ75?\
M2+4?NMJ.Z#\*B1T(Q:/C<['/I6@TT8+6 HHZT4PP5Y7M,CVQ^.:^ 7 J]7^$
MOEOTQ2;9:A^S(=!\?\" M?\ "*=+/"'.=QN[<G"O@5>7K'=KE*O.H6,=_:K(
MP'W(Y(SRN+*DH0K'PE6=^E1GXA_:P2933K.@="]P-P)^HWN90]PRV<?BHBH
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M5GXR3M\JVI<^0TRIJ.GE"NKJ@!2?*1\3BG%9\OZU!L<O*^T _P"4?7_[D/\
M]QFJ;VNKOUHHJ-712CP_?1\D_P JW>JC\J**N1(Q2Q_NS@_\?^HJZCLODI[,
M6DPDX'*]T_SW:**IN]$T+S2JU*NP!42"VK8G_$*IC[7$EZ;VIN))D.K?(OTA
M(+JBK 22$C?R   ] ***%TQ*78W-U2!"D;#[@'YUF;_O/G116@B!F4=T_OBN
E9,_XM?\ E_ZT44[Z)B-NJU*D*25$IQT)VH0 &MAY4450QC__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>cdna-20240429_g11.jpg
<TEXT>
begin 644 cdna-20240429_g11.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBN7^+WQF^''P&\%7'Q&^*^OOI6AV947FI?V?//';[F"*9/)1
MR@+,JY; R0,T =117EWA_P#;0_9H\1W_ (>TZW^):V3^+55O"LFN:1>:=%K
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M^+FF0_#_ ,/7.A:)K>C^/OMC70UATL5BCM(/W<8MIF+E"&9MLCQ=5*E_9_\
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M'P672_&NC^.Y_B=XHOKO1=#?2H8KZ>U>*>!VB>0R@6X9I&:"(F0$-\O! )!
M/D3_ ()[?M'?&;5?CCI?[%/[4FC74?Q"^%UGJ*'5IB775--,<*0RES]]@"F)
M/^6B.C'YMYJ+_@J=HVE>'/VI?V-_#VA6$=K8V'Q*CM[.UA7"0Q)?:,J(H[ *
M !]*^R]2^"GPZU3XR:7\?)M#5/%.DZ-<:5!J4)VM+9S.CM%)Q\X5T#+G[I9\
M?>.>-_: _8Q^&/[2?Q"\'_$SXA>(_$,6H^ M2&H>%5TR\ABBLKGS(9#+M,+&
M0E[>(X<L/EP  2" >IV.BZ3IM[>ZE8:?%#/J,RS7TJ+@SR+&L:LWJ0B(N?10
M.U?#D_\ RGVA_P"R6'_T2U?=5O$\-ND,EP\S(@5I9 H9R!]X[0!D]> !Z 5Y
M%)^Q9\-)/VH!^UZ?%?B0>,ELOL2RB[M_LPM-NSR/*\C&W!Z_?[[L\T ?-/[9
MO[&7CSQ?XB\0?MJ_LI2RZ?\ %KP!XSGGC2S7+:W9QVT!: ITDD52X"G_ %B,
M\1#90#I/@_\ M/:9^U_^P/\ 'OXWV6A2:7<WOAW5+?5M.D!Q;WD/AR!)E0G[
MR;AE2>=I&<'(KZJ^'/PPA^'%SK-S;^,]:U4ZYJKZA=+J\D#".=U56,?E1(57
M"*-O(&. ,G/.2?LH?">V\&>/_ 7AB"\T+3OB7J%U>^*8M(>-/-EN;5+:X\O?
M&PB\Q(P6*C.]F8$$T ?"_P .]'\-:Q_P;LWR^*(8FBMK+4;BT>4#,=RFNRF$
MJ3T8OM7CKN([URG[5>M^.?$?_!-3]E+7/B++<2:E)XMLU:>Z)+R6ZK,ML[$\
MDM L39/)SFOM[PO_ ,$V_P!GOP_\*-*^ FJ:GXHUSP'HU^U[9^#]7UD?8FG,
MK39E\F..2=?-8OY<KM'G^&N\_:'_ &6/@Q^T]\*4^#?Q1\-,VCVTT4^EG3)?
MLTNFS1*5CEMV48C959E P5VD@@CB@"?XQ<^/OA8O<^/9\?AH.KG^0KXV^+&B
M?MN?L,?%CQ_^T_\ LMIIWQ-^$_BKQ/?ZUXQ\)SDFYTZ[21HKUEQ\XV/$Z;X]
MX"Q@21$1AC]E^ ?@3;^$-4L==\4?$_Q5XROM)MVAT>Z\575LYL@R['95MH(4
M>5ERIFD5Y=K,H<!W#8=M^R7X=TC3_$VA^%OBOXUTC3/&&K:AJ.OZ9::E;R12
MS7LSRW'E&>WD>U5O,9<0-'C[WW\N0#BV\7?"OXJ?\$W=?^,/PG\*'2=,UCX*
M7EK96DJ_O;6UMK&Z2.U8_P 0B9IE!Z')/>N5_P"",NBZ3K'_  3F^'TFJ:?%
M.UEJNJW-HTBY,4JZC= .OH<,PSZ,1WKZ!U3X"^ ;CX&2?LZ>'8+C0/"[Z"VB
MK::,R*\=BT1B:)6E5\$HQ!?[^3NW9YK/_9P_9I\$_LL_"F+X,_"[7=9_L.U>
M9].BU*>&:2S:5WD<H_E MEW+8?< >G'% 'YN?#KX^?$+]G3_ (;6\<>#?A"G
MBJTG^)%S8:I+_:)C_LM9[K58ENI(O*;SH59L, RD97^$LR_8_P#P3_\ V8?A
M);_\$Y])^"S>.(O'/ACQCI%U<7^H1Q&**1;PGS(HD8EHC$?EY^99$9B%;Y1W
M7P9_88^#7P1U_P =Z[X?O]:U-?B7<2S^-K#79X+BVU.21IB[,@A7:#]HFRJD
M*0^"" ,:?[,'[(WPW_9$\)W_ ("^#^O>(5T.]O'NHM*U74ENHK*5_O- 63<@
M.!E2Q4D9QDDD ^1?^":H^)>E>.?&_P#P3(^(FIQ:AX?^%_B5]0;4O,RU_IIE
M#Q6&S^&.29HYW!)RAEA(*OQ^AM>/_"[]BSX:?"/X\^)/VCO"_BSQ+)XE\7C;
MXBDO;NW>"[7<K!?+$ $8&U0-FTX[U[!0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >8
M?M>?M+67[(WP3U'X\:_X-N=:TC2)8$U*WL+M([A!-/'!&R*XVN-\B@_,"!R,
M\XIW/[4LP_9Z\+?'+2OAG=W]]XQM+*Y\/>#+748SJ-ZEU&LD:1Y&QI%C<22#
M(2-%=F<!":\V_P""T) _X)N?$+)ZR:1_Z=K.OFWX*?'+XP?L#?$+X4?%']HK
MQ WB3X2_$WX8^'],TGQ'+8H'\),MC"XM5V#Y(@3N<#F9 )#ODA8$ ^K?VK?^
M"@5E^QE9>%=;^-7P6UC^S?$C%;F\T/4(;K^RBKQAQ,ORDX$J<IN4D[0<XSZ9
MJOQP2:Z\#7GP_P! @\2:'X\NA#INO66K(D,0-I-=B5@5)9&A@<@KD[L*0N<U
MA_&+P/\ #CXY>/M!^'WC?3[+6_#OB7P!K\4]N9 \=S"\^DL'1E/4?*ZNIRI"
ML"" :^3?V2O WQ\_8S_;/\,_L&^-KF?6_AX^L:CXG^&_B*Y)W1P+IM]%-:Y
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ME:5.Q8+:O<%7>2<E'!2.-@I1@S J0/FWXWZ)JOQ=_P""Y/PXF^%RM<?\*_\
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M*** /K[_ ()N?M3RZ9J,?[//CO4B;6Z<GPQ<S/\ ZF4Y+6I)_A;ED]&RO.X
M?;5?C997MWIMY#J.GW,D$]O*LD$T3%6C=3D,".A! (-?J+^R1\>K?]H/X.6/
MBJYE0:O9_P"AZ["H Q<H!EP.RNI#CL-Q'\)K\QXRR98>K]=HKW9/WO)]_GU\
M_4^PR#,'5A]7F]5MZ=OE^7H>G4445\*?2!1110 4444 %%%% !1110 4444
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M@IQV>H4445F6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^CZ%??'KQ#9%9]25K+0A(O(MU;][*/\ >=0@/7$;=FKR<[S&.5Y=.M]K:/\
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MM5(W-GIN/"J/[S#L#7ZF^'] T?PKH5GX9\/V*6MCI]LEO:6\8^6.-%"JH^@
MKSS]E+]F[1/V;OAO'H$9CN-:O]L^O:@@_P!;+CB-2>?+3)"^N6; +$5Z?7XY
MQ+G7]K8SEIO]W#1>?=_/IY>K/O<HR_ZC0O+XY;^7D%%%%?-GK!1110 4444
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>9?M!_LG?"?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>cdna-20240429_g12.jpg
<TEXT>
begin 644 cdna-20240429_g12.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9_LK:)H;^)E\&?%GQKH=OXOU6\U'7K.QU&VDBEN+EB96B^T6\IML@[?W)C/
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MP-_P6KB\8> /A^?%.IZ;\&YKB#0(]0^S2WNR*X8QQOY;@R'&%4@ GC(KJ_\
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M+(W CE8ID),%'K?Q@^"?Q&_:8_9I^!OQ(_97^*]OX?\ B)X5T7_A)/!<-_\
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MKQ[X9_\ !4?1OB?\"?%G[1^A_LZ>*Y/#'@G4IK/Q$;?4+%[N#R8XY)I%A:5
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M/2N"_P""T9 _X)O?$ $]9M(Q_P"#6TI/V,;35/@E\&?#_P 6OBW\4I-5\/\
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MY+K 8_+#9YR!G-=)X6\)^%? ^A6_A?P5X9T_1],M(PEIIVEV26\$*@8"I'&
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MN.T#]E?]FOPKK0\0>&O@1X4L+I;L72/::%!&L=P#GSE0+M63(SO #9[UWU%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5>CW1TX?%XG"RO2DU^7W;'ZN_!3]I'X1_'[3#>?#WQ,DES&FZZTJZ BN[?\
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %-EEC@B:>:0*B*6=F.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MORSCFHI9G3@ND/S;/L^'(VP<I=Y?H@HHHKXH^A"BBB@ HHHH **** "BBB@
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MA]-+G-[;1JDX$DDGFJ5D8KS(1M(/ SGM7 T444:,*%/DCMK^+N%2I*K+F?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7FG[07[*7PH_:+TW'BS3#::M%'MM-=L5"
MW$?HK9&)$_V6Z9."I.:]+HK;#XBOA*JJT9.,EU1G5I4ZT'"HKIGYE?'[]B#X
MT? F6;5'TIM=T)"2NLZ5"S"-?6:/EHO<G*_[1KQROV8KQ_XQ_L-?L_?&2675
M+[PP=&U27);4]"*P,[>KI@QN<]25W'UK[[+.-[)0QT/^WH_JO\ON/F<9P[JY
M8>7R?Z/_ #^\_,>BOI_XF?\ !+?XP>'99+KX:>)--\16HR8X)F^QW/TPY,9^
MN\?05X9XW^!'QE^'$KIXV^&.M:>D?WKB6P<PGZ2J"A_ U]GA,WRW'+]Q53?:
M]G]SU_ ^?KX'%X9_O(-?E]^QR=%%%>B<H4444 %%/@@GN9EM[:%Y)'.$1%)+
M'T '6O0O /[)?[1?Q)D7_A&OA/JRPL>+O48/LD./4/-M##_=R:QK8C#X:/-5
MFHKS:7YFE.E5JNT(MOR5SSJI;&QO=3O(]/TVSEN+B9PD,$$9=W8] %')/L*^
MO/A9_P $IM8N)$OOC+\0H;:/(+:=X?7S)"/0S2*%4_1&'O7T_P#"+]G#X-?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
9HHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>cdna-20240429_g13.jpg
<TEXT>
begin 644 cdna-20240429_g13.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[F4%49\(<;AW?[>>A:1X7_X*-_LF>&?#]A':V&G7KVME:Q#Y888YH%1!GL%
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M^#+_ .*W_!-?XSQ_L&?$:2_UWX9>/?%.G7/PK\02+N-G/_:=L[V[GH,])%'
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M[80F=N0#7VE\:_$7P1^/G[-MQX1N]*B\3:/X^2?1_#FD6\R(VK3*TBI);O\
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M(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/(((."*_':O<_P!B[]KS4_V>/$X\-^*)YKCPCJ<X^W0#+&QD/'VB,?EO4?>
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M(NG)^ZUT2Z]G=_EI8^;S7-ZV#Q:ITK62UOY_\#\S]!XY$EC66)PR.H9&4Y#
MC((/<4M?$/P\^-/Q&^&$JKX7\02"U#9?3KG]Y;OSD_(?NDXY9=K>]>]?#?\
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M#SSR%W;%[,!DGDX  _"E^#&JZG)^S)\7](DU"=K2/3M(DCMFE)C1CJ,>6"]
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MEM3T(K SMZNF#&YSU)7<?6OOLLXWLE#'0_[>C^J_R^X^9QG#NKEAY?)_H_\
M/[S\QZ*^G_B9_P $M_C!X=EDNOAIXDTWQ%:C)C@F;['<_3#DQGZ[Q]!7AGC?
MX$?&7X<2NGC;X8ZUIZ1_>N);!S"?I*H*'\#7V>$S?+<<OW%5-]KV?W/7\#Y^
MO@<7AG^\@U^7W[')T445Z)RA1110 44^"">YF6WMH7DD<X1$4DL?0 =:]"\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
2**** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>cdna-20240429_g14.jpg
<TEXT>
begin 644 cdna-20240429_g14.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***YSXK?%KP#\$?!5W\1?B=K4FFZ)8 -?:@MA/.ENI.-SB%'*KD@;B
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MNZ/^U-\$->\->)O%FF^)[XVG@U]GBA)O#E_%<::1%YI\V!X!* (_G)V8 Y-
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MWA7XW>--8U8Z%\=M*CT[QBNJZ;<V\.E:HS 0VR-/&@:.W/V6-7_YYF4G'?\
M0+XL_"NP^+WAZV\-:KXIUC2[:WU2UOV.CS11M-);S)-$LADC<-&)(T8IC#;=
MK94D'D/VI_V.OA5^V)X*TOP#\9=0UB33])U!+ZW_ +,N(H)6N5C>,2&3RBP^
M5VRJE5)(R.!@ X7]N_\ 9"\ _MIZSI/PD\9D6MVO@S6[KP_K*)NDTV]6ZTL)
M*!_$AR5=/XE8]#M8>/\ _!/;]H[XS:K\<=+_ &*?VI-&NH_B%\+K/44.K3$N
MNJ::8X4AE+G[[ %,2?\ +1'1C\V\U]=Z1\%ETOQKH_CN?XG>*+Z[T70WTJ&*
M^GM7BG@=HGD,H%N&:1F@B)D!#?+P0"0;.K_!+X>:O\7]-^/$FC^3XJTO1+G2
M;?5;?"N]G,R.8I,@APKH&3/W2S8X9@0#X]_X)SQ17'_!23]JV">)71]>A5T=
M<A@;FYR".XJK_P $.[K6;'5OCQX(T:20^"-'^(07PHH),*.SW2S+'V_U4=H2
M!Z@]Z^@?"W_!/OX7^"?'_C/XF>$_B9XZT_5_B#(S^+KFTUB",WNYV<A2MN&@
MP7;#0E& /!%>F_!CX(?"K]GKP#:_#'X-^#+70M$M&9X[2VW,7D;&Z21W)>5S
M@9=R6. ,X H ^,?'NJ:GXM_X+U>$?"GQ,!?2M \$RW'@:SN1^Y:9K.622=%/
M!?>)_FZYMT_N#'V[XU\*:;KGV'Q(=$@N]8\.RSWOAV27@PW3VLUOD'T:.:1"
M.F&SV&.0^/7[)_PB_:'U;0_%OC"SO]/\2^%[GS_#?BS0+XVFHZ<^<D)( 0R'
MNDBNAR?EY-;'@_X.#0-<M_%'BWXE>)?%VI6*.FG77B&:U1;0.I5F2"S@MX=Y
M4E?-:-I K,H8*S @'R+_ ,$$+FYUWX _$7QEXMN);CQ9J?Q0NCXBNKP'[3(P
MM+9QYF><^9)<'GN6KE/V2KS7=-_;3_;'\(^%B_\ PB M-0N[R&+_ %$.ILTH
M&!T5VS<@XZ^6,_=&/L.U_9%\!>%OB)XB^*'PB\5^(/ NJ>+F63Q0GAF6U-MJ
M4Z[L7#P7=O/&DWS,3)&J%B26W$DF?P%^R1\(_A9\*-=^$WPYBU'28?$\EQ-X
MBUR.[$VIZE/.")IYKB=7+R,&8;B/ES\H7B@#XJ\%ZEXF_P"">_\ P4/U/P?X
M-T&2X\._'WPI%?>%K%(F,">(-I\M'V_=3[0TH8@82.[0GA*W?V0?!EC\/?\
M@M]\7/!>GW,DZ:=\)+&)[J;'F7,GD:"9)WQU>1RSL>[.3WK[23X"^ +K4?!7
MB#Q);SZUJ_@ 3_\ "-ZSJ9C-Q#YT!MY-QC1%;,9 SM'**>HS7(^%OV*?AOX/
M_:5UW]K31O&/B8>-/$FG"PUB\ENK9H9[8+ JQ>5]GVJ +:#!7#?N^2<MD ^-
MOVI;*[_9 _:*^'7_  47\-VKII,OQ$\2>&?B*L"$^9;/K>H!)6 ^\WDF4#/
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MR^)?C'XK> /$GB*75/'VHF_\5KJ5Y!+%?7/F32"3:L*F,A[B4@(5'S8P0
M?*7[2]QX^TK_ (+?> 9OA/H&DZCKL/PCN!I5CK6HR6MJ[B#5<!Y(XY& 'H%Y
MQC<N=P^E->4R_L2Z[X@\6Q)'XRUGX(F?Q*9&Q<32II;AFD7/4222+NZ]LG:,
M7_&?[#_PX\:_M(V'[6%QX[\5V7C72K V.E7]A>6HBM+8K*IB6%[=D=<3RC+A
MC\W7@8TX?V3_  R;;QL-8^)WC+5+SQ]I$.EZYJ6I:G!)+'91K<*(+=?($=NA
M%S,2$0<MN&#S0!\F_P#!(2#XH>*?V8O 'PZ\1>$M+G^&6KZ9XJ@U69-0DDGO
M+EKM46">+RU6*,QO<;=KR%L9.P@ _H!IVH6.KZ?!JNEWD=Q;74*RV]Q"X9)8
MV *LI'!!!!!]Z\,\"_\ !/[X?_#+X+2_L]?#_P",?Q#T?PC+Y^[3+#6K:-P)
MB3*%N!;>>H8DY <#D^IKV[0-$T_PUH5EX<TB'R[33[2.VM8R<[8XU"J/R H
MMT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #
M)S.L#M;1H\@0^6DCE59L< D X&>^#]#7AO[,?[;MC^TY\8/B#\']#^%]]I%S
M\,]7.F^)KV_U*)XVN/-N(5$ 0$R O;2<MLPN#U.VO=:^$/\ @E&RG]MO]L$!
MAD_$J/ S_P!1#6* /I']M#]K72OV+_A./C-XH\#7FN:0FH16=U'IMVB3Q/+D
M(P60!67(()W C(X(R0_0/VDO&VH>)_!>E:Y\ =4LM,\:D"UUR#6K6YBL2UI-
M=1"XC5A(@=874,%*[N"02 ?G/_@L]\2?"WQ(_8#\4R^$KY;JWT7XB66E3W4;
MAHY+B(@RA"#SL=VC;T>-QVR?8OV<K35/@;H4'BOXP_%.37;3QG#X7LO!SWL-
MO%-%));B!;&..(*'".[3%@N=DCL<E6- 'H_[1_[2'PR_99^'D/Q,^*VJ&UTV
M;6[+3$9<;C)<3*FX ]1&GF3-WV1/C)P*V_BQX]F^&7PQUSXEVVA_VI%H6DSZ
MC<6<=T(GFAAC:1Q&Q!4OM4X!P">I'6OF[]N;X-ZM^VWX:\<_##0_ -WK5KX>
MTEM.\,ZA;7UK'%;>(?W=S+*PEE4D(JVUOO4$J)KQ.I(KF?V-/VEKK]H3_@E9
MXQTCQ7<O_P )3X$\$ZOX>\107!Q-F"QE$$K@\Y:':"QZR1R>AH [?PG_ ,%1
M?!.L?L\:=^UAXD^!_BW3?A]?:BUG=:_;O:W9TPB<V_FW,"2B58C(-NZ-9.67
MCYA73?M9_M^^!/V5_AIX4^,LGA.X\6>&/&-Y!:Z1J.@ZA%EWFB>:)]LF 8VC
M0D,&)SP0."?D;X+^*_#'A;_@WTUK_A)KJ%?[2@U73].@D(W3W<VI2)"B+U9M
MQ#8'("$] 37(_MH?#KQW\*/^"07[/?@3XE07%GK-MXW@FN;>Z7$MJDT>HSQ1
MNK?=9(I8U*G[I7!'% 'Z,Z7\<?B /BCI?PU\6_ B_P!*CU>VN3::ZFMVUS9I
M<0Q"7[-)Y9\R-V0[ERF" 2,X-><_#S_@H3>_$_Q[\2_ASX._9R\07^I?"FZ:
MW\206NL6>Z=P\ZC[+YCH)<^0Y 8H?N\9.*[3X56FJ? OQ!JOACXQ_$Z3Q'K'
MCGXB2R^$+F\AMXKJ[A&EVY*"&$*B"".VG#%57*Q[B,O@_!/@=_VGK3XV_MK:
MW^R?K-I%XCL?$<<DUA-IHN)[RV^T:B)1;'=\DZKN9,J^XC;C)!H ^V]"_P""
MB_[.?B;]DR?]L31;_47\.V]R+*33I;9([Y;]I$B6S92_EB0M)'\V_8%<,6"@
MD=II_P 9_&UMXYT;X>>-_@U>:7=Z_!<RZ=J=MJL5WIP,,1D,$LRA9(YB,87R
MBI 8J[;&%?)'[+7A[]@?XK?\$MM(^$2O>Z;X7\4Z_!I7BF6[U-#?:9XCF=-D
MTDI4*#YJ0"-M@0QM&&7!<58_9S\*_MA_L&?M>> _V3O&_P 4Q\2OAEXW@U+_
M (1FZOHR;[0Q9VQD9L,6:%5#1Q[=[1%9/E"-\M 'O/[//[< _:.^+_Q$^"_A
M;X376GZE\-+]K'7KG4]7C$$MQYL\2+"8T9F5F@<[F5<+@XS\M4?V<?V_(/VF
M_"OCWQ5X(^#M]91_#ZZEM=2M]5U>))+JXC5F>.'RU<?=1OF8J"2HZ$E?G?\
MX)\>$/%?BW]O3]J]/"WQ9UCPL8/'BF=M(LK&8W.;W4L!OM=O-C;@XV[?O'.>
M,'_!(2-[?X-_M'P7%ZUP\?C#4!)<2!0TA%O+ER% 4$]> !Z 4 ?07P?_ ."A
MNF?&K]D[Q/\ M@>%_A#J$'A[PO'>RW.GWNJQ+>7$=I#YL[1JJLG"_=#."Q#=
M.,Y?A'_@J=\+=1\,_#GQ[\0/A?XD\,^&_BC?2V7ACQ#<26UQ;1W*3&'R[D1R
M^9!E@<-L9<<D@!B/GW_@G\RC_@AO\6<D?\@/Q</_ "G&NK_X)^_L8>$OVF/V
M-O@5XW^,GC;4]0T7P9-?:EH7A&TAA@M&NAJ,^'N7VM), 4X4,@Y((()! /LS
MX[?%%_@C\(?$/Q??PX^JVOAG2;C4]1LH;I8I7MH(VDD,98%6<*I(4E0?7H#Y
M#\/_ -O;7OB7\ M)_:6\)?LU:[=^%]5\R3,6N69N[>WBNFMIKAX"P)2-E+-M
M+$+SBNV_;I('[%/Q=R?^:::Y_P"D$U?,?_!*W1M6^'W[)WP^_:,^(7Q:"?#[
M2OAUXFMK_2]2CMXK;29FUQ)#*'50\HD2WE!$F[:5PI&_;0![7^T5_P % M%_
M9E^/OA7X'_$;X4ZE;VWC.ZB@T+QC+J,4>EEFD6-A*Y!>(HS+N&TX#JW0Y'I5
MA\7?%.M?&;6OA1H7PT>XM-"T^&>]\3-JR+:+/,K-'9D!#(+C:%=E"D)'+&Y/
MSJI\O_;\^#?@S]LGX.6O[-Z:5&_BS7(DU?P]+=,$?0%C(WWTY4,53#F#8 3*
MTNT8 :2/A?\ @DC^TKJ7B3P9K?[(GQGT[^ROB=\-K^>'6[:Y?,VJPF8YO"Q)
M,L@=MLCY.[=&^3YG !KZ;_P55\,7.C_$KQ/>?L^>*SI?PEUT:7XVN+"]LII+
M9_/D@,L4;2H98PT39(.0,';C.-[XR?\ !23X>_"^W^%NM^'O ]]XHT?XOSQ0
M>#]2TV]CB_>NT*A9TF"F+F= ?O$;6! (P?F+]BW]GM_VH/B)^UO\']7^)6I:
M#X>U;XL21Z]%HMM ;F\A%_?OY:S2JXB4[<$A22#C.,YW/^"I/PO\*?"7Q+^R
M3\(OANKZ/I6B^.X[#2FC99)+9%GTY5DS(&#N#\Q+ @MDD')H ^R?"WQN\?:Q
M\3YOA9XC^!U[HUPWAZYU33-5FUJWGL;QH9H8I+??#N>.0&XC)W)T.1G%>3?#
MC_@IC:_$[P/\0/B+X<_9Q\3W&F_#*\GM_%,=MJ=DURI@#-,T,;RH)0J([?>!
M.W !)KTGX&1WOP6M=/\ @_\ %CXA'Q!XOU[Q'KM[I]Y,D*7-W9M<S7/GM''@
M1QK&T,9V@*',:@ $ ?FK\,G_ &F;+]E[]J#6?V>=6MGLT^(]]#XRTI-/#WD^
MDR"=;B2VE)(C=4)W?(3LWLI#* 0#]"O&_P"W]\,=#_8W3]N'P-H5[XD\'B&.
M2Y@AE6WO8=UTMJ4\M_E+I,VUQN'W25+#&<CXN_\ !1'2O@Q^R=X8_; \4?"#
M4)O#WBE+.2UT^RU6)KRWCNHC+ TBLJIRH.0KG:2O7)QX3\;+_P#9[O?^"#>L
M?\,RK-'X6CTG3U6VOKD2W=O=MJ]J]S'<L ,S"5W)P I!!0!"M<W^WV1_PXU^
M$O(_Y!/A3_TWF@#[4T/]HGQQ=^./!_A?Q#\ ]3L+#QDTB6NNPZU:W,-FXLI[
MQ%G1&$B;TMW56VE=W!.<9XKP-_P4?^&NM_M<:A^QE\0_!FI>$O%5LS1Z;=:A
M<Q266JR@!EC@E4@DNA++N49*LAP^%.C\!+35/@592Z[\8?BG)KT?C74="M_!
MLMY#;QSJ9+.*W%G''$$#>61)*650?+9V.2&->>?M6_L/:)^V?\/O&,WA:_CT
MKX@>%?'5U=^"_$4,IC>"X6WM6^SR.OS+&[*O(YC<*XZ%6 /H+2/C2PU?QLOC
MOPY#X>T;P.X&H:_=ZM&T$J?9H[HR@;0418I%+%\8.0 P&:XKX/\ [8?B#]H7
MP[/\3?@I^SUK^K>"EFECTW7;[4K6QGUGRF*.]G;3,"R;E90TSPY(QQ@X^3[7
MQ+^TY^UI_P $O/CSI?B[PG=VOQ)TSQ#!I?B#3X(BL]X^G0:8;D^6HXDDAB?*
M+D,Q(488 ?4'_!,#QUX-\7_L#_#>^\+ZA;&'2O#<>GZFD<@'V:ZM\I.L@_@;
M<"_.,APW0@T 9'QP_P""DWAGX'_"?P=\9=:^#/B";2O&FM2Z3964D\4%]97:
M331^7<0N<1\0DG#,5.5(X!/IV@?'#QS/\6M.^%WC/X&ZCH\6IV-S/;:]'K%M
M=V@EA$;-;OY;;XY"D@90R@, 2"<''R1_P7!UCP[XD^ /PFUSP?JMO+I]]\3H
M)[2^LMICE#PSDS(<;7!)+;N0V<\@Y/U)\);;4_@?K]]X+^,/Q+?Q%KGC?Q_=
MS^%;R[B@CN;R :;%(1Y40546"*WEC+*H!$:G ,@! /7**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!LL45Q$T$\2NCJ5='7(
M8'J".XK@;;]D[]EFROKK4[/]FGX?Q7-^6-]<1>#;%7N"Q)8NPBR^223G.2:]
M HH X>Z_9D_9MOO!MM\.KW]GSP/-X>LKAY[/0I?"=FUG!*Q):1(#'L5B226
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLG[;_P#R573?^Q=B_P#2BXKQNOV_AW_D24/\)^=YK_R,:GJ%%%%>R>>%%%%
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M?V.J6<>HZ9>PW-O,NZ&XMY0Z2+ZJRD@CW%2U\JTXNSW/9335T%%%%(84444
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MJ_WZA1117AGHA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!YW^U3\(5^-WP,USP/;PA[_ .S_ &K23W%U%\Z
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MBBB@ HHHH ***T/"GA7Q#XX\1V?A+PII4M]J.H3K#:6L(RSN?T '4D\  DX
MI2E&$7*3LD-)R=D=C^S-\!]9_:%^*UCX(LEECL$83ZU>HO%M:J1N.>FYN%7_
M &F'8&OU,T'0M(\,:):>'- L([6QL+9+>TMHAA8HT4*JCZ "O//V4_V<=%_9
MO^&D7AR/RI]9OML^O:@@_P!=-CA%)Y\M 2J^O+8!8UZ=7XYQ+G7]K8SEIO\
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MC!&G:=%!QZ?(HK5HHKCE*4W>3NS=1459(****D84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
-10 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>cdna-20240429_g15.jpg
<TEXT>
begin 644 cdna-20240429_g15.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!JNEWD5Q;7,*RV]Q"X9)4895E(X((((-35^6--.S/M-PHHHI %%%% !1110
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M*97M?[0&KZ1K7[-GPNN/#VCK8:?'J.OPV-O@;Q$DMJH:1A]Z1L;G;H68X &
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M445\V>L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOH0,[[.4?FAJY2.BR(8W&0PP10!\X45)=V[V=W+:2#YHI&1OJ#BHZ "BBB@
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M>UJI&X@_WFR%4?WF'8&OU,T#0=(\+Z'9^&M L4MK&PMDM[2WC'RQQHH55'T
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M%%?&'T 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !6+XN\!:#XQ@Q?P>7<*,1W4
M0PZ^Q_O#V/Z5M44 >)>+/AAXE\*EIS!]JM1TN8%)P/\ :'5?Y>]<Y7TA7.^(
M_A=X1\1LT\MC]FG/6>UPA)]QT/Y9]Z /$:*[C6_@7XBLV,FB7D-XG96/EO\
MKQ^M<OJ?A7Q)HS$:GHES"!U=HCM_[Z'!_.@#/HHHH **** "BE56=@B*22>
M!R:U])^'_C'6B/L6@7 4_P#+29?+7\VQG\* ,>G1Q232"*&-G=CA549)/TKT
M+0?@+<N1+XDU=4'>&T&3_P!]$8'Y&NX\/>#?#?A=,:/IB(^,-.WS2-_P(\_@
M.* /.O"/P6UC5BEYXB=K*W//E8_>N/I_#^//M7INB:#I/AVR73]'LDAC'7:.
M6/J3U)^M7** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
# /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>cdna-20240429_g16.jpg
<TEXT>
begin 644 cdna-20240429_g16.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-OCE\*OB[J.JZ-\/?%T>H7VA>2-;L#;RPW&G/+YFR.>*5%>&0^4Y\MP'  )
M#*3KR^-_"4/C6#X<2^(+8:[<Z7+J4.E[_P!\UI'(D3S8_NAY$7/<MQT. #5H
MK@?CO^T_\#?V9=+L]<^.GC?_ (1^QO[@6]I?7&F74L$DQ5F$?F11,H<JC$*2
M"0I.,"NUTC5;77-,AU:RCN$BG3=&MW9R6\@'^U'*JNA]F - %FBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_(KX:?'SX@?
ML^_"?]KGQ'X5^$2>)=.U7XC7ND:M??VB4_LA;I[Z%;F2'RF\V(%P" Z_,R@X
M!+#]<;J&2XM9+>&ZD@=XRJSQ!2T9(P&&X%<CJ,@CU!KQOX,?L(?!+X(_\)Q;
M:%=:SJME\1II9?&.F:_<0W%OJ$DGF>8Q40J5W"60%5(7YNG P ?,_CSX2>$?
M@O\ \$'M9\)^!_B2GBW3;CP[%J,.N01F.*8W.I13,L:$DQJA<H5;YMRMN"DE
M1Z+_ ,$\[KXA:S\"O!NE_&?P[H]KX"TGX3>'-4\-W,.IR3))<6\SSO<7&^.,
M0RQF&V<(-ZJ #O;) [?0/^";/P/\,?L\:S^RKHWC/QFG@77;H3W>BRZQ#+Y1
M\Q)2L4CP&2)&=%8JK $@GJS;MO3OV(O!NG?#;0O@TOQ>\>OX2\.FV6PT#^UK
M:.)XH)%>."9XK999HLJ 4=R".#Q0!\X_LMWVL^+_ /@MO\:;SXG,\FIZ!X1-
MMX6M[KD6NG^;9A6A!^Z&20,2.IG<_P 1KZ)U7]I#X!Z]^V-I'[/.I>$M9D^(
M^@V<]WIDQL(Q'!93P@2RB?S,>4R!24^\61?EW*!72_$[]E?X9_$GXEZ5\;;>
MXU/PYXWT:W:VL?%WANX2&[-LV=UO,LJ20W$1S]R6-P#]W%4/!G['/PQ\+?M
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M^S[\??BU\0;_ .$_AO5;77M!>UTKQW?:A8I;HDUM)<I#$Q\P^8ZDW WJ"-J
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MVIN!$\:R2QV]M%YS*KL07)()S0!Z51110 4444 %%%% !1110 4444 %%%%
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M!^SQ:?L^Z_J>N?#?0#K.O'2]5M&2:S\J"4-;^:T9D?9<1G8=IZCD@ TOB/\
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MXC_:;^%&@:E>6OA**\;Q!X>U3;:7]H]K#YTT)&70OY>"N&VMNQN!! PO#/\
MP41TOQ5^Q=??MQZ?\(-07PQ8^:YTV758A?2117!MY) H4Q\2#@%\D GC #>(
M_L(:E\!;O_@DU\38?A)%>V^OIX5UY_B+:ZQ=B6\75SI\BO(_RKB)U0&,!0
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M Q7=44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M22<DD\FDHHH **** /ES]N'_ )*IIG_8N1?^E%Q7C5>R_MP?\E4TS_L7(O\
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MS"E+O'\F_P#,^RX;?^RS7][]$%%%%?#GT04444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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#!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>cdna-20240429_g17.jpg
<TEXT>
begin 644 cdna-20240429_g17.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@"
MV 48 P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _93P]X>\1>-_$6I65EXDEM_L\K-\\KD$%R,#!K<_X4KXR_Z'
MC_Q^3_&CX*_\CEKGX_\ HPUZ90!YG_PI7QE_T/'_ (_)_C1_PI7QE_T/'_C\
MG^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5\9?]#Q_X_)_C7IE% 'F?_"E?&7_0
M\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!YG_PI7QE_T/'_ (_)_C1_PI7QE_T/
M'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5\9?]#Q_X_)_C7IE% 'F?_"E?
M&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!YG_PI7QE_T/'_ (_)_C1_PI7Q
ME_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5\9?]#Q_X_)_C7IE% 'F?
M_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!YG_PI7QE_T/'_ (_)_C1_
MPI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5\9?]#Q_X_)_C7IE%
M 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!YG_PI7QE_T/'_ (_)
M_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5\9?]#Q_X_)_C
M7IE% 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!YG_PI7QE_T/'_
M (_)_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5\9?]#Q_X
M_)_C7IE% 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!YG_PI7QE_
MT/'_ (_)_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5\9?]
M#Q_X_)_C7IE% 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!YG_PI
M7QE_T/'_ (_)_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5
M\9?]#Q_X_)_C7IE% 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!Y
MG_PI7QE_T/'_ (_)_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT
M?\*5\9?]#Q_X_)_C7IE% 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ9
M10!YG_PI7QE_T/'_ (_)_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/
MR?XT?\*5\9?]#Q_X_)_C7IE% 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?
MXUZ910!YG_PI7QE_T/'_ (_)_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q
M_P"/R?XT?\*5\9?]#Q_X_)_C7IE% 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?
M^/R?XUZ910!YG_PI7QE_T/'_ (_)_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9
M?]#Q_P"/R?XT?\*5\9?]#Q_X_)_C7IE% 'F?_"E?&7_0\?\ C\G^-'_"E?&7
M_0\?^/R?XUZ910!YG_PI7QE_T/'_ (_)_C1_PI7QE_T/'_C\G^->F44 >9_\
M*5\9?]#Q_P"/R?XT?\*5\9?]#Q_X_)_C7IE% 'F?_"E?&7_0\?\ C\G^-'_"
ME?&7_0\?^/R?XUZ910!YG_PI7QE_T/'_ (_)_C1_PI7QE_T/'_C\G^->F44
M>9_\*5\9?]#Q_P"/R?XT?\*5\9?]#Q_X_)_C7IE% 'F?_"E?&7_0\?\ C\G^
M-'_"E?&7_0\?^/R?XUZ910!YG_PI7QE_T/'_ (_)_C1_PI7QE_T/'_C\G^->
MF44 >9_\*5\9?]#Q_P"/R?XT?\*5\9?]#Q_X_)_C7IE% 'F?_"E?&7_0\?\
MC\G^-'_"E?&7_0\?^/R?XUZ910!YG_PI7QE_T/'_ (_)_C1_PI7QE_T/'_C\
MG^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5\9?]#Q_X_)_C7IE% 'F?_"E?&7_0
M\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!YG_PI7QE_T/'_ (_)_C1_PI7QE_T/
M'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5\9?]#Q_X_)_C7IE% 'F?_"E?
M&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!YG_PI7QE_T/'_ (_)_C1_PI7Q
ME_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5\9?]#Q_X_)_C7IE% 'F?
M_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!YG_PI7QE_T/'_ (_)_C1_
MPI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5\9?]#Q_X_)_C7IE%
M 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!YG_PI7QE_T/'_ (_)
M_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5\9?]#Q_X_)_C
M7IE% 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!YG_PI7QE_T/'_
M (_)_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5\9?]#Q_X
M_)_C7IE% 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!YG_PI7QE_
MT/'_ (_)_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5\9?]
M#Q_X_)_C7IE% 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!YG_PI
M7QE_T/'_ (_)_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT?\*5
M\9?]#Q_X_)_C7IE% 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ910!Y
MG_PI7QE_T/'_ (_)_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/R?XT
M?\*5\9?]#Q_X_)_C7IE% 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?XUZ9
M10!YG_PI7QE_T/'_ (_)_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q_P"/
MR?XT?\*5\9?]#Q_X_)_C7IE% 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?^/R?
MXUZ910!YG_PI7QE_T/'_ (_)_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9?]#Q
M_P"/R?XT?\*5\9?]#Q_X_)_C7IE% 'F?_"E?&7_0\?\ C\G^-'_"E?&7_0\?
M^/R?XUZ910!YG_PI7QE_T/'_ (_)_C1_PI7QE_T/'_C\G^->F44 >9_\*5\9
M?]#Q_P"/R?XT?\*5\9?]#Q_X_)_C7IE% 'BWCKP?XG\"VD%W=^*9)Q/(4 CE
M<8P,]S173_M"_P#(&T[_ *^G_P#0:* *OP5_Y'+7/Q_]&&O3*\S^"O\ R.6N
M?C_Z,->F4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YOJ7[9'[(6C:C<:
M1J_[57PWM;NUF>&ZM;GQSIZ20R*2K(ZM,"K @@@\@BM7P#^T?^SS\5M<;PQ\
M+OCSX,\2:DL#3MIV@>*+2\G$2D!I#'#(S;064$XP,CUK\T/^"Z'_  3S_8]_
M9W_9@E^/WP;^#ZZ-XMUCX@V\>HZJNO7\XE6XCNI9@(9IWB3<ZJ?E08Q@8'%>
M]_"?]E;]D?\ X)__ +&%S^WK\%O@M%8>/+#X+G4&U.;7;^Y6XN9;".8J8I[A
MXD#SA,[4! ) P.* /J[XI_M._LW_  .OXM*^,OQ\\&^%;N= \%GXA\2VMI-(
MO]Y4E=6(]P,5O>!_B9\./B=X<'C#X:_$#1/$.D,2!JFAZK#=VQ(&2/-B9EX!
MSUK\RO\ @D5_P3>^ _[8WP+U+]L_]L_1;KXA^*?''B&^,,NL:K<*D,44AB>0
MB)T+RO*LG+$A55 @7!)Q? 'PRTO_ ()H?\%N-$_9N^#E_?1_#;XLZ#']L\,W
M5X\R)#<1W4<:%G)+F*YMV*.V7$;LA8[F) /T<_X;9_8R'7]KCX8_^%]IW_QZ
MNB^'7QZ^!GQ?O+G3OA+\9_"?BBXLXA)>0>'?$=K>O A. SK"[%03P">,U^1_
M_!<;_@GS^R%^Q]X ^'6N?LZ?"+_A';K7O$UQ::M+_;VH7?GPK$K*N+F>0)@D
M\J ?>OTT_9H_X)__ +'G[%VM:MXQ_9V^$T?AF\U6Q6WU6\?7[^[WP(V\+_I<
M\@0 C)*XZ<GB@#O?$?QX^!W@_P :VOPU\6_&;PII?B.^:);+0-1\16T%[<&5
MML82!W$CEVX7 .X\#-=!KVOZ%X5T2[\2^*-:M--TZPMWGOM0O[E88+>)1EI)
M'<A44 $EB0 *_!G]HSP%\0OVV=&^/O\ P5:\+:M>Q6O@_P")6FVOA-X,_-IT
M)\G>!C*O%&^FRY' W2D^M?IW\=_CSIO[3W_!&/Q;\>M,:/\ XJ;X-WMU=QQ?
M=ANQ;.ES$/\ <G25/^ T ?47@SQQX*^(_AR#QA\//&&EZ]I%T6%KJFC:A'=6
MTVUBC;98F96PRE3@\$$=JU*^._\ @@Q_RC$\"_\ 81UG_P!.=S7U3\3+?Q?=
M_#CQ!:_#Z=8M?ET2[30Y7( 2\,+B$DG@ 2;3S0!R_C#]KK]E3X>^,3\//'O[
M2O@+1=>#A'T?5?%UG;W*,>BM&\@92>P(&>U=#XX^+_PE^&.CV?B'XD_%'P[X
M>L-0E$=A?:YK<%I#<N5W!8WE=5<E02 "3@9K\2O^"<ES_P $SK1/%W[/W_!3
M[X8WFF_$>_\ $\ZR^*/%LUY"L(944P22QR*]I,LPE=I) %;>"TG  ^A?^#A'
MP5X/^&W["_P1^'?P]NFGT#0=7@T[0YFNA.9+.#3#%"QD'$F8U4[AUZ]Z /U#
M\3^*_"_@CP_=>+/&?B2PTC2K&+S+W4]4O$M[>W3(&YY)"%09(Y) YI/"OBWP
MKX[\/6OBWP1XFT_6=*OD+V6IZ5>QW%O<*"0622,E7&01D$\@U^:__!1+_@L1
M^P9^T'^Q%X^^"OPM^)^I7OB'7M'BM]-M)O#-Y"LDBW$3D%Y(PJ_*C')/:O<O
M^"9WQ5\._ S_ ((U>#_C+XL<#3O"_@W5M3NUW8+K#>7C[%_VF("@=RP% 'TW
M8?'CX':K\09/A+I?QE\*7/BJ*22.7PS;^(K9]01T4NZFW#^8"J@L1MX )/%:
MWC7QYX'^&WAZ;Q=\1?&6E:!I-NRK<:IK6HQ6MO$68*H:25E526( R>20*_ _
M1/!OQD^ '@;X5_\ !9C7+N[NM2\3_&?4KS7(5&!-;M+N '<>>8M41B3@JT6.
MN3^CG_!>OQ!H_BS_ ()?77BKP[?I=:?J>N:+=V-U$<K-#)('1Q[%2#^- 'U?
MX/\ VH?V9_B%K<7AKP#^T3X%US49VVPZ?H_BZRN9Y#Z*D<I8_@*V_B%\5_A;
M\(]+AUSXK_$K0/#%E<3^3;WGB'68+**67!;8KS,H9L G .< U^''[4/A+_@F
M/<_L(_"W_AE\QW'[0%W8:"FI67A:YO[BYFO6M4^VK/&2T:OYQ.T( _F8"?+N
MKWC_ (+F6GQ'T_\ X)Z_LX6/QNEF?Q9#]E3Q4]R^Z4WPTN,7&\CJ^_=N(ZMG
M% 'Z8>%/VK/V7?'GB&U\(^!OVDO .LZM>N4LM,TGQC97-Q<, 6(2..4LYP"<
M '@$UOZ-\5_A;XC\;:A\-?#WQ*T"_P#$>DQ^9JN@66LP2WMDF5&Z6!6,D8RZ
M#+ ?>7U%?#G[$&@_\$&O''[1FC#]C#1[.X^(.DQS:CHV(/$<9B$:%9)!]N A
M8A7/#9/.0,CCP#X:?M?? G]B[_@M[\?_ (F?M!>)KG2M'U'3;O3+6XMM-FNF
M:Y>XTZ55*PJS ;(9#DC'&.XH _6+7OBO\+?"OB_3?A]XG^)6@:;K^LC.D:'?
MZS!#>7PR1^YA=@\O((^4'D&K?C/QSX)^'/AZ?Q;\0O&&E:#I5L!]IU/6=0CM
M;>+/3=)*RJOXFOR,^/?[97P"_;4_X+%_LX^/?V>_%%SJNF:5>:?I][-=:9-:
ME)_M\\FT+,JDC:ZG(XYKKOCQX6?_ (*@?\%K+W]D_P"+.NZ@?AE\*]'>YD\/
MV=XT*W;1PP&9B5.5>2XN4C9Q\WE1 *5)R #]&OAG^U9^S#\:-8/AWX1?M$>"
M/$^HJ"3I^@^*;2ZGV@9+>7'(6QCOC'%=!X\^*_PM^%B64GQ.^)6@>'%U*X\C
M3FU[68+,74O'[N/S67>W(^5<GFOS-_X+"?\ !,;]FS]ES]FB']K/]DOPI<^
MO$O@G7K!Y)]'U>Z(FBEG6%''F2,8YHY7B99$*G&X-N^4KQG_  5R^,>L?M!?
ML6?LE?&?Q&%_M/Q%,+K5&1 JM=&"U69E Z R!R!V!% '[!2RQ01-//(J(BEG
M=VP% ZDGL*\WMOVS?V/KVZ6QL_VKOAK+.[;4AB\=:>S,?0 39)KI_C'_ ,DB
M\5?]BW??^D[U^4?_  1%_P""<?['7[9'['GBGQO^T'\)?[9URW^(%YI=GJ\6
MM7EM+;VRV%A*BJ(9E0E7FD8%E.=V#D<4 ?KU8WUEJ=G%J.FWD5Q;SQAX)X)
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M=/%=U"]RVG_-8MMB62X^9U^W>4T8<ECLD*909KSK4+O_ ()]6G_!7+X_2?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH \]_:%_Y VG?]?3_ /H-%'[0O_(&T[_KZ?\ ]!HH J_!7_D<M<_'
M_P!&&O3*\S^"O_(Y:Y^/_HPUZ90 4444 %%%% !1110 4444 %%%% !1110
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MUMY[^*-24MKM;9X[B $_W9HID&>H3-?KT0&!5@"".0:2.-(D6*) JJ %51@
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M?^"A/[)/A.W\&^-_!&@Z!=^)M0\.VHMC=Q7-I"#=3J@ D<7#*KDCYTN) Y8
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M .C#7IE>9_!7_D<M<_'_ -&&O3* "BBB@ HHHH **** "BBB@ HHHH ****
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M'KUNU[9PJ%9I)8 _F1J ZDLP  8>HKES^VS^QD#@_M<?#'_POM._^/5\*_\
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M)_84N/B_\*-._P"".LDD_P 3I?$!9H_!5Y?3Q1;2A@E9IRPC=7#$E" $#F3
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M@*:SOK>ZTO6+M_M4)N8HF5_-E?:Z>9YJR+A]T8!)!X\F_P""GOQT\3_M)?\
M!%O]GWXQ^-KMKC6-3\5I#JMV_P!ZYN+:VU"UDF;_ &G: N<<98XH _5WP/\
MM(?L[_$W55T+X;?'KP7XAOFSML]#\4VEW*<#)PD4C'I[5UVHZCI^CZ?/JVK7
M\-K:VT32W-S<RA(XD499F9B J@ DD\"OSH_;,_X(L_L>V/['VM?&#]GCP/=^
M"O&WA3PJ_B#3]2T[7KR5;J2V@^T/$Z3RN%+!&"NFQE<J<D J?$OC=\>_VGOV
MS?\ @@EI/BZUO-4UC4_#'CM-,^(U[;;GGU#2K6.1DGF Y<*TMBTK'.6C,C<!
MC0!^I7P^_:P_9=^+7B=O!7PM_:-\#>(]87=G2M#\5VEU<$+G<1''(68#!R0"
M!7H%?F7_ ,$S--_X(T?M":E\.M2^#W@Q/"'Q=\&I;W<>EW^IW%O?7EW#%^]8
M,TAAOT8AWPN7"C)6,9%?II0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 >>_M"_\@;3O^OI__0:*/VA?^0-IW_7T_P#Z#10!5^"O_(Y:Y^/_
M *,->F5YG\%?^1RUS\?_ $8:],H **** "BBB@ HHHH **** "BBB@ HHHH
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M <8 QQ4G_!57]G+3O^">/BWX5_\ !1']C+P-:>$CHFJ0Z;XQTCP]!]EM+M'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!Y[^T+_P @;3O^OI__ $&BC]H7_D#:=_U]/_Z#10!5^"O_
M ".6N?C_ .C#7IE>9_!7_D<M<_'_ -&&O3* "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"_P@WBJX;3YV47.JM*&L[.0 C=F&"X;:>#YJ_@ ?4M%?/W[1OC[QA\7?V1=
M^)_P@@UJ?3-8NM+U#Q-9^&9BNHOHS$->00,A#>:!\IVD'"N.F:M_L^I^S5<?
M#SQ/XS_9?\;:A/:3:2Z7^DS>(+R?[!.D<A#-!=.TEO*>03P&V#&<9H ]VHKY
M._9P_99T?X@_LI>%OB1X1^('B[P]XXU+0%NH_$5GXNOG5KKYMIE@EE:%XR0
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M_'GPATO]F&V\6:#\6_$.G_&NXUZ>+3[H>)]0CC:<ZK(L2S^=)]C6'[.%W;L
MJ.<DD$ _2"BO*/$&M^&(OVK_  3H>K>%Y+C7KKP9J4UOK=OJ\J001I) )(_L
MX^23>7R')RH7H<Y',S?MC_$/6/".J?&3X<_LZ3ZY\/M)EN2VO?\ "2Q07E];
MV[LL]S;6AB.^-2DA4-(C.%X Z4 >^T5\W?%O]HCXQW'QS^$3_!3PK%J_AKQ9
MI>H7UE _B!+1=<0V*S*)0T+&#R0PD!YWEL8&*[WQ9\?O'B_$%?A%\+/A);^(
M/$EEHD&I^)([SQ$+*RTI9B1'"9Q#(TLKE'P!&!M7<2,XH ]4J&_U"PTJSDU'
M5+V&VMX5W2SW$H1$'J6/ 'UKQZ3]LK0H_@ZGQ /@#4CXAD\6GPHG@Q;B/[0=
M=$IC-IYW^KV\%_-Z>7\V,_+7+?M1^-/BWXF_9!^*.G?%?X.1^%IK7PXKVEQ9
M>(8]1MKQ7?E5<1QNKIM&X,F/F!!/. #Z/5E90RL"",@@]:6O#O!_[3GCS2O$
MW@KPO\2?@)>>'="\9$6/AW6I];BFN!<" R1I=6JI_HYD1&P [D$8;!SAVI?M
M3_%35_'OC/X>_"3]F^?Q%<^"M06"^O+CQ)'9V\Z-;QS*(V:)B9V+.HC ( 4,
MSC>%H ]OHKQVZ_;$\-WWP<\%_$KP-X,O]:U7X@SI;>&/#*W"0RRW&&,JRRME
M8XXO+??)@@8'!S5_X<?M!^+=4^*Y^"/QE^%2^%/$%SI#:GHSV>N+J%GJ-NCA
M)0DHCC99$+#*,G3G.,9 /3=/U'3]6LTU#2K^&YMY,^7/;RAT;!(.&!P>01^%
M35\L_LN_&VW^#7[#_P .([#PM<Z_KWB+5;S3/#F@VDZQ->7+7UVQW2/\L4:H
MK,TA!"@=#FO3_ G[1GBJ3XH_\*<^.'PK3PCK-UHTNJ:-/9ZXNHV=_;Q,!,JR
MB*-DE3<"4*<KSGID ]7HKYRNOVV_BI/X8\,_$?P]^S7;W'ACQIKT&E>&+Z\\
M:I;W,LD\C) \T MG$*R%>,.^,C=C->C^#/VB-)UO5_B-HGC#1/["N/AQ?M_:
M0>[\X3:>UO\ :(;T'8NT/&'.SG:4(W&@#T:BN5^"'Q%U+XN?";0?B=JOA-]#
MDUW3UO8],DNO.:*%R3$2^U<EH]CXP,;L<XR>JH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#SW]H7_ ) VG?\ 7T__ *#11^T+_P @;3O^OI__ $&B@"K\%?\
MD<M<_'_T8:],KS/X*_\ (Y:Y^/\ Z,->F4 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR7,D)9,RRD$A2Q11CDU]$7O@/PCJ/C6P^(M[HL<FM:9936EC?EVW10RE3(@
M.TABB]03QQ6O0!\X^-](_:1_:7\-^'/A!XZ^ \GA*TM];T^]\7^(+O7K2X@D
MCM95E,=FD+M(S2N@PSJH0$YR:J?M(?##XG?$KQW+??#;]G2]T#QK;:C;QZ'\
M5=.\36L,"VB2(6DN5219IE\L,AMWB?T!QS7TS10!Y+X9^%/C.+]I#XH^--2T
MP6^C>)_#6CV6DWYGC;S9(8KE9AL#%UVF1/O  YXS@X\OT+X!_&SXB?L.7G[*
M7C/X9KX>UCP_IUG%I.IWVJV]Q9:O/;W7G*%$+LZ1LL2*Q=5(\W@'::^JJ* /
MGGX*?"OP];?$'1M3F_8"@\&W=BSR7/B*XUC3YH[&41, ;<0RO)-N;Y02J8#;
MCR-I^AJ** "BBB@ HHHH *^2_P#@J-_S(W_<3_\ ;2OK2B@#\EZ*_6BB@#R7
M]AC_ )-9\+?]OW_I=<5ZU110!5UNVFO-&N[2W3=)+:R(BYQDE2 .:^?-(_9=
M\?:I^P_X.^'%U;)HOQ"\%VD&H^'IVN(W^Q:I;NSHADC9E*."8VP2N')YQ7T;
M10!\F^&OV9OCGXD_95^&?[-GCCPM-I-O<>*[N_\ B-+9:Q!NLK-+ZYO(H49)
M"7:61X,-'OV%<MC&:Z/XF_LB^*/!?BCP9\9?@WXK\:>*?$/A7Q-"\FG^*/&D
MEX)-,G!BO8XC=R!8W,9!SD9$>,$X%?1]% 'S]\?]0_:%^*7@OQ3\#KO]D6WU
M1-66ZLM(\02^)[)M.6)RRPWDBR$3QR1@J^Q4+;E^5NAK/\1?"KXX?"7XB?"?
MQ5X)^&]WX]A\&?#^XT'5Y;76K2SD><I;(LO^E2ID-Y3'C)]??Z1HH \.\-^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH \]_:%_Y VG?]?3_^@T4?M"_\@;3O^OI__0:* *OP5_Y'
M+7/Q_P#1AKTRO,_@K_R.6N?C_P"C#7IE !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45G:SJ5U8ZAI]M 5V
MW-R4ER,\8SQ6C0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%9UMJ5U+XFN=+<KY45LCH,<Y)YYH T
M:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HK.\,ZE=:KI[W-V5++<R(-HQP#@5HT %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
MGO[0O_(&T[_KZ?\ ]!HH_:%_Y VG?]?3_P#H-% %7X*_\CEKGX_^C#7IE>9_
M!7_D<M<_'_T8:],H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** ,?Q+_R%]'_ .OT_P#H)K8K'\2_\A?1_P#K
M]/\ Z":V* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ K'LO^1WO?^O*+^9K8K'LO^1WO?\ KRB_F: -
MBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH Q_ __ "")?^OV;_T*MBL?P/\ \@B7_K]F_P#0JV*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#SW]H7_ ) VG?\ 7T__ *#11^T+_P @;3O^OI__ $&B@"K\%?\
MD<M<_'_T8:],KS/X*_\ (Y:Y^/\ Z,->F4 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/XE_P"0OH__ %^G
M_P!!-;%8_B7_ )"^C_\ 7Z?_ $$UL4 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/9?\CO>_\ 7E%_
M,UL5CV7_ ".][_UY1?S- &Q1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDZW_ /(5'_#\O_@EI_T=#_Y9.M__ "%1]<PG_/R/WH/]5^)O^@&M_P""I_\
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M?O0?ZK\3?] -;_P5/_Y$^LZ*^3/^'Y?_  2T_P"CH?\ RR=;_P#D*ND^$/\
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M%% !1110 4444 %%%% !1110 4444 %8]E_R.][_ ->47\S6Q6/9?\CO>_\
M7E%_,T ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHK[T_BX**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M//?VA?\ D#:=_P!?3_\ H-%'[0O_ "!M._Z^G_\ 0:* *OP5_P"1RUS\?_1A
MKTRO,_@K_P CEKGX_P#HPUZ90 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 8_B7_ )"^C_\ 7Z?_ $$UL5C^
M)?\ D+Z/_P!?I_\ 036Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %8]E_R.][_P!>47\S6Q6/9?\
M([WO_7E%_,T ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!^7G_  <[?\DC^%/_ &,>I?\ I/%7X[5^Q/\ P<[?\DC^
M%/\ V,>I?^D\5?CM7QN;_P"_R^7Y(_JCPP_Y(VAZS_\ 2Y!1117FGZ %%%%
M!1110 4444 %?2'_  2%_P"4DWPE_P"QC?\ ])IJ^;Z^D/\ @D+_ ,I)OA+_
M -C&_P#Z335OA?\ >8>J_,\CB'_D08O_ *]5/_2&?T>4445]Z?Q<%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'GO[0O_ "!M._Z^
MG_\ 0:*/VA?^0-IW_7T__H-% %7X*_\ (Y:Y^/\ Z,->F5YG\%?^1RUS\?\
MT8:],H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** ,?Q+_P A?1_^OT_^@FMBL?Q+_P A?1_^OT_^@FMB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *Q[+_ )'>]_Z\HOYFMBL>R_Y'>]_Z\HOYF@#8HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /R\_X.=O\
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MUL5C^)?^0OH__7Z?_036Q0 4444 %%%% !1110 4444 %%%% !1110 4444
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M--6^%_WF'JOS/(XA_P"1!B_^O53_ -(9_1Y1117WI_%P4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 >>_M"_\@;3O^OI__0:*/VA?
M^0-IW_7T_P#Z#10!5^"O_(Y:Y^/_ *,->F5YG\%?^1RUS\?_ $8:],H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** ,?Q+_R%]'_Z_3_Z":V*Q_$O_(7T?_K]/_H)K8H **** "BBB@ HHHH
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M% !1110 4444 %%%% &/XE_Y"^C_ /7Z?_036Q6/XE_Y"^C_ /7Z?_036Q0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %8]E_R.][_UY1?S-;%8]E_R.][_ ->47\S0!L4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y>?\'.W
M_)(_A3_V,>I?^D\5?CM7[$_\'.W_ "2/X4_]C'J7_I/%7X[5\;F_^_R^7Y(_
MJCPP_P"2-H>L_P#TN04445YI^@!1110 4444 %%%% !7TA_P2%_Y23?"7_L8
MW_\ 2::OF^OI#_@D+_RDF^$O_8QO_P"DTU;X7_>8>J_,\CB'_D08O_KU4_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K'LO^1WO?^O*+^9K8K'LO^1WO?\
MKRB_F: -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH _+S_@YV_Y)'\*?^QCU+_TGBK\=J_8G_@YV_Y)'\*?^QCU+_TG
MBK\=J^-S?_?Y?+\D?U1X8?\ )&T/6?\ Z7(****\T_0 HHHH **** "BBB@
MKZ0_X)"_\I)OA+_V,;_^DTU?-]?2'_!(7_E)-\)?^QC?_P!)IJWPO^\P]5^9
MY'$/_(@Q?_7JI_Z0S^CRBBBOO3^+@HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH \]_:%_Y VG?]?3_P#H-%'[0O\ R!M._P"OI_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/9?\
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M 'XD^ /A]_P4#^&_P]^'W[/OQ2T;2=-^"D_ARUM=>\$3P70>76+9VU&X4\B
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M5Y+9V5U=Y^U7%M9R2FWMI9LD.\4:LP9@3\S9 /2J*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q[+_ )'>]_Z\
MHOYFMBL>R_Y'>]_Z\HOYF@#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB9[_ +K'_%^C/UOP=_Y*&O\ ]>G_ .EP/F6BBBOEC^C0HHHH **** "BBB@
MHHHH _7_ /X-A/\ DGWQ>_[#.D?^BKJOU-K\LO\ @V$_Y)]\7O\ L,Z1_P"B
MKJOU-K[3*_\ <(?/\V?R;XC?\EGB_6/_ *1$****] ^)"BBB@ HHHH ****
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M2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !OCT4Z:?$^@V]_)8&3?]GD= 70-@;E#9 ; R,' S0!W-%%% !1110 4444
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MJVS\G\6,HRK+<NPTL)AX4VYM-PA&-].MDCU^BBBOHC\,"BBB@ HHHH ****
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M_DX+P;_V,5K_ .C!7#5W/[,__)P7@W_L8K7_ -&"@#]+Z*** "BBB@ HHHH
M**** //?VA?^0-IW_7T__H-%'[0O_(&T[_KZ?_T&B@"K\%?^1RUS\?\ T8:]
M,KS/X*_\CEKGX_\ HPUZ90 4444 %%%% !1110 5^,'[<G_!6/\ X* ?!W]K
MWXA_"[X<_'W^SM"T+Q/<VFE6/_"*Z5-Y$*G"KOEM6=L>K,3[U^S]?SJ_\%,?
M^3_/BU_V.MW_ .A4UN!VO_#ZS_@IK_T<M_Y9NB__ "'1_P /K/\ @IK_ -'+
M?^6;HO\ \AU\L45=D!]3_P##ZS_@IK_T<M_Y9NB__(='_#ZS_@IK_P!'+?\
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M (-A/^2??%[_ +#.D?\ HJZK]3:_++_@V$_Y)]\7O^PSI'_HJZK]3:^TRO\
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MXU\._''PO=>&K[4/%<=S96VI*%::(6T:EQ@GC<"/PK[D_P"$_P#!G_0PV_\
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M *!EO_WY7_"C^R=*_P"@9;_]^5_PH S_ /A/_!G_ $,-O_WT?\*/^$_\&?\
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MI_\ XNCE _IC_P"$_P#!G_0PV_\ WT?\*/\ A/\ P9_T,-O_ -]'_"OYG/\
MA;OQ8_Z*?XB_\'4__P 71_PMWXL?]%/\1?\ @ZG_ /BZ.4#^F/\ X3_P9_T,
M-O\ ]]'_  H_X3_P9_T,-O\ ]]'_  K^9S_A;OQ8_P"BG^(O_!U/_P#%T?\
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M>?\ 0/3_ /)O_DC^:G_AV[^W1_T;-XE_[\)_\51_P[=_;H_Z-F\2_P#?A/\
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MAM_^^C_A7Y??\)1XF_Z&*_\ _ M_\:/^$H\3?]#%?_\ @6_^- 'Z@_\ "?\
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M^%'_  G_ (,_Z&&W_P"^C_A6A_9.E?\ 0,M_^_*_X4?V3I7_ $#+?_ORO^%
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MT_\ R;_Y(_FI_P"';O[='_1LWB7_ +\)_P#%4?\ #MW]NC_HV;Q+_P!^$_\
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MQK]-/[)TK_H&6_\ WY7_  H_LG2O^@9;_P#?E?\ "@#\R_\ A1GQ<_Z$._\
M^^!_C76_ 3X4?$7PS\:O"_B#7O"-W:V5GK=O-=7$JC;&BN"6//0"OT'_ +)T
MK_H&6_\ WY7_  H_LG2O^@9;_P#?E?\ "@#/_P"$_P#!G_0PV_\ WT?\*/\
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MC3KC2=1A\RWNH'AGCW$;D8%6&1@C()Y'- 'Y/45^AW_##'[+/_1+O_*W??\
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M)C\,_P#?U?\ ],][0]@/WXHHHK, HHHH **** "BBB@#'\#_ /((E_Z_9O\
MT*MBL?P/_P @B7_K]F_]"K8H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** //?VA?^0-IW_7T_P#Z#11^T+_R
M!M._Z^G_ /0:* *OP5_Y'+7/Q_\ 1AKTRO,_@K_R.6N?C_Z,->F4 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% &/XE_Y"^C_ /7Z?_036Q6/XE_Y"^C_ /7Z?_036Q0 4444 %%%% !1110
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MQE_8D_9N^/7C+_A87Q#\$WG]M2:>+"\U+1?$-]IDM]:9/[BX-G-'YZ<XP^[
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M ,FS?#K_ +$32/\ TBBK^9VOZ8OV7?\ DV;X=?\ 8B:1_P"D453(#NJ***D
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M^S?^A5L5C^!_^01+_P!?LW_H5;% !1110 4444 %%%% !1110 4444 %%%%
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M:1_Z115_,[7],7[+O_)LWPZ_[$32/_2**ID!W5%%%2 4444 %%%% !6/9?\
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MZ^G_ /0:* *OP5_Y'+7/Q_\ 1AKTRO,_@K_R.6N?C_Z,->F4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/
MXE_Y"^C_ /7Z?_036Q6/XE_Y"^C_ /7Z?_036Q0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^_XB_EIE?E=7ZH_\'+G_ ![_  7_ -_Q%_+3*_*ZK6P!1113 **** "BBB@
MHHHH *^I/^"+7_*3'X9_[^K_ /IGO:^6Z^I/^"+7_*3'X9_[^K_^F>]H>P'[
M\4445F 4444 %%%% !1110!C^!_^01+_ -?LW_H5;%8_@?\ Y!$O_7[-_P"A
M5L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% 'GO[0O_ "!M._Z^G_\ 0:*/VA?^0-IW_7T__H-% %7X*_\
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MHHH **** "OZ8OV7?^39OAU_V(FD?^D45?S.U_3%^R[_ ,FS?#K_ +$32/\
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M_)E?OK11S,#\"O\ ARG_ ,%-?^C:?_+RT7_Y,H_X<I_\%-?^C:?_ "\M%_\
MDROWUHHYF!^!7_#E/_@IK_T;3_Y>6B__ "97O?\ P3#_ ."7G[=/[/'[<O@;
MXQ?&'X'?V/X<T=M1.I:C_P )-IEQY/FZ;=0Q_NX+EY&S)(B_*IQNR< $C]>J
M*5V 4444@"BBB@ HHHH **** ,?P/_R")?\ K]F_]"K8K'\#_P#((E_Z_9O_
M $*MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH \]_:%_Y VG?]?3_^@T4?M"_\@;3O^OI__0:* *OP5_Y'
M+7/Q_P#1AKTRO,_@K_R.6N?C_P"C#7IE !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^)?^0OH__7Z?_036
MQ6/XE_Y"^C_]?I_]!-;% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7B?_!2'_DPKXM_]B)J
M'_HHU[97B?\ P4A_Y,*^+?\ V(FH?^BC36X'\Y]%%%6 4444 %%%% !1110
M4444 %?TQ?LN_P#)LWPZ_P"Q$TC_ -(HJ_F=K^F+]EW_ )-F^'7_ &(FD?\
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M "BBB@ KQ/\ X*0_\F%?%O\ [$34/_11KVRO$_\ @I#_ ,F%?%O_ +$34/\
MT4::W _G/HHHJP"BBB@ HHHH **** "BBB@ K^F+]EW_ )-F^'7_ &(FD?\
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M!5^"O_(Y:Y^/_HPUZ97F?P5_Y'+7/Q_]&&O3* "BBB@ HHHH **** "BBB@
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MQ$TC_P!(HJF0'=4445(!1110 4444 %8]E_R.][_ ->47\S6Q6/9?\CO>_\
M7E%_,T ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!C^!_^01+_ -?LW_H5;%8_@?\ Y!$O_7[-
M_P"A5L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'GO[0O_ "!M._Z^G_\ 0:*/VA?^0-IW_7T__H-% %7X
M*_\ (Y:Y^/\ Z,->F5YG\%?^1RUS\?\ T8:],H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,?Q+_P A?1_^
MOT_^@FMBL?Q+_P A?1_^OT_^@FMB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7_D+Z/\ ]?I_]!-;%8_B7_D+Z/\ ]?I_]!-;% !1110 4444 %%%% !1110
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M C[PQC%7J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@_QU:>!?$^JW=W823B>1D C8#&')[UT__#0NC?\ 0O77_?U:** #_AH71O\
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M?]_5HHH /^&A=&_Z%ZZ_[^K1_P -"Z-_T+UU_P!_5HHH /\ AH71O^A>NO\
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M=&_Z%ZZ_[^K1_P -"Z-_T+UU_P!_5HHH /\ AH71O^A>NO\ OZM'_#0NC?\
M0O77_?U:** #_AH71O\ H7KK_OZM'_#0NC?]"]=?]_5HHH /^&A=&_Z%ZZ_[
M^K1_PT+HW_0O77_?U:** #_AH71O^A>NO^_JT?\ #0NC?]"]=?\ ?U:** #_
M (:%T;_H7KK_ +^K1_PT+HW_ $+UU_W]6BB@ _X:%T;_ *%ZZ_[^K1_PT+HW
M_0O77_?U:** #_AH71O^A>NO^_JT?\-"Z-_T+UU_W]6BB@ _X:%T;_H7KK_O
MZM'_  T+HW_0O77_ ']6BB@ _P"&A=&_Z%ZZ_P"_JT?\-"Z-_P!"]=?]_5HH
MH /^&A=&_P"A>NO^_JT?\-"Z-_T+UU_W]6BB@ _X:%T;_H7KK_OZM'_#0NC?
M]"]=?]_5HHH /^&A=&_Z%ZZ_[^K1_P -"Z-_T+UU_P!_5HHH /\ AH71O^A>
MNO\ OZM'_#0NC?\ 0O77_?U:** #_AH71O\ H7KK_OZM'_#0NC?]"]=?]_5H
MHH /^&A=&_Z%ZZ_[^K1_PT+HW_0O77_?U:** #_AH71O^A>NO^_JT?\ #0NC
M?]"]=?\ ?U:** #_ (:%T;_H7KK_ +^K1_PT+HW_ $+UU_W]6BB@ _X:%T;_
M *%ZZ_[^K1_PT+HW_0O77_?U:** #_AH71O^A>NO^_JT?\-"Z-_T+UU_W]6B
MB@ _X:%T;_H7KK_OZM'_  T+HW_0O77_ ']6BB@ _P"&A=&_Z%ZZ_P"_JT?\
K-"Z-_P!"]=?]_5HHH YGXE_$NQ\=6-M:6FF2P&"4N3(X.<C':BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>cdna-20240429_g18.jpg
<TEXT>
begin 644 cdna-20240429_g18.jpg
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M/^$)UC_H.?JW^-=-10!S/_"$ZQ_T'/U;_&C_ (0G6/\ H.?JW^-=-10!S/\
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MS_PA.L?]!S]6_P :/^$)UC_H.?JW^-=-10!S/_"$ZQ_T'/U;_&C_ (0G6/\
MH.?JW^-=-10!S/\ PA.L?]!S]6_QH_X0G6/^@Y^K?XUTU% ',_\ "$ZQ_P!!
MS]6_QH_X0G6/^@Y^K?XUTU% ',_\(3K'_0<_5O\ &C_A"=8_Z#GZM_C7344
M<S_PA.L?]!S]6_QH_P"$)UC_ *#GZM_C7344 <S_ ,(3K'_0<_5O\:/^$)UC
M_H.?JW^-=-10!S/_  A.L?\ 0<_5O\:/^$)UC_H.?JW^-=-10!S/_"$ZQ_T'
M/U;_ !H_X0G6/^@Y^K?XUTU% ',_\(3K'_0<_5O\:/\ A"=8_P"@Y^K?XUTU
M% ',_P#"$ZQ_T'/U;_&C_A"=8_Z#GZM_C7344 <S_P (3K'_ $'/U;_&C_A"
M=8_Z#GZM_C7344 <S_PA.L?]!S]6_P :/^$)UC_H.?JW^-=-10!S/_"$ZQ_T
M'/U;_&C_ (0G6/\ H.?JW^-=-10!S/\ PA.L?]!S]6_QH_X0G6/^@Y^K?XUT
MU% ',_\ "$ZQ_P!!S]6_QH_X0G6/^@Y^K?XUTU% ',_\(3K'_0<_5O\ &C_A
M"=8_Z#GZM_C7344 <S_PA.L?]!S]6_QH_P"$)UC_ *#GZM_C7344 <S_ ,(3
MK'_0<_5O\:/^$)UC_H.?JW^-=-10!S/_  A.L?\ 0<_5O\:/^$)UC_H.?JW^
M-=-10!S/_"$ZQ_T'/U;_ !H_X0G6/^@Y^K?XUTU% ',_\(3K'_0<_5O\:/\
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M0?<4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KSB]_X_)?^NK?SKT>O.+W_C\E_P"N
MK?SH Z'P3_R&+[_/\1KIJYGP3_R&+[_/\1KIJ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *\-_P""D_[:OAW_ ()X?L/_ !#_ &P?$6D)
MJ/\ PA^C"32]*>0HM]J$\J6UG Q'*H]Q-$&89*IN;'%>Y5\%_P#!S%\"_'?Q
M]_X(S?%KP_\ #C2Y[_4M"CT[Q ]A;(6>:UL;Z&>Z( Z[+=9I<=_*H ^&/V#_
M -A;_@M7_P %C_@7!_P4/^-W_!9;XC?!U?&%U<W/@#PAX$%W#91VT<SPI,]M
M:WMK%%$61U1"LDDD8#O(2_/Z0>%/VG]3_P""4?\ P3@\.>./^"QO[5.AZKXJ
MT&XN],U7QCI=K)*_B*4WERVGQV\"0I)-<M9+!O CX:.5W8JK2GY^_P"#>S_@
MJG^PSXB_X)2?#;X>>.?VF/ O@WQ/\-/#QT7Q7H/BOQ1::;/;"WD<1W06XD3S
M(9(?+D\U<J&9E)#*P'R5_P ''7[3'[/?[3WQQ_81_:/TSQ_9>+?V;[KXG:I%
MXAUR&"0Z9<K::WIMMJ0D$BKO40V]PJL05=$E:,LC%B ?=O[)'_!S/_P2S_:_
M^-^C_L^>%_&OBSPEXB\27$5OX9'CSPU]AMM6GD.(H8IHY)45Y#@)YA0.Q"J2
MS!3Z=^UU_P %NO\ @GG^PK^T#?\ [-O[3_Q5OO#7B#3O!2^)Y99=&EEMI;5G
M9(X(GCRTMR[*=L2J21R2 #C\VO\ @[H^(/P#^-?A;]FOP'^S)XS\-^)?BY=>
M/"/!H\':C;W5Y%831QQQ!6MV8HDET;3RL\,T;%,[6QN?M=?#7P-\5O\ @\@^
M!7@WXJ^$-,\0:;_PJ\7LNG:G9K-;O<VNDZY<P2F-P03'/#'*N>C(I[4 ?57P
MI_X.G/\ @CO\4/AKXM^)-W\;=9\+#PC!'+-H7BGP^\.HZHLC[$^PPPM*+IBY
M *JVY =[A$!<>S_\$U/^"S_[#7_!5F3Q#I/[+GBS68]<\,11SZOX;\4:3]BO
MDM7;8MRBJ[I+%O\ E)1R4)4.%WIN_."#X#_!CQ#_ ,'G>KZ1KOPNT*\LH/ L
M.OPV-QID;P)J::%;E;SRR-OFAOG#XR'^?[P#5O\ [!?AW0O O_!XE^T]X=\&
MZ3;Z983_  K>XFL[&(11O+/!X;N9G*K@9>9WD)[LQ/4T ?2WC[_@Z=_X)#_#
MSP-J'B[4_BEXFNK_ $_Q;=Z WA2P\,.VJR2VPC,MR(F=42V_>*%ED=-[*ZJ"
M4<+]0_L;_P#!2C]CS]NO]F6\_:W^ WQ7MW\&Z1]I7Q+=:XGV&707MXA-.EZL
MAQ!LB(D+9*%"&#%>:_&S_@UM^+O[!WPN^,G[5A_:3\;?#[0/&-QXCE:QN_&U
MS;6\DN@K+>?;8XI;G"F+<4,T:G)&PN" N/G#]AO3?'&H_P#!&[_@IMXL_9QL
M;^'P+?Z_X:7PBEK$ZHNG1ZQ<R:@JCC:%TN6'S!V0C.!0!^OD/_!U'_P27E\;
MQZ&WBSQ_'X8EUK^RXOB9+X NE\/-<>GGG]]C'/,.0OS$8YKZ._;(_P""KO[$
M_P"P;J_PMLOVCOB<=,L?B_=3Q>$?$%I;_:--$4*VS/=3W"MLB@"W<#>9R"K$
M] 37XU_LL?LK?MR_MX?\$/\ PS^SYHW_  44_9=\._ R\T*%+W0]9T8V^IZ!
M/;7WVIUN[G_EC<BXC+O(<;PY;E7R;O\ P7*_9STKX9?"[_@EM^RUXZ\=:1\1
M-+TVZ;0+W7=.?S-/URQ,GAN$-"VX[[=X2%1@?F3!XS0!^D'[)W_!R;_P2R_;
M+_:?L_V3_A'\2O$4'B#6;Q[3PSJ7B#PU)9Z?K<X!*Q02LQ='<*=BS)$7.%&7
M95/4_MP?\%X?V"_V#OCK_P ,Q_$*\\9^+?'\%@E[JOA7X=>%)-5N=+MWC$J/
M<_,B(6C*R; S.$9690KJ3\)?\'&7PW^'WPP_X*F?\$Z=7^&_@C2= N!\3;?3
MU?1M/CM@MK::WH1MH (P (XO/EV*.%\QL8S6]_P4P_8X_:*_9F_;F^,/_!97
M_@E%^W-\.+7QEHOAGR_C=\,/%>H6DS1P6UE:R26_S%PAEBM;:;R9?(D#+NCF
MPZH #[R\>?\ !:#_ ()^_#+]A#PO_P %&_&_Q5O['X:^,[O[#X9G?P]=-?WU
M^'N$:S6U5"ZRJUI<@EL(/)8[]I!/GG[&/_!Q=_P3?_;<_:!T[]E_P-K/C/PI
MXSUM6_X1[3/'WA8Z>NJN$9_+AD621 Y56*K(4WXPNYB ?CGXW?\ !QCXJU7_
M ()/? ;]JW0_V/?A_/\ %/XC_$J_T?1H?%ULS^&_#^KV3M%/K$)9ED0O]I&W
M]ZC1^=<!I7$;>9X)^W3-^V_9?\%W/V(+7]NO]H'X.>,O&:>/=",%K\(K&6#^
MR+*76+8B*Z,W[UUD+2-$6 !7S"!\QH ]S_:/_P"#IW0?@C_P6<C^#L_CFXC_
M &<O!\.I:%\1;=?!'F:H->M4OX6,#DB1HQ=QV@!&%*;SBO9/VROB1^QO^T%_
MP58_8G^/-S^VM\6/">K>,_#.DZ]\.? &A:%+_97B&SN9VNK=KU_-7[(TPD$,
MRLDA:-%4[,9KQK]L#Q+\./AC_P 'CGP3\4?%'6]&T'0I?A3,)]1UR>*VM#)-
MI.O0Q[Y)2$R\Q5 2>7( Y(J]_P %?=9T#Q%_P<=_L#^(/"FJV=_I=_8:?<:;
M?:?.DMO<6[ZE.T<D3H2KHRD%64D$$$<4 ?=O_!0S_@N=_P $^/\ @FAXYL?A
M+\?_ !]J^I^-;^V2Y3P9X+T9M1U""!S\DDPW)'#NZJKN'8?,JD<UTO\ P3F_
MX*]_L._\%2M(U>?]E;XBWDVL>'D237O"GB#36LM3L8G.U93$25DC+?+OB=U5
MB Q!(!_,O_@FUXX^&'PZ_P"#J']K6\_:W\1Z1I'B^ZMK^/X>W_BNZC@_T4SV
M;0QV[S$ 2-IOD; IW&%9 /EW"K/[#^H^ _B;_P '?OQF^(7[(=]I]_X)M? $
M_P#PFNJ^&W1].N+HV.FQ7.'C^1F;40I8C[TL4K<X)H ^IO&7_!UC_P $?_!O
MPYD\?3?$_P 4WUTGB:[T4>%=/\+.VJEK=8FDNC$[JB6Q\Y0DCNID99%4$QN%
M^QOV)/VX/V<?^"A?P T[]I3]EWQJVM>&K^YEM9?M%JUO<V-W%CS;6XB?F.5=
MRG'(*NK*65E8_D9_P9_? ?X+_$'X9_M+^*O'?PLT'6=2O_'0T&ZOM3TR.>5]
M,D@D:2SW."1$[,2Z# ?"[L[5QV/_  9/3SK^PA\7-/\ .8PP_&%FCC+<*QTN
MR!/U(5<_04 ?K+^TQ\>/!_[+G[/'C?\ :.\?2A=&\#>%K[6[]=X5I4MH'E\I
M2?XW*A%'4LP ZU_/!_P2O_X*;_\ !3?X._\ !03]G?X^_MU?M)^,]=^$?[4M
M[K%EI6CZ]XCN9M,M7EU&:PC:&WF8QVHAO1:,I4 +;S8!"M7WG_P=R_M+>*?#
M'[$_@O\ 83^$L4U[XT_:!\=VNE6NDVC@37=C:30RM&O(PTEY)I\8S@,'<$XS
M7YX_\%8OA%_P5^UW_@FG\,O OQQ_X)2Z=\*_!?[,EI8OI/Q!T+Q[8WU[:6JP
M163F2*&Z=SYLPMII)$4D/%O.%W$ ']#_ .V-^VE^S;^P/\#K_P#:'_:H^)-O
MX9\,6,Z6Z3R0O-/>73AC';6\,89YI6VL0J@X569MJJS#Y&^!'_!SQ_P2Q^/_
M (=\;Z]X=\4>-])D\!^%)_$FI:;KO@Z2.XO-,A>-))[;RGD23:TL?R,RL0Q(
M!"L1^<?_  78_; TO]M_]BW_ ()V_M@_$(&Y^&_B/Q!=3?%J&*(M:IJ<+Z9!
M>0NJ]2/(U=4&,E0^!S7[=>#_ -H#_@GG\3/C'X2\'_#OXF_"KQ+XYN?"=T_@
MZ#0+NPO[Z+1 (3.('@WM!:L/)RN51]@P&V< 'YD?\$1?^#FI/VJOCQKG[.'[
M:_C5[GQ-XU^(,.G_  ;CT'P9Y,(LY?-Q'<R1'Y2"(L,X)&6R?3])/V3O^"F?
M[+7[:7Q]^+?[-GP/U?69_$_P4U]]'\;Q:EH[V\*7*W-Q;-Y$A)$JB6UF7/'0
M$#!!K\N_^#2CXB?"#P=X[_:B^'OC?QMX=TKQ->?%ZV71M'U74((+RX)>^C"P
M1R,'D.\;<("<X'<50_X(>?M%_ ;]F+_@L_\ \%#]-_:*^,7AKP,VH_$O5=0L
M)/%>M0Z?'<6]OKVK/,Z/.RJVU+B%\ YVOG& : /U!_9H_P""L/[&O[5GBGXW
M>%?AIXOU2W?]GN_DMOB7>ZYI#VMO9A&O5>:-R3YL:FPN<D '" X^85\P7'_!
MVA_P2(M_%<.E'Q#\2&T">_\ LL?CG_A7MPNDDY(+Y9A<%1@D@0[\ _+7Q/\
M\$'/VM_A7\,=2_X*C?MKP>&U\;>#;+4$\46FD^3M37;![KQ-/%$RRH=D<R.H
M;>AVJY+*<%:\_P#V_/VN/^"B_P"W!_P09U?]J+XK>/\ ]FCP+\$O$FKV5CX3
M^$'A#29H]=)L];B@C@MVD=DBFC,+3ND9R;:.0[4#%  ?3/\ P=Y>,?#OCKX%
M?LI>._ _B&WU+1M:^)HU#2-3L9P\-W;RVL$D,\;#AE9&#*PZALUH_P#!1J61
M?^#OW]D15D8 ?".' !]9_% /YBOF3_@L+-+/_P $3?\ @FN\TC.1:Z*H+'/
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M%:QMO%<NHCXA>.;&Y2\BCG@MXH=)MH&NKR:<[X)9%1'))FD.U54M7FW[.O\
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M,'Y!Q\PKR3X-_P#!RC_P2X^/_P 7?A7\#?A/X^\3:MXD^+5Y]ET>QB\-LO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQL61#)=32;$!8G:FU2<$@GFOHNB@#Y+T'_@AQ_P3#\+?MF1_M\>&?V:8-/\
MB5%KLFMQZC9Z_?QVBZG(6+W@LUG^SB0EV8@)LW'=MW?-53]IK_@@U_P2J_:_
M_:';]J/X]_LL6>K>,+F6*75[NVUR_LX-5>-55'NK>WG2*9@% +%<N  Y<<5]
M?T4 > _!C_@EU^P=^SQ:_%C3O@K^SY8^';/XWP>1\2[#3]4O5MM3A\JYB$,<
M1F*6482[N0$MA$%$O &U-O6_L?\ [&/[-O[!?P7M_P!GO]E/X=?\(OX1M;^>
M]BTLZM=WI%Q,P:5S+=RRR') X+8&. *]1HH \7_98_X)[?L@_L4^._B+\2_V
M9OA(/#6M?%?6H]6\>W@UR^N_[2NTDN95<)=3R)  ]W<MMB"+^](QA5"K^R9_
MP3W_ &0_V&M=\=>)?V7/A(/#%[\2=;75O&<W]N7UY]ONU:9E<"ZGD$(#3S';
M&$7YSQ@ #V>B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KSB]_X_)?^NK?SKT>O.+W_ (_)?^NK?SH Z'P3_P AB^_S_$:Z:N9\
M$_\ (8OO\_Q&NFH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*** "OW@_P"",O\ RC7^&_\ W&/_ $\WU?@_7[P?\$9?^4:_PW_[C'_IYOJ
M.^_:K_X*"?L7?L/3Z):_M9_M&>&_ DOB-+A]#BUVY9&O%@,8E9 JDX4RQ@D_
MWA6GX-_;3_9+^(O[/VJ?M5_#_P#:)\(ZY\.=#L;F[UGQAI&M17%E816\?F3^
M<\9/EM&GS,C .,C(Y%?&'_!3;XZVO[.?_!97]E'XGWOPJ\=>,X[?X<_$" Z%
M\.O"\NL:G)YB::N]+:([F1>K-_".:\@\;_ GXKZ9^QA_P4J_;7\4_L^ZK\(?
M"'QM^'[2^!_AMK\$%MJ,*:;H-S;W6JW=K [QVDUY-+O,>?,_=9?)*LP!]U?
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ME))(;9%*$@M&Q#KM(S0!]3_LJ_M]?L9?MOV6HWG[)_[1_A?QPVCE?[6L]&U
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M_@1K_BN\:XO+#PM<:'YSL26ATR_NM.AY/4>5:QX]J /L>BBB@ HHHH ****
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M?!K]HX>%/&G[>W[,MC^P7\4OC7J/C;]H+Q!%I^G^&O!"WGA^::?2;&".VO\
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MX[_!S]F?X6ZK\;/C[\1]*\)>$]$2-M5U[6KH0V]OYDBQ1@L>I:1T15&2S,
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MAX)N]2LX@ES?^'-3L+T7\$Q7F:%!$C -D1EV(P6)(!]_R2)$C2RN%502S,<
M#U-?.'A3_@L!_P $O_'/QHB_9[\(_MT?#F_\6W.H?8+/3;?Q#&8[J[+!1;PW
M'^HFE+$*(T=F+$  DXKS+_@XI^)'C+X;?\$COB9+X*\27&BR>(+K1?#NJ:W:
MR;6L=.U'5K2SO'W=@UO-)$3Z2U]->%/V3?V:?!OP/T#]F[1?@?X8/@?PQ#:I
MHGANZT6&:UMFMBK0S!'4CSE=1)YOW]_SYW'- $G[0?[5'[.G[*6B:+XC_:.^
M,6A^#;'Q%KT.BZ)=:Y=B%+R_E5FC@0_WBJ,<G@!>2*U?C9\;OA+^SA\+=7^-
MGQT\?:=X7\)Z#"DNL:[JLVRWM4>18D+'!^\[HH Y)8 =:_+;_@JQXI_8L_;K
M_P""A/CG]CK]K']J?X:^ ?#7P<^ E_::&?'OC:PTG/CGQ)$/L]W$MU*GG_8K
M&"&3*@F-[T XW?-G?M>?MC/^W)_P:4^)?CSK.KQ7WB)?">BZ-XSD@N5F+:Q8
M:_I]I=2;D)4^:\7GK@D%)T()!!H _1?]F+_@I%^P;^V=KUWX3_9<_:O\%>-=
M8L;<W%SHVCZRAO$A! ,HMWVR-&"0"X4J"P!(R*]0^)_Q(\&?!OX;>(/BY\1M
M;CTWP_X7T6ZU;7-0F^[;6EO$TTTA]E1&/X5^?WB)/B;_ ,%'?^"E?[.O[0/P
ML_8I^)OPNT+X*7^M:IXU^)/Q4\(KX>O=0M[JP>UAT6T@D<W%TDCN6D+*L4:J
M<$LVT^A_\'".M:@G_!,O7_AO8W<EO'\0O&_A7PEJ%S$Y4QV=_KEG%<C(Z!X?
M,C.>TAH ]WUK]O;]F+P#^RKX;_;'^./Q%M/AMX-\4Z)9ZEIC^/[J'3KK%U )
MX;=HC(V;DQG/DH6<8;CY3CF_V$O^"E/[/'[<O[&MC^V'X;\:^'=*LK;P_P#V
MCXZTB#Q-#?-X1D6 SS6][(BH8WCC!9MZ)P"0,<UY[_P4R_8__:.\=?%SX!?M
MA?L@>"/"'B_7_P!G[5-9EB^%/B^__L^RU^TU&RBM6-O<['CM;RW$(,#NNQ3(
MQ)&-K<5?_MR?"S]JW]CC]KKX?W_[->M_!_XR^"_A-JX^*O@7Q1IUJM]^_P!%
MO#:7:7EL6CU&V=%D$<X;H/NJK(6 /L?]GG]I3X"?M9?#*V^,O[-OQ7T7QGX7
MN[B6W@UG0KL2PF:-MLD9[HZG&58 X(.,$&J6L?M<?LS:!^TCI/['^L?&WP_!
M\3]<TE]3TGP0]\/[0N+1$E=I1&.@V0RMS@E8V(! S7YI?\$4?%F@?\$]_%G@
MGX,>-=7@T7X;_M!_LJ^$_BSX5O+I_+M;+Q!IGA^QM_$<()ZO);K:W[GH KGV
MKB_V6_#^O_%#_@J3^R/_ ,%'/B)I,]KXC_:6\:_%+Q-IMO>)B:P\*6_AF*S\
M/V1[8%D@N<CJUZYZF@#]8?@%^U!\,_VC-9\?>&O R:C:ZI\-/'-UX4\5:7K%
MJL$\%Y#''*DJJ&;=;S0S1312\;T?H"&4>BU\/_ ^[D^'7_!P!\=_AUHQ(L?B
M'^S]X1\9:M&/NC4+*^O=)5\=F:W6-2>I$:?W17W!0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %><7O_'Y+_P!=6_G7H]><7O\ Q^2_]=6_G0!T/@G_
M )#%]_G^(UTU<SX)_P"0Q??Y_B-=-0 4444 %%%% !1110 4444 %%%% !11
M10 4444 ?'__  5<_9;^.W[2O_"!?\*4\"_VU_8O]J?VG_Q,[6V\GSOL?E_Z
M^5-V?*D^[G&WG&1GX_\ ^'6_[=O_ $0S_P N?2__ ))K]@** /Q__P"'6_[=
MO_1#/_+GTO\ ^2:/^'6_[=O_ $0S_P N?2__ ))K]@** /Q__P"'6_[=O_1#
M/_+GTO\ ^2:^P/\ @E'^RW\=OV:O^$]_X77X%_L7^VO[+_LS_B9VMSYWD_;/
M,_U$K[<>;'][&=W&<''V!10!X=_P40_8Q7]O?]FBX_9V;XD'PIY_BC0]8_M@
M:/\ ;MO]G:G;WWE>5YT6?,\CR]V_Y=^[#8VGW&BB@#X.^$'_  2^_P""A?[,
M>H>.]*_9@_X*B>%O#OA;QG\3-=\9)H>M_L\1ZI/8SZG=M<20FY.LQ^:$RJAM
MB9VYVC.!Z/\ M:?\$YO'_P 8/CYX3_;2_9C_ &HKCX3_ !K\,>%G\-7_ (G7
MPK%JVE^)-&>7SVL+_3Y)8]Z"?=)&Z2J\9<G+$(5^JJ* /DW]GO\ X)S?%JR_
M:ETO]MG]NO\ :N/Q?^('A71;O2OAY9:5X.BT#0O"4%V MW+;6BS3O+=3(HC:
MXDE)\LE-N NWW']IGX:_&[XI_#)O#W[/'[1,OPP\50ZA#=6/B8>&+;6(2J$[
M[>>TN"HEAD4D-M>-P0"KJ1SZ#10!\C? S_@G/\<Y/VQ]#_;H_;F_:SL?B=XP
M\$^&K[1/AUHWA?P&OA[2- CO=JWESY9NKF6XN944)N:0*JD@*3M*^M_MS?L7
M?"C]OS]G#6?V;OB]=:E8V>H36]YI6NZ'<B'4-%U&WD$MM?6LF#LEBD4$<8(+
M*>&->O44 ?(WP?\ V-?^"G&A^+/#Y^/7_!67_A+/#/AF[2X72]!^#5CH][K[
M1 F)-2NQ<REXMP4RQVZ0&8 @NH8UT'[$7_!+KX"_LG_L[Z9\(_B+X>\,_$_Q
M5_:6HZKXL^(7B'P7:K>:_J5]>S7<]S(DAF,?S3;%3S&PJ*,FOIFB@#X2TC_@
MB=#X<_9]M?V8_#O[2AM?"&@?M2VWQ;\$:</!H(T'3XM1&H'PXF+P!X_.,Q6Y
MPI7SCF%L<_=M%% 'QU_P6\^&7C3Q!^R5X=_:'^&GAJ\UKQ#^S_\ %?P[\4+#
M1=/A,D^H6^EW)%] BCEB;&>[;:.6V;1R14G[>GA7_@HCKWB+P-\;_P#@GC^U
M7>:7IGBG4M T'7?!VH_#RQUG3;/3KF\8S^(E,SPW$4D%M.7>+S-LHAC4A#\U
M?8-% 'Q+JW_!&;2M;_8:^.O[,6O_ +2^L:SX_P#VA[R34?B+\7=;\/0/)/?$
M0I&8M/MY(8HK>**%4C@60;0S?.> -+_@H1_P1P^%O_!0;QG\%?%WC/XEWFAK
M\+-0BA\2V5GIGF)XTT$36MQ+HUUB9-D+SV4$FX^:%_> )E@R_9%% 'B.L?L;
M+JW_  45T+]OS_A8IC.B?!^_\"CPG_9&?.^TZG;WWVS[5YOR[?(\ORO*.=^[
M>,;3X_\ \$E?!OB'QK\0OVD?V\O%.AWEA_PNSXR3)X5COK9H99_#>A6Z:/IU
MRR. R>:8+F500,HZ,.&K[.HH **** "BBB@ HHHH **** "BBB@#\E_^"FG_
M  3+_;>_:#_;>\;?%_X0?!/^U_#NK_V;_9VH_P#"2:;;^;Y6FVL$G[N>Y21<
M21NOS*,[<C(()\'_ .',O_!2C_HV_P#\O#1O_DROW@HH _!__AS+_P %*/\
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MQM<>'_#/[+U[>RZ/HMUI_P!LFUR*XTJ;3\2W'FQ^3)NE,[R"-P[;@%0'(RO
MW_!(?X7>!_\ @J[XB_X*AV_Q#NYWUG0I%T[X>MIVVSTK7I[:WL[S6HI?-QYT
M]G;1P,HB4_/(Q=MP"_7E% 'Q[KOPHOO^"6_[-O[6/[3FA>+;[QCJOCWQCK?Q
M"T/1=-\.NEQ;:C=:?:V=GI<:QR2M<LUQ!$!* F?.^X-N3Z1_P2[_ &6]1_8K
M_P"">OPB_9BUY%75O"O@JUBU]$8,JZE,#<7H4C[P%S-, >XP>]>]44 %%%%
M!1110 4444 %%%% !1110!_(%_Q"X_\ !=?_ *,9_P#,F^&/_EG1_P 0N/\
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M5^SQ0_:+F23+!F,DLS$EL *!BN>UO]CM=8_X*'>'_P!O8_$0QG0OA%J/@?\
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M?!/X?:AXOUKX"_';PM\49/".CQ&2\UFTTJ>7[1;P(/\ 62"*=Y @Y/E$*"V
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MX(^)D>BVQ@M9;ZSN"T-U!&>1#-:2VTBMT8EB..!T?[<?@C]M_5="?Q]^R?\
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MHH **** "BBB@ HKP7]H/]E7XH?%SXC2>,?"GQ:_L>T>TBB%EYDXPR@@M\C
M<UQ'_# _QT_Z.$/_ '^NO_BJ /8_CE^U;\-/@1K.G>'O$+S7E[>3*;FVLL,]
MG;GK,X_DO5N:]#T'7M&\3Z-;>(?#VI0WEE>0B6VN8'W)(AZ$'_.*^"/C;^QU
M\:/AQK-C(X?Q,NL7"P17VGJ[O]H;@)(&Y4GLQ.#@\C%>A^'/^"?7QPL=&@C3
MXRV^F,Z!Y;&UFN"D3GDC*D GU('YT ?7]%?)W_# _P =/^CA#_W^NO\ XJO>
MOV?/AEXD^$?PYB\'>*_%/]L7B7<LK7NYSE6((7YR3Q0!\3_\%EO^"F7[77[
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M]!_\$.O^40G[.O\ V2G2O_1(K\V;JP_X(CZW^V/^V=X+_P""J7C"QL?$=_\
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MX$)HUI%H^N_#4:SJ?C*:ZL([J74IHI+V$VE@9'6-/(WL V6?)4'J?V8%8?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7G%[_Q^2_]=6_G7H]><7O_ !^2_P#75OYT =#X)_Y#%]_G
M^(UTU<SX)_Y#%]_G^(UTU !1110 4444 %%%% !1110 4444 %%%% !1110
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MMHX8HUQ'%$@55'H .!26UC96;RR6EG%$TTF^9HXPID;^\V.I]S4M% !1110
M5#-I]A<745]/8PO-#GR9GB!://7:3R,^U344 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5YQ>_P#'Y+_UU;^=>CUYQ>_\?DO_
M %U;^= '0^"?^0Q??Y_B-=-7,^"?^0Q??Y_B-=-0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117P
MQ_P4P_: ^/?Q&_:D\'_\$FO@5\3O"/PQ?XQ_#'7]0UKXE>+]&EU&4VZ%;0Z=
MI-JMS;++?%9GE)>0[(TW!210!]ST5\Y? 3X-?M[_  ,_8FF^ TOQ5^%FO_$'
MPQ;0:+\.O%C^&=0L]+?2H8;:&&?4;(7,LAN45;@E(I@DA2$;TW.1XW\'?VA_
MV]/V??\ @J7X0_8'_:5_:$\(?&?0_B'\,]4\3KJ^A> 5\/ZEX3ELI8T!GABN
M9T>SG+F-'<AS)P#\AW@'WC17Y[_\%//B_P#\%5?V*?@C\1OV]=(_:R^$=GX7
M\#:J+G0?A%/\.99(M9THWB0P07&JR7BSB_FCD4[88EC$O[M=P.^O3?VR_P!M
M3]H#2_$_P4_99_9:TC0O#GQ/^-NG7NKWFM^.K.2ZLO VAV%I#/?WD]M&\37%
MPK7$4$,1=$:0DNP5"* /KNBO)/V2_ _[3G@OP_JG_#1?[66@_%R*]GBE\/:U
MHW@*'0GMHPK+-'((+J>*X!8*590A7Y@=W!'K= !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT:UT.&-869=1O+^9([><^<%2!1([F*7@!":^8OVD?V/_ -HO]A&T^+W[??\
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M?&3X=_%;QPG@&\\ ^.O"^D0ZEI4(LI'BU.QN].MK>0QVPA02I*LB[''(+!@
M?H[1110 4444 9S^+O#4;F.36(0RG# GH:3_ (3'PQ_T&H/^^JN'3[ G)LH2
M3U)C%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\
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M\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT*
M*?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\ ^?&'
M_OT* *?_  F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\
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M<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\
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M\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT*
M*?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\ ^?&'
M_OT* *?_  F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\
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M(\5:C^SWJ'A2/1H]4MQJ$*6D8U>VF:2Z>&26.1(I8_*F*Y=6(52 ?4G[6_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7E?
M[8W[('P1_;;^"MU\&_CGX T_7[2*X_M'03?33Q'3=4CBE2WO(I;=TEBD3S7&
M^-E;:[#.&(KU2B@#YF_X)U?\$OOV??V!_AII$VE^#['6/BC>^#K#2OB)\2[^
MYNKZ_P!?N8X8_M+":]DEEAMI)U:06Z%8Q\OR_*,8?AK_ ((;?\$R?"OBK2/$
M=C^S_?W5EX>U5-3\/^$M7\>:W?>'M-O$.Y9H=)N+Q[)"IZ+Y6Q?X5&!7UK10
M!\__ +2O_!,3]CW]K'XCM\7?BWX1\31>))M*BTR^U7PG\1M;T%[ZRC9V2WN%
MTV\@2= 9'P74L Q (%=-IG["/['VC?LJ3_L/Z9^SWX<A^%%SIKV-SX)6T/V2
M:)W\QF<D[VE,G[WSBWF^8!)OW@-7K5% '@7[+7_!,;]C']CGQW<_%+X)_#34
MO^$HN-'72(_$?BGQ?JFO7UIIH8,+*VFU*YG:V@W $QQ%0Q4;LX&/?:** "BB
MB@ HHHH **** "BBB@ KSB]_X_)?^NK?SKT>O.+W_C\E_P"NK?SH Z'P3_R&
M+[_/\1KIJYGP3_R&+[_/\1KIJ "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** .(U+]GSX<ZO^T9H_[4M_:W;^+-"\&ZAX8TR4W9^SQ6%[=6
MEU<?NNGF-)90?/U"J1WKL[NSM+^V>SO[6.>&08DBF0,K#T(/!KQ/]M_]LS_A
MC7PMH7B7_A6__"2?VUJ$MMY/]L?8_)V('W9\F3=GIC ^M?-__#]#_JUS_P O
M;_[BH ^_HHHH(E@@C5$10J(BX"@= !V%.K\__P#A^A_U:Y_Y>W_W%1_P_0_Z
MM<_\O;_[BH ^_P (BN7" ,V-Q Y-+7Y__P##]#_JUS_R]O\ [BH_X?H?]6N?
M^7M_]Q4 ??5SIVGWD\-U=V,,LENQ:"22(,T9/=2>A^E35^?_ /P_0_ZM<_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5YQ>_\?DO_75OYUZ/7G%[_P ?
MDO\ UU;^= '0^"?^0Q??Y_B-=-7,^"?^0Q??Y_B-=-0 4444 %%%% !1110
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MUX+^.<EO\.OBK'!X;\9 B%8Y"4M=1D'&(BQS')GCRF.2?NEN@^FJ^=/VP?\
M@GE\/?VC([CQIX,:#P[XRP6&H1QXM[]AT%PJC.[MYJ_,.X<  >,_ W]N3XR_
MLH>,$_9__;2T+49+.VQ'9Z[*IEN;:+.%<L,_:X..'4EQ@CYL;0 ?>-%4/#'B
MGPYXUT"U\5>$=<M=2TV]B$EI>V<PDCE4]PP_+V((-7Z "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KSB]_X_)?^NK?SKT>O.+W_ (_)?^NK?SH Z'P3_P AB^_S_$:Z
M:N9\$_\ (8OO\_Q&NFH **** "BBB@ HHHH **** "BN6^(OQI^&/PGUWPEX
M:^(/BJ/3K_QUXD&@>$[9K>61M0U'[+<7?D+Y:L$_<6MPY=]J 1X+9*@]30 4
M444 %%%% !1110 4444 ?#W_  6__P"27>!O^P_<_P#H@5^<%?H__P %O_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"4NM$GM0NO7)#2D8;]R..*_.ZOT?_P""W_\ R2[P-_V'[G_T0*_."@ HHHH
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MO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\X
MO?\ C\E_ZZM_.O1Z\XO?^/R7_KJW\Z .A\$_\AB^_P _Q&NFKF?!/_(8OO\
M/\1KIJ "BBB@ HHK\HO^#JBV_P""F>G_  6^%?CO_@GUXI^+NE:1HNMZJWQ*
MN?@[J=]#?10/%;?999H[&1)I84"71Y/EJ2"Q7*F@#]7:*_EO_8W\0>/_ -L6
M>W\.6_\ P=>_%[X<>*)F$;^%_BIJWB'1Y5DSC8+EM::T=BV0%68N3_",XK]B
M?^"2W_!+3]O7]BWXZZG\;/VF_P#@KQXX^/\ X6UCP7+IVE^%_$&J:G=6<5S+
M<VL\>H(;N_N(]RQPR1J44$K<-\P&0P!^@]%%% !1110 4444 %%%% !1110
M4444 ?#W_!;_ /Y)=X&_[#]S_P"B!7YP5^C_ /P6_P#^27>!O^P_<_\ H@5^
M<% !1110 4444 %?KC_P2>_Y,C\-_P#80U'_ -+):_(ZOUQ_X)/?\F1^&_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M &'[G_T0*_."OT?_ ."W_P#R2[P-_P!A^Y_]$"OS@H **** "BBB@ K]<?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***\G_;/_ &Q/AA^P
MY\$I/C7\4-*UK54GUFQT70/#GAFQ6YU+7-5O)EAM;&UC9D5I9'; W,J@!B2,
M4 >L45\I_P#!/?\ :0_;J^(WQ \<?#S]N']C_P <> 9[O6]1U_P#K&HRZ)=Z
M7!X?,T$5KI4ESI=U+B^0.9"LHW./,(<B/%<)\5?^"SGC7]G[5-&^(7[1?_!-
MWXM>!/@SK?BVW\/P_%3Q#?:6LME-<3>3!<WFD1W#7EI:N_\ '( X4C*;F5"
M?<]%?+/[6_\ P46^)?P$_:CT3]D;X#_L1>+?C'XMU7P#-XON8/#OB?2],2RT
MZ.]6R9F;4)HE<^;)&,*<X<<'!QO>-?V_X_@!^Q%??MD_MB?L^>*/AK<Z?-]G
M?X=M?66KZO=74MV+6RM;8V4SPS37,CQ!%#C;YF7*A6( /HBBOD[X'?\ !33Q
MMK_[37A;]D_]KK]BKQ?\$?$_Q$T>^U'X:3:YXBTS5[+7Q91K-=VGG6$K_9KN
M*%O-,+C[BL=WW0WUC0 4444 %%%% !1110 4444 %><7O_'Y+_UU;^=>CUYQ
M>_\ 'Y+_ -=6_G0!T/@G_D,7W^?XC735S/@G_D,7W^?XC734 %%%% !7X@?\
M%K?VF/\ @H9X7_;F^ _PU_;@LO#WPM_9CG_:/@?3_'/@KQ?<6\FMZ3#<1A%U
M=EGS;@6SN[Y5$&^1A_JLC]OZ\G_;0_8B_9G_ ."@?P/N_P!GG]JSX;P^)?#5
MS=1W<$1N)()[*[C#".YMYHBKPRJ'<;E/*NRL&5F4@'XS_P#!57XF6_\ P<$?
M\%@OAG_P2D_9A^/HOO@QX,TR76_B+XI\&WZ7EC+<JAEN;A)(RT-P8HC;6D,A
MWK'<7<HP1N!SOV-?VH_!'_!M=_P4V^-W_!._QKXL^*/Q)^";>'-,U[PY#HNA
MIJE]HE_-';R&6>&-XDA1H[B1)98U'F&*V)09^7]9/^"=O_!'_P#83_X)<P:W
M<?LG?"^YLM7\1QI%K/B36]4DOK^X@1MRVXD?B*(-\Q2-5#,%+;BJD;O[/O\
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M/1110 4444 9$G@O2I9&E:YO,LQ)Q=,!2?\ "#Z1_P _-[_X%M6Q10!\(?\
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M+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\
MP+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8H
MH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A
M!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$
M'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^
M;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GY
MO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "
MVK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+
M:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'
M_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!]
M(_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'T
MC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W
M_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;
MW_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MB
MB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C
M_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_
M^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_
MY^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_
M )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P
M+:MBB@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8HH Q_^$'TC_GYO?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$DD@C!8D1A@@)R%H ]PHHHH **** "BBB@ HHHH **** "BBB@#X>_X+?_\
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MC$CGH 9UBY/ /4BOUCZ]* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ7)?%KX$_"+XZZ3#HGQ9\"66M06[%K9I]R2PDXSLEC*NF<#.UAG STK5_P"$
MEU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: /!/CK_P3*^ /COX7_P#"+_"?PM:>
M%=:L"\NE:E$TD@E<@9BN&=F>2,X'))9#RO&Y6\J_9*_;0\<_LZ^,_P#AE/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@KN,1HL<8*G]3]*TK3-#TRVT31-.@L[*S@2"TM+6%8XH(D4*B(B@!54   #
M  %3T ?"7Q<^&?[8W[+?_!1W5/\ @H!\ /V3]1^*GA?XL?"S2_#_ ,0_!&A>
M*=,L=9T'6-.EE>UNT:^GBM[F PSM ZI)N5E+@E< ^/\ BO\ X)7_ +:7Q=_9
ME^)G[3&O^&O#^A?M%^+OVC=#^,GA/P-/KJ3V6EG0C#%IFB7%]&/+DF^R1S*T
MZ?NO-F49"@M7ZFT4 ?!NF_#_ /;1_P""@/[;_P $OC?^T-^QYJ'P1^'WP(FU
M37GTWQ/XOTO5-0\2>(KJR-E!' NFS2I%:VRR2RF:1E:5F11&!N(^\J** "O$
M?^"E?Q;^(GP%_P"">GQN^-/PDDDB\3>%OA9KFIZ%<Q)N:UN8;&5TN ._ED>9
M@\?)S7MU8?Q-U/X=:+\-O$&L?%^_TFU\)6NB7<WBBZU^6-+"'3EA8W+W+2_(
ML(B#ER_RA0<\9H _##_@E'_P;5_\$X?V_OV /"?[8'Q[^/7Q"\6^-_B#97&I
M>*-:T7Q=;QIIE\TLGFP$202LT\9_UC3LY9]S8"L!7TE_P:V?$#QCH?A#]HS]
MB,_&.?X@^ _@5\7Y=#^&GBZ:<2I<Z8[W*".%P2OD@VJS*J$H#<MM)4K7Q_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1_T<A_Y9^C?_ "'1_P /FO\ @I1_T<A_Y9^C?_(= '[P4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUVBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY5^S_P#\%<?^";'[5'Q5T[X'_L\_MA^#_%GBW5DG?3=!TJZD:>X6&%YI2H9
M#MCC=SST4UXG^R3\%O&/[2/_  ;6^%/V>OAV]FNO^.?V3VT#1#J$YB@%W=Z(
M]O#YC@,43?(N6 .!DX-)\%/VROVEOV+_ (B_!+]E#]O']B?PMX1TKQW);>"O
M!?Q.^'WC]=:M7UF*S_<6E[;RV-K-;F=87VR)YB[N"  6 !]\T444 %%%% !1
M61)9^,S(QBUFS"ECM!MCD#\Z3[%XW_Z#=E_X#'_&@#XV_P""W_\ R2[P-_V'
M[G_T0*_."OT1_P""U,&OP_#+P2=8OX)E.O7.P11;2#Y(K\[J "BBB@ HHHH
M*\N^-7_(UP_]>"?^AO7J->6_&G/_  ED.3_RX)C_ +[>@#D:*** "BBO*?CC
MXP\7:UX]TW]GKPIKNG:$?$NA7DUUK>I6S3-L&(_(MXPZ!I2&+<MPHSB@#U:B
MN.\$:3\2OA_\,WT361I_B+4=)@\C1TTU#9B[A2-%B63S7<1OD,"02,8.,Y%8
M?P'\?_$[Q3XT\;^%?B>^E_:?#^H6<=O%I,;>5$LUN)2@9_FDQD#<0,D$X (
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M_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P"
MQ_QH V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H
M-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\
MZ#=E_P" Q_QH V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'
M^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\
M:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'
M_&@#8HK'^Q>-_P#H-V7_ (#'_&OB#_@I#\=_VGOB%^U+X0_X)._!SXP>"OAN
M_P 8_ACKVH:O\1O%6A27TC6Z%;0Z=I5LMQ;K+?%9GE):3Y(TW!210!][T5\U
M_L[_  Z_;L_98_8[G^''C74_!GQ5\5>!M,&G> +;PI9/H(US3[:UABLXKLWD
MTR6MP6619)%=TV!6 +$K7FO_  3+_:@_;T^./[1?[1_P+_; UWP''J_PI\4:
M!::?9>"=.F^PV<=_I2WK0+--B6YV;T4RNJ[F5B%12%4 ^WJ*_.S_ (*3?$K_
M (+'?L=?!3XD_MXZ%^U-\'4\*?#V]DU#3?A*/AU/*FJZ(ETL:"YU66Y65+V2
M)U8I%$L8D^168'>>\_:C_;@_:<N=3^!/[//[+$OAG0OB'\>M#NM?DUSQGISW
M-EX)T&SLH;F]O9X$DC-Q.IN88(8BR(TC$NP530!]KT5XE^RO\/\ ]L3PAH&I
M'X^_M@^&/BO%>312Z!K.D_#^+17MT 998W$%S+%."P4JRA"OS [N"/5?L7C?
M_H-V7_@,?\: -BBL?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&@#8HK'^Q>-_^
M@W9?^ Q_QH^Q>-_^@W9?^ Q_QH V**Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,
M?\: ->2..:-HI8U9&4AE89!!Z@BOAG]K?]BSQQ^SWXR_X:L_8^DN+#^SY6NM
M5T/3UR;,=7DA3H]N1G?"00H)P"F0GV?]B\;_ /0;LO\ P&/^-)]B\;_]!NR_
M\!C_ (T >4?L9_MK^"OVJ?#'V&X\G3/%MA #JVB[^) , SP9Y:,GJ.60G!R"
MK-[A7Q!^UQ^PA\0? ?B1OVG_ -ER?[%K6GSF]O\ 1M$C,;AADM-;(.#D9WPX
MPP)P#DJ?1_V+?VWI?VG=-_X1/7=;T_2O&-G#FXTZ2WVK?(HYF@YY]63JO7D<
MT ?3%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\
M!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_
MXT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\
M!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_
MXT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\
M!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_
MXT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\
M!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_
MXT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\
M!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_
MXT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\
M!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_
MXT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\
M!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_
MXT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\
M!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_
MXT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\
M!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_
MXT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\
M!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_
MXT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\
M!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_
MXT ;%%)&'$:B5@6VC<0.":6@ K%^(OQ(^'OP@\$:E\3/BMXXTCPUX=T:V-QJ
MVNZ[J,=I:6<0(&^665E1%R0,DCD@=ZVJ^9/^"M7[&/Q._;C_ &3HOAG\&-=T
M"V\4^'/&VB^+-#TSQ?%(^C:W/IMVMP-.U!8P6-M+@AL*W(7(QF@!W_!/S_@J
MK^RU_P %%M:\>^'/@C\1/#=UJ7@KQ;?Z?;Z78>)HKJ[U32;=XXX]:6$*CI;3
M22%5.&487YR7 KU?4/VL/V;-+_:(T[]DF\^-?AX?$S5-+FU&S\$1Z@KZ@;6-
M-[3/$N3$NW+#?MW ,5SM./GK]DO]O^#X@_M8VG[+'[8G[$-_\$/CTW@VYN?#
MTEU-9:KIOB'2(I(C<II>KVP!D166*5[5U1D"H2"5.WRCXG_LT? ;]F__ (+H
M?LIQ_!+X8:9X?E\3^&OBEK'B6^M8V>[U>^FM]/=[BZN)"TMP^78 R,VU<*NU
M0  #ZP_:E_X*1?L+?L3>)M,\&_M6_M-^&/ VJZS8M>Z78:W<NLEQ;ARAD4*I
M^7<"N3W!]*Z7X7_MB?LN?&;X 2_M5?#7X[>&]2^'%O!=37/C0:BL.GP1VS,M
MP\DLNT1K&48,6P!BOG7]KOX _MP:)_P46T/]MO\ 95^!7P]^(FFVGP1NO!>I
M:!XU\<RZ+(D\FL17_FPLMC=*QV0!!NVC,A).%P?FO]MS]N#0O^"@/[$?PU^&
M7B'X.7W@![O]N?P?\)/CS\.-2O(KJ/3Y(=32>\L_/A"QW=LY6V82A55PW3@T
M ??/[,'_  4B_85_;0\4:CX'_9?_ &G?"_C#6M*LQ=WND:==,ET+8L%^T)%*
MJ/+#N91YJ!D!=1GYAGVZO@W_ (*9:+I?@?\ X*0_L*_%+P9IL-IX@_X6;KGA
M=Y+2((\VC76AW!GMVV_>B0Q(ZJ<JC?,,$YK[RH *SO&'BCPMX'\(ZKXT\<:U
M::;HFCZ=/>ZQJ-_*$@M;6*-I)99&;A45%9F)X !K1KQ[_@H/\ _%O[4_["_Q
M>_9P\!:E%::YXW^'6KZ-HTUQ)LB^U3VDD<2R-_#&SE58]E8\'I0!_-A^W1^T
M5_P;G_';XYZ[K?[+O_!-[XT:D#?/)?ZIX \4IX?TZ]<N<SP6,L%Y]GB;JJB*
MW_ZYJ<U[+_P1<^-?_!N/X&_:_P#".B^.?V0_B9X$^)DNKVX\$Z]\8]?35]*L
MM09P+<_NE@2&4R%?+FFM2B, WF1D!J]%_P"">O\ P</_  W_ ."-O[-7AW_@
MGG^V]_P3D^(W@?Q=X!6>TU.?P]I]I&=7<S2/]MDBNGM]SON4&17E23&]7VL%
M'&?\%*?^"J\'_!R)H_@G]@S]@/\ 8&\7S>(_^$XL]0/Q \36\!E\/VZB2-V)
MM?-%K 1('EE>95 BP%=BI4 _HYHJ*R@DM;*&UFN6F>.)5:9_O.0,%C[GK4M
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M"$ P1RO"!&\@7:6"@C]'J;##%;Q+!!$J(BA41%P% Z  =!3J "BBB@ HHHH
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M1:?$7_A+]/M7:ZN;:T@>XU"T&F23Q7-M,\A\OR,DN'C5,K@YO[ O_!2;PO\
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M1NK&XO&N%VSS27L,JW33NH ,_F^;A5^?Y1CS7X#_ /!%S_@G1^S/\9+?X_\
MP5^$'B;2?%MO>K=G59_BWXGO1<S+$85:XANM2DBN<1L5 F1P!C X%?4U% 'R
MO\>/^"+'_!.;]IGXLW7QQ^-GP?\ $VL>)[O4_P"T3?Q_%SQ1:);W7E^7YMO!
M;:E'#;'9\O[E$&"?4UT_Q:_X)B_LC_&?PAX,\$^+M%\:VUIX!T,Z-X:N-!^*
MWB'3KM-/*QJUO/<VU\DUXI$29:X>1^"=V68GZ!HH XC]GC]F_P"!G[)_PJL/
M@E^SK\---\*>%]-9WMM+TU&PTCMNDFDD<M)-*[<M+(S.QY9C7;T44 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q/[2GP
MA\#?M!?LZ^/?@/\ $_6KO3?#7C7P;J>A>(-1L+N.">ULKNUD@GECDD5DC=8Y
M&8,ZLH(!92,@]M7(_'_X*^#_ -I+X$^-/V>/B#->QZ#X[\*:AX>UJ339Q%<)
M:7EM);RF)V5@L@21BI*L <9!'% 'X[:U_P &FO\ P0YM-'NKF']O[XCV;QV[
MLEW>_$SPRT,+!3AW7^S4RH/)&Y<@'YAUKK_^#0"R^#G@7X,_M!_ KX=W<>M:
MOX*^+;6.K>.=,OVETWQ19@3Q6-[:H21$K)!,<*2&1HFSDX'AW[77_!"[_@V%
M_81$\/[3G_!0'XA:+JEKDR>&+7QWINH:L2.BFQM-+DN%!/&YD5?5A@D?</\
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M>9]4BM[FWM0LUY]NNKB1U:]!1'(C4&3;M)PP!^LE%%% !1110 4444 %%%%
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M)=#_ .0AX(^V8Z_\2VUDS_WY84?\-1?MU:)QJW[/OGJ/O/\ \(M??^A1R8%
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M0#[HHHHH **** "O.+W_ (_)?^NK?SKT>O.+W_C\E_ZZM_.@#H?!/_(8OO\
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M^Z: /TJHHHH **** "BBB@ HHHH **** "BBB@#X>_X+?_\ )+O W_8?N?\
MT0*_."OT?_X+?_\ )+O W_8?N?\ T0*_."@ HHHH **** "O+OC5_P C7#_U
MX)_Z&]>HUY=\:O\ D:X?^O!/_0WH Y"BBB@ HHHH **** /Z@**** "BBB@
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M ()F_%/_ (4I\<;6XU7P'?SM)87MNI9(T+<W-J3]1YD!Y!.1R07 /T+HK/\
M"GBOPWXY\.6?B[PAK5OJ.F:A )K.]M9-R2H>X/Z$'D$$'!%:% !1110 4444
M %175E9WJ>7>VD4R_P!V6,,/UJ6B@##O_AE\-M4S_:?P^T.YSU\_287S^:UY
M3^T9^Q5X!^)/A=KOX:>'--T#7K-2UJ+&U2W@N_6.14  )[/C(/7(KW*B@#P;
MX ?L-_#KP-X32;XI^'[+7=<NP'NA<KO@M?\ IE&.AQW<]3TP*]$B_9P^ 4.=
MGP;\-G/7?H\3?S6NUHH Y2'X$? ^W.Z'X-^%4.,97P]; X_[XJU#\(_A1;8^
MS_#'P]'M^[LT6 8_)*Z&B@#'B^'W@&W&(/!&CH,YPFF1#G\%JU%X9\-P9\CP
M_8IGKLM$&?TJ]10!'#:6MN<P6T:'&,H@''X5)110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>8_MJ
M_ *Q_:I_9!^)_P"S9J.N0Z7'XZ\!ZKHBZI<?ZNQ>XM9(DN&]5C=E<CT6O3J\
M/_X*8_#[XH_%C_@G?\<?AE\%+>XG\6:_\*=>L- M;3/G75S+83(L$>.CR9\M
M3_><=* /SD_:-_X)T?\ !036/^";W['<_P"R/^T=\&+CQW^S1>W+S?$"/Q,D
MGA]88HFL[:YAFN+9HYO+CC1)%D0 2;@ V*^M/^")7_!/'QW^Q)\'O&GQ6^/7
M[0^F_%3XJ_&SQ4?%'C[QIH,WF:=<2[66*&VDVIYL:EYFWA(QF7:J*J+7XT_!
M/XM:O_P6B\"_LD_\$*/@'\)_&_@/P-\+[-+K]I.Z-O';K+/9_P#'S.NQGV!I
M/M++]H52;N^C!C)B#-^F'_!M[\&O$/[-GB']JW]G+P2WBN3X,^"_CE+IWPIF
M\51R;GV)(E]Y+NBB2/<EL=Z *Y)?J[$@'Z>T444 %%%% !7G%[_Q^2_]=6_G
M7H]><7O_ !^2_P#75OYT =#X)_Y#%]_G^(UTU<SX)_Y#%]_G^(UTU !1110
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M,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%
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M_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G:?\
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M^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\
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M#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\
MSXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V
M=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_
M 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#S
MXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_
M ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V
M=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:
M@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_
MT&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ
M_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A
M,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@
M_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#
M'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?
M#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X
M3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?
MH4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SX
MP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_
M //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=
MI_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?
MH4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\
M^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I
M_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]
MG:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^
MJN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#
M'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3
M'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X
M3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_O
MJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'
M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 2HZR
M()$;*L,@CN*6@  8 P!T HH *^9O^"LG[;'CG]@_]E.#XL?#32O#[Z[KOC?1
M/"VFZQXP>1=%T%]1NU@.I:@8F5_LT*DLP#+DE1N&:^F:\6_;V^-_[(WP0^ ,
M\_[<NBQ7WPU\3:C'H>OKJ'A&XUG3HQ+'+*K7T4,,OE6^8-OG.NQ)&BRRE@:
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MD\;?LO\ P,^(_P >?!7[37CCP,-1\;?#FTU&V\$ZO/J5SLTE+^-8KMH[<2"
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M6[273;6W4VMP96A$4B$*Z_*V<Y^]:\._99_X)S?LC_L<^+=6^(WP4^'NH?\
M"4ZWI\>GZEXM\5>*M2U[59+*-MR6BW>I7$\L5NK!3Y*,J$JI() ->XT %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C?$#X?>#OBEX0O?
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M N+";&3'(H_'##AAR.X'>4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%<M\+_C3\,?C.?$0
M^&7BJ/5?^$3\4W?ASQ 8[>6,6FJ6NSS[<F15WE/,4%DW+DX#$@XZF@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7O;6V;Y03,$65^8]R("H!^FM%%% !1110 4444 %%%% !1110 4444 %%%%
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M_!.+X7?\$Q/V<([K4-'U9?#7@;XI>//[3MK272/!]G!%'J-VJ32AYIKB.W6
M11K(2+B3=M W5]G>$O"GASP'X4TSP/X.T:#3M(T;3X;'2M/M4VQ6MM#&L<42
M#LJHJJ!Z"@#0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M *^;7_T>E?$E !1110 4444 %?5?_!/;_D3_ !%_V$XO_19KY4KZK_X)[?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN_B/-I7PMTNP74M2_P"$WC?*Q:K<3O9JUK-*L<8V7<KR*-BER%  !^NM%%%
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M/_0WH Y"BBB@ HHHH **** /Z@**** "BBB@ HHHH \J_;1_Y-\U;_KYM?\
MT>E?$E?;?[:/_)OFK?\ 7S:_^CTKXDH **** "BBB@ KZK_X)[?\B?XB_P"P
MG%_Z+-?*E?5?_!/;_D3_ !%_V$XO_19H ^A:*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P *<_X*^WORS_%3R@O(/]N6JY_[X2@#[LHKX3_X9^_X*VWORS_&WR@O(/\
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M%?C'_P $QO&_PK\/SZ;+<CQ?KOCS0-0MU<!2D)ALKJ2;+YX(7 QSBL+XC_\
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M*/ OQ)\,RM#'J<%RD42 R-"\,Q,<$)9?,66%RZ,K#;CW7_@C)J/[5'_!2/\
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MM'2_B1:?"?59-8\!^"?!GPV7PYIJ:P86@34[QGO+N6YEC1W,<:M&B.<\@E2
M?8U%%% !1110!D26?C,R,8M9LPI8[0;8Y _.D^Q>-_\ H-V7_@,?\:V** /A
M#_@M3!K\/PR\$G6+^"93KUSL$46T@^2*_.ZOT?\ ^"W_ /R2[P-_V'[G_P!$
M"OS@H **** "BBB@ KRWXTY_X2R')_Y<$Q_WV]>I5Y=\:O\ D:X?^O!/_0WH
M Y"BBB@ HHHH **** /Z:/L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MB
MB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\
M@,?\:/L7C?\ Z#=E_P" Q_QK8HH \8_; MO%$7P'U1]3U.VEA^T6VY(X"I/[
MY,<U\;5]M_MH_P#)OFK?]?-K_P"CTKXDH **** "BBB@ KZ=_8+@U^;PGKYT
M>_@A4:C%O$L6XD^6:^8J^J_^">W_ ")_B+_L)Q?^BS0![;]B\;_]!NR_\!C_
M (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\
MC6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_
M\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P
M&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]
M!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&
M[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B
M\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+Q
MO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8
M_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-
M'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL
M44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8
M_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_
M (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;L
MO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_
M\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&_
M_0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]
M!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (UR7Q:_9\\,_'728=$^+/A_1M:@
MMV+6S3VKI+"3C.R6-E=,X&=K#.!GI7HM% 'G7PE_9\\,_ K29M$^$WA_1M%@
MN&#7+06KO+,1G&^61F=\9.-S'&3CK76_8O&__0;LO_ 8_P"-;%% &/\ 8O&_
M_0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]
M!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\
M8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B
M\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%%
M&/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\
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MMDUBQ89!P;4GD'(/YUX#_P /%/\ JCW_ )<'_P!ST?\ #Q3_ *H]_P"7!_\
M<] 'T!]B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-?/\ _P /%/\ JCW_ )<'
M_P!ST?\ #Q3_ *H]_P"7!_\ <] 'T!]B\;_]!NR_\!C_ (T?8O&__0;LO_ 8
M_P"-?/\ _P /%/\ JCW_ )<'_P!SUZK^SU\>?^%\:/J.K?\ "*?V5]@N4A\O
M[=Y_F;EW9SL3'ZT =7]B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% "1AQ
M&HE8%MHW$#@FEHHH *^9/^"M7[&/Q._;C_9.B^&?P8UW0+;Q3X<\;:+XLT/3
M/%\4CZ-K<^FW:W T[4%C!8VTN"&PK<A<C&:^FZ\E_;0^&?[0/Q*^#3#]F/\
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MI_#*U^.GQ7?3O%OC/1A$MW#90W&G6WD1/*K*I;^T6?H,M%$"=I8'],J^._\
M@M+_ ,$E/"/_  5M_9HL?ALGCAO"/CKP?JIU?X?>+A"TBV5V4VR03*I#>1*
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M10 4444 ?#W_  6__P"27>!O^P_<_P#H@5^<%?H__P %O_\ DEW@;_L/W/\
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MW_(G^(O^PG%_Z+-?*E?5?_!/;_D3_$7_ &$XO_19H ^A:*** "BBB@ HHHH
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M*OVT?^3?-6_Z^;7_ -'I7Q)7VW^VC_R;YJW_ %\VO_H]*^)* "BBB@ HHHH
M*^J_^">W_(G^(O\ L)Q?^BS7RI7U7_P3V_Y$_P 1?]A.+_T6: /H6BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHH **** /A[_ (+?_P#)+O W_8?N?_1 K\X*_1__ (+?_P#)+O W_8?N?_1
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M=_90^#&O_M ?'SQM:^'_  KX;LC<ZGJ-T2>X5(HT&6EED<JB1J"SNRJH)(%
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M5X/O= O;NYTC_A"=$L=\T 5XF\VSLHI1M;G < ]P:_3NOP2_X-[O^4C>F?\
M8I:K_P"BUK][: "BBB@ HHHH *^J_P#@GM_R)_B+_L)Q?^BS7RI7U7_P3V_Y
M$_Q%_P!A.+_T6: /H6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M236S_P -A_LY_P#11/\ RD7G_P 9H_X;#_9S_P"BB?\ E(O/_C- '!_M@_\
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M[F.WD"3,]M+%M8C(&)$4G\* .LHK-_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZH
MTJ*S?^$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJ@#2HK-_X3'PQ_T&H/^^J/^$Q\
M,?\ 0:@_[ZH TJ*S?^$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJ@#2HK-_X3'PQ_
MT&H/^^J/^$Q\,?\ 0:@_[ZH TJ*S?^$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJ@
M#2HK-_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZH TJ*S?^$Q\,?]!J#_ +ZH_P"$
MQ\,?]!J#_OJ@#2HK-_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZH TJ*S?^$Q\,?]
M!J#_ +ZH_P"$Q\,?]!J#_OJ@#2HK-_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZH
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M^!FFQ>!OAOX@TW6_!7AS2[FXLH-,OK!V>VE7[/(C/M9W+*Y99"[%PQ)-;/\
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MK][:_!+_ (-[R!_P4;TP$]?">JX_[]K7[VT %%%% !1110 5]5_\$]O^1/\
M$7_83B_]%FOE2OJ#]@;6])TKPEX@CU&_CA9]1B*ASU'EF@#Z0HK-_P"$Q\,?
M]!J#_OJC_A,?#'_0:@_[ZH TJ*1'61!(C95AD$=Q2T %%%?,W_!63]MCQS^P
M?^RG!\6/AII7A]]=UWQOHGA;3=8\8/(NBZ"^HW:P'4M0,3*_V:%268!ER2HW
M#- 'TS17R-^P)^S#^U[^QMK_ (^\2_'[]K'P#\2O 7C:_P!3\;ZGJVF>!KG1
MM0L-:N7@>3RO].NH9=/^SQO@?*ZE(\9!:OFX_MO_ /!6/X@_L#:W_P %FOAQ
M\1_A]IO@'3[*_P#%6A?L^ZCX$:6:^\)6<\@=[G61=>9%?26D4EP/+B,2D(NW
M!( !^I5%<_\ ";XD>'OC)\*_#/Q>\(M(=*\5>'[+6-,,H 8V]S D\><=]CKF
MN@H **** "BBB@ HHHH **** "BBB@ KSB]_X_)?^NK?SKT>O.+W_C\E_P"N
MK?SH Z'P3_R&+[_/\1KIJYGP3_R&+[_/\1KIJ "BBB@ HHHH **** "BBB@
MKY$_X*E_&/\ X)16FC:3^SO_ ,%5=+T@>'M>MGU+0M0\6^&KYM.BFC8Q-Y.I
MV\9%E=@-QB6*4H_RD@FOKNN(_:)_9]^'/[47PHN_@O\ %BUNY]"O=3TR^NH;
M*Z,+R26-_;W\"EASL\ZVBW+_ !+N7O0!^.6H_"'X\?M(?\$T?VVO@K^R!X@^
M)/Q'^ ND7WA35OV:+KQX+ZYOM1?3KFWU/6;'3I+Q!=7=DDEI'#;Y!#-E8R[%
MF/OW[87[<_[-7_!7"7]FW]F;]B#QV/&GB'4OCCX7\;>.=/TVTE\WP;H&DR->
M7LNI$J!9S!UCMTBD*L\CX7/&?U&J*WL+&SEEGM+**)YWW3O'&%,C>K$=3[F@
M"6BBB@ HHHH A.GV!.390DGJ3&*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT
M*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_
M .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B
M@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA
M_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/
M[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\
M8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"
M'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?
M^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.
MT_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&
M'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^
MSM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_
M0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T_
M_GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\
MOT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM
M/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J
M:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\
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M /EX:S_\F4?\.9?^":__ $;?_P"7AK/_ ,F4 ?@_17[P?\.9?^":_P#T;?\
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M^&WP,UBY2:[\%^ =&T*ZFC;*R26EC#;LP/<$QDUWU%% !1110 4444 %%%%
M!1110 4444 %><7O_'Y+_P!=6_G7H]><7O\ Q^2_]=6_G0!T/@G_ )#%]_G^
M(UTU<SX)_P"0Q??Y_B-=-0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 0:KJFGZ)
MIESK6KW:6]I9P//=3R'"QQHI9F)]  3^%?FGX'_X*0_M ? [_@B=XR_X*O\
MB9G\2^(?B+XWN=>\&Z'XMO9O[*\+:5J.MQ:5I4,GEG=%96]J(+F0)@N\DOS
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M  ;,:XGQ)U&VMY/!_@GXCV'CR&[<!K:^CU'6&N(I@>DC>8K;3R?-7U%?2O\
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M8HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\
M@,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_
M (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_
M .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\ Z#=E_P" Q_QH^Q>-
M_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -B
MBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\ Z#=E_P"
MQ_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
M@,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\
MZ#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[%XW_
M .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**
MQ_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'
M_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P"
MQ_QH V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H
M-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P %[/"WQNB_;$\'-X2L/V9M6\+7FOB[?[/%K$GB*TF2S+;/]88T=AVPIYH
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MZKK6A76KV.CSZ9-<6]W-IEF)H_/EDD2U=([B541)I S.47=Y1\"?VO/V>/\
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MB?5D565;IURMK;DG[.AWG$C;B ?LG1110 4444 %%%% !1110 4444 %%%%
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M)&F_&'XRZ5X&\0_"GPS\-I-+;2TU#?NO-,O'O);BY6T";G,Z ,I!8)D;9O\
M@CS\??V ?#WA_P"(6I^"OVV_#OQN^//C"TN?B!\<_$/A6VGFN;\VZI%Y5G;B
M/>+*T66.VMH%!;#Y"@R%1\M?M=?$'_@F=XD^,?P\_:4_X(M?%6[UO]K'6OBC
M9#3=%\.:OJ^H/?6%W>9U>+5]/OBZ:=:"%YGD9HX&C(&"H!P ?MM1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7G%[_ ,?DO_75OYUZ/7G%[_Q^2_\ 75OYT =#X)_Y#%]_G^(U
MTU<SX)_Y#%]_G^(UTU !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%=6%C?&,WME#,8I
M \1EC#;&'1AGH?>I:** "HDL+&.\?48[*%;B1 CSB,!V4= 6ZD>U2T4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P +"L_^@=+_ -]BC_A85G_T#I?^^Q0!T-%<]_PL*S_Z!TO_ 'V*/^%A6?\
MT#I?^^Q0!T-%<]_PL*S_ .@=+_WV*/\ A85G_P! Z7_OL4 =#17/?\+"L_\
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MT-%<]_PL*S_Z!TO_ 'V*/^%A6?\ T#I?^^Q0!T-%<]_PL*S_ .@=+_WV*/\
MA85G_P! Z7_OL4 =#17/?\+"L_\ H'2_]]BC_A85G_T#I?\ OL4 =#17/?\
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M+"L_^@=+_P!]BC_A85G_ - Z7_OL4 =#17/?\+"L_P#H'2_]]BC_ (6%9_\
M0.E_[[% '0T5SW_"PK/_ *!TO_?8H_X6%9_] Z7_ +[% '0T5SW_  L*S_Z!
MTO\ WV*/^%A6?_0.E_[[% '0T5SW_"PK/_H'2_\ ?8H_X6%9_P#0.E_[[% '
M0T5SW_"PK/\ Z!TO_?8H_P"%A6?_ $#I?^^Q0!T-%<]_PL*S_P"@=+_WV*/^
M%A6?_0.E_P"^Q0!T-%<]_P +"L_^@=+_ -]BC_A85G_T#I?^^Q0!T-%<]_PL
M*S_Z!TO_ 'V*/^%A6?\ T#I?^^Q0!T-%<]_PL*S_ .@=+_WV*/\ A85G_P!
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8S_Z!TO\ WV*Y>>02SO*!@,Y('U- '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>cdna-20240429_g19.jpg
<TEXT>
begin 644 cdna-20240429_g19.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@#
M8 4L P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _<C3=-U#7-0N88=2:/RV)^9CZU>_X0G6/^@Y^K?XT>"?^0Q?
M?Y_B-=-0!S/_  A.L?\ 0<_5O\:/^$)UC_H.?JW^-=-10!S/_"$ZQ_T'/U;_
M !H_X0G6/^@Y^K?XUTU% ',_\(3K'_0<_5O\:/\ A"=8_P"@Y^K?XUTU% ',
M_P#"$ZQ_T'/U;_&C_A"=8_Z#GZM_C7344 <S_P (3K'_ $'/U;_&C_A"=8_Z
M#GZM_C7344 <S_PA.L?]!S]6_P :/^$)UC_H.?JW^-=-10!S/_"$ZQ_T'/U;
M_&C_ (0G6/\ H.?JW^-=-10!S/\ PA.L?]!S]6_QH_X0G6/^@Y^K?XUTU% '
M,_\ "$ZQ_P!!S]6_QH_X0G6/^@Y^K?XUTU% ',_\(3K'_0<_5O\ &C_A"=8_
MZ#GZM_C7344 <S_PA.L?]!S]6_QH_P"$)UC_ *#GZM_C7344 <S_ ,(3K'_0
M<_5O\:/^$)UC_H.?JW^-=-10!S/_  A.L?\ 0<_5O\:/^$)UC_H.?JW^-=-1
M0!S/_"$ZQ_T'/U;_ !H_X0G6/^@Y^K?XUTU% ',_\(3K'_0<_5O\:/\ A"=8
M_P"@Y^K?XUTU% ',_P#"$ZQ_T'/U;_&C_A"=8_Z#GZM_C7344 <S_P (3K'_
M $'/U;_&C_A"=8_Z#GZM_C7344 <S_PA.L?]!S]6_P :/^$)UC_H.?JW^-=-
M10!S/_"$ZQ_T'/U;_&C_ (0G6/\ H.?JW^-=-10!S/\ PA.L?]!S]6_QH_X0
MG6/^@Y^K?XUTU% ',_\ "$ZQ_P!!S]6_QH_X0G6/^@Y^K?XUTU% ',_\(3K'
M_0<_5O\ &C_A"=8_Z#GZM_C7344 <S_PA.L?]!S]6_QH_P"$)UC_ *#GZM_C
M7344 <S_ ,(3K'_0<_5O\:/^$)UC_H.?JW^-=-10!S/_  A.L?\ 0<_5O\:/
M^$)UC_H.?JW^-=-10!S/_"$ZQ_T'/U;_ !H_X0G6/^@Y^K?XUTU% ',_\(3K
M'_0<_5O\:/\ A"=8_P"@Y^K?XUTU% ',_P#"$ZQ_T'/U;_&C_A"=8_Z#GZM_
MC7344 <S_P (3K'_ $'/U;_&C_A"=8_Z#GZM_C7344 <S_PA.L?]!S]6_P :
M/^$)UC_H.?JW^-=-10!S/_"$ZQ_T'/U;_&C_ (0G6/\ H.?JW^-=-10!S/\
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MS_PA.L?]!S]6_P :/^$)UC_H.?JW^-=-10!S/_"$ZQ_T'/U;_&C_ (0G6/\
MH.?JW^-=-10!S/\ PA.L?]!S]6_QH_X0G6/^@Y^K?XUTU% ',_\ "$ZQ_P!!
MS]6_QH_X0G6/^@Y^K?XUTU% ',_\(3K'_0<_5O\ &C_A"=8_Z#GZM_C7344
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M-=-10!S/_"$ZQ_T'/U;_ !H_X0G6/^@Y^K?XUTU% ',_\(3K'_0<_5O\:/\
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MR=A=:A$SRHC+A2J[WAE5=Q!=HV"Y(Q7YJ_%K_@NQ_P %;/\ @G[\2_AWK?\
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MQQ'-X+\4S:GX]O?$FABVET-)KBQ^T^:$=_+2UCM)&D<D!W>-$W-@'+_X*=?
MCX,?LB_\' GQ"^./_!267XN>&O@C\7M#CN?"GQ&^%VH7-H\=Y]FL@T,TL"LT
MB1R6MQ&]NN7 >WEV[<5_1M9:)HNFWESJ.G:1:V]Q>,&NYX;=4>=AT+L!EB,G
MKZT[5-)TK7+%],UK3+>\MI,>9;W4*R(V#D95@0>: /Q]_P"".'@O_@CAXJ^*
M?QV^-?\ P33U7XU^,/%-M\)[G2O$WCWXCRW,MC<VUR4D^S1/<*DKW&ZR@)WI
MD(@"G!(KD_\ @U5@E?\ X((_']/)8F3X@>+=@V_>_P"*9TH<>O/%?M?INEZ9
MHUE'IFCZ=!:6T0Q%;VT*QH@SGA5  YJ9(XXEVQH%!))"C').2?Q)S0!_/G_P
M1N^(?[%7PY_X-K/&/_#P_P"$6O\ BWX3:_\ 'N\TOQ'%X?TI[F73/,M=/:+4
M&,<B20I%+&O[V,EU9E 5LX-/_@A]XULOA_\ \%IK'X"_\$>/VB/BC\2?V4;G
MPK>7_P 0+;QO87,6GZ)<-:W31JHEBC".+I;-4G$,4DGFR1D2*C2-_0L;:W:!
MK9H$,;@AHRHVD'J"/?)JOHV@Z'X<L_[/\/:+:6%N7+^196RQ)N/4[5 &>!S0
M!_+GX<_:@T3]IW0?C_X>_P""MW[4/[4%Q^TY)K&H:-\./@'X)N-1ATV6=[<B
M*V2R@B,*(MR2KQ,T:F% RB5G)KZ@_P"">_PR\=_%K_@SL^+O@7X=^&;S5M7N
M;K7KJUTZR@:2:=+;4+:XE$:*"781PR$* 22N ":_>PZ#H9U@>(3HUI_: B\H
M7WV=?.V?W=^-VWVSBK,4,4""*")44$X5%P.3DT ?AQ_P3:_X*/? ']I'_@W1
M^,/[#W@"P\1KXZ^$G[)WB_\ X2Y;S2=ED@>TU!(O*G#'>SA@P7 . W]VOFO5
M?V0_C9^U3_P:%?"S4/@AX/U'7[[X>_&#5O$^JZ-IELTUQ/IJW>K6DTL<2 M(
M8C<I(=H.(UE;HIK^E/3=$T71FG?2-(M;4W,QEN3;6ZQ^;(>KMM W-[GFK,<<
M<,:Q1(%50 JJ,  = !0!_/7_ ,%,O^"Y_P !?^"KW_!,/PU_P3H_8X^#?CKQ
M'\9_B#/X?L]3\(6_AEMND2V<T%Q,(Y%)$P,L"HA48$;L[F/;MK9_X*L_L_\
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M\>6^GZ.\GB34K&*.$V:2M&\=I<1+)\[9.X$\X/'%?IW_ ,%S[[XV_P#!/?\
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M HHHH **** "O.+W_C\E_P"NK?SKT>O.+W_C\E_ZZM_.@#H?!/\ R&+[_/\
M$:Z:N9\$_P#(8OO\_P 1KIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "O.+W_C\E_ZZM_.O1Z\XO?\
MC\E_ZZM_.@#H?!/_ "&+[_/\1KIJYGP3_P AB^_S_$:Z:@ HHHH **** "BB
MB@ HHK\?_P#AZ1^W;_T7/_RV-+_^1J /V HK\?\ _AZ1^W;_ -%S_P#+8TO_
M .1J/^'I'[=O_1<__+8TO_Y&H _8"BOQ_P#^'I'[=O\ T7/_ ,MC2_\ Y&H_
MX>D?MV_]%S_\MC2__D:@#]@**** "BBB@ HHHH **** "BBB@ HHHH ****
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MN2^"?QU^$_[1?@AOB1\%_&$6NZ&NL:AI9U"&VEB0W=E=RVEU&!*BD[)X94W
M;6V94L"">MH ***S]:\6>%?#5WI^G^(O$VGZ?/J]Y]DTJ"]O4B>]N-C/Y,08
M@R/M1VVKDX4G& : -"BBB@ HHK^0+_B*._X+K_\ 1\W_ )C+PQ_\K* /Z_:*
M_D"_XBCO^"Z__1\W_F,O#'_RLH_XBCO^"Z__ $?-_P"8R\,?_*R@#^OVBOY
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M**R/B#X]\(_"OP%K?Q/^(&M1Z;H/AO2+G5-;U&5&9;6TMXFEFE(0%B%C1F(
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M_P ,?VQ/ /B?Q',WW(;&.YN+=G;L 'N8AD]-WO7NW[?/[>G[%'[(%CI'@/\
M;LMKRU\&^.;*\CEUC4_ MUJ_A_\ <F+=:WSPPS)$T@E#(LJ;6$;\C;R <[_P
M32_80_9\_9)TFY\7_L>?M>>/?'/PQ\1V$C:;X9UCX@Q>(M!MKJ2Y:XEO["8*
M6BDEDDF:7;(R2-*SD;N:_/7_ ()<_M>?M0?"#_@ISKGBGX]_M!^,?%/PH^./
MQ^^(7PRTW3?$_B*XO++POXBTN^6[TI;99G9;9+BWFEM$BC !*#/"*!Z3_P $
MO_#?[/'B#_@L1K?QA_X(^^$];T;]FC4/A3*OQ4NK'1K[3O"6J>)S= V@TRWN
MT13<)%@LT"")$W 8\P[^&^#O[*7BO]J__@D=^UQHGPN$T/Q#\#?MD^./'/PQ
MO;9,W%MK^DWT-U;^3_TTD5);<'MY] 'TA_P7W^/_ ,:+[PSX5_84_9;^*6N^
M$?%OBS1=<\<>-O$WA;4Y+2^T7PGH%C)=S;9X2LENUW=BVM4=3S^]4@@FO.?C
MI%\3?C%_P;$?#']JB?Q?J.J_$_X5?#[PK\4?#GBO5[N2ZO%U;23#<2W,LKL7
ME=[;[5&S,Q+"5B2><X_["WBWQQ_P4#_94_:P_P""T'Q@\&2:->_$KX0:GX+^
M&FC3'?\ V5X=TK2I_M?DMW2YU1KEV'/S6PKK+CQWHWPW_P"#14>(-?E2."X_
M9*72XS)@ S7VG"RA'/<RW$8'N10!^DGP7^)VB_&WX.^$_C-X;0KIWB[PU8:U
M8*6R1!=6Z3H,]_ED'-=+7DO[ WP^USX2_L*?!7X5>*('BU/PS\)?#FDZC'+G
M<D]OIEO#(#GG(9#UKUJ@ K^ .O[_ "OX Z "BBB@ HHHH _O\K\LO#7[..O?
MM]_\%G_VTOA9\4/VN_CSX7T#X96WPZ'@G2OAM\7M2T2VTTZCX>::Z9((9/*R
MTL"R?<QN9R02QK]3:_)7X=?\$_\ ]G?]NS_@NI^WCIW[1-MXLN=/T"#X8+;Z
M?X=\=ZIHL%VESX:82I<K87$/VA?W"8#D[<MMQN;(!Q-I^V3^UG>?\$+OVUM,
MU?\ :8\1^*=5^!/Q+USP3\/?C59ZDUMJNLZ;:W5D(YWN[<J9)U69E:=&^=77
MEB"S?2'[!O[,W[!VM>)_AOXY^'__  5)^)_C?QW%I]EJ[>#KC]JN[UB*\N4M
MUFFCFT[[4_G1*0Y>)E("J=PP#6G_ ,%E?V=?@Q^R_P#\$"/C7\"?V<OA?IOA
M3PIH?@8+INA:+;%8HA]N@>20]6=V.YWD<EF)+,2<FN8_X)]_MN?\&]EOK_PO
M\)_L[ZU\#=.^+NI:;I^D:7-X;^'D5GJTNHSVZ020K<QV:,'D9G1CO ;<P)()
MH @.E_%W_@L-_P %$?C?\'O$O[2'C[P#\ OV>M4L?"\?AGX9^))=%O/&'B&6
M S7LU]>08F^SP$>6L"L W[M\J0X:CK/A7XL?\$;?^"B'P$\"?#O]I3XB>-_@
M-^T#XANO!VL^"OB9XIFUN7POKGD^9876G75QF6.*5\H\)8K@2,=Q9/+Q_AK^
MTE\/?^"+O_!37]H_PY^V_)J/A+X5_M >+K3QU\,_BE+H]Q/I$FH26Y34--N9
MH$?[/.LF"@? *)N)7S$W7/'G[0'@;_@M3_P4A_9YTO\ 8O34O$_P>_9]\77/
MCKXB?%4:/<6VDS:M'!Y>G:792SHGVF?S26DV JJ-D$[&% 'Z;^)QXE/AK41X
M,:Q76/L,W]DMJBN;87.P^5YPC(8Q[]N[:=VW..:_,[]D[P_^U]\&/^#@YO@_
M^TO^VEXF^)]QXB_9"N/%FKZ>4.G>'M.U!_$\-HL6G:9&QC@BBAA"+(Y>=R\C
M.YWE1^F?B'7]'\*:!?>*?$6H)::?IMG+=7UU+G;##&A=W..P4$_A7XWWG_!9
M3_@F-+_P<'67[5T?[7_AL_#N/]C^3PH_BGR+K[.-9/BC[6+/'D[]_D?O,[=N
M.^>* /V<K\L/V/?A=\2_^"Z^K?$']M+]H3]J?XJ>%OA);>/]2\.?!;X9_##Q
MM<>'[4Z;82^2=6OI+4B2ZN990Q 9L1%7 RK*J_J7:75O?6L5[:2B2*:-7BD7
MHRD9!'X5^1O_  3._;;^!?\ P1"T/QQ_P3$_X*1:_>_#3_A%?B#K&J?"KQIJ
M^AW<FC^+O#UY<&XAEM[F")T$R,[^9&V-I<+DNCJH!]__  '^%W_#NK]F?QE-
M\9/VKO''Q%\)^%9-1\16OB/XDWJ7FJZ)HD-G'))92W8"M>+$T-Q*LL@#[9A&
M21&"?SI_X))?M!_MB_"S]NKX>?$;]L7XL>)-2\+_ +=W@#6O%_@_P[KFK33V
M?A36;2_GOK33K-9&*6\+:)<6[!5"EW*)@B-:[K_@J)^WMX8_X*6?L4^%_P!D
M+]BNX\5:9/\ M,?&.V^'6A>+/$'A.YL$O=!MX[>_U?7;*"<QRW-A'"1 S,L9
M<F=1@*'/&_\ !5']@3_@IS\%/V2- _:SU']OKPM\1_\ AEC7-,\=^#_!6B_
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M9+JX@FTW[6QFB!60R0LI&Q6## -1Z[:_&'_@KK_P4J^,_P"SGJ?[1WCSX>_
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MOEDDLQP"I1WR?V[OB7\3?^"N_P"UO^S%^R+^RUXBUGX6KHVES?'7Q+J/Q \
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M/.MV/[4G[=FN?&OXM:BWA3P!\6X);:3Q!K,LMGH&FQ:)#-/Y0D8K;PJ%9V"
M+P3BOF#_ ()X_L,:A^WA_P &O7P@^'W@/5#HWQ*\*7.L^*_A'XE1Q'+I'B6P
M\2:I+9R+(?\ 5K(=T+MSA)BV"5%<%_P3RN_C]_P4M_8*_P""C5U8?#>^\._$
MKXCZB]E=^%9XC!(FO1>'XX;K3U#XV;[B)X@&((65=V.: /MVQ_X+L_#&'PSH
M7Q]\=?L;_&CPK\!_$^J6MEHGQVU_1+&+2"MS,L-M?7%JMVU[:V$S/'Y=S)
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M_P )38:?*;A-)=_-3[/%)<);R/)MD.(=H4;MP]UHH **** "O,_^&//V<_\
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M7_KJW\Z]'KSB]_X_)?\ KJW\Z .A\$_\AB^_S_$:Z:N9\$_\AB^_S_$:Z:@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY9^]N^7V>@ HHHH **BO)Y+:U>>&V:9E7*Q)U;V%9G_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
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M^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\
MH4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI
M: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_O
MI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V
M**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$E
MU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (27
M5_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+
MW_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4
M+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^
MEH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:
M/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_
M (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?
M_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU
M?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]
M_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W
M_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -B
MBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^
M$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:DL]>U*YND@F\,W4*LV&E=EPO
MN: -2BBB@ HHKX8_X*8?M ?'OXC?M2>#_P#@DU\"OB=X1^&+_&/X8Z_J&M?$
MKQ?HTNHRFW0K:'3M)M5N;99;XK,\I+R'9&FX*2* /N>BOB/XC?&K]I[_ ())
M_P#!+'5M8^-.J^"_B;XQ\$R:9X3^$_\ PC>CW6E0ZVMPUEINE)?02W$QCF6>
M1VF\J4JT40*E7)QA:C\=_P#@H_\ L%_M(_ S0_VTOV@_ WQ4\"_'+QB/!>J-
MX>^'QT*?PEXBGM9;BQ6UD%S+]MM9'AEA;SE60!5<<DK0!]\T444 %%%% !11
M10 4444 %%%% !1110 5YQ>_\?DO_75OYUZ/7G%[_P ?DO\ UU;^= '0^"?^
M0Q??Y_B-=-7,^"?^0Q??Y_B-=-0 4444 %%%% !1110!S/QG^)WA/X+_  H\
M0?%?QY8ZC<Z)X?TJ:]U:'2-'FU"Y:W1<R;+:!6DF(7)VHI) /!K\A]<\5?\
M!/J?]KCX2>._^#?[Q]K%K\3/$7Q<TH?%+P+\,K75(/"UUX7=V_M2XUK3Y8UL
M[ 11 ;&"Q2AV&U&<*R?L]7$?!+]GWX<_L_1^+$^'=K=QGQKXWU'Q7KSWET96
MEU*]93,RD_=3"(JH.%"@4 ?GW_P5C\>?\$%?CUXC\;^%_P!N'XOW6@?%3P+I
M0TZSMH]8UO3-8MYX?,N+.73K)62#4F\V;?&Z13([,%8D+@;OPV^,/[-^N?\
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MT6HS_%O2_!,$L3[9+6PTG0X$A$9/W 9+R>7TWR,><U]S5\1_LZ?#?Q5\#/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX(W.P4?\%"?A]DG S>RC_P!IU]<64DMYI\4M[;>6\L*F6%A]TD<J?Y5\#_\
M!2'1?#_[9'[='P0_X)8^&]#LWT"&[3XJ_',06J!?^$?TNX TW3I<##)>:D(P
MR\,$MMPR,T ?7'AS]J'X9>(_VH?$O[(*+J-GXR\->$].\2M!?6JI!J6EWDL\
M"W-HX8F58YH'BER%V.R#D,#7HU?#_P"V7=R?#K_@MG^QGXS\/'R;GQWX=^(?
M@[Q&T?WKJPATNWU:W1L=52YM=WH"^>U?<% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %><7O_ !^2_P#7
M5OYUZ/7G%[_Q^2_]=6_G0!T/@G_D,7W^?XC735S/@G_D,7W^?XC734 %%%%
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M_A!/^"E'AK_D%^,3J&WD?\3&SES_ .!"C]:/^%C_ /!2+PU_R%? 9U#;R?\
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MOXV_9W^'VL:;<Z7X$'PYALM9UFQTV9)M-TK4M46Z=)K6!HH ?+MHGE$*@E,
MC] Z* /-?#GPI^.>E?M3^)?C%KG[25QJ/P^U7PM9:?H?PM;PY!'%I%_%(S37
MXO0WFRF52%\ME 7U.% XS]EC]AP?L_\ [27QO_:M\;_% ^,?&'QE\3VLXO&T
M7[$FA:%90"#3M'B4S2[Q$ID9Y@8Q,[[C$I'/OM% 'QC\0?!OB']HS_@N%\/-
M7BT.\7PO^S9\)-7U6YUA[9E@E\0^)&2RAM%9@!(R6%G<2L5SL$R XWU]G444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7G%[_Q^2_\ 75OYUZ/7G%[_ ,?DO_75OYT
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M/_)X!_[%:Q_]"EK]/_\ A)=7_P"A0O?^^EK\N/\ @KM>7%]^UN9[G3Y+9O\
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M[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI:
M-BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A
M)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$
MEU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%
M"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z
M%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\
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M8QM2XO\ P[)#J5G=R =9%MKZ[A!/\#8_A%?;U !1110 4444 %%%% !1110
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M*XO]FW_DW;P#_P!B5I7_ *215VE !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!R'Q$^ OPA^*J,?'/@.PNYV&/MJQ^5<#_MJ
MF'_ G'M7AGC3_@G,VF7W_"0?!#XG7>F7<1W00:DS H?]F>$!E_[Y8^]?45%
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MBB@#]S/V;?\ DW;P#_V)6E?^DD5=I7%_LV_\F[> ?^Q*TK_TDBKM* "BBB@
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MY<'A7Q[9B[DP!I]\WV>?=Z!),;S_ +NX>]=5XG\'^%/&NG'2/%_ANQU.V/\
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MP7EQ=:C-<6T4P#WD<=Q<F!$0!BJ*=J[OEX[P_P"$/V\_^">/[6'[0.K? ?\
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MBB@ HHHH **** "BBB@ K\J/^"Q/_)X!_P"Q6L?_ $*6OU7K\J/^"Q/_ ">
M?^Q6L?\ T*6@#Y6HHHH **** "BBB@#]S/V;?^3=O /_ &)6E?\ I)%7:5Q?
M[-O_ ";MX!_[$K2O_22*NTH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M444 %%17D\EM:O/#;-,RKE8DZM["LS_A)=7_ .A0O?\ OI: -BORH_X+$_\
M)X!_[%:Q_P#0I:_3_P#X275_^A0O?^^EK\N/^"NUY<7W[6YGN=/DMF_X1BR'
MERD9^]+SQ0!\O4444 %%%% !1110!^YG[-O_ ";MX!_[$K2O_22*NTKS7]G3
MQ#JD7[/G@2)/"EVZKX-TL!U9<,!:1<UV7_"2ZO\ ]"A>_P#?2T ;%%8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%<3\1OV=/@
MO\50\OC+P%92W3];^V3R+C/J9(\,WT;(]JWO^$EU?_H4+W_OI:/^$EU?_H4+
MW_OI: /B?]KW]DW3/@#::?XH\&:MJ%YI.H7,D$Z7J*6M9  R NH 8,-^,J,;
M.IS7B_A_6]1\-Z[9^(='NVM[JQNHY[>9#@HZL&!_,5^F7B)K?Q;HT_AWQ/\
M#B2_L;I-L]K=(CHXZ\@]P>0>H(R*\]/[+/P#72K[2;7X!/"+^(I)<"Z=Y8N<
MAHFD=C&00/NX'8@@D4 >L>%O%7AWQMH%MXH\*:O#?6%Y'OM[F!LJP]/4$'@@
MX((((!K0KXGM9/C9^P;XR-_#8W6I^"]1N</%<#;'+[$C(AG '!Z,!T(&%^H/
MAM\=-!^+/AJ/Q3X&TJXO+9CME59$WP/CE'7/RL/UZC((- '<45C_ /"2ZO\
M]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[
M_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\
M0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7
MO_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\
M]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[
M_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\
M0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7
MO_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\
M]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[
M_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\
M0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7
MO_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\
M]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[
M_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\
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M!/\  V/X17V]0 4444 %%%% !1110 4444 %><7O_'Y+_P!=6_G7H]><7O\
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M?_0I:_5>ORH_X+$_\G@'_L5K'_T*6@#Y6HHHH **** "BBB@#]S/V;?^3=O
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M3FOR/^%/A7_@\1_8T^$6C_L6?"+X+_#OQ7X;\+:7'H?A+QY_:6B3/9V$*"*
M1M<WD#%(HU54^T6Q?:H!#$8K[;U__@C;^T?K/QK_ &H_BG8?\%-?&^E6GQ_\
M/_V?X5T^TL[HGP/+YT4@GA(OD$AC6-H4$?D'RY7&X=_@?5O^"+VK:!J<^BZ[
M_P '>5Q97EK(8[FTN_$;1RQ..JLK>*05(]"* /T4_P""!O\ P3-^,'_!,K]D
M'6O!G[1GCRSU[XA_$#QO=>+/%S:9<-+;6=Q/##$(%D95\U\0[WD"@%Y&5=RH
MK-]Q5\@_\$5_V:6_9:_9:UWP"?\ @I))^U$+WQW=7X\>MJ/VD:?NL[./^S0W
MV^]QL\KSL>:.;G.P9W-]?4 %%%% !1110 4444 %%%% !1110 5^5'_!8G_D
M\ _]BM8_^A2U^J]?E1_P6)_Y/ /_ &*UC_Z%+0!\K4444 %%%% !1110!^YG
M[-O_ ";MX!_[$K2O_22*NTKB_P!FW_DW;P#_ -B5I7_I)%7:4 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !7F_[0_[-/@K]H#0/*U)%LM9MHR-.UB*/+Q]]CC^.,G^$],D@C)SZ
M110!\@?"+X__ !)_9-\6K\$?VA+*XET6,A;#4!F0VL><+)$W66#_ &?O)T R
M"E?6^D:OI>OZ9!K6B:A#=VEU$)+>YMY Z2(>0P(X(KG/C!\&? WQN\*/X6\:
MZ=O RUG>18$UI(1]^-NW;(/!QR#7R[X?\5_&/]@;QPOA+QE;RZUX+OYRUO)%
MG8XSS)"2?W<H'+1$X/KR'H ^S:*R/ WCOPI\2/#-MXO\%ZS%?6%TN8Y8CRI[
MHP/*L.ZGD5KT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2XTJTC48GEMXK:*9FCD?(N0-HV$GW;]J3X+S?M'_ +,WQ$_9ZM_%<^A2>._
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ML45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\
MP&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_
M ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_
M /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&
M_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q
M16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P#
M8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\
MP&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\
M]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_
M /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%
M8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C
M_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P#
M8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T
M&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\
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M (T?8O&__0;LO_ 8_P"- &Q16/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MRF9?M=W,;DQ#RQYLHVQN_P G(9?U;H **** "O.+W_C\E_ZZM_.O1Z\XO?\
MC\E_ZZM_.@#H?!/_ "&+[_/\1KIJYGP3_P AB^_S_$:Z:@ HHHH _%S]J/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/L00 #MZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/BCLTSQ5"?)1Y4\J._8<$ ''ERY'*=S]W^Z #WNBBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7(&T;"3[M^U)\%YOVC_V9OB)^SU;^*Y]"D\=^!]6\/1ZW:INDT\WMG+;BX4
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M?^ Q_P : -BORH_X+$_\G@'_ +%:Q_\ 0I:_3_[%XW_Z#=E_X#'_ !K\N/\
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M_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P#
M8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T
M&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\
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M_P#!4W]HWX]_#?2O$/QN\'_&C6;.RUC7[1;FYT*P;40;:6T$@(M_,/VA5E0
MF.)54[1BOZ0ZY;Q1\#?@IXXT3Q'X:\9_"'PQJVG>,8%A\6V.HZ#;S1:W&H*J
MEVCH1<  D 2;L9XH _#K_@CMXP_9$^./_!;'X7^._P#@E?\ #.YT3PGX8_9N
M>Q_:"U32- ETO2K_ %-H51!Y+JH\PW2VY+;5$K0LZAMCN?WNKD/@U^S]\!OV
M<_#+^"_V?/@GX2\"Z/)-YLNE>#O#EKIEL\F,;VCMD12V.Y&:Z^@ HHHH *\X
MO?\ C\E_ZZM_.O1Z\XO?^/R7_KJW\Z .A\$_\AB^_P _Q&NFKF?!/_(8OO\
M/\1KIJ "BBB@#\RO^"EO_!NS<_M:?MA7G_!1O]DO]M+Q3\(OC1.EFXN_LBW6
MG/+:VD5I$4\HQS6^Z*%%<EIE.#^[Y(KX*_X*-?"S_@Y1\%ZW\'O$O[:GP%TS
MX_>%_@3\3[#QGI?C#X5V*27NI&TFC=H+A+6))HHV2,9F:Q&TDL6?!!_HJHH
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M_.?^Q#_R>C\(?^RH:!_Z<8*_HPH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "JNM:)I'B/2;C0M>TV&\L[N(QW-M<1ADD4]00>M6J*
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M1Z\XO?\ C\E_ZZM_.@#H?!/_ "&+[_/\1KIJYGP3_P AB^_S_$:Z:@ HHHH
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MPS0W$*7%O*LD;J&1T;(8'D$$=10 ZBBB@ HHHH **** "BBB@ HHHH ****
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M)?\ KJW\Z]'KSB]_X_)?^NK?SH Z'P3_ ,AB^_S_ !&NFKF?!/\ R&+[_/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*VHZ5X-OM.T-=/%[I26]K+&9(U9D:5&E=&D0[25V\E&)^^J^5_\ @C[^W_\
M!_\ X*-?LD?\+J^ ?[..M_#'PCI'B.YT'1="U73+>UAGCABAE:>T6V_=&#?.
MT>5X$D,J]0:^J* "BBB@ HHHH **** "BBB@ HHHH *_*C_@L3_R> ?^Q6L?
M_0I:_5>ORH_X+$_\G@'_ +%:Q_\ 0I: /E:BBB@ HHHH **** /%?'__ "/>
MM_\ 87N?_1K5DUK>/_\ D>];_P"PO<_^C6K)H **** "BBB@#U#]B'_D]'X0
M_P#94- _].,%?T85_.?^Q#_R>C\(?^RH:!_Z<8*_HPH **** "BBB@ HHHH
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M=,]CX7TB<R74_)V^;/=VZY/620 '-?>M !1110 4444 %%%% !1110 4444
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M ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ
M-BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_
MX0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\
MA!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^
M?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y
M^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\
M MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\
M"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**
MQ_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0
M?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!
M](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F
M]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?
MF]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH
M V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"V
MH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL
M?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2
M/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](
M_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_
M\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_
M ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ
M-BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH H3_  7^%MS\9;;]H67P59_\
M)K:>&IO#T'B-0RW']ERW$=P]HQ!P\?G1)( P.U@2N-S9W+'0=#TS4+W5]-T:
MTM[O4I4DU&Z@MU22Z=$6-&D8#+E455!;)"J . *I?\(/I'_/S>_^!;4?\(/I
M'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M0!L45C_P#"
M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\
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M/X5\'6.G/@YS\UO$A[G\Z[^BB@ HHHH *\XO?^/R7_KJW\Z]'KSB]_X_)?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKVH:#%HDJ1^4C0?V7<6Y7:G"C)"]1@\U[W10!X5^S'_P3:_9"_8^\6:EXV^
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M11,LC1RP1&V@C\Z/*D0J5/[WYOV6K\*?^"OG[&?_  ;I?MD_MF>)/BI\2_\
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MSX*:OX@^&?A.X\&?#;Q1K'BC3K?4=/T.Y&SR9;2ZM'G:38!@LMPZ8PDC8!H
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MHG_E(L__ (S0!]R45\-_\-A_M&?]%$_\I%G_ /&:/^&P_P!HS_HHG_E(L_\
MXS0!]R45\-_\-A_M&?\ 11/_ "D6?_QFC_AL/]HS_HHG_E(L_P#XS0!]R45X
M_P#L=?%+QW\5/!^K:KX]UW[?/;:D(H)/LL46U/+4XQ&J@\D]:]@H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(V8G@ \_\*?VG_VP_%G@;QMKWQ3_ .";OBCP=K?AW01J'A;P_P#\+#T+4?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?JO7Y4?\%B?^3P#_ -BM8_\ H4M 'RM1110 4444 %%%% 'BOC__ )'O6_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M _\ 8K6/_H4M 'RM1110 4444 %%%% 'BOC_ /Y'O6_^PO<_^C6K)K6\?_\
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MF>#_ !IXQC\+2ZAHMF)-)U.ZGGMK2YGC<1F6SC*AY=RJ2"QZUY-_P4K^+O\
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M$7LAN3IG=+7ZK_V=I_\ SXP_]^A7Y6?\%A(8H?VOBD,2HO\ PBUEPJX'WI:
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M_OT*/[.T_P#Y\8?^_0H I_\ "8^&/^@U!_WU1_PF/AC_ *#4'_?57/[.T_\
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M_?5'_"8^&/\ H-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\
MH-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC
M_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"
M8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H
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M2Q20*RNI&"I!&"".,5'IGAOP[HFFV^C:-H%E:6=I D-I:6MJD<4,2*%5$50
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ,AB^_S_ !&NFKF?!/\ R&+[_/\ $:Z:@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@#^OVBOY O\ B*._X+K_ /1\W_F,O#'_ ,K*/^(H[_@NO_T?-_YC+PQ_\K*
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M:U;_  ]\!+;KX6T71/'NM:7+:B"&2&,-=65Y%<3@)*^5ED<$D,06 ( /C_\
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M? S)B57"YW*%;F@#MZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJO[(_@#]GGPW8?#G7H;F/7O"WV,RPZI]H4+-)=/(6DN)7 4&61FD^5?F^5<
M'S?_ ,%EYK7Q1\7_ -B7P%X7N(Y_$=[^U[H.M6%O P,LFE6&G:C+J,RXY,:1
M21[R. '7-?<EGJ>FZC)/#I^HP3O:S>3=+#,K&&3 ;8P!^5L,IP><$>M?/O[,
M?_!*C]AO]D+XBV_Q:^"WPHU!?$6GZ2^E:'JOB;QEJNN2:+8-C=:V']HW,XLH
MB!@B$(2ORDD<5UOA7]A7]EWP/HGQ7\/^#_AW<Z9;_&[6;W5OB6UCXCU"*;5+
MR[@$%Q,DRSB2T9DZ?9VBV$EEVGF@#YW_ & ?^4RO[?\ _P!A?X8_^HHM4?\
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M^#>RUM9_V,/$[SVT;D?$^] +H"<?V=IM 'W%_P )CX8_Z#4'_?5'_"8^&/\
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M7AZZ_8E^+%M;ZM"[O\/]55%!Y)-L_%?SVU_3U_9VG_\ /C#_ -^A1_9VG_\
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MU'0%L9(%3T4 17=A8Z@J)?V4,XCD#QB:,-M8=&&>A'K7D_[9?[(OAO\ ;3\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *\XO?^/R7_KJW\Z]'KSB]_P"/R7_KJW\Z .A\$_\ (8OO\_Q&
MNFKF?!/_ "&+[_/\1KIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGPXN+KP_-^S)KR^*]<T;P79^7:J]Q*+K2YHHH=52]#2&2\;Y0B%2%$>?5?\
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M#R]\6:)\2-<TEM/TS7K:VOK>SD:PCG"S7$!DGPMSM6-S$^S>N'/UI0 4444
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M@CQM?^$/'W@GQ-Y1N]#UJS\LSVYDA9HYDVRQLLJ':P;L00 #W:BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KF/BE\%_A;\;+'1M.^*G@JSUJ+P[XEL?$
M.A?:@P:QU2SE\VVNXF4@I)&W0@\@LIR&(/3T4 5+G0=#O=7M?$-YHUI+?V,4
ML=E?2VZM-;I+M\Q4<C<@?8FX @-L7.<"K=%% !1110 5S'Q,^"_PM^,DOAR;
MXH>"K/6CX1\3VWB+PXMZ&*V6J6ZR+!=JH(!>,2N5W A6(8#<JD=/10 4444
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MI>_L_P#@K5[VWV/8>%O#$P6-%Y/SW$LHEE]3!'[U^@_[0/[0'P@_9:^#FO\
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MJ=F-,'[+][HQ8NNW^UC!+8"+_KI]O(3'7><=:^VOV;_^"7G[&/[)?Q)7XM_
MSP5XLL-=2QELUGUCXK^)-8A\F3&\?9]1U">$GY1AMFX=B*YN'_@BY_P3:@^+
M+?%^/]GAA</XH_X24^&SXJU0^'O[8W[_ +=_8WVG[!YV[YL^1@-SC/- ''_$
MW]L3QI^Q5^Q+\%OV<OA]X+D\8_M'^-?AWI.A_#WX=*W[R74HM.ACN-0OB?\
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M-*D\3>*?%VIZ]J$.G(P=;*"XU*XG>WMPP4F*,JK%5+ E1CWF@ HHHH ****
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MUI.N6*W4L!N+.YA:&:,21,LD>Z-V&Y&5ESE2" : /A*SNI_^"Q?[=W@/XM^
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M_P +"L_^@=+_ -]BC_A85G_T#I?^^Q0!T-%<]_PL*S_Z!TO_ 'V*/^%A6?\
MT#I?^^Q0!T-%<]_PL*S_ .@=+_WV*/\ A85G_P! Z7_OL4 =#17/?\+"L_\
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MT-%<]_PL*S_Z!TO_ 'V*/^%A6?\ T#I?^^Q0!T-%<]_PL*S_ .@=+_WV*/\
MA85G_P! Z7_OL4 =#17/?\+"L_\ H'2_]]BC_A85G_T#I?\ OL4 =#17/?\
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M+"L_^@=+_P!]BC_A85G_ - Z7_OL4 =#17/?\+"L_P#H'2_]]BC_ (6%9_\
M0.E_[[% '0T5SW_"PK/_ *!TO_?8H_X6%9_] Z7_ +[% '0T5SW_  L*S_Z!
MTO\ WV*/^%A6?_0.E_[[% '0T5SW_"PK/_H'2_\ ?8H_X6%9_P#0.E_[[% '
M0T5SW_"PK/\ Z!TO_?8H_P"%A6?_ $#I?^^Q0!T-%<]_PL*S_P"@=+_WV*/^
M%A6?_0.E_P"^Q0!T-%<]_P +"L_^@=+_ -]BC_A85G_T#I?^^Q0!T-%<]_PL
M*S_Z!TO_ 'V*/^%A6?\ T#I?^^Q0!T-%<]_PL*S_ .@=+_WV*/\ A85G_P!
MZ7_OL4 =#17/?\+"L_\ H'2_]]BC_A85G_T#I?\ OL4 =#7G%[_Q^2_]=6_G
=73?\+"L_^@=+_P!]BN7GD$L[R@8#.2!]30!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>cdna-20240429_g2.jpg
<TEXT>
begin 644 cdna-20240429_g2.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !P ' # 2(  A$! Q$!_\0
M'    04! 0$             ! (#!08'" $ _\0 .1   0,# P($ P8$!@,
M     0(#!  %$082(3%!$R)180=Q@10C,I&QP4)B<J$54H+1X? 6)#/_Q  <
M 0 !! ,!               %  $" P0&!PC_Q  H$0 " @(" 0,$ @,
M   ! @ #!!$%(3$2$U$&(C)!0M&1H>'_V@ , P$  A$#$0 _ ,^2WP13H2,
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M8"W%'/E3@XW9]>,?//%1:7VF@D*2O8HX0Z2 #Z#Y]:;44^\,UX4<=*)4WM4
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M@D@9R.WSK/J#^X 3 ]_MK26 DKHFU*F3&VOLZ%I'1PC"D)]_IP*U5+(;2$)
M"0  *BM"6--ML+#RP?M$A.]14,$#L![58%-]31>:[J!*;Z]J;+>,T8I%(4W2
MC23::);/SHE+6 /6O6F]J3Q1*$<"E)QI+/KS5-U)H-MUN:]!82M3P*ELGNH]
M2/\ :KV&_EFA+I<H5C@.S;C+9@Q&AE;\AP(0GYDU( D]",0/W.<[="E:/OLC
MQL?9W1A:>X.3V^6*T>PR;=J1TPK@RA^(XWM(6,@\\?E0FL/B!I'6=JC(L-V@
MW:2)8"S'Y6E.U6<Y .,X'I5;L5R.G;D$R!]V%\9[<T*O!6T_,/89W5\B=$P-
M3VJQ0TKU-I:UWF!$83&:F14F++(_"D*=;(R0"/Q _AZU3];77X2R+5<5Z-TG
M*5<L*6H7B[NK;3Z!+:5Y621C!]:CKS.M]VM(3&EA+A'')Q\JSB5;H]J4X](G
MI:2.2E)QD?\ -4+;WK4)D(J%B#O_ %*K'L\'3461(<'BW.3E6%K*MBCT '0
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LL:L/:>SXC[R 3N/TJ+N#'EVXZ]ZE6TE(R2:&D)270,G'O1@H"(%#D>)__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>cdna-20240429_g20.jpg
<TEXT>
begin 644 cdna-20240429_g20.jpg
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M/^$)UC_H.?JW^-=-10!S/_"$ZQ_T'/U;_&C_ (0G6/\ H.?JW^-=-10!S/\
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MS_PA.L?]!S]6_P :/^$)UC_H.?JW^-=-10!S/_"$ZQ_T'/U;_&C_ (0G6/\
MH.?JW^-=-10!S/\ PA.L?]!S]6_QH_X0G6/^@Y^K?XUTU% ',_\ "$ZQ_P!!
MS]6_QH_X0G6/^@Y^K?XUTU% ',_\(3K'_0<_5O\ &C_A"=8_Z#GZM_C7344
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M-=-10!S/_"$ZQ_T'/U;_ !H_X0G6/^@Y^K?XUTU% ',_\(3K'_0<_5O\:/\
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M*3P1JWP2W1?$;PSITQN/,D9 ;1K3S-K#[3)F!(Y""LJLK,5 <^":O_P<!_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0P0*B19SG: ,+U/3U/K2:KHFC:[ EKKFD6MY%'*)(X[NW615<=& 8'!'KUH
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M_;6^&O[!7[8WQI_X)K_M(^#_ !9I7Q-^(/QH6V\.V,.AF2'S(_M*2><Q8&)
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ML9W!7A'6,Z;=QY^_-;.><,:_HD,<9D$I0;E!"MCD XR,_@/R%?GY_P %A_\
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M?^NK?SH Z'P3_P AB^_S_$:Z:N9\$_\ (8OO\_Q&NFH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\XO
M?^/R7_KJW\Z]'KSB]_X_)?\ KJW\Z .A\$_\AB^_S_$:Z:N9\$_\AB^_S_$:
MZ:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCWQA%I^N?$+6)]+\':>UM+(^I7<-I+=RQJ41@FV""5RSE5^7&<D @'6T444
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M !4GK: "BBJ?B#Q#H'A/0[OQ/XJURSTS3=/MWGO]0U"Y2&"VB49:221R%10
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M3_ P^&5^*OC"+2#XR\6V?ACPR)+:60WVK70<V]JOEHVTL(Y#N;" *26%=;0
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M.TC*NP/!->"_MG_"7XC?\$C_ (P_LX_%W]EG]MKXU>*)OB/\=-$\#>)_A/\
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M(GXD>$8]5A:X6-_.,"R6\P1MN 6 &<8R<5ZU_P %#/#'P2_X*(?\$?W\2?\
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M/AK_ (*7?M ^'?BUHO@5O$JW.O\ Q>O=3T+5;R.]>)+"?3KUI(94GVI$J?\
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M\VS36T2:/IK1X=&LRJ2SA)?,$CI(QYW?4'_!$F=OAI\6/VY_@UKEO,^L:/\
MM?\ B3Q7-:1QEYWL=8M;6YLV"]6+QPMM]>U?/O\ P4I_;A_X(+?\%"O@1XET
MOQ1X$U?6?C^OAZ>+P-X>L/A3K%E\0-/UU8V%G;H\=JLBLEQY>5:1K?Y>=PZ@
M'KG_  < :)^T?+\$_P!F/]FCX'_M4>-_!_B3QU\;]*\)7GCCP]X@FTN]O9)-
M*O8TFN7LS'N5IU29XP A(X PN/H+_@E)^W%)^U!_P3@\.?'SXZ:JFE>*O!FG
M7FA?&#^TG"-IFM:06@U"2XQQ&6\K[21_"LXKY$_:6T#]H[PW^SE_P3"T#]K>
M\N[GXDV?[0_@V+QA+J$WFW(NQIUWE;A\G?.J[5D?)W2*YR<Y/EO_  43^'/[
M1?P+_P""A?Q)_P""8'[/>CWUMX,_X*$:CI&KP:Y8\1^&9XY/*\7RJO\ &T]A
M%YTO7Y9U% &__P $K_VD?VN?C[_P62T3X_\ Q:^-'C5?!7Q\^#_BGQIX+^&6
MHZ[<?V7HF@PZU;V&C[;(OY*3O;6_V@RJH+?:BW!9L_4O[#.I']G7_@LA^U1^
MQ;8GR?#OCC3-&^,?A73EX6VN;U?L&M2 =_.O(8I>,8);KG-8FI>!?"_PR_X.
M'/@I\./ FB1:=H?A[]C?5=,T?3[=<1VMK!J\$442^BJBJH]@*O?"Z)_B#_P<
MP_%/QIH?SV?P\_9,T/PKKKITBOK_ %MM3@1L?Q&!&(SSCVH _0"BBB@ HHHH
M **** "BBB@ HHHH *_!_P#X+-?\I*/B1_W!_P#TS6-?O!7X/_\ !9K_ )24
M?$C_ +@__IFL: /E^BBB@ HHHH _>#_@C+_RC7^&_P#W&/\ T\WU>$_\%>M$
M\8_&'_@IQ^Q%^R;#\=_B/X,\'_$6;XC_ /"7P?#GQS>Z%<:A]@T6TN[7?+:2
M*6\N521NS@2.!C<:]V_X(R_\HU_AO_W&/_3S?5\V?\%F?@-X)_::_P""MW[
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MG@7PG?:S<0;]IN#!"SI I_O2.%C7_:<5^8O["W_!)G_@IG\2/^"<UUH'B?\
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M0VWB7Q9X;^-Z3-X#U+P3I(O7O3]@%Y:QI 725Y+HO#!"BJ299E#[ "1^5O\
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M2?L^?'_Q1\--=^)7[4GA/P=)XI\)ZW<V%S!#J$-_#\SV[H[QB3RI"F<$Q+W
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M;<<11^(M)NCIESY:= TUF899&&-QB!.3S7WG7P!\3XG^(7_!RK\+]'T(;_\
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MLNZ*TMU\M9"P+EW;:N0H]UHH **** "BBB@ HHHH **** "BBB@ KP?XS_\
M!,O]B']H/XE:E\7_ (O_  3_ +7\1:OY/]HZC_PDFI6_F^5"D$?[N"Y2-<1Q
MHORJ,[<G)))]XHH ^7_^',O_  37_P"C;_\ R\-9_P#DRC_AS+_P37_Z-O\
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M .6=??\ 110 8 .0.3U-%%% !45[8V6I6KV.HV<5Q!*N)(9HPZ./0@\&I:*
M([6UM;&W2TLK:.&*-<1Q1(%51Z #@5)110 4444 17EA8ZC$(=0LH9T5MP2:
M,, ?7![U(54D$@9'0^E+10 $ C!%(J(@ 5  HPH Z#TI:* "O+?VV?V4? ?[
M<G[)_CS]DSXE3M;Z3XX\/RZ>]]'")'L9\B2WNT0D!GAG2*95) +1@$XKU*B@
M#R+QQ^RF/CC^Q!=_L9?M%?%#4]?/B#X>IX7\9^,-$MTTZ[U0M:K;W-W''(;A
M;=Y3O?83*%WD9;K7J'AOP_IGA/P[8>%M%A,=GIEE%:6D9.2L4:!%'Y 5=HH
M  !@#'TI%55&U5  Z "EHH \*_;Y_8EM?V\_AUX2^"_BKXB'1O!VF?$71_$7
MC;0TTC[3_P )38:?*;A-)=_-3[/%)<);R/)MD.(=H4;MP]UHHH **** "BBB
M@ HHHH **** "BBB@#,\8^#O#GC[PY<^$O%NG?:]/N]GVBW\YX]^UU=?F0AA
MAE4\'M7#?\,>?LY_]$[_ /*O>?\ QZO3** /,_\ ACS]G/\ Z)W_ .5>\_\
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M$5M&OA\-;KP7XY\-'2?.B\1V7VE+JQF\WS5^S36TPE^?RY3)'+L^0+D^ZT4
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M R2.2* +]% (8!E(((X(HH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'C3Q9%+_ &M>>)=/U"2[:>(2VML?WTEO/#&XB576XWJ6#AS8_P""/_C/7_\
M@JM\5OCC_P %:=1TJXT&/Q9X'TSX6_"U+I&632;6VL4N]6=#U:-]5N3M8?\
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M?PY\+QZE?>&O#5QJQTI)]-B#37,-JCR+!&RE)&56VL0,<T >9?\ !-C]A_\
M8JO?B%IW[<?[#'_!33XN?$>75&BF^(,VH_%I=>M?&#?8FMH1K-M-&7BN(5*>
M6"(I(?*V!0HVCY0_X*$?M6_M7_LQ_P#!:;XB_M4^%_CMXV?X6_ =/AY/\0_A
MS#KUR^CR^&M:2>RU&Y%B',33Q2R6\RG9D,"Y(VYJ?QMK_P#P3Z_:>_X*0?L\
M_&'_ ((/^')?^%EVOQ6M+CXV^*/AKX2O]'\/+X)P[:G'JV^"&U>:7Y5C&/,=
MBP8[S%7T%X0^"/@K]I/_ (+.?MR?L_\ Q*L#<>'_ !K\ _!NBZM&%&?(N;.[
MB9E)Z.H8LIZAE!'(H ]^_P""NO[67C#]GK]AR]N?V=]62?XE?%;5-/\  WP=
M:RN!NFUO6'\BWN(G7(_<Q&:Z#<C]P,\&OG#_ ((V?!SQ;^TW_P $Y/VG_P!B
MC]J'XU^*?B3:VGQV\>?#A?$GC?69]2O380V]K:QL))W9EVLS3* V%=B5P>:\
M;_X(S:;^TQ^U[^U]X(^"W[6/ANYCT[_@GKX<U/PA-=W.3#K_ (MGN9]/LKQ0
MW^L2#1K9"KG+"202 @2J3]/_ /!!"ZMM,^'O[5]_J,Z000?MM?$:2::9@JHB
MS6I9B3P  #D^U 'H?_!"7]HGQA^TK_P2S^%GBOXE73R^*_#NGW/A/Q0\TA>1
MKS2;J73S)(Q^\\D=O'*Q[F0U]=U\"?\ !M5IU]=?\$O['XI3VLD%I\0?B5XM
M\3:5#*I5EM)]8N(XSM/W0PA+#U# ]Z^^Z "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7G%[_Q^2_\ 75OYUZ/7G%[_
M ,?DO_75OYT =#X)_P"0Q??Y_B-=-7,^"?\ D,7W^?XC734 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%><7O_'Y+_UU;^=>CUYQ>_\ 'Y+_ -=6_G0!T/@G_D,7W^?XC735S/@G_D,7
MW^?XC734 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %><7O\ Q^2_]=6_G7H]><7O_'Y+_P!=6_G0!T/@
MG_D,7W^?XC735S/@G_D,7W^?XC734 %%%% !1110 4444 %%<)^U)\:)?V;_
M -F?XA_M#0>%)]=?P)X'U;Q"FB6K[9-0-E9RW(MU.#@OY>W.#C=G!Z5\6?\
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M)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\
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M^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\
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M%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\
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MH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\
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M[NK&&66 DP2R1!FC)ZE2>1^%.N[2TO[9[.^M8YH9!B2*5 RL/0@\&@#\T/\
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M\2(/BOKW@L77POT73O'FO6L>AW @:TLCI<-F\=C;&2\MC*[W)8&0R-(PCPH
M/T_HKQC_ ()U1?'2']@[X0)^TSXICUOQZ?AYI3>*=6CU".[^U71MD+.T\;,D
M[D$;I59E=MS!F# GV>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5YQ>_\?DO_ %U;^=>CUYQ>
M_P#'Y+_UU;^= '0^"?\ D,7W^?XC735S/@G_ )#%]_G^(UTU !1110 4444
M%%%% '"?M2?&B7]F_P#9G^(?[0T'A2?77\">!]6\0IHEJ^V34#96<MR+=3@X
M+^7MS@XW9P>E?%G_  3Q^'7_  4"^/'Q+\&?\%7-9_:\^#GB?2OBYX T2R\6
M^ -!\#WL5KHFC1-=WD=MI^H#492]Y#/?RI*9H0&9"I"E01]T?&?XG>$_@O\
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M_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\
M?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C
M#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\
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MQLR*TLCM@;F50 Q)&*\K_P"">_Q__;:^(WQ \<?#S]N']C'QEX!GN];U'7_
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M<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\
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MB#-&3U*D\C\*EDCCFC:*6-61E(96&00>H(I:* ([6TM;&W2TL;:.&*,82*)
MJJ/0 <"I*** "BBB@ HHHH *_+K_ (+2_P#)UNC_ /8B6G_I7>5^HM?EU_P6
ME_Y.MT?_ +$2T_\ 2N\H ^1**** "BBB@ HHHH _8O\ X)H?\F/> O\ KTO/
M_2ZXKW6O"O\ @FA_R8]X"_Z]+S_TNN*]UH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^*-[X.L-*^(GQ+O[FZOK_7[F.&/[2PFO9)98;:2=6D%NA6,?+\ORC !\G?\
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MA5=4UR^G:YO)D7 Q&)'V)P#Y<:$C<37C?_!(/_DY+]MW_LZ6\_\ 3/IU>Y>
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M"LRDJ6()% 'T11110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5YQ>_P#'Y+_UU;^=>CUYQ>_\?DO_ %U;^= '0^"?
M^0Q??Y_B-=-7,^"?^0Q??Y_B-=-0 4444 ?SO?\ !QKXX_X*I? G_@ICKOQ'
MM/VF/VDOAE^SOJ6D:2NB^*?A7J&I3:18.MG%'<*\%M?6L$<IN1.S"219&!!
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M%Z_9XHX;K5+JQ>*:^;$?F@B54=Y7=E?*[?GG]KG]L7]LSQC\5?%__!-;6?\
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M'BW6K>_DT:[%C;QS:;;RVZ+']E@D1DB4%\*/]8XP: /?**** "BBB@ HHHH
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MBIOB/_P3=\'#P9(OPJ\07_\ ;<3AXSK5TC17"X.8SLC783P0V#TP>N1]/44
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO_75OYT =#X)_P"0Q??Y_B-=-7,^"?\ D,7W^?XC734 %%%% 'RM_P %$?\
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MYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV** ,?_ (0?2/\
MGYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ M
MJV** ,?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]_P#
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M;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%%
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M[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\
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MX0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\
MA!](_P"?F]_\"VJUI6@66CR/):RSL77!\V8L/UJ]10 4444 %?"'[0O["?[0
M'P ^(/Q/_;N_X)B?MC:;X*U+Q)-<>(/B+\,O'NEQ:IX.\0ZG9PF.:=I%=+C2
MIV$&V::*0Y:/#*NWC[OKXA^+G_!"K]C;XR?MJ3?M$>*_AG8?\(9KVB:I<^/?
M MIK6J6UKXF\37-[:31:K=V\%REO*%BCO%=&3$KW6YPY4$ ';_L__'KX\_\
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MZ/'&D2"*) JJ %51@ >E+0 4444 %%%% !1110 4444 %%%% !1110 4444
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YQ>_\
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MD'@@CC% 'YT_L8^ _CA_P4$_;T^&G_!8?5_V8-,^"O@>W^#]S;Z'YOB.UO\
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MP3^!S^(8)].\/3Z8\#?8YKBVS;6\MYLN'9("T$3O$-X&[;^LM% 'P;IOP_\
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M,?(C^O+?[7:O6Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX%\/Q0PZGKUS=6YN CF=UBM(X8E=IYI6"0A#DDX!XS_@J/\ M&^.?B=%=?\
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MJ*\M8[ZU>TF9@LBX8HV#^!K,_P"$'TC_ )^;W_P+:@#8K\NO^"TO_)UNC_\
M8B6G_I7>5^EO_"#Z1_S\WO\ X%M7YD_\%D=+M](_:ETBVMI)64^![1B99"QS
M]KO!U/TH ^3:*** "BBB@ HHHH _8O\ X)H?\F/> O\ KTO/_2ZXKW6OG?\
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M;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\
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M16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\
M"#Z1_P _-[_X%M0!L45C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\
M(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?
M\_-[_P"!;4 ;%%8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/
MI'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\ "#Z1_P _
M-[_X%M0!L45C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>
M_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!
M;4 ;%%8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^
M!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M0!
ML45C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_
M  @^D?\ /S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8_
M_"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I
M'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M0!L45C_P#"
M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\
MWO\ X%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
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M'QYF^-&G%M0U'P?XIU;PGX5LR\4UI=F&9[9Y[G#+YD! +Q\J>5&:^7?V)O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<Y*P01+&@)[G:HK5HH **** "BBB@ HHHH **** "FR21PQM--(J(BDLS'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *_*3_ (*,_P#!?3_@BW^S'XI^)G[,S_ -?C#XW\0:E)H?Q,\)^%_
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M;_@SY\2?#&\_X)L>+_!/P\\(16=SX<^,&I6NO:]:7-Q);^))S9V1BU!%G9C
M6MQ!&T*X4>4'VJ9"!^K]?$__  0A^-/_  3W^)_[).O> _\ @G!\%=6\!^#/
MA[X_OO#^JZ5K9BEN+W4DCADDOS<1W-Q]J659(P)6D+8CV@*BH*^V* "BBB@
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M&)SZ5R_[-FEW_AWXI_$[PO>>*-4U9;'5M."7>KW9EE<O9AV). !EF/"@ #
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/Q6UN+5O"0U'6=7\%)&NGW-Q"K+=O86UYHZWKP>;%*(@\7F2(%(!W#/ZU?\
M!5K]E/QG^V__ ,$Z_BU^RS\.=2AM?$/BWPH\.A/<3>7%)>0R1W$,+O\ P)))
M"L;-T"N3SC%?DU^S_P#\' O_  4A_8,_9Q\)_L*_%'_@B+X\U#QY\.O"]GX6
MTG4+5[^VM;Y+2!;:VF-M'ITWFY6-"3#,4F.61D## !^D?_!#3X1_\$V/@_\
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M$\.>%?B1I46H^$]6:*%WM(Q>O#!J$*N\L9FBF4YB#!"K9'T77#?&/]HGX6_
MZP,WC/7E:]9-UOI-GB2YF],)GY1_M,0/?/% 'R__ ,$I?V4OVAOAI^T#^T?^
MV;\>O@[I_P *A\>/%6C7NA_"/3M:M[\Z)%I]E);R7MS+:$V_VN]>0S2B(L 5
M&YF)X]N^.O[<'PP^$WG:%X:D7Q%KB94VUG,/(@;_ *:RC(R/[JY/&#MZUY'J
M7Q*_:D_;3OY?#_PXTE_#WA4N8[F=9FCB*]Q-/C=*<=8XQCGE3UKV3X$_L6?"
MWX.^3K>J0#7]=CPPU"^B'EP-_P!,HN0O^\=S>A'2@#QW2/@Y^T[^V-J</BGX
MOZY+H'AO>)+6U>$HNT_\\;?.3Q_RTD.<'@MTKZ2^$/P#^&'P1TS[%X&\/I'<
M.@6YU.XQ)<W'^\^.!_LKA?:NSHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M10!C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^-;%% &/]B\;_ /0;LO\
MP&/^-'V+QO\ ]!NR_P# 8_XUL44 8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_
M ,!C_C6Q10!C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^-;%% &/]B\;_
M /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XUL44 8_V+QO\ ]!NR_P# 8_XT?8O&
M_P#T&[+_ ,!C_C6Q10!C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^-;%%
M &/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XUL44 8_V+QO\ ]!NR_P#
M8_XT?8O&_P#T&[+_ ,!C_C6Q10!C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\
MP&/^-;%% &/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XUL44 8_V+QO\
M]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C6Q10!C_8O&_P#T&[+_ ,!C_C1]B\;_
M /0;LO\ P&/^-;%% &/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XUL44
M8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C6Q10!C_8O&_P#T&[+_ ,!C
M_C1]B\;_ /0;LO\ P&/^-;%% &/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P#
M8_XUL44 8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C6Q10!C_8O&_P#T
M&[+_ ,!C_C1]B\;_ /0;LO\ P&/^-;%% &/]B\;_ /0;LO\ P&/^-'V+QO\
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M\-OV&_V9/"?[+?PGN+ZYT?PK9/'_ &CJDPDN]0N9IGN+F[G8 !I9IY996P
M7(   %>H4 %?SU_"_P#;N_:N_P""0O\ P4R_:N?]FK_@DC\6OB5\.OB/\3+R
M[6&[T"_T^>'4;:\N5DN;2^@L+I+BPE:6>2)"F0DD6&&US)_0I7X,_P#!0?\
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MZM_.@#H?!/\ R&+[_/\ $:Z:N9\$_P#(8OO\_P 1KIJ "BBB@ HKYN_X*_\
MCG]HKX:?\$R?C5X]_90EOHO'NE>![FXT2YTM"UU;(&7[3/!CGSH[;SY$*_,&
M12.0*_(C_@GC_P &U_@C_@H;^QSX&_;)\6?\%5?B-JNM>/-(34M<&ARBX2PO
M6_UUE++-.\CSPONBD9L$NA( &,@'] D%G:6KRR6MK'&T\GF3M&@!D? 7<V.I
MPJC)[ #M4E?,G_!*?_@FGX>_X)8_L]:Q^S_X;^.7BCQ_#K'C"XU]]7\5;1-
M\MK:V_D(%) C M0W7.Z1J^FZ "BBB@ HHHH **** "BBB@ HHHH *_+K_@M+
M_P G6Z/_ -B):?\ I7>5^HM?EU_P6E_Y.MT?_L1+3_TKO* /D2BBB@ HHHH
M**** /)?C#_R4*]_ZX6W_I/'7,UTWQA_Y*%>_P#7"V_])XZYF@ HHHH ****
M -OP3\1_''PXO7U#P3XDN+"24 2B/#)(!TW(P*MC)QD<9K^A;]CWP7X4\-_L
M\>#M=T+0+:UO=<\)Z9?:O=11XDNIY+6-W=VZGYF8@=!DX K^<ZOZ1/V6/^38
MOAQ_V(>C_P#I%#0!WE%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S/Q1^-/P@^!^
MEZ?KOQF^*'A_PG8ZKJT6EZ;?>(]7ALH;F]E5VBMDDF95,CB-]J9RVT@9-?G1
MK'_!%3]HSPS^R#^W'^S7\-OB1X/U+3OVCO'%WXM^&,$\]Q VFS7<PFN+:\?R
MF55 C@2-X]^0I+;<U]W_ +7_ .QU^SO^W=\"]4_9S_:?^'EOXD\+ZJ5D:WDD
M:*:TN$!\NY@E0AX9DW':ZGH2IRK,I^6O^"3O_!#73/\ @E)\;?&7Q$\'?MC>
M.?'7AKQ#H$>D:'X.\40 1Z1"DZRJYD24I-(JJ(U*PQ *S\?-@ 'F?_!*'_@C
M_P#M^?"_]J_1OVZ_^"J7[3V@>-O%_@;X?_\ "'?"_P +^$H_]#T/3RGE-)(Z
MVUNF\1>8F%C8OYI=Y&( 'Z?T44 %%%% !7G%[_Q^2_\ 75OYUZ/7G%[_ ,?D
MO_75OYT =#X)_P"0Q??Y_B-=-7,^"?\ D,7W^?XC734 %%%% 'G/[7/P(T3]
MIS]FGQG\!/$GQ)USP?I_B?1)+2\\3^&M06UOM.CR':6*5@50@+R2,;2:_G#\
M6?\ !.7_ (-5?"'Q%E^&NL_\%FOB/-J$5T8)[W3?#[7M@),XXO8-(>W=2?\
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MA_X)M?"S]JGX[Z;IUIXK\7Z3=SZM%I-D]O;L8K^YMXY$C=F*AXH8WZD$N2,
M@5^<7_!%O]@__@U_^)K:;K'P;^).E_&;XCR%9)-*^-MZ(]2$YY=8]&G6*WG
M;^(1W&./WISD_M3H^C:1X=TFVT#P_I5M8V-E;I!9V5G L4,$2 *L:(H"JH
M    &* +-%%% !7G%[_Q^2_]=6_G7H]><7O_ !^2_P#75OYT =#X)_Y#%]_G
M^(UTU<SX)_Y#%]_G^(UTU !1110!\S?\%4_V</\ @G_\7_V2/'?CS]OOP!HL
MGACP[X.O'U#QG_8EM+K6B68Q(YT^Y>*22&5F50JQ\NY P2:_&SX:?\%X?^#?
M[X.^!] ^%?@3_@BS=^)=.\.Z5!8:5XB\4_#SPS<:KJ<5N@C^TW,I#M+,VW<[
MEB2Q)-?LK_P6-_9E^('[8O\ P3$^,W[.?PHLS=>)O$'A!VT&Q60(U[=VTT5W
M%;!F(4&5H!$"Q"YD&2!DU^=O[0FF?MV?L??#']A;_@I;\'O^">GB;Q5JGP>^
M$E[X%^*7P:L;22'4;%9K"&U694MH9WBB,D,\OF>4X0&(.!YA*@'Z _\ !'W]
MO_X/_P#!1K]DC_A=7P#_ &<=;^&/A'2/$=SH.BZ%JNF6]K#/'#%#*T]HMM^Z
M,&^=H\KP)(95Z@U]45^=?_!M9\&?VGOAC^R)\1O'G[2?P6O/AC'\3/C9K?B_
MP=\,[VUDMV\.:9=K 1 D$BJ]M%YJR!(F53M0/M'F<_HI0 V66*WB:>>541%+
M.[M@*!U)/85\H?!S_@LO^P[\>/VY]8_8C^&/QX\#:O>6/ANQO-(U_3_&MM-'
MKFJ2W%XEQI5I&HQ/+;Q6T4S-'(^1<@;1L)/NW[4GP7F_:/\ V9OB)^SU;^*Y
M]"D\=^!]6\/1ZW:INDT\WMG+;BX4 C)3S-V,C.W&1UKX3_9G_::^(7_!/G0_
M@C^PE_P4Z_84T?PUIFFZEI7@WX7_ !N\"/;:MX4O]76,06<DL;HESHUU/M^\
M\9#2,[;D3<4 /N7XY?M8?LV?LT:CX9T;X]?&OP]X6OO&6MP:1X4T_5M05+G5
MKV618TB@B&7D^=T!8#:NX;B,BM/XZ_'_ ."?[,7PSO\ XR?M!_%#1?!_A?3-
MHO=;UZ^6"!&8[40%N7=F("HH+,3@ FOA'_@NK^S1\!O#VB?#S]I[3/A?IG_"
MP?$'[2OPUL-2\77$;37OV.'58D2UBDD+?9X?E#-%#L1WR[!G):NR_P""C4%I
MX[_X*U_L(?!CQE:I>^&+G7O'WBB;2KI0\%QJVE:'"VGS,IX+PM=3RH>H89'0
MT ?3/[+G[;/[*'[:OA_4_$O[+'QVT#QI;:+=K;:RFDW)\_3Y6!*+/!(%EAW!
M6*EU ;:VTG!QZE7PAJVFV?@;_@Y#T2\\'6B6S^._V2[]_&4-L@5;M['7K=;2
M[F ^_(JRO LC<["%S@ #[OH **** "BHKQ;I[5TL9524K^[=UR ?<5F?8O&_
M_0;LO_ 8_P"- &Q7Y=?\%I?^3K='_P"Q$M/_ $KO*_2W[%XW_P"@W9?^ Q_Q
MK\R?^"R,6J1?M2Z0NKW44TO_  @]H0T2;1M^UWG&/SH ^3:*** "BBB@ HHH
MH \E^,/_ "4*]_ZX6W_I/'7,UTWQ@S_PL*]R?^6-M_Z3QUS- !1110 4444
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MQ16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\
M 8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_
M  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_
M -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;
M_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%
M%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !
MC_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\
M 8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\
MT&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_
M -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45
MC_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/
M^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !
MC_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0
M;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\
MT&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/
M]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_X
MT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/
M^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!N
MR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0
M;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V
M+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1
M]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_X
MT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\ T&[+
M_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!N
MR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XU:TJ#7X9'.L7\$RE?D$46T@T 7J*
M** "OEC]NW_@KU^QQ^P/X^\&?"KXJ?&#P@OB7Q/XPTW2]7T.\\6P6MSX?TRY
M#L^KW2$.T<$:H" X0/O7##K7U/7YN>)_!?[6W_!++]I'X_\ [1EG^QQ!^T!\
M&/C%XG_X2WQ/J?A"_MQXP\-QBSBAGLY+"["KJMG&L688H90R!GRO)P ??OB'
MXT?"#PG\*)/COXF^*7AZP\$Q:2FJ/XNNM8A3318N@=+G[26\LQ,K*RN&VL&&
M"<BL[X>_M(? OXK? >W_ &GOA[\3-,U3P!=://JL'BJ"1A:M90[S+/E@"%7R
MWSD#&TUY58^#?V%_^"B/[(OP[^->A?#;0O%OP^LM$3Q!\-M-OM-,=AI[):O#
M"38'$(DMUW1K'(C"%T^0*R@CP+_@CI\/M>^+?_!N3X!^%7A5H!JGB;X-Z[I.
MFFZD*1"XN9+^&/>P!*KN<9.#@9X- 'NGP3_X+%?\$Q/VCOBEI'P4^!W[:/@S
MQ+XKU^9X=&T/3KJ0SW;K&TC*@9 "0B,W7^&ND_:<_P""E?[!W[&GBZR\ _M.
M_M1^%?"&N7]H+N#2-1NV>Y6V+;!<21Q*S0PE@0)) J$J<'@X^5?V??VHOVJ?
M^"9OA7]G?]EW]O']B?PEH_A+57\/?"[0?BS\//B"-6\G6OL:6EF+ZSFL;:6%
M+EH&)EC>18]V&SP3U/\ P2*T30?BG\=_VX/BW\0=$M-2\1:I^U'K'@W49M0M
MUE:;0=+TO3X+&T8,#F 1S380_*=YXH ^XO"7BWPKX^\+Z=XW\#>)+#6=&U>R
MBO-*U;2[M)[:\MY%#QS12(2LB,I#!E)!!!%:%?#'_!N\]QIG_!.@_#NVGDDT
M;P9\6/&>@>%S(Y;;IEOKMWY**QY*KN9%] H X K[GH *_)+]IK]N;_@Z;\,_
M'[Q]X&^!'_!+'X3^)/AY8^+=3LO!VL:G \LNJ:,ES(EI/-_Q/X@S26XC9AY4
M?+$;%^Z/UMHH _E^_;(_X)R_\%G_ -M&>XU_Q-_P;^_!CP-XDG<N?%7PN1]$
MN@Y.3(T4?B%K65R>2\L#MGOR<_O1_P $<?A=^T_\%/\ @F=\)?A7^V6-27XD
M:)H4]OXABU?5TO[F%?MMPUM%).CR*Y2U,"<,VT*%SQ7TS10 4444 %><7O\
MQ^2_]=6_G7H]><7O_'Y+_P!=6_G0!T/@G_D,7W^?XC735S/@G_D,7W^?XC73
M4 %%%% 'S)_P68^//QI_9B_X)>_&?X[_ +/%]+9^,?#OA%IM'U""W65[$O/%
M%+=*KJRDQ1/)*"00/+R1Q7Y9_&S_ (*'_M3?\%5_'_[,/_!*_P#X)A_M\:_9
M:KJ/PTM?$'QU^->@S3VM[#=QV:M,DTMKY$D;1LCEX8F17FO+>)F&UL?M'^UO
M\:/@;^SO^S+XY^-'[2YMV\!:!X;NI_%5O=6*W27=F4*/;>0P(F,N\1",\.9
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[7>C_L&?L6?$;]KO6_#S:NG@?P[)>VNE"7RQ>W3.L-M"SX.Q7GDB5F )522
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 ?,W_  5D_;8\<_L'_LIP?%CX::5X??7==\;Z
M)X6TW6/&#R+HN@OJ-VL!U+4#$RO]FA4EF 9<DJ-PS61_P3M_9*_;._95\;>-
M+CXS?M3^ _BCX-^(>KZAXPN;_2/ USHVI6NOWDMN2D/^G74,M@8$<*/E=2D6
M,@M7H_[>WQO_ &1O@A\ 9Y_VY=%BOOAKXFU&/0]?74/"-QK.G1B6.656OHH8
M9?*M\P;?.==B2-%EE+ U\%_\$X9?@-I'_!3?3/!__!'+XF>,-=_9HN_AYJL_
MQ<T<7VI7?@_P_J_F1_V=_9,U^"(KR5C)YD,#E1$N< +A #UWX#?'O_@H=_P4
MCTS4?VD_V>/VM?A]\%_AOJ/B/4]/^$7AS4OAPGB'4?%-A87<EJ^J7SRWMN8D
MFE@F*0VZ@I%M)D8\M]_QB01J)64OM&XJN 3WP,G%?SM_#WX3_P#!+KX1?\$C
M?%G[)7Q<^#FFV_[<'A&36?#.AZ+:Z3=OXVG\4QW]Q_8MUIC*#/\ 965K28/
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M1/V6/^38OAQ_V(>C_P#I%#7\W=?TB?LL?\FQ?#C_ +$/1_\ TBAH [RBBB@
MHHHH *I^(_\ D7K_ /Z\I?\ T U<JGXC_P"1>O\ _KRE_P#0#0!^;=%%% !1
M110 4444 =M^SA_R77PO_P!A:/\ K7WU7P+^SA_R77PO_P!A:/\ K7WU0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^D\=<S73?&'_ )*%>_\ 7"V_])XZYF@ HHHH **** "OZ1/V6/\ DV+X<?\
M8AZ/_P"D4-?S=U_2)^RQ_P FQ?#C_L0]'_\ 2*&@#O**** "BBB@ JGXC_Y%
MZ_\ ^O*7_P! -7*I^(_^1>O_ /KRE_\ 0#0!^;=%%% !1110 4444 =M^SA_
MR77PO_V%H_ZU]]5\"_LX?\EU\+_]A:/^M??5 !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M?AU_P7%_Y2%^(_\ L":7_P"DJ5\B5]=_\%Q?^4A?B/\ [ FE_P#I*E?(E !1
M110 4444 %?T.?\ !/+_ ),8^$W_ &(>F_\ HA:_GCK^AS_@GE_R8Q\)O^Q#
MTW_T0M 'LE%%% !1110 4444 ?+O_!0/]O/Q;\"-8M/V4/V6_@UXE^(WQ[\=
M^#-6U/P/X;\/?8(H=*B@01+JFH7&H30V\-LES+$H#%C(P*A>:] _85^,/QM^
M,?[/>F7W[27P/\6^ _'NA"+1_%VG^+;:Q1M0U"&V@::_M7L)I;>:UE>1BCQL
M &61-HV5P7[;?_!/Q?VH/C%X6_:*^ ?[3^N?![XW_#_19[+0_&&@V=MJ,4VE
M7<FYK/4=.N?DN[1I86902A#HQ#97CY6UG_@IC_P49U+]D7]HCX"GX1'QA\>?
MA1\0K#X?#QK\$?#-WJ5H\&I6ZRG7H[%2\J7%G;F5Y+<,5%P(4^56(4 ^E_@'
M_P %;?A#^T=_P46\7_\ !/WX<_#C79O^$3\/:EJ"_$.26(:7JD^GW=G9WUM;
M+GS)/)N;LPM+C89+>91G;FOK&OQK_8^^./P>^#7_  6.^"'P;^#G[''Q^\,>
M'=$_9;NO!-A8>+OA7=VFH"6X\2V,LFM7B,<BT,IDDN;T_*)96+<M7Z#?\%0?
MV@?CO\%OV*_&GB;]C_X>:]XS^(<\L.@Z/;^#]$DU>ZT2XNG6.347M8 SO]EA
M=KCR\?,RQJ<*Y( .<^$/_!6WX0_'#_@I#XB_X)X?#_X<:[=/X=TC4IY/B&98
MAI5[?:=):17]E N?,D:"2\2)Y,;1+'(@SM)IGQQ_X*\?!OX1_M?>!OV/_#_P
MG\:>)[WQ5\0[;P;K/C&RTEK?0M!U6>WDN$M&NY@%N[D1)O:*#>(U/SNC81OA
M3]EOXV_"+X&_\%9?V;_@U\)?V/?VA="T7P]^S_K'A1(O&/PIO+34[NZO=:L)
M)];ND<EC;M,99KJ[/RH\Q)ZU]=_\%B_^2Z?L3?\ 9VND_P#IJU.@#[DHHHH
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MT6.T\8ZAJ'PX36FU.^3B2]6Z=BQ68_O!&0OE[C&!M4$_O_\ MD?$WX _!?\
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M%H$M!!9VERSQ&3[2\\QB\])#$+=_OC KM/"__!/CXQ_LK_LL?#?]F7_@G/\
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M+X>?%/4?#=OXRNBK2:M8K!;W$,CN!\[ SR*&.3L$>23S7Z04 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH _#K_ (+B_P#*0OQ'_P!@32__ $E2OD2OKO\ X+B_\I"_
M$?\ V!-+_P#25*^1* "BBB@ HHHH *_7*#]NS]I/]B#]D+X#:SX9_8K3XG>
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M_F:@H **** "BBB@#H_@]_R5SPM_V,=C_P"E"5^AM?GE\'O^2N>%O^QCL?\
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <_\
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M#W&DW.H:9=--(]\X^T337+LJ[[B9Y6F=L %I3@ 8  /I:BBB@ HHHH ****
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M>_Y*YX6_[&.Q_P#2A*_0VOSR^#W_ "5SPM_V,=C_ .E"5^AM !1110 4444
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MF\9:?X.UWQ->ZM%H7B"PU6.UFDM)+V666&*>WG#/'O(,B ] H7]!Z "BBB@
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M\W_@?;?_ !R@#SFBO1O^&2OVAO\ HF\W_@?;?_'*/^&2OVAO^B;S?^!]M_\
M'* ,_P#9P_Y+KX7_ .PM'_6OOJOCKX.?LX_'+P9\4-#\5:U\.YTM+&_26=EO
M("0H]A(2:^K?^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W
M_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK'_X275_^A0O?
M^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^E
MH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\
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MO_"OMO\ XW0!ZE17EO\ PM_]H;_HU>;_ ,*^V_\ C='_  M_]H;_ *-7F_\
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M^(7_ /X+H_\ 1BTW_AQ/#?\ \L: /@:BOOG_ (A?_P#@NC_T8M-_X<3PW_\
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MDE@@9FCAACB65VV*Y;:2-WVE110 4444 %%%% !1110 4444 %%%% !1110
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MKVEWYRQ).'.;:60+@NOWL9SQG!K[AHHH **** "BBB@ HHHH **** "BBB@
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M^#/%WPUO+]^([:_:*'5;&)C_ 'IS:7**.[)CO2?M<?MS?M=^!?C[)^Q#J_\
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MIZ9XU\-0CA+2V\4Z<-0GMHEZ)&M[#>,% P#*W8BOMJ@ HHHH **** "BBB@
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MB'X:6?C:WL[71;6^N+:V%BNHR@13&SL80S,!AY-X4N I:]^T%\+OVM/V7/\
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M=6_G0!T/@G_D,7W^?XC735S/@G_D,7W^?XC734 %%%% !1110 4444 %%%%
M!17+?%OXT_#'X%:!I_BCXK^*H](L=5\1Z;H.GS/;RRF?4=0NX[2SMU6)6;=)
M/-&@.-J[LL54$CJ: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%%
M&/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_
MPDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!
MC_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+
M1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%%
M&/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_
MPDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!
MC_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+
M1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%%
M&/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_
MPDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!
MC_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+
M1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%%
M&/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_
MPDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!
MC_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+
M1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%%
M&/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_
MPDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!
MC_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+
M1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%%
M&/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_
MPDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!
MC_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+
M1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%%
M&/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_
MPDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!
MC_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+
M1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%%
M&/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_
MPDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!
MC_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+
M1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%%
M&/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_
MPDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!
MC_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+
M1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%%
M&/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_
MPDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!
MC_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+
M1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%%
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M&D-Q="TM]4GTH3?;+?3Y)F7$[KNV.C;/G53][4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 445\\_M_?MY7_[$L7PXT7P
MG^SUKGQ,\4?%+QP/#'A?PUH>M66GO)=&UFN<M/>R1PH-L##YF R>H[@'T-17
MQ]\2O^"G?QO_ &;_ -G36/VG/VO_ /@G3XT^''ASP]XJT>PUOS/&VAZQ+;:7
M>3&"?5L:;<3?NK61H?,C;:Y67<N0C8]3^-'[<'@KX6_M)?!_]ECPQX5O/%OB
MCXO2WUU9KH]W%Y.D:+9P"6XU:Y<D@09>*.,#_6O)M4Y% 'MU%>=_M._'+Q7\
M /AF/&7@3]GSQE\3];N]2AT_2O"?@F" W$\\N[;)--<RQ06MNNTEYY7"ID#D
MLJGQ_P#8V_X*73_M%_M$>-/V.?CS^S'XG^#7Q9\$Z!;>(+OPKXBU:RU*WU#1
MIY/*2^M;VRD:*9%D*HXXVLX&6(<( ?4E%? ^K?\ !=2QL_A[=_M;:/\ L.?$
M74OV:+#7VTZZ^.]MJ>F^6\"79LY-5ATDS?;9=/6?CSPH8H"XCX(KV_\ :B_;
M1^/OPH\6VG@W]F'_ ()]^/\ XUO)X;BUV^U_0M;TO2=&AMI'E5(8KR^G07=V
M?*+FWA5BJ21,2/,44 ?1-%?-_P  ?^"I?[,7QX_8,B_X*$QRZ]H'A"(RVVM:
M5JFB2RZKINHQW8LGT]K6V$CRW!N2D2)&&,ADCP/FP+/_  3N_P""A&A?\%"O
M"_Q"\2Z/\$/%O@"7X??$>[\(W^A^-HHX=1,T-K:W!DE@C9OL[%;I5,3,S(5(
M)SP #Z'HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3Z+=:3KEBMU+ ;BSN86AFC$D3+)'NC=AN1E9<Y4@@&@#X2L[J?\ X+%_MW>
M_BWX#A;_ (9N_9J\87&KZ-XM*X3XA^-H4>WC>P/\>G:>6DS=#Y9IRR)O12Z[
MG_!*&[BTO]N/]NGP3XBF5?$=O\>K'5+F"4XE&EW>B6AL'(//EE(Y-IZ<'%==
M\.O^"$W_  3'^$MWHUW\./@WXPTE?#]S#/H]K;?&WQ?]FMGB</&! =5,14,
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MO_ ?A7P%'^TSXV^U^$];^$LFJ7TH37)?M&V]74H0OF#(7]T=F?XJV/\ @O\
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M_P#H'2_]]B@#H:*Y[_A85G_T#I?^^Q1_PL*S_P"@=+_WV* .AHKGO^%A6?\
MT#I?^^Q1_P +"L_^@=+_ -]B@#H:*Y[_ (6%9_\ 0.E_[[%'_"PK/_H'2_\
M?8H Z&BN>_X6%9_] Z7_ +[%'_"PK/\ Z!TO_?8H Z&BN>_X6%9_] Z7_OL4
M?\+"L_\ H'2_]]B@#H:*Y[_A85G_ - Z7_OL4?\ "PK/_H'2_P#?8H Z&BN>
M_P"%A6?_ $#I?^^Q1_PL*S_Z!TO_ 'V* .AHKGO^%A6?_0.E_P"^Q1_PL*S_
M .@=+_WV* .AHKGO^%A6?_0.E_[[%'_"PK/_ *!TO_?8H Z&BN>_X6%9_P#0
M.E_[[%'_  L*S_Z!TO\ WV* .AHKGO\ A85G_P! Z7_OL4?\+"L_^@=+_P!]
MB@#H:*Y[_A85G_T#I?\ OL4?\+"L_P#H'2_]]B@#H:*Y[_A85G_T#I?^^Q1_
MPL*S_P"@=+_WV* .AHKGO^%A6?\ T#I?^^Q1_P +"L_^@=+_ -]B@#H:*Y[_
M (6%9_\ 0.E_[[%'_"PK/_H'2_\ ?8H Z&BN>_X6%9_] Z7_ +[%'_"PK/\
MZ!TO_?8H Z&BN>_X6%9_] Z7_OL4?\+"L_\ H'2_]]B@#H:*Y[_A85G_ - Z
M7_OL4?\ "PK/_H'2_P#?8H Z&BN>_P"%A6?_ $#I?^^Q1_PL*S_Z!TO_ 'V*
M .AHKGO^%A6?_0.E_P"^Q1_PL*S_ .@=+_WV* .AHKGO^%A6?_0.E_[[%'_"
MPK/_ *!TO_?8H Z&BN>_X6%9_P#0.E_[[%'_  L*S_Z!TO\ WV* .AHKGO\
MA85G_P! Z7_OL4?\+"L_^@=+_P!]B@#H:*Y[_A85G_T#I?\ OL4?\+"L_P#H
M'2_]]B@#H:*Y[_A85G_T#I?^^Q1_PL*S_P"@=+_WV* .AHKGO^%A6?\ T#I?
M^^Q1_P +"L_^@=+_ -]B@#H:*Y[_ (6%9_\ 0.E_[[%'_"PK/_H'2_\ ?8H
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M>_X6%9_] Z7_ +[%'_"PK/\ Z!TO_?8H Z&BN>_X6%9_] Z7_OL4?\+"L_\
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4.E_[[%<O/()9WE P&<D#ZF@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>cdna-20240429_g21.jpg
<TEXT>
begin 644 cdna-20240429_g21.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0+R17AI9@  34T *@    @ ! $[  (
M   -   !2H=I  0    !   !6)R=  $    :   "T.H<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M0VAA;F1E($-H86YG    !9 #  (    4   "II $  (    4   "NI*1  (
M   #,C0  )*2  (    #,C0  .H<  <   $,   !F@     <Z@    $
M
M
M
M
M
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M-T)U=H&1T3125E<D,V)D<J'3)5-TDK.TP1@V-41'8X)%<Z/P\?_$ !4! 0$
M                   !_\0 %!$!                     /_:  P# 0 "
M$0,1 #\ _2*(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B+!. @
MRBP'9\C_ "6<_3_) 18RLCH@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
M B(@+#NBRL'H4'Y^U!V:WS7_ &EZFK:"]QTL-%6QP=S.Z4Y'<L=@;3P.4G[
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M-T?F7=03QMX\R?179>::QK++3:IJ9+E9:NX/9!#WY;"[8(L2< M][)(#@<C
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M?ENX7*AU*RVR-J^XJV4T9[Y[N[;"UIP<EHE<PDXQP1ZK3:XM,5M126^/2U?
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M%VV&)H+G/XQASF8!X],#).U33H=13:?I6-EA@N41;WSB_P ,V&X)R&';EW)
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MBJ^^DU;)-W#@U\4]PB+-S@<!PP/I ^9=-3:6NJ0YVH+C"ZI>3%&VJ8T$]=K
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M?88W4T3V4+H*78*=QA;$'!N><[3N;T.X]%S2V"V1.Y[5M3.8T.+Y&7)I:S:
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M5]6O0=?1W"&2JOLD]'AW>TH$C0,LD8&,<7DM8!)QG)RT<^@7;(PL%P:TEQ
MZDKS^;LTKZLSBOU-4U+:ELC)=['##"US&L: _;C:6!V02XL!!:25MI>SFH9I
MJ]6BMO4E2RZ,C8"YKBV%K>H:TN...!ST SG""\]]'M)[QN ,YW#IZK[RO/;C
MV5QUU1*&7%M/3.F[QNVF#I2W<P]V][B0]C0SP@MP#C.<<]=1H.X2"U"FO\L
MM]N-%W;6N[M[MI:)"W=SG(R"?(8*"Z/GBCDCCDD:U\I(8UQP7D#) 'GP"5]K
MSAO9=7OIH&5>HGSST[/S52YDG>1N[IS&X/>>ZTD.QU)SDD'CT<(*SV@W.V6G
M1E54WJG-53!\313-D##-)WC=C<GCW@,YXP#GA5_1M198=>UE%8J,B.:UP3-J
MW53I"Z$;3'&UIX:UHE(&#T&%Z')#'*6&2-KS&[<PN;G:<$9'H>3S\ZTPVZEI
MI ^FI8(GANP.9$UIV^F0.GS(*])V=Z<?6U%6ZA?WU2Z=TCFS/&3-MW\9X]P8
M],G'4J@7:Z:2M=1>O8+=)55-AKV2ALM>YK7O>&A^T#)#6%K6X/'IYKV@C(PN
M62UT4K0V6CIW@9X="T]3D^7F>3\Z"K4W9MIMU-3R1TM3&8HV]P6U<F8/UO <
M\>(EV?4D^:VZF;06+3UEM?Y,DKJ8UM-24]/WI&TL!<PN)!+@.[Y&.?YJW@
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M[J"0R-C C8P#<6MR?!GH.J":4=<[Y26N>"GG[^2>=KG1PT].^9Y:W&YV&@X
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MZ[NH6LW&HDC<V/.2"W)'O#!W#]7!W806"EIFTL0C:^1P!)!D>7'DDXR><?\
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M/VF:-SWM>64[P8@P!SG/#@"&@.:<X/!R%\MU[IM]+[3'=(Y( 0#*R-[FM).
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M[Q^ "X.Q[W(RUI .0,#'1=%;IFTW&=TU;0LE>]VZ3+G 2<!N' '#AAK>#D9
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MOF;1EAJ*E]1-;FNE>\R$B1X\9<'%^ [ <2!DCD@ =.%+.KJ9@R^>)HV=YDR
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M3<X#*V Y" >A5(N5DO,D5_MU-21207>J$[*HU :(FED32',QDD=V>G7(5W/
M6LU$39!&Z1K7GHTN&3_!!L'18/3^*R#D90G""CTECO#8K7;)J2)D%!<W5;JL
M5 (>S?(X ,QG)W@<^A5X'1:Q41&0QMD:7CJP.&1_!;$%#OGZ;]+_ +,KOOC5
M\5#OGZ;]+_LRN^^-7Q 1$0%0>U+^T:._>2E^YRORH/:E_:-'?O)2_<Y!?E!Z
MFM=SND=$RUU\=*V&JCFF;(U_YT->UVW+7# X/!R#QE3B$@=4'Q$7F%IE:ULF
M/$&NW 'Z<#/\@JYJZU7RZ1TK[#7Q4;Z-SIP'[_SL@&&-.T@;>79SD<@XX5EW
M#U3(P@\[M^G-7/Q'572>G8:5F7&X2R%I.[>P<<NZ'?P6\-;D<CHGTOJYS)_9
M[_L#P\;'U4I#G8\+P[&8\DY+!D-#0!G)5\W!9R$%)?I:^_D>FHX[JULFZ=U1
M(R9\>YTCP[?@#Q'&]N#@#?N'( 7W7Z6KY66^GH?9F04=O]GWFIE8^1V -AVM
M.8R ><YR[/E@W+(SA904&KT??ZFGJHJ:X4U*98((MXEF<7[-QP<;2TAQ: X$
MY:P CDK9J'3=_GN=UN%HJ2#40M$3&5KX79;&0 ,,.,/\7O8=T('57H$'HG"#
MSNHTSJQU,RMFNCI*NDA:(605,F9'-BVA[A@!Q+_$6'@Y(SYJ2J]-7^I%-)!?
M)*:>*A:QSQ*_Q5 #R'N X<T.?[IZ@8*N60404'X*:IEK'.EU!+!3]WQ#'72N
M\88X [BT'!D+7$ XQX<$ +7\#M50POCHM1&G#F.#B9Y9"X@N<T@D>')<0<9P
M,8]T+T'(\EE!2*[1MTKGT-3)=2ZIHJ:G8.\>[$DK'ESG.< .#QT )(!.,!;M
M+V'4=JJ147F[^WESWM=$:F5S&1$,V;=PY<TA_)Y.X9*N*QD(#>BRL9"R@(@.
M>B(")U1 1$R@(L;@LY" B9XRF<]$!$1 1$0$1,A 1$R$!$)P@.4!%@.!Z+.<
M("(L;@@RBQN"R""@(B("(F1G" B(@(B#E!1=0T=._4-WDN=JEK&SVN**B>*!
M]0!(#-N:"UKMARYAYQGCTXM5@BG@T[;XJP.%1'2Q-E#CDAP8 <GZ<J01!@^Z
M5YQ>K>U[M212VF>:ZU5<Q]!.VA?(=FR$-+9@TAH!:_\ 6&.5Z0B .BP>G\5E
M$'FU!;FM=9XF6F>*[PW=\M54&A>T]WOE))FVAK@6EOZQSD!>DCHB(*'?/TWZ
M7_9E=]\:OBH=\_3?I?\ 9E=]\:OB B(@*@]J7]HT=^\E+]SE?E0>U+^T:._>
M2E^YR"_*K:YO-^LM#33Z;MOY0DW2F>(0ND=L;$]PVX/7<&\>?0<D*TJ%U))>
MHX:8V&(2/[W\X-K3Q@[0=Q&&DXR1D@= @J]3J'6#XJWV:C$<\,3WB-UND<&$
M/8U@#MP$F]KG.\/N[<%=MMOFHG,O+*R"-TU,^H92M%%*TR!G#'=-IW=>''.>
M//&*VLU=%+;Z:CC$U2:)TM3F&,,[PN (+MW! )V@9W$#<0,E1U96ZZ@I14/9
M4M9',QH;'30.>]CQM!<S?C<#@G!VY<!T!*"1JK]J8:9JJJ.VQPUC)(RQH@ED
M_-OZ@-ZE[<C/!'S+CJ=6ZOIIF4@TZ)I&-/>3QLDV/(W<M&,XX /GXLCHND2Z
M[E<&B)D)# YSC%$6Y$>0T>/JYV0[R;QMR.5IIYNT26/O)HJ:&1O>.,+8V%KB
M 2UFXNS@D!NX<X=D\A!T7_4&HZ"]14]OH&2Q,B:Z0^SRO;(3C)W-!#6@D\<N
MXS@A:?ACJ1]NGJH;$28J?O#3O@F9(UVYC0.1@\.+\-)( QUROACNT*>VS.E[
MNGJ-CVM9%%$2"=YW N."6X8!Q@AW/()79=(]8"\SU-J?(^&.,24]-,(Q'(2R
M,=VX@Y!W!Y)\O(G.$')#JW54=1.VHL37@2@1MB@FY! .S=C!."3OX&&D8W'B
M3DOUY=I>O>VEC9>J1K7&)L,CV.:2#N:WWCQN&/5JAXJCM)%OCD,%(^H=5%IC
M?&UH$08,%V'>;BX$C&-K>,$J:TW'?S<YJF^FJ,4L#(X6/$;0PM<\ESVL<0'D
M;>F1TZ<H.*S:GU(ZY4M!=K, P4O>S5H:]C7N[L/  (X()VD'SSCH0N6DUMJ.
MJML56RRL=%(V-S9&P5!#RX$@!NW=Y;-V,9.[W5Z"0",$<%8:UK6AK0  ,  =
M$'GIUKJD/R--$;GEHWLE:UN-^'%VW/B :< ''(Y)4C6ZIOD<]KBH;-),ZKIF
M2RF2GD8(G%P&">@\_">1QDJY83""B5&LM0Q:6@KV:<EDKY:E\8HF1R$EHZ9/
MZA\LG(XXZK75:HU-+<X9;7:]]"&3/,3Z29KYN[W<!S@-I=ANT$=3YA7_  F
M@\_.K]3NAFF%D#(H '.=[+4.<XG?EC68!):6M!(X.X$<+X^&&J*F'N_R+[,X
MU4<0E;!+)N:2W.&[>,@N(<[  !S@A>AX1!4*74-_?J.:VRVUAC$\S8Y.XE:#
M&-Q8XO\ <P,-SSD[^!P0N)FKM2U)C(L9HVO?&7-F@F>Z.+>T.><#'/B :,N&
M XC"OF!C"804J+6-Z98HZZLL$D,LCY&=R&O<6D%FT.P#MX+\D\>#.<%<E/K/
M4M9'2>RV6-YJA&&2F"<1N:\C,N2!M8S."TX<[&1X>5?RT$$$ @C!"-:&M :
M .@""GU>K;O2&E<^RRN9+0B>41P2O,<I:_PG:T_K!@ Y/B). .5LOVH*N^1F
MJMXCHGD12Q=Q(U\+RY_.XC#L!K<GIXACY[CA$'G<NI]7U%=$*2U1Q1 /<YLE
M+.<EK2XQEV.".&Y'#G<@D<+KIM3:FN$-V LAH?9Z2>2G<YKW/?(,B-H!&">,
M_.",!7G"8043X:7P0PL-CD=*Z09>VEJ-KHLXWM!;P2>C7$$>?SZ7:OU93QTV
M_3K9#.\ OVRL$8& =_!(+B<C . #GR7H.$P@IC=6WC\@5]8ZT2NJ:>*!\,+*
M67,I>/$,'G((/3H"">I R[4VH9;1#/26=OM#IY6R1RQRAK6-QMQQDDY') !P
M<*Y83""BT>M;Y+J&FM]18G1QU,D<0E>Q\>UY;N?P[W@UK7G(]6^I*^*76=_K
M:5]33VF/V=I>>^$4[@!O8W  ;EY:'.<=N0X-.WSQ>S$QTC9',:7LSM<1RW/7
M!\EEK&L:&L:&@= !A!Y]'KO44SP(-.]Z/:6PR@"4" X&6N);RXYSEN0,8=@D
M+IMNJ-19J:>NM(DJHZ26M:U@<W@.+61[>N2>A\PUWFKPUC69VM R<G QRL")
MC9'2!C0]P +@.2!TY_B4%(FU7J3>Z.BM#*@^'$A@G8W&W.[D?K9.!U;M(=R0
ML#4^I:FBN^ZS&BEHA'W+S%(_O3WFUS@P#+FEH+ACQ ?.KU@)@(//?A7JNJN#
M&,L3J>"")TT@,;R9R(LAHR,@%QS_ 'O#CJ5VT>J=0RW6@IY;$!2U$_=/J-DC
M &AH._#AD9SD CH,$Y5U3 0>=2ZKUA0L=.^S,K ^5L&R.GEC[D_G"7G/5N&M
M&?[S@1QPI.\:CU!!J)E%;;*^6FD9'$*B2%YCCF>027.:>6-9G.!U\PKDF!Z(
M*,-8:@@I'3UFGY,/8YT<<,,SG-<&NVL<-O5SFCGH X9]5B#4NI:J@KJN*SRM
M?"^%D,$M.]O>M[]PD< >0>[QQDX(ST*O6 F$'G4FMM51^T.;I:5S-KY80Z-[
M7!A?AFX>9#<%P'.7<=#G?3:IU;[54B>QQ/CA?N#612M+F98 UKCPYWCSNX&&
MGC.<7Y8(!!!&0>H04BDUI=:JU1U--;XZM_M;X7&".;:[:&G:!C+7$N(W.\/@
M/J%NK=2ZAADM=-36ELE164S7SN,$O=T[W$=7#TSR#SPK=!3PTT+8J:)D4;>C
M(VAH'\ MF$%(;K*]&S7.H-C>:FA?%&V&)CY#*]WB(P.0 TM&3T.<C"CH=;ZB
M=>ZN&2W-CC]FAE9&ZDG)@<7O#P[#=TA'A:2P%N2#G&5Z,R*.,N[MC6[W;G;1
MC)]3\Z=TSO>\V-W[=N['./3/H@I5-JS4=P:QM/8?99.[C$HJ8Y<1RN>QKFYP
M-P;O)+AP0TX*YV:PU7[%)4RZ:QNB<^.)K)=\9WEHWY SPTNP.<.&/GO^ F$%
M-LVH=2UU1;3<[5%115,F9FMCE>6-+)2UNX@ $.C&21CQM'GS<6^ZLX'HB B(
M@(B("(B B(@H=\_3?I?]F5WWQJ^*AWS]-^E_V97??&KX@(B("H/:E_:-'?O)
M2_<Y7Y4'M2_M&COWDI?N<@OR(B#&WG.4(R,+*( &$1$!$1 1$0$1$!$1 1$0
M$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0
M$1$!$1 1$0$1$%#OGZ;]+_LRN^^-7Q4.^?IOTO\ LRN^^-7Q 1$0%0>U+^T:
M._>2E^YRORH/:E_:-'?O)2_<Y!?D1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$
M!$1 1$04.^?IOTO^S*[[XU?%0[Y^F_2_[,KOOC5\0$1$!4'M2_M&COWDI?N<
MK\J#VI?VC1W[R4OW.07Y$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!
M$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$%
M#OGZ;]+_ +,KOOC5\5#OGZ;]+_LRN^^-7Q 1$0%0>U+^T:._>2E^YRORH/:E
M_:-'?O)2_<Y!?D1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$04.^?IOT
MO^S*[[XU?%0[Y^F_2_[,KOOC5\0$1$!4'M2_M&COWDI?N<K\J#VI?VC1W[R4
MOW.07Y$5>U;=+O;::G%AHV54\KI X2-)#0V-SLD@C'( SSUZ%!847G+>TJOC
MVQ26&02;W1DR/<P' ]\X:=HS@D'G#AC/*[:?7M94V&LN7Y%? :>>.)L<KG;W
MAPZ[ W=GH=N,D$?.@O**A4FO;A4UKJ;\B,)B:V2=HEDWQM)<#EO=^\=NYHS@
M@]5]5.OZRGN593.L4HBIIY8>^+WGA@.'%K6$@.( '_$#TS@+VB\]&N[S714,
ME!:HH/:)FQ/@G,AF:3M(!&S:T.&XAV3Q@\'(714]H%1':[?6PVASA70SS-CD
M<YO=LC!(<2&$>+'3KRW&<H+TBIMRUM545T=1P6=\S6-B>97/<T.$C"6- VDA
MY+7M#3CD-R>>,46MJRN_*AI;,2R@I8WY>]X,DS\YB'@Z-(\1&?+A!<T5$DUY
M=!5RTD%@[RHACW29DD# 1WFX ]WDY[L;>.=PZ+FG[0;FUTG_ &)[.VG+>\=+
M(<2'83L'AR-Q&&G'.TCJ0@]$14FOUQ46JV4U1)0FL[Z6I:',:Y@[N/<0\^$@
M#@ YYZD!1[.TNM>VI$=B$Y@<QGYF=^/%LP\ES!AC@_PD\\<@(/1D7GD/:#<Z
MXU3H+,VG@I)&A\\[WM$F6R.#1EG'+ PD]"X8!X78=678MIZJGH6U5,Y\AD:&
MO8XL_,XV^$^)ID<W! SL/3""[HO.V]HUU?1-J1I:5S72MB#&S^)SBUSL#(P#
MQMY/O<>BEK5J^JK*Z-E3;60T9<&.JF22.!<0\@@.8,M_-XR>=S@,8Y06Y%Y_
M7:QU#'4UE'3V=HDB$K(YS%(6.?%N<\X]"UT.T\Y)?UPMGP\NSJ^JI&:<(DI2
MX/<^9P:_8'EQ9AF2#W9#3@ DC.,A!?$5(O.NJNVW.H@9;HC! 3OJ)7R!C!L:
M\%[FL.TG+FX /.,X7/1Z[O=73TDPTXV/VFG%0&&63PM+0\ N[OAV 1C'4CGJ
M@OZ*@'M'F;;JNI_).Z2GD@;[,Q\CI!W@>[8\=WX9 &=.6Y(&Y;+CKNOI[11S
M4-I;-5U8J (SWA8PQEP!W!GB'A\NN<C(07M%0H==75]P;1?D>":5]3W(,<DH
M :9"ULIS'[@;@DYSDC P<C36=H]RM\<#ZO34A#F":8QS$[(RUCN-S 7. ?RT
M#R.,H/0T52O>KZBV1V\TUL]M=4ME$QCG\$+X\!T>X#Q'=D=/U2HR'M$N$XE/
MP=?"YF-HFE<,NV%W=\-R'$C XP2#R,#(>@(O/Y>T2K;55+H+2V>E;S3$&4/J
M TN!#1W9!<X@;0<#@Y(XS<;-<#<;>R:41,J &B>&)Y>(7EH=L)(!R X=0$'>
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B"AWS]-^E_V9
M7??&KXJ'?/TWZ7_9E=]\:OB B(@*@]J7]HT=^\E+]SE?E0>U+^T:._>2E^YR
M"_*#U17WB@IJ0V&A-;-)4-9(PMRT,P<DG(V_3RIQ06JJ>]U%'3LT]*8Y3+B7
M$C6#9M/))!/!P<#D^H""N4MSUQW<TK*?O6&?+63T)C>YI#B=H[WP@%H:,YSO
MS\RV,NVMX71NJ*!LC.Y+CLI<N#A*QNT@/Y<6;W9\(&>>@6; -7UE>Z>LJ*EE
M-!4-8Z.H8Q@F'@[P@=V';!X]O0YZDKE,':%54Y?257L^Z:7 J&Q%P&2&D#:,
M,QC .7 \G(X0:656M:*B=[+:X?;JN:9DLT=N:TX:WPRO(DPYVXG'&"&_/S,6
MN]ZF?=R+M0/BMK(G.D>VC<)-^YK6,;AYW9#BXN XP1C@E<[Z/6DM3*VDN+C2
M%[A!4.D@+G,R[Q$!F-V"S;CCAVX<@+DK[/K:MJ7-FJS%30$&.6.9I>2"X;PU
MK1DENTEI!&[..J*GIZ[4+]3.H64,?Y,,K6OE?"7#NMH).[?AQ<=PQCPX&<Y4
M15U6L'RNI;=3"@I8Y##%W-&"&@.PS]?E@8T.W  '<6X&,B1E&IZ[0[(BYE+=
MJMK.\G=+W0@#SEP;AI(+00T9&<D?.N2ET_J26GKG5M2:6IJ:FFE#Z>HW=WL>
M3(6[FD#(/ (YZ81'W8Z[54^H9&7&T4M#3/F_/3,A.Z5K6. <7;L<X9_>+<[?
MG45+6Z]HY)H6P35(_*#9(7^R@]Y%WI+V9W^!H8!C.2[=@8PM\E+K.:HB>^N8
MY]+*&S-AJ(6NW.C/AC!;AKL.8</SSDC (7Q;;3V@4]K=#4U_CABQ$R)\1RX,
MPT%[@2>?>/'()&0<(KLFOVKG03U$%KF9L:]T5/['ESV['["XE_O;MH+!@C&<
M\X71:M0Z@=>(Z6\T<,4;XN^>(HG%\.9.[8PX<>I\>[ &T.],K[O5NU?-4U4U
MEN?< MQ3PN[LQ@[(QSEA=[QE)Y\FK33LU3/?J<UT[H(A4"?V1E3%GN0Z1I:0
M&Y> '1$\CD8&41P76]:LGN-<VUVQM71TTLU.6.IR&$98T9&XF7PEYX P1CE;
M'W[6;)J\T^GPT@N,?^CG\XX!HW$AW( ! \W8;TP5\W3X:4E;.^&2JEBFJ>[I
MFP;'G'>$M+QL+6,#3@\@D '.>%,T\=[-DN%KFKA+=.ZW0U'>L$C2YC>H:T8P
M_=@[>F.J*C;]J'4T%504%LIZ<5U91"7883)MEVO+CDN!:UI#.K>=Q&00NNT7
M35E?-7LN5LBMS/9#)2G:7.;(1X0>=KB.<C(Z#U6RWVZ^VT:<H89=T$#)/RDZ
M29KG2>$X_5R3N(.1C'\5P5=/K/\ *+(VW'V=D]1L:\RP;-N\EVUI879[H>$<
MX+7%V1A!JHJO5\LEII)Z6KC%(Z)M94%@;W_C\1)+CD; TG'F7?0OFY5FNF5]
MQ;21R301SO%*UE,UG>#.Y@W[N!@8+B/X+DJ:G6D=#&UUV90U51(X4XK98&/.
M'M!<6[.6[2<-]X.<TDX4A76S7$]S?)15YCIXJD^S9J&8DCV>]( SD9 .WKEQ
M\D'5)>]5QZ>ML[+2UUPGG<VHC; XLBC!(!(W!PXP>,YQCS!6^HO>H8&6V9ML
MEE9+2-EK(V4Q+XW[F[@/%C.TNPT9/'*S9J353:MLUPK-\!#F""9T;]K<.+7.
M+&C+]VP'!QC/'FN&"'6=-:+S45M1++,*9K:&%AB?)WF3O=PP#KC;G.!U!*(T
M4]3JFZ5$$M]M3#2M:P5=ODHM[ 2\9<QQ>=SFCG./]G&>5+WRYZ@IKL([/1/G
MIA$S.8-P,A+_  @[A@$!H+N0W(.#E1D=!KJIN<,4M<:6WF!XFD9+$Z4NVNV8
M\'!R6AQ P=N1CHM++;VA1,H^ZN8+"P]^V8Q/<QP+@T [1ENW:2>3N.?(@AT6
M0ZGIKE0MJ*&"EI)ZASJPP436N=X",O(?U<[#MP''1)[[K>*?_1K%'41F;8X%
MA88P'#(!+_&-IR'\ D'@+%39M827*>:"Y2M;'"(H2^:,=YNV;\@,XQAQ#AAV
M3Y# .Z@J=4LTM<G5D52ZN=3S24CW",O8\<-;@ =2<M!!P&G<3D!!RRWC7\+*
M>/\ )=)-+(S,DK8'M8UQ#?#MWGH2XY) . .%U7BKU)/I6=D5#W]::N6%H;2>
M^QH<8Y6M<XAN'!AW.].!R%Q.MVO(9S-35#7-E!=(Q\L9D.&X8"[:&@[>I:,;
ML'&%OM%+KX7:@-UJHO8VN!J@.[<7>'D  ##>!SUW$\8PBM[;QJNDK-E1;!40
MQ/\ SCX*4CO8Q)@R-_.'Q$=&<_WL^2Y;!<M9S34[KM0RQN;33RN@=%M:]YP8
MVNDW'&"2T-QP!DDKGOHUU34]2^WS3OEEE=%2B,QN=DN?W;G#86M8,MW>> .<
M\*;FMFIS:H:>&YO]H;5G=4[HP\P%I']S:2"3@;?(((NBU#K:5\3*RT=RPQM,
MTK:1SMAW@9:W>"[PGD>749 YL>DW7C\E]UJ!F:B,,_.[-ADRP$Y&3D@D@GC.
M,X"B;C;-3B2UW"EE]HJJ.GFBFA[UC&RN<0&NY;C. "3\Q '*D=(VNZ6V&L_+
M,HDEFFWM(D+^,<_1SY(BQ(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(
M@(B("(B B(@H=\_3?I?]F5WWQJ^*AWS]-^E_V97??&KX@(B("H/:E_:-'?O)
M2_<Y7Y4'M2_M&COWDI?N<@ORA=2Z>^$--#%[3W'=.<?%'O!RTMR!D8<,Y:[R
M/D5-*,NEZCMM53TWLM7533L?(UE-%O(:TM!)Y&.7M_F@J7Q:N954SHZR$?GS
M+*]E.6=R UH:R!NX[ "'$')QN=P<K<>S8]P6LNW=R%T9#V4H\+6.#CMR[PN<
M6@N<#R[)\\*=^$COD.[_ %4?B6?A*_Y#O'U4?B00MM[.66UMQ9%<W]W64_L\
M;&Q;6Q-W9QM#L$>HP.KN1N6:C0CFV-]#3U$$DD]9%/,^6 [ QH V!@=RT<[6
MYXXZXYF?A*_Y#O'U4?B3X2/^0[O]5'XD%=?V7QU$5P%7=/:7U0_-NEI01$[=
M&=V-V"X]V,D8)R2MH[,:47&"87"04D+FD4>PAF X.+>'=''DY!R<'R4[\)'#
M_P#H=W^JC\2?"5_R'>/JH_$@K$W9=W=JF92W!IK7-> \0]VU_@:UC#AQ.&[>
MN2?$>?66^ D;Z&@B-8ULU"V3N7LIP&QN?*V0[6%QP !L R?"<*1^$COD.[_5
M1^)/A*_Y#N_U4?B05R#LLBAI(FF[2^U1L+!5,BVN V@ -\1V@8=C_C*WW'0'
M>VBWT\58))+=2RQ,W-+2]SG-<W:\N)C&YH!][PDA3GPE?\AWCZJ/Q+'PD=\A
MW?ZJ/Q((NHT-45#;6X7E\<E!2]TYW<[C/*2'.D<<@D%PR6_R(7%#V6PQOGF?
M<?\ 2IO%[1%3['AS@>\.=WZV?Y<<JQ?"5_R'=_JH_$GPE?\ (=X^JC\2"!/9
MI&7]Y[; 7N<PO:ZCRP,:\/#& /!8T$8;@\ XY6ZR]G@M%QHJHW5]2:4R',L1
M+R7-<WPN+CLSOR[ \3@#QSF8^$K_ )#O'U4?B3X2O^0[Q]5'XD$ SLNI#+%+
M4U4<DL.X,<VE  RT#=RX^(GQ..?$XYP$;V9,<^F[^Z.D9!$87-$);WPW ES_
M !^)[APXD8.&\#"G_A*_Y#N_U4?B6FFU:VJB[VGM%WD9N<S(I,<M<6N'+O(@
MC^""?A:]L8$KFN=SDM;M'7TR5]D9&%!_"5_R'>/JH_$GPE?\AWCZJ/Q()L#
M657JC5C*6FDJ*FT7:*&)I?)(:48:T#))P[H %81T08(R$VC&%E$!$1!@MRL@
M81$!$1 1%"2ZE8RNJ::"W7&J--)W4CX*?<T.VAV 21GAP03:*#^$K_D.\?51
M^)/A*_Y#O'U4?B03B*#^$K_D.\?51^)/A*_Y#O'U4?B03B*#^$K_ )#O'U4?
MB3X2O^0[Q]5'XD$XB@_A*_Y#O'U4?B3X2O\ D.\?51^)!.(H/X2O^0[Q]5'X
MD^$K_D.\?51^)!.(H/X2O^0[Q]5'XD^$K_D.\?51^)!.(H/X2O\ D.\?51^)
M/A*_Y#O'U4?B03B*NU6K64=+)4U-HN\443=SWFDS@?P<MWPD?\AW?ZJ/Q()Q
M%!_"5_R'>/JH_$GPE?\ (=X^JC\2"<10M/J-DU=3TDUON%*^I<YD;ZBGVM+@
MTN(R"<'#2?X*9;G'*#*(B B(@(B("(B"AWS]-^E_V97??&KXJ'?/TWZ7_9E=
M]\:OB B(@*@]J7]HT=^\E+]SE?E0>U+^T:._>2E^YR"_*'J?_O6W_LZJ_P#5
MIU,*M7N[VVS:OMDUWN-)01/H*IC'U4[8FN=WE.< N(R<(+( ,=%G ]% ?#O2
M7^*;+]HP_B3X=Z2_Q39?M&+\2"?P/1,#T4!\.])?XILOVC#^)/AWI+_%-E^T
M8OQ()_ ]$P/10'P[TE_BFR_:,/XD^'>DO\4V7[1A_$@G\#T3 ]% ?#O27^*;
M+]HP_B3X=Z2_Q39?M&+\2"?P/1,#T4!\.])?XILOVC%^)/AWI+_%-E^T8?Q(
M)_ ]$P/10'P[TE_BFR_:,7XD^'>DO\4V7[1A_$@G\#T3 ]% ?#O27^*;+]HP
M_B3X=Z2_Q39?M&'\2"?P/10NDQ_V$?\ Q=5_[F1:OAWI+_%-E^T8?Q*(TQK7
M2\%F+)]36>-WM52=KJ^('!J)"#[WF"#_ !07; ]$P/10'P[TE_BFR_:,7XD^
M'>DO\4V7[1A_$@Z-6@? N]<?_D)__3<I=4S4^M=+U.D[M!3ZEL\LLE%,QD;*
M^)SGN+"   [))/DKF$!$1 1$0$1$!$1 4)8/[???VD?_ $8E-JH4&I[#:;S?
M::ZWNVT4_P"4-W=5-7'&_!ABP<.(."@M^!Z)@>B@/AWI+_%-E^T8?Q)\.])?
MXILOVC#^)!/X'HF!Z*!^'>DO\4V7[1B_$L?#O27^*;+]HP_B03^!Z)@>B@/A
MWI+_ !39?M&'\2S\.])?XILOVC%^)!/8'HF!Z* ^'>DO\4V7[1A_$GP[TE_B
MFR_:,7XD$_@>B8'HH#X=Z2_Q39?M&'\2?#O27^*;+]HP_B03^!Z)@>B@/AWI
M+_%-E^T8?Q)\.])?XILOVC#^)!/X'HF!Z* ^'>DO\4V7[1A_$GP[TE_BFR_:
M,/XD&S60'P.N?_\ 8/WA30 QT\U2=6:UTO4:4N,5/J6SRR.A(:QE?$23GR <
MI@:[TE_BFR_:,/XD$_@>B8'HH#X=Z2_Q39?M&'\2?#O27^*;+]HP_B0;;U_^
M-V#_ ,9)_P"VE4T%4ZC4MCO&H[#!:+U;JZ9M5*]T=+5QR.#?9Y1G#23CD<_.
M%; @(B("(B B(@(B(*'?/TWZ7_9E=]\:OBH=\_3?I?\ 9E=]\:OB B(@+S_M
M7>V!NDZB9P9##J.E=)(XX# =P!/\5Z N"]V.W:BM$]LO-*RJI*ANV2-_GY@@
M]00>00@[E7-84%36041HJ)M9(R8@QN@B>-I:1DND!V@'!X&3@#C.5$,[([/%
M&V.*\ZDC8T8:UMYF  ]!RL_%-:OEW4WVU-_5! T%'=ZRJJVQV"VR^PN EC_)
ML #Y/^Z:_./=P=W&#QC&%MI[7J"/,E1I:AD$L(9'#[!38C>)<;G$$'E@)(Y
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=B("(B B(@(B("(B B(@(B("(B B(@(B("(B#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>cdna-20240429_g22.jpg
<TEXT>
begin 644 cdna-20240429_g22.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0+R17AI9@  34T *@    @ ! $[  (
M   -   !2H=I  0    !   !6)R=  $    :   "T.H<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M0VAA;F1E($-H86YG    !9 #  (    4   "II $  (    4   "NI*1  (
M   #,3,  )*2  (    #,3,  .H<  <   $,   !F@     <Z@    $
M
M
M
M
M
M                                            ,C R-#HP-#HR-B Q
M-#HQ-#HR,  R,#(T.C T.C(V(#$T.C$T.C(P    0P!H &$ ;@!D &4 ( !#
M &@ 80!N &<   #_X00?:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \
M/WAP86-K970@8F5G:6X])^^[OR<@:60])U<U33!-<$-E:&E(>G)E4WI.5&-Z
M:V,Y9"<_/@T*/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(^
M/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R
M+S(R+7)D9BUS>6YT87@M;G,C(CX\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U
M=#TB=75I9#IF868U8F1D-2UB83-D+3$Q9&$M860S,2UD,S-D-S4Q.#)F,6(B
M('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(O
M/CQR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2)U=6ED.F9A9C5B9&0U+6)A
M,V0M,3%D82UA9#,Q+60S,V0W-3$X,F8Q8B(@>&UL;G,Z>&UP/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O(CX\>&UP.D-R96%T941A=&4^,C R-"TP
M-"TR-E0Q-#HQ-#HR,"XQ,C<\+WAM<#I#<F5A=&5$871E/CPO<F1F.D1E<V-R
M:7!T:6]N/CQR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2)U=6ED.F9A9C5B
M9&0U+6)A,V0M,3%D82UA9#,Q+60S,V0W-3$X,F8Q8B(@>&UL;G,Z9&,](FAT
M=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(CX\9&,Z8W)E871O<CX\
M<F1F.E-E<2!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O
M,C(M<F1F+7-Y;G1A>"UN<R,B/CQR9&8Z;&D^0VAA;F1E($-H86YG/"]R9&8Z
M;&D^/"]R9&8Z4V5Q/@T*"0D)/"]D8SIC<F5A=&]R/CPO<F1F.D1E<V-R:7!T
M:6]N/CPO<F1F.E)$1CX\+W@Z>&UP;65T83X-"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" \/WAP86-K970@96YD/2=W)S\^_]L 0P '!04&!00'
M!@4&" <'" H1"PH)"0H5#Q ,$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL
M*QH@+S,O*C(G*BLJ_]L 0P$'" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\  $0@"F (#
M P$B  (1 0,1 ?_$ !P  0 " P$! 0             %!@,$!P(!"/_$ $<0
M  $$ 0," P0$# 4$ 00# 0$  @,$$042(08Q$R)!!Q11818C,G$5%S955W6!
MDY6QT=,W0E*1M"0S8J%R-$-SP36"X?'_Q  6 0$! 0
M 0+_Q  @$0$!  ,! 0$!  ,!         1$A03%A<5&!L?#!_]H # ,!  (1
M Q$ /P#](HB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@+7DOU8K<566Q$RQ.'&*%SP'R!OVBT=SC(RMA5#VCZ
M1;U'I8V-&;.-6HRLEI25AF1CB=C\?$%CG9'[?12BT5;U:[7$].>.Q"26B2)P
M<TD$@C(^!!"S;OD5S;7]*UO2I/P?TY#J3:M;3HH=&%&3;''8:X[C/S@@C;R[
M(QN]5DT[Z3MZOIUKD6IFO'JUR2><N/@.@=$3" <\M![#_*?@J.B[PFX97)M:
M=UG+>UE^GUM6K"6G=8V.-[WM;(TM\!T;B_&2,D;&M S@DE2%BAU54ZKJ0U;-
MYU%ONQ@GEDEF!&2;#90/+DYQE_88V]BDVCI.X87S>,]BN>ZY'U-^%.HA2&I&
MV^)OX(?"\BLV+:WQ!WVB;._!>.^W'"TX:/45W6Z,$,FO5="?J1(,T[VV&Q"L
M[=O<27!AE QDYSG'!"171;>JT*#PV]<KUG%CI )I6LRUN-SN3V&1D^F5DL7:
MU2G);M3QPUXF%[Y9'!K6M'<DG@#YKC=_2NJ[)=++4UJ74XJ&HQS3..Z+Q7/;
MX8AYX!:!C&!QSSE;?45;JS4':U!'I^HB"SI]ZL^ME\D;SX8\%S27[<NYP&M&
M,X))4XO76*U^K<=**EB*8POV2B-X=L=@'!QV."#CX$+TZY799CKR31MGE:YT
M<3G .>&XR0.YQD9^]<AOP]0:!/>MZ>+->?4-6-** OVB9LU6&-DP;GDQR-SG
MN '*>ZZT_J")E2+IY^HS&#2+,7CP/)>9<Q!A)_UD!Q'[5JQ*Z)O"PMO5GSRP
MLL1.EA+1*P/&Z,N&6AP],CD9[KG5V+JO1WZG:TQFJZ@VAJ/_ $E:64O-F&6N
MUKNY\P9*=W/;#@%&7^F==VS1WVZKJ$='4-+F\6*9^^9C(P)WLP07$.R?B#V4
M..O;QC*PQ7JL[IVP6(I'5G[)@UX)B=@'#O@<$'!^*Y58AZ]<[5/!DO,F^MWL
M89#XL1F:6>"7>1CQ$' ;>23SSA;M/I_4+O1_7-5M34HGZC/(ZBVW(YDTP]W8
M&Y=G."1CDY]#ZH.G![2,@Y'Q7W<%RMD'4S! S3X=;B>V*DW3 ][A%&UN!8%@
M./?[7V\\;=JE=>=U')UW4_!]:_%2CMUV/?$][HIJ[@1*XX>&MP>/LEW8@A"+
M[XT?&' Y) P1SCO_ "7K<%QK2.EM5TV;0)8Z6KML4+6HQ2&2:5S&R2$F!^-V
M#&>-SAQWW+;H5.LIZ=.*Y-JL6^_2;;:U\H>S[?O#A([_ "'RY#?*.,)!U6Q;
M@IUI+-N9D$$32Z261P:UK1W))[!>VRM>T.8=S2,@CU"XSJU#JZWTY;HWH-<M
M1FC<KTV0N)<Z06'AAFR?,##LP79R,^I"M'5,.O"6NVDS535&E.97;IK]KFWN
M-ADY'EQ_J\O?/H@Z!N6O=U*GIM5UG4;4-2!G#I9Y QH_:5SAPZPBU1M6S%J4
MCW:Q'8DG@<? ]W-3#F@Y^SXH/E]#@^JWJTNM=/\ LKIV)=.U+7-=FCB+X;(,
MSXIG-P7.!Y#6XR0.?VG*'<+H=;TMKJC7:C5#KO\ ]*/';]?_ /#GS?L2KK6F
M7K$\%+4*MB:L<3QQ3-<Z+_Y 'CLN4.Z4O0Z=#1TS3K\K+6G5:M:Q/7$9KRQV
MG2R/>TG,8.=X^X <@+>G@UGJ#7M7LT]#MZ;,8OP=698B-=CJGC!TTAE (WOY
MVC' Y[DH==,K:M0NZ=^$*=VO/2PYWO$4K71X;G<=P..,'/W+)4NUKU2*U2GC
ML5YF!\<L3@YCVGL01P0N6UM'ZBC]COT<I:,:-V[=EJM9O.RO7?,]SGN(&6MV
M9:.^<@^JS5--ZBK5*FA-HV].K5M?8=VG3N,7N4D;WEK9,-.UKS@\#&1\BK@=
M1WA?=P7'O=.MI-*DD?)KC;-72G^[M;*X&2=MM^S<,^=QB#<Y[@\J3FEZN@UP
MQ1T=5LMAU.[/D2EL,L+J[C"P/SVW\ 8\I_8I!TB>[6K20QV9XXGV'^'"U[@#
M(_!.UN>YP"<?(K S6],?/<@;J%8RT&AUN,3-W5P1G+QGR\<\KF>ET>I;&L:6
M[4*NH25*^LP68S98_,3#5E$G+WN=M#R!R>YX !6'4>E]:?U=K,U/3I_=]<U+
MW"W*!@"J8X7>-\VC9(S[W(N'6*6H5-2I17-.LQ6JTS=T<T+P]CQ\01P5E=*U
MH)<< =R5Q[2],ZPT_3-#IU(;5""*LUL+6B0B&;WAY>)6,X(,>T#?Y<$XY7NW
MHW6&L=/]0TM3%U\\M*8.KB20-FF$N8S&XX8!LXVMX(QGE!UN.Y7FFEAAFCDE
MAP)8VO!='D9&0.V1RLF\?-<OBTW7;?4L<</X<JZ1+;ARXR/C?X(I.!#G9W?]
MS&?7=A06H:EU32T*%VM3ZQ#>=4H15C'-L D,^V82M!!+R-O)!)';U1F.W;AA
M:K=4HOGL0,N0&6JT.L,$@S"",@N'^7CGE4GK"/J4ZW;_  6W4G$UHAI+J;\0
MLL;W>)XXS@C&W[61MR!ROFC],-CTOK:#5*FHN@U*_8^K$CG/FA,;>8PX]R2X
M ^N /0*<M5=J&KZ?JE;WC3;U>W#N+/$@E:]NX=QD'NMH."Y0-+UN[5T6SJ=3
M4Y:^F:TTQ/9&:]B2MX1:))(8R.0\[<X!VY.!DKYX/71HRBG^%6ZE[K/^$732
M#PGR>(W9[MD[0=F[&W  QGS*CJ8NUG774VS1FRQ@D="'#>&DD!Q'?!((S\DJ
M7JMZJRS2L16(),[)8GAS78.#@CCN,+F#Z.L,ZZHZEIM/6AHON]6.T)3)[T_$
MLN 7.)<6M<YI>W.2T_ 86GHNC]8Z3T_#7TEFHPS3:5;,D4K_ "Q3"T"P,#O*
MQYC=)CX\$I/!UN6[6@GAAGGCCEL.+(6/< 9' $D-'J< GCT",O5I;<M6.>-]
MB%K721-<"Y@=G:2.X!P<?'!7*=0T[JFU:BFT:MJ1A@MROTTZD2Z6%QI2-+GE
MQ)#3*0!N]3\,+#7T_J6.;4KFFT]98R:/3FS.O/>)Y8V>)X[6N:2_()';G!.W
MC"#L.\87W<%RREIG55B6V[4=4UF!L>D-]WF@8\_6F64<QN(+Y&QE@.<$\'OC
M%FZ0U*S-0@T?5J5RM>;6=-(9))'^0R.8TE[B7->X N#226CU06MLK7C+2"/B
M#E8W7JS+D=1\\;;$K7/CB+P'/:W&X@=R!D9^\+D6F:5U#I.C,HMK=0,AA;<:
M&UIG;C<,N87[B[F(L]?L9R7*9ZKH:U+?Z>MSUM3FGKZ399:ETDEKFV'-CVC(
M(."\'M\.>,H.D[QG"Q07:UE\S*\\<KX'^'*UCP3&[ .UWP."#@_%<XT2+K@=
M3TAKDLS2#"97,\1\$D7@ 2-PWZMKO$R=Q\V1QPOC])ZAI]3W]1TEMZ-]G7_L
M;CX#X#4QO<WL1X@;YNX(].4'2+%ZM4$1M3QP^-(V*/Q'AN][NS1GN3Z!/?:W
MOHI^/'[R8_%\'<-^S.-V.^,\97)*^F=7VZ-'WZ.W+-#J5&5\=@2/\.9I?XDN
MY_&S.W(;Y1QCNI?H6AK#>K8+FKU=6;(W1!!:FU [FFSXV7AAS]D]QCC&,>J%
M\=+!R$7P=E]0$1$!$1 1$0$1$!$1 1$0%7.I>JH>F9JYO5WNKSQ3N\9KP-KX
MV;Q'@^K@'8Y[A6-1NL:'IVO58ZVKU&VX8IF3L8XD8D8<M/!__P /JH*A%UY>
M9JTE-VE36;4^H1U(JIEC8(":C9R-V.0.02><]O0+/H?7&H6]095U728H7V-6
MLT(703[PT1,<XEW'/V<<?'TPIQFB:#)K\MJ.")^I0V&W)")7%S)71&)KRW/&
M8P0.,?S4+89T)/:UD2R0.DT^=MR_LFD#8)2"W=EIP'$9#FMY.<.!RK2UBB]I
M=9]+1K9H'P]2;"Z5K9]TE<2R;&$@-QC/J2W/.,D*(T[V@:K6<+6I_P#6UXJ<
MTT\;&-80&WC#XF0/\L?./7!]58*>@=$V-%CU"I6A90HQM9O,DD8B$#RX![20
M<L=G[0R.1V*C[DG1HZ<L3Z7;@HFQ'-I_BR5YI7,:\F:5IA)#NSB_)& "#]E2
MKI8(>IWV>F=3UJII[YXZ;YQ QL@S;;$2"YIQQDM=@<]A\5$.Z]BM:SIXIAS-
M/DM.B=8WLV38J&<Y)^R&^49![_(*T:%IU+3.GJ-#3"V2E!69'"X'.Y@;P<^N
M>_[5HP=$].UJ-6C!I43:U1\KX8B7.#3(US7YR><M<X<Y[_<KK*1BZ6ZLCZDF
MO0^Z&O-3,9=AY>V1D@W-<TEK2> ?3'P)[JK=/=?WWG3SJH?99-7:ZQ(T,C;%
MOMR0MDX&>-K 1VQS\5>M(Z=TO0W3.TNL873MC;(YTCWN>& A@)<3V!Q]RKNL
M5.A^EHF4]5@;7CO4Y:H86S2!U<.,D@);G:T.D)+CC&>Z)ZC[OM*TF(5;\FE,
ME<!8GK222L#_  (Y/#+X\C)<_!(8.2!R58>HNK8NG8(;$M1TU>>M++'('ANZ
M1C0YL6".[P3@_$+8;TOH4]"A'!5#:]2 1U7UYGQXB('EW-<"YI !P20>Z^]0
MUM"OUXZ'4,3)(6_]8UL@>&M\'#MY<.!CCN>?GRE57OQGTS0%@T3&7>[1[9IV
ML:RQ-OS$YV,-V!A+G?\ I:!]I5EVH2WZM"6QI,6D>^6(0YC70ED[V2.#B//P
MW@#@@9XRK!I.F]*ZI3M0Z92)BO2C4Y?JYHG.D>3B5KG %I.W(VD8^65J]4:9
MT5H\4%SJ:K+L\(5FRD69LL#PX,>6YR"\C[7<X[IT;#>MQ/6U*Y6HL]QJ3FK%
M8GLB/WB8. +0W:2!D\=R<<-6M1]H<5Z3261Z:^'\(22PF2S+X<;)62&,QAQ;
MYGDC(:0TD?/A;E?1NE]<M6I(*4OBV/#LS-+9Z_F)\D@:=H;)Y/M !PQSW6]#
MT=H4 K"*AAE68V(HS+(6"0NW[RTG#CNY!(.#VPB-+I#J2[K72<VKZS5KTG13
M6&X9-ENV-[FY)(&,;<$GX9X[*#L>TB[/ QFEZ/$ZTW4JM69DTY##'.,M<QQ8
M"<X(SC [^8*Y5>G]+IT;E."FUM:\][[$#G.<QY?G?Y22 #DY P,DK1;T1T\V
MK-6&G'9.8GR.,\A>71?]LA^[<"WT(*=5&]6]3:EH/4.EQT:XM5Y*5RQ8KA[6
M%WA-80=Y'&,GMWRHK5O:)J\$6M6M+TJK)3IZ/!J5>2:<AQ\0$C<T#X ^4'T[
M\\7'5],TA\;M1U:$%M.I,PR.<[R0O;]9P#SD-^_CA:\'373U^I#9AHLDKSZ<
MVFWS/#9*I;Y6.:3YA@\;AD94)I#N]H$U6[/7O:*]D=*2I%<GCLM<(G6 -N!@
M%V"X ]N#GY*4DU>^[4]*K6(6Z?(YLUJ['O;+X<,8V@;L8\SG-.1SP5JTO9YI
M-;7[6I3L=:#W5G5X97O/@F%FUN27'Q#GD;@<%2HZ=T:E1L,?!L@?6=!,^6=Y
M^I)<YP+G.R!ESB3G^05.JI)[1+.E:6Z34=-EMVYZ[+U2&-S6&:.21P#!QP6,
M )SG.5M6/:35B=+(W3WS5/KV5;+91BQ)$QCM@&."XO(!YY:5FL:ST3=JZ;U)
M*^.Q!3,T%.W'!*]L0QLDX:/L@#N1@=P?52,'2?30Z>T^G7T^$Z;0E;<IM:YQ
M:QX)<'@YR>Y/.<Y3B(BM[2:TONTS]-?%6)KQVYG3#%224/\ (X8YVE@!/_D%
MM]+]<LZDMUJS=,EJSOBFEGCDD!-=K'-#,X'.\/!'P"T]W0%G0-;J&./W*U9;
M+J-=T<S7RRRD%I#2 \[B!MV#!QQZK(^7H;WHS[F-?KS:[38C\9K90T[86E[>
M&'+<8RTDC!0:VM^T0U]-U6.O2EAO4([KIL/8XP" -+9,$8._>S&?B?@O&K>T
M#5*^GZK+I&B,E_!MV&FZ>S9:ULCWF/LT#/:0?<?CV4NZETAJO5.NZ8Z&&?5[
M=*-FJ1@O#G0'AH)' [^ASVSZ*5?TKHTM"_2DHM=7U&4366;W?6/ : [.<@@,
M;R,=L]T5#_3EC+38)Z!B/X6=ICWF<;6%L!E+\D#CC'_M1#_:%/J%VA6HP^Z2
M?A:K#/@^*R:O,R1P+7.:.^SN!]Q(*M$G0W3LM[WR;36RS[MY=)(]P+O#,9<0
M3@DL.TDC)'?*5NANGJDD<D&GX?%)%*QSII'$.B#A&<EQ^R'N ';!QZ!(:59_
M7VHZA-HSM*H>%)/J4E6QI\LS1+@0/>!)N;F(Y:#@9X[$Y6]'[2JDS='ECIN,
M.I"$2?6YDK.E<6-W- (QN'<N&?0%3];H[0Z=F*Q!2^OBG-ALSY7O?OV&/)<Y
MQ)PPEH!R .RP1]!=-PFOX6F-8*_A>&&RR 9C=NC)&[S%I)P3D\D=D17W^T]D
M=*.Q-I)@%BS8@K>-<8P2B N$CLXX^R !W)=Z#E8Z/M$F=K]E\M6671YYZ$4$
MAVL=6]XB#AN;C+O,>>>/3*MCND=%=1BIBF610S23Q&.9['QO>27EKVN#ADN.
M0#CE>G])Z*^9\KZ0<]\T$[G&1^3)",1N[]P /O\ 7**IFL^T>P>E+=S3Z<E"
M6QI\MW3+,CF2>(R-[6N+F8\IPX$ Y&#WSPOFJ=61S]4Z5:;I<,=.MJ5BG+J$
MD<;Y'MA@D<\-R-S!N;P0><'MZVSZ"=-^#:A_!<?AVXW12,WOP&.=N<QHSY&E
MP!(;@$K)]"] .KC4SIS/>Q*Z8/WNV[W,+'.VYVY<TX/'/JA\5>#VJ0VZT3Z>
MDOL6)[%>**&*TP@B<.+"7XPUPV>9OID<E9)/:18;=EJQ]/2.>V>U68??& .D
MKL#WYXX;M)P>>1C'JK+#T=HL$<,<=5^RO/'8A8Z>1PB>S.PM!<=H&XX:..>R
M]#I+1!8,_N(\0RSS;O$=]N9NV0]_\PX^7IA!68/:MI,]Z&-L+VUY&Q[Y#(WQ
M(W/A\8?5CDM#< NSP2._=:ECVHRVNG;-[0M-ADLPNJO#)+(<SPIW[6DN:.'C
ML6>F0<GUN%7I#1*,T4E.EX)BB;$&LF>&.:UNQNYN[:\AO&7 G"^-Z.T1NE6-
M--1SJ5@-:^%\\CFM#3EH9EWD ." W&,#":(K?TZN5]1LTFZ;)>L&_9@CC,S(
MVQ"&!DA&['(\Q&2,Y7UOM-AGKQVJ&DSS4R:3))73-88WV2W:W;SG >"3\>!\
M59(ND=$AL"PRE]<)))?$=*]Q+Y&"-Y.3R2UH'_ONH*[[--/L:G0DJNBITZAK
M'P8XW&1_@',8+R_&!VR6EV.,X2"7U'J,T^HHM(KTG6)!6-RS*9 QL$(=MW=B
M7'(/E'P[J E]IC8-*-Z;19F-FI-OTF"=A-B$R,9S_H=]8TX.>#WSE64=):-X
M]>?W1PFKO>^.03R;AO?O<TG=ES2[G:<M^2PMZ$Z<97L0,TQ@BL-:Q[/$?@,#
M]X8WGR-W ':W RH(BC[01-JXI:AI+Z3!:L5)9S8:]K)(8_%/  ):6>O&#QCU
M6MI^K=0:[J5;3&:DW3'G3FZE-(RLR21PED<(XVAPP&M:!N."22.RLD_1N@V3
M(9J <99Y;#SXCQF25FQ[N#ZMXQV6;5.E](UB2"34*8?+7:612QR.B>QI[M#F
M$';\LX5%)EZBU^I:U;4WZG'-3H:]%IWN$E9@#XGF)IV/&';\R$C)(]%'Z/U]
MKKK5.EJEF+Q;>NNCKR")H\:F)98WLQCAS',;D]\.!5^CZ)Z?BUEVJMTX.MNG
M]XWOE>]HEP ) PN+0[ '(&5YFZ%Z<L5JD$VFM='3FEGKXD>#&^7=XA#@<\[C
MQG'^P5/ZJW1'7=CJC7-4K.U*HZ.V)I=+8P,,E9D<AC(>T')SY7C/Q(6.IU'K
MUJPS3J^J^-6NZL^I3U?W1@<^..!SY"UOV'#Q&[0[&" [OC*N4O1N@S5ZD+M.
MC:RG"ZO (W.861N9X;FY:02"WCG[^ZUZ_0'3E72FZ;#1>*C'-='&;4SO"+00
MW82_+."1Y2."5!6:_5.L7JW2EVO?C%G5#'[QIK:[2PQ-SX\Q=]IC1C(.<<@<
MY6?HOK&UU'UMJT1NUI-+=5BL:?!%LWM89'L+G$<DNV!V#V#@K">@^G3JD6HL
MH.ALPPQP,=!9EC:(V?89M:X-VCX8P?5;U3IO2*&JRZE2H007)HFPOEB8&DL!
M) P..Y//<_L"=3B2'9?4 P,(BB(B B(@(B("(B B(@(B("I7M#T/5M=I0U=+
MIQV(S'-N<7L;)%*6?5N!?D 9SD@;AQC')5U1!1ND^F;ND=7W]2O:?&7WZ%4/
MN-D:7"5C-LK7#N2YV#D9!PL&O](:G>U/J":A!$QEF&@^M]8UHED@F=(]I^&>
M!D^I70$0<UL=&ZEJ&B:I%8TQD=[5I+T\4SK#2*/BM8&QNQ]K?L&2W("Q3]+]
M1OUB7J)FFL]XGDE9^#C:9EC'56PA^_[.=S<D?Z3ZGA=/1!1=4Z7U1O1&B:%7
M@AOLK,CAMEQ;NPV,M#F;_+]K'<$X[#*U']/]0ZCTKT[H^J47/?I]BC)<F=;:
M[QFM#O%'!R=O _\ +=QZKHJ)D<RZ:Z8U[IFY5O0Z:9WQZ?:AFA%QN97FR'0-
MRXD8;%G![ <>JF^K>E+?4?4^CO$UBO0AJVX;<M>1K'XD# &#()P[!R0,C'<*
MY(@YC8Z0ZA^E8FTN&/3H(FS5H;,$C ! :Q9#D?;<YK]I(/ P"!W*P/Z)U2UI
M56H-#95;'I%VM9C=:8]L]E[(]DA.?-N<TG+N1ZX7540<KFZ&UJ*-L=6DTT8Z
MVG-EHML!@M"+Q#-%WP,ES3S@.QR5:NJM'N:KT"_3=,I"&=W@;*QD:!&&R,<6
MYSC@-/96I$3#GG4726K:KU=9LM@\33YKFF/(,X;F.(R^-QG/9[>/7/JH-OL_
MZE@T]D6G,%65]*S#8)L[A(/>VOBC/F[>$'-'H <<977T1K*DZ=T[K47L[U73
M()Y*5ZUXQJM=M8*NX<,;L<[:W.<8)QE0;.B-4M:A5+M+%'21J->633O>P\-:
MR&1LLAP<8<YS!M&2<9(R2NI(G<HHU;2-=H^R5^C^XFUJ3J\U5L+K+0&M>Y[6
MDO/&&L+>.^!CNHCZ']15=3@@BK,GK"]IEE]AMD-#601".1NT\DY;GX$'X\+J
M"(?'(*'L_P"IJ>ALKTP*=J;17P6G^\[A).+#7M:<'UCWM#AV!PKST7H]O3-$
ML5]1C<QLUA[V57M8&PL( V-:US@&YR<9/=69$'-;'3>OQ=!W=&K4[(L6[]V0
M&K<BB#622/,>_=G+"'#+1SCA6W19[D=6;3Y=-,?X-@AB9)&=D5A_A N$8/9H
M.&Y/_P"E.^B 83F!RRMH'5&H/?K.KZ,^+6&ZG7O/B][B,<D46]K8(R#QM:\N
MR[&YQ/9?8NGNIZ\6C:39T<VM*AL.U&WX%N,%\[IW2,B.XCR,R"2!YB !QWZD
MB#FNB=,=4=.]6WM6E@IZH):#PY\#O!?9F=.7@'>2&D @9[8  72&Y]1A>D0$
M1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$
M1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$
M1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$
M1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$
M1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$
M1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$
M1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$
M1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$
M1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$
M1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$
M1$!$1 1$0$1$!$1 3T1$$=J&MZ?I=JM!J%AL#K(D+'/X8 QNYQ<[LT ?%>&=
M2Z%(U[H]:T]X8W>XMML.UN[;D\\#) S\>%%]9]'?2R"*,W15$<%F$YBWY\6/
M9GN.W?YJL=3>S.Q+I]R?298Y[$EB65L KM&1*Z 8)+L$-$1./7..%(.@#7=(
M,=>0:I2V6G;*[O>&8F=G&&G/F/R"U']7]/,U2'33K5(W)G.:V%L[7.!:"7 X
M/E['OCLJK-[,7RB=[]6B$MWQVW/^D\FV65LA\$%WU9&S&27=\]PO=?HJN8*;
M-'UNJRU5GN2.FCA9(YPL;L\;OM-W#!.<XY"HMOTFT(PQ2C6M/,<[BV)XM,Q(
M00"&G/)R0./BM:3K'0F:3JNHMOLFK:.Y[;IA!>8BT9<,#D_L51'LI>^M=]]U
MILTEF&PPR/K..QTK(F[LN>3QX6>_^;TPII_1YGT/J+2X=2B\+6WNL1O;#ET.
M]H#B<.\XRW([>O=."5J]8:%:9/*W488X8(X97S3'PX]LK=T9#G8!R OKNK]#
M&INT]FHPRVV20QNBC.XM,N=G;T.._ID?%5>+V;"CJMJWIVKQ,=)>CM5*]BL)
M(X-L3V&,MW#<,2.<.Q;QW"^Q>RYM=M>"+53[K$VIO#H/K'.@#VY#@[ W!Y]#
M@@*Z1<8^H-'E?$V+5:3W3R.BB#;+"9'CNUO/)'J!RM.QUAI-7J)NBSR3LM.?
M''N]W?X0?("6-,F-H)#3@956'L[:RQH\5W6JSC2@CJ-@;$Z'QX8WM>P[6R#+
M\MY/+3QY>%(ZQ[/8M5ZHFUPWG0SR.B  83MC;&^-[?M8)<'Y#L9:0.ZBK'](
MM&]U]Z_"U'W?Q#%XWO+-F\=V[LXW?+NOKNH-&:^5KM6H@PQB60&RS+&'&''G
M@'(Y/'(7-]5]G%_2NGVLTN1^I7PV2%I$.YKV.KF$;Q)+AI  \S>!VVX6S-[-
M9=3W0V^HHGF*J*QK^%O\'+8LM(WXQF+CR@G=SG""XW>M^GJ4[(7ZG#-(Z)\V
MVNX2X8T-))VYQP]I&>_HM]FOZ1)[R&:K2<:@+K&+##X(!()?SY>01S\%2-0]
MEKK=^R^/588*\SK3XHA3&]AG,;G NW#<&F/@8'!^2:E[-G14;$U>TZ68"P]L
M<-5NZ1\EMEAH(+P' %FT@D9![CLFB_%RN=3Z)0TC\*6M4JMH^((A8$H<PO)V
MAH(]<K'1ZKT/4([;Z^J5L4WO;8$D@88MCBTN()X;D<.[%5O2NDM0M^S^QIFI
M&.C=LWY+P^J#FQN-CQ6 L#L>@R [C/=8+7LO;:#]VK"*9[[,I?% 6DOELLG!
M.'9PTLQWYSG(1/Q<-3ZCTO2>GI=;M6FNT^)@>9H?K X$X&W;G=DGC"RPZUIL
M\+98[]<L=X8!\4#F0 L!YX+@00.YRJW/T$+73VEZ/)J,L%>G;-R8U@X.FDW.
M>W#GN<0 ]VXYW9QZ+3H^S?W*[I+GZT^1FG[CX3H1FP6;_=W.Y[Q"4C.,'#>!
MA*L6*[UGH-&K[R[48IX?K<OK.$P!C9O>#MSR!Z=U[N]6Z%1@DEL:G7Q"^-DS
M6O#G1&1P:W>T<M&2.3V5*_%3-8]Y%KJ(3SR,>R1Y@).75S""<R'!P=V.!Z#
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M$<D<_$@$X^ 4BN7U/:'TG1G;-6T7J4/;GEVE679.,9(/<X)&>^.%(_CAT/\
M-747\%G_ *(+_A%7NF^M]%ZJ?/%I-E_O5;!GJ6870S1@]B6. ./GV5A0$1$!
M43VQ>;V>2Q.YCFO4XI&GLYIL,R#\BKVJ)[8?R!'ZRI?\AB"\L8UC U@#6M&
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M#3H&223.V9>_&QQX9R7C! ]>R@H^A-<J]-Z9! VI);BTZ[IT\;YR&,%A^X2
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MLL;XRWQY-H8YXD<UHW8:"]H.!CG[RI>II-*B^X^K &.NS&>QYB=[RT-)Y[<
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MTRM#->C;9\7=;D9(_:]CR1(UHQD8&W;\\]O74'2%X!DWO$;[8,@$QL2>0%C
M,<?%IS\G9Y[*Y^4_!/*#Z*Y%,L=-ZY;N^-//7C:Z5SW-98>?*7[@SEO..,'C
M&.R]Q]+ZC'&Z9DL#;36-CB+IY'#:'2$AYP-Q(>,G _8K>"T#@CE?<M^(4Y@4
MIG2>KMI.:VXSQ=S0&.L2.;X0,AVY '.7,.0.2W'99/HG?A8T0V&R[R]UAC[,
MC!.\N<6N) X(SG  R1^U7'+?B$RWXA!2YNE-7<6&.Y$90YSVV732 QDAXX8!
M@EQ<"23D8]<!>X.D;KXW>^6LN( :UEF7;& V3RC&.-SF'_\ K\@KCEN.X3+1
MZA04R7I;6A*!4U(11-:?#)E>YT3BT9(SW#CG(/IR%X'2.I%A)GB;,^!T3Y&V
M)/(/-AK>/L^;UY&%=<MSR1GX("WXA4]4]VC:A4UVJVM')/ V?Q&/-B0-KQ@O
M):?1V<@<_P#OC&6QH&J3/>\OA+W/D=XOO<H)+OL.P&XS'V#>SODK9EOQ">4\
M<)!3STIJ#(<P7,6'X:^5T\A!#C()#M.1DM<W'S:.V%M_@2Y6H^XTZ]-T,5IM
MB%[Y2TN E#]CAL.,#RYR>PX5ERWXA,M]2$)[E37=(W6VI;L,E5EB66)SV$NV
M>&)3(Z/MV!(+3COG@97R/IG6*L%F&*Q3MQZAAUS?F$[LNWEI#79+@0W)Q@-"
MN66@=QA?<M^2"HS=.ZD&20UF4_">U\+G.E<U[HI)"]W.PX<!Y1W[YR.RVZ.C
M7=-U^;4 ^.PRVR.)S&M#'1-#G$>;_,UK3@#&3\N58\M[Y"9:/4(*?+TQJEG4
M+DT]EC(I=[HF1V) -^'ACL #&-S<\GD9^ 7NOT]JD,M^5TE>22>N(@]\[R93
MXCG$N&,,\IP,9YY[<*VY;\D\H^'*&5)/3>K4]+?-'9?+?C;]5LL/?G:WR-P<
M @/P3P.,K:O].ZK.ZDVM<8QL$ 8^4S/:]Y(=O!P#D$D<Y&.>_"MF6_$)EO/(
M04>'IO5A+/"QK(H@7.;'[U)X>7%Y:0_&7%F6GD 9X] MMG3NK2F)ENXQS(&$
M,>VQ)NE=B7#W#  Y>WC)^S\@K;EORPG""I,Z0G]Z)EL%U9OA>''[S+EH&/$'
M?G<0?]_18ZW2VJ.M :E>$]?+-X;-("]H &T]NQ!P01G)RKCEOQ&4!!&<A!5(
M.G+T&G6(BZ*2:::"64FQ(WWC9&UCVN.,MR6DY&<^J\#I[4:^B^ ]_OUF6[')
M*39D8UT8 &"[N ,>@Y]0<E6X$8]$RWY(*8[I?5C ]CK;97[<>(;<C3)]G:QP
MVD;6D'GNX=\9*PNZ6U46WQ571U6D.D9;CLR88]TSGDAA[DM.T@G@8()[*\@M
M/8A,MS@X0SA4X^F;^\S>\-K/8![O&RS)(V [FEQR<;L@'N/7'S6&ETC?(8=2
MM>+MV#:RS* ,.!?CM]H#G.>2?17++?B$W-^(0FE+BZ4U:2Y'^$+XFKM<"\-G
MD:7@,VAIQ\'<@Y&<G*VF=,SBA)%,V&:9UN"T7&=_UCF-:'9..#D''?.?16G<
MW'!"^Y:?4)D4H]):K!) RC?;'7C8T%GC29;(&@.D!.>^",'T/HLCNE]599'@
MVVNK,CC;X9L2 R!H&^-SL$[7$.=N[Y/JKCEOQ"9:/4((+0=&L:2^9\I9(^PY
MID<)7NV@-( \W?' ]..?DIY?,M/J%]04O6?\8>F?U?>_G&KHJ7K/^,/3/ZOO
M?SC5T0$1$!43VP_D"/UE2_Y#%>U1/;#^0(_65+_D,07OT5=ZZCO/Z0NOTF>Y
M#<B:'PFF2)'.SC& #D<GC"L059ZZZBN],Z#%=TRK%;G?:BA\*4D M<?,1CUP
M#A18JNM6>KZ,]^KI@O2U(;[60V2YSY2SW,G ;L\S?$QYL_:X4CTU=UMU_5(K
M[[]EWN+9HYWQO8R%^P?5;'- +\Y.YI.><X.%#6/;!,UER:M6INA-Z*.@Y\CA
MXU8L<]\KCZ<,./3+FY[J9O\ 7ERMJUA]6.G8TV)]6-@R[QI?>(]S7-YP0.#C
M';)SPKP5EGT^K4=&FGMZDYLD LRM:XR/@&8 ?$'AC>>9"(N" 2,G"EA=Z@S8
M,]C6A/X%O\(1QUB6UW _]/[OY<.)XQ@NR"2["M?1FNV]?Z:JZCJ'@QS6F"1L
M<<,D0 +0< /.7#G[0X*@X^M-7IZL8-5@K3UQJLFGGW&M,^7RP&7<&@NSW QC
MCD_<&C1/6-F#3??;EVM>MW7T]5C$68ZP_P"X)("!@#:W8''(/B'U"F>K=6U*
M7IRIJW2;K<V9W0&."(DO:\.B#]I&<,?M=GX GLH>M[2-4LZ=#<=2JP5 VM):
MLELDC:[)8RXDL!#L;@!G_+G)!4CU5UIJVB=1S4=-T^*W##IXN2;F2;@#XN7%
MX\K6M\-O?DYP$I/4#I]WKIL\0>+EA]<3T9&S@Q,F,,)^OR&'E[R"WC!(X6NR
M[U;/0U*+WG5X=0=3IBM(62>1SF0^([P_#V$AQ>22[(\PPI?3/:#K&J5&,CKZ
M=!9#)YG36?$BC<R)D;BT,)W-=F3U/#6[@""%MU^N]3U+78-*TZI3CFN4&WX'
M6'NPT.BW"!X'_P!S=@\?Y,G">)&DZ[U9=Z2ME\-^#47:^VNV-A,1;!O:UVQ^
MTXC/F(?@\%:4TG7U'5K3!/;MR1UC"R1C-T,LPK-=Y6%H \VXA^<%PVD#*L]+
MJ[4;O24_4)T^.O6CF;B&0DO$+'!L[C@XR")"WY-&>Z@-+]J>H:E2?*S3ZK70
MN8Z4;W$>'+8CC@<.?\S'N=][4FDXQV7=57;4-/IR[JSJ,EG$%R\'0O:? <7%
MY,>3&UX:<$#<<M!QVU)K?5TVF68ZS]6DU :I*UV)9(MT0;,6[<Q;6-RUF,%V
M> 2,JY:-U=9U)W3HEA@9^%JUB:7:X^0QEN W/H=WK\%$=2>T/4=$Z@U6E#5J
MR0TX'.C\02 EXKF89=]D\C&P>;'/HGBL,.L=02=/ZP^*>_)JU&5EVK'-2D8R
MS&V&/='C;]ESB_R@[@?N6]U*=9TW3>FX([FH62ZP1?GA<]CGYC<<N+(W%K=V
M,#'P&?52<_4EVAT=6UNVV%[!-&;A,$D'AP.>&N>&/.X%H(//& 2H0^T+5#3G
MO"G2CKU*\5R2*1[A)/#+(YL8C] [8T'G(+G!O'=$XB]6U+JEIUHPOUGW02-.
MEN9"YKGQ^\,$V\M8YPP,AA(SL+C@E;UBUK4D>I-CM:S':% ?@>.%CW1S$PDD
MO>6#+]^1Y]O9O'*S6.LNH:U]]:1NG.'X7.FM=#5GD=Q#XN\L:XD]P,#MW[*1
MT;J_4+G4D=*[#3->W:N5X? +A+'[N<;G D@AP'<8P2!SE&D3-+K>LZBRW6M:
MU7HR:K5@8UC'PYA,(\4EI;N#=X^T<<YP<%1\%_6G0L&I6]>@;^&)669(&S/D
M$ $VS#?"PUN1']DN!XR1E3E?K75K=A]:**I')/JTNG5I)H96Q1B/Q"7.>3B0
MD1X#6D8)P5J:;[2-1U#J?3=.]RK-BLED<I;O.7%TS7.9)]G;]3EH(RX'CLGJ
M>1*5-4UBWT&92ZP=<TT1RV86Q[72N;B3PB,8+GQX! [%V.ZJ^BZAUM/I-IU]
M^J-FK,@D8YT!:Z;WB=C\8V\F./<P_#)RK%K?5VLZ-K&I1F.C-3I-J2-:R*4S
M.;/,8\<.()&TG@<Y& L>G==ZAJG4]?3J]9D,$D]ECG259G2;8I6,&1QX9(=D
MEPP%9<W)S#%H?4>HFYH3-2=J>/"M0W=]&7'C;V^%N.SX9P>WS41U)J75<74?
M4<>FOU811QR>[B*-[F >%$6[!LP#O+_,"XDY&WC*L&N=:ZEIFK:]#!# Z#2J
MD<S0^&4^(Y[<\R [6X^'<K[J_7%W3-:UV(5X9*NE5XI&CPI/K'/:#YI1Y& $
M\Y!. 2IG1._X?=3U#5]/Z.TW5])9>N259"9Z8+YI)V.#F8.YC7NVN+'?9' *
MCX_I+7U6&E;O:K-=98K0L\.+_IYJQ8WQY'/#=H<'&3G(((: ,'G?U;J'J72+
M=.*1^CSMGK69W.CBE_\ LL#\#S^N0,_M]<+5K>T'49X(KKZM-M62?W3P YWC
MB3P/$\3&<;,^G?:=V?17/M.(^L[7:>I:,VW<UR6O+>N,G,TL@ :R8-AR6QG@
MMS@' =WRM_HO4M:C,EC47:M:@CH23767*[@661(=K(LM!=EF<@9'V<=UL])^
MT&SKM*_)>H,AGT_3(;=B"%Q<[Q'->[:W/=I:UA:?_):-CV@ZQ7CJ1OKT))[S
M:LT,E9DL[8HYG.&US&G<YPV\8P#SP,*>3![MHU]4ZO'2ER/61J5;4&SQW0/"
M),L4A<369)$UVS!: "1D9 <,'*D^JKVMMN4W47ZS5>[2'RUX*T1D#KFYFQDI
M#2WL2#D@8R5.:EU#>J=6:1I,+8FQ6ZSIYY75Y7D;7-!'E/D'F)R_@85>TSVH
M2:N)Z]**DVQ-?C@IO?([PVP2;]DDGKN^K<-H(R7,&>4@T#=ZS/4['R.U)E2*
MXX2EK'>&QAL[>&;?K&[#@<\-\W.%[T34-;DT72CK=G7*\#WR?A":)LLDS90U
MOAM(,0<QA.[.T.&0!N4XSKB['U"W1[-:-\XU2*DZ>**7P2UU?Q"X/.6AV[@-
M)SCT6:WUC>@UR=C*]4TJ^I1Z:^)SW>\/>]@<)&CMM\PX]0''(QA/G_<7JOZP
MS7=/GN/@O:[-7;K$4+<RR8]V-?>X@LC<X#Q#C< ?API'0+FN/ZQ,9FU26(WK
M+;,=J%PKQU@WZES'.:/,78'!.079'"W*/5>L7?9C/U(UE1EN.NZT(I*\S(]C
M6[BT;CEWR>.%IS>T'4:5I]*W3AEL,DHM\2&&7PL3Y+LNY#2., GE(F$-2O\
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M?@NW,;M8[8_Q=V20 2T D JY=.7;#JVK0O\ >C_U5E])TC'./A @8W'(X>7
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MP1$#"81$# ^"8'P1$# 3 1$#"8"(@^8'P7W 1$#'R3 1$#"81$# 3 1$# 3
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MNX[B<9SCG[I?LLN1Z9!X^ILJWO=VQ/E@C+GQCW9T18UV>1N(=^S]JZA@?!,
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M 'U7^Z@NR*D_3K7_ -'6O_OJO]U/IUK_ .CK7_WU7^Z@NR*D_3K7_P!'6O\
M[ZK_ '4^G6O_ *.M?_?5?[J"[(J3].M?_1UK_P"^J_W4^G6O_HZU_P#?5?[J
M"[(J3].M?_1UK_[ZK_=3Z=:_^CK7_P!]5_NH+LBI/TZU_P#1UK_[ZK_=3Z=:
M_P#HZU_]]5_NH+LBI/TZU_\ 1UK_ .^J_P!U/IUK_P"CK7_WU7^Z@NR*D_3K
M7_T=:_\ OJO]U/IUK_Z.M?\ WU7^Z@NR*D_3K7_T=:_^^J_W4^G6O_HZU_\
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M*D_3K7_T=:_^^J_W4^G6O_HZU_\ ?5?[J"[(J3].M?\ T=:_^^J_W4^G6O\
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<(B!A,(B!A,(B!A,(B!A,(B!A,(B B(@(B(/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>cdna-20240429_g3.jpg
<TEXT>
begin 644 cdna-20240429_g3.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !O ' # 2(  A$! Q$!_\0
M'    @(# 0$             !@<%" ,$"0$"_\0 /Q   0,"! 0$ P4%!P4!
M     0(#! 41  82(0<3,4$4(E%A"'&!%3)"D:$C4K'!T0D6)'*"X? 7-&*2
MHO'_Q  ; 0 # 0$! 0$            $!08# @<  ?_$ "L1  (" @(" 0,$
M 04       $"  ,$$1(A!3$3!B)!%"-180<D,G&!P?_:  P# 0 "$0,1 #\
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M2/F+BQQL<0&(G"BAN2.0*C6W_N-K%PE7R]L(V12LQ9HO/JKKDAQ0OIZ!(_=
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M;R$EL&Y4GK_OC:R!F=V14%QW7D-"]E$=<0?_ %3;K-!0P]=UXHLL][X^\M9
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MR&E&YV]-^N+R\1*U38&77);UPTCSD $DXH[Q4HM7DOQ\Z:DQX<J;X8);=.L
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(MK6+-^9__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>cdna-20240429_g4.jpg
<TEXT>
begin 644 cdna-20240429_g4.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !Q ' # 2(  A$! Q$!_\0
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M*Y6KBUK_ $:]\W<[3!F0#A03')"DC/[>E6(X7<9XW$]L18C7R\X-*4E'7"O
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M&P05^!]J=ZML@N3@R4IU^*L'N&4765M1)25ME3@WR!G'MYULN.J8US45AE2
M04D.(P"D]?PI+Z>U-.AWYQMV(<IZA8\/.F\IMZZVYA]YE#+*#SJ"3DFEC:O
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MTV#ZLB6>O=MM[-K4^N,$OD8"TIW!\*#]-2YKS4J$\ZKE4#RY\?04(6/BU/\
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JOH2NW\X;K_>W?\1K*RB;.FB]>Y/VG\T(_K47V+\WK_JUE96E4RLZG__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>cdna-20240429_g5.jpg
<TEXT>
begin 644 cdna-20240429_g5.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !Q ' # 2(  A$! Q$!_\0
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5<+WW_@*VN>^/W?\ 6LK*('B03__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>cdna-20240429_g6.jpg
<TEXT>
begin 644 cdna-20240429_g6.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !P ' # 2(  A$! Q$!_\0
M'@   00# 0$!              8'" D!! 4# @K_Q  Y$  ! P,# @4" P4(
M P     ! @,$  41!A(A!S$($T%182)Q%(&A%2,R4I$))#-"8H*QP31R\/_$
M !L!  $% 0$                " P0%!@$'_\0 )1$  @(" 00" @,
M     0(  P01$@43(5$B,11!(S-A_]H # ,!  (1 Q$ /P"R.BBBB(A1111"
M%'8'T'?- &?OVJ,?5?KRK4MPO&G[&^MFU0W%0Y$A@?O);PSN0A7^5 ]2.](9
MN(V8XB%SH1WM5===$Z/4XW.O;;KR#A345)=(/KR../O27;\4^F)2T&%;KE+9
M6<)="4H!^0"<XJ'&I6Y=S_",MPO[FW(;;"D94&^<;C@C=R3Q2LMVGEN;6& X
M(JE>1MP 0H \YQSZ?F:C&\?0D]<,ZV9+&T>(W2$Z6AB9(<M"G3M0J8!L)_\
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M9DG*OWK: T<'L-N,'  IO>GNOXFL[:R4*29*OIVN<%"_:GDM%N6(R'G' %$
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M=ZF2UN?HL+:D)^L%*O8BL511HGQ2]8.F49N-IOJ%>XL)O!1"D/B2RGX"70K
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*0YW_ "-1HJ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>cdna-20240429_g7.jpg
<TEXT>
begin 644 cdna-20240429_g7.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !: '@# 2(  A$! Q$!_\0
M'@    4% 0                (#!0D!! 8'" K_Q  \$  ! P,"! ,%!@0%
M!0     ! @,$  41!B$'$C%!"!-1(F%Q@9$4(S)"4J$)%;'!)#-B<H(TDK+A
M\/_$ !H!  $% 0                 ! P0%!@+_Q  F$0 " @(" @$#!0
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B*0EU,E)2L#V@0H8P:]"O4DUG[U]0ZA$M^ZA2U"HVQ3__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>cdna-20240429_g8.jpg
<TEXT>
begin 644 cdna-20240429_g8.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !P ' # 2(  A$! Q$!_\0
M'0    8# 0               00%!@<( @,) /_$ #H0  $# P,"! ,&!0,%
M 0    $" P0 !1$&$B$',1-!46$4(G$((S*!D:$S0E*QP0D6<A5#4V+P\?_$
M !H!  (# 0$               0% 0(#  ;_Q  B$0 " @$% 0$! 0$
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MT@7%A4>3=''7HURD _"OH5R@I(/ED I//%0UI#J],T#J-=F,]O5(D*5(7*@
M_=DG^&KD]A@ Y\JS7:/DUVAE_N5I@7MEFUR%NK *\ )\S]*0)]X>EG;G:UC
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I>/UHJTG+HR,C.,TIRXBE94>2#SGO6E+*4NI&PA(X*CS20XSY*''D_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>cdna-20240429_g9.jpg
<TEXT>
begin 644 cdna-20240429_g9.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !T ' # 2(  A$! Q$!_\0
M'0    <! 0$               ,$!08'" D" ?_$ $ 0  $"!0(#!08$ P8'
M 0    $" P $!081$B$',4$3(E%A<0@R0H&1L0D4%<$C4J$6,Y*RT? D)31#
M8G)S@O_$ !L!  (" P$               ,$ @4!!@< _\0 *Q$  @(!! $#
M P,%         0(  Q$$$B$Q!1,B,@9!46%QP11"@>'Q_]H # ,!  (1 Q$
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MIM2 #P>,2M\KI:]9I&W#D<B9XI$H5MI&GFF)&S2M4\,C;NPJI%)2E*<)P G
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M:)?P4KDQ:]_,,LK7^7J2?RSS0/=6#G!/F#@B(RHX)@ZCSJJ;7I"<02E3+G:
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=F! @ ZCD\R_]\!TAN<61.LISMI/^:! C,@>I_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140382403525168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CareDx, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001217234<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140382291134128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="2">2 Months Ended</th>
<th class="th" colspan="2">10 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Value of Initial<br/>Fixed<br/>$100<br/>Investment Based<br/>On:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Fiscal<br/>Year (a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Table</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%;text-decoration:underline">SCT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8221;)&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Mr.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Johnson</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(PEO&#160;1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">CAP to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Mr. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Johnson</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(PEO&#160;1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%;text-decoration:underline">SCT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#160;for Dr.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Seeto (PEO&#160;2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">CAP to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Dr. Seeto</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(PEO&#160;2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">SCT for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Dr. Maag</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(PEO&#160;3) (f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">CAP to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Dr. Maag</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(PEO&#160;3)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">SCT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">for Non-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">PEO NEOs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">CAP</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">to Non-PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">NEOs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">TSR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Peer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Group</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">TSR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(k)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(l)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Revenue</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(m)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline">(5)</span></div></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$3,097,438&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,923,573&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$10,551,753&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">6,665,898&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$4,617,844&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$4,412,835&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$55.63&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$118.87&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">($190,284)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$280,324&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$12,786,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">($648,097)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$3,784,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$118,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$52.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$113.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">($76,613)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$321,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$7,090,121&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">($50,411)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$2,605,699&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$140,603&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$210.85&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$126.45&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">($30,662)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$296,397&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$5,618,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$17,196,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$6,400,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$32,731,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,979,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$7,956,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$335.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$126.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">($18,714)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$192,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureName', window );">Company Selected Measure Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Revenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dollar amounts reported in columns (b), (d), and (f) are the amounts of total compensation reported for Mr. Johnson (our Principal Executive Officer since November 1, 2023), Dr. Seeto (Chief Executive Officer and Principal Executive Officer from November 1, 2020 to November 1, 2023) and Dr. Maag (Chief Executive Officer until November 1, 2020) for each corresponding year in the &#8220;Total&#8221; column of the Summary Compensation Table. Refer to the &#8220;Summary Compensation Table&#8221; on page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i60d05261c6404879b68233510f10856b_181" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">64</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> for additional information. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dollar amounts reported in column (h) are the average amounts of total compensation reported for the Non-PEO NEOs for each corresponding year in the &#8220;Total&#8221; column of the Summary Compensation Table. Refer to our &#8220;Summary Compensation Table&#8221; on page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i60d05261c6404879b68233510f10856b_181" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">64</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> for additional information. For each of fiscal years in the table, the Non-PEO NEOs were</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">:</span><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#aeaaaa;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#aeaaaa;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#aeaaaa;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#aeaaaa;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abhishek Jain</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abhishek Jain</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ankur Dhingra</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Bell</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abraham Ronai</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alex Johnson</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alex Johnson</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sasha King</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abraham Ronai</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sasha King</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marcel Konrad</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ankur Dhingra</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter Maag, Ph. D.</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sasha King</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marcel Konrad</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupIssuersFnTextBlock', window );">Peer Group Issuers, Footnote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">TSR is determined based on the value of an initial fixed investment of&#8201;$100. The TSR peer group consists of the Nasdaq Biotech Index companies. TSR is calculated by dividing (i) the difference between the stock price at the end of each measurement period shown and the beginning of the measurement period by (ii) the stock price at the beginning of the measurement period.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dollar amounts reported in columns (c), (e), (g), and (i) represent the amount of the CAP, as computed in accordance with SEC rules. The CAP does not necessarily represent cash and/or equity value transferred to the applicable NEO without restriction, but rather is a value calculated under applicable SEC rules. These amounts reflect the total amount of compensation for our NEOs reported in the Summary Compensation Table with certain adjustments as described in the table below for the most recent fiscal year. We do not have a defined benefit plan so no adjustment for pension benefits is included. The valuation assumptions and processes used to recalculate fair values did not materially differ from those disclosed at the time of grant.</span><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fiscal<br/>Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Executives</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">SCT<br/>(a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Grant Date<br/>Value of New<br/>Awards<br/>(b)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year End<br/>Value of<br/>New Awards<br/>(i)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in<br/>Value of<br/>Outstanding<br/>Awards<br/>Granted in<br/>Prior Fiscal <br/>Year<br/>(ii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in<br/>Value of<br/>Vested<br/>Awards<br/>Granted in<br/>Prior<br/>Fiscal<br/>Years<br/>(iii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value<br/>of Vested<br/>Awards<br/>Granted<br/>and<br/>Vested in<br/>Current<br/>Fiscal<br/>Year<br/>(iv)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>Value at<br/>Start of<br/>Fiscal<br/>Year of<br/>Awards<br/>that<br/>Failed to<br/>Meet<br/>Vesting<br/>Conditions<br/>(v)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Value of<br/>Dividends<br/>Paid on<br/>Equity<br/>Awards<br/>not<br/>Reflected<br/>in Fair<br/>Value (vi)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Equity<br/>CAP<br/>(c)=(i)+(ii)+<br/>(iii)+(iv)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">CAP<br/>(d)=(a)-<br/>(b)+(c)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PEO&#160;1</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$3,097,438&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$2,406,587&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,347,837&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($55,129)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($59,986)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,232,722&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,923,573&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PEO 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$10,551,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$8,536,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$4,779,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($136,652)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$7,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$4,650,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$6,665,898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-PEO<br/>NEO Avg</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$4,617,844&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$3,641,387&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$3,507,837&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($12,157)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($59,302)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$3,436,379&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$4,412,835&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,617,844<span></span>
</td>
<td class="nump">$ 3,784,612<span></span>
</td>
<td class="nump">$ 2,605,699<span></span>
</td>
<td class="nump">$ 1,979,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,412,835<span></span>
</td>
<td class="nump">118,224<span></span>
</td>
<td class="nump">140,603<span></span>
</td>
<td class="nump">7,956,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dollar amounts reported in columns (c), (e), (g), and (i) represent the amount of the CAP, as computed in accordance with SEC rules. The CAP does not necessarily represent cash and/or equity value transferred to the applicable NEO without restriction, but rather is a value calculated under applicable SEC rules. These amounts reflect the total amount of compensation for our NEOs reported in the Summary Compensation Table with certain adjustments as described in the table below for the most recent fiscal year. We do not have a defined benefit plan so no adjustment for pension benefits is included. The valuation assumptions and processes used to recalculate fair values did not materially differ from those disclosed at the time of grant.</span><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fiscal<br/>Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Executives</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">SCT<br/>(a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Grant Date<br/>Value of New<br/>Awards<br/>(b)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year End<br/>Value of<br/>New Awards<br/>(i)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in<br/>Value of<br/>Outstanding<br/>Awards<br/>Granted in<br/>Prior Fiscal <br/>Year<br/>(ii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in<br/>Value of<br/>Vested<br/>Awards<br/>Granted in<br/>Prior<br/>Fiscal<br/>Years<br/>(iii)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value<br/>of Vested<br/>Awards<br/>Granted<br/>and<br/>Vested in<br/>Current<br/>Fiscal<br/>Year<br/>(iv)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>Value at<br/>Start of<br/>Fiscal<br/>Year of<br/>Awards<br/>that<br/>Failed to<br/>Meet<br/>Vesting<br/>Conditions<br/>(v)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Value of<br/>Dividends<br/>Paid on<br/>Equity<br/>Awards<br/>not<br/>Reflected<br/>in Fair<br/>Value (vi)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Equity<br/>CAP<br/>(c)=(i)+(ii)+<br/>(iii)+(iv)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">CAP<br/>(d)=(a)-<br/>(b)+(c)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PEO&#160;1</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$3,097,438&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$2,406,587&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,347,837&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($55,129)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($59,986)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,232,722&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1,923,573&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PEO 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$10,551,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$8,536,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$4,779,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($136,652)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$7,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$4,650,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$6,665,898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-PEO<br/>NEO Avg</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$4,617,844&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$3,641,387&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$3,507,837&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($12,157)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($59,302)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$3,436,379&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$4,412,835&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_EquityValuationAssumptionDifferenceFnTextBlock', window );">Equity Valuation Assumption Difference, Footnote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.63pt">The recalculated value of equity awards for each applicable year includes the addition (or subtraction, as applicable) of the following:</span><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.46pt">the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the applicable year;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.02pt">for awards that vest in the applicable year, the change in the fair value as of the vesting date from the beginning of the applicable year; </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.46pt">for awards that failed to meet vesting conditions in the applicable year, the fair value from the end of prior fiscal year. </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">for awards that failed to meet vesting conditions in the applicable year, the fair value from the end of prior fiscal year;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.46pt">value of dividend not otherwise captured in the calculation of each Fair Value used to calculate CAP</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><img alt="5272" src="cdna-20240429_g18.jpg" style="height:432px;margin-bottom:5pt;vertical-align:text-bottom;width:662px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><img alt="5282" src="cdna-20240429_g19.jpg" style="height:432px;margin-bottom:5pt;vertical-align:text-bottom;width:662px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock', window );">Compensation Actually Paid vs. Company Selected Measure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><img alt="5292" src="cdna-20240429_g20.jpg" style="height:432px;margin-bottom:5pt;vertical-align:text-bottom;width:662px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock', window );">Total Shareholder Return Vs Peer Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><img alt="5272" src="cdna-20240429_g18.jpg" style="height:432px;margin-bottom:5pt;vertical-align:text-bottom;width:662px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TabularListTableTextBlock', window );">Tabular List, Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.507%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 Most Important Performance Measures</span></div><div style="padding-left:3.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Compensation and Human Capital Committee uses a mix of performance measures throughout our annual and long-term incentive programs to align executive pay with Company performance. As required by SEC rules, the performance measures identified as the most important for all of our NEOs&#8217; 2023 compensation decisions are&#160;listed in the table to the right. The measures in this table are not ranked.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#aeaaaa;border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Most Important Performance Measures</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#aeaaaa;border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pipeline</span></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55.63<span></span>
</td>
<td class="nump">52.90<span></span>
</td>
<td class="nump">210.85<span></span>
</td>
<td class="nump">335.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118.87<span></span>
</td>
<td class="nump">113.65<span></span>
</td>
<td class="nump">126.45<span></span>
</td>
<td class="nump">126.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (190,284,000)<span></span>
</td>
<td class="num">$ (76,613,000)<span></span>
</td>
<td class="num">$ (30,662,000)<span></span>
</td>
<td class="num">$ (18,714,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureAmt', window );">Company Selected Measure Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280,324,000<span></span>
</td>
<td class="nump">321,793,000<span></span>
</td>
<td class="nump">296,397,000<span></span>
</td>
<td class="nump">192,194,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Mr. Johnson<span></span>
</td>
<td class="text">Dr. Seeto<span></span>
</td>
<td class="text">Dr. Seeto<span></span>
</td>
<td class="text">Dr. Maag<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dr. Seeto<span></span>
</td>
<td class="text">Dr. Seeto<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Additional402vDisclosureTextBlock', window );">Additional 402(v) Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.63pt">The dollar amounts reported in the Summary Compensation Table for the applicable year.</span><div style="padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.18pt">The grant date fair value of equity awards represents the total of the amounts reported in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns of the Summary Compensation Table for the applicable year.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.18pt">The CAP does not necessarily represent cash and/or equity value transferred to the applicable NEO without restriction, but rather is a value calculated under applicable SEC rules.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">We determined Revenue to be the most important financial performance measure used to link Company performance to the CAP to our PEOs and Non-PEO NEOs in 2023, consistent with the Total Sales targets used for our short-term incentives (annual bonuses) and long-term incentives (PRSUs). See page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i60d05261c6404879b68233510f10856b_163" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">53</a></span> of our CD&amp;A for additional information.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=1', window );">Measure:: 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Revenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=2', window );">Measure:: 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Adjusted EBITDA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=3', window );">Measure:: 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Pipeline<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=cdna_Mr.JohnsonMember', window );">Mr. Johnson [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 3,097,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,097,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 1,923,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,923,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=cdna_DrSeetoMember', window );">Dr. Seeto [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,551,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,551,753<span></span>
</td>
<td class="nump">$ 12,786,270<span></span>
</td>
<td class="nump">$ 7,090,121<span></span>
</td>
<td class="nump">$ 5,618,698<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,665,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,665,898<span></span>
</td>
<td class="num">$ (648,097)<span></span>
</td>
<td class="num">$ (50,411)<span></span>
</td>
<td class="nump">17,196,016<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=cdna_DrMaagMember', window );">Dr. Maag [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,400,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,731,502<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr. Johnson [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,406,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr. Johnson [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,347,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr. Johnson [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,129)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr. Johnson [Member] | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr. Johnson [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59,986)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr. Johnson [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr. Johnson [Member] | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Mr. Johnson [Member] | Total Equity Compensation Actually Paid Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,232,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Dr. Seeto [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,536,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Dr. Seeto [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,779,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Dr. Seeto [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(136,652)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Dr. Seeto [Member] | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Dr. Seeto [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Dr. Seeto [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Dr. Seeto [Member] | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Dr. Seeto [Member] | Total Equity Compensation Actually Paid Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,650,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,641,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,507,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,157)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59,302)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Total Equity Compensation Actually Paid Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,436,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Additional402vDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Additional402vDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_EquityValuationAssumptionDifferenceFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_EquityValuationAssumptionDifferenceFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupIssuersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupIssuersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TabularListTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TabularListTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnVsPeerGroupTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=cdna_Mr.JohnsonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=cdna_Mr.JohnsonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=cdna_DrSeetoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=cdna_DrSeetoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=cdna_DrMaagMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=cdna_DrMaagMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=cdna_TotalEquityCompensationActuallyPaidAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=cdna_TotalEquityCompensationActuallyPaidAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>43</ContextCount>
  <ElementCount>28</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>14</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="cdna-20240429.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cdna-20240429.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="cdna-20240429.htm">cdna-20240429.htm</File>
    <File>cdna-20240429.xsd</File>
    <File>cdna-20240429_def.xml</File>
    <File>cdna-20240429_lab.xml</File>
    <File>cdna-20240429_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cdna-20240429_g1.jpg</File>
    <File>cdna-20240429_g10.jpg</File>
    <File>cdna-20240429_g11.jpg</File>
    <File>cdna-20240429_g12.jpg</File>
    <File>cdna-20240429_g13.jpg</File>
    <File>cdna-20240429_g14.jpg</File>
    <File>cdna-20240429_g15.jpg</File>
    <File>cdna-20240429_g16.jpg</File>
    <File>cdna-20240429_g17.jpg</File>
    <File>cdna-20240429_g18.jpg</File>
    <File>cdna-20240429_g19.jpg</File>
    <File>cdna-20240429_g2.jpg</File>
    <File>cdna-20240429_g20.jpg</File>
    <File>cdna-20240429_g21.jpg</File>
    <File>cdna-20240429_g22.jpg</File>
    <File>cdna-20240429_g3.jpg</File>
    <File>cdna-20240429_g4.jpg</File>
    <File>cdna-20240429_g5.jpg</File>
    <File>cdna-20240429_g6.jpg</File>
    <File>cdna-20240429_g7.jpg</File>
    <File>cdna-20240429_g8.jpg</File>
    <File>cdna-20240429_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="84">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>36
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cdna-20240429.htm": {
   "nsprefix": "cdna",
   "nsuri": "http://caredxinc.com/20240429",
   "dts": {
    "inline": {
     "local": [
      "cdna-20240429.htm"
     ]
    },
    "schema": {
     "local": [
      "cdna-20240429.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_pre.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "cdna-20240429_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "cdna-20240429_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cdna-20240429_pre.xml"
     ]
    }
   },
   "keyStandard": 28,
   "keyCustom": 0,
   "axisStandard": 4,
   "axisCustom": 0,
   "memberStandard": 10,
   "memberCustom": 4,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 43,
   "entityCount": 1,
   "segmentCount": 14,
   "elementCount": 270,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 84,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cdna-20240429.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cdna-20240429.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cdna-20240429.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cdna-20240429.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r96",
      "r112",
      "r147"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r89"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "cdna_DrMaagMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://caredxinc.com/20240429",
     "localname": "DrMaagMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dr. Maag [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cdna_DrSeetoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://caredxinc.com/20240429",
     "localname": "DrSeetoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dr. Seeto [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r100"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "cdna_Mr.JohnsonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://caredxinc.com/20240429",
     "localname": "Mr.JohnsonMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mr. Johnson [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r183"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r95",
      "r111",
      "r146"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r91",
      "r107",
      "r142"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r92",
      "r108",
      "r143"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r99",
      "r115",
      "r150"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r94",
      "r110",
      "r145"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "cdna_TotalEquityCompensationActuallyPaidAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://caredxinc.com/20240429",
     "localname": "TotalEquityCompensationActuallyPaidAdjustmentMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Equity Compensation Actually Paid Adjustment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>37
<FILENAME>0001217234-24-000042-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001217234-24-000042-xbrl.zip
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M=%^+SM#8R6PL>7WH%*T+)VZ\__/\R[4U$F->=;PPXIZ5@%Q8=O(4O4&?'+Y
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M7%AN[ALQ8 AD 8'L-[9.,A,L<+2C/> XV!&]==X-OU%#IPV[EP2;S4/#[H9
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M25#TGH'4QT%/[)]\//G ^GYLP8^^?+E$%Q4*4@3Q1!"<02+?.*#KHP]K$@_
M@";U&PD"2 74FC%5U^%30]ES?BIX .*;]/,S4%3& Q&PG894;0Q-O"A- "&
MJ@!&&BD%</'?.L#(<)GRT &S&VG%RO8N V)!S'I\#.@7R21O*4N"T&!S$[!)
M*%H<P2^!_4>;E]D&+V\"?L!;S!#V,Q.V!U8#^O7 O@CAB9!LA D0" @G<@E%
M6N,O\%&A'0T+S'H-<T[%Q&NX20IVL7GP&6PRVQ?R+BX(TL'_^N.Q]->!(4'6
M@RB!X=![Y#AAWLMI3(IG9L*/O2LV:U8(;HVD>2&4B9&:%IY/T[]!-1A,%]$J
M6@12?5A@^Z/.25:+-$AF3!<X'5QCJ&%R^?HJJ9<X>-PH'R]$'F18Z'Y9BC2,
MA?'FR4)JHX >11(Y0V+"'7(3/F1-(&W8<@;"8G%AM+,-07%B=*#>7@*EZ@_T
M6)(.2+[J1-]T@*YH7&:B>*K@*K\!$<.?HE9M3H"@.WSXA('Z*O%!2U?[DOIV
M)1NQO0$6EGP;"&1U]/_S.!KY 9JB*D +"X<8/)"LGT:O=2S8\L%D#2CJ!D^&
M8HD]J^C_0O2L/3?XY1(^BW'>6)R@_(*YQIO,)8]1I8QO)7'5]%NXFV0. @[R
M8'=.-%*^\0&F:OPGMF]45&N!Q4/&71I!H_A9(),^IC.<*4-K^'[:86%LMZ*3
M19"-<5DK#@(5O;O#SWPI#I(U9?@)8V@IUT\"@5FE2IG'/<B^:<":H6,+Z;19
M.K:\<=)_Y&/4,AM$7QPK+Z?,_ZS#-?)N1IO:]V0D1Q^35*O9NT[F'C0.I?HL
MG<!HD@/1VJ!T$1$4^%PVWZMX)0]QQJ.-2"VI$'MF*? IZ1N,== 2SP3F9ND9
M,Z-H 408F>T4#R^D!TJ.XZ%6U3.0@A==9X-_6J2 D!BC14>OLN)QC-T4Z7VA
M%( @/B8@WO2-G_4A)!9].=.N6D5PJBA=\@[^(ST7>\U*O7Y8J1\<J$0$?"H'
M=3\SL1DQ/BN-2B%'.:5_(#1L9SB$T^,5.!#1G1 >4R7_&@! 83Q'L@ 1)5HH
M)06_'M!42\M!J^+.$\'&"E]:\=B)X'76$E1SG3^V))UC=BTA<Y7Z/$"9^ L9
M] *TD)>44YC5.:P\>%7,\4 F[88X(>O+D5SODK8TU7:_E!688QVC*D("JA\
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MI8ZJPAQ26C?KS;U'CE99N%]J)9C-Y]0NI+2'1I3XN]"!Y<Y%/&1UF6S61VE
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MU TNT.L>.6[>'SUGPB<!J[G%5#LW-*/T9(:YW^AXORUX-$)S)030I&WK097
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M5&QF?1"AI+P^T%W(.DAUR*^%=+>0[,8\N $X*#I"W\LF3 _('5->QB+UW&;
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ML"?CE*9@=E4PUU.O,PU76_=4$]4X.CR0#5;WMO-#EM=[!%KP&.6+8RT!UM/
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M[EI&]9197M[6!WNG]FK.P8 TR81WFN;_;E/ [COM[E&; K:9*6"K[,%X[*2
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MOPSW/J XVVMO2#_ IW[Y'[WR+[B;U:U0>V.Z;U^YYD%6\$%OC'$#R I2U.1
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MHG]@O:?;W:76NY&G_[E>G\501MH[*H$Q418I2II>2Y#$"$=D7)8J3>MO5.R
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MP@B;LT8G@]E!PU2*S.3J9R-<RU#&@%@1\#!>7!]7MP1*XZ=-/&41'FH3[.!
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M-_A ,Z:)CC/61 KTD5$ &'^-+@0)N@X+6*0'9;>@[85"DZIZ)("9(>]Q(T]
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M-XT:ZZ0&>LJ,'WN1?M6D5JT-:SQ88]9(N/0$FUB8PM6J21P[^7"$V%SZ1J+
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MK0JM0Q!:1X>NT/)V]V#@X]U9J;5WY!\?OZZ36OC5WNO=9X*[!^N&NRZ2<&]
M;IM@6I-CWT%$+>R>6-\>4W)'<,;.=(P/Y[';P^5Q>V<#VRZM&3D^54O_R_Z1
M?[A_0+U59E=H&N^D<@R?AM3C<><U*D1&=J4D@E  DR0O!+E:SM[7O2UP3Z6%
MAMB80>;X3AT@'\M1T"H +\PX.UP[EN(*A[D\1:;KPU-*BW:82M=_?;"[.%/9
MW_5?[W2?DJ>4%MHRE8UA*C6=2C:*S[Q>-SYC],HZ%H,MM==+:[EY&G9@@=!R
M@@WF!$]W$TDCOL%>[F&P )6?R8%,4P#8>:1;NUVE":#)>!FVMC8-F"[BRF'N
M[G2/?J#O_9?KW[DUNTR1:1!98'-*[-S(8),&;!,&F^DP"7P(  %,"1N?4A>V
M<C]#?JJYSY./OJ$@I_9LR6 0!E(W:H)?D,"])$-MRKRHJ-$>+<8O]; W_6]A
M2EHS\Q;J=VC:M"/K;-SH+ .B5GF%9TMY>+D6.3U;D4L&04ZNBJU07QT]0D-,
M'T8SPY6]:[9A7U^*;.2CKPT>+:9&GA0.0ABX<*)0Z^=20^C:$94$Y=4R,--+
MBWA!KJB=H>,0)-BR'"&''L.9V*KKOLE[V!X3.PM&4]T55Q]6J2FN,F)NQIM(
M1RQO)3"?O^6Q9II[.\@64[KHU((.V*_$"T]F=N%X+/LA,$Z8M;QO_MILI3P7
M,M@<<:\>%&T#0,M\]O;;!H!+@NQ3O4<4NX(3\L]C6TTL"UAACIVCQ3>I%8X9
M9JT,20%U6$VC1"L3U"O[ACZ,PE2H4+-*FK<%7 =51F2/, 3H9JEN%JP<!D0M
M_EZ!^C3?AQQC[VFMB\YS&V,O5=Z>;9[,'!OE!_:<)7VGW+'90I?Y^1SXFAZX
ML:.I%LV78;5[!X=:NS0;\8H]&-\NIS<_UJR[_G%WW]\_W&^:&& +FB0<!;"Y
M?B*5:;^]I"!'L9C<T0%(H)00.QRB'R,,0B"43)4W,9!];/6+S!+[KF;B.]H2
M**+OJ-&[F%*+1.H-31@%8Q+_UEOVO5Z>+:FG1"KQ>C ." +3^[6B@C=@#K5#
M-]H%4YNX%2S#QR!U;J4U&"QX!B!9<QC:9P3GUMXLY6(X :5$"NS!PV:QLP84
M=[6-$A#\*;X:)DQVP$J0$LCD %J+IGX9H34RP!RH*X0QH #LBAB77@;H^%H>
M-5.*EN6T[5B,9;]&M3+/E"PYJ_&'*%6H6;R>J-08=\[NN'VQ:<G+O93[6J)/
M)QB<:/O&\XMS.F^^/'EZT"Q/<;EA_Z^_A(<[_9V#W<-N<+B_LW_T^KAW>+2[
MMW?0W1ET=XX.#GO_=[S_RQH(X75I]73UY?/5Y^N3C]ZGSQUOMQ'7UF6Y7TYN
M+MY?G,)_/W_R/K_W3JZN/E]\NKD\_W0#?S[01%WICBX^G9U?G<-_8 =?SC]<
M7-^<?SD_\ZY^?_?QXM0[.3W]_/NGFXM/'[SW%U\N-](&1[_02=Y'VQ$8+L>Q
M2D=NC00U&D]",BC/9)3@Y]Y_B?'DK7>3 %N7WL>/5T\;E;G07N:%99IUKVYU
M3H@K:D(Y6G!].9'D. 8M8!@JE%J@\^2]* S(LZ?C8,%.'Y,DI6-B<7V?GPVE
M'#XY"!6*+>,^P^&J*AA&VMAS)34%C47MB%QZG0T3-_KMW,GO2KCVH.FQW]\$
M=!OC0L1)YD76K#-IGG#XD7:17DJ)V_3+V@RZ97L2MR_4-^UC%[AF]E@S,(VV
M7ISR(YYL$TI=%\OD)9GX;:VK-JTM5* 8XGK^S,.4E2]JA#Z-Q)U"7Q&[TN!U
M6"2IZ1$8'9%Y@= ?IO\MN4.7B]_411T]?GD/F9PQ&YL6I*\19I3(TJ80<\&(
MS3)V&@V3!#-&T@GR(K!"$U@*<598V07;%+ Z"D*D(+-0E:8W,* 9"I>2&.!!
MD ;IW29LY.*L?R1IF$VME<LN+1/F>!NF64Z^*U@S#(1!:U-/U.$6FQIPY%G$
MJ(23:!/"75X10(>,"%1DYYSFR!+8^SELV@MG$0 V;#;KWS<,N?'0<0 L$.T&
M%:02S\ GIZH>%5YE/%D.QT5&)@T9 _T\Q<\717G<UCTKK]A_#%=/NUBMV:&]
M@3VP-,JFS"F<Z]EW&IJV[R DVF7%=970QE*)J.3WB37GR;AA]*A%!"1?7%QE
M1#KWD<#[.R#C"9IS:)5/<4ARX(A"!"$X,(@6"&>$;\)_V0@'\9+P'F;61&8M
MD31=%2HPO^DK\O$#5T=2^C-'"PR=0H,T&9>!,,OE%S0Z7O^RXFN@N4HH==BF
MGMKZGN["P>DO!4Y?,4X[&33O :<W4O3=E&(I*6\./4]*7S^:ZV%@/['V Y'U
MK[W<&.4=6ZYDB,!?7N;Y=4)/5?09Z\HBK(9?Y@1#UN*4WI[Q %#C.0!T)"9*
MOC&_O 5&-XG$]$T8$[CHI;?E\6I*T]&)\M>%0=S98:-8)\_KF?GKG4[W/W6F
M9^7S_9W#AF_JW^AV=FH_?PTO='>7&NKI%]7=[>P<+3OYABWJ:.X;J^X'L>KW
M-Z,C-/*9=:E(OQ'0>EC[X$>K0_](8-^8/L:+FK:D)*-B\Y-:V=>'K3VLQFOW
MB?K8/R(2U'9(6[OJ-']II,UY#>&6AX93>N+^-FHKA<B>OWNXZ^^\?ERNU>)6
MBUL@#/VCXWW_:.]E]]1<F<B[$=\W5>#M/G6;CV?8_Y-"%';?OIP&H)M6S>WP
MP-][Y(+/JS:A-X87GD21]YG<\QO*$?>>R 181DEY&$=<L7K[^GAG2998C^/+
M*5P;U2ERI2?4!27Q<5L>;IJ"N JHWR29>/3NZC^L4:T=F!YFT\W74];<:$.'
M /9^?IA#H,6.YXT=N_[QX:[?W6F+E6Y,L5+K^#:IL$6I@B3/MI/!]B0)OLF,
M8B-BA2'\=R-)NG*24E305&)<R&T2!A@L@Q?4DS092*5 C<4@0','+I1*@I!"
M!&UHO$Y<TY&$ WVU/1L_Z.OR"+>AO+-A]!2,$HX;7L#?\RQ)ISPZ9MLIS)\,
M))<^BCF1FI(BDS'>XWN1Q'BIVIM\?1^?# 82HW#X/;ZOUTEM1:3)((SH$3?E
M%P-B:),#%]2\;PLA&^!?LP""EA,-@%D#P9]YR.8"K9G"%Y]'D9*UJR!IO&5E
M*AE0]KZ)JLO@&=&_#14@W?.MZ[!^E11+QGM!6_&4#ZD71A0^B"%N&)Z*/(L(
MS^<?VV1JPQ.8V@]'B"\AN6))"!IV4'ON@C)Q@S3DJG\FMQ?#P[Q,!J.8\G,<
MDL7(-9%BAFR21 ^.#0-!N];!8<3E #Q%3%@@-S+DZR(V">28C9A1Z<<[2?BC
M\:)>S+E96D7,+N77440EQ2O::.+[(C0!G4Q,*ZXAY&HA('$ JS'2D60#5A/*
M=$4AG7YM8>^&7?X TNVM/](U0/"*"JIX5)I";I]0>09!U5Z*MZYD.@;M@+(T
M,:F8O[DV1PK//O\0QT42;Z1"+1QC9_O Y;A4C0XF-Z')N2IJT#CP6SK4$3CP
M[['&>CW3O9'8%+9M* M+8<*!ZWH<5*9"V%<GSH%CVF=5$>,\WR**?.G<&%"5
M\U06-5N)*RA3_ !CF>UDE&6,0BD$P@8"YS#L\I"VH(1+VER1UAZ#C#&'.)JZ
MVW9SQ^V$H4DBYFH9 0B_89*&?%!E2%1%9/$Y2LI"M4=K@7BB_2B?4+4/.SN7
M,%)FS7:)3(KV-0R9[U&",V5NTS%2,GOJC9/4HM8<)+"@&E,TK,Z-Y@T'? 24
MX=]SZBOI..9!#D@R#[_@,#'2/0::]50 5)"C9C&V0>HZE:(N*K=2'0C&M^)E
MUR]#T@";]0[$.0W"'B)R;JDB$+IVDDYU*VPY6Q1%?X/::YL9;#.##RN7)6VE
MC?M 5D(JQ%&#<B7=VSS V@[J2EKW=E4A^MQ62=*91'.9^FQ9,:RA5<JO>KAB
M<[C6BLT_,*OJBQ9I;W7>V!>)Y1&PW C2W48J&U3=;HDD/'W8:OFTL]J*?(^4
MBL9601*CM=@#E2 VI>Q,6A+EU5'Y+EXCO73RX>3BT_6-40N ?XH(1GB7)M\D
M%Z' Q]QAP.(PH\2<G&??6_/3K\?JS[]_\=Y]/OERADGY9Q=?SD]O/G^Y]N#G
MY\O+\T]GU]Z)]X_/-^>&R[S__,6PEIO?SKUJ6C]^5D[M]\[./WZ^N,$1."_\
M\^^G\!#FA9]<>SC]4HGT'BR WGI_<7UZ\M'[U_G)%P]>QN_/SD_/+]^=?RE2
M31_.BXX7XT5K4XW@Y/>SBQOOY-,9 .;3R:?3<P\/$.$.AW1^]?G+S;JB)XVX
M>)G#&S*JJ?0/<2NL)R-,J;ERG?UYDDQ7E03.A'5ODHPU73FV"8<8UAF$Q&^P
MC4.*/FWT2M&7U3J2,LB!WX5::3S_KO,V:3KR2F =J%3/ILON%5N@Q$[KNR1!
MG&+A'/(9  M.V(&68]D>[=%V5$]G\A-B;CJ__7@/*S?!BL:D_?I>,O.\76CE
MQ?WRB[K^E-;, 35L=C*GG?J@; <=;PN__3FE'I;"F7G%'[!&$P!WG9;K5(/0
M)EM <M%!$3!%LBJ6,%HQ=JR[*&JF[/N\'GSM1"4]^Y3?G2LEN9*W/DIK<Y*U
MC#;UO04QM.,N!BN#M!TJ=]96,_GA:B9^[;DLZWI:!"T*3*"S='R]4E=>*'NC
M>M)YI6<+8IBJ$:X]8W18[5[4NW'=C)]O87C<OK8)3&GY^Z7"SV29#\0G,._6
M 96>,T>CLN=][6[2[ WQXB[%IV+"U"A!'V;1MH"OQ[G.0=4R>WR,QM*-J2YM
MP7-9:D9C+H^UZ>C<L\_;-G#D0+NI71\JUYF<1\YA5O&Z;B16O!.X,UT^DD_<
M%6<$Q]043D3E#WV-_KU038TKHG"BUM2VL5[PAXM+5E=MJ?:ZP18MW;YH)2AZ
M06N^I5".C42 +US7$UW<4U-IJ*!:[2M?P+UN'ID]YC<S<%G-3C_() 6)][74
MM@S,A8N+-5G@Z2@-L6JG]"Z=WBQKLKC+$#0&&7EG1<W?-5G9US"*0C'V3HJF
M<>V=AKW3>/T8U4Z[W=VVW&D!U%*YT[T'LOW5>NC._G%Q_?G+O]B=^OF3=_[/
M\]/?;R[^0:ZZJ_-/U^1%W4B)=N7TP]"^].]3+\TCO'VVGJJ2NPDEFE EG?6:
M@RQ9]!\?V%9<9TF_O_T^%?$W[RLZT*ZS5$J,_:#V/SC0*2@M^1BFN4J33(=J
MGF #C3M)<6;ZEH&"<FI*]G&5<O+W]T*JX>;;Z$%]NY"8>S+=S,8I+FU*5C<4
MI.9N&!B=UC,*$]\: (2L5D5VKG.9@.$3?$\23<O*(!83U!;CM9ANPY*OQ-2X
MY)T[C(O9JSK6-U4>%39 >9=<B#YS.W;L[IC 8'VU3B$"+O"T(CO DP2EG"Y]
MM*]2\0(G@L=7]CQ R>SG 0U7?49WPT"5$.]RD,G5EKHDD-/E?WD 6X&P;C,'
M]VQF,_7)FV4Q,B2,A(5KG,JR5""UC!-XCAH=D"U*W6DR[*:0:?L4 \_3$$TO
MM^X\MP2@<T5_!VKTALKR "O*ZQY3Q4I*J]4>?(6%^ZV!2AVP:$K@#]ETNT=&
MD_N>'K3&QN& ^24*\.O:BVP<)<TKY4+T0)$X6+GY"YS*-P 9]]C!FH=28$-J
MM+V+J&2W9P'QOU26#X+JX=?6J6\\2TW9B;)=)LI%8&/=7(TZ6\P=R1AE(A@A
M-,S%+Q.:2+=A1<QMN4 ^_UU8B 03C,"7PS#PAHF(B@BC!+& )NA+?(WC(\O-
MUD3P#90;Y=XOZ]-XC"/&6+@_\O[0.G@+5.;^#[PL9N_8PGF,;=A@]"2VN0DZ
M;DJW:R[FQ7U1![8&T&XN5RDD#//6(;69F"8YRR$'TS3<2G4_ <0IGOL43XK3
M10I/TM)BM$=KT"+<"&.=]V+^I#N0TJC+"%_:(I;;-4(1#YT;8_ %H58.N/E'
M V;JHI"+(N8"Y8B7QG5NL<(' I16P':&,]#F,BS/RM>,[ +D5_.,&J!H18%%
MZTC&-@::7/0LYQO8I4A35/=,V>4;,XR)G #D0(L.']55C9'M&0>6Z/<)>] W
M:2["C(BHDB '%@+OP? GCME31A?%D%@114LAF[\0WM2%0\V@=>&]U?JP!NC&
M>J^^8K,EP),4N/4L5I&L$>RDUFKJN06OB\%&955:76^ L:]]C;4L@_(0W5Z^
M'*P9(^+1A 7P33<_<ZA*=WU*00W%LZGP]Z6Y$RS?<686Z0H/#T'I'K3A<"L2
M>X4 <.*B"3NOC'WV*>EX>VTL7%,L'.9L@5*:#T?\Q8QH!7J)A:4\-^X>-5GD
M^8+YPJ-)6C(^T56)[:D<%D8A.1465A)3?(&\[LSZ2<+[3JZNOGS^Q\E''_U5
M)_!_X\-Z=W)]<>V;B#_7?X6?X:R?3B[/SQP?U^?W[R].SV'NDVM8R/7IQ\_7
M\/W%)QC@XMJ#:?[Y+^_ZYN3F'.,&V]Y9A3?YZ'&\R4>M-[G!F[R_D=YD39E(
M;M1BXOQ_?[^X^1<0U"G0#Q+<U<>3S70F7P#'3\FD3%#Y0_%U"Z^S8\9V29[)
M<S+9GJB]-UE2?;#L=70% 8V;$:N\]X?NL^A:M%;X-_3!N!B4!_*X4XM-IJCJ
MQCY&[6GO))E6+#Q)C=1I8+H[J=/]W,CY]8\4.K>[.1/K$7_6 2T-3-24L(2Z
MO=JDMK'HN^E;MC-UI[#&\7-T"IFZ%&#ZLQZ5#,KOS/:UY#1,TF+ C$8O(=DO
MN@,W:6<T]\.-@]WN6AL'UZSD?I&Z7=CO#J0UM6PH:PK9W^OKT,+OX3@?NQW!
MF[5[<F=J],/R)P"6?!8LA;\)HZ[AF;W.@3?&ZW8<J''T#GE7?G0]F@V!>9L&
M(3N4#0,V'9(3G>>XWE&PH*0^3>G(9?OYU9TPB(G90^TT)X6N,T&<*&JE;'CB
MHK:8#11+2PX#<VU4%[=6OH!UI'?9/Y1AN;Q9 F##U ;_IH8QH>O>UB*J.2Q_
MJ6UY3L\S?.^2:HS08/+[)-35B=P>Y(40(0=4GQ09BNH\B29X'?%%ZB;@Y=C'
M;.8*#:]U!?JR;Y99,/5T# !$'(PF8A%-_ZUK88#M"Z"GZ[Q>#N(,KW8P1I,;
M9U-XH';_TA6=;IX> ].BXQK):.+U4U)O8#2\-.(KH^*2:&(V3LI/&+%/#7/O
M@ZR D#X*BS-TI.8(U]TL;Y C-:JC<X_1)U^%>_-@.I]QS_H2*_81%!F<$Q4%
M('0O?T0/XZ7,NG-M;!*^#ES;+UW4NMCM-)G$[TFPZN^MH-0W*T[7/G@T8-9C
MZ\?0]78J@0 "G7,29=@&D@>@>AEDS) #,?TFLVVB]RPD"F$F5W=]:ENX3TL7
M^_HN'Q=F[_A)TIL6ZWS+/W-_;^(X^!H?I11P%R7O67Z &_?1G8X1%@2M;(1E
MV' A_3S0,31TPV_;^A$GCK&'NKE:&:;)7<9! 'U0R:-D8B]OQZ&:<U>^D)'(
M7)9BZ2UGFML=OE-N;Q\N1,*$ E'X3493ECM%#HH8XI$H*;\5EB:M:>9.A7RT
M,>!X%=4T \WP*A9OR.9$Z4S2D+,7<?0%(F',?0GO &9,I<"#3Y2^#+?8+?"6
MA?",[L+-#IQ\JDR*HFJ*OCLIKE1ZN0)*5$J'##S<)-I?:Y/H8HQWX\B]3S43
MX)2)C91?7]V8&3?E%B5S:'<:E'9*)%Y"2L!_-Q[$%+-LTO5FH]KGP*I4GV[O
M<(%"?OC0BN!)DN=P95FS=1A; > N5KW_Y7_.F0.=L##$TSY7%%G),N.&Q<A)
M40V3>,47J2^AWJQJA_5@]U:I;9R[>H7OJ1#F$"E'+> =6#:=Z,Q?JG1:^!2-
M)I!PCV_?Z!N&(F?<43UZAJ0;Z(].6)-AP;4A$D" \/38]V2,A<8P[$4Y2H7W
M)T@/70P)([^^<7F9LNSM&_O-JB <74<Y%\/B8=>*XR>*.,.*(.&:85H[<I0N
MTXVU6 !%(,DTLVX1.<#2LL6C6JWQ/3"=0DSR!U@CW-*PEYM (])40/89B>4Z
MB"G.IMX/[&H"=;[@>I]R6>VW5[5"%QBT^G]9):7 P:A&\^D7'<VU?4G1M V5
M,5I6^G-9Z;LT$7T=UWH.H#1E)!$[2VSVJ9GF?!9)@;LS>B?S!L3T7K$-7P?2
M S)*VE D'8Q$C3Y)T![5[G#[#,4,419L!;-9146_1.%F0C37JJMKI>D\2@8G
MQ>=%:#/X,S&W!8%C@,1[OAW >G;(@BF,2S+E%>X/6,#_9^_-F]NVEKSAKX+*
M)%/2%,2(U&X],U6R["2Z$R]C.<D[?TV!!"@B!@%>+))Y/_W;V]D D"(E620M
MWJ?FB442R^G3I_?^-9T[%'7ZR-E'3=Z2(JH&^P]]&1*MB$([RB.J5AS"^^]1
MOR-*N S1-?2-S*6$BI='"";*-*ULH%NI.I8[4* $A]+'5MX,)%:".3,JYLA*
MT=!]>, PUA5.<>[2>RL45BX4+I!\A?=6^>4$12%BW+O2[BDCKUFJ2'^U6F'Q
MD?2RUN*.-L(*(AUO,*J)EN(8'AK'!SQR$U\QM?=,HH;GSU;3XL]L#1VX#O]]
M&=Z:PVQZ3U2X3EMA)#](Z#6B120UAEG!C2[X!%P@V3O]J+R+HG1Q8JI2X0?W
MM&Q/];<XU7]QUY,*NU/X1ZIB\:CP!E_KL/A'C-40<,BKE7HHF$D0#.&:7BZ*
M& ]-9561VPX'?X]?PUDF^%U.S]2[:_ARB[,1WRH;5(*/8 )S7-&N[7!MP-?K
MV>EQK=Z*W=$TTO%.3%;P=O [16HSK!R%W@R,B,&QWI:FZ=*TLTT!;UU$K*V(
MB.3>*HU),?%ADMUUO+]J;6D"Z&*5(]N*:5:[@FXFC5.L=4>M8J+[<+PR:L%D
M/UAK#\O?M!QM"@"'JKFDV46[U3/KHF?>V2PE$8;7F,']!#)M&X)K#6/?X3'#
M>G6!9>&H$ZLK.[T-NLD'+S/!ID>,=Y<J\T$1+HYRBBI2E8M. XFE[##_ UJ2
M\]YRE4ZTUV+GV\.U\L-U >=*<$ _9KG:4PR/2+3FHPF*?#1!ASV">WHFMZP]
M];1R(W+91FQQBJS0C<3)-K*LX>.ZU#58_>4953R3"0Y,;(78[VDGIZ]SQJ]"
M(\"8Z/4XF]/^_TM&8><>?:.G^"C)*J6Y8E.T--?ET3"):-<#[^#HIY^/]G_Z
MN7OTD]@BQ21!A"RN-E U,4ASGB>#_]J*SY6+SS>5E+_1T98"X0NG_.-J3B$>
MYQJ_3I@-@%5^#XIRE8?JE5?#\?MG!<()NT_KM8>UDL/6Q:6A\CPI4LP1X@#3
M<F"$6-5W=Q'EQ@:E<0J<<CCEBU/4F9UUBANCX_!5Y;APB OCJ^AB]\ 3:![P
M'48QN>MHUMS"\?1-A88I@O=Y]A6V9K.G/'5.--<LZ18]U=Y(!3B6G*!"(:X=
MTA[+W]P/_(@ZD).UK@/Y[VCJ_1)1ZR,+J%^I68#H\9%LR4&TL44AE#AQL,P#
MZSSHP4MZ[I$Y 7HDH(V',F$TIQ9$$YYJHJUW41#2WBG]%T32B2)IO5!8UZQL
MJTI6KAO>9]Y;V+$;D'S?O$1DO2UE<R!,2[0>HND%%3 B:-&!%OI)%M"P3#&
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M3V@M*,2GT$I"Z6'#!=$_["7A<$UY49SB">]I\#5"@J<)D.,R$J#!#<[ [D?
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MN"MHVL.W(7]819P=4?2M/P:V0=+-F*F!RW+$ U6K-]1JHU3;-A'M^[!/PWA
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M0^?I-4UXW-20E)U?#?I@U;%16.C4039LAJ=(VNDN()8\;:)&5</@&_$?TXG
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M4AO.C,VD-[!T"H5M,ZHZHWJZS:@N2;*#KH\"X\"1'UU5U#3A"D$:B&9"2-&
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ML/W@*FUO<^%B Q5,>I)#XFH6:U2=>PRHF %CEG&H  DU]/!2_N/+*P XVQ8
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M2CHR:-C#^_*+FG-!20YY,7W,[".TH&)1$6W=FJ  .:PGB>PD(8E-R_1F-O[
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M<Z7S! OZ[65Y/Q[QROI25:N(I<0T,U3!K04%/N1+FMV!F&3'!9]+[5@C;*C
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M\F 2AQ)90F@-8"DT0GSV.?4.>/TL)>"O.VS)IK&*.$VF'U&S&9QVS/O1PC&
MS>?G!-QC28DILJM30P27U[$.VTX1:8:6,8O\[=6?B,P23$D.<9O=G@P!N]),
MHGB?7XHF1TJG6Z@[*W?7?"IHN\CZ)*'E#.N2L:G-@@JZMLS,B_ V+A"U#J?0
M;:9PI@E%%DO41KWA_$VSX((M;\O2+CBV=BNV]34(B"S=0\Y1(]GD #<1?,Z.
M.D<_J;Y.'O$& GL8W&8:7&98)[YS2B4!G5*[8,OD(Y(OP)QX( 0 :1192Z41
M=/SZZD"WO7]&JN8FX,[0VV@J:[6I( 4X%,V*:?R=4F)%-<%HMLS,"\'IB&P
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M3_^"9CM@A"D-807Y5*'B"2YL06-1\JF*DUI1%(0=EPBD?L0X YO>7%N+NQ#
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MM_V!FV5CA+\SQHQJ/OFLXJ,8"/5I]JEJFFDHU[H(*+APU8K8DI'=CQ,\?E@
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MD$W=/AO(3V[&+VBKO=1-?*='7Z?8O8@M+][G/*!^IX^H5*9; LXE(,7C7+N
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M[=/%4 "Q"RF7P[4'9>SOX91 DB!60/SF#RR#%D<A0YB;Q(<?P[ ,H8TCY;N
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M4J"50Y@7M$-"(2U*=/;O<F!7'-F+E"CT!:8K AN"V'B$5@JRFO>L*!%D#F^
M#PM4YOU[F;0F@'D,/.UF2Z M (@Y1".AL/*<@3[0"IS3RH\1KW:+WJ!$)YDB
M;.B'DD1 "0%+C'BL*6_R(*!@$<P6H^N8(FV!K)[U8.#"EX6NZ[*<=:S8PGE4
MCBE*#=C];.9;2(&FHFAZM2?49?8.6!0NH=M4JS9"X"NZ7WX(;SB7H%W]V5K<
M(^;O(>PRO\/"^] F9AZ"Q*! ^+@J9*=RX_HI2"OBMZ-("]1; HVNV.9I6? S
M/.*%>\,!M1?,O<E0R7G7"NKD@G8_N:L\F_D$L6D%,4W"Z0\EI,Z#$&#P#BSH
MAWA#C3\PDD#\8'B#A]C&0=VHW,9ASPQ8W@UZ,BZ(%^@043Z]D((/^#U&/O3K
M"D*Q@KM!T?O050("==M0O]QV5EY=;E?C54(=#B8;\]?-P -.$X[.C+HC_O*"
M.3" 4,B1$ @]#-,GK@SV0[:&K3D"'>/KA/:CGXPI'")N4*/'5:G)@V RYP"$
M' *N>IMP\%B1!9@/B$78(M"5:1R(NE!!D"0E".E?T*"P2,W8MJ)M@K<2^[Z\
MUP%.-,;>$A07W 9@!!?>BC>B0/6)2VV)!"/RQA)QMAD)Q>/9JC@Y.PKB_%NE
MC\LMRWHXS;:+;D5G<S*)7%3!UQQ7-E9N/!>5Q?M)[3EWZR*U0/DI^B)E<_MS
MYE*XL&23X,P62.8$L4Y;PC),K9N#^*/WP">+&59FHIRA6^*ZG/7%X3H-&R1G
M?08[QZ4E;1^NW-GB_F%YNRBQYTANP]S:Y-Y06![:-X-H%$V#;@C9'=N(X#/Q
MOLT'UG0]B=)I@H;-BWEG&5!FW"2@QH.>\@81A-N>1A&&]F3 $L*+![6=1L L
MZB("[XRG[HJI&[]&4&T4WGQ7D'UY'86WJ'N1BSH?1G<2_3K78$?O"/KUT^-@
M&6MPE\I';C%^15/1S0CK$C:N/'\NC&#$KC&3J>;M\NXPPB=CN(&CSZ,BWL]%
M6,NPE/C/S]D\\NF\\4_\NL,@WUNAN9V!/C0. WX,7QC[@1S+H0XTE'DTI&BG
M;:!_XV8XC1@L;"U=Z>BB^KBF*PH]O_#0L[*XAE);+I6Q!L\&<-)LM5OPRYO4
M6#T, _)9&+XUZ;,%G_E/Y\<C0&NP<!],G9?'*?RP!R/[05/:?GU /]Q=8"GM
M4MJ[+>W[W):1TBZEO=O2;M9)^V-A/EH:VCT-N'5;%'[GHLVA.M*TDUFN/=;5
ML34ZF?6.;%4_(?;JJFD:JG-"*[:LDV*P-0+]'9K[I!GVNJK3?B=U:'S53K#]
M$5ZJB\M]C)?JXGH?X:6ZN-S'>:DNKO@17JJ3RSV$E^KR5JJ*>J@JG]Z]NSJ9
M&$4W+=6P3R<F,T"W#=6T[9-9L:G1'<636:^E#HVQ:AJGLV+==DZ*P[HZU"R(
M.;53WEG5@'OU/E21.ZM>KU?NK'J^8KFSDI@W1X0(P2I[4;9_3ZGM0+DDA V\
M2I-@M6ZRX/7_7IR!9URS@$7BRNXJ8C&6P^/] /?Z.F+76(!/X_.+QW/7BXH[
M$HF8Q_H-";RCA'=J?2\FG)V/7U0JOT_Y]8D-X)!?+J_>*9=7[Y7OX<J;\H+B
MH3[B]PEB)E!"8F46*D&8K,]SFF!9<O:;E>O1!$*L7 9Y^C='Q\!?PCQV7*+I
ME$BV#K4&1;(E$MD7@>PZLI+91AFM7LDZ@+!&;.ZS*>?\3K'D[Q22^5#Q0S@D
M/EY)"K,I9+@7;ARGRVR%.!YB#- <P\V9\%O17(X#AB@8;H175&%&')H@A[X1
M<LT71;=!;SV8SH0N7X7702;9>&F$))M?!RL_IBK>7"%,!7I^Z=[QQX5:$/2"
M&U0FJ!"I [S9A0J6KL1-<+Q?%N/=5'%ID",V!#-QKQSFG%]3FXNKLC@<O_Z9
MC\)^XHJSY\MW2,7E-OP)BZ9>S/CGQ0K$",3M=:KBI+/G9D"'*P;*'B;9/7*S
M-&$JR:*[MG,O !% 6(XX@0\XYD@9%@L)*^X9?2/@)Q+9,%J*8;6+_RFNP'LQ
M A7173X6X  ?@+D(6<%_G &'"$;B;1P/D8MR/)RKC^\K&F&,Z &+7\#-[NV7
MB%^6NJ4[(\BO[+9]AA.P4T$JJKF/66S--?OJ[8@NW?KZ+0 '&?EW)925QM<X
M,_O)(U*!6K>))2/, ?\50N?,,L05O&3.[U=GE[Q_L+O2#>!<J,4];8+M :$I
M<&0J@!>E:]NE-Z:(O7(;*DN6@![S,>>P[Z*K_["Z_ YM"H/&B!E4NLS&:<<(
M"P #D]=@F9$(5VX&XW(Y0P;B)81WOWW_<*F<S=B<4"9 LV"AT\B;9!@7YS"O
MWS9U(YL8 4[@=&?YNFD%^T)WT#7R^Z8Y85,7*>,E&U@KW,?0\O'%1+LP3A Y
M"4P/ZG%AL);,14@"3E6Z5RLNVR)K,[B&;#4H8A=D2C8O&0-IP*#Q8"WW<R6V
MJ31*QJ/R'F1?^A1W]F>5>>!]YAAOW,<*)X*XID@WBT'X_/@U2#Q#H".DD[@+
M;FM_+DOG&V6$-Z^C_)>5[W!:N''>\H,-1:F]\HZ#+%S0K]V7MCDP8\!O:!,N
MA,!40I<L1/X,7%KY41!6@G&BEXN)@>/$-9+'Q^<RXC"\2#W/)&3WW7'"TUJZ
M)/(%V8HAJ\3&H<X[Z0:(<1?*[YR\G?0'WSE  +L.D16XHQ(7?HE1%!LA_ "_
M]X^>G@QC=D78"T"Y?)]',").@J] ;J-8W"S.0R?X-PVM@BT"<I Y%(_,O0@%
M[=X'XY1,?A:GYHZCA'2"\6.*0Y?PA,C(9#J 0W92V"H7_3HN=5_ 3I5 FY**
M$(KXNB*'^\B),*L3U\]PL4I1>WG4)<QS@1 WV0Z@L$D$=E&&XSD9X:N'/KA:
M,?+_WW+0G$O:5'92^B FR_9((@S. @J,9"CI3OLPX'0!$L1ACG-@YKA 9A9W
M%CCJK<"MXY$?"9L(^V)6&BS+#>![8;=)* S7H>MG4 R-@QO<SQ5 41CI(+K@
M788IZ'(<%U2!'(JM(N48G"/$$<5T\+,"!CU;#4>0SMQZS B-DF\-$5!S"S9C
M-X6\ ."^+/B,2W\/)A<!NA#Y+O^FD[*_%T;7VDZ!T#G!R@4<QKA((322(?#[
M84+!/M]OA5/"Y(&0$5%DP)Z"<L0$?)IG'(22K2%PO@MQYX@O(E2R,(IYKH?C
M!N%\ B;V5*X2+\.0X_T(\5=Q"R30D7"T"7J" IF+E GG0^I?!\D>KS496-,4
MVE))3*$<4\CH"*90>U0TQTVCT(&$+68(HAP(Q+MI88U*4DF"ES];]FB9GGI1
M^5$1H^3XL[!0TD%ZNO 68KO>17O^!_/GM+-%$\=<'ZCPC@5L[G78=F.^O01*
MR'+HR^7*#^\(:XU6J*P@^LWW9+&[1+SB:,DA%OT\T. 0QPP6YR'84C9*1R$(
M_T! 6C#<=#:B).[/"]RL>G./H0N?,3#84]Y5 G,2EJ:?_3A7LOP=AN^1-TFY
MU /UD+3<594(EE.H##5>GP?%Q&(HCB_N\C,;3FL>I95!Q\OC;8*1<Y12!7'4
M.5)W<,U]J=!BE5(X>5L"Z@"2RP@$HQ^S:=-13+[4#*4ZO TH1TH"XV+CB0N@
M'J(H>QT5!=P!$A-7&,$D<8Y;_H- BZ<+I&B9Y3S0NV4\U[;P8@@LL.H&]H>%
M0>94C-8>%$=<,.BF)JW]]*S5/04^9NO[E%'H?7GV[6@Q4!0-^!YPEJ1=''7]
MN3AN*T6X9^F*= =8]--;ILMZ_N.C+^VB\QC(#<],<O9.8<D34!>0GX#'AGB6
MBRUM>+8;0;-YLEHA@BIS-L-I*KY["_KW)8!M88#G:^((#\_8]!'AI$X8]@G)
MA'--M$2R(9,F%.E"G:-MHLP3MW38G%D.I4 1A6TI2C.I!R$+<XC^N0#XL_^L
M9(OGH4-N\V"JU.(D1>KC._AQY3UB(P)\Y(G/1(^4/*-8F+#!/H#;[3$TE>X%
M!>HM(D!CP(&](U0%2S1<7U5NO#C;<X%;0N<-^W:,ZU0*OS(NN[#[P98"4V'#
M\/>T>8H7893P$X(J]#'LF;*M/T$03Z<>?R>\VDUX1Q[X#=])T;&:B!,X+#+X
M-V3J!64+BB @JX+)?XM.II0'<U<KB,0(IA'$G%M0-Q]:G**(@^<<!98&*928
MD.?C).]U12U:LO?1V9_H[<&_SL[J!":L@()W?3Q.:7>,N@6P7=BPKRP"GP\Q
M=T?QVJOHS^7=1^X]LP@H,]NK8LG983)&MVN0Z^!UL>8E"@-OBH(:WJ)><%F[
MOEN6/NHD___&9M?9R?177_SQ-0H7$"-6(?VZ) VX4_%X1PG<2Y(36H5 $1('
M6EM,#)\5*9R\%<W9?8$U! &%2R*;<\TCZ%)+"1[7>LLEFW%L:5IFEDI2>042
M1-&\M05()9E6B-9]EB>:8GAQQ'NUX%LV'J%=,B],HG32*IW $OV[BX0[V*SX
MC#"H::.%73QN*-=3'GR]=*OZ;K+"&%X40B$VZMQV!]AM@,L-F,(8E O;D57F
M5B[ @,@O[T^C1%[\ [>$<8@@^UE5$!Z*9]2OS&,'6UT_#DN\S72]:+NQL6'*
M65_?/"3CT2I3BG6.4&$>-B_ * N]@!^ZK2\GJD]47/)0,K,#WV'K]5XT9'&[
M:P2^EYR ")9YW0A'V[_@/7JJG3I$"6VAWCR8WE(GN=:Q*:[X'1P&EH_P_Z+_
M$H;#/,VUXIT;LG._[+A.U#!@\42U-I%T,(VKC@UWTIN#8CXFJ\*@%/1Z3P&J
MO_)$@(U:5>)^E%+]#NJ26),HIL@B>0R(W'A1I1JF=(H)B'H-"N7HX!.,TK7H
MH!$C(Z*4[97/:X]$5=(WNF.<+<^S'=]OF.,.Z(3RA@4IX_F>;$^CCT<.N0=W
M20G.\BX20V>")Q?VNQ1Q4@X)+.8LG8J3LV)?!\8L1 K##\I52A7&(+/SNM.7
M.I_+$ELHE61=)&;I'&W#"G*)XU\655AAJ0$:;\L@6I5AV=8"" 8^*)](76L8
M<E>D).Y/"M]Y)S8\LX1-*-]/EM8!/H,V+GN7IA5=I>BD,Z3S3_@)[W)'9*GE
M:;"YBR=R;6E>AWFVM:T)/Y;*&$<A9P>:.E*SQ#+#6I%S$045,"E>]LL=<PWC
M\E*(=<I3+5]1+%9G^O%(KG(?!/;/665D24CC4O40SRO4E3MCB\4XG2Y$[J;.
MQ?#BQ75R[U99JF K)HF5])-<S'"&:>#CH[#B+/$L:EJ+\Y0(=\'S\M89)I,7
M]$?PP^N\(AQW_WCF0Y/)FIB+?19?9C?M^/>PR-//??8SRX>+5IZ<5Z(^@0X\
M*)\/KPTHABZ"60@XEV!4E!LWNN-6*RL4QFJ*?<W5 @B-/,W:>;I9<,MO%0#O
MUR3I+N,?MU8;PK3$=I]5";G'A8AP@)R]SSM2^NQA1C<NVT!!8(QLQ&60F,(4
MWO-KO8*_OH]:#37E.7=^SFW*<^X]2;9+B"D$]L/P!Q5G\^@FZT_GY4$*[C3S
MV$0$^6A4N.B7+0MNE.G"P68;OG)%?%:47Y>4)(NRV06VMM,@QJ!X?XCJ887"
M07R"QJ5D"ZB7>^;A"A/029->2H.30UOK68H+Q,]@4X/= Q\:2,;B=DB^82J/
MB;RI2$0YXX#/\>;4^#.Q5\H.-$K7VFHJG"K;U:QRK^;.4]YO+&NX-O,@S*6N
M8S5#U+#9F_WUA>=H,\TV''WJ6)HU&HXGSL@P35O7YKHVLIW)_^G#T8LV=\FJ
M,+5@(;_(UDG9WJO7'081$;OQV"V;9<<NHO'MALA_*.[6T9T=V+_>Q5ZIA3=8
MB-\2MLSJ%8RS"6UXOU&GKB+ZOKKXGVP??/7Q?1Z%BVP"F<7L@:RD#IOZ\OM5
M\+U:]$NFJ)G/OSS[!VS^4*F62U%/Q$.DS<J]_ 92,\),6.6>9"+RHC_OBIN4
MW32?^XC89ANUYYGS^T7D85D[4SX-8'9I%- A\-G[A>M%L-N+P^"\)5/]!97I
M(\YRP2"._33X,%"5#P/E*X37+9GBKQ%N]6B._G_\R;#,-S#1KPN8:4LF^,F;
M+ESF(]E^#?T9[$3WN7OR7!5AN'.'@.QRH/S-O8X3V"\^V.^.]%;[W2O1S;%B
M1K[C#K6S%K%T4X%VVN(H&;< E$H2"95K-\ICO&IB'",M<C^J0I=-HX"<JIH?
M-HOBU_SLFE^6-\J-=0USSS.E3O2MU$<#8[R[ZV'3H:R!H1UFI-% MP[32_-P
M(XT'IFVU;J2Q4__-\4?:]KDQ,(S#K$[7!H8S.EI#3F/8MD:/ZT W6QH]WF_?
M]^_ZV.XE8[='-,64Z?H*AAKKF7W^E\@0-H#>Z]22_Q?/C96^K>K*]5%T2^VZ
M^K*R=W0ME$3RT:MK33NVADS%"^E;0Z.63/*>:\HMF>7Q^M@9#=Z_K6F=,1AM
M1J /ZT?:'ZGG  QM%R@I]L<3^ST:D_9'[#^'P<5'.L5HNU#]ED$G*5]]M_6*
M6H[FVS[7;JIK;6?5'D2>B!#Z!0_&*?BLR-'^T6CM3KFCA.%0>.OK%_OBM0(5
M?<A3=M551^'M.@5J^HQ,&=N-WUYGXD%DJ_:] F!K8I>.YQ*GFO:[.Z&SCSO9
MYB7T-/VO$8OIRAL>+Q9_4#F] %^Z$H 'S=N*/X#G]>JP]&8SGSTY/#/O#Z49
MYE9+8.RW6$VI67*$+VO3BBUMI!HC4;NYOO0]>4L+UIHN=SW5V$?JPG^+6]*2
MNH>FKCHV+-71+4G?X]@&WL%$4O<XTCNT5%/:AB-1%[S:L 6TW2- JC^ ZR-O
M3%4;#U7+'#T/?_;9W?0MNC5.*[HU1Y8ZLF1\<!SJ4O&L\492]SC:JMKZ&'L5
M2_H>B;Z.C5[(D/0]3GSKZ"#!+8C!^DE=51NU@+8ROJWKW*L.#4LUC&?*JIUR
M?*N?6'QK&NK8:($=Z"5U97Q[W/A+&XU41YX]'"U"T!T#O)#<_1XKMP 2[,C=
MP[&DUW9:X-=D?%N;OQT[L'.VANV/;_/J%..A=8;M+4*9++!1XP_JH=3!*A3>
M#>F7'*A-=$,Z=M7<7K-\:!V==<0ZN@[4QW3/I%F:?6^AQG%\=O=HU:2H1=)J
MGQ(52:WF!2>25LW+1R2MLF*0T3U)LN/L&1IN#;I'4*S@L-2AMGL'\ R)[*Y%
M4TWJ,3HH'OI('>O'%8Z^T*I)DEG2BM-JK('1,61\T/" 6 <S?603W1MJ@609
M]R0<):VR@QOK">/.$XBF#-6T3 CFVQ--G>*EOF^(E>_Z,]ZI6E4^O7MWM1VT
MN[UYU5_":,FB;<WF>?.L[,Y?+Y*M=O-D:V_J7$[LEJ)M.^I(ES>19)U+]Z@+
MDFOJJC.4==S'VN@,(7@?6RVH%N@E?:5U.*[T6O9(-8T66(?#Q_HY80\/Q+V)
M@U-'WX>&E,Y](64_95%3;1O,J?U,@=8I%ZZ?V,5,V[94789$TF5WD+J..K0<
M53=DZ>^QKD]I(UNUS+&D[W%.9\=C"9ISO#/*-ES'DF7K=>&MH0Y'SO/APIQR
M>'MB]S)M2^*^R?"VF]0UU9&#X:T\;3E:OIH2+<^$?M5[^HZ'AK2]Q\Q7M^&D
M10:X-;P9JMI8 \O= =R17M_+C-R%NX21 M?K>OW0Y0R;=L=)1(<GRG^XR]4;
MY>_LNKBO205%5VR*W>2CNUX4% WE[<UN&3[3U-3Q>'<^5E;OROL&^]+*4LVQ
MI1KR]J:\O2FU\/DV=*:ICK3=0>UQ;QSTO=QEU+S<I7OBXZBZ!>'!/6B9\J[J
MJ=Y5;0 1+BVQ]%I[*XRJCS75&4O):HB38CJJ)6]@-J,61-J.)2/M-MJL$[BO
M:H%9,T$ CQN24T3U*G$G/KLO?ZJ/JA3[9QHGWOR.?^0%>-/Q]07^Z,GI95 O
M6/TXO6";O/U-A5"C@4-4^+Y@BKL,TR")%2]0DH47HVBFRT")V"IB,?:#3.!'
M<]>+E!O73QGVBL1/7.R6#3]>KM*$S10WSKZXCEQX:.8F]%/F3A>PT'#Z0SP!
MKW&GTS":N<&4*;=>LE!^N;QZIUQ>O5>^ARMORH5IJ(\&RI<T@H'C=$G]PV/^
M:YC5BDUA6B&]#D1FFOK4PU7,(&9\IK'B1DR)6:+,PP@>A#=_#A/&Q]?-;+Y3
M&#GT/9SP3)GG,(1Q A\L&:?,U$]GC.8>PI0N@R"%7WQC*QA7@?=BJEP,JUW\
M#[Z.1KYC;J2P )_\P*9L.6$1_Y6IJPHF8>%7;J+< NWFG@^_HO7ADU<?W].X
M;!*E;G2G&"-ZP!HT.T=HNQX8G=4#]_HZ8M<HVX_3B) D6JJ$5 FA$F;;5.);
M)O=QKADKUR.Q=I69%^-!'P@8LF(2!FF,PH>2P'*D@9 ?#,:JD!9X!?WB\\<O
M\)F0"%"B%8O@CR4)OQ=P<2!1<&/2)A!9>.VUZP4Q5\+R ]>AZ\<DT4(2/_XK
M]9([ZF,?]T0VK+;)QF^;!@O5\SKUZ!.5V)9U5@?&$+?HW\CU"F Q?3('<0+K
M0<8!BT25!; ^"!-EPEA0L35DF2D6A.^F;@J&[5,TX"/=BH=<)7"7\/,-2:Q]
MUZ AMD?;A<1NFY!\ +X0A KMO(9O8H4M5WYXAPZ$RPP:#18MP;^@GV'S.?@P
M9-?G\(8\@R)\@JJ@2UAXX#<3F+2R0.9?XR*Q.SE8%72UH/KHME(_ 6?;$\5W
MVL;32]]70C#!457#4:]R=N_AZX5FQ\J9=ZZ\U#G\D6&AHL<,-H1D7E;N'8\Y
MSNCG,5=HY:5C4&UU$:"A)&P*'?<D/#Q)W.@:/ 7YJW-EE49QBI&9")OX[*\8
M.!R^K$N(]2C>4<Y PF8,(B%8RX3YX>VY"M/!2=MXD6!4G00.ME4 !8TM&YBP
M>4QSZ\V2A=A>EY^:A$D2+E]KQ2/N!$(T"#2W/K)QC'!H(=:U1E+L6&N'2J7_
M+J)"+Z_9Q21B[H\+=PZ3?>WZM^Y=C F TIK 5ER4";B^=K["MW^91)@XV'SK
MGH;@>=1^&D*< Q(>,6\Y 1GE(HA:M6"N3U%[G'+=F(:H)==,24'-(N7]EW??
M+O>0:Y6*MD"0O7.NF2]MKE.@@,*8HCS/&1/!WRR-\ /2J?77U)FJS1K#.?W?
MFR<B)5_Z^V(INU2Z+Y' L&U>X['A8JF.\C#A(A_JH?%B/L+>@0WH8,(C&U,[
M?&BS!.\&]E&X"AT+!;;(;0N$=-0V(=T1VA0B\]#09F@9F5V]/[ Q;&,SL-D4
MNN:!#9_[OH&-I>JZM1G8'-H[;9^<RCT3!(:Z_6"OQ(=OZ $R?WASKBQ"8 CJ
MGP]?T&KPJ^JB@0I@)1+<>S(?5#P* V\:<PJMHO#&0_F >>2\J_,PWNRO+SQ'
MFVFVX>A3Q]*LT7 \<4:&:=JZ-M>UD>U,_D\?62\:J?S1@[R- FO2YU\QQ4D)
M3TR\7+QS8UCZ)68WXWWLU?%#L(9!*R:$YR'RGN2>/$B6#^.Y*Y[&Y?E2GM$J
M.RZ04Q"- !^F'_(4,/P<EL)XAHKG?I?NC&4"3 <M)7>SR\ ,%.4[.K?R2^-T
MM?)%@A;'*G_G3L(T$:E@>G-<30-3H)@NEYC/>U\V@-]I[2C\^),O:1*#%Z)<
MGLBT<2ZC'_N%S_U_8>X7'^$!>G0??X4E4O2Z?-<3@>' T-%W5S%[G?WCS<R+
M5[Y[]]H+B'7TT)OJ>/9FI1M)%_^ZV#D,-+Y[H+JM_-!2?#V KUYM?CX<@';6
M?J,-]-K/MXTT&HRU^F_V'<D8V*9SD)&&X!&'!QG)&8S-PZSN<'/2C<%X?)A)
MZ?9 UXV648K69^\<JKY&T=@/@$!LY'86-SSW\^/FSS<NON3VXWFNE'T$E[BD
M/<4O:9)&3/GJWH%9CQ5*>/R#HBQAE7\+</H84J)#IN_7W''-9:::VW@/(5Q=
M371.MFV[:A#.\HZ%BD*R#X^>RKJ7_!04X!;A"VT1KK"@H5FVH OK(L%XK7Q.
M,<[HS;(@VHH7+@1M&'?%O>(8Q)]IX.'6\4_'V4=OWC.HF\@Q+U9*6]30%GVA
M2I#>B';5&('J]F9E5VP*^[S$@P')5?MW,-/>K.Z+*$B2%JE[8>5/%DV]F%&4
M^#7RIA T0AR ?UVA U7.7I[+L/'!FD&Y,>4#EO_]XGK]B:]^SXH?KWAY;S!K
M>(#6@;5Q:Y;EMGJSK)(B=\@XZW7&>4L20WM,$J,3UOJSNV2[K'&O%EO8SD,L
M^;%)IDZ0[/L"MKR+T)^1 R^%8[T7EN]T"GIRR_[D_O26Z;)VW5NNHQL';O9'
ME[JL06.XKF>H.+CTV4\BT7^'BR N;9@/VR6N]C+;TTA'_;J-5_JKG8!/AV_W
MTB!H-^R:2 D_/#21&@!F/"(R,0[8<G!OY]2RYTDX!GB*U/CRZC/I!5G-D:W"
M/PZA%9+P>Q$>Z[Q-0W4<Y\&>2MIG:9\;V6?ST"UANZ-FICH<'<2\=6W=0W5T
M&+M^L@M_;H=V:@[1'NOJV!I)=RC=X7'=H26W*Z=J9"SK4-N=CBW\I6X/UK8:
M)[)P@<-[R'Q@!]-^9;"!!E+04U\I7>+C,W@-/<=Q?M8QX],XNR:I=="4F#1?
MIV6^]DAP=50WFN:QNKJ\IEF;4UF?]*Y/ES&2WN*TO,4>^9]G5<=^:FWC%$Q'
MU]<XT]+5]1TAH=*C JMO[-H+7'_&\:94JK7Z].[=E2RTDB<7!TC3E  NY>%%
MQRRGJ1&B41_.ICM&^9>6.C3&JFEH\G19VNACYZ(.:J,[IFFZJ5J&?8+GC+II
MJ89]BD?+!USY<[NU4W.+!FS%#=6T;>D6I5L\=M)-;EU.U]+HMG.HK4_'5GZZ
MA5>Z.M0L=6P]?,_5D](K NZF1"#!W\KR*^D<-_-Z3D<.I3IFA60%EJS DA;L
M2;)>#[!@'5,/681U6NN3#E8684F'<;1\4%="WGXJKJS#ZOCZMM9AO:)&(%WO
MWZ:WKC66Z/\<L;E/;<8KC=!+W<TW>Z)_N_I'3,B@A+]>:7L>J\J,\39I;+\>
MZ+SS#>]*K<Q"QMNX568W3; M%IN&0;CTIF).$0.&_QN[/=W1K[:T?>M)\UBC
M;6+T.XNI U<A&@JP,4XG_RSUKL^YD?<Y Q["8REPBGKB@72$O%V1NUKY8)*P
M7]"-&)JD,&\97S1PBJ<+-DM]]EHQ[#]G$TC"!&0DR'#&LV8!V5CB+2$LC;HQ
MN4$ TXIB[) D1BA$7Z6WBM[E\(K2(-3_*4ZG4Q93B[>2OI2&[(G0M;J-?:D+
ME_(5Q$\5G1<7+K#%59+;D'.ZW%\>_NV%,RY3( J\,1>. .]"6P82)'@]4/ZQ
MRB1SNO#8S4:3.%@Q_!1&05.*(2/V_ J5;_!3D&]N)R]GR%(0]H_O?OO^X5)5
M;.W/\':?OP:[;)&6P"\S*=XQZZQK5\26\'Y\776TJI+@* /EUUIS+HPK[RLF
MN@V>X?!+#CYYOJE':XJ-!.>&7U7<.$Z7'N^N5YGW=>CZG Z\%6.$O=(BT=(,
MD<B7K"^]O:VV:<J:>1:NNI<66G]EC6 &V3A+F/_"IY@ 0@3L/MT3&;-K9>QY
MFS)O;Q$L+*I*5B$-D#L8GI6Z)9+Y"90%\RF&^Q -.#]YFV>R:VX*^Q*7MBK
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MI9'AL!2@+@J0#(>;9#)T#(>WUTS*<+CHH*&=6#R\W4SU;*&6I<(_3LLHZ_;
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M.D2MQ]2X6K[<703*FQOPN'0<68UQ"S4]PPD)ZWB40HA&].5N#M8=\OF^)O_
M*V7Y/$M'J\<MW&@H#\*%G \VXOOM\RV;1[ EW-1BG#GU70]]RS7X'"Q=BXF;
M^4_6OB[M>2*0$Y *E!)A*==,(17EE^0 M]@JO8#J>EGFX5 2O',,HBM;JFQ'
MP_Z%<HE>P=95QW'0>(LR8#3MNL7_X%MXODW#&%_,J7B_BF^@<@!O,\6#GCY
MC^#GP?PJ<D'AIDS,-_-)*@TKXE/NW7@"(8S$U;!$.)M[7TCW9E =^0CQ=,%F
M*?]YWH6UV.U0O57$O.4$F,[RZ'_!7)\N;\0I#]*G(8;K$,;S..?]EW??+N'?
MB>>O5W;IHPKIUEA8XAPG*,9,+.!WCJ8ARG/%QV*!U6K'=+(=DZL$H 9BQQ>U
M(P_;'?.+:N/'X;JYG1;E'ITWMT]6)[>GN24IC[/S8@RD@; !;G,O9S=>S+>[
M%$\O7"\"*U4ZT*.(=#,6-,1UTNZP9KG$NX(D7A_ *K2!+]O<8)T<J731!Y:
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MA+7E3EX/BFFW-;=^^KAV2U.RNJ 6$;0.9*YW-SO<$<O*>^#Y/7!][?2EK??
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M!6(5KD0V@3()9!AFA.^*/ .:>K#/ KYOB;$6(;]M),:C34K*93)K8(A'_62
MXG0"8WNP'\3])/GX]<TXCLAH3Y(/B.)(EQ4O\#*+2B!$XI\Q-W@^P1;! V&$
MEV)!Z#R^F:Y_ 5,6[DQQADXAK/3K%1(H2?*M]Y.8^3W-&NQXD8E++WY.]\,I
M ^+ R 114ILG+<#'E)(39]8YW9FN3UI19EW<LN+2HELE^^%A3TC_VDN7JO(K
M0]1\L()_2X-K@L7^#2AV)SM*%)<OUS:N[;U\V<2@/Q,1"3)B18#,/G/I]F0J
M$B5NR5"B/#N.438??V#2?48'1MQ1\S,C.NUQP01%A*3&LRU!&%SDYO<VC'Y@
M9D[D6&K,<@=[_W;;6WXOQ4X\.[>6"$0W2<DQ0CYD642$!>T4B_'K^=6 JNCG
MR\-N_^["7:U\C\VJ/Q3)XBRQ=UN)X.M])C@OCBL-X]UEWKD2.]:L@L(S5[F*
ME _L1OFRBO%_\?P)$Z[9\0J% /\87$D1?&(11/CYPA-2$^'2\0HP!IFBS/"*
M;!1G<1L6V?"PS5O+XH.<EA\ H<V.B4@&I]E]9WY*'='E<W@)/R6O/S/YA;>S
M@=53&YU\K@LZM!*0%GG Q;<.!%/)IU=6F5B 0MQ17#9A+"B"O[FXH(SJ&+%,
M.^BTA>.C5TPOI;ZYW8V3BW!^X7O\"OP,Y6[9Z@/!?9/7PBIX'>TV_(]"!(''
MQ%%8"G"\8KBJ6Y#,+'O<%(K629EQ7#=P_&PI%;@[-8Z5Q$U<OF=NA%NC.+/0
M9$;G/,ZE=BPK%Z9#2#QJ9N"O(S<@JPPVW]+TLQ_G"(T[7:@EM)^M6^8,O":[
M]/^<^:QC@YKO%(0L.3]0&F2+D; %UAH_)BO!0EVERR7N "N'N-_)NLTX-L\:
MG ^'YUL#E=MXXWHCD-J<-.(HD^WBQH:+*$]YQ*_++7U*QO!-M7\8C(O'\R*
MA&^I6U'>381_K6[B)U4!GWCM2%Y'-$>K# H69DW(7$%81*W*<^@/+C("AK6^
MR.AW$!(@[]>B^]I!3>;6NMAG*A>Y$OA58]M$="<AM!_"V>SB%Q"8'\H?F*R[
M2B*0>MB74_<20JA%H>' M6$BQK@4\/#YIO[F2"4H$Y;<DN?/"SNRECB5,)JL
M-6S\,23*^N2<X6#BUW66[)GYPP5HQJ8AATUY3:47_"[Y^\NO+9RQ"(NQ7D;
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MN1Y^DE-IDW3&BVX+6P'7]>PLUW/L8H)V5695O%@$'!/@P"Y!K10 PG$)GE<
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MQ&E<QE$24)TN_(08LJDB,#%FS'=[;_^"J;L ,03XV!FL2X Q[QFN7A$7I0&
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MO>,-<2,/N^9&UEJ/=EM?^L/M@.I$5WJHKJ-D@IH [ZO;:[#L%V\HLNO$<\/
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M1^D*"4A@^R'3_ J4')E.Z5-2SAFG<_PAA=V+)QC+S;,;_BMZ#$1-.%S<I0-
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M_,6UX*5;=QZW]9;,BQG)*5_RO,V1W>A/E>-2.:<@QVP$X+$";;H@.Y"1W&1
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M:30K#>/G8.M$LAXH*[+$N"74["Y.35TU)G.B;T3T_:[^C=)92?-MJBI=^"[
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MQJ&F5M)VE I>G02]1"3H5@+KW'VH;=Y4P&PI6NYT"D(?M34G1LW=6O(!C9B
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MMQNS.QW:'JE]\JT*0=_B?I&9I\^ZQMW.A"EEK+A5O,[<GJLK @=I6_22");
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MA]G'WV3Y591J#+\I]A\9/=$$F96G!-QF!P&>$K@8S@M,#A1L+DQ5C@!1CE:
MI=8*9TZE(P.MJ":&0:I1SK.$#C!7?D749]I[<K\RS+@GL1K"C&%D!2)D=8;,
M1/IGMD\9?5GGZ70+"@QHSL$<$',5%Y6W4,9=[6INJA&D$QK\5F!MC!F^P:9
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M#ZVT[I+RS=FG'Y557VF;C,'FX!R-"6)H7KV<X23.N2^9S4U+R(V^-)[GW/C
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ML/;=?8O<@K26?(D=59TJ'3O)<6UBNVQGMTYM[0>0 "G$($ #A&3FUV]?9WH
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M]P98BA3VN4_YVM%EM= 7.8 1W/;#WY5$FM'F^0?IF[P$;3,RB20 FV'TEC3
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MB';<F=.A_#QW70&8<6SJ,AYA3_LM"PKZ1@5HY&<P7Q&-N]>ND B^<N]"/-^
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M9EB5O^4/)5@?'8JRR"-B6H[<(L*AN\B*M-E%(_]#R)D@?N"05Q@3GJ$$)%;
MV45JVO1T2(\]&Y)%5PBVST5ZR1UT&2/Q67!XPG<EA%ELKOZM;@B+E&\XKZ6
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MD^^>G?WO#?/Y9_3C3_;[\?\QK[,=_.]BNR[_\G]02P,$%     @ 78*=6++
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M%.B7(7C/6M17H#,#]1* "$1PL*JX?W[F>9O,$<.,+L2MR+WV]//MAUU2J6S
M91FT-@$I"D?<*-CU3(S]2I:S0G1K4R/R9^F[D&NH88WS3ZT6G,PT=2"&S:D
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MA]31"'>C*"5/C+IUP.[S/4$E\F2I8GRZ@(_F&IN_8AA**R(OXH29I!'K=H'
MM,KMBZY,9[K06RP6'=UZ0_?M-$I"2W/*[I9RIT5Y?Y7OJ*) @+QJ5M.+5/.R
M2 D$R:D@CCS>%FD[X*:W<_<:H6AO/K9(PBXI+1C%2V>6[]'XCUKV(<I+[]4E
M\# ^I*/"(\1_J]$_<;2ROA4I^U1B[K[K0Y_7SQC*3*T6L-=U:V;MA!\7^= H
MX1J)QG6^D$Z#"JS2X8C>!UF[.Y> 2:OPZZ74'1U8@B#MN])/08T?RMR5)K%S
M5(GJDQ;7[?"[BEJ-)]O=('_D8>S3;LS!.\E%3^%F^$14[-LGK9< ;86Y)GP\
MC+\ST+\^SBZ[)LPKJWJ\V%GPWU=#;Z.'-I/WB4V$8ABI[T[!J8W;AO!2K^1M
M5//?P=?\5:AB2B-S]9<5%TD;)4B@Y$:SBYJHQ;-A/-QU_EZ(T_L ,S7K+$MK
MU&;>TFTO,Y-!] 3(8+"E4SS]S2>H^VXTR4'T<5-WI[9L"#=/6TOA-C\T**NE
MH'DO,*R:L\7C^5PT?[GLC6'?=;Y^/YO2$4OD\D-M3:92D<]J[^ZD=,_X_BS%
MV#2,E'<O:Q;)'WKXZ: \FU-GN D[3'+ND83PKL,2UYH%EQ'7/QKP+=96IE_&
MLJK]S-AM9T2(3)/]PX]GOAO)(QSQPC;ERTO#2? M[OS_5 ?B9EC4@>LQ(44F
M2K--]!,O73HD#ERC:M-8H3R"83\_G%3U%_1&]G"$J)-;&U>U09AFC8\&2MA
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MV5F/L?TU:-\XV-DX_OKQUT7^Y51Z)@8&)C869A:V?WA0.P$>5KITNA(&.E&
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M4;J>.?82%;!-(G#/:*N91E&!^H-71!BEDR9?BLJ,I[E7L$K'F4F9?3\U[<"
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M-C_-5:^OV3Q?N$.WS@2'G<!_D1L->2W9H-="":#,[6E%71Q>CDLOM%LX PD
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M)E:YZ53,4('\C0_O& 0O,CL<_[RNF](3".GVV1.1'\P2J9[VK'YLNK ;08F
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M>3.?<:E*(0JC] 5<')LS)535.+O1]W&<*NX-U(^BXS/LI-L$JH8.C,:K=ZB
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MT_RE+7RPX7M:V]:=CT>%*5\Z92YXM:M1_1Q^ (U&.R]&+$C@ZRJ[ EM@7L5
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M5M#SI0@'&;2JL\B-W$J?)8,V<L3;.O$-'=!H.#L$B5&*TY'XF7:P0[LP]P!
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M:$(HE60*,& *9/ 1)52MV?8C?6BJ.%9R'9(67XQA/T*=9RL%K,F@#B\2]P-
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MP\3VB-PO-+_0,V30[=$#,"">T;$8Y:\^B%Q6XIX.]!CMLC8I#<K0N/OIVNQ
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MTEW\^:UOW-\D[G<>O05Y]FZ==:QOT<)%8#Q?;AT(L;&%0D?<"\8)9)#;<H]
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M3]F/I]EJD'JF_E&I'O^S2L7\A^N[Z*? .).AF5PW9@#MA!1Q%2JO8-:(4OR
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M2#6'\# 8%;YY7#$=_WY#<S+.KPS."O@8YQ*."0YQ$R,S*D/RKY^_9SKE.4V
M/DE4)00-(S$*>->NH&7L=5 #9X6 &C DS3_DC8P]6:%YD3YVFD8&/4FF0?P0
MM-ZL.0JNC%,4[UFKD0R]SK F0W42.X5JF<<I%TS+[RY(+ >\A;-$^A>/'V0<
M*0V5$*Q,33_7E]M8[=NBER*Y[\#YP_X9*_>_A&46XB>\.J,S>4;)I"]>K<NE
M3$]TUL2_Y_J<P49Y2BS7:?KOU^&%:ZV*<;-L,94O2TN'7R=DW'.R2-/\^>QC
M1>91&OZ$( 8,XZ2MZ@Q&LFU_ODIM^I'&K)P8YIB<'C_WKO)$O\4;[2C?1[I(
MZH+7'/8:.HPKM2C[NIL]2!_;%_^LVE#VX:R'SUC:7)C;3O4/C>K;?;JDA>1-
M],"VCI- 5].71ZN[R (R"-I"[,MO0P&4JJ1M #HPT_9-@,NRB4:W18'T96G/
MJKE3Y5^]B.:^GY91@8M+!KWP:,ZFP%E,4EUQ(3)XV89>&558R@1NGYS&J(8V
M"*.]S#5F"$B?29P.HHV>+PK9$@'/6*SJ'];CV7B7]P^>Z#"<_Y+ICLT+DO1Y
M></,&'R5WGI?"43J1];"NS/Y2!R5+X^K._OB6_79JG63;^^YGX7.]W]R>ZP,
M..^99\7MN2 <W_PV+\4RU!/3AC1+GC[U]-/ZNG^J_L,F/O:=I/(U@0!_;="=
M?IW.MA; BI+3APE%2>.=!#1[7GVR6'T.YF!/4N+GH'CDW7U]T8-],JA3:;IK
M:;)]UAW%2N1R=_,>J+<U>CKH)[:3";] 1=K$A)6M[K%>'% NZ8W<-![0.T0/
MJTYU_N+_]N- NP<X75P+]3O11G9<(IT#CO+PX-XK'W _4KN51SLCD)K'[E?8
MV0+HT%,[<'?B1>#N$EM$&W]\)Y25J'$FQPFLM)K0K[J2D3+T?2O,D, /8MKX
M6#GD<VM/>;#HY+>UMG@M' ?/UBFFSWCT3/[0S6[G&<5[]&G]E\\A_!-@]>E&
MTI,X@38+5 _R+$2[Y"89%&R#%61\0 :U9QI6&-\^C4<ZE!OI*O1UA$D9^_&2
M['5W#4"6'^_8WL,WSLB-;?8'&U:.]0:&:AOL7(/>2Q:'34$)MY+NRA%%Z_LW
MA<R:)795ENM\4=,TA"?##GM/28P;BF&*6)V?4%ECIOTX>4/'H#?C17:>I(6,
MH]3/@3=;9?NV]2VC(8Q+R?0E,,9 #:.1#GX)T]'\B&18BI[KL)[7-[/LEISI
MIKBXZO_O_X'[/_C?"N3I_PM02P,$%     @ 78*=6&VJ1<<U*0  A3(  !4
M  !C9&YA+3(P,C0P-#(Y7V<Q,RYJ<&?M>G=44VV7[T$$I :0+D4I(EU!0&I0
M7YH(" @(*$@7$9":4(-(KRH"@@(*(IU(EQHZTD2:2">A2">AA$#:C>_,-_/-
MW+FS9M[[_7'O6K.S?F<EZSPYV7L_>__VWN>$_).\"+#>TM'7 :A.40$/*2^
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M"RT=!]42K!Z^I4BW_7P)Q+YI2SL.KB2)X,!:(U[-;'#M*W'ISEE$TK<=%?,
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M.Q73S?>MU!M9.&H_YOSP!PIE<"\B=FGVPC1#Y&WYHH=W^']E(9OU*=R]A)-
M+4S5&Q!30VXN"?'<QTGI-EEM/7&:>*AP\8>+WN"\SEZL57P%]*L IQ9P*!2=
M-9^&I.B3PS'N_W:Y/GS-^KZP/HA6WS'^TO>@=(@Y=<-#J0JX1"K6>,2?T8O1
MS588U[F49&R CBYP#/VXSJT:51:P*_.V=.:8I%WC];3H:^+IQ-DB#2W%C?%_
M*&O>Y7O=&,G%/E1@U>OM4W3[LJ%*W(,61AH/Q'V^G'C@.!\;1C$BYC$9J-E]
M1C%\.%*HVJ@A%!1]&'AU8.!<"NN]=F_%?N&&Y/,[G'%,P !3CB1LVI+$(%X8
M-KA TWP.0P:Z$*?4#8IP[MTG'A^W?1W5A0TE@V/_Z*/I5Z$Q&M6R?V%E!56#
MA-137!R$"UQ:X, %W\/DQH2)&+OF07V7HB9^Q8:H.X1?#P9A?77$W/38)71?
MGO/<CKP8L$QMYQ;BCN%N%TK)K?;HC?0\*&HVS,<=BX\05#[:#,9.U_2/2NI[
MDH'+?QB+SM*W"5]#[7OOH<*5Q'%DH&@!AVAOY4(+/<O#B&K*?/]6=M*35M[C
MX3>CQ1JWXJ(UQ)'C$)MYMR82W'_JBF!H&:Q=2VP,YI;"21K@<VUCAEABN"-#
ME*:WUT</;>QD-P9%9=535/+G+G"S)2759[>=?99+1W&<$_17UT(E?)L*!<9=
MG-SFE::^YV*S"^ R$SPFMCK8Z[X.?VO[,']U+04;B?])4XPT9H?^(C%",&8=
M.5R8+=*Y+RVXZQSR&W7IWL-7O6N"''*E]=,LEUF[E*Y\7PW7R.C.19N#(DZ\
MME+=\2XXD0[KNA:DQ<2DP?B6A=[V(;/FUHO3/CI='WKNOJH2%-";I1?Y3M#
M&T G32<)G*YE!&#BR0'\' =7XS+?1$%7 *V!E:<#_H_''7^P5,I',U@&4)U_
MF?L:L5A@5_6K8^$GGD1_/1#MBI16ADVA<54=JZN[)N_TO0-]13M#1N5+*E"<
ME@SO@7"J[E!JO*+UXUSJ9D6W):$$,L"Q/"D=XFR/-!"BJ]U2P@PQ55U?EDGT
M[N*&ZKX8:I8-T-ORK4P"]-^3YHY(EXB%S8[XBSBOQ8NEH2C8Z?526'$-WUS)
M=77IS_*!<A*&@QTH62$7>1\=R5^=QC.[E!3K&7[6B.A>B 2#FK5+-H*XXV3\
M!(S;+:]T>A3-+ Q#F#\G)>@Y,#"U#[[%;NOVT>@)B<]K8XAD8+$LMZ9E8:NS
MW"U]7KX6Y^VJF<I2[" >OYV^H'>1*OU.\ASG6\ESGL@(]TG*XGC5^G8/7:S7
MQ&3[G<=<)%4R$!FAKREAXPZAV@77LNB^L7R\%151J3VM]%+XU6!9%W73"-AK
MSJL+5M,;!W,J/XOU_B&.R8@*T6SLR7^L?MWELSI3^F I?UF[U? TBN<:[["Z
M2R;F+(E!PA&]U(4X0Y H"V'[8?BK1V\[)L;!0X=GNB>0N;%9V3[:\=$\DDH"
M<9Y=Y=B]3Y/V)1D 87']\N#E=&LRL);-DDIBB-<E* ]O)2J0 85QQ(G-ISMT
M8Q"AFIJLWAX/V"*X$WPJ"6:'#DMS#D:MJ'8%5%H1RWD7(X0WK .M6!&2+TNJ
M/%\://0F _QDP&L;M&BY->6!-\;%+![%LKPX63XQ)R5YJU_>L%!FFQMRCTGQ
MU='!G5-SNM:_]+1/T!QO&M8CCDTBYH588H:QRKCCP$6AQ%;ZK+';& X#'XL%
MLSE'+V]/9_J,)&M>D11O*Q'8^>+;Q8I+X-JC7KMXNQIQ EMHB#_FK59=%89#
M4"/%<%Q6^L,]Y+AH?=,KI09MXXS5A^WQ(043_8NL -UL$-VVV)+'S2X2XVCM
M<+AJ07KFDBE-10-MK;LO9YR[?D4>-ULI/:MJQP:/Q(-9=GK@9"[D$*_R.S;]
M+JE;8F)0[[*V"Q.1Z):,YSG8<]!/\?HR78R._-XT+&QSGZ2YU40#5"1[6J/>
MGXJ_](]#7NOGR@GIE;%:M4L5,JLW4J^KVX]J:]R46$QQ-!W1$O1WQPN1^BR4
M+/F<,[8:T!OGW)M#*^;E3O^4-$Q^.ZX=37!WD0O//85L&?&_%,:(,Y155_0\
MCU[IP/F,:Z:Q\K#-* VV?5EZ_-#22AOP)DD1<\( W&[W=TKI[6U;H-M4/41D
M++L'P:,]/&67]KZ9/1G5N>^AGBBH9K851D5@&%/W%^]F5EZLCRPG&$IY9G3=
M@?I,R+U;9'K[3.@-E!K7!+JU^>@]"PS%W>$5!>.^^K/&*WZ!B0!&!5\3V[]0
M@V%)HMDR01CV5XL H6UE2>)89^+;&@%'0PQ7#%X3)SQP9^2-4DJH&U+MVFJE
MR(>H'Y=''.M&I>KSPE5DN!>YVW*9H:-><8("."FD#+C+DG?_$"_'/-T=?-$[
M>ZS,X69V?O&6AF1O#(DI1!"=FP@GB4 MD;K1-<.L&V7;)>[385%>S-M(E]D>
MJQ'JOM2^62-CQ=$1+?[T3#3CHE'"4J:F^",R0!,BYH:RBE. 1L]TIE<NJ%P[
MG?GCRH4UU7K[=8,EN? %ZC 1:/1D]P)K*Q/4V':B[-9; 3,K]';M1'>#*</K
M5W==;K.>:><Y_Z=_3WYMX='@KJ#NR=A#>!0?TW02=B2XB RX]-1S,XCH1:B7
M4,L'>O<TT4M%FB33&*!@SX2H"1Y(=Q U='AQ,DHQ]*R!^0,%W0EU-0]O]T<<
M'B8<IA?TVOB9WS^TM*1<GL]X:QA_[1'?C[<H0T9L&%H[/3__A5\"WIC!JE<Q
MCIJZSS_QZCVA.>&FH']@?/X/_L'X]B/$!HD 41,KR]H90<<N-G)D("0Q=[0A
MU&P)$2.C;RAGV- H@GO+5DPP,E[7$ACB7($@! G7180^/ZKS!IT\MAI>LZA>
MQ8TL%1N9[LR#G>KL-K, ["TI%&CZ.?8[\4,K3XA6Y4BST!+/^=K</PSB+J3>
MJD^5Y_UD.N4DGG>),I-[6QL3.":Q[\8*]N5D_<YA<@\A048C9.!%-FC3SC@*
MJ3[&&YDL_#;I8T4MA( PZRW/7ERS2),H]%^A=&5$CKS6\^AZ F=&C])>"6X&
MR949$$.5:T#A9)%9^M.9)TZA[C_4:2B))4_,5K<2MH:FU7JQW/Y)<WA.3HD?
MKR[V36/JKJ622+1OLWQS41VBR14G Z-^;-7ZP&KJ;GU%;D[,]P,+\/.P"]"S
M*,%<8NFB,8];8_>7GN.KF^.O+VB\=1,SKFPOCT?_HA]+34S+V@FZ\MJI(ON[
MB3:G",.EO/!_&"0K*LO6LYB?;UC73G<R^+OLA ([H:7]S1X82K/'J!@=;]L_
M_$'RYRN3'=WK6V %+8')>)($SK5CZT>>&<2O^5RPS^7"D;?OB<:U@9.Q)&EH
MDYT,!R37,9P,#$B9U;S<F3->TRC-S OGS,Q,N"*:^LHXZ-8_10@H ^PI="R9
MY4I,> E;U^Z&3@3+;;>3 3&SVV2@TD>.>.D+G \^@X.0_G@-[@B#9)&!KSV%
M110';.4$0CKGQ2BM:*W>X3"C^V26QY;ND64 MPQ3PH'S^?@3A<5" L<8JC?"
M*>$6KMQ1*-X/&:4,EN:N3+G3K]27HL,+7H!G%E7P>]H\&[PP$/NIX-=$D,;(
M6$PWZFE5BX3B<>B,4"F"!NPF% D3JND,1!]U]8D-NC5NWFH\)=4$.\H7?TD:
M3;<+VMG$]&K_.,QEWOCLGB,XX?G$R^,CR OBIJ K>ENM5.*T4$%H EZ6#+3?
MLG#T6/2:%M8JTTN>Z6;M#0\&U>0=D(&*^"MC/LG6"/5OUU1;.56_*/T26L$;
MC"%^;80:46L66!59'MF%Y:+!(EM9DFIJ X8ZHU)$S0V5Q1S%5[P?GO8)L[WH
MUSW-]E7X(SS6[5,H%U*;XP[5_RVLPJ0PGFE(YLL;?.\RQ85Y[A)&Z]^3"FL-
M4,9L;O/<HTX3AQ*78R_'@N25G057FRGCJO@XP:JDM;BXKP]UZ=FQHVT_>/@J
M0 8X<4WW,&'OO6I56K7%^YX9][$>")(*6YQ'M $.DW]%2 /^*:SO[AAXZSZE
M:;XE*]53.@7S!!U+-GK]2V"$+70B]D0_D,[N-T^2=!0U;L1?@COM=_PSU8"@
MQ)=@CUS.$*KQ]^B4!-=<,W1D%<K@!L2@<'E?E'<[YW8H2/3A*^.UE"B""7*7
M#Q<VUFW+,;&(&(-_8)^>FVE=?FF\IQ&K'G'FFC!"H'26##CL3N^;$7/4C=25
M47&K7]#)A=?P?M323YS40_.N''N9'(4/WY%"X3*B[9.>=R'-2V1&\7;$^M50
M6I.W R QG>IF5<T%RJX=I,<_-QRO(;H:/;<<]7)HJ&V,<J[[$M4I6OF9QDIO
M,>+,^?'#8T=#-85M94HJOJ#A,-'Z2U"R<HRXF.-V*D_"U>4:P/)QK#0"-[-$
M.[9UMJ-.'F53,.=W?<5QF!'W\A@4!"R%B>"F[7@VM1<#N"R6RTL$Y=4:! N/
M'1HV_G<2_YVB_W8G@L6W$904M32DI&C GREZ[O^0HM"_&[>IL'2$L[[8PJP.
MDMS40J]U]*9[Q! RH3B7>/==M?4K6%2#T\$3N-IK4)T4IJJ#=&30&F,VYKD<
M@9HV3Y^'OBOMV;AN8:IRFO6,XDD*7HP >8Z-P"G;H_"9CGRUE7C!!@9 :?8]
M[U,UJ6)+@6B4&A^A-['*.::DLB:C2=PMT  Q#,\MQO+2:DS$3*P>V@0%'(?9
MQGRB:(DN'/VK3N=HUD4Q2W6$";5B=)K\+E2-E8LV-+VAU(U'!6](6I,]\_S$
M&DW!$//)BTV8V]OO%V;[;_7"SBLM^W!(S])T/#OJ2&ZK#9(C<"R@WK4RXH0\
M%C54-P>:,(9':9?,GF/O/=U;VN@1T_P0"Q^.QU<((M_)NJ;WUPFO]^'+_0S@
MKI!C-\?5_?OS=2"NXM':5S](,#18X4!0A?W>CWOOY%6C=<Q>M"5&@+P-[%@)
MZK@QS#ED9$DK-^9TQ+B2G5$#<:5I/W5/J-%(Q7EZ_G#7CID,/,D]#4T=&&N&
MN$R+(8'0]RX&EIYT=Y1U7QDSG0%\#MLSGR:[1C07R[D)R9 H,Y)4]KW;1W2Q
M-:X[8(U6,K!?N?7ZK@4W5K7@75!R9C#S4/- X[F$P)L?$S;*/D9H=!O828XE
M5,]BS0P?4'RG9__/7$,W *LC X2T!\JD[I^(@SQ4LV=+*G:!#+PJ_40&?C9Q
MDU[?MTR:W":HD0'A6T)(L-H0;-G1;/Q27CS66)UR!/X&J0788C:"KP!GC_D!
MHG]L67 UES.J\HN.5YJGCV$3$7)6:-1LW9;&N*[A2U5#\MXH)/[>.W53$?N7
MS[Z>QYZ?O*A&;RST/$<P6-]FK/I8PQ ]L1(-YZN<4\!:Q"^'G0K13T =M0^S
M$/[0YRP8KQEW_YS-A0S3?QTJ:BD4Y3^!4[0V^V!Q=[4,-1U61)0]FZ0GT>OZ
M.PDRK_\% J;[Y47@Z.P=A99B$V&,W=Z-"YU9][E*P@EY5G3OM@^[8@N)_<>K
MC;G)FA*I/62 5]T,U?L6BIC<68FK'E60>B*DU:2+O%\;MI^&3#\K6Z![[ #?
M]("=W;_M[&K'J9H]0P;"*;0+>=>S^XQT$;J)[$8VH2&Q.])'2L[AK-_[O5.R
ME/HK>WWDU=AL=]&_L#^^^PMGP;J&>-9'<U@^/"P7I8/+",F^>^B-$#TXU>J>
MU_RN5W3 5QN/"UX8K,E8F/SE![%7X+=E)NU8!P3!-[_CCVY.'AB?=>LKQ05;
MUK76ID9^J<UTNA&<^+Q=H-=DOGRRW98#4QA/8"YFMNNP)@Y%$CP?B;:]H'Y1
M@?"?U'C#MFV[A%[ _A09&-.\M!:XAIC.>KS_TQDEOJ%_<XN]E5I^<3" ;[\#
MX28X8[ S1:C=T\RE[^)Y/+_MW$\&0#BA'X7?7UO81:F[(\'\Z_D6Z&2$!XSN
M7!:]YJ.^-0$C7E U$%IJVJI9H/KZ$_+JV /!Q"/':]_41R"4G;O+$5*/]X+U
M68PAMAY02I/N+"46J\)F%O;,:W;QW YD8.2(<\D?#V.AL-ZK&)SQMWV[8Y[Q
M0PJ5MZ0.__L^2W.+#$28X0X/O:+#+N "?9]:'82:RY9/I,S%(\],:SSOZMT@
M'1XZAP53V@6Y$-,3N6V0+_+H36QM"FB8-46=5\0OS7A<LN\XBW@&WH.K9OI\
M/*=3EU9P5 [C&&[ID\3?;U1>]R>&1% JXUN-IWG_S:>A9;O<&^4?H,9W?XQ@
M:W.RU9$M##I#N:,U[NFXY3UMM%D/^Q\_G=%U[^\F]VZ-6M0(%]I>";4F?"TZ
M=JM?#M-[=2_=05_\E=NE/,3[X8&(ORL@C$$76\IQ7B:&-IW3+4-)XX'TWNX*
M.HN"^9)!@DLMP;J=N3.6=F-*;F2 _<"[^,8UU:CX,M_DYJJG*3^]JP6,W#LO
M53 %6(8/?OA;D_:M3$GA;&3:^JV%C-G0B458W/QI7,HCSV8!E%IP56FF1[O4
MU9N%0^?LPX=Y>T .[D$(L+3<;DW3UT,!>:R->^Q]=87V"[HZ F?LOVJB6H*1
MO=LI2RG,@4&09!ENF^K[<KDO!?I9:"%4=;<!XT%E]L @'/] Q!4.N#I'0\9>
MB]!"-0%4T.'-*3%]+:H?7XX8"KN ]\S%-4[#B DCL+7CS5ZI$9A;2IP@-ZY@
MZ8%:U_S9')=G?GK(++786^JF]"X.B:KLU!+]KU0V?S1OM"Z)%%A$F^ED:[N)
ME;A^6S6+NN^O?WU.B9*=086L_^Z&-=7&0B5MV8GRMOGB3$VJ5V:1/I7*AEB$
M'H8,I%AN<(:9A@T8K>/UH+PO/\.0$E6\@M'.= ?PB48"(CDOW?[6@Z5C99+K
MU-,9F'D6Z6CM=Y3$:,;^/8/^5R"5@ZLO["L-D< H97#/-Z /MPP.'_'#K-<>
MJY4^@GLX56?[\E>^]MXXTUY:"'8U,:AN4$BY:KT3ICABJ:Z=-XOS[>*>%VP6
M:OW<G#Y]/P6E*PDSN;MYPJ8HYA=V?\QHD/(3#O_5L46#&ZL[MF!*_!3"YB%D
MCF%N;@[2F1E>JSTIM,M"H(U!+)H(O/F:LII^RNWZIN8,P0@Z;3+0NVQ-E(0/
M7%O-2W<U8OP(5AJN1GZ=H9. 9/SID7C-R/^N1WZ#T$BL;68G41,+0VP^Q6*[
M@XNR=:B3>3TY;GMO"4S!%A57TK#<!$X(,K^]#.J..GPG[MP%*K#[PD]W8[03
M]V(,E,> PR*\OWH;\+XV*0Y]DGIH#?Y*^"7_'HW;>+'?>! 4Q6%BV]#Q]STS
MAXGU24PG&1!PL^;!*!4NSIDN&'F\:<WIT$[XQ6O\)I&Y,XV$7L_*-+KBINR>
MI&/LY$2I1C<8I(P[!5DPRHF[1KG()$&;!DM/XAN&M\D3LX,W*NZ%R^OH SZ/
M0:PXR -T3JTO<OCLVI$2-]8G$&(!>?IF.:Z%(4>71W-QM3"')23#<GN\PLIG
MW^9&-J>O*1K;DF]M;;=Q(C-7QHWA?>+<4.]D$]O>[B<:,I C?VV(2U-PLE9#
M?M]ZK,:F8>O@P +1%#V7I>;L<J;@)Y.L53COAAZ';\=D:^XHH7M :KI;]5)>
MT=]*)]TD&*V_<+IE.(%@B>&ZAZX+\E/U8])E&@._P1V=XB #K9O;)V@R@!.'
M=^K@('C%=4C]4XXF#,=PR;<SOYS"I>V>Q;$A%EU:.A!G4;=->UP577+B]N!X
MB/&W+2)(XOV:,SIAKI1X\MO)O&M1?Z$3%(3@[Q(NV"4M4"L.4\]T")(!"M4_
M'C7V]N?^%A[DV7XCE']RQ3&_9U6%M52B4XJ)-50*:XNXAEC\($25TB&7Q(XK
MU*Z>RH,6M:Q43!S;-PSOHK#';ZX)7+E(-P='+";VW?B(-H-QMPC9ENY,+@^_
M04F+O!:)C9_171\[V5=GIP3NJ/&KO\\-55#D/M1Z 941O:/^E'6M#VZM5";&
M:UQ-GSHXJU8Q^VM&\<#K&8D+NCJ&+<'L0Y?TOF1TA)T?K6V *[I9*D'J6,JO
MRO>*SX86]MO7O(H*=FB]&WTUW2E>/UW1A>KCTX#WPV;A1G2?Q:>;!D!QJN*=
M,.#Q/!,.(CVI6AB[W5W1 A_@3F<?OI U.J4_5_F59CFT()R!%3 (5$GGJH7@
M"\LR9&<>% X%ERHB;-8@]E)F!9CRLXB*MS;E9(#9Z&8'B7^BV1'U -QAS8QX
M&UH\W^WNQGMM3CJ932>8Z>50D%$4FJ[#5@'3TX*&= A*M*9V\UVU=.FW2?#C
MRJKY,:5PDX<NY(\HG\3NYS3'$:XIFFBZ1']03([*" 'RL>O5_;63U\HO>L7G
M I(Z/31[><#6AVR8!"0L@J3X.+=&N;.4J ^'Y[5^&;LJ]9;U4P]V1T($)G^G
MVU94ODGVN]7GDAM['9C1'HE:'3+ N%(W>S1B,(!>*(_KE%:+]U?;) EN#I/H
MWD"#QMI82=W3=?G^7)^JAY9F+E4LAVNGITE76'&<)0/2/:OJ^ZFVVJ6;C0NQ
MBKH_#K===K!8PU;GE;E.?2F/.Z49#OIM  L48)E8<&M51C/!JCF/.IK*/;<5
MFW(YN\MT\MK>G-+U1!\['[EZSQL%+#T;5@_\W'Y-7/#P$\.[?-.RCSE5 0AW
MF>8: GV7X;5VV0'/DYP6O/[CH.1*- *I]*%DP=#76SQ2'*2^QQW0O=7FE&,$
M4*,+<%=*-GS"!G.Y#^(4Z:='-=3T7JFYO'XSDIPO>$].R[C<D>",Z7T68HG&
MM\T+H%LK_346HOW<I+W24;W]^KR_ B$?9GUH"3Y42U=#)"D+U570SWMS&#%<
MU?Z4^2+^R=;[2M9[@2^['C98];VL9Z*=>18>M/IE@I<,N%[::RJ)FY[3@"MN
MKQ<CU,/JYDA#]9M]7H/[\91>JOK;GX&]0:(C7![7E ^Q_$XZMX[OQ6;O%0P6
MJ<33'!>DDJCY*D^>W2\(I7#BZ18<,S$!.;";HGF^NOM;$=_P39;F@JKZ76>A
MW<8HN@H1C:SF=[M7DBW3O]42M_-)XO5SB#RUJBV1'H<EXT^[(S +S<^C!P,"
MW+?K1PZ:G*.G1T]'SW/PZ_(5F9ML :<*\^()*G5S4R?R^N?SXB7^TL-G2QJ\
M/H%I!/$(',5-.C6N_F4'\VN=.QF\-+U^_>?"SKLT+^R]HVY(C46-U$2G19*U
MYVA"H]/=0H::V8L5F;AU%)AETY9M<E?]"DI#U<  SY@1L3-M$IVL?>T\20,_
M(8D?(S%PXD4-,2+Z7DEV+'ZI%UL*VY,<^D\?P[=?/]V@FT\#UB<RDDO>$[CM
MZIVFROD7:$MOZGN(39&!#,?]YC"&3[1-D75K>/@FI8^4FK@6\9_>YI6ZV9'#
MB0$EJ^NZ(N48W$P7'JM&;C(7E(E([\"TZ$R-@5-&0(&$#IM/:M5-_;XI@92M
M(;20%?%#F-0]G'"?<W([CW&Y;1[&X_%'3Y7UAB_F9, MYJ'[H<+U[S4I3(_2
M<_B_2XO45GZN,P@V>!3-=6GD1DG*^U/-^U@SXCL_NRD$\J,M?TI_KE7KC&9+
MT7DR\$#IFK9XK@R59&MS'96C;;9=LK>L/[$\<84R44*8N7,A^^LK^YI'EP9(
M^3?V<"N(C!>4TKCO6O9OR^M_#YP8K^T)/-/L3>]03--B3VJKN(QFRP<;W7V=
MH-HN2=7BC:^J/IV)S[!IG.O.@9_$);HEQ^U*UB9=2:$LMUU8DI52JHOW0DUP
MP]JA$WA;2O^OX4<&^&HGN^#/+.Y,;3)9VQ!I]/3DC$TQ <DWYZ 69,#I%Z1S
M^EM"*0YBGDL9KYH2I&:LF"!*&7<H9;K7W/GA&; U,4%R"!W8PA(D9]YLNTFB
MRT1#9YE#F(VL$XQ2\J4H-F_P_\?3*><H00IW$\.X9!PO@D[IA+,,P?Q^*J@F
M:GMFXO<:D-RSAVOR3R4E[Q;JL/BZB34%<YZY]?&U0\54POLUU<EX_U([%IRO
M00[V!.L<_V-T6GY8*C7\/0.1DY@(=DQ2P :.P) RF,>=@:CM&T ]>P7O5=SP
M19YA'U@<?HGZ6?HX,8T,.*90AWWCL]ZH/@Z"Q\L*=Z]6BX;<.+-ZB0H?]S.W
M>0Y].7]*:F]>! 5Y8\<<%5 X<9AQ+#=<C+4R,OI<5VYC=?  L4BIXW8\H?^0
M?XI89H5]MZO*Z$B9EC/L3;C:Z5:J+3AC&-!]8U9WK?QEW%EB^GIJQ,?5%MGX
M&5 L/+*D9"0U,>.NJT6:ZO>G1169QVD8//8\;@1]T:I6=_3M@^\O7C5^2V.\
MG!3JDI*>,/L.CM=I]D&X2/62KI Z[:J/>O2=)^2:+_MYF-Y/'S\0_JQ07_J)
MR=-W/&TVU'VWZIMRU9W>FZ3YE W$P(ZF*V]G8X/]RAXLGPR FPF]>:VYN$P*
M ];CVI%33HTX-Y2A<I=%_L5K%[TJ9XF7EWO"FGJ_6T9#%Q9U>^QBV!NA,\CD
MVL*/L""4#=WEW(\E#$)MDU-(A9!Z?H2WN?(T%N8[B=8,:Z7CCH8U/[?+6*CL
M&]'F7'OWX<\XT3PCWI#IL?TA4-0W\@]3 R$M.NL#.8#4!ZNQZ\KD)K'!(T^J
M.GH36G1 53=3[NQ[,('G^LK<'2[C'NV;9\7ONX6YO%XW+]D^4T=(&U8M?O+$
MRU_MZP%1Z9M-0MP[T<O7>2$!&H!)GV9':S/.BF+3IQ^RH@:[B0C6#W4IY^NR
MD8?[HB+?AX2CS YT! \/R$"'W%3GXF3;C$<N"^&LA[O/0-V#6T^&_,_O9MI)
M4Y$VD*&E*_LL5P8N%_=$;1@,:!\A1A1^=BSS]'\[U.C&$1=60_SQ&K!V1=(%
MW/$'C%"/RB?TMU==E\<ZGL-43SQ46$$0&L3/73L/PA6<V2+H>2M/0@>8A:!,
MF^TJ)+>2V*>PE/%R>' K5!_+ S"L%<&'?6_O7QXJP*];:PC7V*'MWFH6TF78
M/Y4Z<K?=_4VJO6H=?^F9VG\.%M\N&!V)'==JD=L-8U+7*-8C T$VVWST]\E
M6Z9^A<$=8@+,N?S639G>]E Q W\NDM/-/5W LLCDP5W,EVG)\8V^('WX> \T
M1$-W]SKX;HJP\4\P]G:RF21!L*YOXYQID\B>/*K6+W>*&NLXXKS_A$2_)ALJ
MNZWY'2QAP' 0+Z7O$OAZHL#6BS2?<?SJ,U2O1:)W1\<R1IU^,86NV)@>JGQK
MM)U'Q&@L[WF*\4OMQR/:WOVF;YNSIQKCXZM^WW%)_"OSU__@_P^0I_X74$L#
M!!0    ( %V"G5A)\DU/%#L  !1$   5    8V1N82TR,#(T,#0R.5]G,30N
M:G!G[;IW5)-=MR\:! 0%I$N54 5%0(IT$T5I(B(J78A(AS<@O84$0;KTIJ"
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M6"Z?W+ <#7PB=TGL<?]JB*16N%%34V,3AX8HU%P,;B#-+"BD.)D%^!TD/7R
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ML%WRJ2_2;#@S*!RNZ\6<ZC_IXNO'MU!5PS[1S@S_OLQ+^JIIC U_G-VU?,U
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M&K%H*,K^8,YQX,_.TQI2%AS8XPTW7WFNC5[@#@[KSI#MO-&N+[ZI=K7M7"P
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M<.Y!LP,U&SY;A>UGB(SKY/I9'%BIU]07]_3S$@I/I5ZSP"%W/'#5*:%=T$8
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MHSZ-C(*I%8T&AP0K]+BY0/F<TK]_>TP/CR7W JMZWQ,TMU#8#'R=;2O.[Q/
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M/^[.>LY*UGG/R=[[W>5YWW-H8[0YX,150Z@AP'"$ ;A'_P"T#>"XKJ/G R?
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MNOV*HVDQ]++(-'\7B7$^LGGS^<%N-@[&3/JX+E09QWEQ5<B@[=7N: "'K+<
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MZ9RS0OH3WQ\4QR#MLZV%W85MB*H3W7YC\8$<"''CN>?QUQWOM*2O7P8IPFB
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MLX)DEM//4G)H %R1=!;24<_5KL-76T%*R8:K'1C6.W :>"C:7X^!P9,6/M,
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M2$'WT$UJ-."A58$J&WW!B!%9":K\*E6GZ*M, _*2$D>JM=\EPPR[MZLO'S[
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MZWF&>I15?V<M. Y.7SIIVHW;NHWZC-DU.R0+R(JKWS PL"LD/L$11Q3>M4Z
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ML]_W>9]WGT.<(2( -S14U%4 9)?( ,])'P!Q#W!=T=;UY2O *P"ID1'G 4J
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M\#<KD-6EY5:JE.W-T6N9*'\+Q[YXN=[WZ3\!U/=*+EJ2,C!09#UDF!G",]&
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M^ZJ9H\Z=C?Q:U_+7SM=PPSNH5 ^W@0"&ZXJW#\UA.\$('4Z_+#B$!S>\ F;
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M01,44]["C_6JQDZ16ELSJ1N&Y7-#L,57F')D[0W=G&2X3-*<,]^]/.SO#FP
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M@$ 5!B:/AX.6%*&#^S.K985Q1]I/_N;ZN10W+8>:L#\;TJ2[[][G3?Y$7A7
M%PJR39X30YFIRXFABPQ-@25+13<:(I-UQYEH08O#-A;T,7#5#Y43)CF:A^*E
M&E4F]LK-J]7^P^IV=KYE5JHV+YQX#H>0=Z(9!?=Z$  JGGQ%L'402;>&ZV_[
MBJH&8^)1/,RUMBSC#12B:O"?P[=I2C<3Y+>W]B/!]:Y=(6%H,O1)%_/4B87/
MC_(%.IG?.I8#I\_I3DRN[H)%WKLGF41IZ;:K^]MWG)S="V2UC& S6RK]VG9R
M#AOI[P?5;^!OVJ%4>ZAO8^AZ3U^A^U+47&N9+A.0P9)<=\XZ3$,\VX._H6%(
M8?AR!(1-AQHOC9Y@]RY$#-BPI?GV27W?6/<YX4N*((_;W(2.BOUU\FBXY'S+
M7/YN Q@-SE$HI<Q$N@DLF)\$_MESDE[Z^X[)/Q.>>?=P('1.7](KC"]<B-S
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MZ.D8.&:>DRY8E4:8]2 (M$2DOVG>IQ+LF]+7G:/C?>;DOJ^7+YNDWKP9Y'Y
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MV M*2E* 3:'>A>NW^VKXTCY>1$11%?'' $A+2#?XBYS!;"E$-W#$%"H,/%C
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M],(K: WL\1;UV!*:W5N?8SZI7O 0/L4C3'2HY/CLE== 1G>GT@?95>LDMFR
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M!TBNS-FCU:ZRQDKJ2D2D]^"\\(HO)RS2K$^%:K@[&DA%7'O-UH6^%8AG .0
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M1%@GF-GB=>+P7.V2^]0$H6GO5N7:YEQ,C9FL!K6R$3LLF#Y/-(-.+77-5_.
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MNIT_?] TSF3H?YGCLSC^EW^K""_X+X-\0+$H^;]E*P\S %\X/G(Q81--#&
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ME3T+!4#)'JAXJP]NP><:=FC17/W<#T;C89_+9#E!ISMS I*:3VQ1V6-N+I8
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M/T8J1N3'K8IN_D(VBM<GN-?XB>AL&-S=?&+,4L@^@,):=FFE#TZ^W:%:O?3
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M9??TF ^6)LE57O)J41294RO6J/]UVLPO?\#D+JE< +0YKL PD3.W>:QZ5_-
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MT%R<I/^PD6CE#\D4*(\7=F_(;&+96AF=+BE<+]+UJORCAO! F&823&7R-<O
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M]0GY_4F+V:+D3'?9CUM.!23WG5^;&K<S^EZRYUFGO'T:;P'A,-0Q:\H#ZX,
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MS]S:;QFH[1A&[D2PT!^+@S%/<Y2Z"0,59Z21RE_XQ] GL)QR!VZ.H(]HOA0
M&*WL74:M,Y4>^SS:\1<K_C=EQ3,>9#UP6Z_DMC(;4I)0/3PG-/,>R*; NFB(
M(L3K$0#!QVO</<[,>-]>L4CLPA)A\MMDM+*>WB/O)0!(MHB&,(AB8$L4JBW!
M'@3@V2G3B]FX@5N:Z(4X 3#1!;TD?UT(Q. ;$V2[\.<88 ^P*"8.3B_63FOH
M5UNEEC#:.[G:_'O&ZF@K?2$QH .\J/ Q,^7X1\V"@@8?B?U7*TY)&LY+S3<A
M/".TKK?E"V-.;1@SF6#\M)+>@-@HAO[FC?/SH)[WB"G6&M9.6 JJW,\[CCG
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MQ)L\L;:$J:-.SLF\9;9 =AQ"0I+:D1(+,3U^=' <+"6*?/%/Z,J,6'YT\.Y
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MJ,^AO61*BG'RKG&0%W!"8I-E4%[9"3VHBBS\.KH/&:/YX$[C>LVJ2]4K >+
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M3<]%R]'M>E7#;=]'[<;(O]/^$#U(:V[<[U3Q_7U_AX/]\?;>D[+Q5X$O-]_
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ML77/MO$?7D_D*&_'VU;<_KP2V0HHG):">3RD(44DSU8Q8(J>=!2J8L2P2[E
M&&JFOPLAP;(V:7L"K1,Y)N"?Q.#)%[?ZM7I[NA\''@\5)W?*  >R*7S+6,B"
M29ONQN=B01@(4K#*'5)Q(Z,HD)#98?1UX^_.ABK'5I6A(*.#0?G]AP]^N/[6
MFI]7>#L;-.5(QL BC\7ET=92D9=F$=G7J!_""H=LDWO7H9BC[RL(N_*%.>/#
MBP+['Y9&VJIQ])A6UU@P4B4-<]ZV(.H"6"H:(!\C#IO'V0H5"^8QK1N;,;I@
M-)ED-#A?.MMS^T_,SQ^ARSD:SRS/=XN+>VQN%7]$\79(H#>_%CK!&?X&5E'3
MTJECU+4M7D&DW6._OJZ2QJ=\MBYZJ1^^+KW=_D+^ZR%SP0.6[X66R9O;4:(E
M3"4LT8 E4A4WRVB$[O^]1/I28$<E2P6Y&\0_6ZY5=M6^S1MU]%-;Q=7\9WX"
M-_R$WA'.(2"#)98<#B9_]##GZTA!RU":A%C_SBW^+\&JW"BYJL_!(EN5;J^L
MX#5/[=^A?W%.D_2<>*Q&!C1ER2?TS(F 12S5+*9A7#>C\\/E4(QJ+\@8:T<F
MTK2/3CQJW[M,(]D&(6->M)8?FLU4\7ZK#>AILQ2Z>Q%B&)@*OH7)=G35"HZF
MBCA+[RM^'G2*=>@-V/0A5OS^Y3-%I*T6F6J:8=[R'?[N%BDG*EC/&WFF81?I
M+N03*-_79HW/V.Z %.=WX!R'Q:4&/,:P6PF4)0*DB>TVR&LEK#35HOVGE@CU
M;27'/J!]*N-B''Y96!!;36Q?N\\MUTM4>L[',=/WB$D5<('S'UDH4]:V)F:B
M#0B]-69 !Y]+2!,W.!\OC;4_[.#X?TJ8EN "@F]9%^&XA+)@KIUD@WF_56@U
MF3::_C>4Q=$GA&=L#<C1:F&>*"]7-9D,U?AYB;W0%=^U>C%'H63$H#'L_"TI
M%(PZ)NWQ5&0:C+G'1K.1TAQUJ'K4[GT4(HN4^_AY,.GA^YMS;TEZ<L<+O"IB
MS(ZZG>HI[>K(> ^WW&^;9'6D8;X-*>5,&T4$S6W]8)PVH6NEM=S!^SJYNV%$
M<J^V]K#;DF:C8Z-?27!2R$\D8VMZ_R8MKX";7 $+J;33FEY-;#H?*%7,+I5*
MS^D_$7-Y@1E_?KTOY%.'%&> T()8Y0*;0S-HVOD:%EF!JN^X >YC&53:&ZTZ
MVIO<3T\/:+SK'_?C1:M-5(-FEN&#</+N;SOMA58,5N'V(Q#(SMCD,Z6&4,+F
M=@Z6=OKO'K1C$F.^FS3Y)OFLI]:;ZJ,_AXT&3O3TC*V2E.O">&IPX D#:/?:
M"CR#"QR'_&@&6:CZ=W,[$A'=5EJ)LFS6D0JQ YH/S^>>UPQ6;5#1K+8V"WOT
M%-]/AO365CY3V7*T:99L"\,6>D9+1/;_/=A^S2.EB7UFW):IG:$G,)VNNYB_
MQ;/N9N"&-+'>C3AR(F1CB(B4Y"!81N-"Z9QM<2IV(/OZ3!;L[YM3B'Q%XS_J
M;MO4U7/-W/@>R?- =+BS;&-=9N,W@WZ?,XBK6UM995Z N #5))_NSI%0\7H#
MVK9%!+H[#OO.C:XZ;]O?O]08^,?-GR^)1R43;T4W@/D5M+N?)>/!$1.!@<"&
M7L22CX4AM!%U V,<_#>TL.8Q1%,L_#LB-GS4T^BZH]'/GK&&^+&!@K+!!7/S
M4-?;',D;D$,5*Q'6H(O3B^0SQLH'_]7"9S<Y'I1=\@+9[Y,X?1:U,23!TCE;
M=YEW-X8T%';L%1)Z<@7%CPQ \,'1%R=0YG%\:!-VA2GK)%C4FZ,OADU#*5KM
M&-@P[[@1?=5W2F-14?K/T-6R*;M=HMT1V[(6> <Z$2^P+5R I>C!4(-%7XGK
M/@QYT8=Z_C+JYG&RA_2-L "D8IWHZG'_4\.N!SU/W(UTGRLEU%CU?52Y>%&(
M@F<II7-$)NG?&:>A=.;9."7:]L96TZZL2R4TI71C*:DAR99RG8Z>=;T#<UN2
M 7K#3A?B.;?KK!H(%\WT"2*#T4M]-=ADV$W:W=BT4HL/EEK\5J+3'09!_LM=
MB[V-JSI^M1E?6Z1$!XX8N*B^35S<P2Z'\_;^/[49!FV!D\D%ZF?Z8\9@4D0@
MXA%Q#32IZ\/X+$L)< 2I-5_J7:.8=[+T ^ZSFN)5?5H5NDCRJN15G@4$> 0%
M'<CF3*&V_ Z?P3,^T6L^04-]I0<=$2GY7[=+_-3C]'Q3D_GD(--UR^W*.Y$O
M7_YB;F$&L* K<B:$,0?-TD,8&$BNYKO'=G5(AR:U@E6Q>_9U+53T$[MLF;PA
MZ;#N\:[Q04#N]7E^CX4EUE8$78DJE/*"$,@%TC%&]);TJ%%Y'Y9/,E/#=M)8
M6.W-JT\M^V[P7]T;:Y%?)"REH;#Y7<-V=CF'!S-$ -W)T"[,7:8=V@^<ON'W
M!BK!)OK/Z4P]?NFPNFH\'/C)W.C=8X9>C^ZA01+EQDV ;0;QP'Z)8^<@@P([
M+#ZA]TXW_=%@/ZAXB-$Z^"-9T\H^Q;<H!%T0@* ;M/;MQ5CWO],9M()!C_@6
M"3KFY7$!)8P"2P)RGE^3"Y[3A)KB&3[;^PPDZKG I7=A?LVY!P\UY*E5Q!7?
M]7AGL44UJ>89\@$*/,P%ML5=I,5VX2$=J1X<?_"%#1NZ9%["LV]*23N=K:;B
M++UT3X5>V1*K\8P(9/_DP3]#4N!^/[-!R:EBR?[!&.&[WD@Z*WY'RD1K/(W+
MG3^1Z]VO6&G4XG:7>,F3>*&Z AA9S6Z0Y5E%*&(I2V1(DT"L02K9T,@WK302
M X@<HU:P=REUI7W_VM//GV</.%0F[2=B1IY7Q-=;GLO?G(@,F0"6>!2>(/'0
M[O3.=?HZXS3]85]5Q>RR0=7RU-:[M\^0@XIN5B^*T"[$/,S-WN*H(?C'DS+_
MLX$CD0;9@"U],)*[A,_.]W?LAQ+*@TDC671]"PF-4Q^BH,7"$=+Z:3I/Z\W]
ME!4OS+ @: 5F6M-:D)0Q50-GL+\'-XLD7A,H.Q-TQJ,W1-CHN[#MQ]IYKZ;
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MF<WOSF!-G)0.@<HWXWZ@+=5"[N';?\]:^!@MS'VK0-TEN5]]RWN[$3AX^";
MX@)36,HT'E*W>CT_B(Z/9*K>.Q-R.T(_WV_>YX(8[Y<OJ4D6CV0,1PM+3D:)
M"BG\,NW/@W8:K!@S'5NZ;M"+*#8=58A.9L8BY!,>4HORLGE\K[>Y]W13J?%=
MI9685PY'7JCQ*>NJS#U])*7,AG.& @\%]8C5+/H1*J$/13*E[J K95K)AMBY
M0]BGF_/"&:R_3W'MHO[%YE*C!_&%A6O-?M'LJ7UIY^9,F9ZP60"6<H?0W-]O
ML49",I+8]U5<Z)@7=)/7SX(Z=#ZL*)W:UY?_^+Y.2,KA69G3K=5U? 4G)!*+
MX*3=H,,CGAL,SFQHC:G]E5 GU>,\4V)=1,6E%6N"T^E1C,)1YDX_<N;JTHWQ
MP(6=#F*O$L>W(-X9O&E81 D@*7-KD"9JA4F3$H@;I::O%(7#:,37ZT!#2L8E
M.<L%7_6M?)2=L^VV_?2!5T<#YR^E.8WM/G58XF<8T_8F\ ?'^ EGX"%8?2LL
MY<DU1B9MC<2DF,>EGP%7GS6._V[3"UYW;G,\M3#<,!BBZ^_9TK#7X_/+MKLD
MGX9GS^&[=+#GWF!AA#;(/E/4&3C;@^0UTCFH0G5;P:A]N.@CV3=V>/:PNO<-
MU<YLGF3S@;F*Z?=PW0R16^Q8,CB."$QP!+;1;7!YA."UF?$)+[I6:O6L-<W'
MT*UU(OR^@.;S4T,ANIAKX@_+3C*OQJP.OIAF:,+J1G'Z4. )/)\O"\G.PPA^
MZY!IG-1RB,YZM71_><,EBE^M=)DZ%W3X1^A3[POAH=5MN8GU-P$Z]N/H/X6#
M)5K]0LK&1<+$S]Y2.X"V&L+T[I'>C# JL7HM[/V?]E)79;'.TWLZ9I[\LZ?_
M3V*PY!HZ6T>[PS^N47> :5DTB="FT#.CS*M_N<!HV[Z*A(TY9YT=(EMWN:EA
MSLYKWE[Y=5(HDQ7VSY>8_83&V%4]"H*T,>_<A5PE(UA[=\T)36E/&Y1G.465
MC#H(/(^L;<^M?TBMR,D]O/Y3GWP,:@-+J$O]>:FEZM!N>GBW]'=?);I_5F0%
ME.Q0:F?3UE!JDNNY8?OVZ[$ZGOR[=RC/^'G-]^SB6\1*8(G;"90''<KLG##L
M.6&D_ZS%6LJ&>6-K>1S*:VIM[;AI_;:F'E/#D6G%\>AN&W6%3Q_[&"/8E7UP
M_L%)G+1Y,.> 96PBW9GAPBZ=L*$?9-^><:1)./J\^1!VL?GJ\_<]8971J0YN
M@X>>?^R6-<-7[WHD5? +)JIJ_2PY*3MVPP5V1R-JIE(,D7GE^^J+RBH_/+DW
MB/WTG1<>T]>0A=W;H(C<.=[S^E1_M!O[*8&23 :/K<UJ,Y*134*K?$R],\&<
MO:_B2MS?-$V'KSR>/*/EEO/B4?-#C>*DZF<7VAX>\M %^+XO[^(C<GAA5?<1
MSDO-Y'(!6O12)]SXNVW>4Z%^^9,LF_&ID,Q?;'?A^5*C%L5(>P8#Y&]]A=JI
M/'^X_M;IZX_BE. ABC*#A-1CTXP/QKHVLK-#?V!;GE<V%4H<Z6UMI,_8Z<>6
MG-RP6UD;'5)_^"TOO^@!^SM<K//T9(Z(-NPL%K0!VE%Q*TOTBQ3I2;0JB%V!
MFSG>* ]R:#)#UO?(:+HDZYKJZ%+4=UE%6D7<OCT<198A4$K)]4J]^%DQ>&1I
M:>F12DD^">$I>@BF05?I;AB%LU;<7[\^ET8Z,#5W5F7HN5%^'9N^M.#4,68#
M8*QA>T<1=::K6IM5 S-48\P0CI?@GQCI.:'4T^)AI0=5A50J-8&3=S\T3ZVI
MC#Y\VB;KF*GP&AF0'N:@3O!BB5%PXBQCT#8'7"*>.1UC;G+CB?>W5J<[1Q9:
MFI*T;N[JKR][BC@V"?<89\8PG S1G'XD>-(;(?:-T$0FTFD?T5MJ3)Y0&\U7
MV7DS^IZ[_(<?T+?P"+_V^-0>A;]<!L.)#@,FS4F;!^7VP5T&H?086F<Z<X;K
M@CEZGFI)&UX3QDRVB9.M\G7/\2]GG)3O50,W/L;?4#B]U^VDA=1,-T?$F0EP
M!EK3\\*Y0(#4S(0S> \J+I_]YKN_:2+:<;1ASJM;K"M?TV"?([; R]1H3_:[
MA7N%BQVIL,H:%"F6G"%#A5V,]%M-8!A 2%"P:X*:E_E#?XDNE-+D8[OFFO3G
MQT7[1?V-!D<U ?5L0%G@HRAEW5>!X@R95'&$7X,;Q^A6>>68OJF6?7$O>I_C
M*R8M7:L_.X6$C;PX->ZE?[PP?8]0L9QNZM74MPV[F3"H+'7(HO> 2IWX5,Q6
M2!O$6V_U2+-4>T0*[%"=$'C7D%C0-R6?)MP^Z%5Q^W)@S>N9>_.:!0[XO>S7
M6,H#5!V>)9].W(KL)L]J4Y;C6IQ 3L7TWUT^_HRND ,SXF%#>@_&#KC[BN[;
M=:4BNSK_A_Q)H0)O3!>VWJUJY3KNI25*(&H=S#226O$#+[5X2(DTD GGBRL,
MB\C,4:/!Q? _&V&+[8X,.S@@FY/<;N0%@^P8 J(#YO_@+"PM)E3%?8IU!%NM
MNN^>])G/^DOY&FA9_I+C63-I)S #9==%Z<@,! RS'^=I1:LY5-3L>C]6*'6C
M%\?_[<@)</HFH25\7K%P?E7E]*R=^:R]'>G%WE$YQ%ST']?P9I=#VPQ6$4Q#
M-#\;;R6SC.5%!J%26U'9EMHUJ<RPO)JCQY1<[^2KVL=5N+X=5-%Y]K6KPY]=
M!/<R/*29OI)(O]8_WT+$SYPB<V1SU!?"C X>Z;%2(TQZ'"\^X>ZIWE9J/V5C
MIJ-VZNMIA7/Q^,:OCZ1$V6U82@FB#IZ0RSO_>ES'7G9.?@F535NW%WRW;LMS
M>57?-O$DW^W2/N=0=3,/T1OO"W+J1$ZYV%.MU+%$:23E'D$!>0DGR.G!&+.+
M:\,P"-;!0KB[>KUXC2YJ/=IB:+EAH/"U9!7146@;K_"@_.%K5+X)^SP,")G_
M?.4C#*/)75Q]48\S'\L7DF/JG DLW0/%&W^:4Z'SQJ6?*OCB&"ESTTM?[)-,
M3(RA@)R0YX;J#9T/'-G_(&8W<$UVN<C0\%2"B& 1W9!V\%D+/2\3V6)0R43[
MT:X*M#<T2B\\SKB]+1#C'(G;9('KC#+V'61 ^*PS56"M$T7*HKH_G$>(+,O9
M&?T]47;)J;XRQG%;W7X'\:S;F1I^YY2S*??_=#,\-@]1$R@%J+K1WA)$+DH0
MZV=QD9:SDQIFY./<<XW-J3::.;W@EZ3SNE0S_X3H4.- "N]S*6/&77D>VM\-
MEMPLXS#==/59&99XI(F0DA2>O5UU#.4PQMIDGATVY=V6 E9O&[("K-S>?7M=
MII=IOG"Z>@Y+/ A/>19<8/;4!$=4-1:\9=K+U)/^9C*WR715],0-1)SK,SGO
MG(LT7LPKKIB>O6[7,'8(H8@^ BL;3Z#<0BH@ V?QI-O]R+H?Q?&TT"/NH:ZG
MF[<._[KF]_O[@9C[(?P/O%\'6#PTN7S5(3ITN)3910#MD9!V41+A8IX"I]-7
MF8WKQ7>%JX0XU<3=[JJAA1YG5X-#X;MNG56Y':$XW=C<57'ST5'!O=ZQXXTG
MA7:#II3T+KB;-%#@R=J*%ZT OAI#:U,/[M$S/31N\V4:X=>4?5YN^.&<PUYD
MYLR]C9T=YA !YL=C6**RE0G:Z0V$IQ%F>%7T[%S;0AZ>F.CNV T/'CJ97BV&
M8B$A*;G;EO)E^RSF+:?GX(H>02G#N5.  YW#\[#UZ2E<X/Q:)J'A2>UTURA?
M\*UE*P7P86[;4\_^BY&R9VWK16I?:!0/>M=<G_W<LL4KUUO<7&I6A2,RP=R&
M(>-$?AG<X )-13!4X\6@$+=TES&C7KB-8H8CY UX38L#+$_M_5F1+]H@?21@
M"Y 7"J>1!8.TV?4YO2C0!<G[C2S%!4+6;ER+S=(S"HA]O[9U,<'QL_&#75CU
MY<_CGI/-E5\DZACZ"Z'EVXI6#. NN'D$)1)+-&L_DC ?/F/!B&H8L[1YZFW<
M-)H9K7?B^RF"]#Z!Q[DASS3WJG7]\&P6))F&=>*K8,JM!'G!MS/8MSK$,%.^
MQNQ7'5M8FEO#>Z4R8A 7Z-A,PF;J1VD]OEHVYT6:TVUJY+\W[\HDQ(QF0?T<
MB1^P6&N(R2AXQ:YN]V!N"U+RU6Z?//$,&QSM.#G^8LTQ/&AA8NK\Y85[/R[M
M^Q/FH)OMH+TJNHNOE^"?!VEC5X*8:NC==&SGVG44WV4CG#"T<>;-)-J'^ITY
M]/#8]*E7;:D[7DD6U1_C=Y8/VI)RX6"Y2OR!/_>7.!*;^_GJGZ$%5J3!2MSR
MI=>&S?E*N<9WZB1/7%'S?LD;@-.5?MB\2B,<@DT4@Y9@$R?9F80@Q#;6+BB/
MGDY)V5I:"QYFZ.!3U[V_FTY%?"VPT6K/OZ'02._?7T/REBZH>?KS>M^6Y(0G
M<&ID<MXCP1.$CTN,)Q 37&,\@E9!=$CI <CUJ4T"Y6 X,X8SRS2)^R&[:+*7
M:&YC-5-NQWLZXF[_8>LJYF4LT9!P 0OMRHH[%4Y:IXRRM.0@=48(7FS.&D_^
MUO#187?&4+/W%NK5Y^<S;CD ?17GLJ?;70XA3#&?<: ]&=(>9<D7K#M-P?E
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M:K]?,TUK#"'(Q.5Y-$W\8HH%Z1O@\6&*NT(?V^C^M%\Y7+8GR5$6 &ZCBKE
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M?H__K8.40<= X32Q'+GNJ9S8F+!3&]'#*3*[WTU4T(=X'QT(."[9]!4I8&E
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M0=Z;1S7QO6^"49!]WQ<A(B H A]91 &)BH"(&,6%38B"R$Y$08*$%(N @("
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MN3%Q!B4!T8K*>:K4ZR)GA.7+Q+9VN4*:G,!^SE6@^R#Y/.5FVYND*)2:!\Z
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M+SQBGU4OK#H6T11^Y7C)]UDO[[X)5QWV*4=4"@' I=MM$\QQ)V"A F@@,87
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MS.98_Z\@"_7_Q_)O:8#+8\O_2A!,L$8*\- K/PZ7CY"O+6XE_OO=?SV]TV@
M%;8Z0V88,'7HI:J'H%B6.2Q_MW'VCT$K$3_\Q6C;6W+;%C#V<]<U/B+-"Y[
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M\; 59/K2UP :.L\@0FA;CWFA\*MO)#MU#S=W;AV?BJM2._BC<<EJN,-(1Z]
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M6XBV=#-+<=9[SE-U]T/-]*UN#SWE"R,D=]I_VO &\0]!%NCVLM/&G^!EVEG
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MV4&,;1[0A6]%:AP;^6&[/;QYK,GN2P<E_\B+HTN)GRN^Y[D%*S\W<EF'ID!
M&^W<O5"\P$9XXCK-9%J!ADAF:F<VU'3%?1GZ$8<X77/^O-/DHJ2$H_,#K2M7
M8QQ4--4?W]FE+<5;SZ6\CA[)K2WJ,E6AI[-RV3N!Q#=H72"2:MR9J21'C6U/
M--WK9W"$IC8Y)APG01=0<MU\]\1;Q7=OWI^"#?-E!M'0ZJQ\/+$(\9) J6#
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MY)MUDQ#Q0\%E 5;#.X0;%D;\#DYHW_4^J?JHR3?U0RE@_F&JX"L'!*C8)W!
MWGW;,2W:L*U "7VL\G4=@ TEC2LX.)]I=W)^_;(AR]>M/HZGTJ-RVP=BQ&16
M'6A<BN?'U)_3K.V_]#&EG68([7Z(F=ZY%DN]QD8HV-,NI&MIV[=*BS#=EX6]
M^R+"F?P"/-T*8ONMNOGG]:37BKDK6L-ZP@P@85)&(%OT,%(]!K$F1T1H%N[A
MP0\H_F=V91@D!J[))<C2L4T7KUE*K]O_OQ?\^3]AA"$HR0QEE#BKEBTTA5(
MYHBB<$1UP@S#PLQ@T%9\,-B2?%]S96?&U,"%0EN]3F#<R>?E!]F$G\=W\WX)
M -3M-\H=A+,BV?)>DEYH<,4(;/<T<+#M.!!/TV)_65CG@!"O4F39 ZT^XVH9
M"E[J=G>=\B]T]7QC%LBBY3<:N')E *5!+E-I#X%7L5C#F;$UYX:8<)(FHNOA
MU&IL]62[<8;GC>S$KLK#14_6G&2 <Y?L1ZI/\?=Q0!M&2I)NRBI%J]1U$!+1
MXC1=%]7LXXDGFH=1ZC0%IWZ7]7?Z(=:W[@P&*%OURT'XAEZ*'%*VMWF&;H57
MT),9>VT9X/G<*D+L#N!TT+/7R7U1=OVL-,_'S$X/U16O$[FOOR>&-5^2")CF
MM2\[?4B)CZ&):3F =X6,S76%PJ6:!9FZ0WC2[OJ/HY;8=O0>&KH8AW#TRH\6
MUO"JT<B:F!!]([G]V!%IA:I(;/@_O+_6G^NOQ WA/?IB#^(I<@7LH3IZ70"Y
M5[BE(39&]ZW-.,/$3J;.+M,>TC#_13?C%(IUN%AQL:JQJAI?>\N8<6$NQBQ^
M9Q:O!O@P>$N3+9W JH*3DE&:^<A,MC2>J9H[Z7B[=MJ6WC7&?!P'"4%E&7@\
MVP^K^8YAPH^PRX(X(&@ FYP'QG.YV'E!.?FT^.$G.XF[%4&*=P[BX1P0:1WR
MTR=W[19F51I"98'7:_J8K_&,A @8!R20,-L*ZDUN%[/11&,XH+8?\(51^#<Z
M![2\%_X+&2C\9U"1UVIZ6W"HJTBE4X6G:IIRKYSI4$[L_%G[.0[H5SYPY7"N
M"I\09LM'$U.R:>EL<<@2G"*<^ !?A2;0<Z'OL@KZLF:['E'ZIF0_&"T>4DK]
M?]"#BRCC(OL-00SCW7MXLB-H<14&H8F6U=>QAVIJ'=*09FIV%Q*UR(6/]KL;
M&AJ!7*<]\\!QJ(T\QX#^)9CB6^[36'1,3F)E6M2S_4+#?5\ZG "13>-?D8WF
MWD^/L5>>VD9 Z@@=T/')C@(ZFE5;[7P86BF=0&@W$,^LKSN9,'"_;^*R(=FM
M)Y 9WCQ?+CS# 2U-44OHZ=14*JZ];/-Q6LQ!=%' [8:*(.;I9C%C]Y/G7VJ+
M\8%"'+>]?H(L,*^E@6-^^O@PA+N/UF9FI.]+/1%;H+%'&?O4"??A"Y9>PMUR
MCD@\RKWI/'6:OI+;I/DHG;"B8!P%>\X!469F&;;<S?P4+<4>:)90V@WXE<>K
MQI_S/GC^@\1"1Q^U.\LDN$VDY!+QT790Z-"_0#3/_V%11#S45>8V#HAM%1J)
M7X)S1?D)'_J:/==B_N7=/^ NHAQ.M5I9TX:+<D!C1[A8<>"MS[>#^(L88CKA
MFQM:@0-Z&5/  3U-Z^?_^.,_/,?YD1^F"NT-QSY$DC7W3J]W?I.4'G[\24/U
M[ YBB<8F6<@1A#BZ'_&2OWUEG-$12X]DQ>N5'>:ONIJ!$9L\[D+F6VA5'&<<
MM=C>NN9O2'@$?O4U#YR%<5T!=H]&L8W>!E 7R:77D &=A^+LC 2MG<W-.G?N
M"]J>-?/.-0T][Q\]_V)MD-ZR$>J(,F45J-33BJ+EP6) #U],_G9D'?YR_\6]
M2<N4+[CWQK$@GADX+\;?-@E?&9LD2<>PJJLUS:V-?2T\RM\]<\KVK+ISO0WN
M$YVB:!48!?/U T&0'\^9'"#GBB%'#]70[&\']SA;V[R.L_*ZY;$_S>C<J@@<
M>D5 #_V/:5GYKS[^+BTURYW(T,[<&+C@3X(@TH<,3B@8Q#&#R69YR)/C9;.I
M-:(62W4RZ,-KWBWP0)]KLP1O'B5AM^>F-G]9Y-"4"R?Q'%":,S&  ?[$ 7V-
M1#R27H?_)W=_"?Q8Q#(E;K%/</TQ^M8AS(]*1V8*;A0"J*XRLR Q7)VY@ZO/
MYMVJ>7Z$_V>@)Q"S?2,E_ ZAVC::T(*7;#J8&2B2;=Q-S=0_(\ZNW'/@OJFV
MD5VGK'A'R+U3_'/H8A)VHH0M&#C#3^._4Y[; 1<+\(^LM[!C&+M%QI]SF^A+
MXE%^5P>YM0RNA'M )G))<(HQ"4/IBYWH[!G;JFA[M'&'?^D##B@LZ/L.4\7K
M16.?P69#/WH-' >+!O2X3F:C]8.'&ME.#Z*[]NYOL;/;O%\E"BQ-LZ H;L2.
MT_I:$5*85A8K/MAG4GA1W6N62BF=ZTUL#'_P:"W.X@+$2([WVH[=O)0%C5GL
MN#!;R(*$330XQ80"<R(P>=KMZ^&/U1_(E@4+FDW6?>& 3NLC#]1M9@VF;0VW
M_>?#SW_$D.Y!08%!:M>,$6TKX$Y^_A,!'&6>#27U;96ES"8Y>F<TFC"NNYV?
M/OO^E(.!UDE>";&##_^!?5!Y:76(*M9=E"LCD&E/M6=N6R5S0!V06 Y((K:#
M=1PS/MC1D-FN&-26HU!!;5/&GL@\TE25HPE3>!K_63(+CW0Q%ZW/D@K'<3>$
M"E5]B;^ J4:U2,80\[E6I\G'@^LTMBVL^SU]I*0]3/&M8;S5'#GZ"B\/>XO;
M94E1NW$U8)^<N[%5<%<B>XR+F0F41H;U D*< R+>F^ :%HFV-J4=-/L$$_'G
M4_/R["*:K6UVF]<3FR"U.^5U!ZT%&A(L/^_E@#PL)R[1TI) T\U]I#T87SR@
M;K T3O6@!P)>##5O[O>*I9+ ,71YF?@F*U*NPOQ$R-, C,?F:S'6-B<MS_B$
M;7K\U(,@>TK(8#H/',O>S!Z%R&TTR%;F@@X]QBGT!\*VG\GV+5WD^^QLQOX%
M%S6:X+">IHS9D)XHW+K*(\S%ZLJWJPT9GGFO8-?YMAQ;BX#A&/;H;B6NAHJR
M\LZMPE-L& >8)X$(U+%@&KX-)@R\OD6&0Q8>%J(/#M2$^CB]6O%;7E9-I.R\
MZC"#'-YD9"@K6 ??B/4ZQA[$5..7GC*\U#O /%_Q6WZN3-QJ=[Q:1PR(T9\8
M,JAERS4.'#WK='':UE.>)S L=//UB[*H-_7\6NC37W.,J:%,*5NVD -Y)1(C
MQ %YP<?0 =$N,H 73<."-M<!D?">-ABHV1W<0U$UR5@/R11-^M9-M;G1H])C
M&.OFA<VJ5X8\T?TW1>AF138]K^J&$)S>+W+H4D_T"A=5"FIQE_WPG176CYH*
MKJK<P96!XN& 8'",BZ!UF<2M4PT_WXKND0WXE&*(^[# @G ?B, !O=6B&K!B
MES$_#N$^"/TAR#\Q;$%$V<(V1$5HK!^%:1QT[0D'=*J]HI+(10<]BXA[TNM<
MM+DYAP-*5Z$26+?U(*Q]&1&F!+:$,X)]1YC F/?D@&YGVG- ^8=7V>N.8T\B
M#G!QO=HP5SF?XEJ1Y@PL8!6,69>"8E:>EG'E'O(O1@GS9)5S0%<"^-"#=@-
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MAU"/8@%#?F)FI.O #0B@I11-@HA\I?(E3 PLTUM;WYD0026;NN0_,\1\%B&
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M29??5_N0&:P%O6MTM[0@"+L_=J>)O2#-GBULQ!4!QKF/S3O0'S%4&T*BRV9
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MT]>[PN:K0<4RM#>Z(#<=X\)83&L<JUIW,5G%ON*>DWI<.>6]NQ-@1SG0:7Y
MFUFX]8*K%KJ_JJEZ2',G_F5#"E(]V2W&\Z*VY6TW[=26S=<%\D3PO\QJP1\S
M6G(E =3U[V85_LN$UN[.$\'\)OQ-^)OP-^&_!J%E_S'YSD+2.9[T7LV-@R$#
M1C"Z&\*/]T=$:C+@3 0-5I(?7N)4/832)$/$%A(]7G@=[,U6R';JV2,K/M?I
M&L+KXWZ$EF)1:7^?/4:HY&^!3 80RT9;\"EHT.!/AF4YO/J&9+@N3='@7,J>
M,]/?]OA-J24<_7XQ(/E^;:,(*2X/_ #O@9D TQ=8]^'$)TI;N5C,GST&D4<9
MT(J. I%$9WL$U:+=#]Z66+"X'DH/,E>-M:N)G)@B!U^K^&2^M2EA7$Y5"TZ)
M1G- U OP";@-*P(MLJ<!T*.6=(7(]U'$:5NT_* U"H+;R).M(="!6]&[4ZSK
MCB2Z'STS[1KF\0E/?$2@GH!'P%_RMR7+?S]&?9Q30CNSV"J/SJ()D_TH4\/+
M^3CG8U(8S^"<;P[N,=-60]V:'S,.?$/A=W>)D_" P0Q;T)K8:_B5+09(DED[
MWW_XKF"J,8--\LO_KIAH[(NU$Q*6L#+\W,_OSCB':3$VL:*MTA\.<$ ^B-OP
M6GLL3!SHLZ**-(O+N(@/_,CN+O=5?>TT4-GUW/$#>"5-.X2BJBP'>L2^Q?1D
ME<%,44@6UF1'&,,.V6-%.\CN0U#/](DB+3H1XC]>:QD+0R0\&ZX6R#!//(O2
M^?P&U?-\X!AVU:Q =DYOW8C&8 LB&++H@9P#=4 T3;UE>D^T4^SANH\>0\P#
M-!V7C^ZO!XE3LTZ?LH7'CKTK7UU[*L(!'5A[5=YX@G4;XTI1H)_+I4,&X1YX
ML2/4)W,VMQ1R-Y?E,U0_&J\E?;":'LB"WYK;]AWU1I70M"4/G,UUSI[O@G+7
ML\4<?MEV$Q!R#",.3G2D5[[LQ(0IW??)OQA>>R3E/#Q,(@VI=B]8;_4\4F:I
MYD\M))(PKKF*GYAG '7JX!FN9#^9L7#>"1<'BCK6G[T.]WH6([*O[-E0N8>/
MIP'H1*"TR#G_#UM,Z1%"NTMQBLB95H@(2K(490G<(1O;0 Y1V9F!Q3XWF_/W
MIPAK6*IX7<VQ,-F[4^. >MZ6"#U/W-N5B4RVV#>NV*%1>B-.I-6E2.IB9ZYB
MTUG=YI.Y8I'/WCZ;'Y6\\:U]53P[UFA^ULFR+.K(C;Z4,137XXVN@A.+UCM*
M\4)H(4]"%7^$EO_I[%,CI9DGF_;[BS+:4%6(BB[CO+H[%RYMY^WF7U;\<Y+@
M'T>UHP6COYSB@F[ !#F@NQVK:VP59[V@7S_\&ZA&Y.*IYQ]CV&)B WA/4WDP
MH :)0D,6,&*3K5OU<0;QSP9'YH.Q-<YA)>S[NGZS:Q!W%4\5M5<?CH'0D?:S
MF13!/Q5KKN+Z6IA)G<YI"589AIB!/EC'RC$Q)3OH+D*3<F0_0K]<6/H>5R.H
M.,/0I=5_?O)68;?JIJ5&A<^X<:Z7QW6V^!W8XSD':*O17.<;*L#4I&T%?,CJ
M_:BSI1U%7H%>Q<4[=E#R&M)(K@WNG1?:G0^YJ9+ZZX;PU&/0R3FVT####--B
MUKP/W4F@GNWA@'@\,W/%4+(>KZF:Y0D9$T\[VD>W/1$&E#2I4Q?6H,H>#N#>
M0/Z>[VX@= $*3B/<@>U!@H\"V413YV!1</O-8[7%!8A"WZ@O V2U#+G#]2+Y
MJ<,OWXCG'-+#G;XP-NX5<FK^H?LC._H(;9\=G6HNOO.8[/GSVW>#0" BSYG^
M?]D7J'\MJ6D67SVZE$S-IA=0Y^B89-V5RH41FO2@B=G5B(L3.?E<!RXC=:[4
MKTN=S_8][ BUJQTWD<X6C)T10 G2X"<RV_%@_W*!B@SU78J%GVNJD]G/3KA5
M@[_E6"Y^L?\:[ [TM;A( K&D$CP_<J:-WO L*URIIT2C.[H B[@"WA$CH+S5
M3(H'2_69P;398G/$$CLY(!$3*VE6 <DC<;G79Y>V:X;.N_T_3)3R[IJ55S9O
M 7H8"JA05D*3*[2K;VP5@6_ZF-^S(&_X?G"R[5'U]:Z!!9[%Y/E1 /5N%3<N
M3&<#7@P;QS92\J6./&2+*VL9JXMO;%*^3O^ !E9F<Q^',=[XYX$QI7@%8+ -
M(LJ4*6$>I367/T0GYLV'RJ?@,#MU-&M*Q:LKWQV.:M^KH0]23^$I.\X<YR["
MX$*#?S;C% H:2Y\)B/=B*$X!!A=J@4B#ML;7=L*&S$/?CM;.N83OR%AA&$Z&
M11Z"(1YVA1S2Y5E7(2(4D*YD^Z@;F+AIP6$^>C)NWFX](_7F#B3[HX^)];XS
M?M=*&U/OD2)4#)65-.R:[5GW\!Z0<3!9?4F]&*6XT;S)!['=FP,2-K&_V?<$
MR&[E@+9IZ6E,"7T2#DX_,?A3+L<IT?#<X5/M%WMD)G8)?:QPQNNCE $^$GAL
ME"W\FA@PWD>7H,4F7::B\ZFN=B-L4\#@'*WS:=D\/;?I0G7VJ,&J9+5!6E]J
MVY8#Q9?RW:Z_@13=V$CJEE(A673:QF*H9R'C]C,6"7 ?L+Q/1K,&*T]UH!K'
MZW2\(23ZR;R*1=/=(_0+84WU'B=>#RTOF4MO4U.P'2!0ST$B.2!)M![[?8Y*
M;"N\FI# 5O)TA-S1*[-NST +7*#4B*(ZK@XX36(\M[_U -UPW7WG:+K&YN\J
MIR;?P.X^:?;B3KO>XD%\'(9X+[?JPRO<0IW!:!U"X(>5%@ZJ[N6>U?O$/6LL
MK7T]'6']-Y1._B>,B[:4/52=-DSUZM+*#'Z\L=/Q\6Q&^@Q7-2ZX* ZMW/AR
M.C" CU*:L:)ZK$WKIX.P%M'\4+=* J7D'<8?CV4K;_0NO;*20*C&WV8:*>%>
M(,$D=EGY?(,O*>ELGY^7:D6\_MUIEUD^JMF$ M?'EJ/.L 4V"@5L=*D^Z#.1
MF<PUL&F(:EP;(EY>\U,,5R\)(OM:Z =#BM'&ASVR+NP'@1P"-+]WO=.)_(1$
ML,6B685P=\BV,=1&HQZN^+7L8P91W]&_S&O&)J+4 E3F5\](1O6WA!RVDOV<
M$;/L&G%-4-:0J_!.8"=[V,+GJ1P0_0GKD<DQ+@OR0"\)KH128[W4O;68NV7R
MZXA^ZA32F^3+]_-Y8( 7?\:'9 G9NO=<*3S^[C8$M\$HIM:V,W<2VHZIKELJ
M9G@Z(7W:IW< .VAI*VU%IU_VS\3TG1MX_)FA8.5O#7T@/W'&-O^0^>R^-Y#@
MOSE21OI;*"6("ROF@#:&)9M X,7[8K:PQ]$[J8C89LEWE'*4R2#EBT_ UN@]
M=V/<7B5+OC^S(QUU_:J>[(\\<.^*&+H%3@VT9XI7D?'M ?R8EGVH T1\(IP?
M%3"C@1/W:O!_%7JI:OZ[;8V!C?3P<&F)88+ADY $*Y5 (9A46LD*=P;-5S9Z
METDM]]'9M"ZF=#1;J)=L*M'6-:U"]6"JR*M'ZVJ4>*%[?-WJ_ 84M$=H7?).
M>W>JIE55IRRW1$!)&WV?F.(*9/4[S3K(J!6R!5/1H)P);QS1N_7X.*%-27G8
MO?KA.\%9KS/[*Y%I.\^?;XT1R(L0.&6(R\<0$_ O== ]N35B>-IF3$N8&^OY
M,4*DEB\X0L:)<7PLH*DJG6%91.^EZX>Y6,(<9RBJ 7(37-7QUW*1_QFYA?^=
M@:I@<,6DQ<#D .W*0D "?-.7V#:7_2FVU29;TZ7+F'G+4URD]SS;)%XF"DU]
MJP4K>A(!V\%ZQ/4\8(: #1D+G$+4?KA_ZW*X&UF@R2*8Y_N5);PW+^N*^,"-
M#^:"GP1O+N(#X!L=?Z-8*34X$23^#;QBJJX#&].\/]OBH^Y4:!M>?%]I,!]-
M["G:E^('Z[WQQ(CR1<>1[[':FK"E\^'=-^G8"6/Z!<"6<1) ,,#D+=A*^F:5
M$R,4D%/)+OB4+^IMSO/QLTO7+#K*@AD6F!9]$WL?$C9>:7L=K:[-8]CUU2#[
M(W^6;WK!6FJO_P>%I=#CYM2BJ#>IC_A!$NCWA"H#IA0O79/U&,]5O!.Q1/Q2
M,4D8DXB19;J"XV!*[+Z;D(0R\_NDM<VG'-;2IXWJ:F[%;''JN9.<JOKMO,2A
M#_I]W)WRE)I+R6+H>^.I24RNR8IR0[(AVU!6(_@:M"XSG&;; 1><[BM>@)V]
MXE%;V9SF5IT8ITG9<>:E^2%0VA+!CRG*RH/)H#\J@6WE4/MI$L[M^Z'[/K=>
M'+>T6'_E^N'<SY99)[DS%GH3I_CGH$RI<@);2(<63:\'#I!MHS!<7TP2F=T&
MX45K&L3SQ\T !:1;1VEJQ8-%M1U-!@;SNORH-=:WXE8E(^D?_)14FBW]S0@'
MY"9;C;F-I]KV22"K.C!;F0KAE\D0(2<D!]1&OXXTOY6X,])?2RM 0KBL\GA/
MML<U5&50U*MU[P30&H0MT/$4/0(1WM#&6]A<,%KCL119PMP_!),!-,S[*7JF
M1SH/ZI> XUP,78P*[]Q8S'K((Y>@?732.JRGSM@)<O%?('W^OY5JW\H><N$;
M9>]&]\*W-LLCSW;IPV2'F$>(R?8V@TRKXK&N8+^G-J:%%6I#+WN^66_W;1F'
MS+J? 6]I?#$#]URYC>8%.""&*;!(M._0//FEIPVF0T4_S0<2Z!\HFE_J*AIK
MT@0_6SD[N+JGF.]X(+W9+4I[-R\U^C#76PJ"^V"$YW-$/J*X )F?!^G=VD<:
M_CR*!E57C907)+8%]3;VIG78,87MPGO3E3XMPVK6N>9F\PU6'-P# J@A6B';
MOKHHL^IUX?%H4R">'#+:%#;SV/YB78PUXW'A3KY;6<Y1F???IUGVJ?2J2&A+
M8W8WV3-XN/K@<;,(3900HX<%]L([!/U]GWD^2S_>?&LQY-*UX[9^>6^E2KYV
M+Q55Z"T3*D*9"ER8OV4)TW($I5,&=-&-6.5L'6#P))7"#+DYW"[?KG]U(DSR
MYAZGU_*[?)^K[Q4@)GT^Q;]\/_EG1K&[6-$SEV.!?H$2/0&!FR,'SEV^[WZY
M;9. <HJ GB;7#:@:;8'PHWLA/$TRC(-,D_KF3#.J^IT;'!#X:^5">FD=U,?#
M/X.F6_[BQ8!4TK8=YR0?@0P5[_R-%1)07%><[S9W'U<PM;E_S=F]&1@YIA/1
M"2\#)+;??#>O)$(-3R;6^AU?<;6DJ'9L[Q#QQ.ML#OE$>X[(5>9=8])REV2H
MT3.93,E;](0_A;7T.]8EU!"2E418SPE60+(/ZWG@,R_L\PF+ZXZBC8E5SMV;
MDR;M+YT7GJU%?^82R",EV8)XJ@Q;^.U,;@R!>B)7"M/:3@5SEU5WJ(!V8W35
M0!+IO^2MG^LU.#RVTUHJS_$=1?6JY><]\I645*?BC>);W%7TA'O@)Q3HST;A
MEU<FN1Z-XC.4X"C<2V[[@L'J37%KA,*49=K>8\5'@KPVIV6%'H^'N8/WU>^P
MSH0702H(3$D/NAPK E-;R,)R?591X18=X$XFXRJ]HRCGR_RYC OO1R6LE).V
MJ9K+*JOO\.3]]-?REX%;;&$,!Z3:^(9 A[SB@#YNPAMJ_,#\Y<U?0B3_TMC5
MK"G^)P%_GKQ?U_\>T1+Y9*PP,JBS@6_T#LHY?V+!T6_)W+A1H_MHZKNB"O[O
M2K<W[65)\5 #NJ!C 3/0I=P9?E8>_ HE]'3:NTEM%\_3!S*^3.R;3??JFR#.
MW+MT\1(D6R'V&9.[DZ**F&!:5W1.0')# M+"N2(IO%(R0'=DU3FQI<*AX6=R
M#"E'&&2YGH'?BR$6N8"S6W-KIE^9H+='VU8,:VI"]XG6O$S6.G*X9%\1:(NK
M=D_]3]6@0Y"G<$&T,6HGL%C86\;<19O*J.%KY'MUP4#U9?JC@(1#Y5DMG;-R
M+5W'%WV^!;$%.VBP+E(HQ2EOVF=Z;Z+50+"EOZ^>4;G[N&3LG23+N;PMP8GI
M;TPM<2.PU__\X-C_=C#MQOGG T"KC0QE2E;-Y$;6(.+HS>":89@$$#6]V"&S
MO.CW[.@$:G+N09[FYQ>?F_N=KBYMNJ8QN7@?6,10L<<!M1G%L_2(NH%9JF+=
MG1K!)I]MK[RKQF%IM0-Z8_7)T8([]PL:%&_6_GQI3HJ'N;1Q8 'WA@!ZWTE]
M2[8D/ ^;@-C,-(5T/-ZU\(W0,9'QFIAL[<P>OG?1*&5!./O"LZ1#'W6]G^M+
M[R;LD4WE@%SQ1"Q&A@OP4_$R7%O"=2O8@BJD/O!\#J1R]!*V@_K596O3@(&+
MKE'\8ZW\Y$+6F/+^;EF5:$1*S@'ND[9P?]\P&",_/XJHRF7*SQ)SMP$*SB-S
M@R@UL@('). P>1%(N%#IEC*]6S<QCCF+R'IB==5=,1#Q$DX]BIG08 O.,$ZC
MWQ_,[8".\=/]^ILE\D8GVLC@R!L$$<?Y4,<0G(C/MXN:E2_>F]1N,;I5K'P[
M^,8I<-7?6(H ]Q8*&!':\-7E6!J6#M_HT>R!'S?HP,MDDFS;DZW;Y7&Q*)T\
M9X**E?!\T*2%46W,6:%NO\]"L[:??#UD<2,3NWG7<!LU23$M&Z%P+^!UJQV0
M" Y(^B<4V-'5$2#LC=C4O&L"P)_(&&U].#NX #LW\ETO*V3P5&O*R,?9F.4(
MBJ'T>CS7-&Y$T32PIW+K^BB292AE5A&<>!^M"^S(\VH6K1^FH)S)PGXG#;7\
M9QIJ[NR+G5BZ='@YO4=Y8K:"%U7HAIMF2]#ZHE"8HIX2I&2GO%V=#]]0QN"G
M>?G;H0>Z3/QJ+;,*KO"6;)*S54X2=ZS^T]E3#^K81B4($JR1!!5%F='.W0SF
M@%*:+'7!@I-Z397Z^<]9&>25;H3F!?5E3?_MC91#*BV^]_F+<9U3Z#ZZ&0U+
MZ:(A6A!4)T(B!R2%AC"/0V1^[N%.H.VV!<36X#XQI']7FTB4J;:SV+</R&K
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M<,*'.&K6IDR1+ZZ-(^A=,42GAE8P >A$3N2>=(RL7YRQ3]MFF*8T(2N32-2
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M/8B_5]+"P_FPP/+WUAZO)B;!R&.F"HF#[)M-_>VF=8^*'SQM<1*?0C@1SF/
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M0O#U'VH)/RR&[:>N74FW$D!FKQ'"(/.IP:U%7.K3(LXBVY!W"6--6RJV6"O
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M?J0>D7AE%CZ;X?_(^Q8,%_+W;;1Z\7TE=%G#TF/TJNVV^X]VW-MUE_TX&P]
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M'PAZ'ULH& FO] >?,:JU!CE1EQ(ZBL6*/_\A]5#GPKJNDH N:_/4A9QO$#A
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M'8,H[XB;#8%GL%1RVHK]QUZ9Y+-4U<JC3E575>4W^5\1V;-/?LU<3F"50,2
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M!YEQ#! Y@ETFI=]\8E,0?_L:H%4K\'/5RND9[?R[GQIS*F=_[2=0'I_E_;F
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M$/B$M@(4^32L"LH)K#V47XW@6$33KT:NCJ'[O0XZ<IR,R9BV9#CC,[G!D*R
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M+;_P@^V/\>!6X,[ DRDBZ0G,1V2[1F9? E;_RV2B)^+HD!ZO(S<G>[S+O*L
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M(>JCI0.OEK0AQ$%4A]PKTR\.I=.G**8!\1P-$Q&!GDT6'F^A&]T;_E%5QNM
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M'KJ5ZD:P$\(C'4Q2"PG>]Z3GLCFZ OQA.:P_\L;IUMWS%<7Y!@7"I\1#DUO
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M\UC$L+DGS2#-8AN0UCL6][.NNM*_9KZ2_]>QQEV,]POR9SY<:LC.PE83WN%
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M9L1?[#R)\].ZXQ,<7(SK?'6R4R1KE^)EQB<SQ8/!OF^!/HY,"BL/K&9;<2S
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M IP(DXNL6]S'F"W,ZC>D%X3V<&XN)IS6Z+FK575K#OF B?175Y/9[K%O^G(
MA?R%=$[[Q\8W-H8U&%'VM<X\@UB. S4XJ)6TH; VUY(T>"&XMHM0/"$PT72X
M6D0ALU;<]_I>!<4YUX^$]A!)WA@2L.Q+\((S;9O[)KT,DE=AU7?JT\(RQ+5:
MT(EYIW! IK^<ZW) B.Q5B[(+S@1QF_U5,W1CLNQ9@>LO+2WN@K_6*%B8^#@<
M]%(W8+L1528+P712NJHA8)'D]XQCY2C3=O)"A@]M?%&JN+HNZR/OA/1TKY*B
MR[IUO\[N].Y2?<S>B!U'BY$ND"8H-MPBK/3$UQQCI=MCQGGQ2823B;LE$$?K
M[E%?5;Y*E)/JE:VLNB6RSONZSAM\'HF:NWSL"QYP@I,;FPNVW'%MLV?ZM$[>
MSSR$NSKI^_YZ"$OK4U:^SRV!_M/)"3QAZV<!$@!Z=K&MS--I$BD6.<1J!V.?
M1JHN/7&^\0.5[V3G[>]VW[!IX)#L]LN7!6$1T(51H&Y?,^0UMC_85T< \!T%
M^T87]&OFIR-0P),LRMG^,#;Y0V5](XEX2UA_U'Z\<Y-'GKO"Q>L"IER?B(@@
M[R#]I:5W%YO%@S6&#M&<C 2VWBV "60Y8B"L+ 0YH6XE(F2QQ]$MB)4[7S8^
MA%YC P0A.MRPZR+1K"M@ ("F9R1R]C(=VD@3R(WABW$6TB]'EE246P8*LW@*
M1?7*105+E\ZECSO;/\&6%L:$K<* (R105[Z%!&K+MZ.3*7">+,> *9GQA&,<
MO3W8I.WJD,T+$(\:5OT5'"[FUCQSRZY.7TT19K!IH&Y]T-=)3@4D^B=X0P5"
M8TAJ%;HF(H8CQ-;&N ,N&73$.HS94-@^$S08=.G)05I*L*[M\(CZ\,:&H=D[
M_(_K>)KDN"_H9T;_V11G/CR];V/DM7^N0\MPT970M1WZ2!Q>+'G?<RWRUEN-
MM/2+I<]1+PA0O.]' ;5=&1%L.^P@<0,X046/N])?\7J(IL!TQ3U:AG1/\$/E
MI'#=?.:'H&6YE,@0QD]*M>RO9*JZXDD+P>C7L[WRS;RM@'$MC9)X]&1/(?J+
MB?'DG.O@^>L+,YKN-U/M)N,-W]Q/%?^N^\.57I^ "\*#F_U:"4)@$?43PT"^
M'3?13>YX91LO0S-H<]R.!.UJQ'39-?7)^Q#.]3IC\>J;)T(N*0<G&_*]F2I$
M',9@H'>9!?:UD&IPB4A?^(0RRYB)[H0K1B*LJD>P:II)='T3VTI@(2)QT)UL
M'XK3$;GP,4V\C)\?4Z7P8@[NQ$TFG3>(H]2C%Q:+L ,DD?-+#LH2AX+R'0]:
MC95;*<5GE'H<!CS=IJW$A#\FNTW8K;NQX\V=TZA>-.# +OW9!VH+,::I?1NZ
MR^@:8"6-<<3N,?)UL.$GRWJVS(^WCI5=?)]W6!^$W(/:B%$\:,!<ICM7/ U&
MQ#4%L,]P]@\WP:\.Z31'E?0^U=A1HW=$T<O_L:C\WKW\,6;0E;4X&S]1*1R9
MW",%9-<UWGO5^2MRD^'?&DO X_8A5?ZFT8SOX^1I"L5NG=R\QH)/NGZO7NH>
MR^L/HAM9#\%YR(!.L&E-7OI@--L4[*&G-^*>M98$6,@ )XSI49J9GC>K^T+U
MCI[TV':0&'5*)ZLHQ_?X#WG.)LA_;0M<"VB]<<*XKZ[%KB.4&E>&%!#!.@KN
M)/#Z$0CSX* _S0N[T#7U]6K:@%;#B60CQ0#?S.Y'-H75C3JE&M<M5779<KAF
M^P_<)UADY"QK/SC!WA6)IRZW$_B^&+_J**+!-WS-N9IJ,NG8<SZ9-<AZ.ZG=
M;S%RJ6/THF';'E2I+KT/U,Q]$Y)*DD;Z(Y(0@#-E,N'-LM<&IFM[KTZK%0!O
M)0."E#ASA+\#V?9:1N.U</7H)_Y5F"QG0\DE=,WGOSZYKM4 U._D%*/:*2SQ
M0=+/&TK<WK_<!OME^#OVY5^%)1:1J%"T]1-#^97:M!,R*-U(^K9%<#N)BS#A
M^1B(X[Y7$6&0NUT;&?QO.!9Y]D\,I<"I#% 'Q9A@NY.Q?;A:5\8:G9QK[&*8
M&+GQ@3IOPP/I3DR_8&1^;W55\K':EV\NPB\&_?Q&6D>BSBS^LINYMPH[DP,Y
MW?_5WG='-;5M_6ZD21,!*0(2%1"4IE2E151 Y"!BH0H1D%YR%($ ,0&1WA04
M% ]$0$ 4B$B3(J$CH(9>@I""BB*11#!L37OQCO'N.=]MXWW?_>Y]WQO//]88
M.V/MF;GW6G//^9M[K_6;I5.XN,#_T=D.., 1#6 Z(V-H>*HD+80CLL:$(E:[
M(9)?8=D,U"X/3%JQR=C;CA2'Y/X%&8:]TMEGS1[W/F9U$E3.B59UUWDW\*\L
M:Y&'T4K(.)YSV(ONVH/TP*)&.8:TRMXYV#74MJ=C',4%!-RJ94QC2B=7*T3"
M4L)F;[CNIM<;<$7SND."D*CYSJ4[=#3UQPO(8^R$]DLT* 5.+:-/\\R^%RJ$
M/ ]F/0 A RK;:$L]:P_L2$6.YUSD\F:]Q*K<OQ"TDK:^"#CU\LX%/I]3_.O[
M_FQ+K]'RB&"3 X/51[:?5) 9&?L#/^LIX7[(W^"5*L71W-EPNTF4 KC;PI1S
MZ*[1I]PN2:NWZ:SE?YC5_8%'_:^WN?%2\]\5._%,*"<9^L%(F/WUL.)99SAK
MCZ4"%[@_ =F8_ -7-E_Y/Q!3B?DKF(>MQX4Z2GV(S>ET.#TV<";=39$R<?W,
M8.]'F,+OA.]_C?8ZSF(?0B^$P>W&VM4IF[\J@>2 "9]]RE]5>";X0+.:^+<Y
M'A_RGTA_];?))>,-'_Z4^EU*Z=_,[B598^Y$#R$3$Z\$&?&R%K!04V>WG_2)
M.KM=@JG\[ZRU8U0;+Q/_(Y\'0$$'<0%0';_BQ(2Q[#(6Y?O1R8H%+'7[,K3O
M/"*Q>T%_\HK2\Z,GWWBL1)\.:MZO]/#R26G/&8&$>(=P<)@C0F<J(U9)T0E<
MP/]5!,G_GGQ"AQ*8Z##%DB6_TGU/&9+0_]XU2RV'U;_(9+J]>=KB=Z--7MS.
MJ)X+2*0P#_&L\!C/#ULO<8'M97_)*G)8&4)-Y(7R*G8R&@Z7J<R !A.36I?2
M:E7'2..<5\*]5]$.]2&(@!B*1)#W5?$MPUH%:XKZW\3RO\FKW&4>Y+R";H9>
M7$V^R=H-0AX$-YF*NSR=MX57@Y5.4WNDAZPB&%DVE)BF7"%YU.AK8+":-PS_
MB/D$F*0%K+RC!9!7^U>54*,=DK3 >CJF-\1AWUR_.YZ1U(LA' BJ&Y;-_>:X
M*UU/1^.6O]J1N:?O4@6BOKY'_\>_^F"N1!\@PWK%@K#F&I29S[[--]1>,L;Z
M&E-?*-S<ANF.-QW2,OG;?*S 6&G]WR'ZOR^Q[Z?4[U)"(+'+2QJ\37H.(^-S
M6&9!CS^X<PHN57R*=6#M/JX7II%56BBRE?;BP\MJR5.]+@.8.B[ VKK$.,R^
MVV&(R%C4;:%-GZ0+ODK)V5)%BQHX/=FHQ83Q?\SP"U)V9DQM-$MWY]6\C#Z3
M-FE269R>66K$_\EQ&](=C";-*SJ@>U%[TL6.WSV66WWZN)4/\,W)7N4X]7SS
M7]+DQ!_$$- <D0CF-M0T%Y#V ?OH&')R.<_;G_Y G-GPVDEKSFST%%H]-=XL
MQ]PQ41CV4FA9.>]Z013?S@LR'AT_WI(A40,J9N .$GJV_CRXO:*/!$_F[!R/
MQ DB(NQ;GCU-_*7C251<D,O*%U7+J6CM6K>+NGT]T@ZA7*#'F_,:O>X$_7(S
MAI><!?X55\^(L##S B]B[$-[8^;F>C]2\(1F<G@+)21U_9DA+Y>VHD-@XZ&$
MA>T+B$1W5]A1_J=#[UC]F1U'WG58]T$5>9*[T1?T4GEGAN<QU1 ;9+F6:H3D
M$7HL6&8W]E4R#;4K__W<N;.Y1L\\WN.8;H1ZN]27_48ZSS1W2GW\BT</2G["
M2Y.@WS4QWXZW<X%%0[Y^U"LT[1?HS#3#!LQ&:2-%:+#T=?:EAF^AOWP?Z(-)
M?=IZ1VV?)PK_<%FFY[=2,B-<@93Y&Y,=@_G+&6B5%&)= EWHFP@A>!&PR>P.
M]:V(@45#7=@/0B)K#=K]+4__1X02P\>T88[8)=Y5R]"CV8F&6/;.9%SX'SF5
M'_\H42[F<C6(]Q1T'6&Y1?N:#BL%M9[:\GR+MO=]R5M_A)2LQ#^^P:'R/)])
M&^>T205ZIIR'3S\T8A<(K!]?].)>0&A.S_?+3'?'UD)7"=.K8?]X%WXB0VAJ
MO4BKVVMGCA,N6^ZJS>X2O-.[0N#[D7\P' ]LW;8>S[KM?</VDOUAP6T_UCT[
M._XH<?@$O5(IW)>37.B20O2<1L)+$1X.4^87ONAFW.\HBWJRP_[4 7W<;,EI
MMWB_P7TFXB/"XX8N+XA/-%9ZF%Z<?@(7R&FWIS,9=33)7BP?@O?[#+VC\G%0
M\0^R9C&)X'>D&'/L#[+F<0Y>B82L+5?MMPK^]HPSQPO"SM!4Z!/C9AX<+00O
MT2%DQCW2#LLA+M#G+K_"? A*E1<RNYTC7NSX''DS\KWU5?4'I\]+ZJI*W\AH
M%HCG^W[;FA?&1#K4$'&+&MTX<987+>/X%:PL C7L.BY^7\AX8[\:?6D'P_1]
MJ^B_"M5C;T))56@>M"3=<BXTSF.:\8SBW)7G.Q%Q7DU7[8],F'N0'[\?+RTT
M/F"25S77;WU[1J)?/?UTSI=<$6SMIU1V*3J F )ME._.P%WC G(ZX4LCV$@+
M_>_+2EIE8H/J6>SG+%'7B/K731F7>8[KL]<Z'_CN(6L72&<>1W<9HL.PUW!/
MA5,MU5BVH-@#&.*,,[M0MQVA5PMOE!^O#?MJX3]P,I<N.#F?:Q>D;/Q-P,#/
M5[?O#G.#FL2,X/!R?1<1M#]Q]AYC)WV&7ID:J9=M*4]OSK["-AZ#F72U"N6I
M>GD-5TG?=WNYP[?Y^(-]>%5R1#_:Z9%6G)C2(;_BL2'-XNAYLP&%,ZJQ=3L<
M6^Z+_&_CO_Z1(?!V]HC=\B\^?Z@S45$:OXOS>IP++/5#F.N:OQ_N"];<!/F;
MI2E^BOP4^2GRWR^"D\"1FF[:2K*VV?;5]2D^RC(XT?VPD^?*%4(V+-L-%J-_
M;)O?QRY#[9YGN8*O:#!F0*\\W7K'P@_"6I5R^'.?+%^KIV+7K9).'73Z[>+;
M$>&U=]8H&KKG+II4R 76PWA)/R($RKIKRSI4P!'!<@$;(A<H2.;E(X.W^$#H
MO^;<]>F_4Q;AC-/AK7\L:/5[1099HVU\DC^E?DK]=TH! -"IP'__3_B-0FQN
M[N<"LTJDE,[M2^R6*Z[8#D7PGE/.T>GI4[2L_OI*&_5LMW/8TN3MR,?(KN;7
MD3.YAFY^VA)Q#J?IN@F^%.R68!7YB85S31/5Y8W/ M5FR&I',L^ES!_4$*Z[
M+SD(FRGK@6U"VC)C/5D\''+-A'66'H5E&B'RR"HXX;Z: U@C+;P0&.%ZU]GB
M4$,5-D%J_@5^5Z["CEO'*A.:15X@C=@='"D6E"<JLLR#9/98*;LH3,.[RIZL
M +(B2\+!U'^Z<BK<NK](K ]P7/"X4V&/:>!_%Q/SK;X/U8$4!TU(\-DY4O/U
M#C[D@:>%Q)YB$=ID=E*)U:5#^<<:&A)VIIH5>S)VO\M1>[M1>VO&]=YHE9(F
M:D1U1M>\KEW/LZUUD1!_$#YK3[8LH\DSSH-A- /7%KM:ECQIA]*1UD+CH4'U
M\DSCE<X-@7Z'Z(F_PPST3_&S_+N:U:/E0E1:Q?E/[L\)'@2WSK5YQUW= XI[
M_7VN @(<V6^5)#2X5Y+*1S/C;"Y:U /W<8&TNRQ["B2UPZ1ENEVI!&QBP%>P
M8D'NV<URM\N/:N1'6_O!@W>VW-@CUI[+ZNR@?Q=D'D/8N],W5GC9&W83& (E
MF$XG-II)0(.ZUMXWY!L.L$22D&>X@, :NQSJATN!T Y+7E.!LBO6(^)H%,<4
M=W0RTE.\6 ;CUIA9$B>6$!,F?KKYQI[D8S?OBM:B0GG8OPS=!47[.<[%D2#]
M>O)(+["2Z<4R A^3(9GR2WV6:@5':#JO;T<$/+JGI&0&7_F67!(I/@4-:+!*
M.>=S_->8G:!S =,;W766"P2C9\]0)%FR,@Q7L(^VUH.1-#>(HXCADXF;OV)2
M5M%Z&>L.<A2*B/_SB8Z)7/<WGD8U75F[<GQ\=KI^UCT(FZE88WB,_-CK"A&_
MD@/NPO=B9)9Q@E_#M'I-( W0I/6XFA.?.K_KBSD00AG]-(4:O;?M9LC'_AH^
M-TX;$ML*V3>AX<0$S!,H2XK9STMR,5F$=WT%O-%_3^Q7$1_ER*+]S]L]!DL9
MC._L]:HKH*R8I]7EYE^E#./RE.[<.'!#<C)GUG=Q*85W(YC9LDY(0W-2J,JX
M(WTCL6$>-37DQO_\T?R<K4GN2T#P1LN12Y,.2/5RU!2$QKMS I.DT<M+!C5A
M*UET#'DUR9R/- _O/8 \ /K6L"S#3CHJ?ORN-FYEN-&:0UB,L].M:"KR/2XC
M%9]P-TW/B\H417PBXU>,:(X,GJ%?\T4&3'_6L=0*@6XNLY=0V6$:5))[5;=[
MNY&LR>8*-:GZ)YXO3007<_E ',.8_1RU"=UU$$>ZB_E!B?@;ID$CM7*,8\PR
MF$(&E2"BR0\*0U<?(SH<;$_CVL;>CWN?W?-9"]O4_U@MAE_P7O"7PQ;UE"76
M-B5&!?MA)&Q6=)BA"RZ2H=>C( T:/9);P3;/2:0W66 Z*3/?F7"L;G9?8]^S
MH<$X<^L>B3ZK@>#O2F=!2>:E3Y GZ%[X=:(,-.03?"OK[-25JW;MLG3^3DM9
M2\4P8]_@BCXYM1;,)8];VOAVN%V4+'"1A26C4Z T.]PLC %AWX/Z$D'M_'LT
M D018496DPG*YP+;#.'ZA*&@*8.'5O!H-?\W0_5''HY6%WM+V<S].N3HQ#/Z
MO0["7:TF5-E%QVO$N5B7E2;4[AIBYW'68=W<!1U+,T'3\KYK\YROAE.M@B4?
M[K@99WZ^+UF%(]WC HV.+..E%74:EO'P6?I!;+LOB>E1$ZS@$FQ=M7/_0G_9
MTYJ79S09_.5Q?DB>%Q+Z\*&P*8.G$ Y:&&/]U.LF"[RFPG0>G%>@PAO9-E^(
M*OW;%^&@?/G5QO\D+9[+ %2,-V_5"]+P&0^*,&M;]&)E2E].CX,91:BJ FF8
MTB-WV3/8:_?8_0D7NZ>WCN'3=.%Z^3 =%Y_-;U/K (,1X9D)EQ=<X$DSU989
M@[0!Z8LYPIP98AVT%P)\4%&=Q+B"YZJ6]0.C\TU/9LG>OF5[\GF!0UO^<:Q:
MB_R9!'U,OD-"?V?C .LHS_ FB1]:HW-0!BP5=B)G-^L(J$ZK/_]\C!5)CS@R
MN?[,Q_;)Y<*LOJ3K:S6OR\)"NQ)?)ISZ=EE6^Z%[O.6'TJ>6$,1:-U367+ 4
MZ0BB:ZVK/EBJC>DT.LB<;L871 ==DAX6'[ZQ92IK,CE.\5O! )1V>C45I0K.
M+>I=@]9IK%A15K.>LHPGD@OH_+V%T6GK-9)VXXU'%8<(%^45KP\RAI^-C@S=
M?'@\XU%;\D$ XCH*T^9,\<*;$R:56)^3C=K*4@&CF5*( 8I>-D<W4+&C)H3$
MUNN-/9?4?U/EGFQF@=,;ATC3SM<5WUPV+N_?8]QUP<KT>P'5BNG#"Y)/<+TP
M@BADIG^)O-J+$?WH?GLIF:,"+L'J)_IK=71RR78%]D63QXC/D^01?E?$>X*V
M ]\MTREH?UR.BAC[(0\WX 4XH\0M;_U'S2/(<3O@#BX7O#0_7W [YIB=?2]]
M_\J0;3#U_VC!Y+^T_9?7SO\[6WL&PXQ]T]R$N1V$]4,DVP4IPVUX"3"%LJ>&
M4B1IW=)\UE%2MVSW&T=OOC-KAW4+*1=?"*)&7&[<GZX=/:QLNT)D6K(.L6];
M"B/@C%C0+B1:,L5<QYOAH*/W^>7:+=W7[G:2NGU%:1:#M7TKVFKM#C;VFNX4
M(RUEJH+NH]CX^<-5#^\+:";U)@F1-DMD'S[X@BW\SLG.VUOG;>SUIE.-O2><
M]Q+V>_(M\T<"$Q.G!$P(49A'5HRP$_U*J1M"7Y923=]>.6CQ*9G]"+49QADC
MUJ.S< $U4,J.C>OXK':3R%)'R@[]6?66I]?>&VQ[)=T"'$HK.H>[_L3[12TG
M'>@"W6CC73@AR^V(:!(7Z*G99<@%)$&7HPUCAF8"A^0842/5^_LEKSY,-Z!Z
M_#WL]'>:LB-5#TV1T&)< A,>(>P>*-8T7S-RN](C%RV65']K(#.BB.338<"^
M!KVX.KO$>,D%$I$=HJAAJ%SM9QVD 868U+J/76\[X3S&F#YC8]_PK+% .*PW
M^M*WC)Y-IY*=3P^A#^])UDHM%*&XV)ZNS6X1EQ38&IL.#C,L>9[%!Q%RA)T2
M200U3*AY--QQ>D /1I1E.^E!OE/@%)6[V(./C90P]L_=8U<37D-X[X%\K,47
M7NX1(@HL=L@C0]CM7. "<>X3:75%ANG(&2G4&T +( .?3I?2 C)KS<T+7=+7
MMZ\_UFM\,B$]GRG?1%608M_???QBV&N;_9Q(GM^NH:<DLF1YCOQE2!I=PZFI
M.:^+(P+F>"^^"'\CU-21XS2E2-F;\%$U)GW.4>,5S EV@@MT&:))>5Q@$T\U
MC#]P06/2_) OQ3$3-@.=7=@'8N+BXJ[&("ILHM(7[#_ZY1(DGYD_'-**"7:5
M>>4)\D"$ "\MO_8K\@Q87\WRIE>NL-4VBM6G9=SI)Y/@E%?.Q"/3D6H7NC]O
MV"6_"PTOURZY,R@6DS6<K%8(M/&$$\8C80+H+EU< $0 \9X<%HD#S[C+Z&(B
M=[IUBRFXZO:L^4DM.BM\0PC+TH17M&CW&,_R&)KL!]! 2 J,=IHHC=2?,N>C
M5U*<RZZ2PZ#=BLK?(YOJ@JY:3*P^&HP+,^I[<5/@6(*:E:I?IYH<?%)2_@<O
M,6 >S;0"(8P*NFW/^C/Z=$^6@=,X:WN-.KOWZ,GFCBR?%BO1X[OR+NN.7+39
M)S+74/@%GHFFV4) #?0 )D-QM1^:!N77K9AH=XN0P&<V4$WZ39LPY8ALQ*5W
MPP^#IIJ=" L'"?I^:<U<0&496),40.&Y@!24]!A6O[3"\TR"8A/00+0"4@Z\
M6X[4+J:'MPM7!HT]R*KU"%J-9-;8+)"=]Q@'CF9>5'NF'3MMS1NF:O8#=.!J
M&EH*%PB;5644@_<J67;/P>V+3$_)D^"]H!*K2BX )\S/U$S?C(2'"XA%AMJE
MP[3WY1[>MUG]N2,CDS='P9P7L$:5EE)$)<4VH;$&>H[V.;75.*<*5.TG-*?L
M2700=W63*7_3J0*XU2E=D[\TEUGXFNZXDE/!&20^L<WY$ROAGI2N&J7#TZOM
M%E62HJ[&#^C5A%=O;':AHV-^Q6M_T9*]^>[V@NW6I/F-7_G>\F)6N$3?JP&6
M5!E9=%#K>8,!F"NQ]TVN>S]4:CDHC OP?7'>CUM)@/TZ?1?5#ZFW3<;YPF?-
MR$LK]62SI&?U-(WKU0V)B*IF:I[U5IGS-V>&]>[N5:D-&0_\&5_^?VW_34NS
MU^"$2D8+NQCMLYHDCU;XL8 WPPM"*\X3-9VU;'ML'1PI=E/)=.ZP\GLWU[W=
M._T[-12$2MA5T%#'>%@=)LEP50DUXK5S:IUJXCR!ZO'532'5>'A$88:#C!MB
M_6IZ;V8]&HA[5&MCD"N(;&;Z(HW 2>99I"U/'^D1[ZEPQ(D$PF0D>\P<$!XL
M0S!E!S$%=O[I1*ZF%^75*G6R@0D2YD2GI?8]M;P,\'5:##-^5!F[R7F%;L2L
M'/5C7@I"2[4;503*H:0< @884PNJZ6PD+];JS,\7K=0]NI4_K[ JGGI<Z1HI
MO8H)Y?GW\VC2/4BC;9^G&0F]LL;T!J%]Q3J3N='C5W;L6[8I)GLGO;_U\")
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MT\H!?&9.)3354M\+U.\9>JH8&^-L/-5J:TPG#,@<3]9?67W?MCTZS.][=SH
M+O80:2<AA&C*!E6$MK%8P-HFSQ@?ZU#]R 5$&O.G6&*D'"&D$6Q+$''.R[Y'
MKC(6'Q.M\[+N0?:?S"&4U7G[D)<N[QJ\4!,=?& -W;<7]@1'79/LQF]&AD]7
M3+/"R$7VY(;8B>_^C9=$C\95!9G8?):L=_BUKFS_[3WG;L"]ABS?E,9#S;A
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MI'. $-3TT( !'CS4+^&BG?W,I#PR.$A\S@FE>\!;W3$U,.W8SNV@"/LC/!S
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MA.[9@39?I#_KF%3O?.D<6QJ\/-8USHXY;EN2>?O&TSAA;D\LU0,Y/44:7"=
M%O"#4U0=>A2(? R>[BF%)R6OMLMF7SZGFSY[/U[3RF,^;R5>N?BB\P$=[9?Y
MH YQXR4'X*-[K7$ (:8.PV(-R1VSE=U>7%:]JNB]H 3&RU34[7MDU7Y$4R]:
MI71_O$*Y_!97VW[-Y.!=W%7,/QLD>K'=QS"F3%6:X8;:XA; W,6J:'&&"PV2
M<6D8S1*[3EIZ1N"-CPG&O[[(EZU3)99J!5^;;A+WVJ8]J@7=*8-,B3:VH!I5
MZC5.E .$N&94F((B#!LP;:U[9BBY2QO].#P"*;16X7K7+[;:Q_O2><J=[_D"
M%U]('ICSL.S$IA&:2WJ)H/H64WJ*GD]=V2!H/R(;IF*;8=EUEK'4(<KM=JN^
MW\=*;Q8O&8N8+ =+L(?,WR8G406U*>X?7*8LXQDV:"6VT&D(-FJLBAC"YU?&
MAE),518NT2=Z$9^!D['/CPRO_/C, 592'7+5[5,F_2YSU-/EQM-' 5(-J0#F
M-M.52LCH1%&G^JR%J.EY6Y8&ST)_J\P7EU#"S1?,(HRR,_W0BYV96KPJE*L>
M,MXR6L!N2!UL,Z5-Z4A:&U.RFB*VOD1;I)]@M5F;@R44T]PNZV",& V6QE9+
M=&Z?,F"B_.*7R_#-GDX9X_5]2HO'')DD&_?OT]C3;$0BBBJV/D*U[2<TZ_0[
MSV9C14"]WJEKDR^-JYI<]LYZ]8V^;31>F@V]!8MRT*C#F+ '_VRF, 2UL1M:
MC'-XIO0/MJ 51%'11VCVV3(+=ZEZ)"(]XE$LK'=^GYN;U^Q=]9;@ZHF(6R+?
MU?24 W3-9I[?P)#<E]+7$Z@=%"13#GD.3&&$8(9Q+8A^5Z%$S58:NXH\E$P4
M9LNC9Q9[Z=4NSTO>FK?\+*YTBHW6?Y A_#GC6=*=P+.L$ZTOTC87+#I"N ?W
MPG('[=T.BBTA"W#4$UNS*!*2*2%D"[&2E!1;T Z_P#3B #?=*:(-3Q/WTA[C
M'\R_?01V]$Z5\%$4PC<O9 Z?R-E:MO\\X[W/^='3&]<A ^'D.*;%,WH0[391
M 1&ZI9QH1\6E!HPGVH51$)FF3^*??BW5-(E\JW6[[8*>K[Z+2-\S_1O6TS<#
M"N1U?E2S!;081]B?"4*("'PZ3H)P&9FMJCG>:<B(0W-[TK I3(OZT#'7(+++
MI5%VPIJ+^<> B\74ULS(B.XS>^)T_U8WKE]C"V8R$M#^;$$/AC2(I!]E96U:
MGGWLRCB1Z-\*QCY -_6I2KU\[CS/MV"1P$+Z-"9'*[>92/0<$_[04*(=*R^H
M3"-0S\(_0]9'4T_3'8<1858.]-_4MCXL&)@;?8)&3&'*/&3RM5'7DU6,"W1R
M?&UK/KW=Y7'7@W*@\<WSU,.O=W-/(TB5;&$:<D," G81ZQXD!.J<Z<G@@S\R
M"YU.3L\VMKK42R;T*;%X-S?K<ER$"XTKLSOK#_S@[M;(F<"#.HBLKD/L3SCJ
MN:$< O7$!.MQ9Q@-T@WIUG*KOOM'C0TS2E<G?F$%OKG+"0B%'"3NESQ>V+<<
MXW30S<B%,#"TC&C%)F%X(1)SQI+JB T##YZ$LM6M^6E;ZRR*J\1J"4:!9KQ0
M@*9_[T5%PW[;W2MX=[\V^Z7MA9]F^.'\:3&Z& M*DWYPH= **59QE_@,&&%U
M#?0%4TX5_J8P_IJHYXLTF%B:*YSSEGA)3X^22PCGCGP#2\)VOX9+,3W(2%"G
MC\AM#0\[N+J@!M(6YV'DB(+K CL4]N<."6]2G,&E$J=\^H^93B);Z A-[S2K
MH-.,8<C^9"XV@)5FBK'*6_ RA#1K':8]5:;78P'$NC:/C<24\;PZ<[4A+5ZF
M8,7[8"7/IJ"\:CI;5#Z7:4$-HD>#*PG?OW( 8>QE5P#$]46;SJ4-6)1E7[VZ
M#B3\G>;JLO!KD]@VM+'*D,:\D35WN $EF?=A[Y%\X/*[[V:QN:ZOVSP)Z1P@
MZN)\6"*U]^"Q40%;]7=EY^V9N9TWH@E4%\//MO1$5F%,&4Z./8AK6<E/C*8.
M]EV5-"DCE_M3A'W5A\/K*U^&9:+6M04]]V@5.I7Z-!YT'&TJZ"C]\^]GR=[L
M*5P+K$<,W//I)067CVV&YR2>ICY:S!_<RD *-\^;]K'57W0V0FS6W+'4,5H\
M?>FJ5\"+ME*O8UG[N70/]>BJ0A'A(5")ZS2*&*AOWT9+9_,SR%8H>U:IL5CJ
M07R_\S,51<9):O$32G2,R/TQ@\T1Z3G-\_K#NS.EKLC_$&4KD;;6JRB$&0);
M0(7A'8P3NCG,M*6:;A0MYD-R[U7KB3FOL-\N/TW/L5U91@5N7E<2XG]R_4QG
MRA$7.<! ]I8PZ$Z79A6S]X1U2=!0V48^T8.J)C33U!8S \-FI,!7V8,^'UO1
MQ]]&3,5=G)E0<46\<N/7[EQ9K$1*80Y@NQO@PMC03":RYAM!BBV3: W5YW!1
M--Z]H_ ;+39<LS?2X$-CA]R=A=F-4TV')'O.:59$YS.$T&V#<.I?B.G3].?_
M$-47J &EQEM]^)N*N&2V8O"8"@>8]E49;7["GOK2%O-R0G'I<_0/+\&U?99Q
MC_ZL^Z78.608[[@=WH<(J!I=/'B!VYA^3_^!\O;!.7O82VFNWTY4).5J-JV-
MM'63?0@=+KBZL(\ZD=9RH:KQF-RY57/A[9T Y2EG7V<&=Z+UE+4DNP?'BY%!
M/X1EGZ8.]2!%0\QSHE:B7%&/O7IWFZVHW?J%][R_BW##G,T!]$#N_UQ]%=OZ
M3M#O-&8<7B.V$9FR6/HHZ$&SI7> /\C7N<EWVGH?D,KUR&W]&\['6L=./B(O
MEZX6\@=\;QQ]W7C]0T20IN0 X738=W?R%%.* ]#C6!T(4CNN+:^<<6P6W;CB
M.KP;O-#Z&YN>&/<T^+E/U5#:W\=+]/PBQ6;DM@5N?-EX'SZP_ 8F%<((8$_&
MX:A'MV:]3DQ R3Y? JP^"TK1#+VIKKW$W'/7BKQ"VS^5A<4&:)1O;KR[JW/V
M[IUJ^YV)J>+=3=?5&'SL#\3G5ULHV#2VV9^]'KQ.(&X1J])?/1VZ05K+GZG?
M.I_U?<E@,N11V4G&Z9V1/:*^VFZ[GLSM%PF!B"@0&X1,@3=R *:XQB+R-6[Z
M/1E31G85#,;P"3W^ZFG0</XA/"+IRZU?05<MRK]$>63J]]TK74:0<-C6%:;2
M- K/-*3BUK?J$D7&NO9]\XS 589$HU'D+^>N-;?GT%=Y;M5]N!K<_>52C'\G
MW]SK0H'[_*(EM#BV$*22>25 (C6AC]"<GM_)316B7YO03S2$IV$4P$(?V1\#
MJFK%W,;K4U.W+J*:7CL4/]<#B!V)3T05\YK(R&PXU9X(ZJ:_=MV5:,&JLE9'
M$TFF&]P4)3PLS%H0O$NYV_(RT; ^WCHP=;(\-O*N?Y;[.TNM+)+C8&3 =QI;
MD3V*%,.2L@G4T\@91"^NE5F:?[-+ACVLNJ^9-M6+R'+[NBVU*ADJZ75[W&CV
M[GT'AN6:MB#LM6Y9)O* J3=M98.+A (-7)G2Z?3X40YP\>=XIRLU@7Z=%CN4
MUZ6>>%;1JK^UR*1.6=6WO&K:V5QG)NB'4XC)KJ>YMTX.0.A&42(II\EUQ] '
M:MW/,X2)TP9/]<K\HI_O^%[)23NP-=L1,M]V>)EPB!"P)<:>(O(A2*1E$,%P
M9L_X:H.X2(KAM.!B?VE7Q5^K"ZIC+3":I4FV;/EC^X'#ZEGR1_7S?.,,-2S*
MEQQ6<1FQ+'A/*>]V5J)=C=9CW./I]['78_==[14.]IE;?/Z7*QF9NXVC>KB"
MVD8$ZI78D@T?^ :6W$3=1'QFNPHBLA*S\4VY >"CC8M#JB=9;(>M0VT1%BM9
M .L>_KW8YVUR7!\!W-=51X/11UD/$*'8K I9T"E\D>7<B^/M4F#NI[4,IF^<
M+/,S+(P-6S5P+/RV[&$KKM @X<Z]]]VSWR4AL:CK83(;E0\='^?Z[I%[M$>!
M!R.SHP01ZB=6*_M/GA1O1BACNP] >=N3M=7K"MIA=J\I5O?@%2$U.5>*R.ZT
MBK\2H5:\L,Q?SO/F$SL@/+>JYTN[>0V,R &XV'+8WG;"):R""ZV(7D\;[$,*
M@.=<'/K.=6F 1==*2NLS']H&*1=Z.%_=U4+I&YX[WOB&>^-O>R>)9*PYEE2(
M;(9O9%.;Z-_ >)H2O1]LH+@X]W" MK@;QG@Y$-';OEQG1,=(3X8;KG0UC]5.
MVN]!"067R*[+'"V)RDS6\-PDD&IP;6UI"%(5KL$U%1(;AI_K%_L] _XL$P]8
MH-(]Y;(MCY MH 0Z'+[81ICX-:NK<^!]M)^RILV']PI10:=N/!B"G,%[BI6$
M(%4C>!$!N=STIG$L"B^4Z, !TLY/&0VI@(AN3\/785C1-VIC'I+H_B_F.>NW
MM.[>J=!0TL_F/YVS"[ J8@NZDH9DV"-PJ@=B>HA^?)P0;)BE*D9US\#(HYM.
M3UZV5F(>(0S[;G[[W#?\5L/3L>/=(GR_I>3ACYX0NT>#SQ81ZZM_]LF"[Z'8
M?$3.A T09-GR8#09<V=11,,-S*PO1[I3*ZHBK]QJ+3+XP:7Y1/]DT+$B+8UC
ML\S+;']&$"@'Z5=IJ*299RB'*A;C*1JD?%7VT((F3?5N'!DGY;,JEX_2-]G>
MCZWT>*O\5/!-QVT3,=M2%C_K%@>X "43!%V"VOJ$C)@.(XO@TQ:G\*E;&<8*
MAO6&+2*>I"#)>5^?MP;]W4JXX#BUN-9A4^4;:#FF,A<-T5\A YF0Z$(]1*8W
M[2NGP/-5K88QLJMRP[@*PXWL!IE/L*C)D)B_.0#*ZME'J'1OADNV(*:5>G$0
M)ZXOWF<&T5Q?0_W/>M*\0'\*M@_%Y6U<OI7^D^%B)>?TW'G"(4P^J,!#-;9W
MK\U)TH.DK_\'>^\!U=2W]@D?!$5 "+U#4)H*B'2E)%AH(@(B(D6B(M)$1%K0
MD"@(2(V P%\0HB BTJ1W0D=!1$2Z0HJB I'$$HZF?8>Y[_?>>]?[SEJS9N:;
M^6;69:W#2G*R3_;9>S_/[_<[^]G/QI'(=Y;ZB=MP <C,&.(^/'V8.4"'I;#M
MC.)>7/9K:VT)N-(CV';GXL\/Z[XT%H:[2*BS6[OE]Q@-8ZXU=S;1PS(OUZKG
MGWG'%HFJ!'$;6GK3+>,[C#2<U.X9ZE8TW0Y[L?!"T +JA;><V\B \3EMAS8&
M;BV6Y8O>&$;NP-B=5P_J5IA&J U2]+;-KSCFM>9Q^\Z5E61[:MPO6U#7R- Y
MJ-16.XX"-<=IL2P7C-KFH\?5XCW@!NL0.#R(%$8<8&/!1/JHTR3&F:*3-JHO
M J8Y=GMW[0G-"_!O=DR++6NT+P4D$RQWW?J*I#OR %'NN.KF509"</(X$KY;
M:OIGV%RI"^BVEWVJO6ZBMG%=*+A8V\QZ7M1PD2;AU&<3/[9E>Y89'W[_.KE;
MC#OBJ\.IA)H]:ZEI*(7>Z@0;0/)CYQ '&./]2@L7QP:;B8^7CD2%?>0!DPXR
MFBV"+01KN#VN-XZ+9 =VT\<3<>>=Y\(H>1UDN"S88#-C&4X-DT)[NV6_9=G0
MBV_Y:;Y?"+A=E4>+B=:K=GWW@S6E%A_R&FMNPS"CRK&5)*#.>4H8_)-9R4"2
M/?K7A=FN],^IOVZT[:N5._WVN)GD^U&=NMBSM.XI)2,#7<T+#I\/\(#G+6F8
M<,@8^#FYR! 8J"<X!-OF4.K+/@8>J@#UR4\R#)8XN>0/.L<(-*QCC&.1:\W9
M9*3)\YIZZO!ULWX<:'P*G8#*58^G,H^=W6>D!1BA@OI&),8C] ;.W<BRAC\F
M;.5J!Q*5L&*@,]4LZ4U-$65=]$S(:6%OC4-15W(>CN/R#HU%-GTD/C?KIT60
M]=?VT#W('JEJZ";D#K8F?3GGZ?"^& WF'_].0_[B:PHPKU_/ )T?".)QZ-^_
MSQPBH7?#7)&8"NP;>./Z "H13G>$SRE1][61PN39AUJFV><I.&DPX'3>Z\_'
M)GX6*FQ]YJ!QO";K;+";U^!=6TR>PA;BD<KO?LQKH#LK%-=K@R,](C3J;RZ/
M.LEI^(E*5)1-H\B"ATB%10%D8X1VJ+/#Q*MK9\>N3/HNW#F7[Q*KN?5(F*6D
M9;<UX@XG%4EZ*HG&<[=7/.%";ENZ4X$"DPSA 3!+J2BY03CLJY!2<++;Q*AW
M\/&3 38>",</,I<$;#FO^7[AY^6XPMYT?B:6$V^\#N[VG\IKH.@+A<S;IMT@
MQZE;Q^\QT?/_Y7%+ET;*^.AN6-=Z<K3CD_#GHB;&#%MR@SP^$#9+V(SB/0(A
MC1XQ>/W.]0!\%=8D$$YOL;2J]D:[1X:H7/">4QP]>]M3=U)#]WML;,I%I,8.
MT(7L\7E\UJX7JBUB-W<6)8PD)<,E([ML5_L)=<F#/$ 231VXGLL.N%1=ZF5\
M#3R4IBK?V%YI<(<'C.Z64ABR%OR:3(-!@\ATHEN*'>T\YTS*7^MGP*AR ZPP
ML2.UZ/R^8H',7G7ZA]L#=PJXW[\O*Z'][U;&7JWL:#TY*^Q>: @'=9%K2U$0
M_SW*Z5:CVZ63ZD#7&S%/,(=!7$50N!>8?&0JM"SUX,_?I%A,6>[QB>:C9<+/
M=Z:\@ M#-$<6]&-MQG\&\H! O#QV =7B/(2<6X#03<%X7'@5OH,=18K#6AG9
M,21G@Y)>?^O[MN*M<]L[+4C.P-83EJ]>!^\\OL@I02AP!_X(LL43F"-@&Z3@
MWA9;@FW^U+3^""I,!5SY]#G'=>H\:TO'(8.&)L<[M\/DC6QKTLGYKS2%GPHN
M$/EPI"J$ N=A)YSJG.XKP<%C38?IJ_W=RJ$!?5B3G%ZMHXQ7PES?#UK3!Q4I
ME^Z22\12EM4%?Y^NYZKB>GU#:Z"Z._-C^#B/B>>)Z;BM2Y3<G]-(,<P1ZJJ*
M2563XPNR45RFGW^LA>=[<_[Z@X*O#BD(G,ZG=3%FJ)_7"B$/&LT0'$;.&?54
M5*&I?3B1QI>=%D^T"J[(?HCVMC'IN84%6UIBKYCZ!7W??TA!YG<=0YV*A) @
M ]>DO>99P]:$?!X!<XKS^%<2YQ';(I;"RO!Z_18I%ICC%'K597NU,0N]MN_C
M+E>5TF/?MY<2KK$[GO+_)%#7V3(Q#F (8V&(T##>XSS+ RBU0UTQY,S\(!S#
M')6<=QW=3/_^ON^*6HO^C2B^]@ZTW5]Z)(_0QQ$=>_=@C#?%%O8U=C-S6!P<
MW /+Z)9';_1V;^^:\IMD:S]>58PKFJZEW/\42&UQ,E\<6@DW&K/H%%$R/(#6
M7)00[\((,BR8V>#+S=7V]UGG@Y#"Q""8!$8]3!S,.9R :H)D+.TI^^A-ZW:5
MSJLA>R+*W\/65I>W^3%C<RYMD:P:"0EA]H!Z+',P@;O]/LLX&$D_@4M3-6:4
M]\'G?E"?)-2 PP-8P?BC#+VBQ*J6A%/O3LZ?L7RA3_O<9>;KULMZN#"RYO-&
M<)$H@"15_ G+( 82=G!'B8UA:VF,(Z3DU,ZX\S&Q](^80RV3'QL9B@MVR^-A
MTDPYMRJS\$'64$M^R-9O#L ?)%LZ8A"A24>RI2:IPQD8!8K(!^TS$]P=8 G+
M82IR(2^)\GI93VO9_DGJT9VE62KNN??BMPLHIX)(IM];'"D'USA.RZ#'G*9O
MIJ^B!@R/JZ#]O%IGV/SDLS<&_4XU-K0Z*A1XUDR+[E6_U&T?SOJ]\_V"WZ>_
M=K*2N<)WA*"6#\!.J.W(H>L,SO)S>V8B^1@0E)!99[EOBF%GE9C;."V(O:M8
MO9E./WKA(;"![C>TN/M=67O[3*3>Z3Z1--K!\OOW/^4-?7.0.6)T,+T-L%/T
MT"/Q@'DYZF?V$1;+E^V)5.KTP;@_Q-B!B6&/T+F=#I%1HJ;R34Y9=F%7+_[8
M>>KDX=OGI)5W>'@PU)FGP$<,?>[V1ZQ=V#E"?7?>.*,?\LH6I'4Y<-L!=2VG
M"Q.12@857S):EM'?:.[YHW"CSL $I3$T<NT3-0KLX@';&K%3*)G&:K'OKY<&
ML;J,Y8:@@&OW\W8'O),,K<X4<K&_<&"$< SXD\\58K!,L7W%^W+(9GBV >2]
M3H"E5/@=_..OU]\OBA0RJSNG))E_+"ZVM\:'FM$N7[HC<_>ER!XEF80=_*ZK
MS42('M00Z2?_RV1C<3G+#OV#O-Z#FGOWU4N3F4R?'# ,G.$:,V0^=?B<F(EY
MSOT=&MKW5V>B_XX%^$$]SR7Z"?W_$K7P-K1;%/0@33?1S9S T1LE7_[L*XIX
MA+%,G3D3=VEYVL)AI_?C!@_)48U:*5,>4/CJG,..$)U^9",2XM#I*+H[;E[K
M!W-2,3\)(<Z=N%Z30UE*)DH7VK6VOCTW=:$Y,.SG:-LYN^]:AJ8_WP-S\AIX
M@T#^(T-<$; "\ACG.)VX !8L$=?8,H!38 N#OZ@XT!KC1-)/*=8A^(3!5CTD
M<LI]@UH\MI8E^EKWV:?)[/0I&KP[N,$#:!Z,#6M.+NX2Z@Z\D9BJZ[O2W^,K
M^JZ)57A@*>2LB'>0EGC%VFL7-425SH])"O1]*3J+*W*>A>6^)L*(%\S>67K3
MRTG(@2@0SS"C5%VW&NO&RY;Z2XF:.385H-^<];&L&>R[N'?_.>^01-8PD\XI
M6L>%A,TV4&K71LM6)+Q0Z-4>Q9J,)Q]>.^=O?<>LUY!$')RMOZ>7>544P%BP
M();<:X8PP/4>1E["BVRF56M)IBTQ%F<HL$$]6;C4EP*[?EB*AZ_*6TN%\^CX
M&THW1!QQ.:^\8^YT9B?K#B3M.-7!V<H*Q5P&\9OR#;(2)W3I8/OZD*@W!3X
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M!]Q^II^(-6^=X$H=(2<\"?3JS1\I)C_J:I7J%5V<>WXX]VKK!Z),Y4-N+PY
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MG6Y&WDC3Q021QY GO6GFX7H-CD\;GEZ6>#&\&=S SU#BBK[FM$(=0DC<(.Y
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MGN(@_/2@7W;<="I0Z_<XR,O[V)]+]\,N!^1@EK>[[\C@+/=\9!74S51+NP
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M' 7-SE<YD9>VU.1\]PG)9PQ?,3E8<[SUO&AKEGKR"/F386R"DG/[Q'],"@P
M^[<)-DF[6LL,997M>QR5.ZDW2+65J!G069:!]W<H##<AO@\-NR:LS2<^<!MN
M-<LW/I^O]E%9E?0#&I=;=Q[=Z_*P][7M@8.0?Y?(/7/^GFK$BZ>U/UFBIR?6
M3"SDKYS+X5PT&E!1>O =)EA0D K8N-ML3]URZR9 $DYP?MO8I:FJI^/4TNRI
M86C?3'^V+6(J4U#CSU3J;KXM3S7CTXO+50+=W>7=^1_0]P1NFJ_+LX? ?D!E
MKZB%_=O&V^C&(L/%J8MW.]/"A!]>LLRSL'Z):+J0"I13D+# XGWT7SP@T=+I
MR9$;3U:BK\T'RWJ(M%O<T3B<;=O?7E\G<%WQNSZHO;2648'MP]67)_, _SU8
MW7&JGE&?F5PS5V$JS)A8_][[Z\FSCB9E]XA==X]-,^R?QY:>BTHY,?C5=Q(R
M]?&U+)8^^R G;7.9GS#W%5(HS,01#T/;#M(:5XNN?-7J^,OR[?%UG9)=#0TO
M/MY]=O"K;\:MHMF/OXQ=K;?+G,J6WG+BA*#7=QZPX,;$,0)H[BQMD,4,IB,'
M$TC>ZRKHZ#A99^GA4D[76FB-@<I+>\LO,18];X>JE_<-W46.M03]4MS-7P":
MT M[X7Q8"1!%PO4[Z:\A5.BXY+6?H6*3!PV\O _?'7B\82%^<>.@U6K9/Z7^
M2 5T_IZLI4OU']*X?.%_1'=F)^D3QQF*7ROO__WUT_\EF7S^;S_^E:GH_]Q,
M13JW.14(8T>6&?<5Q,)X0&"@Y1Y$.U> CJBF2$_HH2X7W*IOR/OH7=';B]._
M<C6\XX"5#F4<U,;WUX*[Y8;Q*=@=$#K6A"";/O>.2WU%R5GRE7BB6WH48;?6
M+S1-& <6?/MN$8IT44PO6]]9S#UU;VS[CA>G$O=N!SAB)=T&FPO]-W?:.,&5
M W4H^30;>AKS!>A.ASY"PBP-$ UD@G#PDACJ9-PE"V_-8O]WOX2^45D&V1?S
M-&0G5)Y.U%VZ9A-.:,31?K!\P'ZF*B>+J\L69P@F=TN!X\Q4!B'9>$E\"9W?
M3YAO+E"6^[/MT5.GYD7/$MT2QT!F7E1H<DYV(/_/;:D,_.PZ^3,MGW16W[N5
M4X,+00ICW+EO0@+H'\83NY5K;N9M+W&VP"Z,W@I?EDT3_#3WB=#5\8EY_6^N
MYVFM=O;\U.>DN2?^/E4.4UV)EW!]CI4\X,VC&SP@3@^X['J&!]"S5WC S]V0
M0EYRM&-KM!,YPG+$C;=OM@W*X"%ZMJ^6!QQ.7.?\;/S?5+;I<Q9V5E6H@U-1
MQL$WK@N%Q/CJ-] -P893+$N)IAK"N0V<_ZU+^;B7QF]UGQQ@9H\*I%\%7@A6
M3Z"40S:W>ZJ=;;#AM$?JSUZ IW:+M4[]LMK'7KG>PM8V#2ZX4B<Z5=;5G3XZ
MTO5^F7)!_8?,NP69V5=+^BW<"1[0'-.#GQ,DKV+<.>68B#(0WD\AGW-R'%!\
MX*([:69?<C+FV,>+:]9C-T_L%P)4ZVRN$J0V$^OQL:7!L K,>;"KP@L=T-=N
M];!MRO)03;#+@I?7@#U?L=VY4LU<Z]>>?_%E6]=:<N[C2$_@]8*T+(JH<Q^R
M 3G(41\L&,('MES/R_"/^N1[Y/+ WO>Q4GOM)R1'+'O*#$>,L@WYUM]YY'#?
MHIH#>GC +(O\!FQA.8$UD[U8Q=##.C+3)AU9REK+UH.[!+;$B&=:#],+?NC?
M7*)[XD%M% W)\'8$55A([B1"GN&1UD1$LK2MWS9MF9'S/2[IO*_G5,!E5_O/
MQ7<"^5>\=%XB+Q$6^'N13:A;3?K*;$-Z<8ODEV*=*4NSVJ#KC4*BR_>?!6TX
MAT:$6I[_2WV;-37G7I826/F&!Y UIR#)ZP)YX.Z\FZ:[JW"@0Q3NC[0^;KVL
ME"MY%L5-%%EB?0WDOY Z#$FZ? \>\.CP!O>/%_)?!?]5\%\%_U7P7P7_#R^8
M/>[[KN9*ME"G491PP_FR:!_]MH>BQ_XM@1H2 KU&P6'BG:4F[00>0,I!;>G6
M1MN1T]A^H%_MBN+,0*W<E[<KAH61.H&1-*VI*Z%YWI0&R\>=R1>#6O?LNHGX
M7-*M#F8P*IG%FUEM(%ZF&Q7J1SU122*F=!O0CQ<$W.9":-QG5OHAR&4UY.JT
MUY5[^6\<PPTR_8OM@CHKCC6Z;BGS>7 ^>#,9+JF4!SQ'T=3I1D<XC<1 )#_F
M%%U_6%\>OW4E@[R>/'R8T.>[JWC:.TVFZ:[/*'/!4U7A?-C!T]8R/M>.O1%<
M,O[_9B,@OE?L +"(C(SG <*6AQBHX3SSC-<I9,[>D ]>*NIVA2YM(9$^+^OG
MMP9I[;P679)M;:G(3IZQW(Q8^4-@MH(.5")HQAJ>'ZP=&)? ^+Q-'M3?PC9L
MFE*C-\TD?EA@G:1Z37[*N+PFX,I7%S^X.UK)]8&.]MJO<+@ ,6 I&=GP$ZOK
MG!S=$DY0!)=<&;Z=&_FVI_-/=OD;&>9LN&U/?7K Y:&+X.<EM@Q^F$ _A,+[
MJC.(B3S@"CQMPTMPT'G+UR,G&IKQ9Z9_CEU81&-&TPY&KFI>3#@99AK*:+<Q
MM-A_6F/?MO7^L'1D [8-JG,%IZ@*1R)GZ/35H?$#>;8_;1C._0*>-8^  HN@
MFI3D%PT=(2)W1G6'3/4T>G94;N7(MTXVLCKNU'RK.I]W1FB_H\:A L/KN=I9
MH%L-34^?5OSZS_3!1W<OV)=9C_2_2>A]"!N#@>K3&72(>_8>[3X $KA"M7X1
M0:P]8Z0N5?FA(I576.4.QM-BMZA]F0UD4[V:@:*'6XQV'O]XN7;2_/+^_C#)
MA86!"L7=IX[Z;.5_"$1*K_Q=Y-?@*,.9PWU+B<6:8$&D3I$;5V(<MKA"F,M#
MK=9PQ_E'/P[W_EZZ--'[,97-A ;L]2\0-77!+7@,X41QI.?3A"9<;V4E3 D\
M/&DSS97^BA7NNA$JUU\?# ]I:TH[>=;F?E-@0].K/ K25._VWO0W@E^=9+[G
MTUX^A.[E6.A.1NW@TBV(#?;#$HNWTW%)%]\UAHB&D1>")U>N';I\J37TV/<;
M3TOK$ZY+HW:9^3LO&DE]%T8!R$#80BGS-U2=2YB=G$>(+8MH.#D9S]T5%.VQ
MN.<=QO/AV973[4XY=OL+5OI>^J>/:V1K2!Y1_J%[84]*P+5GRORKSW0H2%";
M!]"<6!</L3"8B]"UKF%G<>*6!@S)'^2-Q)]A4N@(BET2QHB3OF&:S[HW[SM7
M]798>J1'>O?[D@;E;WS8-$XEFX_E@3E*UTS*8NW"3OC"P9#:_DK=^:0&BOX6
MF+A-Q*5=65X?SIF9<KT5%,U^F*F*UR NWX2YEA"1FWNVP.DGH6$77[7* ^H(
M0[CYCEZ4-%N%I)_DLKHD$:4G2+[PQ>GQ2LSWW$EC$N4[J7%<V"$RH@GST#R/
M*L>L!'G YO;/G%N_PA+ARMU&V+=$X<X(/RH/2%?43_A5&[^H"$;HW<G4.^8G
MP1UY=['C1F4;F1_KG^(^M+S[4?1=V,3(IDL# [A"Y<L8#TX;\0HN[?K8^XE@
M([;W6[:40!UB3N^R<9&8P&U;Y_?;'%]^^KFDKAJ!BO 8P#64]^-D,)M"M8([
M2=QZ\:SWL3<(<]#;'DPAU4H$-?, S:*?IOUV4U1/3R^#:_5I2KFV@I\*#YP3
M RSY26:97$AC]\*0EXH$F<>@BZ1AA\P]4A'\H/? 8278/+PG)?3IF6%FD757
M];>.LA,EE-?^V8']'[0?=(PDOI_5^XJD7S-;FZ/#!I'TX[49R";3+OKXL:G-
ME>KFC6\C85*H/:WY3@VA7D(*H4>R\]:6/6"ZQ^KM.USG<MUME" I@6-+&S%'
M&3!(KOGQ@ 46\].,Y2&Z7/_\8HHRZAP8\"3P#WZ@\-#6+G:6<QQ_2]8.CYVA
MG_;;*(U<P!CRIS+QX-X MM3DYIX.\<ELC2G<I?5D7'-F,GV43$RQM)(MHH3!
MQNFY4965;7YM4BDE'=R)YOW[)*6_#X1NR'_[_1PX2 #WV26Q8= 8U.)4@H44
M'U75&>-:>3#D%'C#+ZK$Z=DPQ5G2^^RP25+JM#B_'JD]:X>OS[G<\;\.G9GU
MR,0.HQ2Z]; 32_0S.%&V+52+%/:60B86K'B$D6Z?1,ABS(+R7=(&FV=@6U]7
M8-H[D6T/%G+=%:^J7A11?S%XYW(<'R.-*]3$.H)]2VC03NQ69.,X+;3:;FW,
M0?#1>2HAB2B-,:+WJ9B*[OHSI*[2&*/HO7@B/^N6WHNKE_#H7+O1!KTP,M0$
MJ\P,AADMG!2V &=^X51'HNZ8+_5UZ7LT@F'D]:UL"PA5;YR8#'A']@X9G7N5
MGW_MPS'FBKK[8M:0D)JDPT-859CNY:;M3DV<!VY#)XY'V"I$_#2A>ZSEGB_#
M+D!NQ@.6BFNVJ2F\LLC'*:)I@>[T-G+B43.$6O[%Q5WOW/B3\1NR.V_M?0%_
M-!:G3T\@X6A'2/IS/& (+H95P\XZ4V%*(5Y)+>'D,'BPJG \WT.[2)_9OLOD
M^Z>_AHKL63YJ2-.Y)]_+ KA#B^*<6\B+>$'LR"*,(3#_AOXAK0@U$'.:>^K/
M8IEEK=6GGZEG1QHG7ZK3]GTZ]>S*N8=O-I-T6%WY2 ]@R^"87T"54H+^8?R
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MA7AS[AYLQ/BAV"@SGE/'YJ/O"XE3%9&=:?+^Z^AH0$!DA;)KMG5 CFCC V5
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MAU1F:!NURN*7MMNT7R /^)=\%VK;)<FS3RFE)RYZ[KH\R*Y,#<BAC0XY=F(
M]:"5(OJA)>ZOWQ#:OB3'A _,:&9O8I,9SXI>EB(VXVZ$7ANS>,:TF',9G(B5
M0NYG<%.&T8DL#?@;4\730R86A0N9+N @C>:05ZA0L1?Y'%>=;WXRZ2^\71,:
M>/4-KZP#T@:)2V=]_H5FB Z2'&.@A-II#2"-N!:SI0L/"1K/\DCM,)I+)308
MI@Q[+IT++N@5=5J*1T@YZE*;G>+.QPC-KVR#<(JTE 'HE;XQ:)L. T0-V.J
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MN8%"+AB-U996,LLYN& ?WOX3%*YP<L.0^0)ULV]\,;FO!1.WK\RW0J8LHY&
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MDT\SEZL@!HG!0SMQ>^H23 Z5MD5<"9.CAS^55FL;'!*$RQ.B>.2EOF'BR=>
M<3H7T(UO\PHN ;3/U+=UW#+HTJY0/"#Y448NB?LXE\02^!%>5@^2:":5VF'&
M-5"NK?F4G.%\ L\Y\UMP7T_;YI(NCQ['Y'^'O(-_]OV_N^]9UV5<QI<!"\-'
M@:^<;^J5]\9LZ7&4[+ "UV85:M9#$Q'?H&)X7X=;8-J>*8:XP9.EK/Z)_-%S
MW8J/=NL*2MG)9@AQ?_YL#GKB=H%J2,84HY-A%&?\N"/MW!#XQ4O <[ =+19,
MYZ9G2=Q'"(WY:MF@U.9^^<;2SW2&.W&/0"20>@P= $PLA4HP+E+/W[=^40R/
M=NC7*)>;=D60C[-6U8UM=[6_'4\/RSLUX[<ZV7%>V.@9(X59H\S,WH0"AXK:
MT7RHEH!&5ZIB&YY_]1IE!5^EU0!)"/X":0D)DGW3-%2X;)^I^FI8&-#+]9Y!
MO!(LX5/L*]L&M;C^8%H2;59X*7?;/46 NAFL)*NO69#ZZ$DHM>O2-T28$FXK
M#B'QW?;UW>(VC;N>'[W#0W-Z'MOKP>713[]Q+]2(_>2FRR'96 EN%H'?I34Q
MZ[&$'#GM$0SJ.HJ#(9T9Q+M@=I JMOE#(O=H1>V'^O?U535#RN$-ZC#ME7Y;
MY8L/O]H?J'RI:$A+8&9BL%Y@0 FV<^(*8[8+Z*<*T&F)E*^)1)0LT-#YH:A=
M]C1)6U1_\\L3/R/OX=^>Y#A6Z+F<M4Y34J^X$L>Y50="-OLB=2F/ZDBRYUK=
M#!.J)YI<3AQ.]C]5TYQBG\BI&_;X)[5$4_S'SZQ;TEEI:>Q'!6XO"X0^@%$\
M4 _-5"@;^W_@<9:$W"8B,W!$IT9+FV&L9)3Q8C(R."T 4TYDZU6<7H!51-,_
MR.PC%DT]O4'20E/:VD.W0=P_DHV=J#>E]GW/%7\W<O &62M8[,&7ZG.5CWM%
M3@I=C.(Y:ZO?9 5"RK$^0>MLNF"\J!8DPIOD"&C6M:_Q(T2'$>H4>>V'B(.Y
MQH?A[N&]@9UP*?='";[3$@V7"[(_:8$^FX-YF,]15TQ=6 +YS/IMT WM">A,
M42=& NY#=(S1UP9LFL4,,OB.J#'F!L3LAM.$C>^ED$C*?'V:"PJC2J,KL0Q1
M&Q;/)_HN5(O3IH=(!ZP&UCK1@!&$(X=POLW*WX)];VK'O+JS#?).&YS-U%SY
M_&:I@[_^>,-$:#ZK#_4.N[),5T;VGD5VPRJW03'E)KQ$Z\%R\@SZ>)-7L8UI
MCV@ZG7PD+&G+5>$AIF&/($>-F#GWG I#VG$;M"<A]A+@0PP"#CJ2A<"I#+N9
M)NF.7WVQC0HSQ3\,&_K+]29LI994#V)UQ5T53[P0<^6Y&/-^*KIK90J>Q1!9
MHW$PT>PU]0Q6%9RZTD0W=%_JLJ@>*@_F3R3?W]32QI077?;TS;>=L0YX$V?P
M.C*MN&LW.N"E0-",0!G5W@+PP/C#=C=""H#HCMIGURH!E.5(C7-%#?;#F=^B
M[&-L#C^":C'?<LBG)8W.89.UL'XP0-.E?2W6[2;Z7>8+2M0$08+,ZQL^ TLP
M6DNM9IYS&ER[Y^IL_P5BYZZT<>V(<6>R\5-"Z[Q_922V)..<W;=[IGNT%+]5
M^]LK-S2D+RT&:([HZ*W+-&*J]WWM2N]*O_\,Q, Q:Q'2[&F1 \CL5YZZD9T2
M6/H(&ZH-#06XAOD7(W0HF-AF%>!Z:U_[AZ670>07SNKTA=G'[E6Z[KCJ*YR<
MBN)?P<-R.LP2;$#0/H8L):AC'X3%FT4*\'(9GF]RE&) *X&,E\FP-E^9 LU9
M&_\'WDAEJPV^KCME^^_M/A+(_\-*E(/JN&)*-T4.R9FP==6'B)W4#$^1@U#.
ME\!)$T<*W9[B^+!9MBXN(-C4VMW8/5LK?ZA&\N8X>>1ZB.U,LMSQBA)G1<Y0
MW-#OMM'?1"?5_,+\X<0;"%'V/]'7_K_.6O_OT/9H"\%#+:F!\7>)?<*+3M-C
MTR>\ZFO>.W0O1=@L@9W,%9_]E"8YMO0E8"M\DO"DM1;C\37$$<4'$;Y:ERSE
M4,.75.G]&^L]A\_GVA[5I.GKDJ;YW\N-+.W./.24G];]*F,H2=""$&7LQ+V/
M(D&+H4"[\/M0?L =5-62^!*TNCK^N63 TZUM4 #OPDPTGEL^-&,]M@LS[M()
MY3)A(QC_!.U:+FG,3>?9AFW-S]S)8"^I;5"O;1R]7X9PKX?27$#718YXB@.;
MA>6))3_=@N)?)AH:W;ZI_)$S6T$EW3B#WKMJ=I5C^3_+QO./:&*4+?)=7Y56
M,*")6JFBTL_)>2;.8+G@#<2R63I5MH9N)5#J)0)9.QV@=<8FY%0HYKW_4Z"
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M)EUZFA5X,6CB/9?ZBR*07(P5G)NLSOZ7IW?*?2*[4$)91 GR,?I%X%Q+KG*
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M8S1/2MV I?[@O9,=7_X=>; H?ES+22J[=^)[+;K)[:55;2-A9.'?=C?^L0/
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M5$'M.8%W2%GD9MJR@%26$SC&;.%$$_U2#:D>E0Q;BZ&R5M4YG"H8G+_GU7"
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MW40C[ 0W8)T#8#B5W/%#Y*$9L^E%+5K]W&JC&9KW?.%[K<X4<16YHRH\5 2
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MS/5/H>Y%MK>8]M5QUS\,M+<Z'K5Y+?5+07++ZAK]!+2*FSE)1#]XXG;L=7
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M\3$<^7C]LSU1MM5=TL,KP[0=+Z/?'_?]\E\;B/"_+*!A#!&"=NI(NBY-)]6
M*("GY)*KL^]Q53J Z!E7@B^CMY-T:"YKU'Q@]Z'IN2R+BXV)R^C35K @81[%
MFPA-C642:,J,Y<1 @P>/0&S'J7&GR, 9VPEY&\"^:,:JPN@$0X::G1;\NLY6
M !-O5Q/3<YB^I_&*M]VK:+\A,Z5>B[A+$V\%&KF#*. <'(;[A-C"EF+X=F[
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M3=Q<2XC /&LL?#R;,K)[W."J_^4QJZ CM]K:60GVIY5F&#=>*L$K?[+2FR6
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M='2]/+Z60!E[?1K'ZF3NA,M40]88[5_[4I'7W>LCS!+FR4+68+K.2[%GL3\
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M KGM3<Y$B Z.01B!,$[6\N?$^70! )@A'GHD-2RNEP930F_ )GFR0@0(\ZD
MI'9&86,%#=5:5QN=SL*5<A^]J6H7?O]]Q:</%_>?7.%7^(N'AX>$"T;)A/5H
M>>3BH6Z4* U7[';25\*R.R):+-3NX^N7[V);+N9$7FH-T_XMC[&&#.HH<%)5
M(;P&"3Z0,XE?]4CJX&^9DMU\0#*&O0_3O9</O+41P!)%_-;L2*NM/&4I5J*@
MHP4UN9L XVVU_>W3Z][' U\[?T.5C AG>+;L)"9 Y:;5-)DB4R2CP."AR9K,
M]N-C$Y<O/A("A1!9_8L+\W3!4#%O(K-6Q7QW$/7^=TO!PX9]%/TZ2YF;9WF$
M44M;DZ5?RUB,@\JB]E8PX3%FSR1";H\Z[3!8T-=8L^]4346&"V*E]-W3*9$0
M]^S([5A%7B=A+2J<26R$E!O%%@5,,"'-(Y(>O<V!JL,NZH?L#'HFLZ#)(_XY
MXO#1-7Q@[,78W_IRA5ZMA.KN(T;SCQ_8;D2V=$>3FG/6?%4?J,.QVKFW4>9L
M7U"T&2=N&4YKKX6L\<V"=G-L:59JI%%W2^M5#V&D[-Y\??1^M8\682J)*1M)
MQK7J@SY_[[WOS[.>_G/>VM_Y'/GF\5M'@<!WUQ]*(K7^-VZJ_9"_7F7]Y4NQ
M]>\YJ';^@ON=M=8?: ._9N.$NR/SZ3."[CXZPFMF8*8+"X3'G_Y0 VC)W^F(
MN088!0?[#/]&9J_!\^)=%Y?^Q[>E_%[Z#/G[]5/,WF6*ZW?CA00$"QZ"X&JF
M$!Z2?E'U="EPLQ!X$PI#'82)B51Q-#&,G&]X<!]T!*O-MJ8[0<Y],;]4UC'\
M@)DXV/J-5<595_.%F!%*5V4J.( G'L^0<'$44._9&VJ'N?,K/S_[VF]UQ=L8
MG29ZY4=,'Z]_H+?^Z/Z5B0ZBQP1&R_,NC* 1I:$:*%@M]TF]%><L TXGYI@]
M!J/R40? .R]F7-M>A:WYZ/L5+#+,DU=8.OY>8]C?7UE8&"/6[ER$:6S!B:--
MW-#O%@GEN5CZZ?%#ZGL9G?$HB#]U(0:MD!H\(E^+:]EV\>08HE-A8>%-O'M)
MT[M;+<YHXF5%Y'+<A'QZJ #NE6T3F'SK.SFR;'OP6 0C8?SP+<M0IO=),"G_
M?"GRP!)QWO4!:^FG<FQG]<LT4GB(S!F=2)S?K8:;WW"@(?:F *5WDA"4?3GL
M3;QV6#&T=KS6P/XHXV,%'Q#[ %EG"<MWM3%(+A&9KXP>6_JL=YWG7B#4-/\N
M9R7=5&CQ&]J%8Q\X[,UZ+!AB13R!IA,E4 3R LEE3,7P5*;5-L!OJ*T;0.N,
M(MT.NYLL'/)=^):)T9H=#?@$[7/==B_]I]C^M3\9L\X5L6W0'ZIP0AP]IE03
M@0'W:X<KSF99E?9PX P^T *1_GK-,.%QW7RZ4G%M19I;>-+MJ$LKS.^%9IE4
M6QK17]$PB1F$EF&.MJ <C1O\H3O>Y)'VCJUB#M3BP=/!KZ>"G2[!6#<)?J4N
MD]3$BZ]/&DZ\V0ZH60DZ\46/8%:_GH%I-':CD-O()#C10Z>+(\+$N#.JF80H
MU"6KI(6DK^[;/ATO5;@:57@B[[J;+V6L>S_6*"7JP:<(08T;C2V%_1D*//%Q
MMBWO';F4F(2"1S 4FM36=+D=[0K!RXZ=9WE F*G-IBFDX<XP_5+=;8_JNF/.
MO'A;E!2; W?D9L H3W#%4AR9RV0*?MZ<8F5$4R"2E9!-B\<$>B36].&!IC;R
MOMK^3X:!(09'WUH=\$.^D*PUO3+ K-4]<^9VW].=SN'+X><94VW8X;FF-%@I
M;WG+70NSJ@FWICDPY.D<0KK.G6G;G$&?BC4K=%<*KQW/'[._9#7:+G_E[HO6
MH77^#O' -@+E$>+S\6 ,&S#B8=/JE%Y-\<1%^("FK:U@%ETA@!O?_1I_B6^"
M)V"\ []OJI<77#2%O:U?\9L3D18[_U%B\)\%Z/_I)K>_(-]_GNIEN 48RA,^
M4$Y,K#<=XZ@*'AJ(?BLP<>](-4G%78W $XUD?3JSW4XH[XWL#,\^H7IT5OOE
M*UT-H7<Z:\(:4,5X!#</1LG.,&^ B' ,;C23RQ:2ZIR91N-V8HPOU)72;BY^
M,J_3$D)#68/5=ZW/I-TVX3X>'=K7(I59 "SMC/].9AES">/<?)XF.,<* 0L9
MLBTP<:@>:KN]'DX&5&AQ3<J=3FEBGB@*G%\P4'U<>XUE4F:X)J#613AQ$5;A
M33_-6&3M9VBF)Z \J0199,*Q@6]F/1Q=JI3(M,RL:^6K M/ +:01ZPT-%NJW
M27:NVW..ZW]Z="[2"AK/Q(/:G?3;U$Y0!S(?1L&/B#9Y2-0S/CT<MW<KI)?[
M'YC4RAJR#K,J7#.]HM)UQ8<KISV\:010+[!)58HG'D2%@UKPF'H5OYHQ/#XS
MT]VY;>!R2XU34F%K[LGS^8?O7"(;$(<W)=N*M9R9527J[P*6VG[/U_!_F;Z'
M\L1%V6%@%65?B2];!]V.655GSU0>)R=S%)^=1XLRR#'UC7([CSMLC LYM&?<
M(4,9Z9_RT>7N*OVSIXX;F:*@W/IOB.7/&/X(5J&@=Z^A-)GYS1%NU*S[JNDM
M$D;2,ZQ#EYZ=-VZ^$#T.9Z_L<?O0&GIIIZU84O_!YYY-_EJ1T.SL^EV@O6"*
M.<CL)Q,7A%"KN"\(I^$J')D[M)Z3^&;5P!97UOV"D?.A#GL"E)JF3QRDY[N7
MPW8VZWR/+UWUH1IVA',0O$/!WL!)F1'B^8!,Q40/!T;M,(RP/=%W-FY"GM7U
M. QRX?Q[T 'M*(+=);;18=7D^B^P>07!.W]B8.ES3&<:N1DBR1%C$JYK@HZA
MV<2?F!\?Z!N9;3"SL#.DOX"VD5]5.L7)V]A=VF3G4)KCI1#%+8)1GI,%6NCL
M%]I"W-4ICJPZ[>,S1@R55S"0901F9$2G^CAMF)1NC_#*.W39<,% [M9>MN>^
MD]460E<!]H'XMPRCI#ICIE&CDGE+X,K9N(@<Y(T#57WE"4-]4=4569IINL#&
M=8J*<'7+@=]W"/HOHX)-0$UY8X0*+$>VJFF #RCQ 4]\/)D1 V8>[Y/=6]\G
M4 G/S:2V->T-&X,8+HGEG&SW%PX0WW"A8:/\2N&E)[VFJE)[4S[Y*^\K+P]G
MEX6@695SBB\?/"U,V_,H\')!0O4$];CW-:>Y[P+='IM#H-3P@:\H\O?$.F.!
MF?(61M-9  T)7(@YS]-H#>9S:20,3]+[;[GW2>!OC2A\*H&"Y0-51+JW8"3(
M<-,K< )#J=*\%0,>M+3/12Y]L2GN(Q0_-^4#6]HL],1Z((9MJSTOV%W:&K#%
M9:%QN[AHO^DO#"LRH:R*<XLL@1E2@DPBA'[]>Y?JPW^4*OX#.6LP9_ 'WA80
M#!7C [=:%[_SU-W-@G[\\5^[C/W?&!?'0Y=]%?-&KE(PPCB0I2WG635,^$@O
M;W]N%3>&(I@9CSF($H__4(D(3P'>^"Z8VC O^,"0%^;KT4'"8"3FUU3.K_\P
M)^[?=SDP8N@2;#%>%P2 ;N3 N;4$RCU<Y;9,2I%]RYV3R!LTHV8CM9E+Y[/6
M,M?F>XLE^Y)L@JM[\D^O&LZ+MT[#KGE6A54!]=CNA]B>F$8;PJG.$0A1;2UT
M0PP-UP!1T<(^.7G U2+"%TK4[+M8"[B8&F_=M'&K3?G28,W/'\'7H]O(BC!_
M.X(/=CUG:S$?N+G5H]O,'J<&RO>Z]AL4H0[1_#)'[++[ ^B4E_9A>UI5:34F
M9YQK/E#?7A<@2U8,][I ">%)Z53H-09\7*JQ5I%C1=7+#,>*[G[\H?-))W7&
M?_PS-5PB02':S23NLY"L#FG%+5LYH2_I-[0JF*(<E3"F<(N'4G62 #2(HXE+
MAG?&Q7).EPX>K6:N'YTLOYP5_['[1%O84%!/_51)?6G??'9?^<CK%P:?U$]L
MS!(3?A*[SUIO[6KU6[:N3.QU,N/PPK P"P/"QHVND271LN6NVBTN+SR9W]KR
M7Y 1LQZ;%-:9U>4M.+R\_^FCEO;9HU[?A54S@QSKW'YF*&-1?FP3T()E-0"%
M^#GQ 2G4RLHYJK_"7N:GBMSV\QNC]WM*AGB%K6^A:.!3TVQ7WFJ1!R*E!#),
MN450A.J@.PF,"X/7H"8H&=#B&6H7,SJ*$G$Y4 *TL"Y.^3A^C. ?L+1=77JO
M1(V8JCOK>I/IY1WK/_.!:*@%&,2ZR!7@MC.21@[<.S!?>X+<=/U6YD)LO>8<
M5!TT"O=[BB2W7*V*R5-8'+AEWAGLY/WA2-CU 9U&FC'B&:8DGR.KQS(4=">Z
M_2JYU+G9 -&\CCR4L&,^ !51-)M6N/I6>VS1-XDWM)L+&FE)CLF'#XOAK<$;
M[!TH13"?Z=< 4[4,HW1C:/AH ?SOO%:!H$O$$LHTZ\O]+/(^C]_VS$2M>1/G
MV#1U.2K 1[CJSWP9^R@U$L@3 PD5HFU&$NANA #>^7*#*(MM?"!F29_E"DDT
M5;;PWZ=;_NREN5E63OY)3OJ5)'W]MV)[5#=$OV4*Q(X=P!O&E7NW+0R)CFLW
M=H[(-S=5N?*!^4&V'2AQ&(P:-UI!W.)3P[I%*HIZ_=+XP+M3J>:/JF,NN9 W
MC'1%3 KTSS+Z.\:1YQ+,,&*<W82>1]UU_H_F:LQ>+2;.A[BQ)?=@UE@7%+U_
M_$1_8.O>5N^X%^KN$[$DZL,K56:SB.6X1@*Q_T*UG9]\RGO- [A9*//3C"F/
MZ(]6X4UD3Y/FIQ&/]W1H]KYVM8\[*;+JA.*3[\X?OSL#$'.!]>3UL8)IVRK(
MG][@H5"=C)$>XPW6K*TX'2@LK)_A&/VPH+W@7?5$VVT[M<_;A0;-%C6S\O-F
M3>!K<06-%J2.B5']K7H;SC;X)PI]=UN3+_I >@X!Y;W#, Y@AP)9>\"$0*8?
MI:HI:3?*)G_&*-?G*CZNSNOI7(I/I6320"6$9+XU02=VP^9U-_%O[52<W:B(
M(6>6.P,:QT0T\Z3 T* \-T[ 0&!(8)R_)\UJCVZ%?7OU2@59C?;M*=WW=T8\
MS!ZR\R*%/9)Z*&@"R/>#>/IRU+W3F&C84KS!\N9U',>6":./TPS@O-6#;!V/
M^Q5869(;!%N_LVJW9G[SPIH#LY_WT-_6YX<KW7M4,5E7%88X WR;@:PD4.(Q
MC,-&PX/CFE5T(0:&LACWE: P@K!&AH35&R&SO]"W[HG>GM3BO//N;7>1/<?U
MW\XJ))XI '&\U<NZ^ W3NP6S'N7:!Q5#9@TBF(38%Q5DN3$?P@:48[[6XX(/
MKWL.65C[%1)ETLY9;GE:T.   $"$-45*& RDIE\SA4>/21:S#;%4^N:1@SU%
MH?*?_1_%G8DS"=N^]PCN_.!SJ2C,&I0R T%M2V#@J/2'H_4Q5"[40G6+!-?I
MXY(/97>4<W5-BEW>=MX.U7N+6E6_:Z#\F6_"#V"4?/+G75^Q;!4# :Y(^U2/
M_?MSD5"9'U^S*,&3% #@.Y),.#=U5##E';KJB(YRGL)SE(_Q 2UE&HZM5Q/#
MR_CZE"O^"_ZNYW(?$B:B03=>0Y< 9H#BOSD!S$__HPY7_I2CAU^UU)=E9QVV
M="^!J.[F5J"WH)OXP"J,3Z 09V,WQALN#\(0T9TG&:BE@0K:Z#ZCLCGY19D6
MHR(G\L$3*1N2&]7MHC6C)X_,PRJEZ$?87ASM<BX.YHD!SJ.%JT NL]>QMG>!
MXYIAT]%V[;'K3-JJ+\[]!O,3J5[WGH:=40[S NH:+!X2S)?]Q/]I_O%@\C34
MBEO($T59".0B=#D&,('RI')L\W58S!UPL)D/R'-L7OA>CJC=5SSHGS&RKR]D
M?_>)1U#'HGO5M]L</W*I8T./EJ,%>$F1;%FUX'+ Q=6#&$HFIC*FI7,M9^_+
M>O D;AU4#67;5:=CNB.@2(;C,C:S>"7.M"3N3"HM&/EZ5%&S]+#"_%O.(O<A
M5!<4Y8D+"1[R L=ZR;U?,<FT;<)'00!OQDV>5:]G4-XL>G-?B,^GC/<#EU>X
MK_8_):G>YJ+^-O[B_L[IOX$>DX\?);8KS<XZW'[47AN\HN 'ZI%30O;^7(U=
M;Z]&*Z[*_B-J$-H5T^A1(6$ 9[TTWZ:@IX]A) Q+ONFUR,7W8WZ?N003\L&3
M\?_B:_<)D'6HD*)UR)T5[V$+<TZ','#$[S,U,#^5.W_]]ONL(-$O$C9_G'$G
MIL2RVPT]C!$SU+Y8"&FA"SW$[EJ5(Z1%R);Z7\$X^A5I7(G[$K4[YSQN%9U>
MSMVWXZ1?L?%QR_'V](Q%R!^TH9D/ON>/VO=/7H.&<Z^'=*@?8*A5R>=@5/1)
M-:EKKV)U_<;^^QL@YQ<^V O,?Y"^Y7XX%(+_;Z.,_57^?[3\,0[@-<KHEJ:(
MHVQ$U,;*J-S[#>=(\6+:@ Q25=0L]P_$^\'/_F#>8W[V!Q/V'_Y@!*=_7N;\
MP@<2!W/^H+!3,,80I@SWLY,8#\R_^8CQAOWL(Z:.#XR;39-_OU'".CG;(/-3
M_[8BJH#[F]^8X<Z?%T.-8&#'5?,_Z@ 5[YL"& V[GK6]GU!B:3SN55WS.0-N
M,&^X67F?2:B=4O+XJV ^\/\XM?1?57J$J&"Z;KY268Q^6R_I8Y"S![VQ36RO
M,.]DP-SG59&PO(7?%X]GWV]G_W^XBA_J!,U+!P8P0\TM"U;E ;8M["Z)1]J"
M >(/1+3^;VJX[08(5A$H_/A\NI)AX3A5M>-YAQPSR63F>LT#Z=38&YT7]S\E
M_UH$O@;^_I,LIY9) 4'_3@KH_!LIX%<B\$KY#WC$._Y.(O]&/!"<_QOS8&J9
M>;#O]QM(N/,YP0\SO.!0%]_42UOMZYWJ&7<X]8K)NXNK#KJH9'TC_3@V_G\V
M_/^H]$S,R%2KAUH--PZM[^8VVU5+:.8Z'MD]<><"Q_G+"*)W\(^4$^2=P7JN
MU1]H2TY3]W^>%445H%8H'T@1?8(9H@;R@2=5(<N.H_[@<2N[$>2J/WQ<PZ'U
M7/8?E>0_S_H>P5$^:LOY*30^6C A1+TLP,S@#^"[GG*W_,$0^^(4_R>OU=.Y
MN+ICU#GX]:P-E2_[L^UD]\?N+)E0<0[_!R:\B*IX2UC83A)IML0R^6)L?LKY
MSA_J<2!MVY%BY#S-256\34A.R.!GGR"9[&"4-X@MX(T@RB#SQQCY1*7D2)07
M[16\3<VRSS0\+_X<@W?CO-8V0^?;ZT<G6Y\<%AU+TO2X>>-;*LJ<^5V#@>&H
MB+ MP9R3KTN9,0V!2LAPZW/L/-[ ;!O/$4*/P&E_T/UJ*C1%*,?%P\XO@+J+
M]"*F&VLE:,:V1LI25\6QK< [C?4;W2*"FF3]7 <3*E:RH66!%GL%)IVDL5;R
MZGN/;C^(;I=\FS,'B8<*-,/U)&09!7*#H\X@CHLV$5:C]E:GZ/ V@ST(\;'9
M*]M*8A'OT@_T3F29?+9LLC1X-W)$8J)6!)_"!RBY. 48Y09N \]@3DV:6X$Z
M'4'!)/)6GBOI1AW)GEYZGT";NR)6KVCZK':_\*P8NZ/[J2+M W'BS>;B8 2X
MA4S$@EI\@"-M395JQ8S4#[ $\SDN6:.Z"[7)>YP[(&6)#;W$DAB][%'9OCZR
M,FOBSI3Q=_B"8GSDU<%Y,[8?;X@%4>4#YXV&!EDO:KMX.LA,UM6>KTG>ULR8
MZY;0X$)+._]"W]ZQ9B^S>RF.UZ?#=LMMVE3UU<(:=@,IS!-W%DC"RDS6!5!*
M<+ *5N'<1%89%O3<[1PD>IR%8O"!R):M;A+LDC6L;:Z1=>'I]:58(Z-,Q5U'
MVH&GYJ$0QF$^@,65+@K@QC!L?-G%QR#]"!5/LF#E]%MJ%J%LF*.L>RGE8UI,
M\1'I0!GKBH-7CKSK<FT,N.F_#Q#Q]D3(^%S%S=L*WD-9:":,8%FKN$\^<0X)
M"B,\:+D[;PR9T,A*F\2CX,]GG;=USV5L>_SXN=[:3#\EY5OGDK<KKA1ZU[-U
MU2FI'IPB!\FMX0,7"".!M,[Y9K8\"LG(;X*+<20J>R[4V=*XW@V>+<Y9FP:_
M2< K(])TGKR,M@AW0RIM4@]2WS^Q%KIP!\GFB:NRCRZ__+H=\@ZKO?H>,I V
M.-_(S'"#)7BH,:+Z2F8RV#X[LT?\Y,/=$\QRVW 6[]4O']@O*SKA_ PG(1B'
MD3"&_;*;?3P=00T<":=9Y3>/RM+RJAZ#"]2J.(ZURNUA/U;S 7NW.:2FN.,+
M@ZF;NC>@GJ)'G^[&F_X_1/S],=$L3[.AG!W,02)\):\;NJFB]DX+3NIKQQEB
M<T"ZS:EXJX.N1;V6$:IO27O78T=%F(M)5WIL5;K+C[8]3WQB4OQZX[>51[MW
M29-(KD,CN;E)Y1=;-S39R(@XJD6N%;'[YY9#_HFT^^EL!CHN[^2<ZRN2&^E$
MPY=1^*8FHI+NN3,1P$J>G)#5^N_W*1A05XHNQ+#@K7XX;@1NX0-Q]SGV-$AL
MO?G+P3KEQV E*W >+^'KFEPEGYIKK9T6:N,5>'[CRUM:$G4IG(9ZYB<$ TX>
M/L8: T69":UDA7I=WB!!$KT%M!T7^<Z$QVEVU4D$Y9X<GLUK:WL_PH:>+G"W
M-L,.T]>=[G=)45';OQ%RJAMQ?R>"OAP'\ABWD ]XP6-AC./P8<]QA>;.M2A+
M1L="K!%4&:4^@(:\XM0;=9NZ)<1J9BP>91^U\[L4/%"URC3:*B[VFF=U-7N*
MY0)^7_8AF\_R88C2#:ANHN6]G @*W1Q149JV:^%\U97NCHDR0.BLH<.#D&.[
M5.GKOS_+10] ?@[3R*9H+SO0TT',)S%QU(4H2R'*:&"+,<H8]"SB0/T/PY5F
MEC1Z=YLNUF!)X^%VAGF5#SWWRTI'7KL?9^2*$&C01^0*<[KU4]YK)T1)*!$B
MQE$OYCZ&;D#&M)(^/1N76JU5IW^VM+)',_F-0&[:G.R':88; K:LM7 0G6Y=
M_R6@D %AC0_ 3O&!6+)8O19Z<&!L$UCX?'KI#E*/)AJ)VH(R)5UHZS\4KV\7
M!*55Z9S (<=2YK< ;V8(R_LM*N"<;5/SF@P\JZ Z?CN^SI/"=BLZO\'YO$WA
MQI_&VG)*B]X=TV$)YP+A7O^D?RPU#'LONAVW G-^0?P$4GU\\1JAZNLKF(/"
MP!4"*=2IWKTA:5RJAN0RQ"G=WJ@1U+O1&2NP%.]C?O;4Y"^ 2D@_&.<^PN'(
M+HC1[URPY>Q(_]G1TSXR'TB/+N,#;U*_B<@)+<<T^+LK=S'_^(,]WK M>>\(
M*V%>,)%1E"4H2L'-JZHM'H_8][&3?>#C7$0[4>60%ON^QJ6[T<;EZPB&EU+L
M%OX,2^-/I+H$UA/N;4MS]D%D#C6T1='R1"AU00:E!<;YT7!K_9SDY]1KGE]V
M&W/9OR&Q,<3/M+A^M;I.LR8 K;4!+JEMY>+0*N#B./8ZS <A[3KZA@:+J51Z
ME1\]9E%:O"\CQ2VW7:"/*D?VR>%J%/G *_=7<@Y"#K9Y,UUDN\+F_(8JDX(3
M ?(;5?N"14I21. V@$WH:<^"+9K<NUMC)Z0V9/PTXA)\.NOFU<$[O&%,J5$T
M'_"' 6 0U1:+.A'J24W:2B3!8CFV.2-NS_)C3_7FLX^[!D]BWPA_( :JWT[9
MJ[S/_.Q5^K_,S\G_M70RE"Y--? CD@4C+;E.@OJ<#_C,>:SMFS?EYHMV9O2X
M]$(86NN'NG=!<! &'$8ZQG(#+_&!E0"X:5R@0 )MS0EK-<"0?-"[M>L-=<>W
M3)>W"L75"FE=K7IA*WS.VBG>>CKUL:$#635_+(QM,(UA',=&[[3EK)NBP>.^
M(:XO5:;2E+$D2-.2U4!N""5"422/OBW<$[G&*?VSAVJ]8YELR7Y=I<#1)6VV
M*F^9OYW(,1J7BAE;P?0:G8KF6#-EG9B'8[(_C#S5CDD_<CM NSBR\/LCA4.7
M3,ZN(/CHO7;PR^,*%(4W.096FM^P(,GK1(@9!% 94U'/H6]R<[G#69>CAMOM
M-DT.E95HOS05^F[-WHP>)0C#3F% ]<5$ <"Y#U.N:$\P(@E3.PB)EHHYG"V\
M=]5WG)DV=/HW]LS1&<86^9KKDP&4S3Z+6N;&&SUA%WE-63O!(+8D2I:;3J#<
M(RM^8R? XTF=33H]S;8QAS-\SN+LBZ,/V1QJTHU;>6%>(4BR$3D1B7X1+B%F
M)'LDY:U\==(!HL4^B:=9C\P=MAR-/;G?(0"(')H03L1VH8\+@=_9RN@Q@A",
M\@#!.-@9RP<8A^$DV99C,QAEM.(<U+2KSH+1<VA;:'\=0BNG$#$Z$^1;_%0V
M=/W@B*=CBN6UZQT58=!4*B8&QK C#"-8$&XFS),,ZJ=E,D@0):0%54/6-TV
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M+ZJ4V*&\$22^U37@OE99H1;NB6T!PE8"X5YJ452WZ?47+UV51.G++>HJIY2
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M^'O$%=PEFF@%4B,N/G OUU G43]_0@?360LC_R_;&V>1H@];5=*CS@TA&4"
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M15^[GG0K.24U+3TCO^#.W<*B>\4EE54/JQ_5/'[RM+&IN:6UK;WC14]O7__
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M_HO8OXC]B]B_B/V+V+^(_8O8OXC]EXEUEWQ;W>ZC<4U]JB_D&LTOTR\JC@?
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MU[!<X1F(<!W(8EWBCA)D>, YU#26Z3_"5<2< R-JNFJNU/R8R'>*,&V^TBO
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M*.9")Z1A=I8,]AJJ>%\XT;SQQDP,;?X,9N@OA;0W(Z^T ?(S+O1<MCRJS_H
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M%NYX=X?1!_S. :^N8XDV&M,R3C;PZE.>?1!Y!Q2H&PP%>D%X*A5)).4@^'D
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M'+C$3S\-"4Y56&@D>\\GVVB1_>VBEY8*4L6%MKPZP)5T3/&$! 2%&J+%6?4
M7.8GX/"?@5<5*I[+:P[*C4T56I)N>>O'A5__)N>!'S\-+-?^$+&]HWEC)-'H
MX'[->!,^4 (J._C1W[G"#^904X;4HC2K:U12)ER0$&Z8>G5WEPH#EM(L]KB*
M<6/^ZFZF-"H5$R%U4F7+_*O:"L/9Z&P[__@)4FL-6Q[>C:0?0DS64(4&$&E8
M:8Q:N0ZC;*&H/S?MA8DTD>K5::D]4*RY)M'8-](=Y*^S>^2O&>MK<>D[;F*+
MH20ZSOME&V'LM[)N!TTYIG;"[(E&SV5)M^=:QVU^_O2(I.D;T@(;NUIS0H,.
MY_?NV>IYDBBP0]CZ#A^;($;X\@R"^=[#7TC]/."Y8?]P-@^0L5**U_YI=AW?
MYYK9YKDNA5R,(DT[Z;?<+[K=,UV9/1=V-^#TUD -M20DE.Z)7HA0E#B6:$H@
M_X#?(K7A:-J4&_&&*8UL_?Q)TSKX,?.M3DJ#)QMBLH).SUJ$))?Q1WK->Q"_
M5G 7OX1NV!>%":845_OZ'HK -=D*B*;+7RFK$#<\.3*Z\?G"BUW9]=V%+[[E
MA5^3O9RND?-K)O!TU*>$<Y<<\#X VQ[26P[FZ,>N_1 3?5BZ*RK;3Z*1D.G(
M2+UIDHTZFNG>LO>K5LO[][0>O8;YY=N:F1V7K][/FI C#T^%V$"=1;%$+ \(
MVUS30]WL= VB+\TU^5WHDF2,WZUTBA4HO[%(VFGP5>'4VJY$NV,OG&2OG<U2
MB6?=FPN1-MHR5%;KH''P0FO#@Q_EZHV65PE54R3?0O%SG6W>;GD?:>?L0_D9
M#EQA[BR4R1-+($)=4)@B!G!5,$83; 3]/$Q,0JQG:OS5N8AIWY>^NOH'Y;9&
MJ:_20LJ8A:MMA[-3_'V0]."+TOCE,I:-WNWGP_W9#XW6Y47R_GRO>17_:=K7
MU]O7(20D,L]66B!C]^T]E3<3 !5 Z,)E!Y5S:1]W:^;+!FC>+["!9\/I@<LG
MH/)5X"_X*##[#K9GX<[E?:\_1[,S8MFJ9^=0*O$C.&E$, G4P!-G7"K&N8;H
M7Q*^?L7G#5I;TW6:6@KM!!22?7R'4K<KLD1QQ^+?/HSJ>QE@4Y'OZ)[C] :1
MKOG99&_SLP-''ATY(?5VM6).;<=D-SL9P")(= \"J(9BRV;V8NG'<=O0PU0\
M6^ZD._B&@D_RL;K^*YW^;85"_=(O\>J^WS&\^%"L>N:;QK O!CW; Z8'Q:V^
M,T'P#0//? ?)SY/; Z=[(,5 0S=&!G?86JU]Q%K?>]K^\QNYF>H/)?*K-RJ6
M<Z*JMUYSG'JTJA9UW_-W@3LQ+#P\4E^_KBI'2]$K#W [N'=_!2P%PD4X)!V)
MG73FBL:PCDRS^3EWK!4PMJ\R8")?P^-W,>P[*JJK<S)>TQ]Z7#9ZL^OO0R.$
M6C*']':XH&VME"O1Q&GI4N(2D:WF SAP%X&F0>8!\F%(F7@U=J@O2O)+[X-B
M]34-UE&G[_O.G;=Y$ A+K,U1E-9=GW;X&(V ^92J\MLW-]R\_](V)+)!/6#L
M>84XW8)9;;DK*\8?7[9SE)2&>1#'C%F[=>W#>W"F[6!3!L"]1@AT!7>'W"20
M4Y!T+]*T*Y$'M!H22:I?71F>@YY*A)OGZ -I;<87TJ8>/8@)U'#(,]=_Y_FS
M9?2Y9/)QR:A8KK _ \9LI^?VXL ]L %8$D&XQ45H3OI-6.V/+LF7#2R[7W>?
MON9JM+/,\W]8+:4YWS]RTN#'4[=?T\B/0;.IE:1%^8T69EZXZ5CY2N.9H<@Z
M3>7V XI9]7%S==ZGCNB]3I"W."]T,BN0"\2?XF/G0!AMDF7"_0R!N*,T7S\P
MB>7+'4'(8</%AMJZ&*FW6E[YGGA)7T^-T&_9^_GL&8W!>;&@9CM1S$1@^9&_
M&N[)&\-<J(Y!72+1'5? 75MJ)5V9\0GMHM?+#(]U;Y1PT_4Q!R@LY<R70_JB
M'[:C/J"J,\;DZF&()>'M\37UUTN:SZ??/5UY0C:Q G_8\GP"0A&+\@I&@5;.
MS%-!Z6D(8:* X;ER[>$%Y$$L<<@2.0 'M=K8L@/8Z>_,*PF3883F$.(,JF>'
M=LG!UYF/3=,:RHA^4N/&CV8&<033IO)+ X1*6Y7@0SJ'.@Z)?IGGS\KB\J_*
M_?T+(:Q4R$X/8<*@<VW\9_B6D+$N0_25HZ A?<*7.\; )1NJMX=S(D/:T]ZE
MR1T[HAR*N1-RSFU8IS=$EH\$108(WP;@P?.&H)9#3V[R]?HB)G);N*4: Y$Q
M-G(1-Z648W#L,FRE5Z8W$KOT-68)"65UXG=+07SZ;\1D>.]&=NEP&)8!.]W2
MD2TF\7/G%YTS>+7;KL=OZ#)_GG8_O#,!Z 8N"8JG@;,)Y/G :.MFOM7<Y<V%
MX(,0OSZ0=VVC@B]9IO%OICSN4I\%^0=157T]NL;J:]=U/,QH-ZQZ9C+RJRM%
M^[T2+SGBWPZ#.B&TBP@*B-S&%<02?0CA/" '*6P-_+"6R_A..9Y'KV=RWX[X
MWNL-#;@F<>>$Z?"]X6O%1QN<W(X$9KL]X28\?51=\>/ZN]:UQ0W3ZJ^%^7\+
M\5<B&Q61N<5B_,UT"Q6&#7P8Q5;NK?RYX5<#R79G*WTXI1/Y*,P8M*@W48:K
M]LWY.HO,33QJ9EWE ?>^MKSL^W \UEBFX/Y$:?Q[4I-"/VXJEBLAR^C*IL?V
M*DQ]J*.@<A5V["IP&*D(,S#4HU4UY\P-V6V_HG+%JD\R2BQ >POAT9&4W3/S
MCG>]7QL0+WG=O(GSTPG(V5\4Z"CG8%.U)0%1@I]>XHJAZ+E,&B0S*3"."0=%
MZ J#L5Q#>LTMC E!M@6^?*G$(3FBN:8UO5XI)EBRX*N#]!'AX[O^IEV2(EPE
MD.^*OH%$WLDI=1]-M.8#]V]S@!#9>1_/=B\0>^CS^(+)C/2'&91FF$&?_.O$
MV,A:$+[OX)LES]W\]!JNI/-HO#JD<RB=D!_S@"W01R-2P 1F>=;99M3*F+H_
MH<]XMC?<9%]QSEX?7^<>695<L"B)N!V_F>@,,=M 4Y8,EOBRRX13@XA );T@
MY9@@LR2N47'I2H(I=YDSAWG D?9BO7.<::N@CS9*Z^A+;]LD*4E\N9,',L/#
M7_O,_IK1RFYX8;'-J/S*:Y,-@!M&.(]58HN#KI!^,D$M* Z"Y@7,5+"#BDNU
M-F&(R[##Z; T$]:GAS]>N+>G1[[#A6;LVUG]H+C06VY61R-+<]6DU&'9O!L)
MZA6E=%EBB6>L-:'YZ40@0B+BCKT"KST8>NPT%Y?MY*?<J]BLI_3EB/B^MJF)
MP!1[TLW5>@HR(&R'"A1&WKVO^&'F8;^P_E79^53F>]2*V4?S':[:X[5U=4_/
MF$[YVFO%B*[>4KXGF5#^*,%Z<PFI7V-3"Q6<AR=,]+ 4)W1I@C$/V#NYQ(AC
M;LKJ"$:1TXPE?XD!5^ASY-GB$,9$S_IU".QV[IMST7#=MCB5&;9Q9_EB>6AW
M7 *38>6N*]-X2.I,Q/<-HX=''&\[* F>5CSMGB!4#6"M2,W(?M24 E<LDP=L
M[41?Z8^7:1SK#& <('OVO42 7N-7\P[V<^ODDN^.$::WB'?^&B_);NG+XM.J
M;+>BX0U +)4 F@W.$8C#@J #%=\/GYKHZS(;#7B>LDXY9CG&?*#ITTI4'@3R
M]UU<K/\@56@S#;/3?,PM44\4B]%!B:KI>=URXSM_V57US;<G4VC/7GFESA><
MW%0]=0+.^L:R66B34_G+^Q*#^U5=@'A32/@?22(MKE_6!K&-PVRY3#(NM3H\
M-['<J('.;9,U<'9]]#!Q\>UVE?DTPI4X?LC;K@N=_(!D;]-@6H)E+&^HOPDB
M?'AJ;2!*G] 'G][B*A?VPO[!9<?3B<[A7SQ.7UUPQZ]$WIG+\E5?!C@M)8KU
M.T.UT\^J'GUA.;_WX"&AQ]5''#_^L_AT<,^/8HE:U@)L& .^_ FRLU@PF744
MHPW64,JN<H>\Z/')3R_L#9L8;[PL%W$N?=S<(CI*37@N/.7<=[@+Q$Y8O$K\
M6QP,09Z$)7[D]LV*,UK3Z=]/@[2M3RHGV;:'7W1(3X>_73O>H>YA?Y8Q!PPP
M[F\9(%34.?=T*8ZCR&.FN9)>9V=\ Y8GS,W"-//.S4<$"^"M&)[E^Q?.-JKY
MW[[4:Y5T&VL)L(]"%6A;W0*<;H=/.-<S74!%I/9B.I_P@%M73I(WKGAAZ9=R
M,R !?YG@BIYER4*L.;&OT%D^HUP5M+%K<P-# LJOWR"8'QV2K](@W&2B(,[0
M:$P7-^!3]LJ=4<BQ\+R8IKA%6-SXM84074TI]>3GW^\O#+@8>XU4O&R]PZ?_
MZIWNSOU"&GNZDUX+T2M@W]OZ$6TY29# #"#&\@F!N5-5% 01IPC&4DB3@73H
MGRTK"F&X(*PTY_8%!07/2_9B?*('R9GJI;N,G$[>01IP*N*%N.\(#4)L^3EF
M,H2]#L;..22P^1BN?2]R,ZQ5T3R 4EAS+0QUW6"EG.Z@ZZMQL&?G5ZLC:L$9
M7I<\8>W88Q]]?'SM9.7'/PW<KG!TW\:G=#-!5C))Y=PIRX'D2G3&,.M G]+!
MNC]=Y%F[A1=O2U-M6VYNKX"]^T<4Z=[$#F(D.4P N/G^_1U<H:4@UKHX@$I0
M9A^_5J)ZWM[<>'?SM<3.^EK%=Y_5SODA5I0XEH]KEVM_+SDNF[ <*Q)E163W
M#LA).=@ 9-B%P@31W97_/6TMDP2RB[@OVM;P#OC]KWA [AOLTC/(1GY@9'B
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M&KN J\*NJ@+Q]/_*HWXP2"E#X#!#EYG$2</(,+!4'I".:&';/>,!8=C0141
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M/*9 D)\LZ]*'OU>:8&:*$V5[0?*"0@CQB/46M R%1--AR SP #Y"*'S;#/J
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M Q75C7G !JI0O2$)4,$VY:6<;!4#$$M@JML'[>*O]6K(F.PY\BW<Y*',=]A
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MW>]-%GQT[367.^E";\[ODN-9PH-J]F2763U</TMPBC!]C_1]NI]Q@G*BP5,
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M7C;"?MDRT\/U@^6\]\@+=E^SJH/#0&$"<A+)$N*(:]Y)YE.$_(7'M\1XX4=
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MEP,#.>#;<!BQ ZY*P=.LXFZA3.FF9^A7QE5<\O4'M5:UPM-K-%+Q^DK![>V
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M;S'=EB_R-9WWWN3YX(+%$0GIN=QGN5&'1';V22_6_N/T3Q  V;T/2CF&VCR
M9KQOXVCV[T\A5&$48T<)*]F7#1P,26 #OWUAR"__L[=&L@'.6ESB23M\Q&[K
MY9;WO'U>NK6FEOA*=TN\T8CUZRI!'1/;QF%@];JZNJH&6UL=/V(BAV)/W'>R
M*N2Y[_COQ&%YY[+WB^Z=(WN+GDHW\.;M;X=<5/FUTTE#8IO5\44.L_%R[[=4
M*U;E<@!*A("%([O]"KE;&FB3S$=P?OH-Q'N6&3/37//,V*9]JAET7\'&ETZ-
M>_(_-1J:3VALB_"U?NZDP?TEZHS.R(M",35JW\IS\T.L;EED50Y9FGK\W/A@
MO+E*60S#=U9$8MI@N=6A[M74U^D^I5ABT,RY5IJDML<WGZ;Q%Q$A79N^#QFF
MEXE!,I+*!;D^TJ7/KGQ[?;;0$I(F?3L1 (!+VR-W2SN=''4 %@#.%YOIT'XS
M$X*0(= X3PE0CX2)CSM)N9U+E;6BRJ;4&@R9#[,!0;M8].ZW=IKX ?N:'LU.
M]W<_@])(RD4GR5W3?O\X;$O?S)NP*AI![\HQEZ &/Z6UFJ_ZXG09\RC$N LL
M5^!RK).9RF@7LDL%\0FY?H8-_,3<80-]Y<-;^XU;N6FW'( 7GG+6SI.C'U!G
MV<#V._3#;."+*1OXT#K/!E0PISE#'V3)K=%N<C1'.!O(NC?(.N*&$&7F(X0C
M^+MOS^A2<AZ8OW_A%D(_TD=+^9AOK*X.Q^S\MVB3KU\L!#Z\+G4]RGLIVF2(
MPYAJQ;LUSW/W[;58NHL\)2V^3=Q"7@L(U]J5G0A@;C[S=VE(6Y+-\VEID.G.
MO_,]QI4TZ/'ZI OEY8>7JEG\_.KJI;I27-+DK.Q2?\W8$G_I;LF=KI?S]B\L
MW8T6X[WG8DI%$8UCVXP8"E18^ZJD75C@LPALYP9.M&1?KG9B1-";BIGICW;1
MXIW6/6=$145URHJCH&9[D81,*,5A@YFYDP-Y;P5"*8ZK0F+1Z: E7-T Y]LA
M0*3N9:GL8#Z>B"RMXZ^W49C:V#6_LC*_2OYJ@VEBR3!V4: =JP_-%4%Y0JN>
M;RQ#A]A_1,RZNBG$."CKM2"O]O>VW^*]A9EC3:>TN75,=8Z8C.Z]1;<NC-6<
M4MK?*^UP%S@DO1OX);_YY7\(1@>.8(3U*[S)"0K[U@:V?>%NZ_TES\__U2GO
MWQ2N]NN]EQHS?@IK9_B'SGU(CQI$G1L927Q5(E1XLX!/5PJ(V?'V1LEU7IY4
M"RBKZ+=C%- NM[GU8*+;^(I= ))0[*;%D)+M@(J[GVR#B 2WR,ZB192U/B5U
MWX;YVY;+M^ -$0.&M9TP=/^C]TK-YA:-YEORL!M;S8$:''@2& \-D@\)<Z8&
M8;IRX=(AP<'G5G:7V2*5UU/5)[&?_"\GR^ ; K@:S,9+T@0Z_O9=.YV\!!VL
M#\LK[[ZNWZR4NL[!/])T,U8W#;L-&@A)@=9#DLS5&A(8YZ@WV,#IV'$3^TEO
M"BVN#!<?=.L=]I[6X_#:89O]/QE]:0CR[2OTBG\06O9/P&3_:9/V''09"E/,
MS]>%GFLH"-Q](CRMRZ3&XOMQONNBY[-4";/1(A?^0;CH5M.!=K'V4C!)CC_M
MA;:"]\;M1S0KL4'FOW;)C)]5LN7-%YQ44Y$7E;=W^%OH7HLR=8H([19+1!P$
M=0AL0,[R'@D9-U"&239X5I_E;F<\-D<:T:_FO:FACA#/YU&LM)8>X^!3Z>,]
M*CH4[/UU8;0T.-Z=K6"><^7^JJ&N(U673'"TV/[3^MB+]SP:J=:%PNL. I?D
MK553!?X7!9K_J[5_1N![)W6\&\\%UZ^-IO>U:=<-$9O2^D(TAW<H1[WGX1EJ
MQ( !;&!RD)7X(YT-(!49.K:S8NV#7/";P]?6T2I3TS8BR63#MW6-!W;TW'Z2
M/IY(@!+QD)H<)H]A"$.A 73@YZ+;L68:-ITK9&/:@&4CQ^[*!#U#O*I=SA'U
ME(M!!.^]1[\1O/FU5M[3[^*7FFK;9$#FZTE+R6-7:L;A]T65PE(MCS:D/]G/
MD_[@2;(CN+%5&F!$]\H#%Y#W^9R>7M!,Y@N8=B;BC,IAB-!1)6FO \G1-Z/@
M6^GW(I9D'>W+&9'G@F1SZH=MAE<?O<>JZVDD9 &BW"\/?[*1ZP VT/_QZ\+;
ML5MI2T\W%_2U>QI4C^ZJ2[8)52[/.&O3KJ4^UC+.4J;2#R,_ZV^=/90C8VY#
M^;%7L;$0'D.= 9=VYYST 21WS_5@S/;"%]>2N0_-11T>Q,W2]E%@Y)2RA;OA
MR6T'&.<HT0OZ]IHMZ.T(=1AXYT=R$9?LMB_C@\+?4XIJ:FN\5Q48/SBC-T9T
M+=-/3\(O@3'4>[0OS%)#X<%8:!TDT6PWL3R4NNKN'CZTWDA.>>TB+O_N"6-%
MJ0'/OPU[L9RC^5@B5&?[.$B=JH\J1\A=8QQ;@BY6E )WQ3AH&]1Y\Z 0'D9%
MKORBZR'ZD#((TT"8Z)54O?@&-B!Z:WEGF9_+O@+?B92![Q_52!2M70+'TS=L
MMLM;Y2"^0BBNS\:P!%3!/F83])*>$#BWYO(34YMYMT"QVA@M%N8>%G+X5[[I
MN,Z.F$?JVC8=!WN/55<&K$$FQ&C?F;E00B96&AL@-AG.$E*G*ILK1.2[,(M;
M;*G\76Y]\;53Z!JP^=BH68+NJNZN5"-9B1?))=W/FNJEN#LZJ0AN4)&:2=)B
MB.O0?H&+S^&[QM?+D3BQ/I8A=:,+(X#WSSC^PK;X5-KC8,^1E$7#SJGWJBAY
MGY\??H@V G0D;2N5,2IBO@=?I8&O;>@5FRB;3<U_X6=R,CFEF&.O0OS#7X%M
M<V15%%G!IS3EXWV2OX^CF[WFV0LUURR]7E+464(-OK-L (?J0E?SDT7H2HQS
MX.Y9,>5%ETU45]7LA,'O(#-+Y4=>[B^\"GJ7PE))AU!Y7\SW/]"L/F_\"2:S
MM;^I<(4-4$[TAZ1R3!)L8G;>3#.A0K'3!)(*/^Y#; R3I>R5%9_JNW=/\UDZ
MN<#=[T%5<JS3(5^^DV)QX'&2<?M@(F?V5R>:SX%\;(!/!"RE6[M/!,SHJ^RD
M6B46C$7*VC:ANXQ%LVD9.']:99]9DA1*LZDV1<%*AM#(%V7>PIF LUNQK]"0
M$/I>'(25J_8: ^KUQ3/.;4=7#W8IF\YBDLVX"B-6:3E#!GKR2VW;J5F?8D+W
MY1J6?LXV;FI(ES]7<N-V]*N)=]+E'!9\Y@RAG+6?FLA2A\K7FEU!CDCLF8<2
M"- XA"!8-PN;Z">BNS&"%Y9G5,:1@1ZB?6Y?ZDPO&]:1:[-S C4<2[CEY6\(
MF(GG 20VX#OMVPVIQC)DRHGXE1BZ&NLK=@?"@&%(+>L:N'D>;";"%.''D#)B
MO.\#9:[I>3>GM63'DFXJF=M"3?MWA/<U+"*3L!0GIEX77K'%FP*A^3)3VW08
M-T98"K4V5"T',,RWK"(UQK1O+DDS;_.'6+UG_#OO(."V1X>-2!;DR")6 *',
MX65Y**$2(F: C#*7>-")Y,(&D,V1(LLJ<L-I*:8GJ*T9O^N-=Q2]B_+H[/UZ
MXK%SY,I)Z=L,(J7D!"A&5T-P#,I:#AF)3<VSA'RH?;3 <;@5=<V3VO=@N*M-
M)\[Z,]RU*"!(JGZ#8FOX</G(T*6N/0GFL'T&PH_@ "+9'TNY@)^T[_:491:P
MU$''KNX<E@2',SR,8^"'2?:5EMO=9.KOCQJ03QW6<-WY=#XQ,.R\ZS;PPGSP
MF'D.U90V 891QFD#H ]=U#C6L!76@Y>HM?-V39VU392I^UQ+-M>\VM2JI]:D
M,509K9OX.U.5S*-%Q,:S@4K9E46J+4M D[2UM=9Q&*$)]O<LERWGQ75ST+2*
M ?6*(P<@>4;DV(]H-/N3)'!3$+Q-B-F!MPE.8[-WLT65ME)U0\'!+?? <K@S
MR.$0/O^16^4IVZ R$9#3H#NE;E]ZMMVN,5S/OE^^QT=+(IV_D2^S ?./A]4-
MN)8+-#G]YN&''ARC&O=B8]A %:8W1 4N17$N#?<AH5(*9+ZL0*R/!NY,_?%C
M2#!XZ ?KTS97LZG'7MK%NX5^"&?B$6-HB@MF,H1F&4<8JR#IZO5XZ@ZUF;K-
MV%/H#I1=*<QBW/W$#XKE?B7W77VR;6M">??OV;W-)N=.RM'0WW9T 3=$%YX?
MZL7+3(42"O$4IU6<),$89;93I9PS/5!>5)):5?6)C"6"MWU=T+ZKS?6-L4=5
M#Q@T?QQ(_N:[O!5*+,R2AD.8E4A"-E08L<TCT!@A_)E ]6B("3:SE$I :D:#
M9_2#-P0U0IM.>>-<%0Y]>!*=E%+(LXB?H+.$4$0]W#U: I5_)8&J2 L"491P
M4G "\3'#+I (C=^,?!U2[H<Z%.4Y91MH]N6=C//YL'=[!J+< \FK2._!J7 B
MEEQ$$%-@G  CB9$AIVLIQMUV-SLVGYA\='B=.;UX(WXN;Z=4ZG;[-)=0D24^
M.)'J> 1+N6'?>2=]OSOM/)6[F6M$)(";BV&_[,G%86@&9RVB$8-HBKVP'LZ7
M=I#Y;-?XRI8G9I=U!-:%$M?EH=_E$GZW(6GEEXVCAY''P4.S.H?0:8(^3G+A
MVG%A0&02T1[<:[_2L!7.:\S8VG/5'UN'2B\B)*DI?1,M^L3CI7UAF("F3-B
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MKY-?]I6'1"NZY,&RO.76E).VF7YT6I=]:"X ZM R.1T_(;ZBM]Q"RGE"B6Q
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M25B*O?T$SGY"DA90R\RN74V4C"CK:H.,U]G Y37''@?-#]7>RW^_+VA]4FY
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M7SD*=RGU,W+^"2([=?1R,& VP8K7)/A)QISC/KTK%XI%LH6(^3^J,(^@7FP
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M_'\<U35QT,00&W@_ML &:&INR$6/[XCB\7^TV__MU)_W1+RVO#0@/[UGN-D
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M=O F\:A8)UK"7X'6&+8[%5KCL9>"4X48H"J)* M9L\S,]@Y@(T"')/802W&
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M_7'/&4W840"$^00C*_%MR@UQ/9?QF#O3P4JFN(S2B _G0@_-!'C'@E!,-.'
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MH7V>E^>9K.+J^/-IV]!+CS\D;76>*WO]0B(Y'VAE764?#,3+H&0]_OA427V
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M^F7J=8JU+J;M;ZKL.!_W@SV71ZF.J;LC>-00:,U'4:#TT#HB-ADK8B8WBS,
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MQO7Z<\4MMX)-Y.O2UZ7,O>*_*%^KOW"Y4^8ECZ/=0[#W "^IE+M9V,6]DU!
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M>)#R&L7VI!LX)R,K[=M"5-_"2,KG_#[#2J=+Y](ZL1S'+4WU^W1O7OPPU'[
M5&1*R34-_D"J)K$C>6&>P9F$<O2,*$. T+1G%%4[A5=L'H9;^I*DM7[JMW&D
M:P2(BX,O_W T4#KD+4"DQPL)YFDCRF+N[J_!3Y9+Q^I*_H1K/ E3EN$?NT5.
MB[>9I&A:@.Y/W4>'H*WJL\0HW3</+U.GUS1?S'SM]$7';A="^J:'Y=90B0LW
MI0<)QT:I'EY;C,8J+EU/.[]OHQCU^Z62'=UQ[ZR>BG:0I;#B;329BCDU<);7
M:#[P<WQC_Z='/O2935RK#-ZYU8J=(65)Y[4-[51W3O;MH$\0U$T)-_$&'+TD
M>!4M<"DBI5+#(7YD>D"!'^]=M49A>ETKR9#2).?!%0*R=FL]-]Q^3O]24:(E
MBF<Q3/U>C0^Y1TDU<RQ631X7^R!U;\OA+U7K2B+WB:M]"^86<0M!9QZA"%+L
MXX;RDPC>I&%:B[4>B(X$NNS[X*U@2B-LWE-Q)JSBANET@ #QV@AYO"[&.[+K
MH>.E[ ^; #$TJ2,+3D/Y$G^9FR0BN5K"A[QD*X/ DMB#'$5N#H!DYS I8EAQ
M6,(I"G@RS:B.2T=>I\B&F]R@RK16)VTZJ#?/SJ_IF_7WW*NI?ZJPQJ!F-+1#
M?B(4<N8_0866)HRO!J^QK*1@B<XH5M*/.2F;RQS%YEQE,*W0]BGH[!+P**+B
MIE?#UB#YXH:R!X\?'#DG+5]\/DKUM$4;BJK'P+R=%K6X^>-+\(#3P))3KDYM
M=I\$Z2ZAHD4.Q]F+-!'JA\T$7Q.J!J-H1I1G#P]3-,FR4P*$9&([43E@L [9
M9+7'HYJR6\<CZF[&O-=H1X 3A3KG96/Z>.-;98T'2:P1\FYX%"EMK7B-JII0
M@%X3G'3/?."RW,;E]_7E-V\29U\ZK]WSVV#:=[0")<AYY B,EH-V]J*;QY6-
M?6IS_ *8!J-.UA:'P@9VMNWZXNS!=8Y!E?DWT>+(1ZJ?[S7C7[7<VF_R6/.T
MC !Q^/&$":_]\F]K>J,M(PZ"NWA'X"'J0^O-(.6E8QX6@TT?^,S0KU\."OOD
MC)SOM7FH*76EM( L#XD*39;]89YJ3(-UVNCN5;7]L]MT.]MY7;?$>0;QW)>?
M_O$NZO__-K(;OYY +T67M;/E6'-BN"W@,TY<DQ03K0@V._7^B))=:'WE,0H2
M#M?*=A6/:<GV-*KG;=BYES<HO;M;O'_1]1X.RZ\E^,P-IS!"TSBEK/89) ,I
MB_5L<53$7G9O&-#&_KB7IG*P\_[-UV<2[%PUC^*>R?1E]?.S!8B@N>%Z+@4\
M3U%#^:%3U<53<3NXB=69+MUSUY-6OA.U//ZLV6:#BXL^P\U@<]MJ'='N@%(2
MO(;0> I%ST%JPJ8F[!_ 96XS8'\#YVWXNM4W?VKI*:;Z_>I-)ROOQBCWZ:],
MDZIM*OLFH2I$GEW@9C1[/4\=6]?Q%E4Q-V//0*\.SN3&SLIH'ZOWK_4\-[*J
M):VEI+O)35[G]A:%(O&X:+FPQZ\A7:%1!'E-2Q&ID S34<;?[C/[<4-O98CQ
MC%Y50W6:3;OI<2V#C=MO-]Z]O6^E2SQ"^9<,[Q!^A 8$8A)0 :6:8# W&?0$
MQJ>9LCDLHR.#[:X6!-$?&K6^ ]IU:28>#KVM&?X[DJ0.EC1^<E-\2!K,@C8N
MCT?Q<FQLJ21,I<B3I:&M0A6MBKW,^IE2@53P:F?15-U!5:<3UXH-V2:ZTH:S
MFVKX\(]K$Q+DO2VA*_<@?(7K=B/>$M]J;2I Q*6:71%>?A"G(X];R[%ONC;!
M22(U/1F0T3M6[;)IP=D]\U-9S"CU[8F?07-A)N_VIF#F4O%"JM.H0J _6W:[
MLL#W"#OS@2*D7?1D"Z&*RWU0$O#3X]8CII/%OH2V3_95>X_IR4]Q&</5RBY^
M>GIK=Y5^_B.Q%:)T&KB9 *T3]F'ETG+4$\@[!JIQ- 6(%K(1>.?)R#ZCP5B<
M;GY&)-I:.4O.^BN]?:4WZPI.^QW#;?W#:((9)8@&[KR\7*('GF[4U.0_))Q7
MYN= 1AR?-A6R*J":8GGJL6/XM6?C8P?3[+3K*?%GMT'T!QLK0QXR]^\MK:70
M"RE :&?73"#/VXO0*.35YRDCCJVHU633(QFAQO"[:H_+'<&!R@6VEOGK!GB/
MXY7?!]ZEPW/I!O124'^PJ0O<9=_X&ZUQ3@&FDD2N=!''54%%CG5SVV_HF];*
M0P69=6D5618!Q@H#.EGZP]IJ#TKL>AU5</)[45X$^BT!HMQBII:GB>_<3;N.
MHN<A*T_25,@;P#MM@^J+2QW!JID]@57S'A[[J[9V7%7^&,2=WWGJ(.O$-LFX
M='Q9Z7WA&-U% 2=HB23@5-=PQPGP%QT5[Z4-G(:1G)#VA 8;QISBM1"CJD<R
M;RJ;;XSOX+WCGK';WJ$QZ[I*3 1UY*BX!.\X3C6;2^0_(&_$=[G !J3]=]KQ
MXI\;K#2K@[(+^CIG'E8Q&7NU=2T[A]Y]&CT?7GI=@/ C4(.9JI#BI VHS9,@
M-!ZA>#LAFSW\LI\%>LF :$[]6V)(,?:X$-:YM:A<<M1X?/K;X(D97I>:C/:>
MT .C)Q;E6'*Q#<X<)./J&SIZ%>3TV5*M^'O6^:HE_^1%-ZV,Z4,YB>_#U(\0
M->Y=6/^R8.L[J\MH:9P&/Q852J+RVC(\B)"R./=EOZ4-?>XZ6HUV#'".O5*:
MZ*(NB:TZL\5V=V@UP7+[H3FI=UT;J6W:^X\YJJS41RQ'(WZ'.Y$B#5:/<9;\
MHHJN^"5_R! IC^^ER%PP,U$];=?GQ;^UWD7'T:W@=O4PXY>-Z5&V/:Y>[)+'
MFSY8,H=G ?>B-1=)L603?B9N/<-9?EJ D,*;NV/;IO=S,F_H]!G.A7CW5NXY
M@22M?],H\]7K0-B77)&IY*\4NA '.PD0(W+<18YLYA.L(Y</"!#1#7)YV-(#
M'/-X1B!9ROC%9<SSJ?*2G@[=J<\;MN<?ME@+%8K@3^<6]31X QJPY+8H(**Q
MSCZ60L_+52L#8_*Z?AO?PI&9;'3S[;4\H52>$6O1UPIFO7]$/">>,#VY9_CN
MK&3TNCFV$P^+'616SR!9Q*$[W Q^Q@NR(LX%P"2R&^RNC*FV] 3O/O+F\>B'
M;EU^(76?*/1Z<RHK0]=7YVQU9_7WY[_RN:;\:&$/]%B9J93@.:HK-S&36=0Z
MMW[*W,-H[L99H/\WX^R" &[)O$V1F[M.^?W\A?4%$=?.!ZXUP!5=G2O\]I<
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ML,FS+PC RW(.(.P+]M\I>?[UP-V"WBU/4P\URTMVM7=&+Y<(.H0$M06(F5\
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MMACE+(5.)%5&M-)&$F&)2N U]QDX]V1J(-> @[\38?U"Y<YY+I=]CE);?>M
MZG!R8O):VK.5M=J(&/1#-&!+&4+!,@0PBQI:!F"81S(YV4S+^/-W#H$COVGW
M7Y_,=%L,'#"X]A;#7#/J0QQ_. 'W?ULR3V.,;1K9"\#W0GQ\?$-O+V=4+;-9
M>7!%24#RBN="3HI K,V3,EW.3O_70'\OXN]S %P1Z0;U8!M5VB28>N7SQ[]^
M[O^+<5^P@)2=N<)G$$N T/QTRPA6U\C<6W7#W+7 7%PI\BB'Q-6MJ!M(\MNF
MG6/]A9E^T-?OE&39_.S>QDT4#6MU0B.60*?-Q9'%NZV5045X]>L(YID]S74G
M5=1=;S2< !::+=1?%BG7K8;[+F^6[?TX$K$G0Z=,9Y!="JE8<'W!&-ZY9>UM
MO0/_B2!IV#F8U+"/(1XBUGI^]6#UU3[;".57?EK[[N6M6=%B?%YMP_G!2<R,
MQ!/\&*GL9S-RR!.6] 0B88DI)D8YB"1.5O "59F9C<4:#EK]%UR"5X>X^#H&
M^&,?;[>Q)/O?98C<V*GIO45D270Y&0.? LLMNX)3SA/!,VB$T'RMQS"(UZ\0
MUXQ^VVT<_WPJ@_NJ:]TV&P/G@"I:W59,3OX'0"?AU'>9J&/H' (0XM](HD8R
MB$(@I]%.JB U!G<E;(,.@\,O0$HC37HNY'PU1C8P,UA$7D=ARYL*KZ!W"IM.
M[3EJW?/U\M+FO3(9;B^8@9/WCJUQW%-_5G^]@U4\[A%P&98RX<E"6'[M#^(0
MD4%L)XH&_<RPUBAKZ#7CH]JJ^NQ?!J6/>NFVW0M4O^ELU.#2<[AS'3'MDEC/
MJSNSM$J]QFN4  %B.)NIQ_Z!8=8N;K:,H$=Y-O=,7WU6YV0Y/MP1:JRT8ON)
MCV,W;\ZTV7N SEQ__A.R%J'1^@HJ%O4J$U*:YBKU0&9/ NLR[M%I\0*$1L-J
M+K4ZWN1'^,U]_CIE=;J?4L.M:0V<V[T[JB:<6A'67\ O/#=\)^FU73XC1X,U
MV$:1PWKPVCQ&U>WC3?F>1T_6?B[U3?,YF'?#=^+7F,A9\Y>,FIO)?> T9WD'
MCMT*?!(@6'HSXAP;6X 0O]CY^*?G8&G&ZC7W9PZLJHWPV[!%W["%OB*8@02-
M2]D]@$8S5:^YBQIY&$0_(30U<L1G#("!YN.<\)80L[DAQN=S!RJ3':2B<I%W
M=]C*MD1TO/+7+2X73NW4?8$L"FB %EH@GS:79Y&,E)S(]G'][$-U1X'30527
M1*G A>VY4DV#)SXD/O5.Z^X6[T.53PI-ESZ>2D;V0XX\0]S5;LO D,=C+ZK*
MLYS>+RS^<E-(L518E;&^T>U9N$A55>_%L.^G@(073X9!#5C6IL?$<GU 1A>+
M,FS,AWQERE=Y5I<-OACHG3UK#267-TAI7WX5_PDA.KOT+TG^5*9FSACZGKQ;
M.CLVN $9YDXZQZ'PQ=@48*T D8JX\&\A]\5JMI>% )$WE@F+(CFE'TF@X4V/
M G2E\>VZ-_TGA-1KM=4C&840#?S@M3;4;L0O\]]7LM3]N^W=02=.' IX57J)
M\"7UGUXT_+7P!7\CO@,Y?P$MBV+;] @0B\GJ<.CTDC$_DPV=I[VV;ZZ*<ZLX
M:;VJU]S ,WTO3\EM?8!H_],20AF6!L==18/2A#;B[SY'F^O_=V4OG=M@O7YK
M#=#$%4QB$=9.+>%3\J8BU&^5$G2SRT<\&C4<#0N,W>)M_=ZNY+PUS5W%.?*(
M8]"X&]6"60G6?>#9#2X61SD>?*.B8,]-<6>ZG[L3'.\[>K-(6D2M$<'9NSY$
MF<@UT1 @ND,[! @1(MCS-T?=8JU_RO^4_RG_4_ZG_$_Y_P7YYQ=;9/!JZZ95
M@<.%^'U*G@=-17Y;-N!_P"UYL/_'KUHF814\0 ,<3:CV+ %B1LV?MVX?;R]N
M+=C*)("...=GX'YX%-O<'):R\U'N)T>I5\7/A]O*_-8^NKM=#%>JAT#BP426
M?9.<!*1_AT5)(F_&_M;<N"UP\W-4RLO*&R><5(QC>B=G=!M>*QH8&"10&Q,D
MWI7,)5(J$M]2DFDB,P)$H/!(T;3SQ%M5#\NE$LTML78J+WQE%PQ_G5U]:IZV
M2U3#Z=HI8AS!FP#J$]DIP!S+*QX8V<_!-$\;K;'<!XPXD?L.7U6/U"UNEC 7
MET\R&KP2O.Y&DZKS;0-][;<4^BV27.5<"@$(=8[&*V-/Y:D7)9%EINN.9(46
M;):OJ4V'U_Y\M?+Y;-B=N)A<&41D42,*-'2%%!6YM\#" IP2N)X7 .YH(1L,
M?L5>"9$[4G>[Z^JTQL$/,;=7[->V0#->WN$^%*+*>W CK:PHI:1!E'<$[L<K
M PFUA !C>J^91E7DO2JC5Z<=UAWJE-:-6>&PXM&6B]B=OURY4?RGE" 2N D3
M3_ G#$=P.?PD2#<?=#Q%D,,9=^,-(4LPU@RCY\%3]W!/F=Y5$E(8;^PAMLEM
MW)9X5<-2L7_9=[G"29Q):B>,Q#%I+>L5^HYS5)[QCDUKRO3[]1L-N&3OZUU\
M8RVE82<M>W9-I[D\5'2-&6W-!#)3< :L.:FI<0O (LG0+$?#M3QYX=#GBOJ*
M7.K\N*W<NIZ#UTMN?+ 1.[YOY1H/9: =TFCXJ>X/*>9!>ZIR'4PQ8C@W3FX,
MX[)VQL@3S^EJ_"$#S4,OO]HN2B+HDKS<:$DHG?^$$HH!=V.:4<B&*#HF!@DX
M(J_#.N U'^;8D8Y&:EN1:(?QLWS=CTF!EC0.ZL8.AU!M/\V3N#(-U5GB %5?
M]!>>7XZB/Z0 [@+$B%UD*J&%!F#F&HFBV/0(8]PIH!9YH$[VR.%4);Q6L/OI
M7,<.T:K(^<L\(21=&0:>X3E#2LMI%W"ZH"O/-]4!KQ.0I<2%M5)</_?"7Y5Y
M(<V>MCK?Y@WN5F[5DQ[9']^EO-CYSR^M?[<[\9O5[S8NNL5MZ*1?TF@"B6G6
MY[KCKY__*?3G(PEP)Q)1Z@0_$U!WKHUP2X!XW;I8A=\&S%WW"$$>C1WSC518
M:%6J/O2RI*!5\;V^CKQE0UHKWAVZ(.QH(MQ/ TX1D/!'%'!(@  W(6<XI<-!
M=<1F1[0\+AP<S.NT>L&V"!LN/GS',7C"0</NW1=&4II7< ?V0<) ^PQR!L/)
MIV/8<[SMX"3+?L8X9.2MAWC";!'GU)O/R6.Z8P_V$T,FMF[T,>;(WP2^[BV*
M0\<O.U!#JC18HHBG%4S6YG1!B@OP:D]6E.9(2WF%*EFW)W1?34,\.N).C>[;
MZKU#/BN/7Y!^'G9O+8(O*T#$A:,"*=1@%HG=SME!%RH.;XX5=(U)BD6I5Y)$
M3(@ZM]\M?:G,:CKN>A?JV^E_6T+#L.=^BL*PSY(,6I;0B"!O%[)\=8*/3,1I
M_GW4.:,(.BJQA*P3I#+HI<*18?]T54^=]ACN,G[L7\-GU[>\U_RJ0]0.V(F0
MJ_DFF@TVTTL5(7OP3"E6M9&@&.XL%K3TY($1^0'SC<IJW[K>(N_YTW9W\MN^
M>(H'/Y/>+G=ZL!DI)D"<)8X4<<F<PHQ\ 6+5/GYQI9P\N(>AVA;1CU.DYQ@P
M/B?$YAIE'DH[DOV"UB6=7M\TO^-=5=F-[KO'6V,D4?N_Y<G=)/PQA^1@;K1P
MM*_BKO ?DY5PFP<A;Y[WB#L.#^YBIN1$-*'7+J(2TT;<W^O 5W9X=!68C28/
M]%(/WCZ4<E'MYOZ]'>GW?A0JB2R@V$2>F/#V3_!LP5)N'[^8$("UUH/<.*B$
M$-RVP&=37DIG% \!<-S*F4NF/ -GZXB63&F_#'?=JU=/OCU:A#K\^TJ&_V:.
M&K[MOWXW>E3\W=W?77C-I WY2]^5\J-I1(!P8+WTJ\/\[>;T?\89_^/]9)%?
MKX7]*OI\9<R"FP>BY6;:: I]W#WU0&A9"&<%)C'BMQ*5,#!F(BGD4\.2C1&-
M&U:UL"(:1S&[Q8X.'B/X888-N"+@%YZX%TZ"3X(ML)E,O49GQ:".:X7.WIRX
M$^2HS5K!?F=V=QU+GO#RW*>4\9WF%YABX+"E6OKHLH^/&+\>%8@:BFOU0@[@
M=O"4BUKF$-C<A8, _^6S?"S<=>3S!LZF1T\U#((W5338.IR]5U@AM?V#^0['
MK_JVM-.3D *):PD.\K:.XL+Y>=9&T*;N!@D")[L]OX7JWUBZZGOW&!6\I']A
M )$0OL;SS9>.9^E^Q#6APPLLK;W6EP 26XYGC3T!2X4!+#J:'?44*T X]EE+
M@X<PZR$_"@4L+@UZU64U'K+HM#[_34.&:82W&>L9.G=M__GSD]_1H#&A#9-*
M0*#H&20E6!\2$=J%Q\$#+G57%,&4 ZFY"W9]+\T,/"-YW_:G=NB8IW]B#-[G
M_HI.?5"X'  #?Q @-,@2D#EG;D:<=P;T6V_"<FXWN6$Q;L"!<S3S92:YEB*I
MY <%NBVRG [E%P_#XK=\%'7<L))E-M[,*>*VU@#^;3(VK;17S[TZ&41EQR+(
M#/A"))I.WFFO,]Z(O$#;YG8AY]Y7:]MFXT,7=/S#$"#R)$>.;<:3QX^BRS,J
MA3I\E/]R T<$+&3Y,)!)7G(5X/LPYC%FU);Y-I<XM[K8R%JH-J_NX-#IC>UW
M]FA]2*_L"$95%K'U>*[X/EJ%7@L!W.R<2C8"$_>"_ASG4P ZKD&*'F+06OY-
M4[;G2E[&PG1$>8"^MF-*,;%B5SK3+DT[U7S5F9HE;88%.X:#XC[@EUFOA;P'
M!0AZ#EZ3GX57@38.O&PX;FI_YT (I@VO$^EP848GW6A]0?(XM4>O)O-*^@.=
MM-LKI3*>>TD#XI"2#5>$@YY1!ISIB6Q=X4J1QGF!I)?8208EY8)E6,$4U\/W
M4^6ZD'#OXGV1EI?ME50E9S65LCM3N=$:T2(_7=E?GN(V?<8CL%MX=(N;<C<L
M%<957FDJ#HRX9Q\+GK$Z:QOK4I<S[CZ<+^GAH)9SRU%A^.6G!A-8(H>G.XUZ
M5<I6!NJYASDF28\&S)Q78;WV.'D>JS3TSI@9^_KP@)O8-L/RND<;%)(+HK&:
M4__X8/G_R89#<NJY@<)97 I2N*6?R:MPIL*#Z\&_6302UX&19P9-((=PX/6A
M>@I00HS$K/-8E3H+=J@F?__"S HHP/I4B!H?].4U)2-^E<]Q5<%LP)4K!$GL
MR\(IR>4_KIB+5_>/99\XLKLZ"1(CZV? [VPWI'GLB AX9GH']7 ^+G4DVE;\
M%I*[<CG[!3R$>C7')E[C:=D(%8IT7^4;O4/ ZT""3'B.!7WL3?QD0JB'NZ_%
MI6N#/X]]%[U"^5YP<NWIT$EB^;*A03%&4)41[92;2#G+L+_HH]HKI!OXM: K
M<QJCC/5LU)0"3^>NJZ(,AIR*+X0?&7B-O;=(/Y-SEMA!Q$N%BH;L88I#BJ[<
M/,!Y1IECPDID*_(N#4.;R\!.LS=S1&A7*<Z,V++&\WN/9XK/\ZF7H3-PYYZ6
M9V]TW'W\CTY<5(K*%JIX AO-VP29\Q,$"#]G";B#(#%K\O(*07+8DD#=7=#D
M^&;_U\!<YM?9JPBQC, O&2YO$:H;$ CE[W\_*O]M_P]<N_#6<P#_6/P&(=PU
MA"U &Z;J=9S3R\ (_&H2/H<^K77YV8.T'GK&ZJ05-NLZUA5*($HN;#>8UX,E
M?@D0XCKP9T(9B7V9CAQV;4,#]J7KL8]9;W=+>YB]?)/O=*W0_EKPZA&I-[5]
MFT;,WY)]Q*U]9G$K6N2H<Z ^:B8B'VXDE?FW8*ASGL!"T!2=(/L^,KA0 E<6
M>>73JY']77%E7M<VNIR5.*43'1:W7-!C9<]R%F)Z5>[RI'L@I&)GA-U7'+1<
M7P#JL5R;.EW;K#4 DX1%3]M@*3>FN]'PEU.!++SK3XQE8K \?2M==!8-ZM @
M)<<V)'#"9+C+%>2PT,..+>C5QA64M:,!8:#0DJ<[&XV&>5 _&?=,5%7KKAVM
MP [M#?#\:AGS8Q4.+>S#<?X;>#=^E"()&P52*BK4Q:%-! FR13!^-;D!^!PW
MXH'>%_AE;=&:AG3E<UZV&\RWJ><6#%+_;6>G_ZU.(LJ>'C59?7;U]=51Y;8A
MVOD^.[4<Q+,0H:5YWWZ#+MJ4!@QD/@N)4/Y<?F:D)'8SZVS/AT<QU.]OM[^:
M6'/;UK-4.)\9KP2(@*XE?=*O@T*@P3(E-'O#/:3%8ZCY-'\!HBU =/:0 8,"
M7D!1=\#)>O!Q0R$J[T0"0X0*?[Z2,U0@I"6<+ 0O/1G$P!IRW)L"Q.,D >)N
M"@K>80^9(V?4! A;10%BLPH!\HNVGGA,/@!NYAW%7>%$M$:)-WMI<=JIAJ7A
M2LE?Y=@=)\<3=ZFYQ2!CE'^,_4/*6?]7&JY3.)?/\ZLL+_/$X0\7<6Y@8"$V
MZL=81-N27GS%F$^;W,9O=5+?+8)%^BM%%0WX6<JZ]\5.I^=?[#Q/:-Q#.%\Z
MLH=[BE.=:FR] ]\/BX+Y=-J-W\B/6%+9?.VW@[O-"X-+QQU##]G .>'256(K
M+^9_"=^LLEW*-1\>IVD($.<QL4B$/XG[I><<&0QFAMA9R:'/V#19J'_*69NQ
MR]>%G+S6=_[%@AAMU^"Y@SV^=U^9 6A(,0$=3;6'E&B' 0*TIH/I?].,-OQX
MCO&U&-7:N0X=Y(J7 ^#2K_;\'/X=,W"CP7NW]U]M1.^M,;ZX@H&PBJ!;M%-
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M//E%&E^^0F3J;V)2D+\_N'!LK_#/'Q C-06(1EL"_0YY)9\<7BH)[1^0S2D
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M)1D@38*?P8<Q$509B[VL9#HJ"F<0;)UKYAA7C_0L\8DZ+J1R^Y%,\(]['-4
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M:I7/,=@&F-"T[S]P2N -3@OJA58JX(0?*>XTI:ZR%,,-48<;90%B6D$PWE8
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M;_\",K/K,^W0CIDJEQ^G7"_5.LN6?RR K=,G"6 '(A=XBQ6K2O^21O=30=M
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MHF&P,;@2J3P\?;.JBH)5-$LI[M1]T&/4L[=5W2#SP)-[HM4<&? R:CB9+[;
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MG;CFF\+$ICJ %%.)UCM"/=Y7D/S6;M9E=)ORM@>7MM_;37F_UBE:=-5/37G
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M[^9K-VE1GALA'UA02(K3AWP@"2%MN1%[% S(YW]$ <<PL61Q"V&61T=JIAR
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M\%_=XY6.M**'K96GK=+5(?=7@"'"XA!12</_.\""HF(2<*%_IP<7^G<-_5^
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MJ8,RO&2##)-^=,]# DRXO&Z)RC[,]B[1,"&-;7@*J6O*:\R?4^9)Z%&%VGA
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MLA@'3^4"LIQHGK5K*K2PG6I=.8&6QK)D:BN-I[H[6VE]&2I;%N3>TU3?]UC
MHC.!7S\],O'<<XFWN.?R.KL\3]!:60GCF1"F<ZE$Y^$^,S#Z3"N-4T?5F-H
M,IM&\5G)[2#WL/F&PD4C>J) &TH>T[E@KA,34_I<F2$[*:*8+Z%:XD6*1*E@
M+X_$8D./XLL)[X@0 F_+Z.+]?#XCT;S%B0=$1ZH?J>,9ZM(;VK9$,-HN# XE
MQ"?2)G?5 PB;T.A<]E>-FS3?9WK';A*)\;HRX+_-/AG'IZH0 61R&N,!?$4
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M/DSQ-:$/.G*7CT2)9,0A]47%<J?O(<X^4_N]AV)@[8AGV@*3*;49J(^^EQO
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M V/H]_+Z !#C&:-!>R&?S23DFM2E ,T*AP7H4!OD(;_95\JA)LOV:$?-;&/
M@!+4-KZT#8#00!WAWQ-"=Y*8)B=;OE1K]E[.L3-(<?KM;WW)7?;#_8J<,$P=
MG"EH'@31[-Q=J./C!JSYHD/7R%B>^#PSW_A]83#5:_.ZR=V+QRSN\Q=5@]/
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M ??[C)S663SYB$IRV%[7^KS9<B:./HR(V-^E1E>!<CWYL2ATUF*3H1-!JOY
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M7 &RC(_XKB_9"Y(A5?SZ*?%"#[**:B:FE'E^#",*5SVUZ:&]HD\X)A*;WO.
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M]&5UE,SA$"*$T.0%.T+9'+8MGE8H#*@O\;M7^1\M[3Q<*VF2O9WY+K?^TUL
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M "*9!T^"H_Y"PI(N=F=18REF[-@\^Y)ABKC;BL20G+S0HN\Z."@Q+1C(;W5
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M4]EAD<IJ1.7T.7^/VJUO'/?O$_\KT<YW\0 S_8XKK;+_:H[0H.Y!-M?R*1H
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MTUOITKATH;1WK!U4F357AD6UQ@0IC;PCKTZT-H=5/-S>W@5MNUO./)D@#(=
MPF>\%IK<P!)R$*'5NV8C/2':'TI*PD>DZ\<'S"10$9<>'AR.CI0++5U>REU=
M..*4N?WPD4^3$Y#  D]D\?=\W/>NV1&#=()32,(;&(8[3DM]?$CKBC,TI6^S
MP^P._NE2S?K6%HGN)\.E&@$S^G'DE&R.>WE(65[9Z^/V-@B(9O3ZK!]80[ZC
M$V ?9\$5!FOJY?7?;,PTN_/K:WZ6^#(8)%W>Q<7U%M13WT8:G=1(-G>'D@K&
M!QI=8S;7!$9:]]*W3?H8?,IRPX:SJ#\ EO"Q]PHJ?MYKNA(\W1UZI M=L<23
MV4Z+].IQ7=PE8^P)M2&%#%.3$#EDWNA]]MKI[6T9)A@WTIK&50L*+341=-SU
MTV DO+H'6J^WD>+CR,;HWE7RZPT<YHTAH7H!'3E6_/#]5\;VS*TQ/</9X9=2
M?+F8NY;6J^(]"=B-'SA_ME',=DP[LF4*D$0"U^._$IHG:9OAR KHY"U8,:JL
M>GMA:C6_[?RN5?^D+[M1E,4:CUX3\3&WZE(4DH^C<A\B\6RQ@U6GX@XSRY.Q
M$[0HK]=5L$PE'QGNK@VY$JN(C4;5O#W]46O7#&V.DF:U^VF*ORYAP*Q5II%P
M$H4OT'Q^XT\%YMO;32;:W IJ0[_[Y1!:+.%[.3[$$VTI?22CZ^*(& =D7L_R
ME,(0AYSGO0Z*)&)<D^!%1']G%V$ J=COD4KJ94IP1 )'0WPVKA(O1,FT"KGI
M&?(J'J.7M92U5#,@4=;@IJD] +_P]WP1I@ERJ;B^A#F&^M_M,N=-Z,B?/%:4
M0@,SR7P1OAB ;*[!AMG@]?2,NID94>_\@U^I-W;@43EG  G"*DN:RCMVU:DS
M $?\KNW1QUXK(H?23*V*0,DQ8VW#BT_1Q<7-X"MB@K.[\M]&AX<%ZO0,%+[H
M6 E,3&I1H)NEI 8O6@9ARIULC]:4^!MKK.;*=KY09UJ(RN6E:>0E#T7ON_E2
M<S:3 $N3.')DK*PJ/<8G^A4DS<OB1$7A!6Z0@TS0\<]8KAEYCKC$>FU(34Z!
MV936'"NHTJ$L2""C[;-"FXS_J_;LWE+T_/+0V:YM]\-2%N<$>R*C(^O!U>0L
M-DUPCJ:"6=#4^<>;I-03[(*;:_;!ZR\468Z>_9T*?B0UNJ:.TZ:0*I]%Q^JO
MX*X#QZ7!5Y[>[:<X7-1-+S!YA)-$PO+V %%)W0*0#UI:>? J/U68,+:3DHDD
M AD>%GK2YC3A/R4Z)M7XO*+F6=EY[& ]J.6F2:*-L<\-2Y)&W](0G4ECJF-Q
M/TY-5?^)WA<OGS["=9)(:J9.ZSI$5.E:1GR8U7N6S+5M._+YV4706.V<E\I/
ME1[4WS7NILZX4?@XN>B^6UJ:?3KM?:A9_H(4X0<8 7YY@:J4JZ^2XRZ .4[Z
M:6M+5+V'[;"GR53.+I7*N%*N4D5XL.:[1:%LS*TW#V$AY=(RS7T<GOV$?N,*
M>R 7HM"!>?KL2+^YW;8RRR%L@<;B["F:W$^]7220>JIKZ17];4OG\2]<L T?
MPB3'8-^-%%2.[Q] ]W(>Y_2TQ1>DS*9  H\&/M-"J6>EMI %WMR<2"4>2:TZ
M>##FCV6IVP13O0Q\ATONE"-<35JD0#:C?@"2W]*_,BFL.3OE8R6<JD;J'V'K
M+(.9M\DHN5P7TEV"@)-X5GJ+FDK:275*;F],NDRWNCK+&P=*Z++VL @D?O94
M40F55W>_>JA:H-9JR(H7[?R:B>EUD@9XX'7GK"5KUBU?U'$G+V"_ <9BLE:B
M\2"7?P/5QO$$3UD%]NHC!""R7)BX6(.49>,(,N=[P#8;)M7)+8*^GO*E;DS<
MU3VA8.*6+Z [!+P)IB^8S7]EGS+W GH;I<7GOA\"L\2F]Q;:P'[$,H3L(I'!
M=,Y_]<59G<:$!?B9]+XP.D?MXS%Z?\&'Y?=8YX9?O5F-QV0.]D(Q4,4$7"EV
M0>T:BY6WZ@(D% YDY=45U'RMVDO)L*)\4A-JH/G0H3CU%=(%(2WA>&DMND.=
MKXUHJ%^D$'V]0G'2Z2*J3;[0$.]EJ]VXWP./5.Z4=Y'G^'@_RJNV3I&6"P82
MY7HF$" ?@3OX7B4@N$@&2I"U/^//40ATD9:]9HX9TI.D79P)3/I,30EJ:29!
M;5 ;H5PXB9+OL?>0ZS4J L7?/7/S'T9+B[=TH0"KJZ0CSU<$?,)NXYG_ '3H
M/PVU8E>[-YL;9:A(W7S9#@MM$JWOR# J.ZH"#:H\)!K\#">M@2YOO(/9 SCA
M8N-[S<1' $)TV(J\D/-YM/TA[]W)?O+[CW8=(W )7DM?KWHI@-E?"!+@D;?)
M9?E^MHY/]T$S'[EE2BOL!SO)=<6*D,B,4 &0X9M9JT=^# ,!!^_#A#&]_@D:
M!(!O?<N;F)1P,LK57($?(-0K>K!)(DI0<9VA?DH3DHQK*RQ-"B?E?8$X699%
M'2EO?]N.L;3@6R\/Z*A9T)'P3E/K[ X5P 9#O'=OR6R 4 GZ>O=1#7;;P@2;
M\76X6E7I!+'%1K4#+X7G[&N%:].3=R=ELS%3.:.]"HFQW6(S&,C?I1%[XLV5
M%:2K\4# M<#3,B'RV-1M*YL_9]YU1]-?M6J!E\/Q]\=3-@LFPSZ.74Q\!<[
MP$">VE/U267JA#K_NZ--$:R(.H>'$*&_7&+%DFJIX/F^Y!4QDD'9FT:6'MM/
M*@BM3V*=#'CT^'O+#M\\+-63NV.)2"FOR,GX,*?L:]+:3\D\T3D(ZD>O?O%^
M0V6+U<,/4#<HGX-C%:PU?#.2X+?KPU16])R-"</'?@.5)VR](]J$X\^>]:11
M?EV^0RU/570B9A8@[?S<"RU=QZRI=M2I6>9[H:MN*QOM)7_+Q+;-=&K\MW$9
M<NX>1JH".3'"5?'&R5<0FF4^] I$1F)&L7JFS.DV(4&OX12WR/,:_16D2QPH
MAY1H*+H;A%BD2%3>*F":0V8BDS&8R88[$TT^!] /29)=0Q1!7/(Q$@#<9M5Z
M:J1/9+ZP,[.?I;=+*)W-&$=+9+723)*U,A=D/:2]?;(J16/>_V<5>@ZX#H?Z
M0_VK7T8/4RGHE9$CWYN9Z.Q)BEDY.!$%P,K6DDQH^37@\Z!-#R#AQS/?';K2
M_O_7"TIK:7X=[IFY7W72G^=*:+\VFM7#L$J*=\4G?]@,Y%2WIKU2@_'=#]<Z
M9J%(I%Q<'Z6XRENX]XS1B@6.1%$TI_P<X?:Q$3#='0!Z^5=E2187"G&$:_ 2
MTB1$I8*IU$S+W?/#L;QID,&:@W7J(*\+^^Q"!5T"R%4<J8:_6DY$&[0!2SRZ
MR-".NJ7WOO4D>"=T^@6Q^>#^N]$4+BZ:6FPP&52E";#"\ HXP4K""C%<ZW@;
MKOKDB:?02-!R5.3S,PM)#"[AY4OZ:9#,TFKG(UG2"@4NQ[ST]J(F,6G -.;0
M=W:Z7:'*E;=[=#,*8^\R@&X<WWZC TJ]:S1:6UT>/Z:=WC*'RDJC2$%>2]A3
M9 E=?B@OB=0LS$!"<LX5KCK=W#@[4[:4[6SG].K4+XX]$U<0Q\A?BK'W<>-I
MSX/+>9#156DH N#%9T'@7VWTXW2$3U9WN)(Z>3@AQ]42+WH#+0NBA#L*+\KT
M@;-<RD#23'P#^TD>(6U;Y[V'V>N4UV'TZ39;3$:2<CLXCX^B-<G5293QOIQ%
MUXZ1=]3KU6<+<QYF>*$4&6*^KB&X..@OU7P@O) =73U^RK%S*>SE'P#/$V@(
M.3EYEK(;(?UJ#L'B7F+6=;FW5PE1Y^03<C\-,2J9WIH:\N\7S!H[ZR5A3SPS
M35O&/C8[=34O)1;Z_';E8BD2B"\Z=UZ8O]_'^6G]1+2-4:Y.]--L[].J%>)]
MVSE!@P*W3)N%+.OUPUNL$5D4![X0K"9O#3]FT;4G7%(_<O.0/<M;\,?N6)BQ
MJ;)6]_5K"UH5Z[U/G3[$>B? !YP=A+/DS#,+%CRS@XX=ZLV?2H&PUPA;")!J
MF.0),T\WX_EOW?ZDR(N,(J$7HJ@VA*Z(:,J&PJW#N#\ 6*:E:V%-^( 9BQ-2
M[*?,OD\?1!Z5:#+MGD=!+89EM,% VNUSGU[G(7-5S?D>/-PJ;6PX.YL[6#]D
M#R>/JCWT$YM.HE+J[%4=LRKQE&9:DO0DYPY9:GW:TJG9Z04BZ$$R+U.I*4%&
M^#\O;&NZGL?ZK9*_A"PK_WZX/]DF??/$"G$P$B2*6E=X[D2HJHBJ,[S('B+[
MN7ER=+7QXF35$L\Z+./KQA5H[9OSYG U^JV16#9&S@&Z 3?O+W+]N3I_W/-I
M'+(PL6GHMUBV2CAB0FC/6M1AB@)%)'044:_1--U6#X>61Z\F$7C$R_"6YF:2
MXMWDY/;O6H$+J(O0NN=JK>KI&C_Q\!S=M1?HH/6"2UE9K"M704"[;*;8&I?8
M9ZJE^*YE85I=8LN]!!(0$;>)?V$AG,7( .0=6OFZ2JA?.+A'C43^#^ HC'[,
MA&R1L)([!H8\QBG&C!$^958;T//.29 E?L?'3:LUTW>1P8[R C>C?0 ['<YC
M:<QQZ9,Z7K#BD,%7K]GDG;J^7E)U^G(X)F@ _'':LJT94<(Y//'9FT_#@UY^
MFBD=SEG228\RH#<G\SDD>445?(8CI"..^C@JI8#AL3!?0KJ!?4-ZD^1/2)*V
MY,.MG,9D7[C9@=.P# I?\:>)G>#FYH@V(/?PL"P^J]P!7B@I;A3WKFV6<8[;
MZW@55A\9)A[9R-Q, !A@T]653A0J@W!-I#5_/[10FV[>(Z%"4'7/2'-!( )>
MBHE9FP+G85 &/O=WJZ$&$XYU.3*@Z<-CAZMAOU$\\2EV/5I!<!I)7'LZ;82=
M(Q" ;[I2 1S7>;.H3(_EG5480[0[^[UP28JO[B1MM5'0B1JK>$(=W]@[W'T4
M_QYQW ;R<+M6,QOI?$.K$J_ 4-]>IT:BSM4N-[^))I +HGXA1B4-@O(WVFB[
M(M?IR _NW,YHO/"-P2/V]C=\AR<27ARU$06(>H5<UL[<5]Y-M#-X=2?J\6Q(
MH^2DGB]4*B;S=2 M.I"VC7LQE^$OSE"50M<;?-M^^( %F-.K]OM /8++)BL&
MX(-;X\U:1:OS\CE+-ZJ1U'8-^?0)RA *%]'-AU':E\2JZGD=S%)I6\F'0T[(
M%(4T"3$I_6Z",B#!I*T%\-\)J:M<S5J#9EK=0-H1?;X#[4_\"3<B.M>CY6,Y
M+ H%1!N=&V?HY^:6^L:M53*5&+L@O02PHC%$F6?MV-27G:,Y[I3V,E^A)<Z!
MUF ?8OEP4[#R/?_]ROYE9AYOP9! Q[/@8)_=3<>7OYV.]8HKSQH,C564NL#)
MK;0MPSX4?STYB2SBK%M* -H1$Y%8#H>Q1@C?_1Q9T !Y5.;%$-=K'QDJA'4@
MS2@MF@280/\MF]>YL@)=4!!1D_;8^G19W@M,DP5$X7I)RD9NN]TQ8R_P6/YJ
M1ZGP,.+'L>+#36KX\GD[X+>MKA_)'X""V0)&,2=,Z=W\^C((3\W22=1#@EK_
M;??(Q/X)S=WM-T]^!$B*C:IMNT<<)N =KAP<P"Y,@KZ$5]_A3:JS5A3';V#D
M+M"UH)#EG[5#@H(;9_.^">$^]ZXYJL9<W]M(WO,Q(?N0U9\K'2Q??<P03JY!
M>&M1LM"MKY/<I?,-(#I9:IF%1;0A/E,)@M@\8MV )SY=M?>I)(V\K<,*34UN
MF#Y/V -TS[&- QB!G$NB6/E>D\9T[7G79YFRS'I.'E6""E]J'%QYP1(QM\:2
M%!:A_4_OD\Y6^AO?*&3R&NW-/A+G>M]222A9FJ-$]:@WYT-$)EOGO-K$#1"E
M$S_F&?"DM'M_CDEH9/<S2=GR'I17ZIXRG7JI)^+Z#\"S(-]14M<>NNG .4Y]
M/ASZ4KLN=#)O5:" E"4M,R"LNZ2:/%6'MF+[O8[^; 9+U.SX7L@^F'U8KO0/
MX+9E9()<6,=M" &-$7;V'<@/@0$\VF"@ZS5<$ S@R:D+;#3]NJ)0VP-^SX26
MEH/JCG7M)L2,::I(P+O['4(<X_>IH/-^(-(^3I*YK0\!K<H-Z!F,=45^4?,@
M3T4Q%"H8$@[3!5E:CZJPC%[C+.3?*NA68 RFM74,C"TO;:>U<!0)CKH($=#1
M4I4BYV1"X11AY_:WKJTZ&7->4G[_:X4DG:<3?A7H!'3YE,^X3.T^K-_W>U=;
M+!$>]>'!5@'GE-3K70MM.@,Q3?Y\*$J,=/DXJZ&.?I^W.XBDK]S_WK\%(;[^
M>W3B'P%"Y7WM&[6$7QO%-UDUW_[M%H_H2LU.8/^3D8J> !:2(>[D V/6;LP*
M)[O0#>WET['/XKB*KG&D]$@4DZ=@2([OG;D--':#_)#7?PVK<+/19=NB("KT
M>.5SFA3,>-)+>/V! >U$=&ME+EI>^%9=>9V:6P;+>SH)CP&L\M8R4Z2\ ED_
M0I=^^T:L:6BY;<$=&C)[V5,8)R*5C#Q@\3E9;#Z01_OI 1G"UJ>DFZ:(_%C!
ML_X_IWTM+PS318\.7A</PFW9 EUB(E<A7*7D:6_JY\D1.1\PHR9ZY'SY'H;:
MM='#7Q)?K&/)%' DFT#&[L9#QC[\EM(1+BTK:C0AFDA7D$!%S[&JR7!*[TYE
MZ0%W:J4S/NA-$YN,_'[_23=.(<T*7':WH_$#I6 GC,MK%80'K#<)]RR"Q$<;
M.N(NFI^S;[R/&8Y,9W">/K;LQV=/U,GFNMV1S>$8WT.S9+<<'(4-9QP'?'=^
M7W^IVCA%:6*UH$"0?!#Z%-8D<PB[A+]/QM3&$]KO>U'?QC<+>+/+WI9@?3>F
MHKTDA=-_*;[DV,,.;N/^I8#[O@'!:2UAHH2K2\+&R_K!3_W]Z)4&-<A&".8$
M3H8GUD!L="DAIH$$4T263<I6L-W[.2YRI\:H$E<:]>1ZSAK")LY.VD0.C'C]
M/.,>JK&N(@R%-DMOJ0K) GM-'#J2V%- [*-R#:N^KU*D9O=,$?%X#0D>%KZ5
M,G3/;AEZV\/BLT8%Z D5[!\>F^@/'3N'>B(K9#,S<@VXS#O/97E(!S*5C^I9
M+"<B<$ F?#G?2>R#P;WAV-OZNZ\.G3CA!="\6 PD[41M.=A9]_E&Y<2Y'2P:
M-U*>:;N?Z*%ZK-Y2/,O]=<$/?TL>?#*JP7C[*)9?>,S?<(?!9B/C($EW'BF"
M'2''RK:QQ*Y">;O)L&*%&WOS:$U\:A/SNU]Y:7TLH!</!GK.4YK2O8#84'/&
M;VWW;Q<O/-9?S$@;X1:(9-Q> !N(WY<2W5\8"!L';U KHQQ\^N<"BL\\(U)T
M:+^$4%3%1XP<0[Y_H<AI[GT'X/_&4:PRUT H57%-;#*R.!4;WF-)CM#8)M;X
M?@6//;[K&Y&:AS#S\#3(2$WE: O&3N.J$3)8&3::KCXN#CRW'0V1X*\L@Q&A
MG;@YL/.,A/K>,7%#C; 8 6[=-WE%:=6GH^I7EI7G#SIQL>IJ,^.Q?FVN[R^L
M52[_XD1(Y_9UWH]O+?=O0T,D&_8&T7U.0E3^R5]9J/SVD+@.FK4M67MA),+%
M\WQKIX+'_R"!DQ&*<PGL 74B")H*ZU$!3*=FCLI?7?("JB>(:"O8#3GLH8[)
M56X</A"0OTW9?]^GDB\])&Q>;FB\8.7QM^9JJ<OM",E;XK2S3AN1,B3MK JW
M<^H-%)>@!06I72,EI0D,,I_(8$K@E]SCU['/.#2Y&/5TAH'\]C*D)/G&;U+1
MIV"SFP!)L*%R8 5M7=DD<6RF!:T&7!2MCG@>T&<&[[0<>J*3I+;-/),3+\3T
MJ(NX:\S^[#<_QX836?=M!>Z$H]DJ1'_Y?<=[#-(FK97&M]B&3B" 01?>(- U
M71 K?:T!31)VCME6]B/$\251[?\K$-1_GCD#;U5_,F 3ZE^%K) I\8A_B5>Q
MG?$<L!:!R(.BL,9K=TF,V6D8WEDZP:QXY)6K%PFN?<1_1E:[[YJ<;+/R[TD>
M&W3$#V>1'/[<"W>(E]-@"4; D_L@.(M :N.^;FJYINTAZY_J)OXYV<C4#-]F
M;4XWN::/O@.MK#_ICZ8W_&1YQZ];!G/G#F^ /=C>*2V5[$3RGMIW)[K:Q"HJ
M2DS]9D-=+IQ$W->6-U=LF0ER'ZQXMI<,N'A"0[*Y>II6J6FPYZNKE#<Q'$07
M=L4?OCMUY,3,91"Q?IZ[R,PPOV(-EV*MDD&%!P_[[5W9+]:)1[^]Q_R)_65Y
M:45<)DY'RRF2M.FUL^^+H5X2%FT-7U<JPN^5@ 2MN3+_I=\AV=,XUW*.R<=C
MM$R6ES9I6"4@!:3GI^TYZVC$E&T$28%/U/".Q'!E@#B_<ZNL5JN&):<CG9BS
MNI1@_@$CP9?/7\R#9+@4W;5J=.QV5"62[, E.7STM2-W/W_5!_:%A..&J%ZV
M/H^(K+8@NJ/_XK9[!@RT'4#XT>@B5(75O_H8"0$V8T!,Y-9*D-X80D##3ZHI
M_>[+K0::4BIHU.L<"_)8(;@&.,C/6AGK(YKH+ZS<=V*AK%$]UJ2%'YWL#Q J
M+R@IM3]DV]/D9[/&RW124;,"P.&Z(O3[P@Z3B(ID@^"VFV#X\LP3=R<X$PW%
M7)//]R'.GSFZ.'0U/Q,IY59=;5)=>"S5\_NW>(V5GCS-NX]=K4\*?YTCEO%?
M&39]?^FO"!_[A'\GH =&;-5G<=P7\"(5>\,2V<>1]X\.2(XNI/\X5%%O[]FH
MJ.O^4@E$X]W3:NOGU^)>KT7\ &A0+&226^['"#G@F=8GWIA$/ER=:+S\ (Q^
MXE\KI;^.!C$2]%_[%=$04[>:9=E6[8<T@ WG73)W3:Q[1W7G&?H0'J\D&NW'
MF0E@?P#FT-1MTG!9 ;;<KTYW@AN(6JH"<G@L7>(.*9=.IHR9&3 7(=_!&8W(
M9OJTW[7#2K9HV?L<^2N/=*[MSIT"5YC_KY)BJZJ]I7<%*26NO1:N'NN,9ZS=
M:57W\-#S68B:\?%F"R,!\VM%3Z)M"Y'O9I_=??3I+SB<P%*-!M(@4U#):!*E
MR!JCLH"HM:IS=U'0T9>+V"6OY*Y7"O'V5(N$[^?Q<CT'^UTVC0N;!7!A@<I(
M:9VGUTA#C('6!(<+1:!.:: M")XC?QPW/V1SK_':'?)EBN?U^.0F8X]<]RJI
MT%(7(#O/Q1?H"^16-S7=+7NHJC)G.*TNSLS"*D$5,GN,81!_(0V,]$%\[_0G
MS$NN^.SN4.)>4=C82PD%HVH+R!Q_+ER'+Q?O]XT0A@XDE)KN7+ME:$AL9:I)
M7*1@^Z7DXQ<Q4,@J$+_6M]7ZI/7 C#@V@XR""HXRH-]03QI;W\$[RO6W>_9]
M=RM]C]&$'O+$93*Q+$.Z9V<MUP@$G=?V5I-8FN$QCB=W_.U^$!?F?5+5\\YS
MK!7C:579._E41XO*'B*4S$OI%5J'<+I=0LO9O7(J6&AX^%X<372097#9M,0#
MDZ-ZWAR-:P!9_3H8#T9+&P>W0UJ?QR?"+.X9W"5;#KRU'FF%),"2!LI'FCF-
M*]@+BT_.YW+A$D2Y%22Z14&OZD27FJ.2 DG0H>VOA^_XJ7P(, Z@;2SX,A/Q
M@*;Q <_&':JAV2X(^'#5H0CJNZ:K_>/[O.VG_>+X] JU!BQ/#]?L)IIJL^DO
M1&'\X1X35XA)]DY0(>+:836VA(9ZNM(04S X+'L)$:*@L* N/IA.[TMIF0KO
MDK*O A0)]/)JH]TS\ND*E;X$&Y[;R1/_J[;K#FMZR=I!$%"J]!(Z"$J1%@@$
M4$0ITJ2)-(%+#3V$:NA(4T"*@ +2NS2!0"""(-(E]!9(Z 20C@(*PJ>[>U>_
MW?OMLWN?_?Z9?\Z<=\YYSSDSS\QODBD6 I=CL_7EES65?6H!;9KX?E.V ]#6
M5GLK()Y<$$HV %Z]N5PPCHTOFV8T$RGWTI>1E5%MNZO2%\I-NHE;KO612$;C
M'H3=X"/QN,<VCLRM  #$ 1RT_FOC3077^;0O-2[G(P2<S>*.8#XS1R'05C)@
MO(8^J*GH"_  5>(RK+7>9*]Y)2E+E3S3G/3"JL*)8&+GG49K\; 8O7(DI:GI
MQ0-HCVU5:N'NX\MJ/ +Y1;KK7"*9\>!UY)A3G+8HAM75I_D33[+"^Z\:Z5_0
MS3-D8*K"2;=!-8,5QC/ A9#P 4S5Z%8D-")!4@@ ?[F!I(;'S*:"GI.DIM;1
M@2&AP&M/(]GRBCBW]Z[5@L?4:%.J-2^O),W,H_VZQ7@PK0#@7,2JWRW&BQ8J
MP4'YZ=.BR$@)A?YXG85[X2PS]Q?. '!BJ@$YR!&0%O7B%5)4(_8):[[S+"O<
M/LRA"=Q0)T<@!AZ%./9%$D>_:[&RN?"(H009MY8J]/&5")V*R-/$E]W.,Z;*
M]H,;Q UA)\E=X7)MYL^^#GRO%(V-^OMXIT?62<\%+S56\4DNA2)C,10ZP U;
M/W_CO4%EDG/D;>3CD76D(8#5<Q<#'U2@A]F,E?J$7XB29^D!Z=YT77$^$736
M_4@*D%/BU0$LN[QUNHA>LB_#\^7Y7])DAO%94O1E8Q;$-T@;!(NC;0BH>5K_
MF:9LXU'C6U=$]3IH:> 9 B($@0HQB32;,+";&K4O=^*[CT6CV/1YJDD*GMR#
MAQI+Q?#T0\4]RF@L$8M@[,E<['G_=];GZ><+=U0HJ.+5[JR1/L":QE4^ >,'
MS=H$\\V5.8.5TIR^F>ARR'R3GZ+<!KQU*;\4&N*[HRXFR >8(\X66 5K<1?)
MWL-?YS8>EQ\2+H,NA.Z\ZS6!7_';I>3T)%>4/W=A_48?4B8W=8CR4ZK/L4IQ
M2HV:B&<D,JYS!I:DH\8/\/"HO*_%G3?TT6RI*3)]5N\W+]AH#_"F\>O=37\W
MPLZV'ZC"O_NS>ZGP0IK)[$>HI8$N].D4]@%BGF$+X&[C 7![8 HD<#124T$"
M=A$2$L,R:A*%&YB)2WWP";(>NW)G-K;.R-!!HD><@9SH40,%<NGMAXJ%U;V
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MUJYQ>M&NL4M(\N]S5-BODU+)+[/5CPZ_G$JD?/GEP(3[K=##[-//#:>8LC/
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M_$/X;XSZ)X3LH 0NXLK@,X#5MWEM@,1(O[ZW/7+X,YO^(J-286T?7RY/N5W
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M *"D!'@)   P 6@H0H!'#S4<  !%/M@*@/901WEX:Z6F_?D$D , CT9W*0#
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M_4$+TP_V3*NI>!:C+"#\BCA\(7R\1*JP<JW+B;<*/(R[O._LC/>Z5I8.XQ$
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MM\<A[$37$&$_0!.&(U[FN?*'@!]L4MN!#JH![_Z"D"R#,.Z";NLA9*MXBL7
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M@2:H2OB*,-PO25[6W6DN5/'G6T@EO'7TK>ICVY?K;3;G6&=3"6TVJ#DEKRN
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MKVH:F4SO4B>PL]&DX+DQ2\1J?IL NY0.L^PSH^](6\X+J,W=+I+5/O]LS_B
MH$O3DJDS"A$U'7+(PFN>ZF]AT6YP2R_/Q27NGX.;^M&8EXOO1_ ])0MBL]'^
MJX195UI/IZ&ZR)0PL846RSV?@$NG=K9D=5XWT8XQ(0^D>1M-%\3CA%.=Z^?
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MK"^S/K65;"H8O;E9BLCB5!#W3+E8'"2&'YD^W(8V.H]8!NRU)#<SD@#"0"<
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MFZH7(:&P!IPG6@EQ[WL(!7IDWGL> O%%:R4LF(S8MWNZ'2\A&D97DN7WP</
MX!_&61:/K+."_PI!"!>DPBY)]^3U:ALO4_C-"P"8]<?_6LX=Q:6DUCE!'5)P
MUJAJH7\#V-*3*?-F70BC<+H .FQ[/&6ATK#F39]/_XTD]X0<QA?/'FU.6GVB
MU\O24[_9<G!_9(3STVV^#O8R59ZJUX:"N"S,L[M/G$BS!I*N$KFV&._;7C<Y
M$FLEBLX'>9*@,Y3)FHLMQR/<@M$OJ$?<AY7WWA1_I(48!S>M_>WH*@I;(:\Z
MO8D34)7ZON#0O^BFIO&["C;(*%7(RL+N^^MT8?:%]]L55IEVM9]66+*!OKS'
M)EUBF/Y297Z'O&_$366RD\COE<_$,3J[:0=7N#%+Z59CQ1&[F/Q'H2NC9J.R
MW>LL>QV8R>MXSU9[+5)7J03D@^T-#SP'#P^1U)-GG9_T0L!?B#0"\MIK^9UA
MQMT2[[Q*O"[<3:*?,,ZRRPCII!?G: $@TD4W:+4\YVVO^4.9)56M:P]%?**5
MAN.9VEOZ*WEI*48] (-<#>9_N]!N6J,WV-K6L>B/ED>QJN9<S'M/DK+RK$>3
M1)B;4_)NP&9)@B*+W#IE@C8KFL/89DS37:RD]?X9D"5L_>77*JP T@RY*CZQ
M<_<OWLR@C.&&!@Q/9_*I,RV)3]<FDB4(LD3N:Z_[X9-R*.N'_MD2*]YZJ$;>
M$SIIMB6EL>Q9U%N?(<0@ZQ6WT-5;O9>7COBW.K[E<'7>(^DW#(G2O#15+")\
MI1/S6- ?P&&\7<U'YQ3%0Y&HCC'4DDC'-TKAG[1=;A)<5DNC/P3L_P)E4\$C
MR7#LN3-UC*AY?\QJ52H.JT(K3DF+0R7/RG!)(^?,WH0+&Q4>2.[BO,6@KN\L
M?VAIA7U0AD7WQM,)>P71WDO_B_FA$(TG0:E2BV"?QN(VZE13&U,;Q)Q6H[^-
M(;AP?XZ12E>>&)YZHI0Y\V^W/4N%81/GIQCSY0S=O;8 )QI?K7":P0'2)RUV
M'_U8_GZ@OV2P*%]&KDEC;WB4-]M#E#.6.GBO2;4XVAM#LLGQDPBN72@LM,#Y
M_&@ 7.V)+X!CA^&J'$RJ.>K9OT;@NH !O:%4V%#0QD.HXI,[P1UB7TRGA'44
MT\0?^;4^5+=Y++.ZBNPB92$03@)8KVX??-5S3AH*-=:TU.2O?$ 7?/C0< W2
MUPRC/LFA=L@+\D"WN \J%*Y^8S70T]F9.FL:X4@?"I7^;31$%^K;A"6 ;I$>
MZ9'&H\M_RW\9W=%!>\:[T),K&4K@+Y,YVD&D29J@#5C>K_\>YK\\IZ(>4W)N
M+7A44_&>VWP+<VC@'^ 9X$0W8&Z:EO>8=7U<J-'[ /TH-NU ;#@\2FR_YN&V
M1:S')34 $N0_^%.9^^]<ABA[[J3(/7D3^-#L]G3VJK_GS^$61Y9C8*@?_9OE
M"1AZ$E^()BFS9)H=DHD>X19Q!+@JMM%[J+ .?FO>_,KP@8PA)^J>AIS7&9O/
MN[B"9*>2"%/-&G#(NJTK#+\>W\17M.&@5-ZUO:_6&;>B>//;WJQF\)&T+<R"
M!6#5UDS*&9G_PNM5,T/BTZ%0C4?([1"3K@NY!;M0@G\T(4$\)+?" Z\VDQ1P
ML+K,*D#5:O:*>?F>L?JK(CDU,^1P!FQ1(D_#^D!+=Y)RQ2HB2  KI/@WBV1E
M565?KF]G_QQ>.L*/67$>L@L.@JWDL\R]/-NX.==GN:2BTS66>6(,&M;VYZ1K
MAS]2R]Y?;\*3YA"30^X-_<4=8?G=$R>MN&(I)V'UJR=766WF5+T.J.(5"4<G
M3#<A$I63@R[Q'EZ+0FG/V6?.K-2;.[R9@20X^NK*0H <I_G/G @$CR<_T_)?
M9-XMG(16,#[^)K/ X3\W;KJNF89E(RTB(W92=)\IQ8%;7[^R0ZTLP,O%91=6
MLQE)N1W9UQ'5NK/T1+?#E)W_P=J*3RB$@&HU19T.WTS!>Y 2=4K+_8^280J+
MQUUGZ_G)>:_%<3OWI^YV./RRWLZ?OOR:X_R][+\6"23_#R>DAQ/&@3OR8]M4
M59,.+338+"[*$@W4Z*A8&*TZ?[P _:N\UAV!#HF/_7[:Y?=:EIW_"7ZD"6C
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MB;69["<>^]DFD0@!DNZT>&\NT*++G_P!!"J?&[W6G!0;5:+GAGEB5S>[J"]
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M?I'P,&)97IL@W_Z')YN%3PWC18BI;:[#TC1]0_[*FQ.#V'9DDCK[3R:=;W#
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MFIR<&DI'0P?]KW'9 T"H &_ "T3" Y!"2$ 0DLM^@!, KI+]&_?_04%)3@6
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MLMX$LW.PL7 PL;"R_!="!KJN(:>@IJ"@9J&CI6/Y7^NJ&\!X ^ !< >1"0"
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M4%7<+&5^C-;XV1#/X/4EON;75C])+/1]CBN(ND5_Q1[P#EJ+&:LWHN8?=2=
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MBT+O47V96S-U:>!O%D."HS.:AYYU'<IQN7H32:U[G_W8[_0[((UH4+VCASY
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M>.LO-)"9;(23H\3N -^9I)L]G[^7'4ZWQ'EA-#,37BHS"U%T)K@3P]T;+[W
MG86&#,HN5PF2-:WFCP$U"_V&\>FJ R*Z4RB@H"ZMZ,H3SG68CR)EKHJK_K(N
MW<6PL_'N&-B Y?5XO!" ?C^_TAA;MESV!/TW[D-VA0^^T3U8AN]G3'MP&T
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M.QH/PSVEO"*"DZE<C\;=0?Z:9U?X5E5JMJK\K:1W4M.-ZOT0/W >\9939.2
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MA"A )RFF!HUO#.6^%>*&:J&30M!1,%P(V?X"))'2NIU@Q$)0AUT]HTF/B4"
MW!##ZH2REL6KC@J<*ZE1@II1.@SIJ0@,UN([S]YJ!XO!CC3 0\GO%Y+&WO7,
MP%S?Q2Z^9C:.9)\UXX5TI\3M+9=5*K,P6HS\ILM1=TT,=]WE5YY\O;X=,6MQ
M2N3J\58ZP3"9VO/C\>LSW<@[R4>PMR3GF*('0,TY$'K5W@#<*^P08@,SS]F
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M&  1              "  0    !C9&YA+3(P,C0P-#(Y+FAT;5!+ 0(4 Q0
M   ( %V"G5BRP \$$@,   @,   1              "  9IB @!C9&YA+3(P
M,C0P-#(Y+GAS9%!+ 0(4 Q0    ( %V"G5@N E;24@,  (8/   5
M      "  =ME @!C9&YA+3(P,C0P-#(Y7V1E9BYX;6Q02P$"% ,4    " !=
M@IU83Y=AN;P1  #8$0  %               @ %@:0( 8V1N82TR,#(T,#0R
M.5]G,2YJ<&=02P$"% ,4    " !=@IU8Y?SJ,AL/  !##P  %0
M    @ %.>P( 8V1N82TR,#(T,#0R.5]G,3 N:G!G4$L! A0#%     @ 78*=
M6,$.FI7C+@  0#@  !4              ( !G(H" &-D;F$M,C R-# T,CE?
M9S$Q+FIP9U!+ 0(4 Q0    ( %V"G5@5'#+%]#X  -%'   5
M  "  ;*Y @!C9&YA+3(P,C0P-#(Y7V<Q,BYJ<&=02P$"% ,4    " !=@IU8
M;:I%QS4I  "%,@  %0              @ '9^ ( 8V1N82TR,#(T,#0R.5]G
M,3,N:G!G4$L! A0#%     @ 78*=6$GR34\4.P  %$0  !4
M ( !02(# &-D;F$M,C R-# T,CE?9S$T+FIP9U!+ 0(4 Q0    ( %V"G5@=
MZ\X.O24  'DO   5              "  8A= P!C9&YA+3(P,C0P-#(Y7V<Q
M-2YJ<&=02P$"% ,4    " !=@IU8LS5.D<LU  #Q/@  %0
M@ %X@P, 8V1N82TR,#(T,#0R.5]G,38N:G!G4$L! A0#%     @ 78*=6)*9
M-\>EC@  7_@  !4              ( !=KD# &-D;F$M,C R-# T,CE?9S$W
M+FIP9U!+ 0(4 Q0    ( %V"G5B;C.^DU78! -43 @ 5              "
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M &-D;F$M,C R-# T,CE?9S,N:G!G4$L! A0#%     @ 78*=6#=V%/$G$@
M11(  !0              ( !L,H) &-D;F$M,C R-# T,CE?9S0N:G!G4$L!
M A0#%     @ 78*=6,;1)-IV$P  F!,  !0              ( !"=T) &-D
M;F$M,C R-# T,CE?9S4N:G!G4$L! A0#%     @ 78*=6']9B-F$#@  H0X
M !0              ( !L? ) &-D;F$M,C R-# T,CE?9S8N:G!G4$L! A0#
M%     @ 78*=6#CR*,<I#0  40T  !0              ( !9_\) &-D;F$M
M,C R-# T,CE?9S<N:G!G4$L! A0#%     @ 78*=6! ;[OTO$   51   !0
M             ( !P@P* &-D;F$M,C R-# T,CE?9S@N:G!G4$L! A0#%
M  @ 78*=6- YXU18$   =A   !0              ( !(QT* &-D;F$M,C R
M-# T,CE?9SDN:G!G4$L! A0#%     @ 78*=6!#1B,@' P  9!   !4
M         ( !K2T* &-D;F$M,C R-# T,CE?;&%B+GAM;%!+ 0(4 Q0    (
M %V"G5C,[^U.C@(  ) *   5              "  ><P"@!C9&YA+3(P,C0P
A-#(Y7W!R92YX;6Q02P4&     !L &P  !P  J#,*

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>cdna-20240429_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cdna="http://caredxinc.com/20240429"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cdna-20240429.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrMaagMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cdna:TotalEquityCompensationActuallyPaidAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:Mr.JohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cdna:TotalEquityCompensationActuallyPaidAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cdna:DrSeetoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cdna:TotalEquityCompensationActuallyPaidAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-2">0001217234</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-3">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-4">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="c-1" id="f-1">CareDx, Inc.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="c-1" id="f-5">&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Value of Initial&lt;br/&gt;Fixed&lt;br/&gt;$100&lt;br/&gt;Investment Based&lt;br/&gt;On:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Fiscal&lt;br/&gt;Year (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Summary&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Table&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;SCT&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;&#x201d;)&#160;for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Mr.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Johnson&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(PEO&#160;1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;CAP to&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Mr. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Johnson&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(PEO&#160;1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;SCT&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;&#160;for Dr.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Seeto (PEO&#160;2)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;CAP to&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Dr. Seeto&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(PEO&#160;2)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(e)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;SCT for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Dr. Maag&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(PEO&#160;3) (f)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;CAP to&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Dr. Maag&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(PEO&#160;3)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(g)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;SCT&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;for Non-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;PEO NEOs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(h)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;CAP&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;to Non-PEO&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;NEOs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;TSR&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(j)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Peer&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Group&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;TSR&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(k)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Income&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(in&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;thousands)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(l)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(in&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;thousands)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(m)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$3,097,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,923,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$10,551,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;6,665,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$4,617,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$4,412,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$55.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$118.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;($190,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$280,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$12,786,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;($648,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$3,784,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$118,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$52.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$113.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;($76,613)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$321,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$7,090,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;($50,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$2,605,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$140,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$210.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$126.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;($30,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$296,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$5,618,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$17,196,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$6,400,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$32,731,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,979,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$7,956,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$335.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$126.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;($18,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$192,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-2" decimals="0" id="f-6" unitRef="usd">3097438</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-2" decimals="0" id="f-7" unitRef="usd">1923573</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c-3" decimals="0" id="f-8" unitRef="usd">10551753</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-3" decimals="0" id="f-9" unitRef="usd">6665898</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-10" unitRef="usd">4617844</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-11" unitRef="usd">4412835</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-12" unitRef="usd">55.63</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-13" unitRef="usd">118.87</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-14" unitRef="usd">-190284000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-1" decimals="-3" id="f-15" unitRef="usd">280324000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-4" decimals="0" id="f-16" unitRef="usd">12786270</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-4" decimals="0" id="f-17" unitRef="usd">-648097</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-5" decimals="0" id="f-18" unitRef="usd">3784612</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-5" decimals="0" id="f-19" unitRef="usd">118224</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-5" decimals="2" id="f-20" unitRef="usd">52.90</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-5" decimals="2" id="f-21" unitRef="usd">113.65</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-22" unitRef="usd">-76613000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-5" decimals="-3" id="f-23" unitRef="usd">321793000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-6" decimals="0" id="f-24" unitRef="usd">7090121</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-6" decimals="0" id="f-25" unitRef="usd">-50411</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-7" decimals="0" id="f-26" unitRef="usd">2605699</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-7" decimals="0" id="f-27" unitRef="usd">140603</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-7" decimals="2" id="f-28" unitRef="usd">210.85</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-7" decimals="2" id="f-29" unitRef="usd">126.45</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-30" unitRef="usd">-30662000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-7" decimals="-3" id="f-31" unitRef="usd">296397000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-8" decimals="0" id="f-32" unitRef="usd">5618698</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-8" decimals="0" id="f-33" unitRef="usd">17196016</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c-9" decimals="0" id="f-34" unitRef="usd">6400015</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-9" decimals="0" id="f-35" unitRef="usd">32731502</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-10" decimals="0" id="f-36" unitRef="usd">1979508</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-10" decimals="0" id="f-37" unitRef="usd">7956557</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-10" decimals="2" id="f-38" unitRef="usd">335.88</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-10" decimals="2" id="f-39" unitRef="usd">126.42</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-10" decimals="-3" id="f-40" unitRef="usd">-18714000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-10" decimals="-3" id="f-41" unitRef="usd">192194000</ecd:CoSelectedMeasureAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="c-1" id="f-42">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dollar amounts reported in columns (b), (d), and (f) are the amounts of total compensation reported for Mr. Johnson (our Principal Executive Officer since November 1, 2023), Dr. Seeto (Chief Executive Officer and Principal Executive Officer from November 1, 2020 to November 1, 2023) and Dr. Maag (Chief Executive Officer until November 1, 2020) for each corresponding year in the &#x201c;Total&#x201d; column of the Summary Compensation Table. Refer to the &#x201c;Summary Compensation Table&#x201d; on page &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i60d05261c6404879b68233510f10856b_181" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;64&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; for additional information. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dollar amounts reported in column (h) are the average amounts of total compensation reported for the Non-PEO NEOs for each corresponding year in the &#x201c;Total&#x201d; column of the Summary Compensation Table. Refer to our &#x201c;Summary Compensation Table&#x201d; on page &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i60d05261c6404879b68233510f10856b_181" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;64&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; for additional information. For each of fiscal years in the table, the Non-PEO NEOs were&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.172%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.144%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#aeaaaa;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#aeaaaa;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#aeaaaa;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#aeaaaa;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Abhishek Jain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Abhishek Jain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ankur Dhingra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Michael Bell&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Abraham Ronai&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alex Johnson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alex Johnson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sasha King&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Abraham Ronai&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sasha King&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marcel Konrad&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ankur Dhingra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peter Maag, Ph. D.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sasha King&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marcel Konrad&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="c-11" id="f-43">Mr. Johnson</ecd:PeoName>
    <ecd:PeoName contextRef="c-12" id="f-44">Dr. Seeto</ecd:PeoName>
    <ecd:PeoName contextRef="c-13" id="f-45">Dr. Seeto</ecd:PeoName>
    <ecd:PeoName contextRef="c-5" id="f-46">Dr. Seeto</ecd:PeoName>
    <ecd:PeoName contextRef="c-7" id="f-47">Dr. Seeto</ecd:PeoName>
    <ecd:PeoName contextRef="c-14" id="f-48">Dr. Maag</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="c-1" id="f-50">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dollar amounts reported in columns (c), (e), (g), and (i) represent the amount of the CAP, as computed in accordance with SEC rules. The CAP does not necessarily represent cash and/or equity value transferred to the applicable NEO without restriction, but rather is a value calculated under applicable SEC rules. These amounts reflect the total amount of compensation for our NEOs reported in the Summary Compensation Table with certain adjustments as described in the table below for the most recent fiscal year. We do not have a defined benefit plan so no adjustment for pension benefits is included. The valuation assumptions and processes used to recalculate fair values did not materially differ from those disclosed at the time of grant.&lt;/span&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.997%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fiscal&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Executives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;SCT&lt;br/&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Grant Date&lt;br/&gt;Value of New&lt;br/&gt;Awards&lt;br/&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year End&lt;br/&gt;Value of&lt;br/&gt;New Awards&lt;br/&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Change in&lt;br/&gt;Value of&lt;br/&gt;Outstanding&lt;br/&gt;Awards&lt;br/&gt;Granted in&lt;br/&gt;Prior Fiscal &lt;br/&gt;Year&lt;br/&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Change in&lt;br/&gt;Value of&lt;br/&gt;Vested&lt;br/&gt;Awards&lt;br/&gt;Granted in&lt;br/&gt;Prior&lt;br/&gt;Fiscal&lt;br/&gt;Years&lt;br/&gt;(iii)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;of Vested&lt;br/&gt;Awards&lt;br/&gt;Granted&lt;br/&gt;and&lt;br/&gt;Vested in&lt;br/&gt;Current&lt;br/&gt;Fiscal&lt;br/&gt;Year&lt;br/&gt;(iv)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value at&lt;br/&gt;Start of&lt;br/&gt;Fiscal&lt;br/&gt;Year of&lt;br/&gt;Awards&lt;br/&gt;that&lt;br/&gt;Failed to&lt;br/&gt;Meet&lt;br/&gt;Vesting&lt;br/&gt;Conditions&lt;br/&gt;(v)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Value of&lt;br/&gt;Dividends&lt;br/&gt;Paid on&lt;br/&gt;Equity&lt;br/&gt;Awards&lt;br/&gt;not&lt;br/&gt;Reflected&lt;br/&gt;in Fair&lt;br/&gt;Value (vi)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Equity&lt;br/&gt;CAP&lt;br/&gt;(c)=(i)+(ii)+&lt;br/&gt;(iii)+(iv)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;CAP&lt;br/&gt;(d)=(a)-&lt;br/&gt;(b)+(c)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;PEO&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$3,097,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$2,406,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,347,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;($55,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;($59,986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,232,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,923,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;PEO 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$10,551,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$8,536,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$4,779,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;($136,652)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$7,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$4,650,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$6,665,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-PEO&lt;br/&gt;NEO Avg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$4,617,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$3,641,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$3,507,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;($12,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;($59,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$3,436,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$4,412,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="c-1" id="f-49">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dollar amounts reported in columns (c), (e), (g), and (i) represent the amount of the CAP, as computed in accordance with SEC rules. The CAP does not necessarily represent cash and/or equity value transferred to the applicable NEO without restriction, but rather is a value calculated under applicable SEC rules. These amounts reflect the total amount of compensation for our NEOs reported in the Summary Compensation Table with certain adjustments as described in the table below for the most recent fiscal year. We do not have a defined benefit plan so no adjustment for pension benefits is included. The valuation assumptions and processes used to recalculate fair values did not materially differ from those disclosed at the time of grant.&lt;/span&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.997%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fiscal&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Executives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;SCT&lt;br/&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Grant Date&lt;br/&gt;Value of New&lt;br/&gt;Awards&lt;br/&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year End&lt;br/&gt;Value of&lt;br/&gt;New Awards&lt;br/&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Change in&lt;br/&gt;Value of&lt;br/&gt;Outstanding&lt;br/&gt;Awards&lt;br/&gt;Granted in&lt;br/&gt;Prior Fiscal &lt;br/&gt;Year&lt;br/&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Change in&lt;br/&gt;Value of&lt;br/&gt;Vested&lt;br/&gt;Awards&lt;br/&gt;Granted in&lt;br/&gt;Prior&lt;br/&gt;Fiscal&lt;br/&gt;Years&lt;br/&gt;(iii)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;of Vested&lt;br/&gt;Awards&lt;br/&gt;Granted&lt;br/&gt;and&lt;br/&gt;Vested in&lt;br/&gt;Current&lt;br/&gt;Fiscal&lt;br/&gt;Year&lt;br/&gt;(iv)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value at&lt;br/&gt;Start of&lt;br/&gt;Fiscal&lt;br/&gt;Year of&lt;br/&gt;Awards&lt;br/&gt;that&lt;br/&gt;Failed to&lt;br/&gt;Meet&lt;br/&gt;Vesting&lt;br/&gt;Conditions&lt;br/&gt;(v)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Value of&lt;br/&gt;Dividends&lt;br/&gt;Paid on&lt;br/&gt;Equity&lt;br/&gt;Awards&lt;br/&gt;not&lt;br/&gt;Reflected&lt;br/&gt;in Fair&lt;br/&gt;Value (vi)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Equity&lt;br/&gt;CAP&lt;br/&gt;(c)=(i)+(ii)+&lt;br/&gt;(iii)+(iv)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;CAP&lt;br/&gt;(d)=(a)-&lt;br/&gt;(b)+(c)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;PEO&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$3,097,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$2,406,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,347,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;($55,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;($59,986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,232,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1,923,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;PEO 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$10,551,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$8,536,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$4,779,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;($136,652)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$7,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$4,650,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$6,665,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-PEO&lt;br/&gt;NEO Avg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$4,617,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$3,641,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$3,507,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;($12,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;($59,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;-&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$3,436,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$4,412,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-15" decimals="0" id="f-51" unitRef="usd">3097438</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-16" decimals="0" id="f-52" unitRef="usd">2406587</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-17" decimals="0" id="f-53" unitRef="usd">1347837</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-18" decimals="0" id="f-54" unitRef="usd">-55129</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-19" decimals="0" id="f-55" unitRef="usd">-59986</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-20" decimals="0" id="f-56" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-21" decimals="0" id="f-57" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-22" decimals="0" id="f-58" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-23" decimals="0" id="f-59" unitRef="usd">1232722</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-15" decimals="0" id="f-60" unitRef="usd">1923573</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c-24" decimals="0" id="f-61" unitRef="usd">10551753</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-25" decimals="0" id="f-62" unitRef="usd">8536615</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-26" decimals="0" id="f-63" unitRef="usd">4779452</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-27" decimals="0" id="f-64" unitRef="usd">-136652</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-28" decimals="0" id="f-65" unitRef="usd">7959</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-29" decimals="0" id="f-66" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-30" decimals="0" id="f-67" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-31" decimals="0" id="f-68" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-32" decimals="0" id="f-69" unitRef="usd">4650760</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-24" decimals="0" id="f-70" unitRef="usd">6665898</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-71" unitRef="usd">4617844</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-33" decimals="0" id="f-72" unitRef="usd">3641387</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-34" decimals="0" id="f-73" unitRef="usd">3507837</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-35" decimals="0" id="f-74" unitRef="usd">-12157</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-36" decimals="0" id="f-75" unitRef="usd">-59302</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-37" decimals="0" id="f-76" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-38" decimals="0" id="f-77" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-39" decimals="0" id="f-78" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-40" decimals="0" id="f-79" unitRef="usd">3436379</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-80" unitRef="usd">4412835</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:Additional402vDisclosureTextBlock contextRef="c-1" id="f-81">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.63pt"&gt;The dollar amounts reported in the Summary Compensation Table for the applicable year.&lt;/span&gt;&lt;div style="padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.18pt"&gt;The grant date fair value of equity awards represents the total of the amounts reported in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns of the Summary Compensation Table for the applicable year.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.18pt"&gt;The CAP does not necessarily represent cash and/or equity value transferred to the applicable NEO without restriction, but rather is a value calculated under applicable SEC rules.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;We determined Revenue to be the most important financial performance measure used to link Company performance to the CAP to our PEOs and Non-PEO NEOs in 2023, consistent with the Total Sales targets used for our short-term incentives (annual bonuses) and long-term incentives (PRSUs). See page &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i60d05261c6404879b68233510f10856b_163" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;53&lt;/a&gt;&lt;/span&gt; of our CD&amp;amp;A for additional information.</ecd:Additional402vDisclosureTextBlock>
    <ecd:EquityValuationAssumptionDifferenceFnTextBlock contextRef="c-1" id="f-82">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.63pt"&gt;The recalculated value of equity awards for each applicable year includes the addition (or subtraction, as applicable) of the following:&lt;/span&gt;&lt;div style="padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.46pt"&gt;the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the applicable year;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt"&gt;the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.02pt"&gt;for awards that vest in the applicable year, the change in the fair value as of the vesting date from the beginning of the applicable year; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.46pt"&gt;for awards that failed to meet vesting conditions in the applicable year, the fair value from the end of prior fiscal year. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(v)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;for awards that failed to meet vesting conditions in the applicable year, the fair value from the end of prior fiscal year;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(vi)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.46pt"&gt;value of dividend not otherwise captured in the calculation of each Fair Value used to calculate CAP&lt;/span&gt;&lt;/div&gt;</ecd:EquityValuationAssumptionDifferenceFnTextBlock>
    <ecd:PeerGroupIssuersFnTextBlock contextRef="c-1" id="f-83">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;TSR is determined based on the value of an initial fixed investment of&#x2009;$100. The TSR peer group consists of the Nasdaq Biotech Index companies. TSR is calculated by dividing (i) the difference between the stock price at the end of each measurement period shown and the beginning of the measurement period by (ii) the stock price at the beginning of the measurement period.&lt;/span&gt;</ecd:PeerGroupIssuersFnTextBlock>
    <ecd:CoSelectedMeasureName contextRef="c-1" id="f-84">Revenue</ecd:CoSelectedMeasureName>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="c-1" id="f-86">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;img alt="5272" src="cdna-20240429_g18.jpg" style="height:432px;margin-bottom:5pt;vertical-align:text-bottom;width:662px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock contextRef="c-1" id="f-85">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;img alt="5272" src="cdna-20240429_g18.jpg" style="height:432px;margin-bottom:5pt;vertical-align:text-bottom;width:662px"/&gt;&lt;/div&gt;</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="c-1" id="f-87">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;img alt="5282" src="cdna-20240429_g19.jpg" style="height:432px;margin-bottom:5pt;vertical-align:text-bottom;width:662px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock contextRef="c-1" id="f-88">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;img alt="5292" src="cdna-20240429_g20.jpg" style="height:432px;margin-bottom:5pt;vertical-align:text-bottom;width:662px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock>
    <ecd:TabularListTableTextBlock contextRef="c-1" id="f-89">&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.769%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:34.507%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:3.1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023 Most Important Performance Measures&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:3.1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The Compensation and Human Capital Committee uses a mix of performance measures throughout our annual and long-term incentive programs to align executive pay with Company performance. As required by SEC rules, the performance measures identified as the most important for all of our NEOs&#x2019; 2023 compensation decisions are&#160;listed in the table to the right. The measures in this table are not ranked.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#aeaaaa;border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Most Important Performance Measures&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#aeaaaa;border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pipeline&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:36pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:TabularListTableTextBlock>
    <ecd:MeasureName contextRef="c-41" id="f-90">Revenue</ecd:MeasureName>
    <ecd:MeasureName contextRef="c-42" id="f-91">Adjusted EBITDA</ecd:MeasureName>
    <ecd:MeasureName contextRef="c-43" id="f-92">Pipeline</ecd:MeasureName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
